Citrus Sinensis ID: 019843
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 335 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.991 | 0.328 | 0.415 | 2e-72 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.931 | 0.304 | 0.423 | 3e-66 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.928 | 0.301 | 0.411 | 9e-61 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.910 | 0.311 | 0.386 | 9e-57 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.871 | 0.248 | 0.364 | 2e-49 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.743 | 0.208 | 0.399 | 3e-46 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.883 | 0.416 | 0.352 | 5e-45 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.743 | 0.206 | 0.391 | 7e-45 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.743 | 0.206 | 0.391 | 7e-45 | |
| Q9FN94 | 868 | Receptor-like protein kin | no | no | 0.832 | 0.321 | 0.336 | 1e-44 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 273 bits (697), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 146/351 (41%), Positives = 211/351 (60%), Gaps = 19/351 (5%)
Query: 1 MIVVILLISRYRKRGKQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVY 60
M V L+ R RK+ K+ N + SY +L AT+GFS +N++G GSFG+VY
Sbjct: 658 MASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVY 717
Query: 61 KARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN-----DDFK 114
KA + + VAVKV ++Q G KSF ECE +K IRHRNL+K+++ CS+ ++F+
Sbjct: 718 KALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFR 777
Query: 115 ALVLEYMPHGSLEKCLYSSNC--------VLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
AL+ E+MP+GSL+ L+ L + +RLNI IDVA+ L+YLH P+ H
Sbjct: 778 ALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAH 837
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK-----SQTQTLATIGYMAPEYGREGR 221
CDLKPSNVLLDD++ AH+SDFG+A+LL D+ S TIGY APEYG G+
Sbjct: 838 CDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQ 897
Query: 222 VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281
S NGDVYSFGI+L+E FT K+PT+++F G TL + + LP +++IVD ++L +
Sbjct: 898 PSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLR 957
Query: 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICTRES 332
+C++ VF + + C ES R+ +V L+ IR+ +R +
Sbjct: 958 VGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFKASRTT 1008
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 252 bits (644), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 142/335 (42%), Positives = 201/335 (60%), Gaps = 23/335 (6%)
Query: 14 RGKQLPNDANMPPVAT-WRRFSYLELFQATDGFSENNLIGRGSFGSVYKARI-QDGMEVA 71
R ND + PV + + + SY EL++ T GFS +NLIG G+FG+V+K + VA
Sbjct: 687 RANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVA 746
Query: 72 VKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN-----DDFKALVLEYMPHGSL 126
+KV +L G KSF ECE + IRHRNL+K+++ CS+ +DF+ALV E+MP+G+L
Sbjct: 747 IKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNL 806
Query: 127 EKCLYSSNC--------VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD 178
+ L+ L +F RLNI IDVA+AL YLH P+ HCD+KPSN+LLD
Sbjct: 807 DMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDK 866
Query: 179 NMVAHLSDFGIAKLLTGEDQSK-----SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGI 233
++ AH+SDFG+A+LL D+ S TIGY APEYG G S GDVYSFGI
Sbjct: 867 DLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGI 926
Query: 234 MLMETFTKKKPTDKIFAGEMTLKYWV-SNLLPISVMEIVDANLL-SREDKHFAAKEQCVS 291
+L+E FT K+PT+K+F +TL + S L ++I D +L +HF E C++
Sbjct: 927 VLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVE-CLT 985
Query: 292 FVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326
VF + + C+ ES RI+ E +++L+ IR+S
Sbjct: 986 LVFRVGVSCSEESPVNRISMAEAISKLVSIRESFF 1020
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 234 bits (596), Expect = 9e-61, Method: Compositional matrix adjust.
Identities = 142/345 (41%), Positives = 194/345 (56%), Gaps = 34/345 (9%)
Query: 1 MIVVILLISRYRKRGKQLPNDANMPPVATWRRF----SYLELFQATDGFSENNLIGRGSF 56
+I+V L +++ K +D N T F SY EL AT FS NLIG G+F
Sbjct: 664 IIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNF 723
Query: 57 GSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN----- 110
G+V+K + + VAVKV +L G KSF ECE K IRHRNL+K+I+ CS+
Sbjct: 724 GNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEG 783
Query: 111 DDFKALVLEYMPHGSLEKCLYSSNC--------VLDIFQRLNIMIDVAAALEYLHFGYSA 162
+DF+ALV E+MP GSL+ L + L ++LNI IDVA+ALEYLH
Sbjct: 784 NDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHD 843
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK-----SQTQTLATIGYMAPEYG 217
PV HCD+KPSN+LLDD++ AH+SDFG+A+LL D+ S TIGY APEYG
Sbjct: 844 PVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYG 903
Query: 218 REGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277
G+ S GDVYSFGI+L+E F+ KKPTD+ FAG+ L + ++L + S
Sbjct: 904 MGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL---------SGCTS 954
Query: 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322
+ A ++ + V + ++C+ E R+ E V L+ IR
Sbjct: 955 SGGSN--AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (562), Expect = 9e-57, Method: Compositional matrix adjust.
Identities = 129/334 (38%), Positives = 192/334 (57%), Gaps = 29/334 (8%)
Query: 16 KQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVF 75
KQ ND P R SY +L AT GF+ ++LIG G FG VYK +++ +VAVKV
Sbjct: 638 KQNQNDPKYP------RISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVL 691
Query: 76 HLQCGGVFK-SFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS-- 132
+ F SF EC+++K RHRNLI+II+TCS F ALVL MP+GSLE+ LY
Sbjct: 692 DPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGE 751
Query: 133 -SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191
S+ LD+ Q +NI DVA + YLH V+HCDLKPSN+LLDD M A ++DFGI++
Sbjct: 752 YSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISR 811
Query: 192 LLTGEDQSKSQTQTLA----------TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK 241
L+ G +++ S +++ ++GY+APEYG R ST+GDVYSFG++L+E +
Sbjct: 812 LVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSG 871
Query: 242 KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSF-------VF 294
++PTD + +L ++ + P S+ I++ LSR K E+C +
Sbjct: 872 RRPTDVLVNEGSSLHEFMKSHYPDSLEGIIE-QALSRW-KPQGKPEKCEKLWREVILEMI 929
Query: 295 NLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328
L + CT + R + ++ + ++++ L C
Sbjct: 930 ELGLVCTQYNPSTRPDMLDVAHEMGRLKEYLFAC 963
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (498), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 110/302 (36%), Positives = 178/302 (58%), Gaps = 10/302 (3%)
Query: 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQ--CGGVFKSFDV 88
+RF EL QATD F+ N+IG S +VYK +++DG +AVKV +L+ K F
Sbjct: 856 KRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYT 915
Query: 89 ECEVMKSIRHRNLIKIIS-TCSNDDFKALVLEYMPHGSLEKCLYSSNCVL-DIFQRLNIM 146
E + + ++HRNL+KI+ + KALVL +M +G+LE ++ S + + +++++
Sbjct: 916 EAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLC 975
Query: 147 IDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206
+ +A+ ++YLH GY P++HCDLKP+N+LLD + VAH+SDFG A++L + + T
Sbjct: 976 VHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTS 1035
Query: 207 A---TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPT--DKIFAGEMTLKYWVSN 261
A TIGY+APE+ +V+T DV+SFGI++ME TK++PT + + +MTL+ V
Sbjct: 1036 AFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEK 1095
Query: 262 LLPISVMEIVDANLLSREDKHFAAK-EQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320
+ +V + D + K E+ + L + CT E R + EI+T L+K
Sbjct: 1096 SIGNGRKGMVRVLDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMK 1155
Query: 321 IR 322
+R
Sbjct: 1156 LR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (471), Expect = 3e-46, Method: Compositional matrix adjust.
Identities = 101/253 (39%), Positives = 148/253 (58%), Gaps = 4/253 (1%)
Query: 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVEC 90
R+ ++ +L QAT+GF ++LIG G FG VYKA ++DG VA+K G + F E
Sbjct: 869 RKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEM 928
Query: 91 EVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMI 147
E + I+HRNL+ ++ C D + LV E+M +GSLE L+ + L+ R I I
Sbjct: 929 ETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAI 988
Query: 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
A L +LH S +IH D+K SNVLLD+N+ A +SDFG+A+L++ D S +
Sbjct: 989 GSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAG 1048
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISV 267
T GY+ PEY + R ST GDVYS+G++L+E T K+PTD G+ L WV + +
Sbjct: 1049 TPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDNNLVGWVKQHAKLRI 1108
Query: 268 MEIVDANLLSRED 280
++ D L+ +ED
Sbjct: 1109 SDVFDPELM-KED 1120
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (460), Expect = 5e-45, Method: Compositional matrix adjust.
Identities = 110/312 (35%), Positives = 168/312 (53%), Gaps = 16/312 (5%)
Query: 14 RGKQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVK 73
R P+ A M T F+Y EL T+GFS++N++G G FG VYK ++ DG VAVK
Sbjct: 324 RSGSAPDSAVMGSGQT--HFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVK 381
Query: 74 VFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSS 133
+ G + F E E++ + HR+L+ ++ C D + L+ EY+P+ +LE L+
Sbjct: 382 QLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGK 441
Query: 134 N-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192
VL+ +R+ I I A L YLH +IH D+K +N+LLDD A ++DFG+AK
Sbjct: 442 GRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAK- 500
Query: 193 LTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFA-G 251
L Q+ T+ + T GY+APEY + G+++ DV+SFG++L+E T +KP D+ G
Sbjct: 501 LNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLG 560
Query: 252 EMTLKYWVSNLLPISV-----MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAE 306
E +L W LL ++ E+VD L +KH+ E V + A C S
Sbjct: 561 EESLVEWARPLLHKAIETGDFSELVDRRL----EKHYVENE--VFRMIETAAACVRHSGP 614
Query: 307 QRINAKEIVTRL 318
+R ++V L
Sbjct: 615 KRPRMVQVVRAL 626
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (459), Expect = 7e-45, Method: Compositional matrix adjust.
Identities = 99/253 (39%), Positives = 147/253 (58%), Gaps = 4/253 (1%)
Query: 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVEC 90
R+ ++ +L +AT+GF ++L+G G FG VYKA+++DG VA+K G + F E
Sbjct: 874 RKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAEM 933
Query: 91 EVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCV---LDIFQRLNIMI 147
E + I+HRNL+ ++ C + + LV EYM +GSLE L+ + L+ R I I
Sbjct: 934 ETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIKLNWPARRKIAI 993
Query: 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
A L +LH +IH D+K SNVLLD+N+ A +SDFG+A+L++ D S +
Sbjct: 994 GAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAG 1053
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISV 267
T GY+ PEY + R ST GDVYS+G++L+E T K+PTD G+ L WV +
Sbjct: 1054 TPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVGWVKLHAKGKI 1113
Query: 268 MEIVDANLLSRED 280
++ D LL +ED
Sbjct: 1114 TDVFDRELL-KED 1125
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (459), Expect = 7e-45, Method: Compositional matrix adjust.
Identities = 99/253 (39%), Positives = 147/253 (58%), Gaps = 4/253 (1%)
Query: 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVEC 90
R+ ++ +L +AT+GF ++L+G G FG VYKA+++DG VA+K G + F E
Sbjct: 874 RKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAEM 933
Query: 91 EVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMI 147
E + I+HRNL+ ++ C + + LV EYM +GSLE L+ + L+ R I I
Sbjct: 934 ETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIKLNWPARRKIAI 993
Query: 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
A L +LH +IH D+K SNVLLD+N+ A +SDFG+A+L++ D S +
Sbjct: 994 GAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAG 1053
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISV 267
T GY+ PEY + R ST GDVYS+G++L+E T K+PTD G+ L WV +
Sbjct: 1054 TPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVGWVKLHAKGKI 1113
Query: 268 MEIVDANLLSRED 280
++ D LL +ED
Sbjct: 1114 TDVFDRELL-KED 1125
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN94|RLK7_ARATH Receptor-like protein kinase At5g59670 OS=Arabidopsis thaliana GN=At5g59670 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 180 bits (457), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 98/291 (33%), Positives = 162/291 (55%), Gaps = 12/291 (4%)
Query: 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVEC 90
+RF+Y E+ Q T F ++G+G FG VY ++ +VAVKV K F E
Sbjct: 552 KRFTYSEVVQVTKNFQR--VLGKGGFGMVYHGTVKGSEQVAVKVLSQSSTQGSKEFKAEV 609
Query: 91 EVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS--SNCVLDIFQRLNIMID 148
+++ + H NL+ ++ C D+ ALV E++P+G L++ L N +++ RL I ++
Sbjct: 610 DLLLRVHHTNLVSLVGYCCEGDYLALVYEFLPNGDLKQHLSGKGGNSIINWSIRLRIALE 669
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
A LEYLH G + P++H D+K +N+LLD+N A L+DFG+++ GE +S+ T T
Sbjct: 670 AALGLEYLHIGCTPPMVHRDVKTANILLDENFKAKLADFGLSRSFQGEGESQESTTIAGT 729
Query: 209 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVS-NLLPISV 267
+GY+ PE GR+ DVYSFGI+L+E T +P +G+ + WV + +
Sbjct: 730 LGYLDPECYHSGRLGEKSDVYSFGIVLLEMIT-NQPVINQTSGDSHITQWVGFQMNRGDI 788
Query: 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
+EI+D NL R+D + + + + LAM C S+ +R + +++ L
Sbjct: 789 LEIMDPNL--RKDYNINSAWRALE----LAMSCAYPSSSKRPSMSQVIHEL 833
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 335 | ||||||
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.955 | 0.294 | 0.603 | 1e-111 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.970 | 0.318 | 0.601 | 1e-109 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.955 | 0.301 | 0.580 | 1e-107 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.964 | 0.268 | 0.592 | 1e-106 | |
| 359485176 | 1160 | PREDICTED: probable LRR receptor-like se | 0.964 | 0.278 | 0.596 | 1e-106 | |
| 359485449 | 1583 | PREDICTED: LRR receptor-like serine/thre | 0.901 | 0.190 | 0.622 | 1e-104 | |
| 147853795 | 1420 | hypothetical protein VITISV_005816 [Viti | 0.967 | 0.228 | 0.582 | 1e-103 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.931 | 0.299 | 0.580 | 1e-103 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.949 | 0.218 | 0.569 | 1e-102 | |
| 255583725 | 973 | serine-threonine protein kinase, plant-t | 0.943 | 0.324 | 0.566 | 1e-101 |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 406 bits (1043), Expect = e-111, Method: Compositional matrix adjust.
Identities = 195/323 (60%), Positives = 246/323 (76%), Gaps = 3/323 (0%)
Query: 2 IVVILLISRYRKRGKQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYK 61
+ +I + +R RKR LP + ATWRR SY E+FQAT+GFS NL+GRGS GSVY+
Sbjct: 761 LALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYR 820
Query: 62 ARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSND--DFKALVLE 119
+ DG A+KVF+LQ FKSFD ECEVM IRHRNLIKI+S+CSN DFKALVLE
Sbjct: 821 GTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLE 880
Query: 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN 179
Y+P+GSLE+ LYS N LDI QRLNIMIDVA A+EYLH G S PV+HCDLKPSN+LLD++
Sbjct: 881 YVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDED 940
Query: 180 MVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF 239
H+ DFGIAKLL E++S +TQTLATIGYMAP+Y G V+T+GDVYS+GI+LMETF
Sbjct: 941 FGGHVGDFGIAKLLR-EEESIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETF 999
Query: 240 TKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAME 299
T+++PTD+IF+ EM++K WV + L S+ E+VDANLL ED+ F AK+QC+S + LAM+
Sbjct: 1000 TRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMAKKQCISLILGLAMD 1059
Query: 300 CTVESAEQRINAKEIVTRLLKIR 322
C +S E+RI K++VT L KI+
Sbjct: 1060 CVADSPEERIKMKDVVTTLKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 401 bits (1031), Expect = e-109, Method: Compositional matrix adjust.
Identities = 196/326 (60%), Positives = 249/326 (76%), Gaps = 1/326 (0%)
Query: 1 MIVVILLISRYRKRGKQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVY 60
++ I L+ R+R ++ P +P A RR SYLEL AT+ F E+NL+G GSFGSVY
Sbjct: 687 VVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVY 746
Query: 61 KARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120
+ R++DG+ VAVK+F+LQ F+SFD ECE+M++IRHRNL+KII +CSN DFKALVLEY
Sbjct: 747 QGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEY 806
Query: 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180
MP GSLEK LYS N LDI QR+NIMIDVA+ALEYLH GY +PV+HCDLKPSNVLLD++M
Sbjct: 807 MPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDM 866
Query: 181 VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
VAH+ DFGIAKLL GE++S +QT+TLATIGYMAPEYG +G VST DVYSFGIMLME T
Sbjct: 867 VAHVCDFGIAKLL-GENESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLT 925
Query: 241 KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMEC 300
+K+PTD++F GEM+LK V LP SV++IVD+N+L+R D + KE CV+ + LA++C
Sbjct: 926 RKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHCVTSIMELALQC 985
Query: 301 TVESAEQRINAKEIVTRLLKIRDSLL 326
ES +R+ EI+ RL I+ L
Sbjct: 986 VNESPGERMAMVEILARLKNIKAEFL 1011
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1015), Expect = e-107, Method: Compositional matrix adjust.
Identities = 187/322 (58%), Positives = 247/322 (76%), Gaps = 2/322 (0%)
Query: 1 MIVVILLISRYRKRGKQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVY 60
+++ + +I R ++L + P ATWR+ SY EL++AT+GF+E NL+G GS GSVY
Sbjct: 727 LVLALAVIIFRRSHKRKLSTQEDPLPPATWRKISYHELYRATEGFNETNLLGTGSCGSVY 786
Query: 61 KARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120
K + DG+ +AVKVFHLQ G FD ECEV++ +RHRNL+KIIS+C N DFKAL+LE+
Sbjct: 787 KGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEF 846
Query: 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180
+PHGSLEK LYS N LDI QRLNIMIDVA+ALEYLH G + PV+HCDLKPSNVL++++M
Sbjct: 847 IPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDM 906
Query: 181 VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
VAH+SDFGI++LL GE + +QT TLATIGYMAPEYG EG VS GDVYS+GI LMETFT
Sbjct: 907 VAHVSDFGISRLL-GEGDAVTQTLTLATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFT 965
Query: 241 KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMEC 300
+KKPTD +F GEM+LK WV LP ++ E++DANLL E++HF AK+ C++ + NLA+EC
Sbjct: 966 RKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLI-EEEHFVAKKDCITSILNLALEC 1024
Query: 301 TVESAEQRINAKEIVTRLLKIR 322
+ + +RI ++++ L KI+
Sbjct: 1025 SADLPGERICMRDVLPALEKIK 1046
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 391 bits (1005), Expect = e-106, Method: Compositional matrix adjust.
Identities = 193/326 (59%), Positives = 246/326 (75%), Gaps = 3/326 (0%)
Query: 1 MIVVILLISRYRKRGK-QLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSV 59
+I+V+L + R++ K + P ++ R + EL AT+ F E+NLIG+GS G V
Sbjct: 873 IILVVLFVQWKRRQTKSETPIQVDLSLPRMHRMIPHQELLYATNYFGEDNLIGKGSLGMV 932
Query: 60 YKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119
YK + DG+ VAVKVF+L+ G FKSF+VECEVM++IRHRNL KIIS+CSN DFKALVLE
Sbjct: 933 YKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLE 992
Query: 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN 179
YMP+GSLEK LYS N LD QRL IMIDVA+ LEYLH YS PV+HCDLKPSNVLLDD+
Sbjct: 993 YMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDD 1052
Query: 180 MVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF 239
MVAH+SDFGIAKLL G + K +T+TL T+GYMAPEYG EG VST GD+YS+GI+LMETF
Sbjct: 1053 MVAHISDFGIAKLLMGSEFMK-RTKTLGTVGYMAPEYGSEGIVSTKGDIYSYGILLMETF 1111
Query: 240 TKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAME 299
+KKPTD++F E+TLK WV + ++ME++DANLL+ ED+ FA K C S + LA++
Sbjct: 1112 VRKKPTDEMFVEELTLKSWVESSTN-NIMEVIDANLLTEEDESFALKRACFSSIMTLALD 1170
Query: 300 CTVESAEQRINAKEIVTRLLKIRDSL 325
CTVE E+RIN K++V RL K+ + +
Sbjct: 1171 CTVEPPEKRINTKDVVVRLKKLLNQI 1196
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485176|ref|XP_002280075.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 390 bits (1002), Expect = e-106, Method: Compositional matrix adjust.
Identities = 195/327 (59%), Positives = 244/327 (74%), Gaps = 4/327 (1%)
Query: 2 IVVILLISRYRKRGKQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYK 61
+ ++LI R R + K P N + RR S+ EL AT+ F E+N+IG GS G V++
Sbjct: 836 VAFVVLIRRRRSKSKA-PAQVNSFHLGKLRRISHQELIYATNYFGEDNMIGTGSLGMVHR 894
Query: 62 ARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121
+ DG VAVKVF+L+ G FKSFD ECE+M++I+HRNL+KIIS+CS +FKALVLEYM
Sbjct: 895 GVLSDGSIVAVKVFNLEFQGAFKSFDAECEIMRNIQHRNLVKIISSCSILNFKALVLEYM 954
Query: 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA-PVIHCDLKPSNVLLDDNM 180
P+GSLEK LYS N L++ QRLNIMIDVA+ALEYLH +S PV+HCDLKP+NVLLD+ M
Sbjct: 955 PNGSLEKWLYSHNYCLNLVQRLNIMIDVASALEYLHHDFSVNPVVHCDLKPNNVLLDEEM 1014
Query: 181 VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
VA L DFGI+KLLT E +S QT+TL TIGYMAPEYG EG VST GDVYS+GIM+METF
Sbjct: 1015 VARLGDFGISKLLT-ETESMEQTRTLGTIGYMAPEYGSEGIVSTRGDVYSYGIMMMETFA 1073
Query: 241 KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMEC 300
+KKPTD++F GE+TL+ WV +L VME+VD NL+ RED+HF KE C+ + LA+EC
Sbjct: 1074 RKKPTDEMFGGEVTLRSWVESLAG-RVMEVVDGNLVRREDQHFGIKESCLRSIMALALEC 1132
Query: 301 TVESAEQRINAKEIVTRLLKIRDSLLI 327
T ES RI+ KE+V RL KIR LL+
Sbjct: 1133 TTESPRDRIDMKEVVVRLKKIRIKLLV 1159
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485449|ref|XP_002276919.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 384 bits (987), Expect = e-104, Method: Compositional matrix adjust.
Identities = 191/307 (62%), Positives = 238/307 (77%), Gaps = 5/307 (1%)
Query: 21 DANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCG 80
D+++P T+R+ S+ EL AT+ FSE NLIG+GS G+VYK + DG+ A+KVF+L+
Sbjct: 1282 DSSLP--TTYRKISHQELLHATNYFSEGNLIGKGSMGTVYKGVLFDGLTAAIKVFNLEFL 1339
Query: 81 GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIF 140
G FK F+ ECEVM++IRHRNLIKIIS+CSN FKALVLE+MP+ SLE+ LYS N LD+
Sbjct: 1340 GSFKGFEAECEVMRNIRHRNLIKIISSCSNLGFKALVLEFMPNRSLERWLYSHNYCLDLI 1399
Query: 141 QRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200
QRLNIMIDVA+ALEYLH YS PV+HCDLKP+NVLLD++ VAH+ DFGIAKLL G +S+
Sbjct: 1400 QRLNIMIDVASALEYLHHDYSNPVVHCDLKPNNVLLDEDRVAHVGDFGIAKLLPG-SESR 1458
Query: 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVS 260
QT+TL IGYMAPEYG EG VST+ DVYS GIML+E F +KKPTD++F G+ TLK WV
Sbjct: 1459 QQTKTLGPIGYMAPEYGSEGIVSTS-DVYSNGIMLLEVFARKKPTDEMFVGDPTLKSWVE 1517
Query: 261 NLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320
+L +VME VD NLL +ED+HFA KE CV + LA+ECT ES E RIN +++V RL K
Sbjct: 1518 SLAS-TVMEFVDTNLLDKEDEHFAIKENCVLCIMALALECTAESPEDRINMRDVVARLKK 1576
Query: 321 IRDSLLI 327
IR LL+
Sbjct: 1577 IRIKLLM 1583
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 380 bits (976), Expect = e-103, Method: Compositional matrix adjust.
Identities = 190/326 (58%), Positives = 241/326 (73%), Gaps = 2/326 (0%)
Query: 1 MIVVILLISRYRKRGKQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVY 60
++VV+ + + R+ + P ++ R S+ EL AT F E NLIG+GS G VY
Sbjct: 875 ILVVLFTLWKRRQTESESPVQVDLLLPRMHRLISHQELLYATSYFGEENLIGKGSLGMVY 934
Query: 61 KARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120
K + DG+ VAVKVF+L+ G FKSF+VECEVM++IRHRNL KIIS+CSN DFKALVLEY
Sbjct: 935 KGVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEY 994
Query: 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180
MP+ SLEK LYS N LD QRL IMIDVA+ LEYLH YS PV+HCDLKPSNVLLDD+M
Sbjct: 995 MPNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYSNPVVHCDLKPSNVLLDDDM 1054
Query: 181 VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
VAH+SDFGIAKLL G + K +T+TL TIGYMAPEYG EG VST D YS+GI+LME F
Sbjct: 1055 VAHISDFGIAKLLMGSEFMK-RTKTLGTIGYMAPEYGSEGIVSTKCDTYSYGIILMEIFV 1113
Query: 241 KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMEC 300
+KKPTD++F E+TLK WV + ++ME++DANLL+ ED+ FA K+ C S + LA++C
Sbjct: 1114 RKKPTDEMFVEELTLKSWVESSAN-NIMEVIDANLLTEEDESFALKQACFSSIMTLALDC 1172
Query: 301 TVESAEQRINAKEIVTRLLKIRDSLL 326
T+E E+RIN K++V RL KI + ++
Sbjct: 1173 TIEPPEKRINMKDVVARLKKILNQIV 1198
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 380 bits (975), Expect = e-103, Method: Compositional matrix adjust.
Identities = 184/317 (58%), Positives = 242/317 (76%), Gaps = 5/317 (1%)
Query: 4 VILLISRYRKRGKQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKAR 63
V ++ R RKR ++ + P+AT +R SY EL QATD F+E NL+GRGSFGSVYK
Sbjct: 718 VAIIFIRSRKRNMRI--TEGLLPLATLKRISYRELEQATDKFNEMNLLGRGSFGSVYKGT 775
Query: 64 IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS--NDDFKALVLEYM 121
DG VAVKVF+LQ G FKSFDVECEV++ IRHRNL+KII++CS N DFKALVLE+M
Sbjct: 776 FSDGSSVAVKVFNLQVEGAFKSFDVECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFM 835
Query: 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181
P+ SLEK L S L++ +RLNIM+DVA+A+EYLH GY+ P++HCDLKPSN+LLD+NMV
Sbjct: 836 PNYSLEKWLCSPKHFLELLERLNIMLDVASAVEYLHHGYAMPIVHCDLKPSNILLDENMV 895
Query: 182 AHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK 241
AH++DFGIAKLL G++ S QT TLAT+GYMAPEYG EG VST GD+YSFGI+LMETFT+
Sbjct: 896 AHVTDFGIAKLL-GDEHSFIQTITLATVGYMAPEYGSEGVVSTGGDIYSFGILLMETFTR 954
Query: 242 KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECT 301
KKPTD +F E+++K WV +P V +I D +LL E++HF+AK+ C+ V +A++C+
Sbjct: 955 KKPTDDMFNEEISMKQWVQESVPGGVTQITDPDLLRIEEQHFSAKKDCILSVMQVALQCS 1014
Query: 302 VESAEQRINAKEIVTRL 318
+ E+R N ++++ L
Sbjct: 1015 ADLPEERPNIRDVLNTL 1031
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 379 bits (973), Expect = e-102, Method: Composition-based stats.
Identities = 188/330 (56%), Positives = 246/330 (74%), Gaps = 12/330 (3%)
Query: 2 IVVILLISRYRKRGKQLPNDANMPPVATW-----RRFSYLELFQATDGFSENNLIGRGSF 56
+VV L++ R++ ++P P+ +W + S+ +L AT+ F E+NLIG+GS
Sbjct: 1131 LVVFLVLWIRRRKNLEVPT-----PIDSWLPGSHEKISHQQLLYATNYFGEDNLIGKGSL 1185
Query: 57 GSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116
VYK + +G+ VAVKVF+L+ G F+SFD ECEVM+SIRHRNL+KII+ CSN DFKAL
Sbjct: 1186 SMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDFKAL 1245
Query: 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL 176
VLEYMP GSL+K LYS N LD+ QRLNIMIDVA+ALEYLH + V+HCDLKP+N+LL
Sbjct: 1246 VLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNNILL 1305
Query: 177 DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLM 236
DD+MVAH+ DFGIA+LLT E +S QT+TL TIGYMAPEYG +G VST GDV+S+GIMLM
Sbjct: 1306 DDDMVAHVGDFGIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIMLM 1364
Query: 237 ETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNL 296
E F +KKP D++F G++TLK WV +L S++E+VDANLL RED+ FA K C+S + L
Sbjct: 1365 EVFARKKPMDEMFNGDLTLKSWVESLAD-SMIEVVDANLLRREDEDFATKLSCLSSIMAL 1423
Query: 297 AMECTVESAEQRINAKEIVTRLLKIRDSLL 326
A+ CT +S E+RI+ K++V L KI+ LL
Sbjct: 1424 ALACTTDSPEERIDMKDVVVGLKKIKIELL 1453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583725|ref|XP_002532616.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223527672|gb|EEF29782.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 375 bits (963), Expect = e-101, Method: Compositional matrix adjust.
Identities = 182/321 (56%), Positives = 241/321 (75%), Gaps = 5/321 (1%)
Query: 4 VILLISRYRKRGKQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKAR 63
V+++ R RKR ++ + P+AT R SY EL QATD F+E NL+G+GSFGSVYK
Sbjct: 648 VVIIFIRSRKRNRR--TTEGLLPLATLERISYRELEQATDKFNEINLLGKGSFGSVYKGI 705
Query: 64 IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS--NDDFKALVLEYM 121
DG VAVKVF+LQ G FKSFDVE EV++ IRHRNL+KII++CS N +FKALVLE+M
Sbjct: 706 FSDGRSVAVKVFNLQAEGAFKSFDVESEVLRMIRHRNLVKIITSCSSVNIEFKALVLEFM 765
Query: 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181
P+ SLEK LYS N L+ QRLNIM+DVA+A+EYLH GY+ P++HCDLKP+N+LLD+NM
Sbjct: 766 PNHSLEKWLYSPNHFLEFLQRLNIMLDVASAVEYLHHGYTTPIVHCDLKPNNILLDENMA 825
Query: 182 AHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK 241
AH++DFGIAKLL G+++S +T TLAT+GYMAPEYG EG VST GDVYSFGI+++ETFT
Sbjct: 826 AHVTDFGIAKLL-GDERSFIRTITLATVGYMAPEYGSEGVVSTGGDVYSFGILMIETFTS 884
Query: 242 KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECT 301
+KPTD +F EM +K WV L V +I D NLL ED+H +AK+ C+ + LA++C+
Sbjct: 885 RKPTDDMFNEEMNMKQWVQESLAGGVTQIADPNLLRIEDEHLSAKKDCIISMMQLALQCS 944
Query: 302 VESAEQRINAKEIVTRLLKIR 322
+ E+R N +++++ L I+
Sbjct: 945 ADLPEERPNIRDVLSTLNHIK 965
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 335 | ||||||
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.925 | 0.302 | 0.426 | 5.1e-61 | |
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.853 | 0.569 | 0.428 | 9.9e-55 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.794 | 0.259 | 0.437 | 6e-54 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.835 | 0.271 | 0.432 | 1e-53 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.910 | 0.311 | 0.386 | 8.9e-51 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.961 | 0.274 | 0.341 | 3e-49 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.898 | 0.423 | 0.355 | 8.1e-47 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.656 | 0.217 | 0.416 | 2.9e-44 | |
| TAIR|locus:2005498 | 1196 | BRI1 "BRASSINOSTEROID INSENSIT | 0.856 | 0.239 | 0.364 | 9.2e-44 | |
| TAIR|locus:2174294 | 868 | AT5G59670 [Arabidopsis thalian | 0.922 | 0.355 | 0.328 | 1.7e-43 |
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 631 (227.2 bits), Expect = 5.1e-61, P = 5.1e-61
Identities = 142/333 (42%), Positives = 201/333 (60%)
Query: 14 RGKQLPNDANMPPVAT-WRRFSYLELFQATDGFSENNLIGRGSFGSVYKARI-QDGMEVA 71
R ND + PV + + + SY EL++ T GFS +NLIG G+FG+V+K + VA
Sbjct: 687 RANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVA 746
Query: 72 VKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN-----DDFKALVLEYMPHGSL 126
+KV +L G KSF ECE + IRHRNL+K+++ CS+ +DF+ALV E+MP+G+L
Sbjct: 747 IKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNL 806
Query: 127 EKCLYSSNC--------VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD 178
+ L+ L +F RLNI IDVA+AL YLH P+ HCD+KPSN+LLD
Sbjct: 807 DMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDK 866
Query: 179 NMVAHLSDFGIAKLLTGEDQSKSQTQ-----TLATIGYMAPEYGREGRVSTNGDVYSFGI 233
++ AH+SDFG+A+LL D+ Q TIGY APEYG G S GDVYSFGI
Sbjct: 867 DLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGI 926
Query: 234 MLMETFTKKKPTDKIFAGEMTL-KYWVSNLLPISVMEIVDANLL-SREDKHFAAKEQCVS 291
+L+E FT K+PT+K+F +TL + S L ++I D +L +HF E C++
Sbjct: 927 VLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVE-CLT 985
Query: 292 FVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
VF + + C+ ES RI+ E +++L+ IR+S
Sbjct: 986 LVFRVGVSCSEESPVNRISMAEAISKLVSIRES 1018
|
|
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 565 (203.9 bits), Expect = 9.9e-55, P = 9.9e-55
Identities = 137/320 (42%), Positives = 183/320 (57%)
Query: 32 RFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGME---VAVKVFHLQCGGVFKSFDV 88
+ SY EL+ AT GFS +NLIG G+F V+K + G+E VAVKV +L G KSF
Sbjct: 196 KISYEELYNATSGFSSSNLIGSGNFSDVFKGLL--GLEEKLVAVKVLNLLKHGATKSFIA 253
Query: 89 ECEVMKSIRHRNLIKIISTCSN-----DDFKALVLEYMPHGSLEKCLY-----SSNC--- 135
ECE K IRHRNL K+I+ CS+ +DF+ALV E+MP GSL+ L S+N
Sbjct: 254 ECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNHSR 313
Query: 136 VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195
L +++NI IDVA+ALEYLH PV HCD+KPSNVLLDD++ AH+SDFG+A+LL
Sbjct: 314 SLTFAEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYN 373
Query: 196 EDQSK-----SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFA 250
D+ S TIGY APEYG + S GDVYSFG++L+E FT KKPTD F
Sbjct: 374 FDEKTFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNSFG 433
Query: 251 GEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN 310
G L + ++L S SR + ++ + V + ++C+ E R+
Sbjct: 434 GGYNLHGYTKSVLSCST---------SRGGRTMV--DEWLRLVLEVGIKCSEEYPRDRMG 482
Query: 311 AKEIVTRLLKIRDSLLICTR 330
E V L+ I+ +R
Sbjct: 483 MAEAVRELVSIKSKFFTSSR 502
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 566 (204.3 bits), Expect = 6.0e-54, P = 6.0e-54
Identities = 126/288 (43%), Positives = 184/288 (63%)
Query: 6 LLISRYRKRGKQLPNDANMP--PVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKAR 63
LLI+ +++ K P+ +M P+ SY +L +ATDGF+ NL+G GSFGSVYK +
Sbjct: 672 LLITWHKRTKKGAPSRTSMKGHPLV-----SYSQLVKATDGFAPTNLLGSGSFGSVYKGK 726
Query: 64 IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN-----DDFKALVL 118
+ VAVKV L+ KSF ECE ++++RHRNL+KI++ CS+ +DFKA+V
Sbjct: 727 LNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVY 786
Query: 119 EYMPHGSLEKCLY-SSNCVLD-----IFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPS 172
++MP+GSLE ++ +N D + +R+ I++DVA AL+YLH PV+HCD+K S
Sbjct: 787 DFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSS 846
Query: 173 NVLLDDNMVAHLSDFGIAKLLT-GED---QSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
NVLLD +MVAH+ DFG+A++L G QS S + TIGY APEYG ST+GD+
Sbjct: 847 NVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDI 906
Query: 229 YSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276
YS+GI+++E T K+PTD F ++ L+ +V L V ++VD L+
Sbjct: 907 YSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLI 954
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 564 (203.6 bits), Expect = 1.0e-53, P = 1.0e-53
Identities = 134/310 (43%), Positives = 181/310 (58%)
Query: 32 RFSYLELFQATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVEC 90
+ SY EL AT FS NLIG G+FG+V+K + + VAVKV +L G KSF EC
Sbjct: 699 KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAEC 758
Query: 91 EVMKSIRHRNLIKIISTCSN-----DDFKALVLEYMPHGSLEKCLYSSNCV--------L 137
E K IRHRNL+K+I+ CS+ +DF+ALV E+MP GSL+ L + L
Sbjct: 759 ETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSL 818
Query: 138 DIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197
++LNI IDVA+ALEYLH PV HCD+KPSN+LLDD++ AH+SDFG+A+LL D
Sbjct: 819 TPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYD 878
Query: 198 QSK-----SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
+ S TIGY APEYG G+ S GDVYSFGI+L+E F+ KKPTD+ FAG+
Sbjct: 879 RESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGD 938
Query: 253 MTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAK 312
L + ++L + S + A ++ + V + ++C+ E R+
Sbjct: 939 YNLHSYTKSIL---------SGCTSSGGSN--AIDEGLRLVLQVGIKCSEEYPRDRMRTD 987
Query: 313 EIVTRLLKIR 322
E V L+ IR
Sbjct: 988 EAVRELISIR 997
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 8.9e-51, P = 8.9e-51
Identities = 129/334 (38%), Positives = 192/334 (57%)
Query: 16 KQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVF 75
KQ ND P R SY +L AT GF+ ++LIG G FG VYK +++ +VAVKV
Sbjct: 638 KQNQNDPKYP------RISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVL 691
Query: 76 HLQCGGVFK-SFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS-- 132
+ F SF EC+++K RHRNLI+II+TCS F ALVL MP+GSLE+ LY
Sbjct: 692 DPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGE 751
Query: 133 -SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191
S+ LD+ Q +NI DVA + YLH V+HCDLKPSN+LLDD M A ++DFGI++
Sbjct: 752 YSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISR 811
Query: 192 LLTGEDQSKSQTQTLA----------TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK 241
L+ G +++ S +++ ++GY+APEYG R ST+GDVYSFG++L+E +
Sbjct: 812 LVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSG 871
Query: 242 KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSF-------VF 294
++PTD + +L ++ + P S+ I++ LSR K E+C +
Sbjct: 872 RRPTDVLVNEGSSLHEFMKSHYPDSLEGIIE-QALSRW-KPQGKPEKCEKLWREVILEMI 929
Query: 295 NLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328
L + CT + R + ++ + ++++ L C
Sbjct: 930 ELGLVCTQYNPSTRPDMLDVAHEMGRLKEYLFAC 963
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 524 (189.5 bits), Expect = 3.0e-49, P = 3.0e-49
Identities = 115/337 (34%), Positives = 201/337 (59%)
Query: 1 MIVVILLISRYRKRGKQLPN--DANMPPVAT---WRRFSYLELFQATDGFSENNLIGRGS 55
+++++L+++ +K+ K++ N ++++P + + +RF EL QATD F+ N+IG S
Sbjct: 821 VLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSS 880
Query: 56 FGSVYKARIQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTC-SNDD 112
+VYK +++DG +AVKV +L+ K F E + + ++HRNL+KI+ +
Sbjct: 881 LSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGK 940
Query: 113 FKALVLEYMPHGSLEKCLYSSNCVL-DIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKP 171
KALVL +M +G+LE ++ S + + +++++ + +A+ ++YLH GY P++HCDLKP
Sbjct: 941 TKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKP 1000
Query: 172 SNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA---TIGYMAPEYGREGRVSTNGDV 228
+N+LLD + VAH+SDFG A++L + + T A TIGY+APE+ +V+T DV
Sbjct: 1001 ANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADV 1060
Query: 229 YSFGIMLMETFTKKKPT--DKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286
+SFGI++ME TK++PT + + +MTL+ V + +V + D + K
Sbjct: 1061 FSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMELGDSIVSLK 1120
Query: 287 -EQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322
E+ + L + CT E R + EI+T L+K+R
Sbjct: 1121 QEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 474 (171.9 bits), Expect = 8.1e-47, Sum P(2) = 8.1e-47
Identities = 111/312 (35%), Positives = 171/312 (54%)
Query: 11 YRKRGKQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEV 70
Y + G P+ A M T F+Y EL T+GFS++N++G G FG VYK ++ DG V
Sbjct: 322 YTRSGSA-PDSAVMGSGQT--HFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLV 378
Query: 71 AVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCL 130
AVK + G + F E E++ + HR+L+ ++ C D + L+ EY+P+ +LE L
Sbjct: 379 AVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHL 438
Query: 131 YSSNC-VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189
+ VL+ +R+ I I A L YLH +IH D+K +N+LLDD A ++DFG+
Sbjct: 439 HGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGL 498
Query: 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIF 249
AKL Q+ T+ + T GY+APEY + G+++ DV+SFG++L+E T +KP D+
Sbjct: 499 AKL-NDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQ 557
Query: 250 A-GEMTLKYWVSNLLPISVMEIVD-ANLLSRE-DKHFAAKEQCVSFVFNLAMECTVESAE 306
GE +L W LL ++ E D + L+ R +KH+ E V + A C S
Sbjct: 558 PLGEESLVEWARPLLHKAI-ETGDFSELVDRRLEKHYVENE--VFRMIETAAACVRHSGP 614
Query: 307 QRINAKEIVTRL 318
+R ++V L
Sbjct: 615 KRPRMVQVVRAL 626
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 464 (168.4 bits), Expect = 2.9e-44, Sum P(2) = 2.9e-44
Identities = 97/233 (41%), Positives = 141/233 (60%)
Query: 111 DDFKALVLEYMPHGSLEKCLYSSNC--------VLDIFQRLNIMIDVAAALEYLHFGYSA 162
++F+AL+ E+MP+GSL+ L+ L + +RLNI IDVA+ L+YLH
Sbjct: 774 NEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHE 833
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK-----SQTQTLATIGYMAPEYG 217
P+ HCDLKPSNVLLDD++ AH+SDFG+A+LL D+ S TIGY APEYG
Sbjct: 834 PIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYG 893
Query: 218 REGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277
G+ S NGDVYSFGI+L+E FT K+PT+++F G TL + + LP +++IVD ++L
Sbjct: 894 VGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILH 953
Query: 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICTR 330
+ +C++ VF + + C ES R+ +V L+ IR+ +R
Sbjct: 954 IGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFKASR 1006
|
|
| TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 473 (171.6 bits), Expect = 9.2e-44, P = 9.2e-44
Identities = 108/296 (36%), Positives = 170/296 (57%)
Query: 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVK-VFHLQCGGVFKSFDVE 89
R+ ++ +L QAT+GF ++LIG G FG VYKA ++DG VA+K + H+ G + F E
Sbjct: 869 RKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGD-REFMAE 927
Query: 90 CEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS---SNCVLDIFQRLNIM 146
E + I+HRNL+ ++ C D + LV E+M +GSLE L+ + L+ R I
Sbjct: 928 METIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIA 987
Query: 147 IDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206
I A L +LH S +IH D+K SNVLLD+N+ A +SDFG+A+L++ D S +
Sbjct: 988 IGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLA 1047
Query: 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266
T GY+ PEY + R ST GDVYS+G++L+E T K+PTD G+ L WV +
Sbjct: 1048 GTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDNNLVGWVKQHAKLR 1107
Query: 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322
+ ++ D L+ +ED A + + + + +A+ C + A +R +++ +I+
Sbjct: 1108 ISDVFDPELM-KEDP--ALEIELLQHL-KVAVACLDDRAWRRPTMVQVMAMFKEIQ 1159
|
|
| TAIR|locus:2174294 AT5G59670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 467 (169.5 bits), Expect = 1.7e-43, P = 1.7e-43
Identities = 108/329 (32%), Positives = 179/329 (54%)
Query: 1 MIVVILLISRYRK----RGKQLPNDANMPPVA----TWRRFSYLELFQATDGFSENNLIG 52
+IVV+ L+ R + +G +LP +M V +RF+Y E+ Q T F ++G
Sbjct: 514 VIVVLFLVFRKKMSTIVKGLRLPPRTSMVDVTFSNKKSKRFTYSEVVQVTKNFQR--VLG 571
Query: 53 RGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD 112
+G FG VY ++ +VAVKV K F E +++ + H NL+ ++ C D
Sbjct: 572 KGGFGMVYHGTVKGSEQVAVKVLSQSSTQGSKEFKAEVDLLLRVHHTNLVSLVGYCCEGD 631
Query: 113 FKALVLEYMPHGSLEKCLYSS--NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLK 170
+ ALV E++P+G L++ L N +++ RL I ++ A LEYLH G + P++H D+K
Sbjct: 632 YLALVYEFLPNGDLKQHLSGKGGNSIINWSIRLRIALEAALGLEYLHIGCTPPMVHRDVK 691
Query: 171 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYS 230
+N+LLD+N A L+DFG+++ GE +S+ T T+GY+ PE GR+ DVYS
Sbjct: 692 TANILLDENFKAKLADFGLSRSFQGEGESQESTTIAGTLGYLDPECYHSGRLGEKSDVYS 751
Query: 231 FGIMLMETFTKKKPTDKIFAGEMTLKYWVS-NLLPISVMEIVDANLLSREDKHFAAKEQC 289
FGI+L+E T + P +G+ + WV + ++EI+D NL R+D + + +
Sbjct: 752 FGIVLLEMITNQ-PVINQTSGDSHITQWVGFQMNRGDILEIMDPNL--RKDYNINSAWRA 808
Query: 290 VSFVFNLAMECTVESAEQRINAKEIVTRL 318
+ LAM C S+ +R + +++ L
Sbjct: 809 LE----LAMSCAYPSSSKRPSMSQVIHEL 833
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 335 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-38 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-26 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-22 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-05 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 8e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| COG2334 | 331 | COG2334, COG2334, Putative homoserine kinase type | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 9e-50
Identities = 68/191 (35%), Positives = 104/191 (54%), Gaps = 9/191 (4%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
+G G FG+VY AR + G +VA+K+ + + + E E++K + H N++K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+++ LV+EY GSL+ L + L + L I++ + LEYLH S +IH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 169 LKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR-EGRVSTNG 226
LKP N+LLD DN L+DFG++KLLT + T YMAPE +G S
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 227 DVYSFGIMLME 237
D++S G++L E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-47
Identities = 71/200 (35%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV----ECEVMKSIRHRNLIKII 105
+G GSFG+VYKA+ G VAVK+ + D E +++ + H N++++I
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
+ D LV+EY G L S L + I + + LEYLH S +I
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRGLEYLH---SNGII 120
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGR-VST 224
H DLKP N+LLD+N V ++DFG+AK L S + T T YMAPE G
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAPEVLLGGNGYGP 178
Query: 225 NGDVYSFGIMLMETFTKKKP 244
DV+S G++L E T K P
Sbjct: 179 KVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 7e-47
Identities = 74/268 (27%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 49 NLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIIS 106
+G GSFG VY AR + G VA+KV + + E +++K ++H N++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
++D LV+EY G L L L + + + +ALEYLH S ++H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG 226
DLKP N+LLD++ L+DFG+A+ L ++ + T YMAPE
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE---YMAPEVLLGKGYGKAV 177
Query: 227 DVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286
D++S G++L E T K P F G+ L + +S E K
Sbjct: 178 DIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI-- 231
Query: 287 EQCVSFVFNLAMECTVESAEQRINAKEI 314
+ V + E+R+ A+E
Sbjct: 232 RKL--LVKD---------PEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 4e-46
Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 33/279 (11%)
Query: 48 NNLIGRGSFGSVYKARIQD-----GMEVAVKVFHLQCGGV-FKSFDVECEVMKSIRHRNL 101
+G G+FG VYK +++ +EVAVK + F E +M+ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS 161
+K++ C+ ++ +V+EYM G L L + L + L+ + +A +EYL S
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGR 221
IH DL N L+ +N+V +SDFG+++ L +D + I +MAPE +EG+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 222 VSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA-NLLSRE 279
++ DV+SFG++L E FT ++P Y + V+E + L +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP------------YP--GMSNEEVLEYLKNGYRLPQP 225
Query: 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
C +++L ++C E E R E+V L
Sbjct: 226 -------PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 8e-45
Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 28/274 (10%)
Query: 51 IGRGSFGSVYKARI-----QDGMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKI 104
+G G+FG VYK + +VAVK + F E +MK + H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
+ C+ + +V EYMP G L L L + L + + +A +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVST 224
+H DL N L+ +N+V +SDFG+++ + +D + + I +MAPE ++G+ ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 225 NGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFA 284
DV+SFG++L E FT GE + V+E++ +
Sbjct: 184 KSDVWSFGVLLWEIFTL---------GEQPY----PGMSNEEVLELL------EDGYRLP 224
Query: 285 AKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
E C ++ L ++C E R E+V L
Sbjct: 225 RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-43
Identities = 78/280 (27%), Positives = 129/280 (46%), Gaps = 34/280 (12%)
Query: 48 NNLIGRGSFGSVYKARIQDG-----MEVAVKVFHLQCGGV-FKSFDVECEVMKSIRHRNL 101
+G G+FG VYK ++ +EVAVK + F E +M+ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCL-YSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
+K++ C+ ++ +V+EYMP G L L + L + L+ + +A +EYL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG 220
S IH DL N L+ +N+V +SDFG+++ L +D I +MAPE +EG
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 221 RVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA-NLLSR 278
+ ++ DV+SFG++L E FT ++P Y + V+E + L +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEP------------YP--GMSNAEVLEYLKKGYRLPK 225
Query: 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
C ++ L ++C E E R E+V L
Sbjct: 226 P-------PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 4e-42
Identities = 83/286 (29%), Positives = 129/286 (45%), Gaps = 41/286 (14%)
Query: 49 NLIGRGSFGSVYKARIQDG----MEVAVKVFHLQCG---GVFKSFDVECEVMKSIRHRNL 101
+G G+FG VYK +++ EVAVK L+ K F E VMK + H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT--LKEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIF--------QRLNIMIDVAAAL 153
++++ C+ ++ LVLEYM G L L S V L+ I +A +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMA 213
EYL S +H DL N L+ +++V +SDFG+++ + +D + +T I +MA
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 214 PEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272
PE ++G ++ DV+SFG++L E FT P Y L V+E +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATP------------Y--PGLSNEEVLEYL- 220
Query: 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
R+ E C ++ L + C E R E+V RL
Sbjct: 221 -----RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 6e-38
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 49 NLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGG--VFKSFDVECEVMKSIRHRNLIKII 105
L+GRGSFGSVY A +D G +AVK L ++ + E ++ S++H N+++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 106 STCSNDDFKAL--VLEYMPHGSLEKCLYSSNCVLDIFQRLNI------MIDVAAALEYLH 157
+ +++ L LEY+ GSL L F +L + L YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEGLAYLH 118
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYG 217
S ++H D+K +N+L+D + V L+DFG AK L + + T +MAPE
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 218 REGRVSTNGDVYSFGIMLMETFTKKKP 244
R D++S G ++E T K P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 68/193 (35%), Positives = 103/193 (53%), Gaps = 13/193 (6%)
Query: 50 LIGRGSFGSVYKARIQDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTC 108
IG+G FG V + G +VAVK L+ ++F E VM ++RH NL++++
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVKC--LKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 109 SNDDFKALVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
+ +V EYM GSL L S V+ + Q+L +DV +EYL +H
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGD 227
DL NVL+ +++VA +SDFG+AK + S+ Q + + APE RE + ST D
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSD 181
Query: 228 VYSFGIMLMETFT 240
V+SFGI+L E ++
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (305), Expect = 9e-32
Identities = 85/294 (28%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 50 LIGRGSFGSVYKARIQDGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRH-RNLIKII 105
+G GSFG VY AR D VA+KV + + F E +++ S+ H N++K+
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 106 STCSNDDFKALVLEYMPHGSLEK--CLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
++ LV+EY+ GSLE L + L I+ + +ALEYLH S
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 164 VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSKSQTQTLA----TIGYMAPEY-- 216
+IH D+KP N+LLD D V L DFG+AKLL + S + T GYMAPE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 217 -GREGRVSTNGDVYSFGIMLMETFTKKKPTDKI---FAGEMTLKYWVSNLLPISVMEIVD 272
S++ D++S GI L E T P + A TLK + P +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326
+N E +L + + + R+++ ++ L L
Sbjct: 242 SN-----------PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK 284
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 63/195 (32%), Positives = 97/195 (49%), Gaps = 7/195 (3%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IG+G FG VYKAR + G EVA+KV L+ + E +++K +H N++K +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
D +V+E+ GSL+ L S+N L Q + ++ LEYLH S +IH D+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
K +N+LL + L DFG++ L+ + + T +MAPE D++
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKPYDYKADIW 181
Query: 230 SFGIMLMETFTKKKP 244
S GI +E K P
Sbjct: 182 SLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 68/193 (35%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 50 LIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFK-SFDVECEVMKSIRHRNLIKIISTC 108
IG+G+FG VYK ++ EVAVK K F E E++K H N++K+I C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+V+E +P GSL L L + + L + +D AA +EYL S IH D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
L N L+ +N V +SDFG+++ G + S I + APE GR ++ DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 229 YSFGIMLMETFTK 241
+S+GI+L ETF+
Sbjct: 179 WSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 85/294 (28%), Positives = 130/294 (44%), Gaps = 50/294 (17%)
Query: 51 IGRGSFGSVYKARI------QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIK 103
+G G+FG V+ D VAVK K F+ E E++ + +H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYS------------SNCV-LDIFQRLNIMIDVA 150
C+ D +V EYM HG L K L S S L + Q L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 151 AALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
+ + YL HF +H DL N L+ ++V + DFG+++ + D + T+
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPIS 266
I +M PE + +T DV+SFG++L E FT K+P Y +SN
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-----------YGLSN---EE 232
Query: 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320
V+E + L + C S V+++ + C +QRIN K+I RL K
Sbjct: 233 VIECITQGRLLQR------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 73/283 (25%), Positives = 130/283 (45%), Gaps = 17/283 (6%)
Query: 49 NLIGRGSFGSVYKARI-----QDGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLI 102
+G G FG V R G +VAVK + +S F+ E E+++++ H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 103 KIISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
K C ++ L++EY+P GSL L +++ + L + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSKSQTQTLATIGYMAPEYGRE 219
S IH DL N+L++ + +SDFG+AK+L +D + + I + APE R
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279
+ S+ DV+SFG+ L E FT P+ + E ++ I V ++ LL +E
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPS-QSPPAEFLRMIGIAQGQMI-VTRLL--ELL-KE 241
Query: 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322
+ C V++L C + R + +++ + ++R
Sbjct: 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 9e-30
Identities = 83/286 (29%), Positives = 128/286 (44%), Gaps = 55/286 (19%)
Query: 49 NLIGRGSFGSVYKA-RIQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKII 105
+LIGRG+FG VYK ++ G VA+K L+ KS E +++K+++H N++K I
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 106 STCSNDDFKALVLEYMPHGSLEK------CLYSSNCVLDIFQRLNIMIDVAAALEYLHFG 159
+ D ++LEY +GSL + S + ++Q L L YLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ-------GLAYLH-- 116
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE 219
VIH D+K +N+L + V L+DFG+A L D SK + T +MAPE
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN--DVSKDDASVVGTPYWMAPEVIEM 173
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM-EIVDANLLSR 278
ST D++S G ++E T P Y+ +L P++ + IV
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP------------YY--DLNPMAALFRIV------- 212
Query: 279 EDKHF----AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320
+D H + F+ M+C + R AK+ LLK
Sbjct: 213 QDDHPPLPEGISPELKDFL----MQCFQKDPNLRPTAKQ----LLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 2e-28
Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 49 NLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV--ECEVMKSIRHRNLIKII 105
IG+GSFG VY R DG +K L + D E +++K + H N+IK
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIF---QRLNIMIDVAAALEYLHFGYSA 162
+ +V+EY G L + + F Q L+ + + AL+YLH S
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SR 122
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222
++H D+KP N+ L N + L DFGI+K+L+ ++T + T Y++PE +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTV-VGTPYYLSPELCQNKPY 180
Query: 223 STNGDVYSFGIMLMETFTKKKP 244
+ D++S G +L E T K P
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 68/275 (24%), Positives = 119/275 (43%), Gaps = 25/275 (9%)
Query: 45 FSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKI 104
F+ +G G FG V++ ++ + VA+K+ + F E + +K +RH++LI +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNC-VLDIFQRLNIMIDVAAALEYLHFGYSAP 163
+ CS + ++ E M GSL L S VL + +++ VA + YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVS 223
IH DL N+L+ +++V ++DFG+A+L+ ++ + + APE G S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 224 TNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283
T DV+SFGI+L E FT + +P M +
Sbjct: 183 TKSDVWSFGILLYEMFTYGQ-------------------VPYPGMNNHEVYDQITAGYRM 223
Query: 284 AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
+C ++ + +EC E R + K + L
Sbjct: 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-28
Identities = 77/267 (28%), Positives = 120/267 (44%), Gaps = 25/267 (9%)
Query: 51 IGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IG G+ G VYKA G EVA+K L+ + E +MK +H N++ +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
D +V+EYM GSL + + ++ Q + +V LEYLH S VIH D+
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
K N+LL + L+DFG A LT +++SK + + T +MAPE + D++
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSV-VGTPYWMAPEVIKRKDYGPKVDIW 200
Query: 230 SFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQC 289
S GIM +E + P + L + +P + + S E K F K
Sbjct: 201 SLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIP----PLKNPEKWSPEFKDFLNK--- 252
Query: 290 VSFVFNLAMECTVESAEQRINAKEIVT 316
C V+ E+R +A+E++
Sbjct: 253 ----------CLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 65/196 (33%), Positives = 103/196 (52%), Gaps = 14/196 (7%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGV-FKSFDVECEVMKSIRHRNLIKIISTCS 109
+G G FG V+ +VAVK L+ G + ++F E ++MK +RH L+++ + CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMID----VAAALEYLHFGYSAPVI 165
++ +V EYM GSL L S RL ++D +A + YL S I
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTN 225
H DL N+L+ +N+V ++DFG+A+L+ +D+ ++ I + APE GR +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 226 GDVYSFGIMLMETFTK 241
DV+SFGI+L E T
Sbjct: 185 SDVWSFGILLTEIVTY 200
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-27
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVF-KSFDVECEVMKSIRHRNLIKIISTC 108
+G+GS G VYK R G A+K H+ F K E + ++S ++K C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 109 SNDDFK----ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
+K ++VLEYM GSL L + + I + L+YLH +
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH--TKRHI 121
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQT-LATIGYMAPEYGREGRVS 223
IH D+KPSN+L++ ++DFGI+K+L + + Q T + T+ YM+PE + S
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPERIQGESYS 178
Query: 224 TNGDVYSFGIMLMETFTKKKP 244
D++S G+ L+E K P
Sbjct: 179 YAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 79/290 (27%), Positives = 135/290 (46%), Gaps = 44/290 (15%)
Query: 51 IGRGSFGSVYKARI--QDGME----VAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIK 103
+G G+FG VYK + + VA+K V + F E E+M ++H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMID 148
++ C+ + ++ EY+ HG L + L ++ LD L+I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
+AA +EYL S +H DL N L+ + + +SDFG+++ + D + Q+++L
Sbjct: 133 IAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 209 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268
+ +M PE G+ +T D++SFG++L E IF+ + Y SN V+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWE----------IFSYGLQPYYGFSNQ---EVI 236
Query: 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
E++ R + E C + V+ L +EC E +R K+I TRL
Sbjct: 237 EMI------RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 63/192 (32%), Positives = 103/192 (53%), Gaps = 8/192 (4%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGV-FKSFDVECEVMKSIRHRNLIKIISTCS 109
+G G FG V++ + VAVK L+ G + K F E ++MK +RH LI++ + C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKT--LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNC-VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
++ +V E M +GSL + L L + Q +++ VA+ + YL + IH D
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
L NVL+ +N + ++DFG+A+++ ED +++ I + APE R S DV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 229 YSFGIMLMETFT 240
+SFGI+L E T
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 47/287 (16%)
Query: 51 IGRGSFGSVYKAR------IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKI 104
+G G+FG V+ A +D M VAVK K F E E++ +++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYS---------------SNCVLDIFQRLNIMIDV 149
C + D +V EYM HG L K L + + L + Q L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
A+ + YL S +H DL N L+ N++ + DFG+++ + D + T+ I
Sbjct: 133 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 210 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVM 268
+M PE + +T DV+SFG++L E FT K+P W L V+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-------------WF-QLSNTEVI 235
Query: 269 E-IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
E I +L R C V+++ + C +QR+N KEI
Sbjct: 236 ECITQGRVLER-------PRVCPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVF---HLQCGGVFKSFDVECEVM-KSIRHRNLIKI 104
+IG GSF +V A+ + E A+K+ L K +E EV+ + H +IK+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 105 ISTCSNDDFKALVLEYMPHGSLEK--CLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
T +++ VLEY P+G L + Y S LD ++ ALEYLH S
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SK 121
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG------------ 210
+IH DLKP N+LLD +M ++DFG AK+L + S + AT
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 211 -------YMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
Y++PE E + D+++ G ++ + T K P
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-25
Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 14/206 (6%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110
IG G FG+V + G +VAVK ++C ++F E VM + H+NL++++ +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKN--IKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 111 DDFKALVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
+ +V+E M G+L L + ++ + Q L +DVA +EYL S ++H DL
Sbjct: 71 NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
N+L+ ++ VA +SDFG+A++ S + + + APE + + S+ DV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181
Query: 230 SFGIMLMETFT-KKKPTDKIFAGEMT 254
S+G++L E F+ + P K+ E+
Sbjct: 182 SYGVLLWEVFSYGRAPYPKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 64/192 (33%), Positives = 96/192 (50%), Gaps = 5/192 (2%)
Query: 50 LIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFK-SFDVECEVMKSIRHRNLIKIISTC 108
L+G+G+FG V+K ++D VAVK K F E ++K H N++K+I C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ +V+E +P G L L Q + +D AA + YL S IH D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
L N L+ +N V +SDFG+++ S S + + I + APE GR S+ DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP-IKWTAPEALNYGRYSSESDV 177
Query: 229 YSFGIMLMETFT 240
+S+GI+L ETF+
Sbjct: 178 WSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-24
Identities = 71/226 (31%), Positives = 103/226 (45%), Gaps = 25/226 (11%)
Query: 51 IGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVEC---E--VMKSIRHRNLIKI 104
+G+GSFG V R +D G A+KV + + K +VE E ++ I H ++K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKK--KIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
++ LVLEY P G L L + R ++ ALEYLH S +
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGI 114
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYMAPEYGREGRVS 223
I+ DLKP N+LLD + L+DFG+AK L S+T T T Y+APE
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKEL---SSEGSRTNTFCGTPEYLAPEVLLGKGYG 171
Query: 224 TNGDVYSFGIMLMETFTKKKP---------TDKIFAGEMTLKYWVS 260
D +S G++L E T K P +KI + ++S
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLS 217
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-24
Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKIISTCS 109
IG G FG V+ + +VA+K ++ G + + F E +VM + H L+++ C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKT--IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
LV E+M HG L L + L + +DV + YL S+ VIH DL
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDL 126
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
N L+ +N V +SDFG+ + + +DQ S T T + + +PE + S+ DV+
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 230 SFGIMLMETFTKKK 243
SFG+++ E F++ K
Sbjct: 186 SFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 77/294 (26%), Positives = 125/294 (42%), Gaps = 50/294 (17%)
Query: 51 IGRGSFGSVYKARI------QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKI 104
+G G+FG V+ A QD M VAVK + F E E++ ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSN--------------CVLDIFQRLNIMIDVA 150
C+ +V EYM HG L + L S L + Q L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 151 AALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
+ + YL HF +H DL N L+ +V + DFG+++ + D + +T+
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPIS 266
I +M PE + +T D++SFG++L E FT K+P Y +SN
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW-----------YQLSN----- 230
Query: 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320
E ++ RE C V+ + C +QR+ K+I +RL
Sbjct: 231 -TEAIECITQGRE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 8/206 (3%)
Query: 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHL-QCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
+G G+ G V K + G +AVK L + K E +++ ++
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
N+ ++ +EYM GSL+K L + I + V L YLH + +IH D
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
+KPSN+L++ L DFG++ L S ++T T YMAPE + S D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182
Query: 229 YSFGIMLMETFTKKKPTDKIFAGEMT 254
+S G+ L+E T + P
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDG 208
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 3e-24
Identities = 67/192 (34%), Positives = 99/192 (51%), Gaps = 13/192 (6%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110
IG+G FG V + G +VAVK ++ ++F E VM +RH NL++++
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 111 DDFKA-LVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ +V EYM GSL L S VL L +DV A+EYL + +H D
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
L NVL+ ++ VA +SDFG+ K + S +Q + + APE RE + ST DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 229 YSFGIMLMETFT 240
+SFGI+L E ++
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 4e-24
Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 37/219 (16%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVK---VFHLQCGGVFKSFDV----ECEVMKSIRHRNLI 102
IG G++G VYKAR + G VA+K + + + G F + E ++++ +RH N++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEG-----FPITAIREIKLLQKLRHPNIV 61
Query: 103 KIISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
++ ++ + +V EYM H L L S Q M + L+YLH
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH--- 117
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE----- 215
S ++H D+K SN+L++++ V L+DFG+A+ T S T + T+ Y PE
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLLGA 176
Query: 216 --YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
YG E V D++S G +L E F K IF G
Sbjct: 177 TRYGPE--V----DMWSVGCILAELFLGK----PIFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 61/195 (31%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDV--ECEVMKSIRHRNLIKIISTC 108
+G G FG V+ + + ++VA+K+ G D E +VM + H NL+++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ +V EYM +G L L L L++ DV A+EYL S IH D
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
L N L+ ++ V +SDFG+A+ + +DQ S T + + PE R S+ DV
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 229 YSFGIMLMETFTKKK 243
+SFG+++ E F++ K
Sbjct: 185 WSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-22
Identities = 76/292 (26%), Positives = 132/292 (45%), Gaps = 48/292 (16%)
Query: 51 IGRGSFGSVYKARIQ-DGME----VAVKVFH-LQCGGVFKSFDVECEVMKSIRHRNLIKI 104
+G +FG +YK + GM+ VA+K + + F E +M + H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLY----------------SSNCVLDIFQRLNIMID 148
+ + + ++ EY+ G L + L + LD L+I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 149 VAAALEYL--HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206
+AA +EYL HF +H DL N+L+ + + +SD G+++ + D + Q ++L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266
I +M PE G+ S++ D++SFG++L E IF+ + Y SN
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWE----------IFSFGLQPYYGFSNQ---E 234
Query: 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
V+E+V R+ + E C +++L EC E +R K+I TRL
Sbjct: 235 VIEMV------RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 13/216 (6%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHL-QCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
IG G+ VY A + + +VA+K L +C E + M H N++K ++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNC--VLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
D LV+ Y+ GSL + SS LD ++ +V LEYLH S IH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLL--TGEDQSKSQTQTLATIGYMAPEYGREGRVST 224
D+K N+LL ++ ++DFG++ L G+ K + + T +MAPE +
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185
Query: 225 NG-DVYSFGIMLMETFTKKKPTDKIFAGE---MTLK 256
D++SFGI +E T P K + +TL+
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ 221
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 2e-22
Identities = 60/195 (30%), Positives = 103/195 (52%), Gaps = 9/195 (4%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVF-KSFDVECEVMKSIRHRNLIKIISTCS 109
+G+G FG V+ VA+K L+ G + ++F E +VMK +RH L+++ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 110 NDDFKALVLEYMPHGSLEKCLY-SSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ +V EYM GSL L L + Q +++ +A+ + Y+ +H D
Sbjct: 72 EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
L+ +N+L+ +N+V ++DFG+A+L+ + + Q I + APE GR + DV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 229 YSFGIMLMETFTKKK 243
+SFGI+L E TK +
Sbjct: 187 WSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-22
Identities = 62/194 (31%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKIISTC 108
IGRG+FG V+ R++ D VAVK K+ F E ++K H N++++I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ +V+E + G L + L + + + ++ + AA +EYL S IH D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI--GYMAPEYGREGRVSTNG 226
L N L+ + V +SDFG+++ ED + T + I + APE GR S+
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 227 DVYSFGIMLMETFT 240
DV+SFGI+L E F+
Sbjct: 178 DVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-22
Identities = 83/288 (28%), Positives = 128/288 (44%), Gaps = 44/288 (15%)
Query: 51 IGRGSFGSVYKARI------QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKI 104
+G G+FG V+ A QD + VAVK K F E E++ +++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCL--YSSNCVL----------DIFQRLNIMIDVAAA 152
C D +V EYM HG L K L + + VL Q L+I +AA
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212
+ YL S +H DL N L+ +N++ + DFG+++ + D + T+ I +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 213 APEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVME-I 270
PE + +T DV+S G++L E FT K+P Y +SN V+E I
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW-----------YQLSN---NEVIECI 235
Query: 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
+L R C V++L + C R+N KEI + L
Sbjct: 236 TQGRVLQR-------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVF-KSFDVECEVMKSIRHRNLIKIISTCS 109
+G G FG V+ +VAVK L+ G + +SF E ++MK +RH L+++ + S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKT--LKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNC-VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ +V EYM GSL L L + +++ VAA + Y+ IH D
Sbjct: 72 EEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
L+ +N+L+ D +V ++DFG+A+L+ + + Q I + APE GR + DV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 229 YSFGIMLMETFTKKK 243
+SFGI+L E TK +
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 49 NLIGRGSFGSVYKA-RIQDGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKII 105
N IG G+FG VY A + G +AVK +Q K E +V++ ++H NL+K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 106 STCSNDDFKALVLEYMPHGSLEK-CLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
+ + + +EY G+LE+ + + + + + L YLH S +
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEG--LAYLH---SHGI 120
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG--------YMAPEY 216
+H D+KP+N+ LD N V L DFG A L K+ T T+ YMAPE
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKL------KNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 217 GREGRVSTNG---DVYSFGIMLMETFTKKKP 244
G+ +G D++S G +++E T K+P
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-21
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV-----ECEVMKSIRH---RN 100
LIGRG++G+VY+ + + G VA+K+ +L DV E ++ +R N
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPN 63
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
+ K + +++EY GS+ + L + + + + + I+ +V AL+Y+H
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH--- 118
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY-MAPEYGRE 219
VIH D+K +N+L+ + L DFG+A LL Q+ S+ T Y MAPE E
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAPEVITE 175
Query: 220 GRV-STNGDVYSFGIMLMETFTKKKP 244
G+ T D++S GI + E T P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-21
Identities = 67/249 (26%), Positives = 111/249 (44%), Gaps = 22/249 (8%)
Query: 44 GFSENNLIGRGSFGSVYKARIQD-----GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRH 98
F +IG+G+FG V + +D M+ K ++ G V + E +++ + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN-ERRILQELNH 59
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHF 158
L+ + + +++ LV++ + G L L S Q + ++ ALEYLH
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLALEYLH- 117
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR 218
S +IH D+KP N+LLD+ H++DF IA +T + + T T T GYMAPE
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLC 172
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKP--------TDKIFAGEMTLKYWVSNLLPISVMEI 270
S D +S G+ E K+P D+I A + T ++
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDA 232
Query: 271 VDANLLSRE 279
++ LL R+
Sbjct: 233 INK-LLERD 240
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 49 NLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIIST 107
+ +G G +G VY+ + + VAVK V + F E VMK I+H NL++++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
C+ + ++ E+M +G+L L N ++ L + +++A+EYL IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG 226
DL N L+ +N + ++DFG+++L+TG D + I + APE + S
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 227 DVYSFGIMLMETFT 240
DV++FG++L E T
Sbjct: 187 DVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 77/295 (26%), Positives = 123/295 (41%), Gaps = 45/295 (15%)
Query: 50 LIGRGSFGSVYKARIQD------GMEVAVKVFHLQCGGV-FKSFDVECEVMKSI-RHRNL 101
+G G+FG V KA VAVK+ E E+MK I +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCL---------YSSNCVLDIFQRL------NIM 146
I ++ C+ + +V+EY HG+L L S + + L +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 147 IDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206
VA +E+L S IH DL NVL+ ++ V ++DFG+A+ + D + T
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266
+ +MAPE + + DV+SFG++L E FT G S I
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--------LGG--------SPYPGIP 239
Query: 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
V E+ L +E + C +++L +C E QR K++V L ++
Sbjct: 240 VEELFK---LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 51 IGRGSFGSVYKA-RIQDGMEVAVKVFHL-QCGGVFKSFDV-ECEVMKSIRHRNLIK---- 103
IG+GSFG+V K R DG + K K V E +++ ++H N+++
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL------NIMIDVAAALEYLH 157
II + + +V+EY G L + + C + + + I+ + AL H
Sbjct: 68 IIDRSNQTLY--IVMEYCEGGDLAQLI--QKCKKE-RKYIEEEFIWRILTQLLLALYECH 122
Query: 158 FGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
V+H DLKP+N+ LD N L DFG+AK+L G D S ++T + T YM+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKT-YVGTPYYMSPE 180
Query: 216 YGREGRVSTNGDVYSFGIMLMETFTKKKP 244
D++S G ++ E P
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-21
Identities = 74/286 (25%), Positives = 134/286 (46%), Gaps = 36/286 (12%)
Query: 46 SENNLIGRGSFGSVYKA--RIQDGMEVAVKVFHLQCGGVFKS---FDVECEVMKSIRHRN 100
++ +IG G FG V++ ++ EVAV + L+ G K F E +M H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
+I++ + ++ EYM +G+L+K L + +Q + ++ +AA ++YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--- 124
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA---TIGYMAPEYG 217
+H DL N+L++ N+ +SDFG++++L ED + T I + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 218 REGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANL 275
+ ++ DV+SFGI++ E + ++P YW +SN VM+ ++
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP------------YWDMSNH---EVMKAIN--- 224
Query: 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
+ A C S V+ L ++C + +R +IV L K+
Sbjct: 225 ---DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-21
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIKIIS 106
I +G++G V+ A+ G A+KV + E +++ + ++K+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
+ LV+EY+P G L L + LD + ++ ALEYLH S +IH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGIIH 116
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKL------LTGEDQSKSQTQTLATIGYMAPEYGREG 220
DLKP N+L+D N L+DFG++K+ + D K + + T Y+APE
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 221 RVSTNGDVYSFGIMLMETFT 240
S D +S G +L E
Sbjct: 177 GHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-21
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 49 NLIGRGSFGSVYKARIQDGM-----EVAVKVFHLQCGGV---FKSFDVECEVMKSIRHRN 100
N +G G+FG VY+ D + + V V L+ G K F E +M + H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNC------VLDIFQRLNIMIDVAAALE 154
++K++ C ++ + +++E M G L L + +L + + L+I +DVA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 155 YL---HFGYSAPVIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206
YL HF IH DL N L+ D + V + DFG+A+ + D + + + L
Sbjct: 121 YLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ +MAPE +G+ +T DV+SFG+++ E T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-21
Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
+G G+FG VYKA+ + G+ A K+ ++ + F VE +++ +H N++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
++ +++E+ G+L+ + L Q + + AL +LH S VIH DL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY-----GREGRVST 224
K N+LL + L+DFG++ Q + + T +MAPE ++
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRD--TFIGTPYWMAPEVVACETFKDNPYDY 187
Query: 225 NGDVYSFGIMLMETFTKKKP 244
D++S GI L+E + P
Sbjct: 188 KADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-21
Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 51 IGRGSFGSV----YKARIQD-GMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKI 104
+G G FG V Y G VAVK +CG S + E ++K++ H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 105 ISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
CS K L++EY+P GSL L L++ Q L + + YLH S
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSKSQTQTLATIGYMAPEYGREGR 221
IH DL NVLLD++ + + DFG+AK + G + + + + + + A E +E +
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 222 VSTNGDVYSFGIMLMETFTKKKP 244
S DV+SFG+ L E T
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 7e-21
Identities = 52/172 (30%), Positives = 91/172 (52%), Gaps = 10/172 (5%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIIST 107
IG G+ G V+KA+ + G VA+K L+ GG+ E + +++ +H ++K++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
+ LV+EYMP L + L L Q + M + + Y+H + ++H
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123
Query: 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE--YG 217
DLKP+N+L+ + V ++DFG+A+L + E+ + + +AT Y APE YG
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEE-PRLYSHQVATRWYRAPELLYG 174
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 8e-21
Identities = 52/168 (30%), Positives = 84/168 (50%), Gaps = 9/168 (5%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIIST 107
+G G++G VYKAR + G VA+K L G+ + E ++K ++H N++K++
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
+ LV EY L+K L L +IM + L Y H S ++H
Sbjct: 67 IHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHR 122
Query: 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
DLKP N+L++ + V L+DFG+A+ ++ T + T+ Y APE
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIP--LRTYTHEVVTLWYRAPE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 8e-21
Identities = 71/284 (25%), Positives = 107/284 (37%), Gaps = 41/284 (14%)
Query: 50 LIGRGSFGSVYKA--------RIQDGMEVAVKVFH-LQCGGVFKSFDVECEVMKSIRHRN 100
+G GSFG V + I VAVK + + F E +M S+ H N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIP----VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHEN 57
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIF--QRL-NIMIDVAAALEYLH 157
LI++ +V E P GSL L L F L + + +A + YL
Sbjct: 58 LIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLE 114
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK-LLTGEDQSKSQTQTLATIGYMAPEY 216
S IH DL N+LL + + DFG+ + L ED + + APE
Sbjct: 115 ---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 217 GREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276
R S DV+ FG+ L E FT GE W L +++ +D
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT---------YGEEP---WAG-LSGSQILKKID---- 214
Query: 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320
+E + E C ++N+ ++C + R + L +
Sbjct: 215 -KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 50 LIGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGG---------VFKSFDVECEVMKSIRHR 99
LIG GSFGSVY G +AVK L + + E ++K ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 100 NLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG 159
N+++ + + + D + LEY+P GS+ L + + R N + + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK------LLTGEDQSKSQTQTLATIGYMA 213
+ +IH D+K +N+L+D+ +SDFGI+K L T + ++ Q ++ +MA
Sbjct: 124 -NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ--GSVFWMA 180
Query: 214 PEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
PE ++ + D++S G +++E T K P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 35/204 (17%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IG G++G VYKAR I G VA+KV L+ G F+ E ++K RH N++ +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLN----------IMIDVAAALEYLHFG 159
D +V+EY GSL+ DI+Q + + L YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPEY 216
IH D+K +N+LL ++ L+DFG++ LT + ++ ++ IG +MAPE
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT---ATIAKRKSF--IGTPYWMAPEV 172
Query: 217 G---REGRVSTNGDVYSFGIMLME 237
R+G D+++ GI +E
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-20
Identities = 66/284 (23%), Positives = 130/284 (45%), Gaps = 38/284 (13%)
Query: 45 FSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGV------FKSFDVECEVMKSIRH 98
+++ ++G+G++G+VY G +AVK L V ++ E +++KS++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDI-FQRLNIMIDVAAALEYLH 157
N+++ + TC +D+ ++ +E++P GS+ L + + F + I + YLH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH 119
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG----YMA 213
+ V+H D+K +NV+L N + L DFG A+ L + + L ++ +MA
Sbjct: 120 ---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 214 PEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273
PE E D++S G + E T K P ++++ ++ M + A
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP--------------LASMDRLAAMFYIGA 222
Query: 274 N--LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIV 315
+ L+ R F+ + FV C +R +A +++
Sbjct: 223 HRGLMPRLPDSFS--AAAIDFV----TSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 67/203 (33%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 51 IGRGSFGSVYKA--RIQDG--MEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIK 103
+G G+FGSV K ++ G +EVAVK H+ G K F E VM + H +++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIVR 60
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCL--YSSNCVLDIFQRLNIMIDVAAALEYL---HF 158
+I C + LV+E P G L K L V D+ + VA + YL HF
Sbjct: 61 LIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF 116
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSKSQTQTLATIGYMAPEYG 217
+H DL NVLL + A +SDFG+++ L G D ++ T + + APE
Sbjct: 117 ------VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 218 REGRVSTNGDVYSFGIMLMETFT 240
G+ S+ DV+S+G+ L E F+
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-20
Identities = 60/195 (30%), Positives = 105/195 (53%), Gaps = 9/195 (4%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVF-KSFDVECEVMKSIRHRNLIKIISTCS 109
+G+G FG V+ +VA+K L+ G + ++F E ++MK +RH L+ + + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKT--LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAAL-EYLHFGYSAPVIHCD 168
+ +V E+M GSL L + + +L ++D+AA + + + + IH D
Sbjct: 72 EEPI-YIVTEFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
L+ +N+L+ DN+V ++DFG+A+L+ + + Q I + APE GR + DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 229 YSFGIMLMETFTKKK 243
+SFGI+L E TK +
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 11/209 (5%)
Query: 51 IGRGSFGSVYKAR-IQDG----MEVAVKVFHLQCGGV-FKSFDVECEVMKSIRHRNLIKI 104
+G G+FG+VYK I +G + VA+KV + K E VM S+ H +++++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
+ C + L+ + MP G L + + + LN + +A + YL +
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVST 224
+H DL NVL+ ++DFG+AKLL +++ I +MA E +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 225 NGDVYSFGIMLMETFT-KKKPTDKIFAGE 252
DV+S+G+ + E T KP + I A E
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 78/248 (31%), Positives = 116/248 (46%), Gaps = 28/248 (11%)
Query: 50 LIGRGSFGSVYKA-RIQDGMEVAVKVFHL-----QCGGVFKSFDVECEVMKSIRHRNLIK 103
L+G GSFGSVY+ + DG AVK L K + E ++ ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCL--YSS--NCVLDIFQRLNIMIDVAAALEYLHFG 159
+ T +D + LE +P GSL K L Y S V+ ++ R + LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH-- 119
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY-GR 218
+H D+K +N+L+D N V L+DFG+AK + +KS + +MAPE +
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK---GSPYWMAPEVIAQ 175
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278
+G D++S G ++E T K P ++ K S LP I D LS
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP----PIPDH--LSD 229
Query: 279 EDKHFAAK 286
E K F K
Sbjct: 230 EAKDFILK 237
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 44 GFSENNLIGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVFKSFDV--ECEVMKSIRHRN 100
F +G+GS+GSVYK R+ D A+K L + D E ++ S+ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 101 LIKIISTCSNDDF-----KALVLEYMPHGSLEKCLYSSNCVLDIFQR---LNIMIDVAAA 152
+I + F +V+EY P G L K + + I I +
Sbjct: 61 II-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212
L+ LH ++H DLK +N+LL N + + D GI+K+L ++ ++TQ T YM
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTPHYM 168
Query: 213 APEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
APE + S D++S G +L E T P
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 5e-20
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 31/205 (15%)
Query: 49 NLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV--------ECEVMKSIRHR 99
+G G++ VYKAR + G VA+K L G K E ++++ ++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKL---GERKEAKDGINFTALREIKLLQELKHP 62
Query: 100 NLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG 159
N+I ++ + LV E+M LEK + + VL + M+ LEYLH
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE---- 215
+ ++H DLKP+N+L+ + V L+DFG+A+ G K Q + T Y APE
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKMTHQ-VVTRWYRAPELLFG 176
Query: 216 ---YGREGRVSTNGDVYSFGIMLME 237
YG D++S G + E
Sbjct: 177 ARHYG------VGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 5e-20
Identities = 73/295 (24%), Positives = 121/295 (41%), Gaps = 56/295 (18%)
Query: 51 IGRGSFGSVYKARI------QDGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIK 103
IG+G+FG V++AR + VAVK+ + ++ F E +M H N++K
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSN---------------------CVLDIFQR 142
++ C+ L+ EYM +G L + L + L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 143 LNIMIDVAAALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199
L I VAA + YL F +H DL N L+ +NMV ++DFG+++ + D
Sbjct: 133 LCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWV 259
K+ I +M PE R +T DV+++G++L E F+ A E + Y
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY-- 244
Query: 260 SNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
+ D N+LS + C ++NL C + R + I
Sbjct: 245 ----------VRDGNVLS-------CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 5e-20
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
F +G GS+GSVYKA + G VA+KV + + E ++K ++K
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
+ + +V+EY GS+ + +N L + I+ LEYLH S
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPEYGREG 220
IH D+K N+LL++ A L+DFG++ LT +K T IG +MAPE +E
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT-MAKRNT----VIGTPFWMAPEVIQEI 174
Query: 221 RVSTNGDVYSFGIMLMETFTKKKP 244
+ D++S GI +E K P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 9e-20
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 35/214 (16%)
Query: 49 NLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKS-FDV-----ECEVMKSIRHRNL 101
IG G++G V A + G +VA+K VF D E ++++ +RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISN----VFDDLIDAKRILREIKLLRHLRHENI 61
Query: 102 IKIISTC---SNDDFKAL--VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL 156
I ++ S +DF + V E M L K + S + D + + + L+YL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119
Query: 157 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ-TQTLATIGYMAPE 215
H SA VIH DLKPSN+L++ N + DFG+A+ + ++ K T+ + T Y APE
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 216 -------YGREGRVSTNGDVYSFGIMLMETFTKK 242
Y + D++S G + E T+K
Sbjct: 177 LLLSSSRY------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 69/282 (24%), Positives = 111/282 (39%), Gaps = 31/282 (10%)
Query: 48 NNLIGRGSFGSVYKA----RIQDGMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLI 102
IG G FG VY+ + + VAVK V + F E +M+ H +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
K+I + ++ +V+E P G L L + LD+ + ++ AL YL S
Sbjct: 71 KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222
+H D+ NVL+ L DFG+++ L E K+ L I +MAPE R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP-IKWMAPESINFRRF 185
Query: 223 STNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281
++ DV+ FG+ + E KP F V N I +E +
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKP----FQ-------GVKNNDVIGRIE---------NGE 225
Query: 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323
C +++L +C +R E+ +L I
Sbjct: 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-19
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 50 LIGRGSFGSVYKAR---IQD--GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKI 104
+G+G+FGSV R +QD G VAVK + F+ E E++KS++H N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 105 ISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
C + + LV+EY+P+GSL L LD + L + +EYL S
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SK 127
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSKSQTQTLATIGYMAPEYGREGR 221
+H DL N+L++ + DFG+ K+L ++ K + + I + APE E +
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 222 VSTNGDVYSFGIMLMETFT 240
S DV+SFG++L E FT
Sbjct: 188 FSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-19
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 8/208 (3%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFK-SFDVECEVMKSIRHRNLIKIISTCS 109
+G G FG V + + +VA+K+ ++ G + + F E +VM + H L+++ C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
+V EYM +G L L Q L + DV + YL S IH DL
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDL 126
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
N L+DD +SDFG+++ + +D+ S + + + PE + S+ DV+
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 230 SFGIMLMETFT-KKKPTDKIFAGEMTLK 256
+FG+++ E ++ K P ++ E K
Sbjct: 186 AFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 3e-19
Identities = 71/278 (25%), Positives = 127/278 (45%), Gaps = 29/278 (10%)
Query: 47 ENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKII 105
E N+I RG G+ YK + I++GM+ VK + + S + M ++H N++K+I
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLI 749
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
C ++ L+ EY+ +L + L + L +R I I +A AL +LH S V+
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTN 225
+L P +++D HL + LL + T+ + Y+APE ++
Sbjct: 806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEK 858
Query: 226 GDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWV----SNL-LPISVMEIVDANLLSRED 280
D+Y FG++L+E T K P D F ++ W S+ L + + + ++ ++
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918
Query: 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
+ + V NLA+ CT R A +++ L
Sbjct: 919 E--------IVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 49 NLIGRGSFGSVYKARIQ-DG--MEVAVKVF-HLQCGGVFKSFDVECEVM-KSIRHRNLIK 103
++IG G+FG V +A I+ DG M A+K+ + F E EV+ K H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCV---------------LDIFQRLNIMID 148
++ C N + + +EY P+G+L L S + L Q L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
VA ++YL IH DL NVL+ +N+ + ++DFG+++ GE+ +T
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181
Query: 209 IGYMAPEYGREGRVSTNGDVYSFGIMLME 237
+ +MA E +T DV+SFG++L E
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-19
Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 49 NLIGRGSFGSVYKARI-QDG--MEVAVK-VFHLQCGGVFKSFDVECEVMKSI-RHRNLIK 103
++IG G+FG V KARI +DG M+ A+K + + F E EV+ + H N+I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCL---------------YSSNCVLDIFQRLNIMID 148
++ C + + L +EY PHG+L L S+ L Q L+ D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
VA ++YL IH DL N+L+ +N VA ++DFG+++ G++ +T
Sbjct: 133 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186
Query: 209 IGYMAPEYGREGRVSTNGDVYSFGIMLME 237
+ +MA E +TN DV+S+G++L E
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 215
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-19
Identities = 64/195 (32%), Positives = 97/195 (49%), Gaps = 8/195 (4%)
Query: 51 IGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IG+G+ G+VY A + G EVA+K +LQ + E VM+ +H N++ + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
D +V+EY+ GSL + + +D Q + + ALE+LH S VIH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
K N+LL + L+DFG +T E QSK T + T +MAPE D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 230 SFGIMLMETFTKKKP 244
S GIM +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 7e-19
Identities = 67/285 (23%), Positives = 117/285 (41%), Gaps = 38/285 (13%)
Query: 51 IGRGSFGSVYK---ARIQDG---MEVAVK-VFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
+G+GSFG VY+ + G VA+K V F E VMK ++++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYS------SNCVLDIFQRLNIM---IDVAAALE 154
++ S +V+E M G L+ L S +N L + ++A +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 155 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAP 214
YL + +H DL N ++ +++ + DFG+ + + D + + L + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 215 EYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274
E ++G +T DV+SFG++L E T + + + E LK+ ++D
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF------------VIDGG 238
Query: 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319
L E C + L C + + R EIV+ L
Sbjct: 239 HLDL-------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 8e-19
Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 12/192 (6%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHL--QCGGVFKSFDVECEVMKSIRHRNLIKIIST 107
IG G++G VYKAR G VA+K L + G+ K+ E +++K + H N+IK++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
+ LV E+M L K + L + + + L + H S ++H
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122
Query: 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE--YGREGRVSTN 225
DLKP N+L++ V L+DFG+A+ + T + T Y APE G +G ST
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAPELLLGDKG-YSTP 179
Query: 226 GDVYSFGIMLME 237
D++S G + E
Sbjct: 180 VDIWSVGCIFAE 191
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-18
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 50 LIGRGSFGSVYKARI--QDGMEVAVKVFHLQCGGVFKS----FDVECEVMKSIRHRNLIK 103
++G G FGSV + ++ DG ++ V V ++ S F E MK H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 104 IISTC----SNDDFKA--LVLEYMPHGSLEKCLYSSNCV-----LDIFQRLNIMIDVAAA 152
+I C S ++L +M HG L L S L + L M+D+A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212
+EYL + IH DL N +L ++M ++DFG++K + D + + ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 213 APEYGREGRVSTNGDVYSFGIMLMETFTK 241
A E + ++ DV++FG+ + E T+
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 72/222 (32%), Positives = 110/222 (49%), Gaps = 35/222 (15%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDV----ECEVMKSIR 97
D F IG G++G VYKAR +D G VA+K L + F + E ++++ +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD--NEKEGFPITAIREIKILRQLN 64
Query: 98 HRNLIKIISTCSND----DFKA------LVLEYMPH---GSLEKCL--YSSNCVLDIFQR 142
HRN++ + ++ DFK LV EYM H G LE L +S + + ++
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 143 LNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202
L LE L++ + +H D+K SN+LL++ L+DFG+A+L E+ +
Sbjct: 125 L---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPY 174
Query: 203 TQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTKK 242
T + T+ Y PE G E R DV+S G +L E FTKK
Sbjct: 175 TNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-18
Identities = 66/225 (29%), Positives = 113/225 (50%), Gaps = 17/225 (7%)
Query: 50 LIGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVFK----SFDVECEVMKSIRHRNLIKI 104
++GRG+FG V+ R D V +K ++ + K + EC+V+K + H N+I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVE--QMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
D +V+EY P G+L + + N +LD L+ + + AL ++H +
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKL 121
Query: 164 VIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTGEDQSKSQTQT-LATIGYMAPEYGREGR 221
++H DLK N+LLD + MV + DFGI+K+L+ SKS+ T + T Y++PE
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILS----SKSKAYTVVGTPCYISPELCEGKP 177
Query: 222 VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266
+ D+++ G +L E + K+ + + LK PIS
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 4e-18
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 45 FSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
F+ IG+GSFG VYKA + VA+KV L+ ++E ++ + I+
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA----EDEIE-DIQQE------IQ 51
Query: 104 IISTCSN-----------DDFK-ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA 151
+S C + K +++EY GS L LD I+ +V
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLL 109
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY 211
LEYLH IH D+K +N+LL + L+DFG++ LT SK T + T +
Sbjct: 110 GLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT-STMSKRNT-FVGTPFW 164
Query: 212 MAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
MAPE ++ D++S GI +E + P
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-18
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 50 LIGRGSFGSVYKARIQD-GMEVAVKVFHL-----QCGGVFKSFDVECEVMKSIRHRNLIK 103
L+G+G+FG VY D G E+AVK + + + E +++K+++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
+D+ ++ +EYMP GS++ L + + + R + +EYLH S
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPE----- 215
++H D+K +N+L D L DFG +K L + S T + G +M+PE
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 216 -YGREGRVSTNGDVYSFGIMLMETFTKKKP 244
YGR+ DV+S G ++E T+K P
Sbjct: 183 GYGRK------ADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 6e-18
Identities = 66/268 (24%), Positives = 115/268 (42%), Gaps = 39/268 (14%)
Query: 70 VAVKVFHLQCGG---VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL 126
VAVKV L+ + F E +++ + N+ +++ C+ D +++EYM +G L
Sbjct: 49 VAVKV--LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 127 EKCLYS-----SNCVLDI----FQRLNIMI-DVAAALEYLHFGYSAPVIHCDLKPSNVLL 176
+ L S + F L M +A+ + YL S +H DL N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV 163
Query: 177 DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLM 236
N ++DFG+++ L D + Q + I +MA E G+ +T DV++FG+ L
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 237 ETFT--KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK---HFAAKEQCVS 291
E T +++P + +T + V+E +A R+D + C
Sbjct: 224 EILTLCREQPYE-----HLTDQ---------QVIE--NAGHFFRDDGRQIYLPRPPNCPK 267
Query: 292 FVFNLAMECTVESAEQRINAKEIVTRLL 319
++ L +EC E R +EI L
Sbjct: 268 DIYELMLECWRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 7e-18
Identities = 75/282 (26%), Positives = 129/282 (45%), Gaps = 36/282 (12%)
Query: 50 LIGRGSFGSVYKARI--QDGMEVAVKVFHLQCGGVFKS---FDVECEVMKSIRHRNLIKI 104
+IG G FG V R+ E+ V + L+ G K F E +M H N+I +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH-FGYSAP 163
+ +V EYM +GSL+ L + + Q + ++ +A+ ++YL GY
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA---TIGYMAPEYGREG 220
+H DL N+L++ N+V +SDFG++++L ED ++ T I + APE
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 221 RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSRE 279
+ ++ DV+S+GI++ E + GE YW +SN I +E E
Sbjct: 185 KFTSASDVWSYGIVMWEVMS---------YGER--PYWEMSNQDVIKAIE---------E 224
Query: 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
A C + + L ++C + +R ++IV+ L K+
Sbjct: 225 GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-18
Identities = 65/290 (22%), Positives = 125/290 (43%), Gaps = 44/290 (15%)
Query: 51 IGRGSFGSVYKARI------QDGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIK 103
+G FG VYK + + VA+K + G + F E + ++H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLY---------------SSNCVLDIFQRLNIMID 148
++ + + +++ Y H L + L + L+ ++I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
+AA +E+L S V+H DL NVL+ D + +SD G+ + + D K +L
Sbjct: 133 IAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 209 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268
I +M+PE G+ S + D++S+G++L E F+ Y + S
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS----------------YGLQPYCGYSNQ 233
Query: 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
++++ + R + + C ++V+ L +EC E +R K+I +RL
Sbjct: 234 DVIE---MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 9e-18
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 45 FSENNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQCGGVFKSFDVE-----CEVMKS 95
F+ ++G+G FGSV +A+++ +VAVK+ +F S D+E MK
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD---IFSSSDIEEFLREAACMKE 57
Query: 96 IRHRNLIKIISTCSNDDFKA------LVLEYMPHGSLEKCLYSSNC-----VLDIFQRLN 144
H N+IK+I K ++L +M HG L L S L + +
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 145 IMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQ 204
MID+A+ +EYL S IH DL N +L++NM ++DFG++K + D +
Sbjct: 118 FMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 205 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK 241
+ + ++A E + +T+ DV++FG+ + E T+
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 55/194 (28%), Positives = 102/194 (52%), Gaps = 6/194 (3%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110
+G G FG V+ + +VAVK V ++F E +MK+++H L+++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 111 DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAAL-EYLHFGYSAPVIHCDL 169
++ ++ EYM GSL L S + +L ID +A + E + + IH DL
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHRDL 129
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
+ +NVL+ ++++ ++DFG+A+++ +++ ++ I + APE G + DV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 230 SFGIMLMETFTKKK 243
SFGI+L E T K
Sbjct: 189 SFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-17
Identities = 70/284 (24%), Positives = 130/284 (45%), Gaps = 38/284 (13%)
Query: 50 LIGRGSFGSVYKARIQ--DGMEVAVKVFHLQCGGVFKS---FDVECEVMKSIRHRNLIKI 104
+IG G FG V + R++ E+ V + L+ G K F E +M H N+I +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
+ ++ E+M +G+L+ L ++ + Q + ++ +AA ++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-----TIGYMAPEYGRE 219
+H DL N+L++ N+V +SDFG+++ L ED + T T + I + APE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 220 GRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLS 277
+ ++ DV+S+GI++ E + ++P YW +SN I+ +E
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP------------YWDMSNQDVINAIE-------- 225
Query: 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
+D C + + L ++C + R +IV+ L K+
Sbjct: 226 -QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 49 NLIGRGSFGSVYKA--RIQDG----MEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNL 101
+G G+FG VY+ R +DG ++VAVK C +S F +E +M H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSSN------CVLDIFQRLNIMIDVAAALEY 155
+++I + ++LE M G L+ L + L + L DVA +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 156 L---HFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
L HF IH D+ N LL VA ++DFG+A+ + + + + I
Sbjct: 132 LEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 210 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+M PE +G ++ DV+SFG++L E F+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 69/283 (24%), Positives = 125/283 (44%), Gaps = 41/283 (14%)
Query: 48 NNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLI 102
+IG G FG V + R++ ++VA+K + F E +M H N+I
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL-HFGYS 161
++ + ++ EYM +GSL+K L ++ + Q + ++ +A+ ++YL Y
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA----TIGYMAPEYG 217
+H DL N+L++ N+V +SDFG L+ + T T I + APE
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFG----LSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 218 REGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANL 275
+ ++ DV+SFGI++ E + ++P YW +SN I +E
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERP------------YWDMSNQDVIKAVE------ 222
Query: 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
+ C S ++ L ++C + +R +IV+ L
Sbjct: 223 ---DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 5/193 (2%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110
+G G FG V+ + + ++VA+K + + + F E +VM + H L+++ C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 111 DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLK 170
+V E+M +G L L L L++ DV +EYL IH DL
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127
Query: 171 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYS 230
N L+ V +SDFG+ + + +D+ S + + + PE + S+ DV+S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 231 FGIMLMETFTKKK 243
FG+++ E FT+ K
Sbjct: 187 FGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 60/218 (27%), Positives = 108/218 (49%), Gaps = 37/218 (16%)
Query: 50 LIGRGSFGSVYKA-RIQDGMEVAVKVFHL----------QCGGVFKSFDVECEVMKSIRH 98
LIG+G++G VY A + G +AVK L + + K+ E E +K + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCL-----YSSNCVLDIFQRLNIMIDVAAAL 153
N+++ + + +++ ++ LEY+P GS+ CL + V ++ V L
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ------VLEGL 121
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYM 212
YLH S ++H DLK N+L+D + + +SDFGI+K + + Q ++ ++ +M
Sbjct: 122 AYLH---SKGILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMSMQGSVFWM 177
Query: 213 APE------YGREGRVSTNGDVYSFGIMLMETFTKKKP 244
APE G +V D++S G +++E F ++P
Sbjct: 178 APEVIHSYSQGYSAKV----DIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 33/207 (15%)
Query: 50 LIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGG--VFKSFDVECEVMKSIRHRNLIKIIS 106
++G G++G V K R + G VA+K F V K+ E +V++ +RH N++ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCV------LDIFQRLNIMIDVAAALEYLHFGY 160
LV EY+ LE S + I+Q L A+ Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ-------AIAYCH--- 117
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE----- 215
S +IH D+KP N+L+ ++ V L DFG A+ L S T +AT Y APE
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGD 176
Query: 216 --YGREGRVSTNGDVYSFGIMLMETFT 240
YG+ DV++ G ++ E
Sbjct: 177 TNYGKP------VDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 4e-17
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 55/212 (25%)
Query: 51 IGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDV-----ECEVMKSIRHRNLIKI 104
+G GSFG V R + + A+K+ + K V E +++SIRH L+ +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKA--KIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIM----IDVA--------AA 152
+ +D LV+EY+P G ++F L VA A
Sbjct: 67 YGSFQDDSNLYLVMEYVPGG-------------ELFSHLRKSGRFPEPVARFYAAQVVLA 113
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGY 211
LEYLH S +++ DLKP N+LLD + ++DFG AK + G +T TL T Y
Sbjct: 114 LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEY 164
Query: 212 MAPE------YGREGRVSTNGDVYSFGIMLME 237
+APE YG+ D ++ GI++ E
Sbjct: 165 LAPEIILSKGYGKA------VDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-17
Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 49 NLIGRGSFGSVYKARIQ-DG--MEVAVKVF-HLQCGGVFKSFDVECEVM-KSIRHRNLIK 103
++IG G+FG V KARI+ DG M+ A+K + F E EV+ K H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCV---------------LDIFQRLNIMID 148
++ C + + L +EY PHG+L L S + L Q L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
VA ++YL IH DL N+L+ +N VA ++DFG+++ G++ +T
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 209 IGYMAPEYGREGRVSTNGDVYSFGIMLME 237
+ +MA E +TN DV+S+G++L E
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-17
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 45 FSENN---LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN 100
+ EN ++G+G++G VY AR + + +A+K + + E + ++HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMI----DVAAALEYL 156
+++ + + S + F + +E +P GSL L S L + +I + L+YL
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIFYTKQILEGLKYL 124
Query: 157 HFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYMAP 214
H ++H D+K NVL++ + V +SDFG +K L G + T+T T+ YMAP
Sbjct: 125 H---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAP 178
Query: 215 EYGREGR--VSTNGDVYSFGIMLMETFTKKKP 244
E +G D++S G ++E T K P
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 8e-17
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR------HRNLI 102
+G G+F S Y+AR ++ G +AVK + +V + K IR H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 103 KII-STCSNDDFKALVLEYMPHGSLEKCLYS----SNCVLDIFQRLNIMIDVAAALEYLH 157
+++ +TC + F L +E+M GS+ L V+ +N + L YLH
Sbjct: 67 RMLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLH 120
Query: 158 FGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLL----TGEDQSKSQTQTLATIGYM 212
+IH D+K +N+L+D ++DFG A L TG + Q Q L TI +M
Sbjct: 121 ---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF--QGQLLGTIAFM 175
Query: 213 APEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
APE R + + DV+S G +++E T K P
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 56/192 (29%), Positives = 100/192 (52%), Gaps = 9/192 (4%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKIISTCS 109
+G G FG V+ +VA+K L+ G + F E +MK ++H L+++ + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKS--LKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAAL-EYLHFGYSAPVIHCD 168
+ ++ EYM +GSL L + I +N +ID+AA + E + F IH D
Sbjct: 72 QEPI-YIITEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKNYIHRD 127
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
L+ +N+L+ + + ++DFG+A+L+ +++ ++ I + APE G + DV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 229 YSFGIMLMETFT 240
+SFGI+L E T
Sbjct: 187 WSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-16
Identities = 64/234 (27%), Positives = 100/234 (42%), Gaps = 21/234 (8%)
Query: 45 FSENNLIGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVFKSFDV--ECEVMKSIRHRNL 101
F N IG+GSFG V+K R D A+K L + + E V+ + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYS-------SNCVLDIFQRLNIMIDVAAALE 154
I+ + + +V+EY +G L K L + V F I + L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGLA 115
Query: 155 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAP 214
+LH S ++H D+K N+ LD + D G+AKLL+ D + + T Y++P
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSP 170
Query: 215 EYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268
E + + DV++ G++L E T K P D G + LK P+S M
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM 224
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-16
Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 44 GFSENNLIGRGSFGSVYKARIQDGME------VAVKVF-HLQCGGVFKSFDVECEVMKSI 96
E +GRG FG V+ A+ + E V VK + + F E ++ + +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 97 RHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCV--------LDIFQRLNIMID 148
H+N+++++ C + ++LEY G L++ L ++ L Q++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
+A +++L +A +H DL N L+ +S ++K + + K + L
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-NALIP 181
Query: 209 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ ++APE +E ST DV+SFG+++ E FT
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 61/227 (26%), Positives = 108/227 (47%), Gaps = 46/227 (20%)
Query: 41 ATDGFSE---NNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG----GVFKSFDVECEV 92
A SE N IG G+ G+VYK + G A+KV + G V + E E+
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQICREIEI 125
Query: 93 MKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAA 152
++ + H N++K ++ ++LE+M GSLE + L R + +
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-----QILSG 180
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT-----QTLA 207
+ YLH ++H D+KPSN+L++ ++DFG++++L +QT ++
Sbjct: 181 IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL-------AQTMDPCNSSVG 230
Query: 208 TIGYMAPEYGREGRVSTN----------GDVYSFGIMLMETFTKKKP 244
TI YM+PE R++T+ GD++S G+ ++E + + P
Sbjct: 231 TIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 50 LIGRGSFGSVYKA-RIQDG----MEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIK 103
L+G G FG+V+K I +G + VA+K + G F+ M S+ H +++
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
++ C + LV + P GSL + LD + LN + +A + YL
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVS 223
++H +L N+LL + + ++DFG+A LL +D+ ++ I +MA E GR +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 224 TNGDVYSFGIMLMETFT 240
DV+S+G+ + E +
Sbjct: 190 HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 45 FSENNLIGRGSFGSVYKARIQDGME-VAVKVFHL--QCGGVFKSFDVECEVMKSIRHRNL 101
F + N IG G++G VY+AR E VA+K + + G+ S E ++ ++RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 102 IKIISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG 159
+++ + LV+EY L L + Q +M+ + L+YLH
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE 219
+ +IH DLK SN+LL D ++DFG+A+ T +K T + T+ Y APE
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 220 GRVSTNG-DVYSFGIMLMETFTKK 242
T D+++ G +L E K
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 32/217 (14%)
Query: 51 IGRGSFGSVY--------KARIQDGMEVAVKVFHLQCGGVFKSFD---VECEVMKSI-RH 98
+G G FG V K + ++ + VAVK+ L+ K E E+MK I +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCL-----------YSSNCVLD---IFQRL- 143
+N+I ++ C+ D +++EY G+L + L Y V D F+ L
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 144 NIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203
+ VA +EYL S IH DL NVL+ +N V ++DFG+A+ + D K T
Sbjct: 141 SCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ +MAPE + + DV+SFG+++ E FT
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-16
Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 32/275 (11%)
Query: 51 IGRGSFGSV----YKARIQDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKII 105
+G G+FG V YK R + ++VA+KV + V E E+M + + ++++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQ-IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
C + LV+E G L K L + + + +M V+ ++YL +
Sbjct: 62 GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ-SKSQTQTLATIGYMAPEYGREGRVST 224
H DL NVLL + A +SDFG++K L +D K+++ + + APE + S+
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 225 NGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283
DV+S+GI + E F+ +KP K+ E VM ++ K
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPE--------------VMSFIEQG------KRL 217
Query: 284 AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
+C ++ L +C + E R N ++ R+
Sbjct: 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERM 252
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 37/225 (16%)
Query: 48 NNLIGRGSFGSVYKAR-IQDGMEVAVKVFHL---------------QCGGVFKSFDVECE 91
+G G++G V KA G VA+K + CG F + E +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR-ELK 72
Query: 92 VMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA 151
+M I+H N++ ++ DF LV++ M L+K + L Q I++ +
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILN 130
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK---------LLTGEDQSKSQ 202
L LH Y +H DL P+N+ ++ + ++DFG+A+ L+ ++ + +
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 203 ---TQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTKK 242
T + T+ Y APE G E + D++S G + E T K
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-16
Identities = 67/239 (28%), Positives = 99/239 (41%), Gaps = 29/239 (12%)
Query: 43 DGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRN 100
+ E + +G G+ GSV K R+ GM A+K + K E E+ KS +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 101 LIKIISTCSNDDFK--ALVLEYMPHGSLEKCLYSSNCVLDIFQRLN------IMIDVAAA 152
++K ++ + +EY GSL+ +Y V R+ I V
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKK--VKKRGGRIGEKVLGKIAESVLKG 117
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212
L YLH S +IH D+KPSN+LL L DFG+ +GE + T YM
Sbjct: 118 LSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAGTFTGTSFYM 170
Query: 213 APEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271
APE + S DV+S G+ L+E + P F E L PI ++ +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFP----FPPEGE-----PPLGPIELLSYI 220
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 31/223 (13%)
Query: 45 FSENNL-----IGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGV-FKSFDVECE-VMKSI 96
F+ +L IGRG+FG+V K + G +AVK K ++ + VM+S
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 97 RHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA----A 152
++K + + +E M SL+K VL I+ +A A
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212
L YL +IH D+KPSN+LLD N L DFGI+ L S ++T+ YM
Sbjct: 120 LNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPYM 174
Query: 213 APEYGREGRVSTNG--------DVYSFGIMLMETFTKKKPTDK 247
APE R+ + DV+S GI L E T K P K
Sbjct: 175 APE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-16
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 13/205 (6%)
Query: 49 NLIGRGSFGSVYKARI--QDGMEVAVKVFHL----QCGGVFKSFDVECEVMKSIRHRNLI 102
+IG+G FG VY + DG ++ V L V + F E +MK H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV-EQFLKEGIIMKDFSHPNVL 59
Query: 103 KIISTCSNDDFKALV-LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS 161
++ C + LV L YM HG L + S + + + VA +EYL S
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---S 116
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT--IGYMAPEYGRE 219
+H DL N +LD++ ++DFG+A+ + ++ T A + +MA E +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKP 244
+ +T DV+SFG++L E T+ P
Sbjct: 177 QKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IG G++G VYKAR + G A+KV L+ G F E +MK +H N++ +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
D + +E+ GSL+ +Y L Q + + L YLH S +H D+
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYG---REGRVSTNG 226
K +N+LL DN L+DFG++ +T + + T +MAPE R+G +
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRK--SFIGTPYWMAPEVAAVERKGGYNQLC 190
Query: 227 DVYSFGIMLMETFTKKKP 244
D+++ GI +E + P
Sbjct: 191 DIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-16
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 51 IGRGSFGSVYKARIQDGME---------VAVKVFHLQCGGVFKSFD---VECEVMKSI-R 97
+G G FG V A G++ VAVK+ L+ K E E+MK I +
Sbjct: 26 LGEGCFGQVVMAEAI-GLDKEKPNRVTKVAVKM--LKSDATEKDLSDLISEMEMMKMIGK 82
Query: 98 HRNLIKIISTCSNDDFKALVLEYMPHGSLEKCL-----------YSSNCV----LDIFQR 142
H+N+I ++ C+ D +++EY G+L + L Y+ V L
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 143 LNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202
++ VA +EYL S IH DL NVL+ ++ V ++DFG+A+ + D K
Sbjct: 143 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
T + +MAPE + + DV+SFG++L E FT
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 9e-16
Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IG+G+ G+V+ A + G EVA+K +LQ + E VMK +++ N++ + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
D +V+EY+ GSL + + C +D Q + + ALE+LH + VIH D+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV-TETC-MDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
K NVLL + L+DFG +T E QSK T + T +MAPE D++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 230 SFGIMLMETFTKKKP 244
S GIM +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 59/224 (26%), Positives = 108/224 (48%), Gaps = 34/224 (15%)
Query: 51 IGRGSFGSVYKARIQDGME---------------VAVKVFHLQCGGVFKS-FDVECEVMK 94
+G G FG V+ + E VAVK+ ++ F E ++M
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 95 SIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCL----------YSSN--CVLDIFQR 142
+++ N+I+++ C +DD ++ EYM +G L + L +++N V I
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV-SIANL 131
Query: 143 LNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202
L + + +A+ ++YL S +H DL N L+ ++ ++DFG+++ L D + Q
Sbjct: 132 LYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--KKKP 244
+ + I +MA E G+ +T DV++FG+ L E FT K++P
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 1e-15
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 11/211 (5%)
Query: 50 LIGRGSFGSVYKA-RIQDG----MEVAVKVFHLQCGGVFK-SFDVECEVMKSIRHRNLIK 103
++G G+FG+VYK + +G + VA+K+ + G F E +M S+ H +L++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
++ C + + LV + MPHG L ++ + LN + +A + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVS 223
++H DL NVL+ ++DFG+A+LL G+++ + I +MA E + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 224 TNGDVYSFGIMLMETFT-KKKPTDKIFAGEM 253
DV+S+G+ + E T KP D I E+
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 67/284 (23%), Positives = 118/284 (41%), Gaps = 37/284 (13%)
Query: 51 IGRGSFGSVYKARI-----QDGMEVAVKVFHLQCGGV-FKSFDVECEVMKSIRHRNLIKI 104
+G G FG V R G +VAVK + GG E E+++++ H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 105 ISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
C+ D L++E++P GSL++ L + +++ Q+L + + ++YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYMAPEYGREGR 221
+H DL NVL++ + DFG+ K + + + + L + + + APE + +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 222 VSTNGDVYSFGIMLMETFT----KKKPTDKIFA------GEMTLKYWVSNLLPISVMEIV 271
DV+SFG+ L E T + P G+MT+ V L
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL--------- 239
Query: 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIV 315
E K C V+ L +C +R + ++
Sbjct: 240 ------EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IG+G+ G+VY A + G EVA++ +LQ + E VM+ ++ N++ + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
D +V+EY+ GSL + + C +D Q + + ALE+LH S VIH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
K N+LL + L+DFG +T E QSK ++ + T +MAPE D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPE-QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 230 SFGIMLMETFTKKKP 244
S GIM +E + P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 50 LIGRGSFGSVYKARIQD-GMEVAVKVF--HLQCGGVFKSFDVECEVMKSIRHRNLIKIIS 106
L+G GS+G V K + ++ G VA+K F V K E ++K +RH NL+ +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
LV E++ H L+ N LD + + + +E+ H S +IH
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCH---SHNIIH 123
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE-------YGRE 219
D+KP N+L+ + V L DFG A+ L + T +AT Y APE YGR
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 220 GRVSTNGDVYSFGIMLMETFT 240
D+++ G ++ E T
Sbjct: 182 ------VDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 27/222 (12%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVK--VFHLQCGGVFKSFDVECEVMKSIR---H 98
+ E IG G++G+VYKAR + G VA+K L G+ S E ++K + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 99 RNLIKIISTCSNDDFK-----ALVLEYMP---HGSLEKCLYSSNCVLDIFQRLNIMIDVA 150
N+++++ C LV E++ L KC L ++M +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC---PKPGLPPETIKDLMRQLL 117
Query: 151 AALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG 210
+++LH S ++H DLKP N+L+ + ++DFG+A++ + E + T + T+
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVTLW 171
Query: 211 YMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
Y APE + +T D++S G + E F +++P +F G
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRP---LFRGT 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 63/245 (25%), Positives = 99/245 (40%), Gaps = 56/245 (22%)
Query: 51 IGRGSFGSVYKARIQDGMEV-AVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIKIIS 106
+G G FG V +++ A+K H+ G + E E+++ H ++K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA---------ALEYLH 157
T + + +++EY G L I + + + A A EYLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL----------WTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYMAPE- 215
+ +I+ DLKP N+LLD N L DFG AK L +S +T T T Y+APE
Sbjct: 111 ---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAPEI 163
Query: 216 -----YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME- 269
Y + D +S GI+L E T + P F + P+ +
Sbjct: 164 ILNKGYDF------SVDYWSLGILLYELLTGRPP----FGE--------DDEDPMEIYND 205
Query: 270 IVDAN 274
I+ N
Sbjct: 206 ILKGN 210
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 51 IGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IG+G+ G+VY A I G EVA+K +LQ + E VM+ ++ N++ + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
D +V+EY+ GSL + + C +D Q + + AL++LH S VIH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
K N+LL + L+DFG +T E QSK T + T +MAPE D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 230 SFGIMLMETFTKKKP 244
S GIM +E + P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 28/218 (12%)
Query: 42 TDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV--------ECEV 92
F IG+G F VYKA + DG VA+K +F+ D E ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ-----IFEMMDAKARQDCLKEIDL 55
Query: 93 MKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLE---KCLYSSNCVLDIFQRLNIMIDV 149
+K + H N+IK +++ ++ +VLE G L K ++ + +
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL---TGEDQSKSQTQTL 206
+ALE++H S ++H D+KP+NV + V L D G+ + T S +
Sbjct: 116 CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-----V 167
Query: 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
T YM+PE E + D++S G +L E + P
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 51 IGRGSFGSVY--------KARIQDGMEVAVKVFHLQCGGVFKSFD---VECEVMKSI-RH 98
+G G FG V K + + VAVK+ L+ K E E+MK I +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCL---------YS-SNCVLD----IFQRL- 143
+N+I ++ C+ D +++EY G+L + L YS C L F+ L
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 144 NIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203
+ VA +EYL S IH DL NVL+ ++ V ++DFG+A+ + D K T
Sbjct: 138 SCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ +MAPE + + DV+SFG++L E FT
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 51 IGRGSFGSVYKARI-QDG--MEVAVKVFHLQ-CG-GVFKSFDVECEVMKSIRHRNLIKII 105
+G G FGSV + ++ QD ++VAVK + C + F E MK H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 106 STC----SNDDFKA--LVLEYMPHGSLEKCLYSSNC-----VLDIFQRLNIMIDVAAALE 154
C ++ + + ++L +M HG L L S L + M D+A+ +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 155 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAP 214
YL S IH DL N +L++NM ++DFG++K + D + + ++A
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 215 EYGREGRVSTNGDVYSFGIMLMETFTK 241
E + +T DV+SFG+ + E T+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 5e-15
Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 51/298 (17%)
Query: 51 IGRGSFGSVYKA--------RIQDGMEVAVKVFHLQCGGVFKSF-DV--ECEVMKSI-RH 98
+G G FG V +A R + VAVK+ L+ K D+ E E+MK I +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLISEMELMKLIGKH 77
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSS-----NCVLDI---------FQRL- 143
+N+I ++ C+ + +++EY G+L + L + + DI F+ L
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 144 NIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203
+ VA +EYL S IH DL NVL+ ++ V ++DFG+A+ + D K +
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL 263
+ +MAPE + + DV+SFGI++ E FT G
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT--------LGGS----------- 235
Query: 264 PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
P + + + L RE C ++ L EC QR K++V L K+
Sbjct: 236 PYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-15
Identities = 59/191 (30%), Positives = 98/191 (51%), Gaps = 7/191 (3%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110
+G G FG V+ A +VAVK V ++F E VMK+++H L+K+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 111 DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAAL-EYLHFGYSAPVIHCDL 169
+ ++ E+M GSL L S Q L +ID +A + E + F IH DL
Sbjct: 73 EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
+ +N+L+ ++V ++DFG+A+++ + + + I + APE G + DV+
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSDVW 187
Query: 230 SFGIMLMETFT 240
SFGI+LME T
Sbjct: 188 SFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 30/226 (13%)
Query: 34 SYLELFQATDG---FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHL---QCGGVFKSF 86
ELF D F++ IG GSFG+VY AR ++ VA+K Q ++
Sbjct: 3 EIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI 62
Query: 87 DVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDI----FQR 142
E ++ +RH N I+ + LV+EY CL S++ +L++ Q
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQE 114
Query: 143 LNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202
+ I AL+ L + +S IH D+K N+LL + L+DFG A L S
Sbjct: 115 VEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL-------VSP 167
Query: 203 TQT-LATIGYMAPEY---GREGRVSTNGDVYSFGIMLMETFTKKKP 244
+ + T +MAPE EG+ DV+S GI +E +K P
Sbjct: 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-15
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHL--QCGGVFKSFDVECEVMKSIRHRNLIKIIST 107
IG G++G VYKAR G VA+K L + GV + E ++K + H N++K++
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAA-----LEYLHFGYSA 162
++ LV E++ H L+K +D I + + + L+ L F +S
Sbjct: 68 IHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222
V+H DLKP N+L++ L+DFG+A+ ++ T + T+ Y APE +
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGCKY 177
Query: 223 -STNGDVYSFGIMLMETFTKK 242
ST D++S G + E T++
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-15
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
+G G++G VYKAR + G AVK+ L+ G F E ++K +H N++ +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
+ + + +EY GSL+ +Y L Q + + L YLH S +H D+
Sbjct: 77 SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG--- 226
K +N+LL DN L+DFG+A +T + + T +MAPE V NG
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRK--SFIGTPYWMAPEV---AAVEKNGGYN 187
Query: 227 ---DVYSFGIMLMETFTKKKP 244
D+++ GI +E + P
Sbjct: 188 QLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 52/190 (27%), Positives = 88/190 (46%), Gaps = 16/190 (8%)
Query: 65 QDGMEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIKII-STCSNDDFKALVLEY 120
G EVA+K+ + F E + + H N++ ++ S + V EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL---D 177
+P +L + L +++ L + +M+ V AL H + ++H DLKP N+++
Sbjct: 61 VPGRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116
Query: 178 DNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT--IG---YMAPEYGREGRVSTNGDVYSFG 232
A + DFGI LL G + T T T +G Y APE R V+ N D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 233 IMLMETFTKK 242
++ +E T +
Sbjct: 177 LIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 28/193 (14%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVFKSFDV--------- 88
F + IG G++G V A + G +VA+K + +FDV
Sbjct: 1 FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLR 53
Query: 89 ECEVMKSIRHRNLIKI--ISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLN 144
E ++++ +H N+I I I DFK +V++ M L ++S + + R
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY- 111
Query: 145 IMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG--EDQSKSQ 202
+ + L+Y+H SA VIH DLKPSN+L++++ + DFG+A+ L+ +
Sbjct: 112 FLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 203 TQTLATIGYMAPE 215
T+ +AT Y APE
Sbjct: 169 TEYVATRWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 32/236 (13%)
Query: 36 LELFQATDGFSENNLIGRGSFGSVYKAR-IQDG----MEVAVKVFHLQCG-GVFKSFDVE 89
L + + T+ F + ++G G+FG+VYK I +G + VA+K K E
Sbjct: 1 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 59
Query: 90 CEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQR------- 142
VM S+ + ++ +++ C + L+ + MP G C+LD +
Sbjct: 60 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGS 108
Query: 143 ---LNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199
LN + +A + YL ++H DL NVL+ ++DFG+AKLL +++
Sbjct: 109 QYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165
Query: 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMT 254
I +MA E + DV+S+G+ + E T KP D I A E++
Sbjct: 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVK---VFHLQCGGVFKSFDVECEVMKSIRHRN 100
F IGRG F VY+A + DG+ VA+K +F L E +++K + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSL---------EKCLYSSNCVLDIFQRLNIMIDVAA 151
+IK ++ D+ +VLE G L +K L V F + + +
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF------VQLCS 117
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY 211
ALE++H S V+H D+KP+NV + V L D G+ + + ++ + + T Y
Sbjct: 118 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYY 172
Query: 212 MAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
M+PE E + D++S G +L E + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 71/225 (31%), Positives = 111/225 (49%), Gaps = 40/225 (17%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSF----DVEC---EVM--KSIR-HR 99
+G+G++G V+KA + VA+K +F +F D + E+M + + H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK-------KIFDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 100 NLIKIIST--CSNDDFKALVLEYMP---HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALE 154
N++K+++ ND LV EYM H + N + D+ +R IM + AL+
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRY-IMYQLLKALK 121
Query: 155 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ---TQTLATIGY 211
Y+H S VIH DLKPSN+LL+ + L+DFG+A+ L+ +++ T +AT Y
Sbjct: 122 YIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 212 MAPEYGREGRVSTNG-DVYSFGIMLMETFTKKKPTDKIFAGEMTL 255
APE T G D++S G +L E K +F G TL
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGK----PLFPGTSTL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 4e-14
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 30/204 (14%)
Query: 51 IGRGSFGSVYKARIQDGME-VAVKVFHLQCGGVFKSFDVEC----EVMKSIR----HRNL 101
+G G+FGSVY AR ++ E VA+K + F S++ EC EV KS+R H N+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKK----FYSWE-ECMNLREV-KSLRKLNEHPNI 60
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSS--NCVLDIFQRLNIMIDVAAALEYLH-F 158
+K+ +D V EYM G+L + L +I+ + L ++H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ-TQTLATIGYMAPE-Y 216
G+ H DLKP N+L+ V ++DFG+A+ E +S+ T ++T Y APE
Sbjct: 119 GF----FHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRWYRAPEIL 170
Query: 217 GREGRVSTNGDVYSFGIMLMETFT 240
R S+ D+++ G ++ E +T
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-14
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 51 IGRGSFGSVYKA---RIQDG---MEVAVKVFHLQCGGV-FKSFDVECEVMKSIRHRNLIK 103
+G G FG V KA R++ VAVK+ + E ++K + H ++IK
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCV-----------------------LDIF 140
+ CS D L++EY +GSL L S V L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 141 QRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200
++ ++ ++YL ++H DL NVL+ + +SDFG+++ + ED
Sbjct: 128 DLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+++ + +MA E + +T DV+SFG++L E T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 23/213 (10%)
Query: 45 FSENNL-----IGRGSFGSVYKA------RIQDGMEVAVKVF----HLQCGGVFKSFDVE 89
F NNL +G G+FG V +A + M+VAVK+ H S E
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---E 88
Query: 90 CEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMI 147
++M + H N++ ++ C+ ++ EY +G L L L + L+
Sbjct: 89 LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148
Query: 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
VA + +L S IH DL NVLL + + DFG+A+ + + +
Sbjct: 149 QVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ +MAPE + DV+S+GI+L E F+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 7e-14
Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 39/228 (17%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVK--VFHLQCGGVFKSFDV----ECEVMKSIRHRNLIK 103
+G G+FG VYKAR I+ G VA+K + H + G F + E +++K ++H N++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG----FPITALREIKILKKLKHPNVVP 71
Query: 104 II------STCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEY 155
+I S + +V YM H L L + + L Q M+ + + Y
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINY 130
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS---------KSQTQTL 206
LH ++H D+K +N+L+D+ + ++DFG+A+ G + + T +
Sbjct: 131 LH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187
Query: 207 ATIGYMAPEY--GREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
T Y PE G E R +T D++ G + E F ++P I G+
Sbjct: 188 VTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMF-TRRP---ILQGK 230
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-14
Identities = 65/284 (22%), Positives = 125/284 (44%), Gaps = 38/284 (13%)
Query: 51 IGRGSFGSVY----KARIQDGMEVAVKVFHLQCGGVFKS---FDVECEVMKSIRHRNLIK 103
+G+GSFG VY K ++D E V + + + F E VMK ++++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYS------SNCVL---DIFQRLNIMIDVAAALE 154
++ S +++E M G L+ L S +N V + + + + ++A +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 155 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAP 214
YL+ + +H DL N ++ ++ + DFG+ + + D + + L + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 215 EYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274
E ++G +T DV+SFG++L E T + + + E L++ VME
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF---------VME---GG 238
Query: 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
LL + D C +F L C + + R + EI++ +
Sbjct: 239 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 7e-14
Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 51 IGRGSFGSVYKARIQDGME-VAVKVFHLQCGGVFKSFDV-----ECEVMKSIRHRNLIKI 104
+G+G +G V+ A+ +D E VA+K +FK +V E +++ + + L+K+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSL--LFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH-FGYSAP 163
+ +D++ L +EY+P G + L ++ VL M ++ A++ LH GY
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY--- 122
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA--TIG---YMAPEYGR 218
IH DLKP N L+D + L+DFG++K T A +G YMAPE R
Sbjct: 123 -IHRDLKPENFLIDASGHIKLTDFGLSK----------GIVTYANSVVGSPDYMAPEVLR 171
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE------MTLKYW 258
D +S G ML E P F+G LKYW
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPP----FSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-14
Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 11/193 (5%)
Query: 51 IGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
+G G+FG VYKA+ ++ G A KV + + + VE E++ + H ++K++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
D +++E+ P G+++ + + L I + LE L + +S +IH DL
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY-----GREGRVST 224
K NVLL + L+DFG++ Q + + T +MAPE ++
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD--SFIGTPYWMAPEVVMCETMKDTPYDY 194
Query: 225 NGDVYSFGIMLME 237
D++S GI L+E
Sbjct: 195 KADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-14
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 50 LIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDV---ECEV--MKSIRHRNLIK 103
L+GRG+FG VY D G E+AVK S +V ECE+ +K++RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 104 IISTCSNDDFKALVL--EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS 161
+ + K L + EYMP GS++ L + + + R + + YLH S
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY-MAPE----- 215
++H D+K +N+L D L DFG +K + S + +++ Y M+PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184
Query: 216 -YGREGRVSTNGDVYSFGIMLMETFTKKKP 244
YGR+ DV+S ++E T+K P
Sbjct: 185 GYGRK------ADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-14
Identities = 56/189 (29%), Positives = 93/189 (49%), Gaps = 10/189 (5%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IG GS G V A G +VAVK L+ + E +M+ +H N++++ S+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
D +V+E++ G+L + + ++ Q + + V AL +LH + VIH D+
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDI 141
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
K ++LL + LSDFG ++ E + KS + T +MAPE T D+
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS---LVGTPYWMAPEVISRLPYGTEVDI 198
Query: 229 YSFGIMLME 237
+S GIM++E
Sbjct: 199 WSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 45 FSENNLIGRGSFGSVYKA---RIQDGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRN 100
F++ IG+GSFG V+K R Q VA+K+ L+ + E V+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
+ K + D +++EY+ GS L LD Q I+ ++ L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH--- 118
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG 220
S IH D+K +NVLL ++ L+DFG+A LT D + + T +MAPE ++
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 221 RVSTNGDVYSFGIMLMETFTKKKPTDKI 248
+ D++S GI +E + P ++
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 63/195 (32%), Positives = 93/195 (47%), Gaps = 17/195 (8%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVM-------KSIRHRNLI 102
IG+GSFG V A+ DG AVKV LQ + K + + +M K+++H L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQK-HIMAERNVLLKNVKHPFLV 59
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
+ + D VL+Y+ G L L + R ++A+AL YLH S
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SL 115
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222
+I+ DLKP N+LLD L+DFG+ K G + SK+ + T Y+APE R+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 223 STNGDVYSFGIMLME 237
D + G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 40/231 (17%)
Query: 29 TWRRFSYLELFQATDGFSENNLIGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVFKSFD 87
WRR L+G+G+FG VY + G E+A K S +
Sbjct: 3 NWRR---------------GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKE 47
Query: 88 V---ECEV--MKSIRHRNLIKIISTCSNDDFKALV--LEYMPHGSLEKCLYSSNCVLDIF 140
V ECE+ +K+++H +++ + K L +EYMP GS++ L + + +
Sbjct: 48 VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107
Query: 141 QRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200
R + + YLH S ++H D+K +N+L D L DFG +K L S
Sbjct: 108 TR-KYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG 163
Query: 201 SQTQTLATIGY-MAPE------YGREGRVSTNGDVYSFGIMLMETFTKKKP 244
+ +++ Y M+PE YGR+ DV+S G ++E T+K P
Sbjct: 164 TGIRSVTGTPYWMSPEVISGEGYGRK------ADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 35/225 (15%)
Query: 51 IGRGSFGSVYKARIQDGME------------------VAVKVFHLQCGGVFKS-FDVECE 91
+G G FG V+ + GME VAVK+ ++ F E +
Sbjct: 13 LGEGQFGEVHLCEAE-GMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 92 VMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCL---------YSSNCVLDIFQR 142
+M ++ N+I++++ C D ++ EYM +G L + L ++ V +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 143 LNIM-IDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201
L M +A+ ++YL S +H DL N L+ N ++DFG+++ L D +
Sbjct: 132 LIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--KKKP 244
Q + + I +M+ E G+ +T DV++FG+ L E T K++P
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 10/221 (4%)
Query: 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEV--MKSIRHRNLIKIIST 107
IG GSFG +Y A+ + D +K L V + + EV + ++H N++ ++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVL-DIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
+ +V+EY G L K + VL Q L+ + ++ L+++H ++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILH 124
Query: 167 CDLKPSNVLLDDN-MVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTN 225
D+K N+ L N MVA L DFGIA+ L D + + T Y++PE + +
Sbjct: 125 RDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEICQNRPYNNK 182
Query: 226 GDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266
D++S G +L E T K P + ++ LK PIS
Sbjct: 183 TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 50 LIGRGSFGSVYKARIQDGME--VAVK---VFHLQCGGVFKSFD-------VECEVMK-SI 96
+G G+FG VYK R ++ + +A+K V + G + D E ++K +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 97 RHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIF--QRL-NIMIDVAAAL 153
RH N+++ T +D +V++ + L + S F +R+ NI + + AL
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMA 213
YLH ++H DL P+N++L ++ ++DFG+AK E + S + TI Y
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS---VVGTILYSC 181
Query: 214 PEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273
PE + DV++FG +L + T + P ++ +N+L ++ +IV+A
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP------------FYSTNMLSLA-TKIVEA 228
Query: 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQR 308
+ ++ V+ V C AE R
Sbjct: 229 VYEPLPEGMYSED---VTDVIT---SCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 66/274 (24%), Positives = 126/274 (45%), Gaps = 31/274 (11%)
Query: 51 IGRGSFGS--VYKARIQDGMEVAVKVFHLQCGGVFKSFDV--ECEVMKSIRHRNLIKIIS 106
+G+G+FG +Y+ R +D V K +L + D E ++ ++H N+I +
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 107 TCSNDDFKALVLEYMPHGSL-EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
+D+ + +EY G+L +K + + + L + + +A+ Y+H A ++
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTN 225
H D+K N+ L + L DFGI+K+L G + S ++T + T YM+PE + + +
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVGTPYYMSPELCQGVKYNFK 181
Query: 226 GDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAA 285
D+++ G +L E T K + F +N L + V++IV N +
Sbjct: 182 SDIWALGCVLYELLTLK----RTFDA--------TNPLNL-VVKIVQGN-------YTPV 221
Query: 286 KEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319
S + +L + E+R A E++ + L
Sbjct: 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 45 FSENNLIGRGSFGSVYKA---RIQDGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRN 100
F++ IG+GSFG V+K R Q VA+K+ L+ + E V+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQ--VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
+ K + +++EY+ GS L + D FQ ++ ++ L+YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH--- 118
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG 220
S IH D+K +NVLL + L+DFG+A LT + Q K T + T +MAPE ++
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNT-FVGTPFWMAPEVIQQS 176
Query: 221 RVSTNGDVYSFGIMLMETFTKKKP 244
+ D++S GI +E + P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVK---VFHLQCGGVFKSFDVECEVMKSIRHRNLIKIIS 106
IGRG F VY+A + D VA+K +F + + E +++K + H N+IK +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 107 TCSNDDFKALVLEYMPHGSLEKCL-YSSNCVLDIFQRL--NIMIDVAAALEYLHFGYSAP 163
+ D+ +VLE G L + + Y I +R + + +A+E++H S
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVS 223
V+H D+KP+NV + V L D G+ + + + + + + T YM+PE E +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYN 184
Query: 224 TNGDVYSFGIMLMETFTKKKP 244
D++S G +L E + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 65/225 (28%), Positives = 91/225 (40%), Gaps = 59/225 (26%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFH--------------LQCGGVFKSFD----VEC 90
IG G+ G VYK R + G +AVK L V KS D V+C
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV--VLKSHDCPYIVKC 79
Query: 91 --EVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMID 148
+ ++++STC D + +P L K +
Sbjct: 80 YGYFITDSDVFICMELMSTCL-DKLLKRIQGPIPEDILGKMTVA---------------- 122
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
+ AL YL + VIH D+KPSN+LLD + L DFGI+ L SK++T++
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGC 177
Query: 209 IGYMAPEYGREGRVSTN---------GDVYSFGIMLMETFTKKKP 244
YMAPE R+ DV+S GI L+E T + P
Sbjct: 178 AAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHL---QCGGVFKSFDVECEVMKSIRHRN 100
FS+ IG GSFG+VY AR +++ VA+K Q ++ E ++ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA----ALEYL 156
I+ + LV+EY CL S++ +L++ ++ +++AA AL+ L
Sbjct: 77 TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 157 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY 216
+ +S +IH D+K N+LL + + L DFG A ++ + T +MAPE
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEV 182
Query: 217 ---GREGRVSTNGDVYSFGIMLMETFTKKKP 244
EG+ DV+S GI +E +K P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-13
Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 51 IGRGSFGSVYKARIQD-GMEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIKIIS 106
+G+G FG V +++ G A K L+ + E ++++ + R ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
D LV+ M G L+ +Y+ + + + LE+LH ++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTN 225
+ DLKP NVLLDD+ +SD G+A L G K T GYMAPE + +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 226 GDVYSFGIMLMETFTKKKP 244
D ++ G L E + P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIIST 107
IG G++G VYK R + G VA+K L+ GV + E ++K ++H N++ +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH-------FGY 160
+ L+ E++ L+K L S +D YL+ F +
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMDAELVKSYLYQILQGILFCH 118
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE--YGR 218
S V+H DLKP N+L+D+ V L+DFG+A+ + T + T+ Y APE G
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG--IPVRVYTHEVVTLWYRAPEVLLGS 176
Query: 219 EGRVSTNGDVYSFGIMLMETFTKK 242
R ST D++S G + E TKK
Sbjct: 177 P-RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 19/223 (8%)
Query: 51 IGRGSFGSVYKARIQDGME------VAVKVFHLQCGGVFK-SFDVECEVMKSIRHRNLIK 103
+G+GSFG VY+ +D ++ VAVK + + F E VMK ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYS-----SNCVLDIFQRLNIMIDVAA----ALE 154
++ S +V+E M HG L+ L S N L MI +AA +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 155 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAP 214
YL+ + +H DL N ++ + + DFG+ + + D + + L + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 215 EYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKY 257
E ++G +T+ D++SFG++L E + + + + E LK+
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 233
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 48/230 (20%)
Query: 50 LIGRGSFGSVYKARIQDGME-VAVKVFHLQCGGVFKSFDV-----------ECEVMKSIR 97
+G G+FG V+ R + A+KV + +V E V+K +
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIP--------EVIRLKQEQHVHNEKRVLKEVS 59
Query: 98 HRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSS---NCVLDIFQRLNIMIDVAAALE 154
H +I++ T + F +++EY+P G L L +S + +F I+ ALE
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV----CALE 115
Query: 155 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYMA 213
YLH S +++ DLKP N+LLD L+DFG AK L + +T TL T Y+A
Sbjct: 116 YLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEYLA 166
Query: 214 PE-YGREGRVSTNGDVYSFGIMLMETFTKKKP---------TDKIFAGEM 253
PE +G + D ++ GI++ E P +KI AG++
Sbjct: 167 PEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 46/180 (25%), Positives = 87/180 (48%), Gaps = 21/180 (11%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV----ECEVMKSIRHRNLIKII 105
IG+G+FG V+KAR + VA+K + + F + E ++++ ++H N++ +I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLM--ENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 106 STCSN-----DDFKA---LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH 157
C + +K LV E+ H L L + N + + +M + L Y+H
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK--LLTGEDQSKSQTQTLATIGYMAPE 215
++H D+K +N+L+ + + L+DFG+A+ L+ + T + T+ Y PE
Sbjct: 137 RN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 8e-13
Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 45/228 (19%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKA-RIQDGMEVAVKVF-----HLQCGGVFKSFDVECEV 92
F + + IG G++G V A G++VA+K C + E ++
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKI 56
Query: 93 MKSIRHRNLIKI---ISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLD-----IFQR 142
++ +H N+I I I S + F +V E M L K + + + D ++Q
Sbjct: 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQI 115
Query: 143 LNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSKS 201
L L+Y+H SA V+H DLKPSN+LL+ N + DFG+A++ D +
Sbjct: 116 LR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165
Query: 202 QTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTKK 242
T+ +AT Y APE Y + D++S G +L E + +
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGY------TKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-13
Identities = 47/197 (23%), Positives = 93/197 (47%), Gaps = 17/197 (8%)
Query: 50 LIGRGSFGSVYKARIQ----DGMEVAVKVFHLQCGGVFK-SFDVECEVMKSIRHRNLIKI 104
++G G FG + + ++ + VA+ C + F E + H N++++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL-HFGYSAP 163
+ + +V EYM +G+L+ L L Q + ++ +A+ ++YL GY
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL---ATIGYMAPEYGREG 220
+H L VL++ ++V +S F + ED+S++ T+ + + + APE +
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 221 RVSTNGDVYSFGIMLME 237
S+ DV+SFGI++ E
Sbjct: 184 HFSSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 53/180 (29%), Positives = 75/180 (41%), Gaps = 33/180 (18%)
Query: 51 IGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECE--------------VMKS 95
IG GS+G V+K R ++ G VA+K F VE E ++K
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF------------VESEDDPVIKKIALREIRMLKQ 56
Query: 96 IRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEY 155
++H NL+ +I LV EY H L + + V I+ A+ +
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVNF 115
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
H IH D+KP N+L+ L DFG A++LTG T +AT Y APE
Sbjct: 116 CH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 63/195 (32%), Positives = 96/195 (49%), Gaps = 15/195 (7%)
Query: 50 LIGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVFKSFD---VECE---VMKSIRHRNLI 102
+IG+GSFG V A R DG AVKV LQ + K + + E ++K+++H L+
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
+ + + VL+Y+ G L L C L+ R +VA+A+ YLH S
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222
+I+ DLKP N+LLD L+DFG+ K G + ++ + T Y+APE R+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 223 STNGDVYSFGIMLME 237
D + G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 51 IGRGSFGSVYKARIQDGMEVA-VKVFHLQCGGVFK---SFDVECEVMKSIRHRNLIKIIS 106
IG G FG V GM A V V L+ F E + + + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVL------DIFQRLNIMIDVAAALEYLHFGY 160
C LVLE+ P G L+ L S+ ++ D+ QR+ +VA+ L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE- 219
A IH DL N L ++ + D+G+A ED ++ + ++APE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 220 ------GRVSTNGDVYSFGIMLMETFT 240
+ +++S G+ + E FT
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 37 ELFQATDG---FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHL---QCGGVFKSFDVE 89
ELF D F++ IG GSFG+VY AR ++ VA+K Q ++ E
Sbjct: 16 ELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKE 75
Query: 90 CEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDV 149
+ ++ I+H N I+ + LV+EY CL S++ +L++ ++ +++
Sbjct: 76 VKFLQRIKHPNSIEYKGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEI 127
Query: 150 AA----ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQT 205
AA AL+ L + +S +IH D+K N+LL + L+DFG A + +
Sbjct: 128 AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------PANSF 181
Query: 206 LATIGYMAPEY---GREGRVSTNGDVYSFGIMLMETFTKKKP 244
+ T +MAPE EG+ DV+S GI +E +K P
Sbjct: 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV----ECEVMKSIR 97
D + + N I G++G VY+AR + G VA+K L+ + F + E ++ ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILLKLQ 62
Query: 98 HRNLIKI--ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEY 155
H N++ + + SN D +V+EY+ H L+ + + + +M+ + + + +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
LH + ++H DLK SN+LL++ + + DFG+A+ K TQ + T+ Y APE
Sbjct: 122 LHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPE 176
Query: 216 --YGREGRVSTNGDVYSFGIMLMETFTKK 242
G ST D++S G + E TKK
Sbjct: 177 LLLG-AKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIR---HRNLIKI 104
IG G++G+VYKAR G VA+K +Q G+ S E ++K + H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 105 ISTC----SNDDFK-ALVLEYMPH---GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL 156
+ C ++ + K LV E++ L+K L ++M L++L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG---LPAETIKDLMRQFLRGLDFL 124
Query: 157 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY 216
H ++H DLKP N+L+ L+DFG+A++ + + + T + T+ Y APE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPEV 178
Query: 217 GREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
+ +T D++S G + E F ++KP +F G
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCGN 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 66/246 (26%), Positives = 107/246 (43%), Gaps = 57/246 (23%)
Query: 50 LIGRGSFGSVYKARIQDGME----VAVKVFHLQCGGVFKS------FDVECEVMKSIRHR 99
++G+G +G V++ R G + A+KV L+ + ++ E ++++++H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 100 NLIKIISTCSNDDFKALVLEYMPHGSL----EK---------CLYSSNCVLDIFQRLNIM 146
++ +I L+LEY+ G L E+ C Y S L
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISL--------- 111
Query: 147 IDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206
ALE+LH +I+ DLKP N+LLD L+DFG+ K E + T T
Sbjct: 112 -----ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTF 160
Query: 207 -ATIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFT---------KKKPTDKIFAGEMTL 255
TI YMAPE R G D +S G ++ + T +KK DKI G++ L
Sbjct: 161 CGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
Query: 256 KYWVSN 261
+++
Sbjct: 220 PPYLTP 225
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 51 IGRGSFGSVYKARIQDGME-VAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIIST 107
IG G++G+V+KA+ ++ E VA+K L GV S E ++K ++H+N++++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
+D LV EY L+K S N +D + M + L + H S V+H
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123
Query: 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE--YGREGRVSTN 225
DLKP N+L++ N L+DFG+A+ + + + T+ Y P+ +G + ST+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARAFG--IPVRCYSAEVVTLWYRPPDVLFGAKL-YSTS 180
Query: 226 GDVYSFGIMLMETFTKKKP 244
D++S G + E +P
Sbjct: 181 IDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 51 IGRGSFGSVYKA-RIQDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTC 108
+G G+ GSV K I G +A KV H+ V K E ++M R ++
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCV-LDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
N++ + +E+M GSL++ + ++I + I + V L YL+ ++H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHR 128
Query: 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGD 227
D+KPSN+L++ L DFG++ L S + T + T YM+PE + G+ + D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVGTSTYMSPERIQGGKYTVKSD 184
Query: 228 VYSFGIMLMETFTKKKP 244
V+S GI ++E K P
Sbjct: 185 VWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 50 LIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDV---ECEV--MKSIRHRNLIK 103
L+G+G+FG VY D G E+AVK S +V ECE+ +K++ H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 104 IISTCSNDDFKAL--VLEYMPHGSLEKCLYSSNCVLD-IFQRLNIMIDVAAALEYLHFGY 160
+ + L +E+MP GS++ L S + + + ++ I LE + + +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY-MAPE---- 215
S ++H D+K +N+L D L DFG +K L S + +++ Y M+PE
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 216 --YGREGRVSTNGDVYSFGIMLMETFTKKKP 244
YGR+ D++S G ++E T+K P
Sbjct: 184 EGYGRK------ADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 41/222 (18%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVF-----HLQCGGVFKSFDVECEVMKSIRHRNLIK 103
+IGRG+FG V+ R G A+KV + E +++ ++K
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADADSPWIVK 65
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH-FGYSA 162
+ + +++ LV+EYMP G L L + + R I ++ AL+ +H G+
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF-- 122
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQ------------------ 204
IH D+KP N+L+D + L+DFG+ K + +
Sbjct: 123 --IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 205 ---------TLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 237
T+ T Y+APE R D +S G++L E
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 12/211 (5%)
Query: 51 IGRGSFGSVYKARIQ---DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKII 105
+G G+FG+V K + VAVK+ + E VM+ + + ++++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
C + + LV+E G L K L + V + ++ V+ ++YL +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNFV 117
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-EDQSKSQTQTLATIGYMAPEYGREGRVST 224
H DL NVLL A +SDFG++K L E+ K++T + + APE + S+
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 225 NGDVYSFGIMLMETFT-KKKPTDKIFAGEMT 254
DV+SFG+++ E F+ +KP + E+T
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVK----VFH--LQCGGVFKSFDVECEVMKSIRHRN--- 100
IG G+FG V+ +DG VA+K VF + C VF+ + C +H N
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLC----FFKHDNVLS 63
Query: 101 LIKIISTCSNDDFKAL-VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG 159
+ I+ D F+ + V+ + L K + S + ++ + + L+YLH
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH-- 120
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE 219
SA ++H D+KP N+L++ N V + DFG+A+ + D+SK TQ + T Y APE
Sbjct: 121 -SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 220 GRVSTNG-DVYSFGIMLMETFTKK 242
R T+ D++S G + E ++
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-12
Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 56/242 (23%)
Query: 51 IGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
+G G+ G+VYKA + +AVKV L D+ E+ K I ++I+ C
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPL---------DITVELQKQIMSE--LEILYKCD 57
Query: 110 N------------DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL------NIMIDVAA 151
+ ++ ++ E+M GSL D+++++ I + V
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVK 106
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY 211
L YL +S ++H D+KPSN+L++ L DFG++ L S ++T + T Y
Sbjct: 107 GLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAY 159
Query: 212 MAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME-I 270
MAPE + + DV+S GI ME + P +I + +L+P+ +++ I
Sbjct: 160 MAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ-------GSLMPLQLLQCI 212
Query: 271 VD 272
VD
Sbjct: 213 VD 214
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 54/220 (24%)
Query: 51 IGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFD---------VECEVMKSIRHRN 100
IGRG++G V A+ + +VA+K +FD E ++++ + H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIA-------NAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 101 LIK---IISTCSNDDFKA--LVLEYMPHGSLEKCLYSS------NCVLDIFQRLNIMIDV 149
+I I+ + F +V E M L + + SS +C ++Q L
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR----- 119
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
L+Y+H SA V+H DLKPSN+LL+ N + DFG+A+ T ++ T+ + T
Sbjct: 120 --GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTR 172
Query: 210 GYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTKK 242
Y APE Y T DV+S G + E +K
Sbjct: 173 WYRAPELLLNCSEYT------TAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-12
Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IG GS G V AR + G +VAVK+ L+ + E +M+ +H+N++++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
+ +++E++ G+L + S L+ Q + V AL YLH S VIH D+
Sbjct: 89 VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
K ++LL + LSDFG ++ +D K ++ + T +MAPE T D++
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKS-LVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 230 SFGIMLMETFTKKKP 244
S GIM++E + P
Sbjct: 202 SLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 22/206 (10%)
Query: 51 IGRGSFGSVYKARIQDGM---EVAVKVFHLQCGGVFK-SFDVECEVMKSIRHRNLIKIIS 106
IG G FG V + G +V VK + + F E + +S++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSN------CVLDIFQRLNIMIDVAAALEYLHFGY 160
C+ LV+E+ P G L+ L S QR+ ++A L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLH--- 117
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE- 219
IH DL N LL ++ + D+G++ ED + Q + ++APE E
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 220 -GRV-----STNGDVYSFGIMLMETF 239
G + + +V+S G+ + E F
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 44/217 (20%)
Query: 50 LIGRGSFGSVYKARIQDGMEV----AVKVFHLQCGGVFKSFD-----VECEVMKSIRHRN 100
++G+GSFG V+ R G + A+KV K D +E +++ + H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLK---KATLKVRDRVRTKMERDILAEVNHPF 59
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLN--IMI----------D 148
++K+ + L+L+++ G D+F RL+ +M +
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAE 106
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
+A AL++LH S +I+ DLKP N+LLD+ L+DFG++K D K T
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 161
Query: 209 IGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTKKKP 244
+ YMAPE R G + + D +SFG+++ E T P
Sbjct: 162 VEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 46/224 (20%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDV--------- 88
F+ T+ + + +G G+FG V AR Q G VA+K + K F
Sbjct: 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYR 58
Query: 89 ECEVMKSIRHRNLI---KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNI 145
E +++K +RH N+I I + D + V E + G+ L +S + F +
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIY--FVTELL--GTDLHRLLTSRPLEKQFIQY-F 113
Query: 146 MIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQT 205
+ + L+Y+H SA V+H DLKPSN+L+++N + DFG+A++ Q T
Sbjct: 114 LYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGY 165
Query: 206 LATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTKK 242
++T Y APE Y E D++S G + E K
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIIST 107
IG G++G VYKAR G VA+K L+ GV + E ++K + H N+++++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNI---MIDVAAALEYLHFGYSAPV 164
+++ LV E++ L+K Y + L I + + + Y H S V
Sbjct: 67 VHSENKLYLVFEFLDL-DLKK--YMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRV 120
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGR-VS 223
+H DLKP N+L+D L+DFG+A+ ++ T + T+ Y APE R S
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGSRQYS 178
Query: 224 TNGDVYSFGIMLMETFTKK 242
T D++S G + E ++
Sbjct: 179 TPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-12
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKS 95
F D + + +G GS+ +VYK + + +G VA+KV LQ G F + E ++K
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKG 59
Query: 96 IRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKC-------LYSSNCVLDIFQRLNIMID 148
++H N++ + + LV EY+ H L + L+ N L +FQ L
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR---- 114
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
L Y+H Y ++H DLKP N+L+ D L+DFG+A+ S + + + T
Sbjct: 115 ---GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVT 166
Query: 209 IGYMAPE-YGREGRVSTNGDVYSFGIMLME 237
+ Y P+ ST D++ G + +E
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVE 196
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-12
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 50 LIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVM-------KSIRHRNL 101
+IG+GSFG V AR + + AVKV LQ + K + E +M K+++H L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKE-EKHIMSERNVLLKNVKHPFL 58
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS 161
+ + + D VL+Y+ G L L C L+ R ++A+AL YLH S
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---S 114
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED-QSKSQTQTL-ATIGYMAPEYGRE 219
+++ DLKP N+LLD L+DFG+ K E+ + T T T Y+APE +
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHK 170
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKP 244
D + G +L E P
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 67/229 (29%), Positives = 90/229 (39%), Gaps = 54/229 (23%)
Query: 41 ATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-- 97
T F +IG G++G VYKAR + G VA+K+ + D E E+ +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-------EDEEEEIKEEYNIL 56
Query: 98 -----HRNL-------IKIISTCSNDDFKALVLEYMPHGS---LEKCLYSSNCVLDIFQR 142
H N+ IK NDD LV+E GS L K L +R
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPG-NDDQLWLVMELCGGGSVTDLVKGLRKKG------KR 109
Query: 143 LN------IMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196
L I+ + L YLH VIH D+K N+LL N L DFG++ L
Sbjct: 110 LKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166
Query: 197 DQSKSQTQTLATIG---YMAPE-----YGREGRVSTNGDVYSFGIMLME 237
+ T IG +MAPE + DV+S GI +E
Sbjct: 167 -LGRRNT----FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 44/231 (19%)
Query: 50 LIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMK-----SIRHRNLIKI 104
+IGRG FG VY R D K++ ++C D + MK ++ R ++ +
Sbjct: 1 IIGRGGFGEVYGCRKAD----TGKMYAMKC------LDKKRIKMKQGETLALNERIMLSL 50
Query: 105 IST-------CSNDDFK-----ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAA 152
+ST C + F + +L+ M G L L S + V + ++
Sbjct: 51 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILG 109
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQ-TLATIGY 211
LE++H + V++ DLKP+N+LLD++ +SD G+A D SK + ++ T GY
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGY 161
Query: 212 MAPEYGREGRV-STNGDVYSFGIMLME------TFTKKKPTDKIFAGEMTL 255
MAPE ++G ++ D +S G ML + F + K DK MTL
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 11/195 (5%)
Query: 51 IGRGSFGSVYKARIQDGME-VAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTC 108
+G G++ +VYK R + E VA+K HL G + E +MK ++H N++++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 109 SNDDFKALVLEYMPHGSLEKCL--YSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
++ LV EYM L+K + + LD + + L+ + F + V+H
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFCHENRVLH 123
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV-STN 225
DLKP N+L++ L+DFG+A+ G + + + T+ Y AP+ R ST+
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTS 181
Query: 226 GDVYSFGIMLMETFT 240
D++S G ++ E T
Sbjct: 182 IDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 57/236 (24%), Positives = 106/236 (44%), Gaps = 32/236 (13%)
Query: 51 IGRGSFGSVYKARIQD---------GMEVAV--KVFHLQCGGVFKSFDVECEVMKSIRHR 99
+G+G+F ++YK ++ G EV+V KV +F +M + H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61
Query: 100 NLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG 159
+L+K+ C D+ +V EY+ G L+ L+ + + +L++ +A+AL YL
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118
Query: 160 YSAPVIHCDLKPSNVLL---DDNM----VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212
++H ++ N+L+ N LSD GI + ++ + I ++
Sbjct: 119 -DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER------IPWI 171
Query: 213 APEYGREGRVSTN--GDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYWVSNLLPI 265
APE R G+ S D +SFG L+E + ++P + + E Y + LP+
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM 227
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 41/106 (38%), Positives = 54/106 (50%), Gaps = 9/106 (8%)
Query: 145 IMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQ 204
I + + ALEYLH S VIH D+KPSNVL++ N L DFGI+ L S ++T
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162
Query: 205 TLATIGYMAPEY----GREGRVSTNGDVYSFGIMLMETFTKKKPTD 246
YMAPE + DV+S GI ++E T + P D
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 53/223 (23%), Positives = 105/223 (47%), Gaps = 39/223 (17%)
Query: 51 IGRGSFGSVYKARIQDGME-----------------VAVKVFHLQCGGVFKS-FDVECEV 92
+G G FG V+ + + + VAVK+ ++ F E ++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 93 MKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS----------------SNCV 136
+ ++ N+I+++ C ++D ++ EYM +G L + L S ++C+
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 137 LDI-FQRL-NIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194
I + L ++ + +A+ ++YL S +H DL N L+ +N+ ++DFG+++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 195 GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 237
D + Q + + I +MA E G+ +T DV++FG+ L E
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 31/194 (15%)
Query: 44 GFSENNLIGRGSFGSVYKARIQ---DGMEVAVKVF---HLQCGGVFKSFDVECEVMKSIR 97
+ IGRG++G VYKA+ + DG E A+K F Q G+ +S E +++ ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 98 HRNLIKIISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRL---NIMIDVAAA 152
H N++ ++ K+ L+ +Y H + + +++ +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIA-------KLLTGEDQSKS 201
+ YLH S V+H DLKP+N+L+ + V + D G+A K L D
Sbjct: 121 VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD---- 173
Query: 202 QTQTLATIGYMAPE 215
+ TI Y APE
Sbjct: 174 --PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 11/212 (5%)
Query: 51 IGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
+G G+FG VYKA+ ++ G+ A KV + + + VE +++ S H N++K++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
++ +++E+ G+++ + L Q + AL YLH +IH DL
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY-----GREGRVST 224
K N+L + L+DFG++ T Q + + T +MAPE ++
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRD--SFIGTPYWMAPEVVMCETSKDRPYDY 187
Query: 225 NGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK 256
DV+S GI L+E + P ++ + LK
Sbjct: 188 KADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 51 IGRGSFGSVYKARIQDGME-VAVKVFHL---QCGGVFKSFDVECEVMKSIRHRNLIKIIS 106
IG GSFG+VY A E VAVK Q ++ E + ++ ++H N I+
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA----ALEYLHFGYSA 162
+ LV+EY CL S++ +L++ ++ +++AA AL+ L + +S
Sbjct: 89 CYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY---GRE 219
+IH D+K N+LL + L+DFG A S + T +MAPE E
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVILAMDE 194
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKP 244
G+ DV+S GI +E +K P
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 64/195 (32%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 50 LIGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVF-----KSFDVECEVM-KSIRHRNLI 102
+IG+GSFG V A R DG AVKV LQ V K E V+ K+++H L+
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKV--LQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
+ + + VL+++ G L L + R ++A+AL YLH S
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SI 115
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222
+++ DLKP N+LLD L+DFG+ K G QS + T T Y+APE R+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 223 STNGDVYSFGIMLME 237
D + G +L E
Sbjct: 174 DNTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 34/226 (15%)
Query: 50 LIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIIST-- 107
+IGRG FG VY R D K++ ++C + + E + ++ R ++ ++ST
Sbjct: 1 IIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSLVSTGD 55
Query: 108 -----CSNDDFKA-----LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH 157
C F +L+ M G L L S + V + ++ LE++H
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILGLEHMH 114
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQ-TLATIGYMAPEY 216
+ V++ DLKP+N+LLD++ +SD G+A D SK + ++ T GYMAPE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAPEV 166
Query: 217 GREGRV-STNGDVYSFGIMLME------TFTKKKPTDKIFAGEMTL 255
++G ++ D +S G ML + F + K DK MTL
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-11
Identities = 65/243 (26%), Positives = 106/243 (43%), Gaps = 45/243 (18%)
Query: 45 FSENNLIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
F++ IG+GSFG VYK EV A+K+ L+ + E E+ + I+ I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--------EAEDEI-EDIQQE--IT 54
Query: 104 IISTCSNDDFKA------------LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA 151
++S C + +++EY+ GS L L+ I+ ++
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILK 112
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY 211
L+YLH S IH D+K +NVLL + L+DFG+A LT D + + T +
Sbjct: 113 GLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFW 167
Query: 212 MAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271
MAPE ++ D++S GI +E + P S+L P+ V+ ++
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN--------------SDLHPMRVLFLI 213
Query: 272 DAN 274
N
Sbjct: 214 PKN 216
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 20/210 (9%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHR-NLIKII 105
I +G+FGSVY A+ G A+KV + + E +M + K+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
+ + D+ LV+EY+ G L + L + +V +E LH +I
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGII 119
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTN 225
H D+KP N+L+D L+DFG+++ G + K + T Y+APE
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN--GLENKK----FVGTPDYLAPETILGVGDDKM 173
Query: 226 GDVYSFGIMLMETFTKKKP-----TDKIFA 250
D +S G ++ E P D +F
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFD 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 11/199 (5%)
Query: 51 IGRGSFGSVYKARIQD-GMEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIKIIS 106
+G+G FG V ++++ G A K L+ K +E E+++ + ++ +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCV-LDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
+ LV+ M G L+ +Y+ L++ + ++ + + +LH S ++
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTN 225
+ D+KP NVLLDD LSD G+A L K+ TQ T GYMAPE +E S
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 226 GDVYSFGIMLMETFTKKKP 244
D ++ G + E + P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 51 IGRGSFGSVYKAR--IQDGMEVAVKVFHLQCG--GVFKSFDVECEVMK---SIRHRNLIK 103
IG G++G V+KAR G VA+K +Q G G+ S E V++ + H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 104 IISTC--SNDDFKA---LVLEYMPHG---SLEKCLYSSNCVLDIFQRLNIMIDVAAALEY 155
+ C S D + LV E++ L+K I ++M + L++
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI---KDMMFQLLRGLDF 125
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
LH S V+H DLKP N+L+ + L+DFG+A++ + + + T + T+ Y APE
Sbjct: 126 LH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPE 179
Query: 216 YGREGRVSTNGDVYSFGIMLMETFTKK 242
+ +T D++S G + E F +K
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-11
Identities = 55/195 (28%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 51 IGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IG GS G V A G +VAVK L+ + E +M+ H N++ + ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
D +V+E++ G+L + ++ ++ Q + + V AL YLH + VIH D+
Sbjct: 90 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
K ++LL + LSDFG ++ E + + T +MAPE T D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 230 SFGIMLMETFTKKKP 244
S GIM++E + P
Sbjct: 203 SLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 11/211 (5%)
Query: 50 LIGRGSFGSVYKA-RIQDG----MEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIK 103
++G G+FG+VYK I DG + VA+KV K E VM + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
++ C + LV + MP+G L + + + LN + +A + YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVS 223
++H DL NVL+ ++DFG+A+LL ++ I +MA E R +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 224 TNGDVYSFGIMLMETFT-KKKPTDKIFAGEM 253
DV+S+G+ + E T KP D I A E+
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 42/253 (16%)
Query: 25 PPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVF 83
P ++W+ S E+ +G GSFG V A+ + G A+K +
Sbjct: 10 PDTSSWK-LSDFEM---------GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM 59
Query: 84 KSFD---VECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSS----NCV 136
K E ++ + H ++ ++ + +++ +LE++ G L L + N V
Sbjct: 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV 119
Query: 137 LDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196
+ ++ A EYLH S +I+ DLKP N+LLD+ ++DFG AK +
Sbjct: 120 AKFYH-----AELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-- 169
Query: 197 DQSKSQTQTL-ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP---------TD 246
+T TL T Y+APE + D ++ G++L E P +
Sbjct: 170 ----DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE 225
Query: 247 KIFAGEMTLKYWV 259
KI AG + W
Sbjct: 226 KILAGRLKFPNWF 238
|
Length = 329 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 46/230 (20%)
Query: 51 IGRGSFGSVYK--ARIQDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIIST 107
+G GS+ +VYK +RI +G VA+KV ++ GV + E ++K ++H N++ +
Sbjct: 13 LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 108 CSNDDFKALVLEYMPHGSLEKC-------LYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
+ V EYM H L + L+ N L +FQ L L Y+H +
Sbjct: 72 IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQH 123
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAP------ 214
++H DLKP N+L+ L+DFG+A+ + Q+ S + T+ Y P
Sbjct: 124 ---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS--SEVVTLWYRPPDVLLGA 178
Query: 215 -EYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAG-----EMTLKYW 258
+Y S+ D++ G + +E + +P F G E K W
Sbjct: 179 TDY------SSALDIWGAGCIFIEML-QGQP---AFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-11
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 51 IGRGSFGSVYKARIQDGME-VAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIIST 107
IG G++G VYKAR + E +A+K L+ GV + E ++K ++H N++++
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNI----MIDVAAALEYLHFGYSAP 163
++ LV EY+ L+K + SS D + + + + + Y H S
Sbjct: 70 VHSEKRLYLVFEYLDL-DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCH---SHR 122
Query: 164 VIHCDLKPSNVLLDDNMVA-HLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGR- 221
V+H DLKP N+L+D A L+DFG+A+ ++ T + T+ Y APE R
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFG--IPVRTFTHEVVTLWYRAPEILLGSRH 180
Query: 222 VSTNGDVYSFGIMLMETFTKK 242
ST D++S G + E +K
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-11
Identities = 54/218 (24%), Positives = 104/218 (47%), Gaps = 11/218 (5%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDV-ECEVMKSIRHRN 100
D F + + +G G+ G V+K + G+ +A K+ HL+ ++ + E +V+
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLD-IFQRLNIMIDVAAALEYLHFG 159
++ +D ++ +E+M GSL++ L + + + I +++I V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 122
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE 219
+ ++H D+KPSN+L++ L DFG+ +G+ + T YM+PE +
Sbjct: 123 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 176
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKY 257
S D++S G+ L+E + P A E+ L +
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 9e-11
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 50 LIGRGSFGSV-YKARIQDGMEVAVKVFHLQCGGVFK------SFDVEC-------EVMKS 95
++G G+ G+V R+ DG AVKV ++ G+ + +V C ++K
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDME--GMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 96 IRHRNLIKIISTCSNDD---FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLN---IMIDV 149
H + K N + ALVL+Y G L + + S F+ + I V
Sbjct: 97 --HEDFAK--KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
A+ ++H S +IH D+K +N+LL N + L DFG +K+ T
Sbjct: 153 LLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 210 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTD 246
Y+APE R S D++S G++L E T K+P D
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 51 IGRGSFGSVYKARIQDG--------MEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLI 102
+G G++G V+ R G M+V K +Q + E +V++++R +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 103 KIISTCSNDDFKA-LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS 161
+ D K L+L+Y+ G L LY + R+ I ++ AL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---Q 123
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGR 221
+I+ D+K N+LLD L+DFG++K E++ ++ + TI YMAPE R G
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGS 182
Query: 222 VSTNG--DVYSFGIMLMETFTKKKP 244
+ D +S G++ E T P
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVEC-EVMKSI-----RHRNLI 102
++G+GSFG V A ++ E+ AVKV L+ + + DVEC K + +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
++ S D V+EY+ G L + S D + ++ L++LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYMAPEYGREGR 221
+I+ DLK NVLLD ++DFG+ K + T T T Y+APE
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEILSYQP 172
Query: 222 VSTNGDVYSFGIMLMETFTKKKPTD 246
D ++ G++L E + P +
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 51 IGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IG GS G V A ++ G VAVK L+ + E +M+ +H N++++ ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
D +V+E++ G+L + ++ ++ Q + + V AL LH + VIH D+
Sbjct: 88 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
K ++LL + LSDFG ++ E + + T +MAPE D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 230 SFGIMLMETFTKKKP 244
S GIM++E + P
Sbjct: 201 SLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 50 LIGRGSFGSVYKARIQDG--------MEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNL 101
++G G++G V+ R G M+V K +Q + E V++ +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 102 IKIISTCSNDDFKA-LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMI---DVAAALEYLH 157
+ + + K L+L+Y+ G + LY D F + ++ ALE+LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLH 122
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYG 217
+++ D+K N+LLD L+DFG++K E++ ++ + TI YMAPE
Sbjct: 123 ---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEII 178
Query: 218 R-EGRVSTNGDVYSFGIMLMETFTKKKP 244
R +G D +S GI++ E T P
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVF--KSFDVECEVMKSIRHRNLIKIIST 107
+G+GS+G V R DG + +K +L+ K+ + E +++ ++H N++ +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 108 CSNDD-FKALVLEYMPHGSLEKCLYSSNC-VLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
+D +V+ + G L L +L Q + + +A AL+YLH ++
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTN 225
H DLK NV L + + D GIA++L E+Q + + T YM+PE +
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNYK 182
Query: 226 GDVYSFGIMLMETFTKK 242
DV++ G + E T K
Sbjct: 183 SDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 50 LIGRGSFGSVYKARIQDG--------MEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNL 101
++G G++G V+ R G M+V K +Q + E +V++ IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 102 IKIISTCSNDDFKA-LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMI-DVAAALEYLHFG 159
+ + D K L+L+Y+ G L L + Q + I ++ ALE+LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLH-- 122
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE 219
+I+ D+K N+LLD N L+DFG++K ED+ + TI YMAP+ R
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIVRG 180
Query: 220 GRVSTNG--DVYSFGIMLMETFTKKKP 244
G + D +S G+++ E T P
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 50 LIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKS--------FDVECEVMKSIRHRNL 101
+IGRG+FG V R + KV+ ++ F+ F E ++M +
Sbjct: 50 VIGRGAFGEVQLVR----HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 105
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS 161
+++ +D + +V+EYMP G L L S+ V + + R +V AL+ +H S
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---S 160
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY----G 217
IH D+KP N+LLD + L+DFG + E + T + T Y++PE G
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQG 219
Query: 218 REGRVSTNGDVYSFGIMLMETFTKKKP 244
+G D +S G+ L E P
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 51/205 (24%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDV-ECEVMKSIRHRN 100
D F + +G G+ G V K + + G+ +A K+ HL+ ++ + E +V+
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCV-LDIFQRLNIMIDVAAALEYLHFG 159
++ +D ++ +E+M GSL++ L + + +I +++I V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK 122
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE 219
+ ++H D+KPSN+L++ L DFG+ +G+ + T YM+PE +
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 176
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKP 244
S D++S G+ L+E + P
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVMK------SIRHRNLI 102
++G+GSFG V A ++ E A+K L+ V + DVEC +++ + H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
+ T + V+EY+ G L + SS D + ++ L++LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KK 115
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LTGEDQSKSQTQTLATIGYMAPEYGREGR 221
+I+ DLK NVLLD + ++DFG+ K + GE ++ + T Y+APE + +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST---FCGTPDYIAPEILKGQK 172
Query: 222 VSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
+ + D +SFG++L E + P F GE
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP----FHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 7e-10
Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 50 LIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMK------SIRHRNLI 102
++G+GSFG V+ A ++ A+K L+ V DVEC +++ + H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
+ T + V+EY+ G L + S + D+ + ++ L++LH S
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SK 115
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LTGEDQSKSQTQTL-ATIGYMAPEYGREG 220
+++ DLK N+LLD + ++DFG+ K + G+ ++T T T Y+APE
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----AKTCTFCGTPDYIAPEILLGQ 171
Query: 221 RVSTNGDVYSFGIMLMETFTKKKP 244
+ +T+ D +SFG++L E + P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 45 FSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDV---ECEVMKSIRHRN 100
F + ++G+G FG V +++ G A K + K + E ++++ + R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFG 159
++ + D LVL M G L+ +Y + + + ++ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE 219
+++ DLKP N+LLDD+ +SD G+A + E Q+ + T+GYMAPE +
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIK--GRVGTVGYMAPEVVKN 175
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKP 244
R + + D ++ G +L E + P
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 40/186 (21%)
Query: 49 NLIGRGSFGSVYKARIQD-GMEVAVKVFH------LQCGGVFKSFDVECEVMKSIRHRNL 101
+ +G G++G V A G +VA+K + ++ E ++K + H N+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKHMDHENV 76
Query: 102 IKIIS----TCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLN------IMIDV 149
I ++ S +DF+ LV M L + Q+L+ ++ +
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQI 127
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
L+Y+H SA +IH DLKPSN+ ++++ + DFG+A+ T +AT
Sbjct: 128 LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATR 179
Query: 210 GYMAPE 215
Y APE
Sbjct: 180 WYRAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 13/206 (6%)
Query: 45 FSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDV---ECEVMKSIRHRN 100
F + ++G+G FG V +++ G A K + K + E ++++ + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFG 159
++ + D LVL M G L+ +Y+ N + + L ++ LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLTGEDQSKSQTQTLATIGYMAPEYGR 218
++ DLKP N+LLDD +SD G+A K+ GE S + T+GYMAPE
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTVGYMAPEVLN 174
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKP 244
R + + D + G ++ E + P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVF---KSFDV-----ECEVMK 94
+ F +IGRG+FG V R + + +V+ ++ F K D E ++M
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKS----SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 95 SIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALE 154
++++ +D + +V+EYMP G L L S+ + + + R +V AL+
Sbjct: 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTA-EVVLALD 156
Query: 155 YLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMA 213
+H G+ IH D+KP N+LLD + L+DFG + + T + T Y++
Sbjct: 157 AIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYIS 211
Query: 214 PE----------YGREGRVSTNGDVYSFGIMLMETFTKKKP 244
PE YGRE D +S G+ L E P
Sbjct: 212 PEVLKSQGGDGYYGRE------CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 38/224 (16%)
Query: 51 IGRGSFGSVYKARIQD-GMEVAVK-VFHLQCGGVFKSFDVECEVMKSIRHRNLIKII--- 105
+G GS G V+ A D VAVK + V K E ++++ + H N++K+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV-KHALREIKIIRRLDHDNIVKVYEVL 71
Query: 106 ---STCSNDDFKAL--------VLEYMP---HGSLEKCLYSSNCV-LDIFQRLNIMIDVA 150
+ +D +L V EYM LE+ S L ++Q L
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------ 125
Query: 151 AALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSKSQ-TQTLAT 208
L+Y+H SA V+H DLKP+NV ++ +++V + DFG+A+++ K ++ L T
Sbjct: 126 -GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 209 IGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTKKKPTDKIFAG 251
Y +P T D+++ G + E T K +FAG
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----PLFAG 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVMK------SIRHRNLI 102
++G+GSFG V A ++ EV A+KV L+ + + DV+C + + + +H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
+ D V+EY+ G L + S + R +V AL +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222
VI+ DLK N+LLD L+DFG+ K G + T T Y+APE +E
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 223 STNGDVYSFGIMLMETFTKKKP 244
+ D ++ G+++ E + P
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 50 LIGRGSFGSVYKARIQDGME-VAVKVFHLQCGG--VFKSFDVECEVMKSIRHRNLIKIIS 106
++G G++G V K R ++ E VA+K F V ++ E +++++++ N++++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
LV EY+ LE N V R I + A +H+ + ++H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA----IHWCHKNDIVH 123
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG 226
D+KP N+L+ N V L DFG A+ L+ E + + T+ +AT Y +PE
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAV 182
Query: 227 DVYSFGIMLMETFTKKKPTDKIFAGE 252
D++S G +L E + +P +F GE
Sbjct: 183 DMWSVGCILGE-LSDGQP---LFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 50 LIGRGSFGSVYKARIQDGME-VAVKVFHLQCGGVFKSFDVECEVMK----SIRHRN--LI 102
++G+GSFG V A ++ E AVK L+ V DVEC +++ ++ N L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
+ T + V+E++ G L + D+++ ++ L++LH S
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SK 115
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LTGEDQSKSQTQTLATIGYMAPEYGREGR 221
+I+ DLK NV+LD + ++DFG+ K + G++++ + T Y+APE + +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPDYIAPEILQGLK 172
Query: 222 VSTNGDVYSFGIMLMETFTKKKP 244
+ + D +SFG++L E + P
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKV---FHLQCGGVFKSFDVECEVMKSIRHRNLIKII 105
+IGRG+FG V R + +V A+K+ F + F E ++M ++++
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
+D + +V+EYMP G L L S+ V + + + +V AL+ +H S +I
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIH---SMGLI 164
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY----GREGR 221
H D+KP N+LLD + L+DFG + + T + T Y++PE G +G
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGTPDYISPEVLKSQGGDGY 223
Query: 222 VSTNGDVYSFGIMLMETFTKKKP 244
D +S G+ L E P
Sbjct: 224 YGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 3/104 (2%)
Query: 137 LDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196
L L+ VA +E+L S +H DL NVLL + + DFG+A+ + +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
S+ T + +MAPE + +T DV+S+GI+L E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLTGEDQSKSQTQTLA 207
+ + LE+LH +I+ DLKP NVLLD++ +SD G+A +L G+ ++K
Sbjct: 106 IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA---G 159
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
T G+MAPE + + D ++ G+ L E + P
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 35/217 (16%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNL 101
D F + +G G+ G V K G+ +A K+ HL E+ +IR++ +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL-------------EIKPAIRNQII 47
Query: 102 --IKIISTCS------------NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMI 147
+K++ C+ +D ++ +E+M GSL++ L + + + I I
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-KISI 106
Query: 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
V L YL + ++H D+KPSN+L++ L DFG+ +G+ +
Sbjct: 107 AVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVG 160
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
T YM+PE + + D++S G+ L+E + P
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 36/210 (17%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-------RHRNL 101
++G G++G VYK R ++ G A+KV + + D E E+ I HRN+
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDV-------TEDEEEEIKLEINMLKKYSHHRNI 75
Query: 102 IKII------STCSNDDFKALVLEYMPHGSLEKCLYSS--NCVLDIFQRLNIMIDVAAAL 153
S +DD LV+E+ GS+ + ++ N + + + I ++ L
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGL 134
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQT-LATIGYM 212
+LH + VIH D+K NVLL +N L DFG++ L D++ + T + T +M
Sbjct: 135 AHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWM 188
Query: 213 APEY-----GREGRVSTNGDVYSFGIMLME 237
APE + D++S GI +E
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 62/230 (26%), Positives = 95/230 (41%), Gaps = 53/230 (23%)
Query: 51 IGRGSFGSVYKARIQDG--MEVAVKVF-------HLQCGGVFKSFDVECEVMKSIRHRNL 101
+G GSFG V A ++ VA+K F Q VF E +++ I H
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS----ERKILNYINHPFC 93
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEK-------------CLYSSNCVLDIFQRLNIMID 148
+ + + ++ + LVLE++ G C Y++ VL IF
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL-IF-------- 144
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-A 207
EYL S +++ DLKP N+LLD + ++DFG AK++ ++T TL
Sbjct: 145 -----EYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTLCG 190
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKY 257
T Y+APE D ++ GI + E P +A E L Y
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP---FYANEPLLIY 237
|
Length = 340 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 23/202 (11%)
Query: 49 NLIGRGSFGSVYKARIQDGME-VAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIIST 107
N+IG GSFG VY+A D E VA+K LQ +K + E +MK++ H N+I +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV-LQ-DPQYK--NRELLIMKNLNHINIIFLKDY 127
Query: 108 CSNDDFKA--------LVLEYMPHGSLEKCLYSS--NCVLDIFQRLNIMIDVAAALEYLH 157
+ FK +V+E++P + + + N L +F + AL Y+H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 158 FGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY 216
S + H DLKP N+L+D N L DFG AK L +S S + + Y APE
Sbjct: 188 ---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYRAPEL 241
Query: 217 GR-EGRVSTNGDVYSFGIMLME 237
+T+ D++S G ++ E
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAE 263
|
Length = 440 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 48/228 (21%)
Query: 51 IGRGSFGSVYKAR---IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR---------- 97
+G+G++G V AR + VA+K + F + +++R
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIK-------KITNVFSKKILAKRALRELKLLRHFRG 60
Query: 98 HRNLIKIIST--CSNDDFKALVL-EYMPHGSLEKCLYSSNCVLD------IFQRLNIMID 148
H+N+ + +F L L E + L + + S + D I+Q L
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL----- 115
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ---TQT 205
L+Y+H SA V+H DLKP N+L++ + + DFG+A+ + E+ ++ T+
Sbjct: 116 --CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFS-ENPGENAGFMTEY 169
Query: 206 LATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTKKKPTDKIFAGE 252
+AT Y APE + T DV+S G +L E +KP +F G+
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 9e-09
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 41/215 (19%)
Query: 50 LIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMK------SIRHRNLI 102
++G+GSFG V AR+ + G AVKV L+ + + DVEC + + + H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 103 KIISTCSNDDFKALVLEYMPHGSL-------------EKCLYSSNCVLDIFQRLNIMIDV 149
++ D V+E++ G L Y++ ++
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--------------EI 105
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
+AL +LH +I+ DLK NVLLD L+DFG+ K G K+ + T
Sbjct: 106 TSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTP 160
Query: 210 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
Y+APE +E + D ++ G++L E P
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 51 IGRGSFGSVYKARIQDG---MEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIIST 107
+GRG++G VYKA+ +DG E A+K ++ G+ S E +++ ++H N+I +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 108 -CSNDDFKA-LVLEYMPHG-----SLEKCLYSSNCVLDIFQRL--NIMIDVAAALEYLHF 158
S+ D K L+ +Y H + ++ + + + + +++ + + YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 159 GYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSKSQTQ-TLATIGYMA 213
+ V+H DLKP+N+L+ + ++D G A+L + + + T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 214 PEYGREGRVSTNG-DVYSFGIMLMETFTKK 242
PE R T D+++ G + E T +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTC 108
+G+G++GSVYK + G+ +A+K L+ F +E +++ ++
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAA----LEYLHFGYSAPV 164
+ + +EYM GSL+K LY+ + +++ + A L++L ++ +
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPE-DVLRRITYAVVKGLKFLKEEHN--I 124
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPEYGREGR 221
IH D+KP+NVL++ N L DFG++ L S +T IG YMAPE + G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLV-----ASLAKT--NIGCQSYMAPERIKSGG 177
Query: 222 VSTNG------DVYSFGIMLME 237
+ N DV+S G+ ++E
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 61/262 (23%), Positives = 101/262 (38%), Gaps = 63/262 (24%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHR 99
D + + IG G++G VYKAR G VA+K L+ G+ + E +++ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 100 N----LIKIISTCSNDDFKA---LVLEYM--------------PHGSLEKCLYSSNCVLD 138
L+ + + K LV EY+ P L S
Sbjct: 61 IYIVRLLDVEHVEEKNG-KPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM--- 116
Query: 139 IFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTGED 197
+Q ++ VA + H V+H DLKP N+L+D + ++D G+ + +
Sbjct: 117 -YQ---LLKGVA----HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS--I 163
Query: 198 QSKSQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTKK-------------- 242
KS T + T+ Y APE ST D++S G + E K+
Sbjct: 164 PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH 223
Query: 243 ------KPTDKIFAGEMTLKYW 258
PT++++ G L+ W
Sbjct: 224 IFKLLGTPTEQVWPGVSKLRDW 245
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 61/270 (22%), Positives = 109/270 (40%), Gaps = 37/270 (13%)
Query: 58 SVYKARIQDGMEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIKI----ISTCSN 110
S+YK I + EV ++ F H + + E + ++ I N++KI I +
Sbjct: 35 SIYKG-IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 111 DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLK 170
+L+LEY G L + L L +L++ ID L L+ + P + +L
Sbjct: 94 LPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 171 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE--GRVSTNGDV 228
+ L+ +N + G+ K+L S + + + Y + + + + D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDI 205
Query: 229 YSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQ 288
YS G++L E FT K P + +T K EI D L+ ++
Sbjct: 206 YSLGVVLWEIFTGKIPFEN-----LTTK------------EIYD--LIINKNNSLKLPLD 246
Query: 289 CVSFVFNLAMECTVESAEQRINAKEIVTRL 318
C + + CT + +R N KEI+ L
Sbjct: 247 CPLEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 25/198 (12%)
Query: 51 IGRGSFGSVYKAR--IQDGMEVAVKVFHLQ------CGGVFKSFDVECEVMKSIRHRNLI 102
+G G++ +V+K R + + + VA+K L+ C + E ++K ++H N++
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAI-----REVSLLKDLKHANIV 67
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCL--YSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
+ D LV EY L+K L Y +C +I N+ I + L L + +
Sbjct: 68 TLHDIVHTDKSLTLVFEY-----LDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH 121
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR-E 219
V+H DLKP N+L+++ L+DFG+A+ +K+ + + T+ Y P+
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 220 GRVSTNGDVYSFGIMLME 237
ST D++ G + E
Sbjct: 180 SEYSTQIDMWGVGCIFFE 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 44/168 (26%), Positives = 69/168 (41%), Gaps = 24/168 (14%)
Query: 89 ECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLN---- 144
E + + H ++K +DD L++EY G L K I QRL
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHLP 165
Query: 145 --------IMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196
+ + AL+ +H S ++H DLK +N+ L + L DFG +K +
Sbjct: 166 FQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222
Query: 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
+ T Y+APE R S D++S G++L E T +P
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 35/209 (16%)
Query: 51 IGRGSFGSVYK-ARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTC 108
IG+G++G VYK +DG AVK+ V + + E +++S+ H N++K
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 109 SNDDFKA-----LVLEYMPHGSLEKCLYSSNCVLDIFQRLN------IMIDVAAALEYLH 157
D LVLE GS+ + + +L QRL+ I+ L++LH
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE-- 215
+ +IH D+K +N+LL L DFG++ LT ++ ++ T +MAPE
Sbjct: 146 ---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN--TSVGTPFWMAPEVI 200
Query: 216 -------YGREGRVSTNGDVYSFGIMLME 237
Y + R DV+S GI +E
Sbjct: 201 ACEQQYDYSYDARC----DVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 35/119 (29%), Positives = 56/119 (47%), Gaps = 3/119 (2%)
Query: 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181
P + L + + L + VA +E+L S +H DL NVL+ + +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKL 277
Query: 182 AHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ DFG+A+ + + S+ T + +MAPE +T DV+SFGI+L E FT
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK-LLTGEDQSKSQTQTLA 207
VA +E+L S IH DL N+LL +N V + DFG+A+ + D + L
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ +MAPE + +T DV+SFG++L E F+
Sbjct: 239 -LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 50 LIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFD------VECEVMKSIRHRNLI 102
L+G+G+FG V R + G A+K+ + V + D E V+K+ RH L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKE---VIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
+ + D V+EY+ G L L + R ++ +AL+YLH S
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SG 114
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222
+++ DLK N++LD + ++DFG+ K G + + T Y+APE +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 223 STNGDVYSFGIMLMETFTKKKP 244
D + G+++ E + P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 7/157 (4%)
Query: 89 ECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMI 147
E ++++ + R ++ + D LVL M G L+ +Y+ N D + +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
++ LE LH +++ DLKP N+LLDD +SD G+A + + + + +
Sbjct: 110 EITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VG 163
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
T+GYMAPE + R + + D + G ++ E K P
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 22/151 (14%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIIST 107
+G GS+ +VYK R G VA+K L+ G F + E ++K ++H N++ +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDI 71
Query: 108 CSNDDFKALVLEYMPHGSL----EKC---LYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
LV EY+ L + C L N L +FQ L L Y H
Sbjct: 72 IHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCH--- 120
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191
V+H DLKP N+L+ + L+DFG+A+
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 73/239 (30%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKII 105
L+G+G G V+ R++ ++ A+KV + K E E++ ++ H L +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 106 STCSNDDFKALVLEYMPHGSL--------EKCL-------YSSNCVLDIFQRLNIMIDVA 150
++ + + LV++Y P G L KCL Y++ +V
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA--------------EVL 113
Query: 151 AALEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT--------------- 194
ALEYLH G ++ DLKP N+LL ++ LSDF ++K
Sbjct: 114 LALEYLHLLGI----VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169
Query: 195 GEDQSKSQTQTLATIG------------YMAPE----YGREGRVSTNGDVYSFGIMLME 237
+ ++T + Y+APE G V D ++ GI+L E
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYE 224
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 63/276 (22%), Positives = 112/276 (40%), Gaps = 39/276 (14%)
Query: 51 IGRGSFGSVY-----KARIQDGMEV--AVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
+G+GSFG+VY KA ++ ++V + V L ++ + E +++ + H ++K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIF---QRLNIMIDVAAALEYLHFGY 160
++ D ++ EY L+ L Q I + + Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--- 123
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG 220
++H DLK N+ L +N++ + DFG+++LL G T T YM+PE +
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG--SCDLATTFTGTPYYMSPEALKHQ 180
Query: 221 RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280
+ D++S G +L E F G N L + V+ IV+ S +
Sbjct: 181 GYDSKSDIWSLGCILYEMCC----LAHAFEG--------QNFLSV-VLRIVEGPTPSLPE 227
Query: 281 KHFAAKEQCVSFVFNLAMECTVE-SAEQRINAKEIV 315
S N M+ + R +A EI+
Sbjct: 228 --------TYSRQLNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 25/203 (12%)
Query: 51 IGRGSFGSVYKAR--IQDGMEVAVKVFHLQ------CGGVFKSFDVECEVMKSIRHRNLI 102
+G G++ +VYK R + D + VA+K L+ C + E ++K ++H N++
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAI-----REVSLLKDLKHANIV 67
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCL--YSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
+ + LV EY L+K L Y +C + N+ + + L L++ +
Sbjct: 68 TLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCH 121
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE-YGRE 219
V+H DLKP N+L+++ L+DFG+A+ +K+ + + T+ Y P+
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 220 GRVSTNGDVYSFGIMLMETFTKK 242
ST D++ G + E T +
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 31/206 (15%)
Query: 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQ------CGGVFKSFDVECEVMKSIRHRNLIK 103
+G G++ +V+K R + VA+K L+ C + E ++K+++H N++
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-----REVSLLKNLKHANIVT 67
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
+ + LV EY+ L++ Y NC ++ N+ I + L L + +
Sbjct: 68 LHDIIHTERCLTLVFEYL-DSDLKQ--YLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAP-------EY 216
++H DLKP N+L+++ L+DFG+A+ +K+ + + T+ Y P EY
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 217 GREGRVSTNGDVYSFGIMLMETFTKK 242
ST D++ G +L E T +
Sbjct: 182 ------STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
VA +E+L S IH DL N+LL +N V + DFG+A+ + + +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 209 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ +MAPE + +T DV+SFG++L E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
VA +E+L S IH DL N+LL +N V + DFG+A+ + + +
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 209 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ +MAPE + + DV+SFG++L E F+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 6e-08
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIIST 107
L+G G++G VYK R ++ G A+KV + G + E ++K HRN+
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 108 C------SNDDFKALVLEYMPHGSLEKCLYSSNC-VLDIFQRLNIMIDVAAALEYLHFGY 160
DD LV+E+ GS+ + ++ L I ++ L +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 128
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQT-LATIGYMAPEY--- 216
VIH D+K NVLL +N L DFG++ L D++ + T + T +MAPE
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 217 --GREGRVSTNGDVYSFGIMLMETFTKKKP 244
+ D++S GI +E P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 38/146 (26%), Positives = 63/146 (43%), Gaps = 13/146 (8%)
Query: 50 LIGRGSFG--SVYKARIQD-GMEVAVKVFHL--QCGGVFKSFDVECEVMKSIRHRNLIKI 104
LIG+ V+ A+ + VAVK +L K E + ++H N++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL---NIMIDVAAALEYLHFGYS 161
+++ D +V M +GS E L ++ + L I+ DV AL+Y+H S
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCED-LLKTHFP-EGLPELAIAFILKDVLNALDYIH---S 119
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDF 187
IH +K S++LL + LS
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 9e-08
Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 34/205 (16%)
Query: 51 IGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IG+G+FG VY+ R +D + A+KV K + EV +I RN++ + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNIL-VRTLLD 53
Query: 110 NDDFKA-------------LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMI-DVAAALEY 155
F LV +YM G L L + R I ++ ALE+
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEH 111
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LTGEDQSKSQTQTL-ATIGYMA 213
LH +++ DLKP N+LLD L DFG++K LT T T T Y+A
Sbjct: 112 LH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK----TTNTFCGTTEYLA 164
Query: 214 PEYGREGRVSTNG-DVYSFGIMLME 237
PE + + T D +S G+++ E
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 60/228 (26%), Positives = 88/228 (38%), Gaps = 39/228 (17%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGG---VFKSFDVECEVMKSIRHRNLIKII 105
LIG+G G VY A VA+K + K F E ++ + H ++ +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 106 STCSNDDFKALVLEYMPH--GSLEKCLYSSNCVLDIFQR-----------LNIMIDVAAA 152
S CS+ D V MP+ G K L S + + L+I + A
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-----DQSKSQTQTL- 206
+EY+H S V+H DLKP N+LL + D+G A E D +
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 207 ----------ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
T YMAPE S + D+Y+ G++L + T P
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 7/160 (4%)
Query: 89 ECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMI 147
E +++ + R ++ + D LVL M G L+ +Y+ N D + +
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
++ LE L +++ DLKP N+LLDD +SD G+A + + + + +
Sbjct: 110 ELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR---VG 163
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDK 247
T+GYMAPE + + + D + G ++ E + P K
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 16/202 (7%)
Query: 50 LIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFD------VECEVMKSIRHRNLI 102
L+G+G+FG V R + G A+K+ + V + D E V+++ RH L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKE---VIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
+ D V+EY G L L + R ++ +ALEYLH S
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SR 114
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222
V++ D+K N++LD + ++DFG+ K G + T Y+APE +
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 223 STNGDVYSFGIMLMETFTKKKP 244
D + G+++ E + P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 48/189 (25%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 54 GSFGSVYKARIQDGME--VAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSND 111
GS G V+ A + G V +K+ G + +E +++++ H ++I++ T +
Sbjct: 77 GSEGRVFVAT-KPGQPDPVVLKI------GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSG 129
Query: 112 DFKALVLEYMPHGSLEKCLYSSNCV--LDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
+VL PH S + Y + L I Q L I + L YLH + +IH D+
Sbjct: 130 AITCMVL---PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDV 183
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVY 229
K N+ ++D + D G A+ T+ T APE + ++ D++
Sbjct: 184 KTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET---NAPEVLARDKYNSKADIW 240
Query: 230 SFGIMLMET 238
S GI+L E
Sbjct: 241 SAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 38 LFQATDGFSENNLIGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVF--KSFDVECEVMK 94
+++ + + + +G G++GSV A + G+ VAVK + K E ++K
Sbjct: 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 71
Query: 95 SIRHRNLIKIISTCS--------NDDFKALVLEYMPHGSLEKC--LYSSNCVLDIFQRLN 144
++H N+I ++ + ND + L ++ KC L + I+Q L
Sbjct: 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 131
Query: 145 IMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQ 204
L+Y+H SA +IH DLKPSN+ ++++ + DFG+A+ E T
Sbjct: 132 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 176
Query: 205 TLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKK 242
+AT Y APE + D++S G ++ E T +
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 54/201 (26%), Positives = 79/201 (39%), Gaps = 27/201 (13%)
Query: 54 GSFGSVY---KARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110
GS G V+ K + +V VK GG K+ E +++K+I HR +I +I
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAV---TGG--KTPGREIDILKTISHRAIINLIHAYRW 157
Query: 111 DDFKALVLEYMPHGSLEKCLY-------SSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
K+ V MP + Y + I +RL AL YLH
Sbjct: 158 ---KSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRL------LEALAYLH---GRG 205
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVS 223
+IH D+K N+ LD+ A L DFG A L + T+ +PE
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265
Query: 224 TNGDVYSFGIMLMETFTKKKP 244
D++S G++L E K
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 56/212 (26%), Positives = 86/212 (40%), Gaps = 14/212 (6%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFH---LQCGGVFKSFDVECEVMKSIRH 98
F +L+GRG FG V R G A+KV L F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHF 158
+ ++ + D LV+EY P G L L N D F +A + +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY-- 216
+ +H D+KP NVL+D L+DFG A LT ++ + + T Y+APE
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT-ANKMVNSKLPVGTPDYIAPEVLT 176
Query: 217 ----GREGRVSTNGDVYSFGIMLMETFTKKKP 244
+G D +S G++ E + P
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 51 IGRGSFGSV-YKARIQDGMEVAVKVFH--LQCGGVFKSFDVECEVMKSIRHRNLIKIIST 107
+G G++G+V + G +VA+K + Q K E ++K ++H N+I ++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 108 CSND-------DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
+ D DF LV+ +M L K + D Q L + + L+Y+H
Sbjct: 83 FTPDLSLDRFHDF-YLVMPFM-GTDLGKLMKHEKLSEDRIQFL--VYQMLKGLKYIH--- 135
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ-TQTLATIGYMAPEYGRE 219
+A +IH DLKP N+ ++++ + DFG+A+ Q+ S+ T + T Y APE
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLAR------QTDSEMTGYVVTRWYRAPEVILN 189
Query: 220 G-RVSTNGDVYSFGIMLMETFTKK 242
+ D++S G ++ E T K
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 54/199 (27%), Positives = 86/199 (43%), Gaps = 12/199 (6%)
Query: 51 IGRGSFGSVYKARIQDGMEV----AVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIIS 106
IG+GSFG V + R +D + ++ H+ E V+ + ++ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
+ + + LVL ++ G L L D+ + ++ ALE LH VI+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH---KFNVIY 116
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYMAPEYGREGRVSTN 225
DLKP N+LLD L DFG+ KL +D +T T T Y+APE +
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDD---DKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 226 GDVYSFGIMLMETFTKKKP 244
D ++ G++L E T P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 52/218 (23%)
Query: 50 LIGRGSFGSVYKA-RIQDGMEVAVKVFH--LQCGGVFKSFDVECEVMKSIRHRNLIKII- 105
+G G++GSV A + G +VA+K Q K E ++K ++H N+I ++
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 106 ---STCSNDDFKA--LVLEYM---------PHGSLEKCLYSSNCVLDIFQRLNIMIDVAA 151
S S D+F+ LV+ YM S +K Y ++Q L
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL------VYQML-------C 128
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY 211
L+Y+H SA +IH DLKP N+ ++++ + DFG+A+ E T + T Y
Sbjct: 129 GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWY 180
Query: 212 MAPE-------YGREGRVSTNGDVYSFGIMLMETFTKK 242
APE Y + D++S G ++ E T K
Sbjct: 181 RAPEVILNWMHYNQ------TVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 51/217 (23%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 38 LFQATDGFSENNLIGRGSFGSVYKARIQDGM-----EVAVKVFHLQCGGVFKSFDV-ECE 91
+ + D + ++L+ G+FG ++ + D EV VK + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 92 VMKSIRHRNLIKIISTCSNDDFKALVLE-YMPHGSL----EKCLYSSNCV---LDIFQRL 143
++ + H+N++ I+ C D VL YM G+L ++C L Q +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 144 NIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203
++ I +A + YLH VIH D+ N ++D+ + ++D +++ L D
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ +MA E S+ DV+SFG++L E T
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 3/104 (2%)
Query: 137 LDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196
LD+ L VA +++L S IH D+ NVLL D VA + DFG+A+ + +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ + +MAPE + + DV+S+GI+L E F+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 51 IGRGSFGSVYKARIQDGME---VAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIIST 107
+GRG++G VYKA+ +DG + A+K ++ G+ S E +++ ++H N+I +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALK--QIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 108 -CSNDDFKA-LVLEYMPHG--SLEKCLYSSNCVLDIFQRLNIMID--VAAALEYLHFGYS 161
S+ D K L+ +Y H + K +S Q M+ + L+ +H+ ++
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 162 APVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSKSQTQ-TLATIGYMAPEY 216
V+H DLKP+N+L+ + ++D G A+L + + + T Y APE
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 217 GREGRVSTNG-DVYSFGIMLMETFTKK 242
R T D+++ G + E T +
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 59/236 (25%), Positives = 104/236 (44%), Gaps = 39/236 (16%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFD---VECEVMKSIRHRNLIKIIS 106
IG GSFG + +DG + +K ++ K + E V+ +++H N+++
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINI-SKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 107 TCSNDDFKALVLEYMPHGSLEK-------CLYSSNCVLDIFQRLNIMIDVAAALEYLHFG 159
+ + +V++Y G L K L+ + +LD F + + AL+++H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF------VQICLALKHVH-- 118
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA--TIG---YMAP 214
++H D+K N+ L + L DFGIA++L + T LA IG Y++P
Sbjct: 119 -DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-------NSTVELARTCIGTPYYLSP 170
Query: 215 EYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEM---TLKYWVSNLLPISV 267
E + D+++ G +L E T K + AG M LK + P+S
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFE---AGNMKNLVLKIIRGSYPPVSS 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 32/210 (15%)
Query: 51 IGRGSFGSVYKA---RIQDG-----MEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHR 99
+G+G+F ++K + D EV +KV H +SF +M + H+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYS---ESFFEAASMMSQLSHK 59
Query: 100 NLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG 159
+L+ C D +V EY+ GSL+ L + +++I +L + +A AL +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE-- 117
Query: 160 YSAPVIHCDLKPSNVLL---DDNMVAH-----LSDFGIAKLLTGEDQSKSQTQTLATIGY 211
+ H ++ NVLL +D + LSD GI+ + ++ L I +
Sbjct: 118 -DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE------ILLERIPW 170
Query: 212 MAPEYGREGR-VSTNGDVYSFGIMLMETFT 240
+ PE + +S D +SFG L E F+
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 3/104 (2%)
Query: 137 LDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196
LD L+ VA + +L S IH DL N+LL + + DFG+A+ + +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ + +MAPE + DV+S+GI+L E F+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 32/180 (17%)
Query: 51 IGRGSFGSV---YKARIQDGMEVAVKVFHLQCGGVFKSFDV--ECEVMKSIRHRNLIKII 105
+G G++GSV Y R++ +VAVK + + E ++K ++H N+I ++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 106 S----TCSNDDFKALVLEYMPHGS----LEKC--LYSSNCVLDIFQRLNIMIDVAAALEY 155
S ++F + L G+ + KC L + I+Q L L+Y
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR-------GLKY 133
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
+H SA +IH DLKPSNV ++++ + DFG+A+ E T +AT Y APE
Sbjct: 134 IH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 51 IGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTC 108
IG+G++G V+K ++G + AVK+ + + + E ++K++ H N++K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 109 SNDDFKA-----LVLEYMPHGSLEKCLYSSNCVLDIFQRLN------IMIDVAAALEYLH 157
D K LVLE GS+ + L +R+ I+ + L++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY- 216
IH D+K +N+LL L DFG++ LT ++ ++ T +MAPE
Sbjct: 142 ---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN--TSVGTPFWMAPEVI 196
Query: 217 GREGRVSTN----GDVYSFGIMLME 237
E ++ + DV+S GI +E
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 11/202 (5%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFD-VECE---VMKSIRHRNLIKI 104
+IGRGS+ V R++ + A+KV + + D V+ E ++ H L+ +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
S + V+EY+ G L + + + R +++ AL YLH +
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 117
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVST 224
I+ DLK NVLLD L+D+G+ K G + + T Y+APE R
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 225 NGDVYSFGIMLMETFTKKKPTD 246
+ D ++ G+++ E + P D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 31/139 (22%), Positives = 63/139 (45%), Gaps = 19/139 (13%)
Query: 59 VYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEV--MKSIRHRNLI--KIISTCSNDDFK 114
VY +D + +K+ + G D E EV ++ + + L K++++ +D +
Sbjct: 14 VYLLGTKDE-DYVLKINPSREKGA----DREREVAILQLLARKGLPVPKVLASGESDGWS 68
Query: 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV-IHCDLKPSN 173
L++E++ +L++ + ++ +I +A L LH V H DL P N
Sbjct: 69 YLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH-QLPLLVLCHGDLHPGN 119
Query: 174 VLLDDNMVAHLSDFGIAKL 192
+L+DD + + D+ A
Sbjct: 120 ILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVMK------SIRHRNLI 102
++G+GSFG V A + E+ A+K+ L+ V + DVEC +++ S + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
++ S D V+EY+ G L +Y V F+ + + A L F +S
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK--LLTGEDQSKSQTQTL-ATIGYMAPEYGRE 219
+I+ DLK NV+LD ++DFG+ K + G T+T T Y+APE
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-----VTTKTFCGTPDYIAPEIIAY 175
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
+ D ++FG++L E + P F GE
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 51/210 (24%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVEC-----EVMKSIRHRNLIK 103
+IGRG+FG V ++++ +V A+K+ L + K + C +V+ + ++ +
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCL--YSSNCVLDIFQ-RLNIMIDVAAALEYLHFGY 160
+ +++ LV++Y G L L + D+ + L M+ ++ LH+
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY-- 123
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFG-IAKLLTGEDQSKSQTQTLATIGYMAPEYGR- 218
+H D+KP N+L+D N L+DFG KL+ ED + + + T Y++PE +
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISPEILQA 177
Query: 219 ----EGRVSTNGDVYSFGIMLMETFTKKKP 244
+G+ D +S G+ + E + P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFD------VECEVMKSIRHRNLI 102
+IG+GS+G V A G +VA+K + VF+ E ++++ +RH +++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKIN----DVFEHVSDATRILREIKLLRLLRHPDIV 62
Query: 103 KIISTC---SNDDFKAL--VLEYMPHGSLEKCLYSSNCVLD------IFQRLNIMIDVAA 151
+I S +FK + V E M L + + +++ + ++Q L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLR------- 114
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS-QTQTLATIG 210
AL+Y+H +A V H DLKP N+L + + + DFG+A++ + + T +AT
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 211 YMAPEYGRE--GRVSTNGDVYSFGIMLMETFTKK 242
Y APE + + D++S G + E T K
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 11/204 (5%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFD---VECEVMKSIRHRNLIKII 105
+IGRGS+ V R++ ++ A+KV + + D E V + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 106 STCSNDDFKA-LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
+C + LV+EY+ G L + + + R ++ AL +LH +
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGI 117
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVST 224
I+ DLK NVLLD + L+D+G+ K G + + T Y+APE R
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 225 NGDVYSFGIMLMETFTKKKPTDKI 248
+ D ++ G+++ E + P D I
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDII 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 18/156 (11%)
Query: 89 ECEVMKSIRHRNLIKIISTC----SNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQR 142
E +MK + H+N+I +++ S ++F+ LV+E M +L + + LD +R
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI---QMDLD-HER 119
Query: 143 LNIMI-DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201
++ ++ + +++LH SA +IH DLKPSN+++ + + DFG+A+ G S
Sbjct: 120 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGT--SFM 173
Query: 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 237
T + T Y APE N D++S G ++ E
Sbjct: 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 21/205 (10%)
Query: 51 IGRGSFGSVYKARIQDGMEVA-VKVFHLQCGGVFK---SFDVECEVMKSIRHRNLIKIIS 106
IG G FG V + I VA V V L+ K F + + + ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSS-----NCVLDIFQRLNIMIDVAAALEYLHFGYS 161
C LV EY G L+ L N L + QR+ ++AA + ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMH---K 117
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY--GRE 219
+H DL N L ++ + D+GI ED +++ + ++APE
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 220 GRVSTN-----GDVYSFGIMLMETF 239
G + T +V++ G+ L E F
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 33/213 (15%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVMK------SIRHRNLI 102
++G+GSFG V A + E+ A+K+ L+ + + DVEC +++ + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMI--DVAAALEYLHFGY 160
++ S D V+EY+ G L +Y V + + ++A L +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFLH--- 118
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYMAPE---- 215
S +I+ DLK NV+LD ++DFG+ K ++ T+T T Y+APE
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAY 175
Query: 216 --YGREGRVSTNGDVYSFGIMLMETFTKKKPTD 246
YG+ + D ++FG++L E + P D
Sbjct: 176 QPYGK------SVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 32/216 (14%)
Query: 51 IGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVE---CE-----VMKSIRHRNL 101
+GRG FG V A + E+ A+K L+ G + +VE CE S RH L
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKA--LKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMI---DVAAALEYLHF 158
+ + + +D V+EY G L +++ D+F + V L+YLH
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH- 118
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS-KSQTQTL-ATIGYMAPEY 216
+++ DLK N+LLD ++DFG+ K E +T T T ++APE
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTPEFLAPEV 172
Query: 217 GREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
E + D + G+++ E + P F G+
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 31/179 (17%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV-----ECEVMKSIR-HRNLIK 103
IG G+F V KA+ + G A+K ++ FKS + E + ++ + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK--CMK--KHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 104 IISTCSNDDFK--ALVLEYMPHGSLE-----KCLYSSNCVLDIFQRLNIMIDVAAALEYL 156
+I + ALV E M E K V + M + +L+++
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVK------SYMYQLLKSLDHM 116
Query: 157 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
H + H D+KP N+L+ D+++ L+DFG + G T+ ++T Y APE
Sbjct: 117 H---RNGIFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYISTRWYRAPE 168
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 35/222 (15%)
Query: 50 LIGRGSFGSVYKARIQDGM----EVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKII 105
LIG G FG VY+ + + K+ +L+ ++ +E V +I + I +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLEN----ETIVMETLVYNNIYDIDKIALW 74
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVL---------DIFQRL---------NIMI 147
N D + Y GS ++C +L +IF+R+ NIM
Sbjct: 75 KNIHNIDHLGIPK-YYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMK 133
Query: 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK--LLTGEDQSKSQTQT 205
D+ LEY+H + H D+KP N+++D N ++ D+GIA ++ G+ S+ Q
Sbjct: 134 DMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 206 ---LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
T+ Y + V+ GD+ S G +++ K P
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 41/155 (26%), Positives = 78/155 (50%), Gaps = 16/155 (10%)
Query: 89 ECEVMKSIRHRNLIKIISTC----SNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQR 142
E ++K + H+N+I +++ S ++F+ LV+E M +L + ++ LD +
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERM 125
Query: 143 LNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202
++ + +++LH SA +IH DLKPSN+++ + + DFG+A+ +
Sbjct: 126 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMM 179
Query: 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 237
T + T Y APE N D++S G ++ E
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (110), Expect = 1e-05
Identities = 59/248 (23%), Positives = 102/248 (41%), Gaps = 56/248 (22%)
Query: 88 VECEVMKSIRHRNLIKIISTCSNDDFKAL--VLEYMPHGSL----EKCL-----YSSNCV 136
+E VM+ ++H+N+++ I N + L ++E+ G L +KC + +
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 137 LDIFQRLNIMIDVAAALEYLHFGYSAP----VIHCDLKPSNVLLDDNM------------ 180
+DI ++L AL Y H P V+H DLKP N+ L +
Sbjct: 121 VDITRQL------LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 181 -----VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTN--GDVYSFGI 233
+A + DFG++K + E + S + T Y +PE S + D+++ G
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAHS---CVGTPYYWSPELLLHETKSYDDKSDMWALGC 231
Query: 234 MLMETFTKKKPTDKIFAGEMTLKYWVSNL-----LPI----SVMEIVDANLLSREDKHFA 284
++ E + K P F +S L LPI + I+ NLL+ K
Sbjct: 232 IIYELCSGKTP----FHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERP 287
Query: 285 AKEQCVSF 292
+ QC+ +
Sbjct: 288 SALQCLGY 295
|
Length = 1021 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 40/163 (24%), Positives = 69/163 (42%), Gaps = 18/163 (11%)
Query: 89 ECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKC-------LYSSNCVLDIFQ 141
E ++ ++H N++ + D +V+EY G L + L+ + +L F
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF- 106
Query: 142 RLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201
+ + ++++H V+H D+K N+ L N L DFG A+LLT
Sbjct: 107 -----VQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT--SPGAY 156
Query: 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
+ T Y+ PE + D++S G +L E T K P
Sbjct: 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 46/176 (26%), Positives = 83/176 (47%), Gaps = 20/176 (11%)
Query: 89 ECEVMKSIRHRNLIKIISTCSN----DDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQR 142
E +MK + H+N+I +++ + ++F+ LV+E M +L + + LD +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 121
Query: 143 LNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202
++ + +++LH SA +IH DLKPSN+++ + + DFG+A+ S
Sbjct: 122 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 175
Query: 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYW 258
T + T Y APE N D++S G ++ E K +F G + W
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 28/185 (15%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFD------VECEVMKSIRHRNLI 102
L+G+G+FG V R + + A+K+ + V + D E V+++ RH L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKE---VIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIM-IDVAAALEYLHFGYS 161
+ + D V+EY G L + S + R ++ +AL YLH S
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLH---S 113
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL--ATIGYMAPE---- 215
V++ DLK N++LD + ++DFG+ K E S T T Y+APE
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLED 169
Query: 216 --YGR 218
YGR
Sbjct: 170 NDYGR 174
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 42 TDGFSENNLIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVMK----SI 96
F ++G+GSFG V A + E+ A+K+ L+ V + DVEC +++ ++
Sbjct: 1 DFNFL--MVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLAL 56
Query: 97 RHRN--LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCV--LDIFQRLNIMIDVAAA 152
+ + L ++ S D V+EY+ G L +Y V Q + +++
Sbjct: 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVG 113
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGY 211
L +LH +I+ DLK NV+LD ++DFG+ K + + T+T T Y
Sbjct: 114 LFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT---TRTFCGTPDY 167
Query: 212 MAPE------YGREGRVSTNGDVYSFGIMLMETFTKKKPTD 246
+APE YG+ + D +++G++L E + P D
Sbjct: 168 IAPEIIAYQPYGK------SVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 57/246 (23%), Positives = 94/246 (38%), Gaps = 55/246 (22%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN- 100
D F +IGRG+FG V + +D G A+K+ K+ +E E + IR
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53
Query: 101 ---------LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA 151
++K+ + + L++E++P G + L + + + + I V A
Sbjct: 54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLA 113
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL------------------ 193
G+ IH D+KP N+LLD LSDFG+ L
Sbjct: 114 IDAIHQLGF----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 194 -----------TGEDQSKSQTQ----TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 238
E K++ Q T+ T Y+APE + + D +S G+++ E
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 239 FTKKKP 244
P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 50/202 (24%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 50 LIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFD------VECEVMKSIRHRNLI 102
L+G+G+FG V + + G A+K+ + V + D E V+++ RH L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKE---VIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
+ + D V+EY G L L + R ++ +AL+YLH
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEK 115
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222
V++ DLK N++LD + ++DFG+ K G + T Y+APE +
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY 173
Query: 223 STNGDVYSFGIMLMETFTKKKP 244
D + G+++ E + P
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 8/153 (5%)
Query: 89 ECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLE-KCLYSSNCVLDIFQRLNIMI 147
E ++++I H ++I++ T + + F L+L P + C ++ + I L I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
V A++YLH +IH D+K N+ ++ L DFG A + +K
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-G 245
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
TI APE D++S GI+L E T
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 45/184 (24%), Positives = 77/184 (41%), Gaps = 36/184 (19%)
Query: 89 ECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKC--------LYSSNCVLDIF 140
E +MK + H+N+I +++ + P SLE+ L +N I
Sbjct: 73 ELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQ 120
Query: 141 QRLN------IMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194
L+ ++ + +++LH SA +IH DLKPSN+++ + + DFG+A+
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-- 175
Query: 195 GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMT 254
S T + T Y APE N D++S G ++ E +F G
Sbjct: 176 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDH 230
Query: 255 LKYW 258
+ W
Sbjct: 231 IDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQDGMEV-AVKVFH----LQCGGVFKSFDVECEVMKSIR 97
D F +IGRG+FG V ++++ +V A+K+ + L+ F E +V+ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET-ACFREERDVLVNGD 59
Query: 98 HRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH 157
R + + +++ LV++Y G L L L + ++ A++ +H
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 158 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY 216
GY +H D+KP NVLLD N L+DFG + L D + + T Y++PE
Sbjct: 120 QLGY----VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 217 GR-----EGRVSTNGDVYSFGIMLMETFTKKKP 244
+ +GR D +S G+ + E + P
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVMKSIRHRNL 101
D F +IGRG+FG V +++ + A+K+ L + K + C R
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKI--LNKWEMLKRAETAC-----FREERN 53
Query: 102 IKIISTCS----------NDDFKALVLEYMPHGSLEKCL--YSSNCVLDIFQ-RLNIMID 148
+ + C ++++ LV++Y G L L + D+ + + M+
Sbjct: 54 VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL 113
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
++ LH+ +H D+KP NVLLD N L+DFG + L +D + + + T
Sbjct: 114 AIHSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166
Query: 209 IGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTKKKP 244
Y++PE + G+ D +S G+ + E + P
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 8e-05
Identities = 16/44 (36%), Positives = 24/44 (54%), Gaps = 3/44 (6%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMK 94
I S V++A ++DG EVAVKV GV K + +++K
Sbjct: 19 IAAASIAQVHRAVLKDGEEVAVKVQR---PGVKKRIRSDLKLLK 59
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 28/77 (36%), Positives = 43/77 (55%), Gaps = 4/77 (5%)
Query: 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVL 175
LV+EY+ G + K L D + + +VA AL+YLH +IH DLKP N+L
Sbjct: 81 LVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNML 136
Query: 176 LDDNMVAHLSDFGIAKL 192
+ + L+DFG++K+
Sbjct: 137 ISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 49/197 (24%), Positives = 86/197 (43%), Gaps = 26/197 (13%)
Query: 68 MEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLE 127
+ V +KV + +F +M + H +L + C +V E++ HG L+
Sbjct: 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 128 KCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH---- 183
CL + + ++ + +A+AL YL ++H ++ N+LL +A
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSP 161
Query: 184 ---LSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETF 239
LSD G++ T + S+ + + I ++APE G +ST D +SFG L+E
Sbjct: 162 FIKLSDPGVS--FT----ALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI- 214
Query: 240 TKKKPTDKIFAGEMTLK 256
F GE+ LK
Sbjct: 215 --------CFDGEVPLK 223
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 33/105 (31%), Positives = 49/105 (46%), Gaps = 28/105 (26%)
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK---------LLTGEDQSKSQ 202
ALEYLH + ++H DLKP N+L+ L+DFG++K L G + ++
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 203 ----TQTLATIGYMAPE------YGREGRVSTNGDVYSFGIMLME 237
Q T Y+APE YG+ D ++ GI+L E
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 56/246 (22%), Positives = 96/246 (39%), Gaps = 55/246 (22%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN- 100
+ F +IGRG+FG V + +D G A+K+ K+ +E E + IR
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERD 53
Query: 101 ---------LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA 151
++K+ + + L++E++P G + L + + + + I V A
Sbjct: 54 ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLA 113
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ------------- 198
G+ IH D+KP N+LLD LSDFG+ L +
Sbjct: 114 IDSIHQLGF----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 199 --------SKSQTQT---------LATIG---YMAPEYGREGRVSTNGDVYSFGIMLMET 238
SK + +T +T+G Y+APE + + D +S G+++ E
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 239 FTKKKP 244
P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 33/169 (19%)
Query: 50 LIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNL------ 101
+IGRG+FG V + +D G A+K KS +E E + +R R++
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLR-------KSEMLEKEQVAHVRAERDILAEADN 60
Query: 102 ---IKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIF---QRLNIMIDVAAALEY 155
+K+ + ++++ L++EY+P G + L D F + + + A++
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDS 116
Query: 156 LH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203
+H GY IH D+KP N+LLD LSDFG L TG +S
Sbjct: 117 IHKLGY----IHRDIKPDNLLLDAKGHIKLSDFG---LCTGLKKSHRTE 158
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 2/91 (2%)
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
L+F + +I+ DLK NVLLD L+D+G+ K G + + T Y+APE
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPE 166
Query: 216 YGREGRVSTNGDVYSFGIMLMETFTKKKPTD 246
R + D ++ G+++ E + P D
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 39/167 (23%), Positives = 65/167 (38%), Gaps = 25/167 (14%)
Query: 98 HRNLIKIISTCSNDDFKALVLEYMPHGSL------EKCLYSSNCVLDIFQRLNIMIDVAA 151
+ N IK+ + + L+++Y+ G L E L + I Q +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ-------LVE 120
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-AHLSDFGIAKLLTGEDQSKSQTQTL-ATI 209
AL LH +IH D+K NVL D +L D+G+ K T+
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------IIGTPSCYDGTL 170
Query: 210 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK 256
Y +PE + + D ++ G++ E T K P + E+ L+
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217
|
Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 42/171 (24%), Positives = 74/171 (43%), Gaps = 14/171 (8%)
Query: 43 DGFSENNLIGRGSFGSV-YKARIQDGMEVAVKVFHLQCGGVFKS-----FDVECEVMKSI 96
+ F +IG+G+FG V + G A+K L +FK E +V+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKT--LLKSEMFKKDQLAHVKAERDVLAES 58
Query: 97 RHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL 156
++ + + + + L++E++P G L L + + R M + A+E +
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAV 117
Query: 157 H-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206
H G+ IH D+KP N+L+D LSDFG++ + S + L
Sbjct: 118 HKLGF----IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 25/156 (16%)
Query: 51 IGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDV-----ECEVMKSIRHRNLIKI 104
IG G+FG V R D + A+K L+ V E +++ + ++K+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKT--LRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQ----RLNIMIDVAAALEYLH-FG 159
+ + D V++Y+P G + L L IF+ R I ++ A+E +H G
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIA-ELTCAIESVHKMG 121
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195
+ IH D+KP N+L+D + L+DFG L TG
Sbjct: 122 F----IHRDIKPDNILIDRDGHIKLTDFG---LCTG 150
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 48/227 (21%), Positives = 93/227 (40%), Gaps = 39/227 (17%)
Query: 51 IGRGSFGSVYKARIQDG-------------MEVAVKVFHLQCGGVFKSFDVECEVMKSIR 97
+GRG+ +Y + ++V +KV + +F +M+ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 98 HRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH 157
H++++ + C D +V E++ G L+ ++ + VL + + +A+AL YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122
Query: 158 FGYSAPVIHCDLKPSNVLL-------DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG 210
++H ++ N+LL + LSD GI + S+ + + I
Sbjct: 123 ---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL------SRQECVERIP 173
Query: 211 YMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK 256
++APE + + S D +SFG L E + GE+ LK
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 20/76 (26%), Positives = 26/76 (34%), Gaps = 6/76 (7%)
Query: 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL--HF-GYSAPVIHCDLKPSN 173
LE+ V R ++ + L L H +IH DL P N
Sbjct: 151 RLEWDILEPRALLRLDL--VEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDN 208
Query: 174 VLLD-DNMVAHLSDFG 188
VL D D V+ DF
Sbjct: 209 VLFDDDTDVSGFIDFD 224
|
Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 36/174 (20%), Positives = 69/174 (39%), Gaps = 43/174 (24%)
Query: 89 ECEVMKSIRHRNLIKIISTCSNDDFKALVLE--------YMPHGSLEKCLYSSNCVLDIF 140
E + + H N++KI ++ ++ + +M + + + +L
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD---WKDRPLL--K 267
Query: 141 QRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200
Q IM + A+EY+H +IH D+K N+ L+ + L DFG A E ++
Sbjct: 268 QTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 201 SQTQTLATIGYMAPEYGREGRVSTNG-------------DVYSFGIMLMETFTK 241
+YG G V+TN D++S G++L++ +
Sbjct: 325 --------------DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364
|
Length = 501 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 54/252 (21%), Positives = 96/252 (38%), Gaps = 59/252 (23%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV-----ECEVMKSIRH 98
F + +G G+FG V A + A+K L+ V V E +++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKT--LRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH- 157
++K+ + + D V++Y+P G + L ++ R I ++ A+E +H
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHK 119
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA--------------------------- 190
G+ IH D+KP N+L+D + L+DFG+
Sbjct: 120 MGF----IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 191 ------------KLLTGEDQSKSQTQT------LATIGYMAPEYGREGRVSTNGDVYSFG 232
+L T E ++ Q Q + T Y+APE + D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 233 IMLMETFTKKKP 244
++L E + P
Sbjct: 236 VILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 335 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.35 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.03 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.01 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.01 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.89 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.89 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.82 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.75 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.74 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.64 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.63 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.62 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.55 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.47 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.37 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.34 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.28 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.24 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.16 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.12 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.11 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.08 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.99 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.97 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.94 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.93 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.9 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.88 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.85 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.82 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.66 | |
| PLN02236 | 344 | choline kinase | 97.61 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.57 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.54 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.42 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.41 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.21 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.17 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.1 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.08 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.83 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.81 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.78 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.69 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.62 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.41 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.3 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.24 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 96.22 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.09 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.06 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.93 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-50 Score=360.25 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=218.3
Q ss_pred CCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
.+|...++||+|+|+.||.++. .+|+.||+|++... .....+.+.+|+++-++++|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999987 77999999999753 4556788999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
|.|..++|..+++ +++++++.+++.+..||+.||.||| +.+|+|||||..|+|++++.+|||+|||+|..+.. .
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--D 171 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecC--c
Confidence 9999999999888 5559999999999999999999999 99999999999999999999999999999998742 2
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......+||+.|.|||++.....+..+||||+||+||.||.|++||+... +.+.++..
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----------------vkety~~I---- 230 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----------------VKETYNKI---- 230 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----------------HHHHHHHH----
Confidence 244556789999999999999999999999999999999999999998742 22333322
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
....+..|..++.+..+||.++|+.||.+|||+++|+..
T Consensus 231 k~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 231 KLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222344455778889999999999999999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-50 Score=341.43 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=217.3
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC-eeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD-FKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e 119 (335)
++...++.||+|..|+||++.++ +++-+|+|++.... ....+.+.+|+++++.++|||||++||.|..+. ..+++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 46778899999999999999755 68889999996553 445678999999999999999999999999988 5999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
||++|+|++++... +.+++..+..++.++++||.|||. .++|+||||||+|||++..|.|||+|||.+..+. .
T Consensus 159 YMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv----n 231 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV----N 231 (364)
T ss_pred hcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhh----h
Confidence 99999999988765 479999999999999999999993 3999999999999999999999999999998763 2
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......||..|||||.+.++.|+.++||||||++++|+.+|+.||....... ....++++......+
T Consensus 232 S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~------------~~~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 232 SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY------------LDIFELLCAIVDEPP 299 (364)
T ss_pred hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC------------CCHHHHHHHHhcCCC
Confidence 25567889999999999999999999999999999999999999987752211 123444555444333
Q ss_pred ccchhhHH-HHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 280 DKHFAAKE-QCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 280 ~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
+.. +. .++++++++|..||+.||.+||++.|+++.=.
T Consensus 300 P~l---P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 300 PRL---PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred CCC---CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 222 33 48999999999999999999999999997643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-50 Score=342.64 Aligned_cols=256 Identities=24% Similarity=0.329 Sum_probs=212.8
Q ss_pred hcCCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecCCC-------chhHHHHHHHHHHHhCCCCceEEEeeeeecCC
Q 019843 41 ATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG-------GVFKSFDVECEVMKSIRHRNLIKIISTCSNDD 112 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 112 (335)
..+.|.+.+.||.|+||.|-+|. .++|+.||||+++...- .-.....+|+++|++++|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 67789999999999999999996 55799999999974311 11233579999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC---CcEEEeeccc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGI 189 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~---~~v~l~dfg~ 189 (335)
..||||||++||.|.+.+..+. .+.+.....+++||+.|+.||| +.||+||||||+|||++.+ ..+||.|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence 9999999999999999887654 7888888999999999999999 9999999999999999766 6899999999
Q ss_pred cccccCCccccccccccccccccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 266 (335)
+...+ ........+||+.|.|||++.+.. +..+.|+||+||++|.+++|.+||+.......
T Consensus 326 AK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------------- 389 (475)
T KOG0615|consen 326 AKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------------- 389 (475)
T ss_pred hhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------------
Confidence 99763 345556789999999999998765 34477999999999999999999988654331
Q ss_pred HHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
+.++...............++++..+||.+||..||++|||+.|+|+.=|
T Consensus 390 ---l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 390 ---LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred ---HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 12222222233333334567888999999999999999999999997654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=327.58 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=208.6
Q ss_pred CCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEee-eeec-CCeeEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIIS-TCSN-DDFKALV 117 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~-~~~~~lv 117 (335)
.+|.+.+.||.|.||.||++. ..+|..+|.|.+.-+ +....+.+..|+.+|++|+||||+++++ .+.+ +..+++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 579999999999999999995 567999999998744 3456788999999999999999999998 4444 4558999
Q ss_pred EEecCCCChHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhccCC--CC--eEecCCCCCCEEECCCCcEEEeecccc
Q 019843 118 LEYMPHGSLEKCLY---SSNCVLDIFQRLNIMIDVAAALEYLHFGYS--AP--VIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 118 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~--~~--i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
||+|++|+|..+++ +....+++..+|.++.|++.||..+| + .. +.|+||||.|||++.+|.|||+|||++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH---~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCH---SKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHh---ccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999999986 34557999999999999999999999 5 44 999999999999999999999999999
Q ss_pred ccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
+.+. .........+||+.||+||.+.+..|+.+|||||+||++|||+..++||.+.. ..++
T Consensus 176 r~l~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----------------~~~L 236 (375)
T KOG0591|consen 176 RFLS--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----------------LLSL 236 (375)
T ss_pred hHhc--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----------------HHHH
Confidence 9874 23344556899999999999999999999999999999999999999998741 1111
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
-.+.-+.+.++ ......+.++.+||.-|+..||..||+...++..+.+
T Consensus 237 ~~KI~qgd~~~--~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 237 CKKIEQGDYPP--LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHcCCCCC--CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11111111111 1124568889999999999999999986555555443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=341.27 Aligned_cols=288 Identities=42% Similarity=0.654 Sum_probs=239.1
Q ss_pred cccccCHHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeee
Q 019843 29 TWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108 (335)
Q Consensus 29 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 108 (335)
..+.|++.++..++++|.-.+.||+|+||.||+|...++..||||.+.........+|.+|+.++.+++|||+++++|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 67889999999999999999999999999999999998899999988765443145699999999999999999999999
Q ss_pred ecCC-eeEEEEEecCCCChHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEee
Q 019843 109 SNDD-FKALVLEYMPHGSLEKCLYSSNC-VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 186 (335)
Q Consensus 109 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~d 186 (335)
.+.+ ..++|+||++.|+|.+++..... +++|..+.+|+.++|+||+|||+.....|+|+|||++|||+|++...|++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999987766 899999999999999999999976666899999999999999999999999
Q ss_pred ccccccccCCccccccccc-cccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccc-ccchhhHhHhhhhc-
Q 019843 187 FGIAKLLTGEDQSKSQTQT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIF-AGEMTLKYWVSNLL- 263 (335)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~-~~~~~~~~~~~~~~- 263 (335)
||++...... ....... .||.+|+|||+...+..+.++||||||+++.||++|+.+.+... ..+..+..|.....
T Consensus 221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999643210 1111111 79999999999999999999999999999999999999887654 33334566654443
Q ss_pred ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 264 PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
.....+++|+.+....... ......+..+..+|++.+|.+||+|.||.+.|+.+.
T Consensus 299 ~~~~~eiiD~~l~~~~~~~----~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPD----EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCCh----HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 4467777777655311110 023344899999999999999999999999886544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=341.04 Aligned_cols=264 Identities=31% Similarity=0.457 Sum_probs=219.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCceEEEeeeeecCC-eeEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIISTCSNDD-FKAL 116 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l 116 (335)
...+...+.+.+|.|+||+||+|.+.....||+|++..... .....|.+|+.++.+++||||++++|++.... .+++
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 33455666777999999999999999444499999975532 22569999999999999999999999999887 7999
Q ss_pred EEEecCCCChHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCC-eEecCCCCCCEEECCCC-cEEEeeccccccc
Q 019843 117 VLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFGYSAP-VIHCDLKPSNVLLDDNM-VAHLSDFGIAKLL 193 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~-i~h~di~p~Nilv~~~~-~v~l~dfg~~~~~ 193 (335)
||||+++|+|.+++.. ....+++..++.++.+|++|+.||| +.+ |+|+||||.|||++.++ ++||+|||++...
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999987 3668999999999999999999999 888 99999999999999998 9999999999865
Q ss_pred cCCccccccccccccccccCccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGR--EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
.... .......||..|||||++. ...++.++||||||+++|||+||..||.......... ...
T Consensus 195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~-------------~v~ 259 (362)
T KOG0192|consen 195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS-------------AVV 259 (362)
T ss_pred cccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH-------------HHH
Confidence 3111 3333467999999999999 5689999999999999999999999998865311111 111
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
....+...+..+++.+..++.+||+.||.+||++.+++..|+.+......
T Consensus 260 ------~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 260 ------VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ------hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 12223333444788899999999999999999999999999998776654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=344.64 Aligned_cols=265 Identities=29% Similarity=0.465 Sum_probs=226.7
Q ss_pred HHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 35 YLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 35 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
.+.-....+.++.++.||+|.||.||.|.++....|++|.++..+ ...+.|.+|++++++|+|++||++++++..++.+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 333344445667789999999999999999977899999998653 3347888999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
+|||||++.|+|.++|.. .+..+...+.+.++.|||+|++||+ +++++||||...||||+++..+||+|||+++..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999999997 5668999999999999999999999 999999999999999999999999999999954
Q ss_pred cCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
. .+.........-...|+|||.+..+.++.+|||||||++||||+| |+.||.+....+ +...
T Consensus 354 ~-d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------------v~~~-- 416 (468)
T KOG0197|consen 354 G-DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------------VLEL-- 416 (468)
T ss_pred C-CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------------HHHH--
Confidence 3 333333344445677999999999999999999999999999999 889987754221 1222
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
-..+.+++.|..||+.+.+++..||+.+|++|||++.+...|..+...
T Consensus 417 ----le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 417 ----LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ----HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 234567778899999999999999999999999999999999988653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=326.63 Aligned_cols=208 Identities=30% Similarity=0.498 Sum_probs=187.4
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
....+|.+.+.||.|+|++||+|+.+ ++..||||.+... .....+.+..|+++|+.++|||||.+++++...+.+|+
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 34578999999999999999999754 5899999999766 55667788999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC------CcEEEeecccc
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN------MVAHLSDFGIA 190 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~------~~v~l~dfg~~ 190 (335)
|||||+||+|.+++..++ .+++..+.....||+.||++|| +++|+|+||||.|||++.. -.+||.|||++
T Consensus 87 VMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999998775 7999999999999999999999 9999999999999999864 46899999999
Q ss_pred ccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchh
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMT 254 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~ 254 (335)
+.+. ........+|++-|||||++..++|+.|+|+||+|+++|++++|..||......+..
T Consensus 163 R~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~ 223 (429)
T KOG0595|consen 163 RFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL 223 (429)
T ss_pred hhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 9874 445556788999999999999999999999999999999999999999976544443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=311.37 Aligned_cols=268 Identities=22% Similarity=0.310 Sum_probs=216.6
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
++|....++|+|+||.||+++++ +|+-||||+|... ++...+...+|+++|++++|+|+|.++++|.....+++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 57888999999999999999866 5999999998533 34566778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
||+. ++.+-+...+...+.+.+..+++|++.|+.|+| +.+++|+||||+|||++.+|.+||||||+|+.+. ...
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~--~pg 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLS--APG 155 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhc--CCc
Confidence 9976 555557777778999999999999999999999 9999999999999999999999999999999874 245
Q ss_pred cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhh--HhHhhhhcChhHHHHHHhhhc
Q 019843 200 KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTL--KYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 276 (335)
......+.|.+|.|||.+.| .+|+...||||+||++.||++|.+.|.+.+.-+..+ ...+.++.+....-+......
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 56677889999999999888 689999999999999999999999998765433322 333444444433333222211
Q ss_pred -----cccccchhhH---HHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 277 -----SREDKHFAAK---EQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 277 -----~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
+......+.. ..++.-+.+++++||+.||.+|++.++++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111111 245667999999999999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=317.56 Aligned_cols=245 Identities=27% Similarity=0.342 Sum_probs=207.7
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
....++|.+.++||+|+||.||.++.+ +++-+|+|+++.. ..........|..+|..++||.|++++..|.+.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 344588999999999999999999754 5889999998754 233457788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
|+|++|+.||.|...|++.+ .+++..+..++.+|+.||.||| +++|+|||+||+|||++.+|+++|+|||++...-
T Consensus 101 ylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999999998665 7999999999999999999999 9999999999999999999999999999998542
Q ss_pred CCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
.........+||+.|||||++.+..++.++|.||||+++|+|++|.+||......+ .++..
T Consensus 177 --~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-----------------~~~~I 237 (357)
T KOG0598|consen 177 --KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-----------------MYDKI 237 (357)
T ss_pred --cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-----------------HHHHH
Confidence 22334445799999999999999999999999999999999999999998754322 22222
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCC
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI 309 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 309 (335)
...+ ....+...+.+.++++.++|+.||++|.
T Consensus 238 ~~~k---~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 238 LKGK---LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred hcCc---CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 2222 1112233577799999999999999995
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=321.18 Aligned_cols=260 Identities=29% Similarity=0.426 Sum_probs=213.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC--eeEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD--FKALVL 118 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 118 (335)
..+|...+.||+|+||+||++... +|+..|+|.....+....+.+.+|+.+|++++|||||+++|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 567999999999999999999765 48999999987664444688999999999999999999999855444 689999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC-CCcEEEeeccccccccC-C
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTG-E 196 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~-~~~v~l~dfg~~~~~~~-~ 196 (335)
||+++|+|.+++...++.+++..+..+..|+++||.||| +++++|+||||+|||++. ++.+||+|||.+..... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999999877668999999999999999999999 999999999999999999 79999999999887642 1
Q ss_pred ccccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
..........||+.|||||++.++ ....++|||||||++.||+||..||...... ...+-...
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~----------------~~~~~~ig 236 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE----------------AEALLLIG 236 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch----------------HHHHHHHh
Confidence 223334567899999999999853 3446999999999999999999999874110 01111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
.....+ ..+..++++..+++.+|+..||++||||+++|+.-..-.
T Consensus 237 ~~~~~P--~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 237 REDSLP--EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred ccCCCC--CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 111111 345567888999999999999999999999999876544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=329.59 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=214.0
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCe
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDF 113 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 113 (335)
.-..++|.+++.||.|+|++|++|+.+ +++.+|||++... ...-..-+..|-.+|.+| .||.|++++..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 445579999999999999999999754 6999999998633 111224566788899999 89999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
+|+|++|+++|.|.++|.+.+ .+++.....++.+|+.||.||| ++||+||||||+|||++.||+++|.|||.+..+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999998775 8999999999999999999999 999999999999999999999999999999988
Q ss_pred cCCccc---------ccc--ccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh
Q 019843 194 TGEDQS---------KSQ--TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262 (335)
Q Consensus 194 ~~~~~~---------~~~--~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 262 (335)
.+.... ... ...+||..|.+||++..+..+.++|+|+|||++|+|+.|.+||....+ .
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--y--------- 293 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--Y--------- 293 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--H---------
Confidence 633211 111 347899999999999999999999999999999999999999986421 1
Q ss_pred cChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 263 LPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
-+.. ......+..+.++++.+.+||.+.|..||.+|+++.+|.+.
T Consensus 294 ------liFq----kI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 ------LIFQ----KIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ------HHHH----HHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111 11223345567778889999999999999999999888764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=330.20 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=220.7
Q ss_pred hhcCCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
+-...|.....||+|+.|.||.|. ..+++.||+|.+........+.+.+|+.+++..+|+|||.+++.|...+.+++||
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 345689999999999999999995 5568899999999888888899999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||++||+|.|++.... +++.++..|+.++++||+||| .++|+|+|||.+||+++.+|.+||+|||++..+...
T Consensus 350 Eym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~-- 422 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE-- 422 (550)
T ss_pred eecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccc--
Confidence 9999999999987665 999999999999999999999 999999999999999999999999999999987422
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......+||+.|||||++....|+.+.||||||++++||+-|++||-+..+-. ..-+ ....
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr--------------AlyL----Ia~n 484 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------------ALYL----IATN 484 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH--------------HHHH----Hhhc
Confidence 234556789999999999999999999999999999999999999987632111 1111 1223
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..+.+..+..+++.+++++.+||..|+.+|+++.|+|+.
T Consensus 485 g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 485 GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 444455567788999999999999999999999999974
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=311.55 Aligned_cols=270 Identities=24% Similarity=0.317 Sum_probs=220.5
Q ss_pred CHHHHhhhcCCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecC
Q 019843 34 SYLELFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSND 111 (335)
Q Consensus 34 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 111 (335)
+..+.....+.|.+...||.|..++||+|. ...++.||||++..+. ......+.+|++.++.++||||++++..|..+
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 344555677899999999999999999996 4568999999998773 44468999999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
..+|+||+++.+|++.+++... ...+++..+..+++++++||.||| .+|.+|||+|+.|||++.+|.|+|+|||.+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceee
Confidence 9999999999999999999753 445999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCCcccc-cc-ccccccccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh
Q 019843 191 KLLTGEDQSK-SQ-TQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266 (335)
Q Consensus 191 ~~~~~~~~~~-~~-~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 266 (335)
..+....... .. ....+++.|||||++.. ..|+.|+||||||++.+||.+|..||....+-+..+....+.. +..
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p-p~~ 252 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP-PTL 252 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC-CCc
Confidence 8775433221 11 45689999999999543 4699999999999999999999999987654333322111111 000
Q ss_pred HHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. .........+.++..+++++..||..||.+|||++++++.
T Consensus 253 ~----------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 L----------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred c----------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0 1122334445567789999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=324.04 Aligned_cols=261 Identities=23% Similarity=0.389 Sum_probs=206.7
Q ss_pred cCCCCccceeeecCceEEEEEEE------cCCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeecC-C
Q 019843 42 TDGFSENNLIGRGSFGSVYKARI------QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSND-D 112 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~------~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 112 (335)
.++|++.+.||.|+||.||+|.. .+++.||+|++.... ......+.+|+.++..+ +||||+++++++... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46899999999999999999963 235679999987443 23346788999999999 899999999988754 4
Q ss_pred eeEEEEEecCCCChHHHHhcCC----------------------------------------------------------
Q 019843 113 FKALVLEYMPHGSLEKCLYSSN---------------------------------------------------------- 134 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------- 134 (335)
.++++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6889999999999999986431
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccccccccccc
Q 019843 135 ---CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY 211 (335)
Q Consensus 135 ---~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y 211 (335)
.++++..+..++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++............+...++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 24778889999999999999999 999999999999999999999999999999765322222222334456789
Q ss_pred cCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHH
Q 019843 212 MAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCV 290 (335)
Q Consensus 212 ~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (335)
+|||++.+..++.++||||||+++|+|++ |..||......+.. ...+... .....+..++
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~-------------~~~~~~~------~~~~~~~~~~ 303 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-------------CQRLKDG------TRMRAPENAT 303 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH-------------HHHHhcC------CCCCCCCCCC
Confidence 99999998899999999999999999997 99998764322111 0111100 0111233456
Q ss_pred HHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 291 SFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 291 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
+.+.+++.+||+.||.+|||+.|+++.|+.+..+
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 7799999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=327.81 Aligned_cols=273 Identities=26% Similarity=0.417 Sum_probs=222.0
Q ss_pred cccCHHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeee
Q 019843 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTC 108 (335)
Q Consensus 31 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 108 (335)
.+++..+-+...++..+...||+|.||+||+|.|- ..||||+++.+ +++..+.|++|+..+++-+|.||+-+.|++
T Consensus 380 ~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 380 ASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred CCccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence 44444666777788899999999999999999887 46999999866 345778999999999999999999999999
Q ss_pred ecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 109 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
..... .+|..+|+|.+|..++......+.+.+...|+.|+++|+.||| .++|+|+|||.+|||+.++++|||+|||
T Consensus 458 ~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 458 MNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred cCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccc
Confidence 99888 8999999999999999887778999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcCh
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI 265 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 265 (335)
++..-.--..........+...|+|||++.. .++++.|||||||+++|||++|..||.....+..-.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif---------- 603 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF---------- 603 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE----------
Confidence 9986421111223334557778999999874 358999999999999999999999998322111110
Q ss_pred hHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 266 SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
.+..+.. ..........++.++.+|+..||++++++||.+.+|+..|..+..++
T Consensus 604 ----mVGrG~l--~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 604 ----MVGRGYL--MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ----Eeccccc--CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 0000000 01111123567889999999999999999999999999988776543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=294.32 Aligned_cols=267 Identities=23% Similarity=0.326 Sum_probs=216.5
Q ss_pred CCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.+|...+++|+|.||.||+|+ .++|+.||||+++... +.......+|++.|+.++|+||+.++++|.+.+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 578999999999999999996 5579999999998653 3445678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+ ..+|..+++.+...++...+..++.+++.|++|+| .+.|.|+||||+|++++.+|.+||+|||+++.+.+....
T Consensus 82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 99 55999999988889999999999999999999999 999999999999999999999999999999988644333
Q ss_pred cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh---
Q 019843 200 KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL--- 275 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 275 (335)
. ...+.|.+|.|||.+.| ..|+...|+||.||++.||+.|.+-|.+.+ +-.++......+..+....+-+...
T Consensus 158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-DidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-DIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-hHHHHHHHHHHcCCCCcccCcccccccc
Confidence 3 33378999999998877 569999999999999999999987776643 3333444444433333222222211
Q ss_pred ------ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 276 ------LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 276 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.+...... .-..++++..+|+.+|+..||.+|+++.|+++.
T Consensus 235 Y~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111111 123456778999999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=320.01 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=211.7
Q ss_pred hhhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecC----CC-chhHHHHHHHHHHHhCC-CCceEEEeeeeecC
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQ----CG-GVFKSFDVECEVMKSIR-HRNLIKIISTCSND 111 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 111 (335)
....++|.+.+.||+|+||.|+.|.. .+++.||+|++... .. ...+.+.+|+.+++.+. ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 35568999999999999999999964 56899999977653 11 24456778999999998 99999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC-CcEEEeecccc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIA 190 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~-~~v~l~dfg~~ 190 (335)
..+++||||+.||.|.+++.. .+++.+..+..++.||+.|+.|+| +++|+||||||+||+++.+ +++||+|||++
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999999998 558999999999999999999999 9999999999999999999 99999999999
Q ss_pred ccccCCccccccccccccccccCccccCCCC-CC-CccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGREGR-VS-TNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
.... .........+|++.|+|||++.+.. |+ .++||||+|++||.|++|..||+.......
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l--------------- 231 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL--------------- 231 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH---------------
Confidence 8762 2334556678999999999999877 75 789999999999999999999987322111
Q ss_pred HHHHhhhccccccchhhHHHH-HHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 269 EIVDANLLSREDKHFAAKEQC-VSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
... .....+..+..+ ++++..|+.+||..||.+|+++.++++
T Consensus 232 --~~k----i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 232 --YRK----IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred --HHH----HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 111 111222234444 777999999999999999999999993
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=294.64 Aligned_cols=237 Identities=27% Similarity=0.322 Sum_probs=206.2
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
-++|.+.+.||.|+||.|.+++.+ +|..+|+|++..+. -...+...+|..+|+.+.||.++++++.+.+.+.+|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 368999999999999999999866 48889999997553 23456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||++||-|.+++.+.+ .+++..+..++.+|+.||+||| +.+|++||+||+||++|.+|.+|+.|||++..+
T Consensus 123 meyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v---- 194 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV---- 194 (355)
T ss_pred EeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEe----
Confidence 99999999999998765 7999999999999999999999 999999999999999999999999999999976
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
....-..+||+.|+|||+++...++.++|.||||+++|||+.|.+||....+ ..++++.+.
T Consensus 195 -~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----------------~~iY~KI~~- 255 (355)
T KOG0616|consen 195 -SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----------------IQIYEKILE- 255 (355)
T ss_pred -cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----------------HHHHHHHHh-
Confidence 3335567899999999999999999999999999999999999999987543 222222221
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccC
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQR 308 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 308 (335)
.....|.-++.++++|++++|+.|-.+|
T Consensus 256 ---~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 ---GKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---CcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1223356667889999999999999999
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=317.40 Aligned_cols=270 Identities=22% Similarity=0.257 Sum_probs=212.1
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCc-hhHHHHHHHHHHHhCC-CCceEEEeeeeecCC-eeE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGG-VFKSFDVECEVMKSIR-HRNLIKIISTCSNDD-FKA 115 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~ 115 (335)
...++|.+.+.||.|+||.||+|+.+ +|..||||.++..-.. ..-.-.+|++.|++++ ||||+++.+++.+++ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 45689999999999999999999755 5899999998754322 1223456999999998 999999999999988 999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||| ..+|.+++..++..+++..+..|+.||++||.|+| .+|++|||+||+|||+.....+||+|||+|+.+.
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~- 161 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR- 161 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc-
Confidence 999999 56999999988889999999999999999999999 9999999999999999988899999999999763
Q ss_pred CccccccccccccccccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH----
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI---- 270 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 270 (335)
........+.|.+|.|||++. .+-|+.+.||||+||+++|+.+.++.|.+..+-+.-.+. -+-+..+....+
T Consensus 162 --SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI-c~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 --SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI-CEVLGTPDKDSWPEGY 238 (538)
T ss_pred --cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH-HHHhCCCccccchhHH
Confidence 344566788999999999865 567899999999999999999999999875443322221 111111111111
Q ss_pred -HHhhhccccccc-----hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 271 -VDANLLSREDKH-----FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 271 -~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
+...+.-+.... ......++.+..++|.+||+.||.+||||.|+++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111000000 01112478889999999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=312.09 Aligned_cols=268 Identities=26% Similarity=0.312 Sum_probs=212.0
Q ss_pred CCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecC--CeeEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSND--DFKALV 117 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 117 (335)
+.|.-.+.||+|.||.||+|++ .+|+.||+|++..+. .+......+|+.+|++|+||||+++.++.... +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4567789999999999999964 569999999998764 55567788999999999999999999998765 799999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
||||+. +|..++....-.+++.++..++.||+.||.|+| ++++.|+|||.+|||+|.+|.+||+|||+++++....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999954 999988887778999999999999999999999 9999999999999999999999999999999875332
Q ss_pred cccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH--Hhh
Q 019843 198 QSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV--DAN 274 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 274 (335)
.......+.|.+|.|||++.| ..|+.+.|+||.||+|.||++|++.|.+..+-+. +.....-+.......+- +-.
T Consensus 273 -~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ-l~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 273 -SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ-LHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred -CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH-HHHHHHHhCCCChhccccccCC
Confidence 334667789999999999887 4699999999999999999999999887543222 22222222211111111 000
Q ss_pred ----hcccc--ccc-hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 275 ----LLSRE--DKH-FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 275 ----~~~~~--~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..... ..+ -+.-..++....+|+..+|..||.+|.|+.++|.
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00000 001 1112356778999999999999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=307.42 Aligned_cols=247 Identities=22% Similarity=0.315 Sum_probs=202.3
Q ss_pred cceeeecCceEEEEEEEcCCcEEEEEEeecCCCc---hhHHHHHHHHHHHhCCCCceEEEeeeeec----CCeeEEEEEe
Q 019843 48 NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGG---VFKSFDVECEVMKSIRHRNLIKIISTCSN----DDFKALVLEY 120 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~ 120 (335)
...|++|+++.||+|... |+.||+|++...... ..+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 367999999999999885 899999998755332 25678899999999999999999999876 4578899999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+++|+|.+++.... .+++...+.++.+++.|+.+|| + .+++|+||+|+||+++.++.+||+|||++..+..
T Consensus 104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~---- 175 (283)
T PHA02988 104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS---- 175 (283)
T ss_pred CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc----
Confidence 99999999997654 7889999999999999999999 6 4889999999999999999999999999876532
Q ss_pred cccccccccccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 200 KSQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+. .+.....
T Consensus 176 -~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-----------------~~~i~~~ 237 (283)
T PHA02988 176 -PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-----------------YDLIINK 237 (283)
T ss_pred -ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-----------------HHHHHhc
Confidence 1223467889999999876 6789999999999999999999999976432111 1111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
. .....+..+++.+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 238 ~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 238 N--NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred C--CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1 1111223467789999999999999999999999999998753
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=312.23 Aligned_cols=247 Identities=25% Similarity=0.324 Sum_probs=205.1
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++.+.||.|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999765 58999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--- 153 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccC---
Confidence 9999999999987654 7899999999999999999999 99999999999999999999999999999876531
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
......+++.|+|||++.+..++.++|||||||++|+|++|..||......... ..+...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-------------~~i~~~----- 213 (291)
T cd05612 154 --RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY-------------EKILAG----- 213 (291)
T ss_pred --CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHHhC-----
Confidence 222346889999999999988999999999999999999999999764321110 011110
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCC-----HHHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-----AKEIVTRLL 319 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~L~ 319 (335)
....+..++..+.+++.+||+.||.+||+ ++++++.-+
T Consensus 214 ---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 214 ---KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred ---CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 01112334667999999999999999995 888887644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=314.14 Aligned_cols=252 Identities=28% Similarity=0.401 Sum_probs=214.5
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.....|+..+.||+|.||.||+|.+ .+++.||+|++..+. ....+.+.+|+.+|.+++++||.++|+.+..+..++++
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 3456788899999999999999964 468999999998774 44578899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+.||++.+.+.... .+++..+..+..+++.|+.||| ..+.+|+||++.||++..+|.|||+|||.+..+...
T Consensus 90 Mey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~- 164 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT- 164 (467)
T ss_pred HHHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech-
Confidence 99999999999887665 5589999999999999999999 999999999999999999999999999999876422
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
........||+-|||||++.+..|+.++||||||++++||.+|.+|+....+..... ++ ..
T Consensus 165 -~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--------------lI----pk 225 (467)
T KOG0201|consen 165 -VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--------------LI----PK 225 (467)
T ss_pred -hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--------------ec----cC
Confidence 233367889999999999999899999999999999999999999988765411110 11 11
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...+.+. ..+++.+++++..||+.||+.||||.++|+.
T Consensus 226 ~~PP~L~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 SAPPRLD--GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCccc--cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1222222 2567779999999999999999999999874
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=308.86 Aligned_cols=262 Identities=23% Similarity=0.414 Sum_probs=203.9
Q ss_pred cCCCCccceeeecCceEEEEEEEcC-----------------CcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD-----------------GMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIK 103 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~-----------------~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~ 103 (335)
.++|++.+.||+|+||.||+|.+.+ +..||+|++..... .....+.+|++++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999997532 34699999875432 33467889999999999999999
Q ss_pred EeeeeecCCeeEEEEEecCCCChHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeE
Q 019843 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSN------------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165 (335)
Q Consensus 104 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~ 165 (335)
+++++.+.+..++||||+++++|.+++.... ..+++..++.++.+|+.||.||| +.+++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 9999999999999999999999999886431 24677889999999999999999 99999
Q ss_pred ecCCCCCCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh--CCC
Q 019843 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--KKK 243 (335)
Q Consensus 166 h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~--g~~ 243 (335)
|+||+|+||+++.++.++|+|||++..+.........+...++..|+|||++.+..++.++||||||+++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999876543332223334455788999999988889999999999999999987 556
Q ss_pred CCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 244 PTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 244 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
||.......... .......... .......+..++..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 241 p~~~~~~~~~~~----------~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVIE----------NAGEFFRDQG---RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHHH----------HHHHHhhhcc---ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 776543211100 0000000000 00011112345677999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=309.01 Aligned_cols=271 Identities=22% Similarity=0.279 Sum_probs=204.5
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
...++|.+.+.||.|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred CccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 45689999999999999999999865 58899999987543 22335677899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||++ ++|.+++....+.+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-- 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV-- 155 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--
Confidence 99995 6888888766667899999999999999999999 99999999999999999999999999999875421
Q ss_pred cccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH----
Q 019843 198 QSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD---- 272 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 272 (335)
.........++..|+|||++.+ ..++.++|+||+||++|+|++|..||........................+..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 1222234567899999998865 45788999999999999999999999764332222221111110000000000
Q ss_pred -----hhhccccccchh---hHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 273 -----ANLLSREDKHFA---AKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 273 -----~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
............ .....++.+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000 00113456899999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=332.05 Aligned_cols=262 Identities=32% Similarity=0.515 Sum_probs=228.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCCc-hhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
..+-...+.||+|.||.||+|... +..-||||.++..... ..++|++|++++..++|||||+++|+|...+..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345566799999999999999632 3456999999877655 778999999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc
Q 019843 115 ALVLEYMPHGSLEKCLYSS-------------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~ 181 (335)
+|||||+..|+|.++|... +.+++..+.+.|+.||+.|+.||- ++.++|+||-..|.||+++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceE
Confidence 9999999999999999643 123889999999999999999999 999999999999999999999
Q ss_pred EEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhh
Q 019843 182 AHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVS 260 (335)
Q Consensus 182 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~ 260 (335)
|||+|||+++..++.+.....+...-..+|||||.+..+.++++|||||+|++|||+++ |..||.+..+.+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV------- 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV------- 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-------
Confidence 99999999999988888888878888999999999999999999999999999999999 9999888654221
Q ss_pred hhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 261 NLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
.+.+.. ...++.+++||.++.+|+..||+.+|++||+++||-++|+.....-.
T Consensus 715 -------Ie~i~~------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 715 -------IECIRA------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred -------HHHHHc------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 122211 12256688999999999999999999999999999999998765543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=305.19 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=203.2
Q ss_pred CCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|++|+++++.+.+.+..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 478899999999999999975 468999999986432 2233467889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 120 YMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 120 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
|+++++|.+.+... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence 99999999887643 336899999999999999999999 999999999999999999999999999998765211
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......++..|+|||++.+..++.++|||||||++|+|++|..||......... ..++.....
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--------------~~~~~~~~~- 219 (285)
T cd05631 156 -ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--------------EEVDRRVKE- 219 (285)
T ss_pred -CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--------------HHHHHHhhc-
Confidence 1223456899999999999999999999999999999999999999864322110 001111100
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCC-----HHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-----AKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 317 (335)
.....+..++..+.+|+.+||+.||.+||+ ++++++.
T Consensus 220 --~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 --DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 011122345677999999999999999997 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=306.01 Aligned_cols=268 Identities=19% Similarity=0.235 Sum_probs=204.2
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
++|.+.+.||+|+||.||+|..+ +++.+++|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 57999999999999999999865 58889999987542 3345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|++++++..+. .....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 155 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N 155 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence 99887666544 33447999999999999999999999 9999999999999999999999999999998653211 1
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc--ChhHHHHH-Hhh-h
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL--PISVMEIV-DAN-L 275 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~-~ 275 (335)
.......++..|+|||++.+..++.++|+|||||++|+|++|++||......+... ....... +....... ... .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF-TIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhhCCCCHHHHHhhhccchh
Confidence 12233568899999999998889999999999999999999999997643222111 0010000 10000000 000 0
Q ss_pred ----cc----ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 276 ----LS----REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 276 ----~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.. ...........+++++.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 000000111235778999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=310.05 Aligned_cols=254 Identities=25% Similarity=0.346 Sum_probs=209.5
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..++|.++++||+|+||.||+|+.+ +|..+|+|+++.. .......++.|-.+|....+|.||+++..|.+.+++|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 5689999999999999999999755 6999999999754 24455778889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||++||++..+|...+ .+++..+..++.+++-|+..|| +.|++|+||||+|+|+|..|++||+|||++.-+...
T Consensus 219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999998776 8999999999999999999999 999999999999999999999999999998643210
Q ss_pred ----------------------cccc-----------------------ccccccccccccCccccCCCCCCCccchhhH
Q 019843 197 ----------------------DQSK-----------------------SQTQTLATIGYMAPEYGREGRVSTNGDVYSF 231 (335)
Q Consensus 197 ----------------------~~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwsl 231 (335)
+... .....+||+.|+|||++.+..|+..+|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 0012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCC-
Q 019843 232 GIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN- 310 (335)
Q Consensus 232 G~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps- 310 (335)
||++||||.|.+||....+.+. ...++.+. ....++....++++..+||.+||. ||++|.-
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T-------------~rkI~nwr----~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQET-------------YRKIVNWR----ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHH-------------HHHHHHHh----hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 9999999999999987654322 22333332 222233334456789999999999 9999974
Q ss_pred --HHHHHH
Q 019843 311 --AKEIVT 316 (335)
Q Consensus 311 --~~ell~ 316 (335)
++||.+
T Consensus 437 ~G~~EIK~ 444 (550)
T KOG0605|consen 437 KGAEEIKK 444 (550)
T ss_pred ccHHHHhc
Confidence 555543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=314.53 Aligned_cols=247 Identities=27% Similarity=0.405 Sum_probs=212.5
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
++|-+.+.||+|+||.||+|+.+ +.+.||+|.+.... +.....+.+|+++++.++||||+.+++.|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 68999999999999999999654 68899999986543 3456779999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+.| +|..++.... .++++.+..++.++..||.||| +.+|.|+|++|.||+++.+|.+|++|||+++.+. ...
T Consensus 82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~--~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS--TNT 154 (808)
T ss_pred hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcc--cCc
Confidence 9966 9999887654 8999999999999999999999 9999999999999999999999999999999764 233
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......||+.|||||+..+++|+..+|+|||||++||++.|++||... .+..++........
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----------------si~~Lv~~I~~d~v 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----------------SITQLVKSILKDPV 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----------------HHHHHHHHHhcCCC
Confidence 4455678999999999999999999999999999999999999998653 22333333332221
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..+..++..+..++...|..||.+|.+..+++..
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1234678889999999999999999999998853
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=288.04 Aligned_cols=265 Identities=20% Similarity=0.278 Sum_probs=213.8
Q ss_pred HhhhcCCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecC-----
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSND----- 111 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 111 (335)
+-...++|++.+.+|+|+|+-||+++ ..+++.+|+|++.....+..+...+|++..++++|||+++++++...+
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34457899999999999999999997 456889999999988878889999999999999999999999887543
Q ss_pred CeeEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCC--eEecCCCCCCEEECCCCcEEEee
Q 019843 112 DFKALVLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSD 186 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~--i~h~di~p~Nilv~~~~~v~l~d 186 (335)
...|++++|+..|+|.+.+.. ++..+++.+++.|+.++++||.+|| ... +.|+||||.||++++.+.++++|
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEe
Confidence 359999999999999999874 3458999999999999999999999 666 99999999999999999999999
Q ss_pred ccccccccCCccc-------cccccccccccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhH
Q 019843 187 FGIAKLLTGEDQS-------KSQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK 256 (335)
Q Consensus 187 fg~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 256 (335)
||.++...-.-.. ........|..|.|||.+. +...+.++|||||||++|.|+.|..||+........+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 9999865311000 1112335688899999876 45688999999999999999999999986544333221
Q ss_pred hHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 257 YWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
... .. ....++.....+..+.++|++||+.||.+||++.++++.+.++.
T Consensus 253 LAv-----------~n------~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 LAV-----------QN------AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred Eee-----------ec------cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 100 00 01111112235777999999999999999999999999998764
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=306.01 Aligned_cols=249 Identities=34% Similarity=0.575 Sum_probs=199.1
Q ss_pred ccceeeecCceEEEEEEEc-----CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 47 ENNLIGRGSFGSVYKARIQ-----DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 47 ~~~~lg~g~~~~v~~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+.+.||.|.||.||+|.+. .+..|+||+++.... ...+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4688999999999999766 367799999965433 3468899999999999999999999999988889999999
Q ss_pred cCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+++++|.+++... ...+++..++.|+.+++.||.||| +.+++|++|+++||+++.++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999886 557999999999999999999999 999999999999999999999999999999876322333
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
...........|+|||.+.+..++.++||||||+++|||++ |..||......+ +.... .
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-----------------~~~~~---~ 219 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-----------------IIEKL---K 219 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-----------------HHHHH---H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------------ccccc---c
Confidence 33444567788999999988889999999999999999999 678876642211 11111 0
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
.......+..++..+.+++.+||+.||++|||+.+++++|
T Consensus 220 ~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112223445677799999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=317.08 Aligned_cols=258 Identities=23% Similarity=0.358 Sum_probs=205.7
Q ss_pred cCCCCccceeeecCceEEEEEEE------cCCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARI------QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDF 113 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~------~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 113 (335)
.++|++.+.||+|+||.||+|++ .++..||+|+++... ....+.+.+|++++..+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999963 235689999986442 33446788999999999 89999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCC-----------------------------------------------------------
Q 019843 114 KALVLEYMPHGSLEKCLYSSN----------------------------------------------------------- 134 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------- 134 (335)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999886421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 135 ---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 135 ---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
..+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 14788889999999999999999 999999999999999999999999999998865422222
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
...+...++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ...+....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~-------------~~~~~~~~--- 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-------------YKMIKEGY--- 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH-------------HHHHHhCc---
Confidence 22223345667999999999999999999999999999998 88888654322111 11111111
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
....+...+.++.+++.+||+.||++|||+.|+++.|++.
T Consensus 335 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 ---RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0111223456799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=313.39 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=216.6
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe-eEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF-KALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv 117 (335)
.+.|..++++|+|+||.+++++.+ ++..+|+|.+.... ........+|+.+++++.||||+.+.+.+..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 468999999999999999999655 57889999997653 3344578899999999999999999999999887 9999
Q ss_pred EEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 118 LEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
|+|++||++.+.|.+.. ..+++++++.|+.|++.|+.||| +..|+|+||++.|||++.++.|+|+|||++..+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998654 68999999999999999999999 999999999999999999999999999999987532
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
. .......||+.|++||++.+.+|+.++|||||||++|||++-+++|........ +.+...
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-----------------i~ki~~ 220 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-----------------ILKINR 220 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-----------------HHHHhh
Confidence 2 245567899999999999999999999999999999999999999987643322 222211
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.. -.+.+...+.++..+|..||..+|..||++.++|..
T Consensus 221 ~~---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GL---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cc---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11 123345668889999999999999999999999998
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.65 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=206.7
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|.+.+.||+|+||.||+|... +++.||+|++.... ......+..|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999865 58999999987542 234467888999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999987654 7899999999999999999999 99999999999999999999999999999876521
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
......+++.|+|||++.+..++.++|||||||++|+|++|..||......+.. ..+........
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------------~~i~~~~~~~~ 218 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW-------------ENLKYWKETLQ 218 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH-------------HHHHhcccccc
Confidence 334456899999999999999999999999999999999999999764322111 01111000000
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..........+++++.+++.+||..+|.+||+++++++.
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000012456779999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=313.56 Aligned_cols=246 Identities=21% Similarity=0.272 Sum_probs=204.1
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.++|.+.+.||.|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++.+.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 378999999999999999999765 5899999998743 223456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+++++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 99999999999987654 6899999999999999999999 99999999999999999999999999999886531
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
......+++.|+|||++.+..++.++|||||||++|+|++|..||......... ..+...
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------------~~i~~~---- 230 (329)
T PTZ00263 171 ---RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-------------EKILAG---- 230 (329)
T ss_pred ---CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-------------HHHhcC----
Confidence 122356899999999999999999999999999999999999999653221100 011110
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCC-----HHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-----AKEIVTR 317 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 317 (335)
....+..++..+.+|+.+||+.||.+||+ ++++++.
T Consensus 231 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 231 ----RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11112234667999999999999999996 6888755
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=318.23 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=217.6
Q ss_pred cCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.+-|++++.||.|+-|.|-+|++ .+|+..|||++... .......+.+|+-+++.+.|||++.++++++++.++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 45689999999999999999965 46999999999754 234457789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
.||++||-|.+++..++ ++++..+...+.||+.|+.|+| ..+|+|+|+||+|++++..+++||+|||+|..- .
T Consensus 91 lEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~ 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE---V 163 (786)
T ss_pred EEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc---c
Confidence 99999999999998776 8999999999999999999999 999999999999999999999999999999863 3
Q ss_pred cccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
........+|.+.|.|||++.|.+| +.++||||.|++||.||+|.+||+... ++..+.
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---------------------ir~LLl 222 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---------------------IRVLLL 222 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---------------------HHHHHH
Confidence 3444566789999999999999987 679999999999999999999998532 122222
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
+.....+..|..++.+.++|+.+||..||.+|.|++||++.-.
T Consensus 223 KV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 223 KVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 2333445557788999999999999999999999999998755
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.15 Aligned_cols=256 Identities=20% Similarity=0.376 Sum_probs=207.5
Q ss_pred cCCCCccceeeecCceEEEEEEEc----CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.++|++.+.||+|+||.||+|.++ .+..|++|.++.... .....+.+|+..++.++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 467999999999999999999653 366899999876532 334578899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999876567899999999999999999999 999999999999999999999999999987643211
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
. ........++..|+|||.+.+..++.++||||||+++|++++ |..||........ ...+...
T Consensus 161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~--------------~~~~~~~- 224 (266)
T cd05064 161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV--------------IKAVEDG- 224 (266)
T ss_pred c-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--------------HHHHHCC-
Confidence 1 111112234567999999999999999999999999999775 9999876432111 1111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
...+.+..++..+.+++.+||+.+|.+||++++|++.|.++
T Consensus 225 -----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 -----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122345677899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=303.53 Aligned_cols=268 Identities=20% Similarity=0.283 Sum_probs=204.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.++|++.+.||.|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 468999999999999999999755 68999999987543 2234567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++ +|.+++......+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++...... .
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~ 157 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--T 157 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--C
Confidence 9965 899888766657899999999999999999999 999999999999999999999999999998754211 1
Q ss_pred cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH---H----
Q 019843 200 KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI---V---- 271 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~---- 271 (335)
.......++..|+|||++.+ ..++.++||||+||++|+|++|..||......+.... ............+ .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL-IFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChHHhhccccchh
Confidence 22234567889999998865 5689999999999999999999999976543222111 1110000000000 0
Q ss_pred -Hhhhcccc--ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 272 -DANLLSRE--DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 272 -~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
........ .........+++++.+|+.+||..||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 0001111234667999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=306.92 Aligned_cols=267 Identities=21% Similarity=0.323 Sum_probs=209.7
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.++|++.+.||.|+||.||++... ++..+++|++.... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999765 58889999987653 3345679999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCC-CeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~-~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
|+++++|.+++.... .+++..+..++.+++.||.||| +. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 156 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence 999999999987654 6899999999999999999999 75 699999999999999999999999999875531
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh-c--------------
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL-L-------------- 263 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~-------------- 263 (335)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||......+... ..... .
T Consensus 157 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA--IFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred -cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HhcccccccccCCccccCccc
Confidence 22234568999999999999899999999999999999999999997543222110 00000 0
Q ss_pred ----------------ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 264 ----------------PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 264 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
........+....... ... ....+++++.+|+.+||..||++|||++++++.-+-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPP-PKL-PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCC-cCC-CCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 0000111111111000 000 012356779999999999999999999999987653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=296.74 Aligned_cols=276 Identities=25% Similarity=0.285 Sum_probs=217.7
Q ss_pred HHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEee--cCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec-
Q 019843 35 YLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFH--LQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN- 110 (335)
Q Consensus 35 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 110 (335)
..+.+.+..+|...+.||.|++|.|+.|.++ +|+.||+|++. .+.....++..+|+++|+.++|+||+.+.+++..
T Consensus 14 ~~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 14 FGELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP 93 (359)
T ss_pred eeeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence 3467788889999999999999999999654 69999999997 4566677889999999999999999999999865
Q ss_pred ----CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEee
Q 019843 111 ----DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 186 (335)
Q Consensus 111 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~d 186 (335)
-+..|+|+|.+ +.+|..++.++. .++...+..+.+||++||.|+| +.+++|+|+||+|++++.+..+|++|
T Consensus 94 ~~~~f~DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred cccccceeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecc
Confidence 45889999999 679999887654 6999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCccccccccccccccccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc--
Q 019843 187 FGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL-- 263 (335)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-- 263 (335)
||+++..............+.|.+|.|||++. ...|+.+.||||+||++.||++|++.|.+... ..++.....-..
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~-v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY-VHQLQLILELLGTP 247 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch-HHHHHHHHHhcCCC
Confidence 99999875432333446678999999999865 56799999999999999999999999976432 112222222111
Q ss_pred Chh---------HHHHHHhhhccccccc-hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 264 PIS---------VMEIVDANLLSREDKH-FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 264 ~~~---------~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
+.. ....+.... ..+... ...-+++++...+|+.+||..||.+|+|++|+|+.
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp-~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLP-QIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCC-CCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111 111111111 111111 11123567889999999999999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=310.01 Aligned_cols=242 Identities=24% Similarity=0.311 Sum_probs=198.8
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHG 124 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 124 (335)
+.||+|+||.||+|..+ +|+.||+|++... .......+..|+++++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999754 6899999998753 2234456788999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccc
Q 019843 125 SLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQ 204 (335)
Q Consensus 125 ~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~ 204 (335)
+|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.... ........
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~--~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccc--cCCCcccc
Confidence 9999887654 7899999999999999999999 9999999999999999999999999999987432 11222334
Q ss_pred ccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchh
Q 019843 205 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFA 284 (335)
Q Consensus 205 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (335)
..|++.|+|||++.+..++.++|||||||++|+|++|..||....... ........ ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-----------------~~~~~~~~----~~~ 213 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----------------LFELILME----EIR 213 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-----------------HHHHHHcC----CCC
Confidence 568999999999999999999999999999999999999996532111 11111110 111
Q ss_pred hHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 285 AKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 285 ~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
.+..+++++.+++.+||+.||++|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2334567799999999999999999 79998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=303.03 Aligned_cols=260 Identities=29% Similarity=0.480 Sum_probs=211.5
Q ss_pred cCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
..+|.+.+.||+|+||.||.+... ++..+++|.+..........+.+|++++++++|+||+++++++...+.++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467999999999999999999642 24568899887655555678999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEE
Q 019843 116 LVLEYMPHGSLEKCLYSSN------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 183 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~ 183 (335)
+++||+++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 25899999999999999999999 99999999999999999999999
Q ss_pred EeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhh
Q 019843 184 LSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNL 262 (335)
Q Consensus 184 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 262 (335)
|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||........
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~--------- 231 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV--------- 231 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---------
Confidence 999999886543222223334445778999999998899999999999999999998 8999865432111
Q ss_pred cChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 263 LPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
+....... ....+..++.++.+++.+||+.||.+|||+.++++.|+++...
T Consensus 232 --------~~~i~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 --------IECITQGR---VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred --------HHHHHcCC---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111100 0111223456799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=297.70 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=204.5
Q ss_pred CCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecC
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
++|++.+.||.|+||.||+|.++++..+++|.+.... .....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 5688999999999999999998877889999876432 234678889999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccc
Q 019843 123 HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202 (335)
Q Consensus 123 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~ 202 (335)
+++|.+++......+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||.+........ ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence 99999998765557899999999999999999999 99999999999999999999999999999876532211 111
Q ss_pred ccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccccc
Q 019843 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281 (335)
Q Consensus 203 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (335)
....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+.. ..+....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~-------------~~i~~~~------- 218 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV-------------EMISRGF------- 218 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-------------HHHHCCC-------
Confidence 22334567999999988889999999999999999999 89998754321111 0111000
Q ss_pred chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
....+...+..+.+++.+||+.||++||+++++++.|
T Consensus 219 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 219 RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0011122355699999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=302.58 Aligned_cols=255 Identities=29% Similarity=0.536 Sum_probs=208.3
Q ss_pred CCCCccceeeecCceEEEEEEEcC-C-----cEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQD-G-----MEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~-~-----~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
++|++.+.||+|++|.||+|.... + ..|++|.+.... ......+.+|++++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 578999999999999999997542 2 579999886443 334567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC
Q 019843 116 LVLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~ 180 (335)
++|||+++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 9999999999999987531 35788999999999999999999 99999999999999999999
Q ss_pred cEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHh
Q 019843 181 VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWV 259 (335)
Q Consensus 181 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~ 259 (335)
.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~------ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV------ 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence 999999999876533222223334456788999999988889999999999999999998 9999876432111
Q ss_pred hhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 260 SNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
...+.... ....+..+++++.+|+.+||+.||.+||++.||++.|++
T Consensus 236 --------~~~i~~~~------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 --------IEMIRSRQ------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --------HHHHHcCC------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 111234567889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=314.64 Aligned_cols=258 Identities=23% Similarity=0.388 Sum_probs=205.4
Q ss_pred cCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDF 113 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 113 (335)
.++|.+.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+++++.+ +|+||+++++.+...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 358999999999999999998642 23579999987543 33456788999999999 89999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCC-----------------------------------------------------------
Q 019843 114 KALVLEYMPHGSLEKCLYSSN----------------------------------------------------------- 134 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------- 134 (335)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccc
Q 019843 135 ----------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQ 204 (335)
Q Consensus 135 ----------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~ 204 (335)
.++++..++.++.||+.||.||| +++++|+||+|+||+++.++.++|+|||++..+...........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 24788899999999999999999 99999999999999999999999999999876532221122222
Q ss_pred ccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 205 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 205 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
..++..|+|||++.+..++.++||||||+++|+|++ |..||......... ........ ..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~-------------~~~~~~~~------~~ 334 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF-------------YKMVKRGY------QM 334 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH-------------HHHHHccc------Cc
Confidence 335567999999988899999999999999999997 99998764322111 11111110 11
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
..+...++++.+++.+||+.||++||++.++++.|+++
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11122456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=314.15 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=219.0
Q ss_pred ccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCCh
Q 019843 47 ENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL 126 (335)
Q Consensus 47 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 126 (335)
.++.||.|+.|.||+|+.. ++.||||+.+ +.-..+++.|++|+|+||+.+.|+|...-.+|||||||..|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~-------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVR-------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHh-------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 4588999999999999988 7999999875 3445589999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccccc
Q 019843 127 EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206 (335)
Q Consensus 127 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~ 206 (335)
..+|+..+ +++...+..|..+|+.|+.||| .+.|+|+|||.-|||++.+..|||+|||.+....+ ....-...
T Consensus 200 ~~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~---~STkMSFa 272 (904)
T KOG4721|consen 200 YEVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD---KSTKMSFA 272 (904)
T ss_pred HHHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhh---hhhhhhhh
Confidence 99998766 7888999999999999999999 99999999999999999999999999999986532 23445678
Q ss_pred ccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhH
Q 019843 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286 (335)
Q Consensus 207 ~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (335)
||..|||||++.+.+-+.+.||||||++|||||||..||..-.. ..+-++ .......++.+
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds------------------sAIIwG-VGsNsL~LpvP 333 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS------------------SAIIWG-VGSNSLHLPVP 333 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch------------------heeEEe-ccCCcccccCc
Confidence 99999999999999999999999999999999999999876321 122222 22234456667
Q ss_pred HHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcccccc
Q 019843 287 EQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICTRE 331 (335)
Q Consensus 287 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 331 (335)
..||+.+.-|+++||+..|..|||+.+++..|...-.++...++|
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee 378 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEE 378 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHH
Confidence 889999999999999999999999999999999998888777665
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=300.59 Aligned_cols=255 Identities=31% Similarity=0.514 Sum_probs=208.2
Q ss_pred cCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCCc-hhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
.++|.+.+.||+|++|.||+|... ++..|++|.+...... ..+.+.+|+++++.+.|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 467899999999999999999753 2478999998755443 457899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc
Q 019843 115 ALVLEYMPHGSLEKCLYSSN-------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~ 181 (335)
+++|||+++++|.+++...+ ..+++..+..++.+++.|+.+|| +.+++|+||+|+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 99999999999999986532 35788899999999999999999 999999999999999999999
Q ss_pred EEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhh
Q 019843 182 AHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVS 260 (335)
Q Consensus 182 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~ 260 (335)
++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~------- 233 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV------- 233 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------
Confidence 99999999876532222223334456788999999999999999999999999999998 9999865432111
Q ss_pred hhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 261 NLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...+..... ...+..++..+.+++.+||+.||.+||++.|+++.|+
T Consensus 234 -------~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 -------IECITQGRL------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -------HHHHHcCCc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111111111 1112345677999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=297.37 Aligned_cols=257 Identities=24% Similarity=0.445 Sum_probs=208.8
Q ss_pred cCCCCccceeeecCceEEEEEEEcC----CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD----GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.++|++.+.||+|+||.||+|.+.. ...|++|.+.... ......+..|+.+++.++||||+++++.+...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3679999999999999999997642 4579999886543 3345678889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
+||++++++|.+++....+.+++..++.++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..+...
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999876667999999999999999999999 999999999999999999999999999999876421
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
..........++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ ...+...
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~--------------~~~~~~~- 224 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV--------------IKAVEDG- 224 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH--------------HHHHHcC-
Confidence 21112222334578999999998899999999999999999998 9999865321111 1111110
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
...+.+..+++.+.+++.+||+.+|++||++.|+++.|.++
T Consensus 225 -----~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 -----YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111234567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=307.77 Aligned_cols=268 Identities=21% Similarity=0.246 Sum_probs=199.8
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecC-----CeeE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSND-----DFKA 115 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 115 (335)
+|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+++++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6899999999999999999755 6899999998643 223345688999999999999999999987543 3579
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||+ +++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecC-CCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 999999 568988887554 6899999999999999999999 99999999999999999999999999999875432
Q ss_pred Ccc-ccccccccccccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc---------
Q 019843 196 EDQ-SKSQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL--------- 263 (335)
Q Consensus 196 ~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------- 263 (335)
... ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .........
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLITDLLGTPSPETISR 234 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHH
Confidence 111 112234578999999999876 5789999999999999999999999975432111 000000000
Q ss_pred --ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 264 --PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 264 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.........................+++.+.+++.+||+.||++|||++|+++.
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000111111111111111011112346678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=312.48 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=207.6
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|.+.+.||+|+||.||+|... +++.||+|++... .......+..|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 57999999999999999999865 6899999998743 2244567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc-
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED- 197 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~- 197 (335)
||+++++|.+++... ..+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999998866 47999999999999999999999 9999999999999999999999999999988653221
Q ss_pred --------------------------cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccc
Q 019843 198 --------------------------QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAG 251 (335)
Q Consensus 198 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~ 251 (335)
.........++..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 011233456899999999999999999999999999999999999999765421
Q ss_pred chhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCC-HHHHHHH
Q 019843 252 EMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-AKEIVTR 317 (335)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~~ 317 (335)
... ..+... ......+....+++.+.++|.+||. ||.+||+ ++++++.
T Consensus 237 ~~~-------------~~i~~~----~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETY-------------NKIINW----KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH-------------HHHhcc----CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111 111110 0011111112257779999999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=298.01 Aligned_cols=255 Identities=27% Similarity=0.481 Sum_probs=212.0
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|++.+.||.|++|.||.|...++..+++|++..........+..|+.+++.++|+||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 46799999999999999999998878999999988665555678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++++|.+++... ...+++..++.++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--VY 159 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCc--cc
Confidence 999999999753 446899999999999999999999 999999999999999999999999999998765321 11
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. ...+..
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~--------------~~~~~~------ 219 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV--------------YDQITA------ 219 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH--------------HHHHHh------
Confidence 1223345678999999988889999999999999999998 8999865431111 011111
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
....+.+..+++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111122345567799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.67 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=207.8
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|++.+.||.|++|.||+|...+++.|++|.+.... ...+.+.+|+++++.++|+||+++++++...+..+++||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46799999999999999999987777889999986543 23467889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++++|.+++.... ..+++..+..++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++..+.... ..
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YE 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc-cc
Confidence 9999999987543 46899999999999999999999 9999999999999999999999999999998764211 11
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......+..|+|||.+.+..++.++|+||||+++|+|++ |..||........ ...+....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--------------~~~~~~~~---- 221 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV--------------LQQVDQGY---- 221 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--------------HHHHHcCC----
Confidence 1112223457999999998899999999999999999999 9999865432111 11111110
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
....+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 --RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 1111234566799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.57 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=207.1
Q ss_pred cCCCCccceeeecCceEEEEEEEc-C-CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-D-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
...|.+.+.||+|++|.||.|... + ++.||+|.+..........+..|+.+++.++||||+++++.+...+..++|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 445999999999999999999654 3 67888898766555555678889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 120 YMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 120 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
|+++++|.+++.. ...++++..+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||++..+...
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999988754 2346899999999999999999999 999999999999999999999999999999876432
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||......+ +......
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-----------------~~~~~~~ 285 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-----------------IMQQVLY 285 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHh
Confidence 22223344568999999999999999999999999999999999999987543211 1111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
... .+.+..+++.+.++|.+||..||++||++++++..
T Consensus 286 ~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 286 GKY---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCC---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 111 01123456779999999999999999999999753
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=309.84 Aligned_cols=247 Identities=21% Similarity=0.259 Sum_probs=203.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEcC--CcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQD--GMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~--~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
..++|.+.+.||.|+||.||+|.... +..||+|++... .......+.+|+++++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 44689999999999999999997543 368999998643 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||+++++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 108 lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~- 182 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD- 182 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecC-
Confidence 9999999999999987654 6899999999999999999999 9999999999999999999999999999987652
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
.......||+.|+|||++.+..++.++|+|||||++|+|++|..||......... ..+... .
T Consensus 183 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-------------~~i~~~-~ 244 (340)
T PTZ00426 183 ----TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY-------------QKILEG-I 244 (340)
T ss_pred ----CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH-------------HHHhcC-C
Confidence 1223456899999999999888999999999999999999999999764321110 011110 0
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
...+..+++.+.+++++||+.||.+|+ +++++++.
T Consensus 245 -------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 -------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111233466789999999999999995 89988875
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=294.10 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=199.5
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCCh
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL 126 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 126 (335)
+.||+|+||.||+|... +++.+++|.+.... .+....+.+|+++++.++||||+++++++...+..++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999764 68899999876432 33456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccccc
Q 019843 127 EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206 (335)
Q Consensus 127 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~ 206 (335)
.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999766557899999999999999999999 9999999999999999999999999999987543211111111122
Q ss_pred ccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhh
Q 019843 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAA 285 (335)
Q Consensus 207 ~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (335)
.+..|+|||.+.+..++.++|+||||+++|+|++ |..||........ ...+... .....
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~--------------~~~~~~~------~~~~~ 217 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--------------REAIEQG------VRLPC 217 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH--------------HHHHHcC------CCCCC
Confidence 3456999999998889999999999999999997 8888865332111 1111111 01112
Q ss_pred HHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 286 KEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 286 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
+..++..+.+++.+||+.||++|||+.++++.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2345667999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=297.14 Aligned_cols=255 Identities=24% Similarity=0.421 Sum_probs=208.5
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|++.+.||+|++|.||+|...++..|++|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46899999999999999999988778889999876543 23578899999999999999999999999999999999999
Q ss_pred CCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++++|.+++... ...+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YT 159 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCc-ee
Confidence 999999998753 446889999999999999999999 9999999999999999999999999999998653221 11
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......... ..+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~--------------~~~~~~----- 220 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM--------------SALQRG----- 220 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH--------------HHHHcC-----
Confidence 1222345677999999988889999999999999999998 99998653221110 111110
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
...+....++..+.+++.+||+.+|++||+++++.+.|+++
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 221 -YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01112234566799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=300.64 Aligned_cols=259 Identities=29% Similarity=0.487 Sum_probs=211.1
Q ss_pred CCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.+|.+.+.||+|++|.||+|... ++..+++|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 56889999999999999999642 345688888876555555778999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc
Q 019843 117 VLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~ 181 (335)
||||+++++|.+++.... ..+++..++.++.+|+.|+.||| +++++|+||+|+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999987532 34789999999999999999999 999999999999999999999
Q ss_pred EEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhh
Q 019843 182 AHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVS 260 (335)
Q Consensus 182 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~ 260 (335)
++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------- 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV------- 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence 99999999876543322233344556788999999998899999999999999999998 9999865432211
Q ss_pred hhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 261 NLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
......... ...+..++..+.+++.+||+.||++||++.++++.|.++...
T Consensus 235 -------~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 -------IECITQGRV------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -------HHHHhCCCC------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 011111100 011223466799999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=305.79 Aligned_cols=242 Identities=23% Similarity=0.311 Sum_probs=198.2
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHG 124 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 124 (335)
+.||+|+||.||++... +|..||+|++... .......+..|+++++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999754 5899999998754 2334456778999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccc
Q 019843 125 SLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQ 204 (335)
Q Consensus 125 ~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~ 204 (335)
+|..++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..... .......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCcccc
Confidence 9998887554 7899999999999999999999 99999999999999999999999999999875321 1122234
Q ss_pred ccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchh
Q 019843 205 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFA 284 (335)
Q Consensus 205 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (335)
..++..|+|||++.+..++.++|||||||++|+|++|..||........ ....... ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-----------------~~~~~~~----~~~ 213 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----------------FELILME----EIR 213 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHhcC----CCC
Confidence 5689999999999999999999999999999999999999875432111 0110000 011
Q ss_pred hHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 285 AKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 285 ~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
.+..+++.+.+++.+||+.||.+|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1234567799999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=304.70 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=208.5
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCc----EEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGM----EVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
..+|++.+.||+|+||.||+|.+. ++. .|++|++.... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 367999999999999999999753 233 48999986543 34457788999999999999999999998765 467
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
++++++++|+|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999999876667899999999999999999999 99999999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
............+..|+|||.+.+..++.++||||||+++|+|++ |..||......+. ...+...
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~--------------~~~~~~~ 227 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------------SSILEKG 227 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--------------HHHHhCC
Confidence 222222222334677999999999999999999999999999997 9999875422111 1111111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
...+.+..++..+.+++.+||..||.+||++.+++..|..+..+-
T Consensus 228 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 228 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 111112334567999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=293.53 Aligned_cols=258 Identities=22% Similarity=0.331 Sum_probs=209.0
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|.+.+.||.|+||.||+|... +++.|++|.+... .......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999754 6899999987642 2334456888999999999999999999999999999999
Q ss_pred EecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 119 EYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 119 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
||+++++|.+++.. ....+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988853 2346889999999999999999999 99999999999999999999999999999886532
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
. ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||........... ..+...
T Consensus 159 ~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~------------~~~~~~- 223 (267)
T cd08228 159 K--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC------------QKIEQC- 223 (267)
T ss_pred h--hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH------------HHHhcC-
Confidence 1 1122234578889999999888899999999999999999999999865432211111 111110
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
... .......+..+.+++.+||+.+|.+||+++++++.+++++
T Consensus 224 --~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 224 --DYP--PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCC--CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 000 0112345677999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=296.98 Aligned_cols=250 Identities=23% Similarity=0.322 Sum_probs=214.2
Q ss_pred hcCCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
...+|.+.+.||.|.||.|-+|. ...|+.||||.++.+ +.+....+++|++++..|+||||+.++++|++.+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 34689999999999999999996 477999999998754 45566789999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||..+|.|.|++...+ .+++.+...++.||..|+.|.| .++++|+||+.+|||+|.++++||.|||++..+.
T Consensus 131 vMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~-- 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA-- 204 (668)
T ss_pred EEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc--
Confidence 999999999999998765 8999999999999999999999 9999999999999999999999999999999873
Q ss_pred ccccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
........+|++-|.+||+++|.+| ++..|-||||++||-|..|..||++.+-... ..-+..+.
T Consensus 205 -~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l--------------vrQIs~Ga 269 (668)
T KOG0611|consen 205 -DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL--------------VRQISRGA 269 (668)
T ss_pred -cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH--------------HHHhhccc
Confidence 3344556789999999999999887 6789999999999999999999998532111 11111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
+..+. -|.+..-||++||..||++|.|+++|.+..|
T Consensus 270 YrEP~--------~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 270 YREPE--------TPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ccCCC--------CCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 11111 1334788999999999999999999999887
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=294.62 Aligned_cols=251 Identities=28% Similarity=0.432 Sum_probs=204.7
Q ss_pred CCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecC
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
.+|++.+.||+|++|.||+|.++++..+++|++.... .....+.+|+++++.++|+||+++++++...+..++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 5689999999999999999988777789999876432 233568889999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccc
Q 019843 123 HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202 (335)
Q Consensus 123 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~ 202 (335)
+++|.+++......+++..++.++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~ 158 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS 158 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence 99999999866557899999999999999999999 99999999999999999999999999999876532211 111
Q ss_pred ccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccccc
Q 019843 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281 (335)
Q Consensus 203 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (335)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.. ..+... .
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--------------~~~~~~------~ 218 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV--------------ESVSAG------Y 218 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH--------------HHHHcC------C
Confidence 22233457999999998899999999999999999999 89998754322111 001110 0
Q ss_pred chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
....+..++..+.+++.+||+.+|++|||+.++++.|
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1111233577799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=303.43 Aligned_cols=268 Identities=22% Similarity=0.347 Sum_probs=207.0
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.++|++.+.||.|+||.||+|.+. ++..+++|++.... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 479999999999999999999765 58889999887653 3345678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCC-CeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~-~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
|+++++|.+++.... .+++..+..++.+++.||.||| +. +++|+||+|+||+++.++.++|+|||++..+..
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--- 156 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---
Confidence 999999999987654 6899999999999999999999 64 799999999999999999999999999875421
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhH--------------------
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYW-------------------- 258 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~-------------------- 258 (335)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||............-
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred -hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 12233468889999999998889999999999999999999999997543322110000
Q ss_pred ------hhhhcC-hhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 259 ------VSNLLP-ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 259 ------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.....+ .......+..... ...... ....+.++.+|+.+||+.||++|||++|++..-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNE-PPPKLP-SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcC-CCccCC-CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000000 0001111111100 000000 1124567999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=309.18 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=205.0
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999755 58999999987542 234567888999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999877568999999999999999999999 99999999999999999999999999999986532221
Q ss_pred ccccccccccccccCccccC------CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 199 SKSQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
.......++..|+|||++. +..++.++||||||+++|+|++|..||........ ...+..
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------------~~~i~~ 223 (330)
T cd05601 158 -VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-------------YNNIMN 223 (330)
T ss_pred -eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-------------HHHHHc
Confidence 1223346899999999886 45678999999999999999999999975432111 011111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. .....++....+++.+.+|+.+||. ||.+||++++++..
T Consensus 224 ~----~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 224 F----QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred C----CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 1111111122356779999999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=311.16 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=203.4
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++.+.||.|+||.||+|... +++.||+|++... .......+.+|++++..++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 57999999999999999999765 5899999999743 2334466788999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999987654 6999999999999999999999 99999999999999999999999999999875431110
Q ss_pred cc------------------------------------ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCC
Q 019843 199 SK------------------------------------SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKK 242 (335)
Q Consensus 199 ~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~ 242 (335)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011235899999999999999999999999999999999999
Q ss_pred CCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCC---HHHHHHH
Q 019843 243 KPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN---AKEIVTR 317 (335)
Q Consensus 243 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 317 (335)
.||......+.. ..+... ......+....+++++.++|.+||. +|.+|++ ++++++.
T Consensus 237 ~Pf~~~~~~~~~-------------~~i~~~----~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQETY-------------RKIINW----KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHHH-------------HHHHcC----CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999764321110 111111 0001111112346679999999997 9999997 9998874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=305.76 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=199.0
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHG 124 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 124 (335)
+.||+|+||.||++... +++.||+|++... .......+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999764 5899999998754 2334567788999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccc
Q 019843 125 SLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQ 204 (335)
Q Consensus 125 ~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~ 204 (335)
+|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..... .......
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKT 154 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--ccccccc
Confidence 9998887554 7899999999999999999999 99999999999999999999999999999875321 1222234
Q ss_pred ccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchh
Q 019843 205 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFA 284 (335)
Q Consensus 205 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (335)
..+++.|+|||++.+..++.++|||||||++|+|++|..||........ ...... ....
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-----------------~~~~~~----~~~~ 213 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----------------FELILM----EDIK 213 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-----------------HHHhcc----CCcc
Confidence 5689999999999988999999999999999999999999975422111 111100 0111
Q ss_pred hHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 285 AKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 285 ~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
.+..+++++.+++.+||+.||.+|| ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2334567799999999999999997 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=298.32 Aligned_cols=263 Identities=26% Similarity=0.363 Sum_probs=207.4
Q ss_pred HHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--------------CchhHHHHHHHHHHHhCCCCc
Q 019843 36 LELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--------------GGVFKSFDVECEVMKSIRHRN 100 (335)
Q Consensus 36 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~ 100 (335)
.+--..-++|++.+.||.|.||.|-+|+.. +++.||+|++.... -...+...+|+.++++++|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 344445689999999999999999999754 58999999985321 123468899999999999999
Q ss_pred eEEEeeeeec--CCeeEEEEEecCCCChHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC
Q 019843 101 LIKIISTCSN--DDFKALVLEYMPHGSLEKCLYSSNCV-LDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD 177 (335)
Q Consensus 101 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~ 177 (335)
||+++++..+ .+.+|||+|||..|.+... ...++ +++.+++.++.++..||.||| .++|+||||||+|+|++
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLS 244 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEc
Confidence 9999999876 5799999999988877642 22334 899999999999999999999 99999999999999999
Q ss_pred CCCcEEEeeccccccccCC---ccccccccccccccccCccccCCCC----CCCccchhhHHHHHHHHHhCCCCCCcccc
Q 019843 178 DNMVAHLSDFGIAKLLTGE---DQSKSQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMETFTKKKPTDKIFA 250 (335)
Q Consensus 178 ~~~~v~l~dfg~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~~l~~ll~g~~pf~~~~~ 250 (335)
++|+|||+|||.+..+... ..........||+.|+|||.+.++. .+.+.||||+|++||.|+.|+.||-....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999999999999866211 1112223478999999999987643 36788999999999999999999876432
Q ss_pred cchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 251 GEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
.++.++... ....++........+++||.+||..||+.|.+..+|....+--+
T Consensus 325 -----------------~~l~~KIvn--~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 325 -----------------LELFDKIVN--DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred -----------------HHHHHHHhc--CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 222222211 11122222345667999999999999999999999988776544
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=294.46 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=204.7
Q ss_pred CCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecC
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
++|++.+.||.|++|.||.|...++..+++|.+.... .....+.+|+.+++.++||||+++++++...+..+++|||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 5789999999999999999988767779999887443 234678999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccc
Q 019843 123 HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202 (335)
Q Consensus 123 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~ 202 (335)
+++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeec
Confidence 99999999775557899999999999999999999 9999999999999999999999999999987653221 1112
Q ss_pred ccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccccc
Q 019843 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281 (335)
Q Consensus 203 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (335)
....++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ .+......
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~-----------------~~~~~~~~--- 218 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET-----------------VEKVSQGL--- 218 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-----------------HHHHhcCC---
Confidence 22345677999999988889999999999999999998 9999865432111 11110000
Q ss_pred chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
....+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00111223567999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=304.01 Aligned_cols=240 Identities=25% Similarity=0.280 Sum_probs=195.9
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCCh
Q 019843 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL 126 (335)
Q Consensus 51 lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 126 (335)
||+|+||.||+|... +++.||+|++... .......+..|+.++..++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 689999999999765 5889999998643 233456778899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccccc
Q 019843 127 EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206 (335)
Q Consensus 127 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~ 206 (335)
.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..... .........
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFC 154 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCcccccc
Confidence 99987654 6899999999999999999999 99999999999999999999999999999875321 122233456
Q ss_pred ccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhH
Q 019843 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286 (335)
Q Consensus 207 ~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (335)
|+..|+|||++.+..++.++|||||||++|+|++|..||......+. ....... ....+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-----------------~~~~~~~----~~~~~ 213 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-----------------YRKILQE----PLRFP 213 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-----------------HHHHHcC----CCCCC
Confidence 89999999999999999999999999999999999999975432111 1111100 11122
Q ss_pred HHHHHHHHHHHHHhchhccccCCC---HHHHHHH
Q 019843 287 EQCVSFVFNLAMECTVESAEQRIN---AKEIVTR 317 (335)
Q Consensus 287 ~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 317 (335)
..+++.+.+++.+||+.||.+||+ +.|++..
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 345677999999999999999975 6666653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=308.95 Aligned_cols=260 Identities=23% Similarity=0.392 Sum_probs=207.8
Q ss_pred cCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCC-CCceEEEeeeeecCCe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDF 113 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 113 (335)
.++|++.+.||.|+||.||+|.+. .+..||+|++..... ...+.+.+|++++..+. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 578999999999999999999743 134699999875432 33467899999999995 9999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCC-----------------------------------------------------------
Q 019843 114 KALVLEYMPHGSLEKCLYSSN----------------------------------------------------------- 134 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------- 134 (335)
.++||||+++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999875421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC
Q 019843 135 ------------------------------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD 178 (335)
Q Consensus 135 ------------------------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~ 178 (335)
..+++..+..++.|++.||.||| +.+++|+||+|+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 24778888999999999999999 999999999999999999
Q ss_pred CCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHh
Q 019843 179 NMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKY 257 (335)
Q Consensus 179 ~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~ 257 (335)
++.++|+|||++..+.............++..|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-- 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-- 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH--
Confidence 99999999999886532222222333456778999999988889999999999999999997 889986542211110
Q ss_pred HhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 258 WVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
..+... .....+..++..+.+++.+||+.||++||++.+|.+.|.++..
T Consensus 351 -----------~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 -----------NKIKSG------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -----------HHHhcC------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111110 1111233557779999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=306.99 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=200.0
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++.+.||+|+||+||+|... +++.||+|++.... ......+..|+.++..++|+||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 57999999999999999999755 58999999987432 234467888999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999987654 7999999999999999999999 99999999999999999999999999999875421110
Q ss_pred c---------------------------------cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 019843 199 S---------------------------------KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPT 245 (335)
Q Consensus 199 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf 245 (335)
. .......||+.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012346899999999999999999999999999999999999999
Q ss_pred CcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccc---cCCCHHHHHHH
Q 019843 246 DKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAE---QRINAKEIVTR 317 (335)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~---~Rps~~ell~~ 317 (335)
......+.. ..+.. ......++....+++++.+++.+++. +|. .||+++|+++.
T Consensus 237 ~~~~~~~~~-------------~~i~~----~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQETY-------------KKVMN----WKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHH-------------HHHHc----CcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 754321111 01111 00011111112345678899988765 444 46899999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=307.64 Aligned_cols=265 Identities=21% Similarity=0.224 Sum_probs=201.2
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
..++|.+.+.||.|+||.||+|... +++.||+|... ...+.+|+++++.++||||+++++++......++|++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3468999999999999999999754 58899999743 2456789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
++ +++|.+++.... .+++..++.++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++....... .
T Consensus 164 ~~-~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~ 237 (391)
T PHA03212 164 RY-KTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A 237 (391)
T ss_pred cC-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence 98 468888776553 6899999999999999999999 9999999999999999999999999999986532111 1
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccccc------chhhHhHhhhhc------Chh-
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAG------EMTLKYWVSNLL------PIS- 266 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~------~~~- 266 (335)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ............ +..
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2223457899999999999989999999999999999999999886432211 111111111000 000
Q ss_pred ---HHHHH-H--hhhccccc--cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 267 ---VMEIV-D--ANLLSRED--KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 267 ---~~~~~-~--~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..... . ........ ..+......+.++.+|+.+||+.||.+|||++|+++.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 01111 0 00000111 1122223457789999999999999999999999863
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=304.51 Aligned_cols=260 Identities=25% Similarity=0.418 Sum_probs=205.5
Q ss_pred cCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeec-CC
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSN-DD 112 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 112 (335)
.++|++.+.||.|+||.||.|... +++.|++|++.... ....+.+..|+.++.++ +|+||+++++++.. ..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 358999999999999999999532 35789999987543 23346678899999999 89999999998764 46
Q ss_pred eeEEEEEecCCCChHHHHhcCC----------------------------------------------------------
Q 019843 113 FKALVLEYMPHGSLEKCLYSSN---------------------------------------------------------- 134 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------- 134 (335)
.++++++|+++++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 7889999999999999885421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccccccccccc
Q 019843 135 --CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212 (335)
Q Consensus 135 --~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 212 (335)
..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25789999999999999999999 9999999999999999999999999999998763222222233344567899
Q ss_pred CccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHH
Q 019843 213 APEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVS 291 (335)
Q Consensus 213 aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (335)
|||++.+..++.++|||||||++|+|++ |..||......+. . ...+.... ....+..+++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~------------~~~~~~~~------~~~~~~~~~~ 303 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-F------------CRRLKEGT------RMRAPEYATP 303 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-H------------HHHHhccC------CCCCCccCCH
Confidence 9999999999999999999999999998 9999875322211 1 01111100 1111233456
Q ss_pred HHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 292 FVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 292 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
++.+++.+||+.+|++||++.|+++.|..+..
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 79999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=293.47 Aligned_cols=255 Identities=25% Similarity=0.430 Sum_probs=207.1
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
..+|.+.+.||.|++|.||+|.++ .++.|++|++..+ ......+.+|+++++.++|+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 356889999999999999999755 4888999998644 33346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+++++|.+++... ...+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~- 159 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 159 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence 9999999998753 346899999999999999999999 99999999999999999999999999999886532211
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........+..|+|||.+.+..++.++||||||+++|+|++ |..||......+. ...+...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~--------------~~~~~~~---- 221 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------------YELLEKG---- 221 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--------------HHHHHCC----
Confidence 11122233567999999998999999999999999999998 8999865322111 0111111
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
.....+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus 222 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 --YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01122344577899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=296.56 Aligned_cols=256 Identities=23% Similarity=0.405 Sum_probs=203.5
Q ss_pred hcCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
..++|++.+.||+|++|.||.|... ++..|++|++.... ......+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999998643 25679999875432 2344568899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEE
Q 019843 114 KALVLEYMPHGSLEKCLYSSN---------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 184 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l 184 (335)
.++||||+++++|.+++.... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 23577889999999999999999 999999999999999999999999
Q ss_pred eeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhc
Q 019843 185 SDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLL 263 (335)
Q Consensus 185 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 263 (335)
+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---------- 230 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---------- 230 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----------
Confidence 99999875532222222223345778999999998889999999999999999999 7888865422111
Q ss_pred ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 264 PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...+..... ...+..+++.+.+++.+||+.||++|||+.|+++.|+
T Consensus 231 ----~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 ----LRFVMEGGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ----HHHHHcCCc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 011101000 0112335667999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=307.96 Aligned_cols=255 Identities=22% Similarity=0.286 Sum_probs=204.2
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..++|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3568999999999999999999765 5889999998642 22334567889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+++++|.+++... .+++..+..++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999988654 4889999999999999999999 999999999999999999999999999998765321
Q ss_pred ccccccccccccccccCccccCCC----CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
. ........|++.|+|||++.+. .++.++|+|||||++|+|++|..||........ ...+..
T Consensus 196 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------------~~~i~~ 261 (370)
T cd05596 196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------------YSKIMD 261 (370)
T ss_pred C-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-------------HHHHHc
Confidence 1 1122345689999999988653 378899999999999999999999976432111 011111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhcccc--CCCHHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQ--RINAKEIVTRL 318 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~L 318 (335)
......++....++.++.+++.+||..+|.+ |+++++++..-
T Consensus 262 ----~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 262 ----HKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred ----CCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 1111112222235677999999999999998 99999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=302.74 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=197.1
Q ss_pred CCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHH---HhCCCCceEEEeeeeecCCeeEEE
Q 019843 45 FSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVM---KSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
|++.+.||+|++|.||+|... +++.||+|++... .......+..|.+++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999755 5899999998743 223345666776665 456799999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+++++|...+... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||++.... .
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~--~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM--G 153 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCC--C
Confidence 9999999999887643 5999999999999999999999 9999999999999999999999999999886432 1
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
.........++..|+|||.+.+..++.++|+|||||++|+|++|..||......+.. ..+...
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~-------------~~i~~~---- 216 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF-------------DSIVND---- 216 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHHhC----
Confidence 122233456899999999999999999999999999999999999999764321110 111110
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
....+..+++.+.+++.+||+.||.+|| ++.++++.
T Consensus 217 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 ----EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0111234567799999999999999999 57777654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=309.54 Aligned_cols=254 Identities=23% Similarity=0.305 Sum_probs=200.7
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|.+++.||.|+||.||+|... +++.||+|++... .......+.+|+++++.++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 57999999999999999999754 6899999998643 2334567888999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999987543 7899999999999999999999 99999999999999999999999999999864321000
Q ss_pred c---------------------------------------------cccccccccccccCccccCCCCCCCccchhhHHH
Q 019843 199 S---------------------------------------------KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGI 233 (335)
Q Consensus 199 ~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~ 233 (335)
. .......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0001246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccC---CC
Q 019843 234 MLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQR---IN 310 (335)
Q Consensus 234 ~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps 310 (335)
++|+|++|..||......+.. ..+... .....++....++.++.+++.+||. +|.+| ++
T Consensus 237 il~elltG~~Pf~~~~~~~~~-------------~~i~~~----~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETY-------------RKIINW----RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHH-------------HHHHcc----CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 999999999999754321110 011110 0001111112346679999999998 77765 59
Q ss_pred HHHHHHHH
Q 019843 311 AKEIVTRL 318 (335)
Q Consensus 311 ~~ell~~L 318 (335)
+.|++..-
T Consensus 299 ~~~~l~hp 306 (377)
T cd05629 299 AHEIKSHP 306 (377)
T ss_pred HHHHhcCC
Confidence 99988763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=293.01 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=204.5
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.++|++.+.||+|+||.||+|... +++.|++|++..........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 468999999999999999999864 5889999999766555556788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++++|.+++.... .+++..+..++.|++.|+.||| +.+++|+|++|+||+++.++.++|+|||++..+... ..
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IA 161 (267)
T ss_pred CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccc--cc
Confidence 99999999886543 7899999999999999999999 999999999999999999999999999999865311 11
Q ss_pred ccccccccccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 201 SQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
......++..|+|||.+. ...++.++|+||+|+++|+|++|..||............ .....
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------------~~~~~-- 226 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------------SKSNF-- 226 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------------ecCCC--
Confidence 223346788899999874 345788999999999999999999998643321111000 00000
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
..........++..+.+++.+||+.||++||+++++++.|
T Consensus 227 -~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 -QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0001111123456799999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=316.12 Aligned_cols=258 Identities=24% Similarity=0.313 Sum_probs=207.6
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC-
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD- 112 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 112 (335)
......++|++.+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+..+..++|+||+++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3445568999999999999999999975 468999999987542 334567888999999999999999988765322
Q ss_pred -------eeEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcE
Q 019843 113 -------FKALVLEYMPHGSLEKCLYSS---NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 182 (335)
Q Consensus 113 -------~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v 182 (335)
..++||||+++|+|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCE
Confidence 467999999999999988643 346899999999999999999999 9999999999999999999999
Q ss_pred EEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh
Q 019843 183 HLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262 (335)
Q Consensus 183 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 262 (335)
+|+|||++..+.............|++.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---------- 252 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---------- 252 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----------
Confidence 9999999876542222223344578999999999999999999999999999999999999997542211
Q ss_pred cChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 263 LPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
++........ ...+..+++.+.+++.+||+.||.+||++.++++.
T Consensus 253 -------~~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 -------VMHKTLAGRY---DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -------HHHHHhcCCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111111 11234457779999999999999999999999864
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=307.50 Aligned_cols=254 Identities=20% Similarity=0.280 Sum_probs=200.9
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
+.|.+++.||+|+||+||+|... +++.||+|++... .......+..|+++++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36889999999999999999754 5889999998753 2334567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++.... .+++..+..++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 81 DYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999999987654 6899999999999999999999 99999999999999999999999999998754310000
Q ss_pred ---------------------------------------------ccccccccccccccCccccCCCCCCCccchhhHHH
Q 019843 199 ---------------------------------------------SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGI 233 (335)
Q Consensus 199 ---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~ 233 (335)
........||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012346899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhc--hhccccCCCH
Q 019843 234 MLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECT--VESAEQRINA 311 (335)
Q Consensus 234 ~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~dP~~Rps~ 311 (335)
++|+|++|..||.......... .++.. ......+....+++++.+|+.+|+ ..+|..||++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~-------------~i~~~----~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL-------------KVINW----ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH-------------HHHcc----ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999997643221111 11111 001111112235677999999855 4555569999
Q ss_pred HHHHHH
Q 019843 312 KEIVTR 317 (335)
Q Consensus 312 ~ell~~ 317 (335)
+++++.
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=318.00 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=209.0
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCC-cEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeee-eec------C
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDG-MEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIIST-CSN------D 111 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~------~ 111 (335)
...+++|.+.|.+|+|+.||+|....+ ..+|+|.+-..+....+.+.+|+++++.|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345788999999999999999986655 999999988777888899999999999995 9999999993 221 1
Q ss_pred CeeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
-.+.++||||.||.|.|+++.+ ...+++.++++|+.++++|+.+|| ..+.+|+|||||-+|||++.+|..||||||.+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 3567999999999999999854 235999999999999999999999 33566999999999999999999999999998
Q ss_pred ccccCCcccc-------ccccccccccccCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhh
Q 019843 191 KLLTGEDQSK-------SQTQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVS 260 (335)
Q Consensus 191 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~---~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 260 (335)
.--....... ..-...-|+.|.|||++ .+..++.|+|||+|||+||-|++...||+....-..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI------- 266 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI------- 266 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE-------
Confidence 7432111000 11123469999999975 477899999999999999999999999987522111
Q ss_pred hhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 261 NLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
+ ...-.++.....++.+.+||+.||+.||.+||++-++++.+..++.
T Consensus 267 ----------l------ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 267 ----------L------NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ----------E------eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 1 1111222224567889999999999999999999999999998863
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=295.17 Aligned_cols=266 Identities=24% Similarity=0.319 Sum_probs=197.3
Q ss_pred CCCCccceeeecCceEEEEEEEc--CCcEEEEEEeecCC--CchhHHHHHHHHHHHhC---CCCceEEEeeeee-----c
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ--DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSI---RHRNLIKIISTCS-----N 110 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~ 110 (335)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.+ .||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999753 36789999987543 22234556677777665 6999999999875 3
Q ss_pred CCeeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
...+++|||+++ ++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 457889999995 5898888653 345899999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
+..... ........++..|+|||.+.+..++.++||||||+++|+|++|.+||......+.... ............
T Consensus 157 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~-i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK-ILDVIGLPGEED 232 (290)
T ss_pred eEeccC---CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH-HHHHhCCCChhh
Confidence 976532 1233345689999999999888899999999999999999999999986543221111 111100000000
Q ss_pred HH------Hhhhccccccch-hhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 270 IV------DANLLSREDKHF-AAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 270 ~~------~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
+- ............ .....++..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000000000000 011235677899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=302.48 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=197.3
Q ss_pred cceeeecCceEEEEEEE----cCCcEEEEEEeecC----CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 48 NNLIGRGSFGSVYKARI----QDGMEVAVKVFHLQ----CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~----~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.+.||+|+||.||++.. .+++.||+|++... .......+..|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36899999999999974 25788999998743 22334567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 154 (323)
T cd05584 81 YLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EG 154 (323)
T ss_pred CCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CC
Confidence 999999999887654 6888999999999999999999 99999999999999999999999999999864321 11
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......++..|+|||++.+..++.++||||||+++|+|++|..||....... ........
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-----------------~~~~~~~~-- 215 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-----------------TIDKILKG-- 215 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----------------HHHHHHcC--
Confidence 22233568999999999998889999999999999999999999997543211 11111000
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
....+..+++.+.+++.+||+.||++|| +++++++.
T Consensus 216 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 216 --KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1112334567799999999999999999 78888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=308.69 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=207.6
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 115 (335)
.-++|++.++||+|+||.|++|..+ +++.+|||+++.+ .+...+....|.+++... +||.++.++.+|...+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3478999999999999999999755 5889999999865 355668889999999988 5999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
.||||+.||++..+.. ...+++..+..++.+++.||.||| +++|+|||||.+|||+|.+|++||+|||++..-
T Consensus 446 fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~-- 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG-- 518 (694)
T ss_pred EEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccccc--
Confidence 9999999999554333 336999999999999999999999 999999999999999999999999999999853
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
..........+||+.|+|||++.++.|+.+.|.||||++|||||.|+.||.+.++ +++.|..+
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-----------------ee~FdsI~ 581 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-----------------EEVFDSIV 581 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-----------------HHHHHHHh
Confidence 2234456678999999999999999999999999999999999999999987543 33334433
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINA 311 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 311 (335)
..+ ...|..++.+...+++++|..||++|.-+
T Consensus 582 ~d~----~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 NDE----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cCC----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 222 22355678889999999999999999854
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=294.03 Aligned_cols=258 Identities=24% Similarity=0.401 Sum_probs=205.4
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCc----EEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGM----EVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~----~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
++|++.+.||.|+||.||+|.+. +++ .+++|.+.... ......+..|+..+..+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 58899999999999999999864 344 47778775432 2344677888889999999999999998764 45678
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
++|++++++|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+..+...
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999876668999999999999999999999 999999999999999999999999999999865432
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
..........++..|+|||.+.+..++.++|+||||+++|++++ |..||....... ...++....
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------------~~~~~~~~~ 228 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--------------VPDLLEKGE 228 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------------HHHHHHCCC
Confidence 22222233456678999999988889999999999999999998 999986543211 111221111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
....+..++.++.+++.+||..||.+|||+.|+++.|..+.++
T Consensus 229 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 229 ------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 1111223456689999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=301.28 Aligned_cols=246 Identities=22% Similarity=0.268 Sum_probs=198.8
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCC-CceEEEeeeeecCCeeEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRH-RNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 118 (335)
+|++.+.||+|+||.||+|... +++.||+|++... .......+..|.+++..+.| ++|+.+++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999765 5789999998743 23345677889999999965 56888999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..... .
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--G 154 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--C
Confidence 9999999999887654 6899999999999999999999 99999999999999999999999999999864321 1
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........|+..|+|||++.+..++.++|+||+||++|+|++|..||......+.. ..+..
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~-------------~~i~~------ 215 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-------------QSIME------ 215 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------------HHHHc------
Confidence 12233456899999999999999999999999999999999999999764321111 01110
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCH-----HHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINA-----KEIVT 316 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~ 316 (335)
.....+..++..+.+++.+||..||.+|++. +++++
T Consensus 216 --~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 216 --HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred --CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0111123456679999999999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=296.23 Aligned_cols=255 Identities=28% Similarity=0.477 Sum_probs=206.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
.++|.+.+.||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 467889999999999999999632 35678899877655556678999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc
Q 019843 116 LVLEYMPHGSLEKCLYSSN--------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~ 181 (335)
+++||+++++|.+++.... ..+++..++.++.|++.|+.||| +.+++|+||+|+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence 9999999999999986532 24789999999999999999999 999999999999999999999
Q ss_pred EEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhh
Q 019843 182 AHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVS 260 (335)
Q Consensus 182 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~ 260 (335)
++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |.+||......+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------- 233 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------- 233 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------
Confidence 99999999875532222222233345678999999998899999999999999999998 8999865332111
Q ss_pred hhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 261 NLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...+... .....+..+++.+.+++.+||+.||.+||++.+|++.|+
T Consensus 234 -------~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 -------IECITQG------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -------HHHHHcC------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0111110 011112345677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=329.37 Aligned_cols=261 Identities=28% Similarity=0.482 Sum_probs=223.5
Q ss_pred cCCCCccceeeecCceEEEEEEEcC--Cc----EEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD--GM----EVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~--~~----~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
...-...+.||+|.||.||.|...+ +. .|++|.+... +.+....|.+|..+++.++||||++++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3455677999999999999997542 33 4888888654 445678899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 115 ALVLEYMPHGSLEKCLYSS------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
++++|||+||+|..+|++. ...++...++.++.++++|+.||+ +++++|+||...|+|++....||++|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999977 567999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhH
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
+++.+...+.......-.-...|||||.+..+.++.++||||||+++||+++ |..||....+.+..
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~------------- 914 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL------------- 914 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH-------------
Confidence 9997666665665555566788999999999999999999999999999999 88998775432211
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
.+. . ...+++.+..||+.+.+++.+||+.+|++||++..|++++.++.+..
T Consensus 915 ---~~~--~--~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 915 ---LDV--L--EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ---HHH--H--hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 101 1 12277778999999999999999999999999999999998876544
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=294.50 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=207.7
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCc----EEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGM----EVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
.++|.+.+.||.|+||+||+|.+. +++ .|++|++.... ......+.+|+.++..++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 468999999999999999999753 344 48999986543 33456788999999999999999999998754 467
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
++++++++|+|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999876667999999999999999999999 99999999999999999999999999999986642
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------------~~~~~~~~ 227 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--------------IPDLLEKG 227 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------------HHHHHHCC
Confidence 222112222334677999999998899999999999999999998 889986543211 11111111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
. ....+..++..+.+++.+||+.||+.||++.++++.|..+..+.
T Consensus 228 ~------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 228 E------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred C------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1 11112345667999999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=304.36 Aligned_cols=252 Identities=23% Similarity=0.287 Sum_probs=200.8
Q ss_pred CCCccceeeecCceEEEEEEE----cCCcEEEEEEeecC----CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCee
Q 019843 44 GFSENNLIGRGSFGSVYKARI----QDGMEVAVKVFHLQ----CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~----~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 114 (335)
+|++.+.||+|+||.||++.. .+++.||+|++... .......+..|+.+++.+ +|++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999964 25789999998642 223345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++||||+++++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999887654 6899999999999999999999 9999999999999999999999999999987653
Q ss_pred CCccccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
... ........|+..|+|||++.+. .++.++|||||||++|+|++|..||......... ..+...
T Consensus 157 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------------~~~~~~ 222 (332)
T cd05614 157 SEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-------------SEVSRR 222 (332)
T ss_pred ccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-------------HHHHHH
Confidence 221 1122245689999999998765 4788999999999999999999999753321111 011111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
..... ...+..+++.+.+++.+||+.||++|| +++++++.
T Consensus 223 ~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 223 ILKCD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HhcCC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11100 111233567799999999999999999 77888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=294.65 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=202.2
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.|++.+.||.|+||.||++... +++.||+|++.... ......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4889999999999999999764 58899999986432 2223456789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 120 YMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 120 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
|+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--
Confidence 99999999888653 346899999999999999999999 999999999999999999999999999998765211
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......++..|+|||++.+..++.++|+||+|+++|+|++|..||........ .. .....+...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-~~---------~~~~~~~~~---- 220 (285)
T cd05605 156 -ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-RE---------EVERRVKED---- 220 (285)
T ss_pred -CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-HH---------HHHHHhhhc----
Confidence 122234688999999999988899999999999999999999999976332111 00 001111110
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
....+..+++.+.+++.+||+.||++|| +++++++.
T Consensus 221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 ---QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0111233567799999999999999999 88898775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=287.52 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=209.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.++|.+.+.||.|++|.||+|... +++.+++|++........+.+.+|+++++.++||||+++++.+.....++++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 368999999999999999999764 5788999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++++|.+++......+++..++.++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence 9999999998876557999999999999999999999 999999999999999999999999999998765311 11
Q ss_pred ccccccccccccCccccCCC---CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 201 SQTQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........... +.....
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~--------------~~~~~~- 221 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL--------------ISKSNF- 221 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------HHhccC-
Confidence 22345678889999998776 788999999999999999999999876432211110 000000
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
...........+.++.+++.+||..+|.+||++.+++.
T Consensus 222 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 -PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11111223345677999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=288.69 Aligned_cols=258 Identities=22% Similarity=0.329 Sum_probs=209.9
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|.+.+.||.|++|.||+|... +++.|++|.++.. .......+.+|+++++.++|+|++++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999866 6899999988642 2233567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 119 EYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 119 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
||+++++|.+++.. ....+++..++.++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998863 2346899999999999999999999 99999999999999999999999999999876532
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
. ........++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ...+...
T Consensus 159 ~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~~ 221 (267)
T cd08224 159 K--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---------------SLCKKIE 221 (267)
T ss_pred C--CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH---------------HHHhhhh
Confidence 1 1122334578889999999888899999999999999999999999865432111 1111110
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
...... .....++..+.+++.+||..+|++||++.+|++.|++++
T Consensus 222 ~~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 222 KCDYPP--LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred cCCCCC--CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000000 011245667999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=291.79 Aligned_cols=269 Identities=25% Similarity=0.413 Sum_probs=206.5
Q ss_pred CCC-CccceeeecCceEEEEEEE-----cCCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeec--CCe
Q 019843 43 DGF-SENNLIGRGSFGSVYKARI-----QDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSN--DDF 113 (335)
Q Consensus 43 ~~y-~~~~~lg~g~~~~v~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 113 (335)
++| .+.+.||+|+||.||++.. .++..|++|++..... .....+.+|+++++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 8999999999999988642 3477899999875532 345678899999999999999999998765 346
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.+++|||+++++|.+++... .+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 88999999999999998764 4999999999999999999999 999999999999999999999999999998865
Q ss_pred cCCccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhh-hhcChhHHHHH
Q 019843 194 TGEDQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVS-NLLPISVMEIV 271 (335)
Q Consensus 194 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~ 271 (335)
...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||......-........ ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 322111 1112233566799999998888999999999999999999999998654322111110000 00011111111
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
+... ..+.+..++..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 238 ~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGM------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCC------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111 11223445778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=290.49 Aligned_cols=254 Identities=23% Similarity=0.417 Sum_probs=206.1
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
..++|++++.||+|+||.||+|...+++.+++|.+..... ....+.+|+.+++.++|+||+++++++. .+..++++|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3578999999999999999999988889999999874433 3467889999999999999999999874 4568999999
Q ss_pred cCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+++++|.+++... +..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 157 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-Y 157 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-c
Confidence 9999999988653 346899999999999999999999 9999999999999999999999999999987653111 1
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......++..|+|||.+.+..++.++|+||||+++|++++ |..||........ ...+...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------------~~~~~~~---- 219 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV--------------IQNLERG---- 219 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--------------HHHHHcC----
Confidence 12223345678999999998889999999999999999998 9999975432211 1111111
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
.....+..++.++.+++.+||+.+|++||+++++++.|++
T Consensus 220 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 --YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0111123346679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=294.50 Aligned_cols=255 Identities=27% Similarity=0.471 Sum_probs=205.1
Q ss_pred CCCCccceeeecCceEEEEEEE-----cCCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARI-----QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
++|++.+.||+|+||.||+|.. .++..+++|.+.... ......+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5788999999999999999974 246789999986432 3344678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC
Q 019843 117 VLEYMPHGSLEKCLYSS----------------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~ 180 (335)
+|||+++++|.+++... ...+++..+..++.+++.||.||| +.+++|+||+|+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 99999999999998532 124788899999999999999999 99999999999999999999
Q ss_pred cEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHh
Q 019843 181 VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWV 259 (335)
Q Consensus 181 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~ 259 (335)
.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999986543322222333445677999999988889999999999999999998 888986532111
Q ss_pred hhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 260 SNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
....+.... ....+..+++.+.+++.+||+.||++||++.++++.|..
T Consensus 235 -------~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 -------VIEMVRKRQ------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -------HHHHHHcCC------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111110 111233456779999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=304.29 Aligned_cols=242 Identities=23% Similarity=0.305 Sum_probs=197.3
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHG 124 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 124 (335)
+.||+|+||.||++... +++.||+|++... .......+..|+++++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999754 6899999998753 2234466778999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 125 SLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 125 ~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
+|.+++.... .+++..+..++.||+.||.||| + .+++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMK 154 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccc
Confidence 9998887554 6899999999999999999999 7 7999999999999999999999999999874321 112223
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...++..|+|||++.+..++.++|||||||++|+|++|..||........ ...+.. . ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--------------~~~i~~---~----~~ 213 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--------------FELILM---E----EI 213 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--------------HHHHhc---C----CC
Confidence 35689999999999999999999999999999999999999965432111 011100 0 01
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
..+..+++++.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11233566799999999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=288.13 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=204.3
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-----CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-----GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
++|.+.+.||.|++|.||.|... +++++++|.+.... ......+.+|+++++.++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999754 58999999986432 1234568889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
++|++++++|.+++.... .+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999887654 6889999999999999999999 999999999999999999999999999998765321
Q ss_pred cccc-ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSK-SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------------~~~~~--- 221 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-------------FKIAT--- 221 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-------------HHHhc---
Confidence 1111 112345778899999999988999999999999999999999998654211110 00000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.......+..++..+.+++.+||..+|.+||++.++++.
T Consensus 222 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 ---QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011112233456779999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=289.92 Aligned_cols=253 Identities=27% Similarity=0.455 Sum_probs=204.4
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|++.+.||+|++|.||+|...++..+++|.+..... ....+.+|+.+++.++|+|++++++++.. +..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 468999999999999999999888788899999875433 34678999999999999999999998754 5678999999
Q ss_pred CCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++++|.+++... ...+++..++.++.+++.||.||| +.+++|+||+|+||++++++.++|+|||.+..+..... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-c
Confidence 999999998753 345899999999999999999999 99999999999999999999999999999976532211 1
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. ...+...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--------------~~~~~~~----- 219 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV--------------LEQVERG----- 219 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH--------------HHHHHcC-----
Confidence 1122334567999999988889999999999999999999 8899865321111 1111110
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
...+.+...+..+.+++.+||..||.+|||+.++.+.|++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 -YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111233456679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=294.88 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=206.2
Q ss_pred CCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5889999999999999999753 235688888765432 335678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCC
Q 019843 117 VLEYMPHGSLEKCLYSS-----------------------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSN 173 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~N 173 (335)
++||+.+++|.+++... ...+++..++.++.+++.||.||| +.+++|+||+|+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 99999999999988642 125788999999999999999999 9999999999999
Q ss_pred EEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccc
Q 019843 174 VLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGE 252 (335)
Q Consensus 174 ilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~ 252 (335)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999876532222222233445678999999988889999999999999999998 999986532111
Q ss_pred hhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 253 MTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
......... ....+..++.++.+++.+||+.+|++||++.|+++.|+++-.
T Consensus 238 --------------~~~~~~~~~------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 --------------LFNLLKTGY------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred --------------HHHHHhCCC------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111121111 111233456679999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=290.04 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=204.8
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|++.+.||+|++|.||+|.+.+...|++|++..... ....+..|+++++.++|+||+++++.+.. +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 467999999999999999999877667899999875332 34678899999999999999999998754 5578999999
Q ss_pred CCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++++|.+++... ...+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+..+.... ..
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~-~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 158 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccc-cc
Confidence 999999999753 335889999999999999999999 9999999999999999999999999999997653222 11
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
......++..|+|||...+..++.++|+||||+++|+|++ |..||......+.. ..+...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~--------------~~~~~~----- 219 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL--------------DQVERG----- 219 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH--------------HHHhcC-----
Confidence 2223445677999999988889999999999999999999 88888654321110 001100
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
........++..+.+++.+||+.||.+||++.++++.|+..
T Consensus 220 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01111234567799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=286.87 Aligned_cols=248 Identities=31% Similarity=0.494 Sum_probs=202.3
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEeecCCCc-hhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCChH
Q 019843 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLE 127 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 127 (335)
+.||.|++|.||+|...+++.|++|.+...... ....+.+|++++++++|+||+++++++......++|+|++++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 478999999999998766999999998765433 4568899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccccccc
Q 019843 128 KCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207 (335)
Q Consensus 128 ~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~ 207 (335)
+++......++...+..++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||++.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999776557899999999999999999999 99999999999999999999999999999876532221112122334
Q ss_pred cccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhH
Q 019843 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286 (335)
Q Consensus 208 ~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (335)
+..|+|||.+.++.++.++|+||||+++|+|++ |..||......... ..+... .....+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~--------------~~~~~~------~~~~~~ 217 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR--------------ERIESG------YRMPAP 217 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH--------------HHHhcC------CCCCCC
Confidence 567999999988889999999999999999999 88888654321111 111110 011123
Q ss_pred HHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 287 EQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 287 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
..++..+.+++.+||..+|++||++.|+++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 345677999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=288.46 Aligned_cols=250 Identities=31% Similarity=0.501 Sum_probs=207.1
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|.+.+.||.|++|.||.|... |+.|++|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++|||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 568999999999999999999876 78999999876544 4578899999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~---- 155 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---- 155 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc----
Confidence 9999999987543 36899999999999999999999 999999999999999999999999999998865211
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
......+..|+|||.+.+..++.++|+||||+++|++++ |..||........ ...+...
T Consensus 156 -~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------------~~~~~~~----- 215 (256)
T cd05039 156 -QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--------------VPHVEKG----- 215 (256)
T ss_pred -cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH--------------HHHHhcC-----
Confidence 112234567999999988889999999999999999997 9999865422111 1111110
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
.....+..+++.+.+++.+||+.+|++||++.++++.|+++
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 -YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 01111234567799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.40 Aligned_cols=254 Identities=26% Similarity=0.331 Sum_probs=208.7
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.....+|++.+.||+|++|.||+|... +++.+++|.+..........+.+|+.+++.+.|+|++++++.+......++|
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 345579999999999999999999754 5889999998876655667889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+++++|.+++... .+++.++..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~- 169 (296)
T cd06654 96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 169 (296)
T ss_pred ecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccc-
Confidence 9999999999988654 4889999999999999999999 999999999999999999999999999998754311
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... ... .
T Consensus 170 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~----------------~~~--~ 230 (296)
T cd06654 170 -QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY----------------LIA--T 230 (296)
T ss_pred -ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH----------------HHh--c
Confidence 112233467889999999988889999999999999999999999997543211100 000 0
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
........+..++..+.+++.+||..||++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0011111123456679999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=300.58 Aligned_cols=236 Identities=24% Similarity=0.303 Sum_probs=192.8
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|..+ +++.||+|++... .......+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999765 5889999998743 233456677888888876 799999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTS 154 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccc
Confidence 99999887654 6899999999999999999999 99999999999999999999999999999875321 112233
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||........ ....... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----------------~~~i~~~----~~ 213 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-----------------FEAILND----EV 213 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-----------------HHHHhcC----CC
Confidence 45689999999999998999999999999999999999999976432211 1111100 01
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINA 311 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~ 311 (335)
..+..+++++.+++.+||+.||.+||++
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1122356779999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=307.37 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=200.2
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
+.|++++.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 46899999999999999999754 58899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc-
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED- 197 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~- 197 (335)
||+++++|.+++.... .+++..+..++.||+.||.||| +.+++|+||||+||+++.+|.++|+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 81 DYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 9999999999887654 6899999999999999999999 9999999999999999999999999999975321000
Q ss_pred --------------------------------------------cccccccccccccccCccccCCCCCCCccchhhHHH
Q 019843 198 --------------------------------------------QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGI 233 (335)
Q Consensus 198 --------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~ 233 (335)
.........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000011246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCC---
Q 019843 234 MLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN--- 310 (335)
Q Consensus 234 ~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps--- 310 (335)
++|+|++|..||......+... .+.. .......+....+++++.++|.+|+ .+|.+|++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~-------------~i~~----~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQM-------------KVIN----WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHH-------------HHHc----cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 9999999999997643221111 1111 0111111122345677899999876 49999987
Q ss_pred HHHHHHH
Q 019843 311 AKEIVTR 317 (335)
Q Consensus 311 ~~ell~~ 317 (335)
+.++++.
T Consensus 299 ~~ei~~h 305 (382)
T cd05625 299 ADEIKAH 305 (382)
T ss_pred HHHHhcC
Confidence 8887753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=296.39 Aligned_cols=261 Identities=28% Similarity=0.449 Sum_probs=208.3
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeec
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSN 110 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 110 (335)
....++|++.+.||+|++|.||+|... ....+++|.+.... ......+.+|+++++.+ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 344578999999999999999999754 23678999887542 33456788999999999 79999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEE
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSS---------------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVL 175 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nil 175 (335)
.+.++++|||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEE
Confidence 99999999999999999998632 346889999999999999999999 999999999999999
Q ss_pred ECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchh
Q 019843 176 LDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMT 254 (335)
Q Consensus 176 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~ 254 (335)
++.++.++|+|||++..+.............++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~- 243 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL- 243 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH-
Confidence 99999999999999986543222222222334567999999988899999999999999999997 8899865432111
Q ss_pred hHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 255 LKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
...+... .....+..++..+.+++.+||..||++|||+.|+++.|.++.
T Consensus 244 -------------~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 -------------FKLLKEG------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -------------HHHHHcC------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111 011112344667999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=308.55 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=201.1
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+++++.++|+||+++++.+.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999754 5899999998643 1233466888999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc-
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED- 197 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~- 197 (335)
||+++++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999987654 6889999999999999999999 9999999999999999999999999999975321000
Q ss_pred ----------------------------------------cccccccccccccccCccccCCCCCCCccchhhHHHHHHH
Q 019843 198 ----------------------------------------QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 237 (335)
Q Consensus 198 ----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ 237 (335)
.........||+.|+|||++.+..++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0000113468999999999999999999999999999999
Q ss_pred HHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCC---CHHHH
Q 019843 238 TFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI---NAKEI 314 (335)
Q Consensus 238 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~el 314 (335)
|++|..||......+... .+... ......+....+++.+.++|.+|+ .+|.+|+ ++.++
T Consensus 237 ll~G~~Pf~~~~~~~~~~-------------~i~~~----~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 237 MLVGQPPFLADTPAETQL-------------KVINW----ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred hhhCCCCCCCCCHHHHHH-------------HHhcc----CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999997643222111 01100 000111112234667889999976 5999999 89999
Q ss_pred HHH
Q 019843 315 VTR 317 (335)
Q Consensus 315 l~~ 317 (335)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=287.80 Aligned_cols=248 Identities=31% Similarity=0.529 Sum_probs=206.0
Q ss_pred ceeeecCceEEEEEEEcC----CcEEEEEEeecCCCc-hhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQD----GMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||.|+||.||+|.... +..+++|++...... ....+..|++.++.++|+|++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999997653 788999998765433 367889999999999999999999999999999999999999
Q ss_pred CChHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 124 GSLEKCLYSS--------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 124 ~~L~~~l~~~--------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
++|.+++... ...+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 468999999999999999999999 99999999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
...........++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. .+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----------------~~~~ 220 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-----------------LEYL 220 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH-----------------HHHH
Confidence 332233444567888999999988889999999999999999999 6999876522111 1111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.. ......+..++.++.+++.+||+.||.+|||+.++++.|+
T Consensus 221 ~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 RK---GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred Hc---CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 10 1122223445778999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=294.02 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=208.5
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.++|.+.+.||.|++|.||+|... ++..+++|++........+.+..|+++++.++|+||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999764 5889999999876666667888999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++++|.+++......+++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~--~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQ 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcc--ccc
Confidence 9999999998876667999999999999999999999 99999999999999999999999999998875421 122
Q ss_pred ccccccccccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 201 SQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
......++..|+|||.+. +..++.++|+||||+++|+|++|..||.......... .+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~----- 220 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL-------------KI----- 220 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH-------------HH-----
Confidence 223456788999999874 3457889999999999999999999987643211100 00
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..........+..++..+.+++.+||+.+|.+||+++++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 221 LKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred hcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011111222234456779999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=301.42 Aligned_cols=251 Identities=20% Similarity=0.264 Sum_probs=197.0
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|..+ +++.||+|++... .......+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999765 5889999999753 233445678899999988 799999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccc--cCCCccc
Confidence 99998886553 7999999999999999999999 9999999999999999999999999999986421 1122233
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...|+..|+|||++.+..++.++|+|||||++|+|++|..||.......... ............. ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~---~~~ 222 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD---------QNTEDYLFQVILE---KQI 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc---------ccchHHHHHHHHc---CCC
Confidence 4568999999999999999999999999999999999999997432111000 0000011010111 011
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCC------HHHHHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRIN------AKEIVTR 317 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps------~~ell~~ 317 (335)
..+..++..+.+++.+||+.||.+||+ ++++++.
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 123345677999999999999999997 6677643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=292.88 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=206.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
..+.|++.+.||.|++|.||+|... ++..+++|++..........+..|+++++.++|+|++++++.+..++.+++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 3478999999999999999999765 488999999887666667788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++++|..++.+....+++..++.++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||++.... ...
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~--~~~ 164 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV--KTL 164 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecc--ccc
Confidence 99999999888765567999999999999999999999 9999999999999999999999999999887542 112
Q ss_pred cccccccccccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 200 KSQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
.......++..|+|||.+. ...++.++|+||||+++|+|++|..||.......... ...
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-------------~~~--- 228 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-------------KIA--- 228 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHH-------------HHh---
Confidence 2223455788899999874 3456889999999999999999999986543211100 000
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.........+..++.++.+++.+||..||++||+++++++.
T Consensus 229 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 229 --KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --cCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00111111223445679999999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=297.40 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=207.5
Q ss_pred CCCCccceeeecCceEEEEEEEc--------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCC
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ--------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDD 112 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~--------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 112 (335)
++|.+.+.||+|+||.||.|... ++..+++|.+..+. ......+..|+++++.+ +|+||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 68999999999999999999642 23569999987542 33456788899999999 7999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC
Q 019843 113 FKALVLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD 177 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~ 177 (335)
..++||||+++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 9999999999999999997532 24788999999999999999999 99999999999999999
Q ss_pred CCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhH
Q 019843 178 DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLK 256 (335)
Q Consensus 178 ~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~ 256 (335)
.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---- 250 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 250 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----
Confidence 999999999999875532111111222234567999999988889999999999999999998 888886432111
Q ss_pred hHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 257 YWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
....+... .....+..++.++.+++.+||..+|++||++.++++.|..+.+.-
T Consensus 251 ----------~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 251 ----------LFKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ----------HHHHHHcC------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 01111111 111223345677999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=287.48 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=208.6
Q ss_pred cCCCCccceeeecCceEEEEEEEcC-CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.++|++.+.||.|++|.||+|.... ++.+++|.+..... .+.+.+|+++++.++|+||+++++.+......++++|+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3689999999999999999998764 78999999875533 67899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++++|.+++......+++..++.++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~--~~ 154 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MA 154 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccC--cc
Confidence 9999999999876668999999999999999999999 999999999999999999999999999998865322 11
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .+ .....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--------------~~----~~~~~ 216 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--------------MI----PNKPP 216 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--------------hh----ccCCC
Confidence 2333457888999999998889999999999999999999999987643221110 00 00111
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.....+..++..+.+++.+||+.||++|||++|++.
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 122223445677999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=293.54 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=204.1
Q ss_pred hcCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
..++|.+.+.||+|++|.||+|.+. .+..|++|.+.... ......+..|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3477999999999999999999764 35678999876443 2334568889999999999999999999999889
Q ss_pred eEEEEEecCCCChHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC---cEEE
Q 019843 114 KALVLEYMPHGSLEKCLYSSN------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHL 184 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~---~v~l 184 (335)
.++||||+++++|.+++.... ..+++..+..++.+|+.|+.||| +.+++|+||+|+||+++.++ .++|
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999987542 25889999999999999999999 99999999999999998654 5899
Q ss_pred eeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhc
Q 019843 185 SDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLL 263 (335)
Q Consensus 185 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 263 (335)
+|||++..+..............+..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---------- 230 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---------- 230 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----------
Confidence 99999886532222222223334567999999988889999999999999999997 9999876432211
Q ss_pred ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 264 PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...+... .....+..++..+.+++.+||+.||++||++.+|++.|.
T Consensus 231 ----~~~~~~~------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 ----MEFVTGG------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----HHHHHcC------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111111 011113345677999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.83 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=207.9
Q ss_pred cCCCCccceeeecCceEEEEEEEcC----CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD----GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.++|.+.+.||+|++|.||+|...+ ...|++|...... ....+.+.+|+.+++.+.||||+++++++.+. ..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEE
Confidence 4578999999999999999997543 3468999887554 34556889999999999999999999988764 5679
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999999876556899999999999999999999 999999999999999999999999999998765322
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
.. .......++..|+|||.+.+..++.++|+||||+++|++++ |..||......+.... +..
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~--------------~~~-- 223 (270)
T cd05056 161 SY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR--------------IEN-- 223 (270)
T ss_pred cc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------------HHc--
Confidence 11 11222334567999999988889999999999999999986 9999876543221110 000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
......+..++..+.+++.+|+..+|.+|||+.++++.|.+++.+
T Consensus 224 ----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 224 ----GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011122345567799999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=289.45 Aligned_cols=255 Identities=28% Similarity=0.484 Sum_probs=207.8
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
..++|++.+.||.|++|.||+|..+++..+++|.+.... .....+.+|+.+++.++|+||+++++++......++++|+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 457899999999999999999988778889999987543 3346789999999999999999999999998999999999
Q ss_pred cCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+++++|.+++.... ..+++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+..+.... .
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-Y 158 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-h
Confidence 99999999997643 46899999999999999999999 9999999999999999999999999999987653211 1
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........+..|+|||.+.+..++.++|+||+|+++|+|++ |..||........ . ..+....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-~-------------~~~~~~~--- 221 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV-L-------------EQVERGY--- 221 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-H-------------HHHHcCC---
Confidence 11122234567999999998889999999999999999998 9999865321111 1 0111100
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
....+..++..+.+++.+||+.+|.+||+++++.+.|+.
T Consensus 222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 ---RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111122346679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=293.22 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=209.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEcC-----CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeec-CCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQD-----GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSN-DDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 113 (335)
..++|.+.+.||+|+||.||.|.+.. +..|++|.+.... ......+.+|+.+++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999998664 6789999876442 3345678899999999999999999998765 578
Q ss_pred eEEEEEecCCCChHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEee
Q 019843 114 KALVLEYMPHGSLEKCLYSSN-------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 186 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~d 186 (335)
.+++++|+++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++++|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence 889999999999999986532 35899999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcCh
Q 019843 187 FGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPI 265 (335)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 265 (335)
||++..+.............++..|+|||.+.+..++.++||||||+++|++++ |..||......+ .
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~---------- 228 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--M---------- 228 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--H----------
Confidence 999976533222222223345677999999988889999999999999999998 999987542211 1
Q ss_pred hHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 266 SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
...+... ........+++.+.+++.+||..||++|||+.++++.|.++..+
T Consensus 229 --~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 229 --AAYLKDG------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred --HHHHHcC------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1111111 01111233567799999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=290.57 Aligned_cols=252 Identities=29% Similarity=0.450 Sum_probs=201.4
Q ss_pred CCccceeeecCceEEEEEEEcC-CcEEEEEEeecCCCchh--HHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 45 FSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVF--KSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
|++++.||+|+||+||++.... ++.+|+|++........ .....|+.+++.++||||+++++++.+....+++|+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6789999999999999998664 67899999987643322 23456999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
++++|.+++... ..+++..++.++.++++||.+|| +.+++|+||+|+||+++.++.++|+|||.+..+. .....
T Consensus 81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSE
T ss_pred cccccccccccc-ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccccc
Confidence 999999999833 36899999999999999999999 9999999999999999999999999999987541 22334
Q ss_pred cccccccccccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 202 QTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
.....++..|+|||++. +..++.++|+||||+++|+|++|..||......... ..+.........
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~--------------~~~~~~~~~~~~ 220 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL--------------EIIEKILKRPLP 220 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH--------------HHHHHHHHTHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhh--------------hhhhhccccccc
Confidence 45567889999999998 788999999999999999999999998865111110 111111110000
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.........+..+.+++.+||+.||++||++.++++
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011101111366999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=289.81 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=202.3
Q ss_pred CCccceeeecCceEEEEEEEcC----CcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC------
Q 019843 45 FSENNLIGRGSFGSVYKARIQD----GMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD------ 112 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 112 (335)
|.+++.||+|+||.||.|.... +..|++|.+..+. ......+..|++.++.++|+||+++++++...+
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999997542 4679999987543 233467889999999999999999999876544
Q ss_pred eeEEEEEecCCCChHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeec
Q 019843 113 FKALVLEYMPHGSLEKCLYSS-----NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 187 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~df 187 (335)
..++++||+++++|.+++... ...+++..+..++.+++.||.||| +.+++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 378999999999999988532 236899999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChh
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPIS 266 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 266 (335)
|++..+..............+..|+|||.+.+..++.++||||||+++|+|++ |..||......+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-------------- 223 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-------------- 223 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--------------
Confidence 99886543322222222334667999999988889999999999999999999 888886533211
Q ss_pred HHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
+.+..... .....+..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus 224 ---~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 224 ---IYDYLRHG---NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---HHHHHHcC---CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111100 11112345677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.31 Aligned_cols=270 Identities=28% Similarity=0.421 Sum_probs=206.8
Q ss_pred CCCCccceeeecCceEEEEEEE-----cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec--CCeeE
Q 019843 43 DGFSENNLIGRGSFGSVYKARI-----QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN--DDFKA 115 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 115 (335)
..|++.+.||+|+||.||.|.. .++..|++|.+..........+.+|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5789999999999999999963 2578999999876665566788999999999999999999998653 45688
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+|+||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999766557899999999999999999999 99999999999999999999999999999986532
Q ss_pred Ccccc-ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC--hhHHHHHH
Q 019843 196 EDQSK-SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP--ISVMEIVD 272 (335)
Q Consensus 196 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 272 (335)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+........ ........ .....+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM---RMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh---hhcccccccccchHHHHH
Confidence 21111 11112234459999999888899999999999999999998877543221100 00000000 00001111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
. . ......+.+..++..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 238 ~-~--~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 L-L--KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred H-H--hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 0 01111222344567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=300.99 Aligned_cols=242 Identities=22% Similarity=0.274 Sum_probs=196.6
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|..+ +++.||+|++... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 4789999998753 233445677888888876 799999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+.+.... .+++..+..++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTT 154 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC--Ccccc
Confidence 99998887654 6899999999999999999999 999999999999999999999999999998753211 12223
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...++..|+|||++.+..++.++||||||+++|+|++|..||........ ........ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-----------------~~~i~~~~----~ 213 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-----------------FESILHDD----V 213 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-----------------HHHHHcCC----C
Confidence 45689999999999998999999999999999999999999976432111 11111110 1
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCC-------CHHHHHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRI-------NAKEIVTR 317 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rp-------s~~ell~~ 317 (335)
..+..++.++.+++.+||+.||++|| +++++++.
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11223466799999999999999999 78888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=304.50 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=197.9
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.++|...+.||.|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 467888999999999999999765 589999999865432 345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++++|.+.. ..++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+... .
T Consensus 153 ~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~ 222 (353)
T PLN00034 153 FMDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--M 222 (353)
T ss_pred cCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--c
Confidence 99999986532 3567788899999999999999 999999999999999999999999999998865311 1
Q ss_pred cccccccccccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 200 KSQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
.......++..|+|||.+.. ...+.++|||||||++|+|++|..||........ .......
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--------------~~~~~~~ 288 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--------------ASLMCAI 288 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--------------HHHHHHH
Confidence 12234568999999998743 2345689999999999999999999974322111 1111111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
... .....+..++.++.+||.+||+.||++||++.|+++.=
T Consensus 289 ~~~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 289 CMS---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred hcc---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 010 01111234567799999999999999999999999863
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.79 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=204.6
Q ss_pred CCCCccceeeecCceEEEEEEEcC-C--cEEEEEEeecC-CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQD-G--MEVAVKVFHLQ-CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~-~--~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 117 (335)
++|++.+.||.|+||.||+|..+. + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999997653 3 34788877643 233456788999999999 799999999999999999999
Q ss_pred EEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcE
Q 019843 118 LEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 182 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v 182 (335)
+||+++++|.+++.... ..+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999986532 25888999999999999999999 9999999999999999999999
Q ss_pred EEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhh
Q 019843 183 HLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSN 261 (335)
Q Consensus 183 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 261 (335)
+|+|||++.... ..........+..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 159 kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-------- 227 (297)
T cd05089 159 KIADFGLSRGEE---VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-------- 227 (297)
T ss_pred EECCcCCCcccc---ceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--------
Confidence 999999986321 1111111223456999999988889999999999999999997 9999865432111
Q ss_pred hcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 262 LLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
...+... .....+..++..+.+++.+||+.+|.+||++++++..|..+....
T Consensus 228 ------~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 228 ------YEKLPQG------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ------HHHHhcC------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0111111 011122345677999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=303.92 Aligned_cols=256 Identities=22% Similarity=0.290 Sum_probs=203.0
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
...++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999865 5889999998642 2223456788999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||+++++|.+++... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++..+..
T Consensus 120 lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999998654 4889999999999999999999 99999999999999999999999999999986532
Q ss_pred CccccccccccccccccCccccCCCC----CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
.. ........||+.|+|||++.+.. ++.++|+||+||++|+|++|..||........ ...+.
T Consensus 195 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-------------~~~i~ 260 (370)
T cd05621 195 TG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-------------YSKIM 260 (370)
T ss_pred CC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-------------HHHHH
Confidence 11 11223456899999999987543 78899999999999999999999975432111 11111
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhcccc--CCCHHHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQ--RINAKEIVTRL 318 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~L 318 (335)
+. .....++....++..+.+++.+||..+|.+ |+++.|+++.=
T Consensus 261 ~~----~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 261 DH----KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred hC----CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 11 111111222235677999999999865554 88999998863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=288.35 Aligned_cols=249 Identities=21% Similarity=0.296 Sum_probs=204.0
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
+|.+.+.||.|++|.||.+... +++.+++|.+... .....+.+..|+.+++.++|+|++++++.+...+.+++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5889999999999999999765 5889999998643 3345577889999999999999999999999999999999999
Q ss_pred CCCChHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++++|.+++.. ....+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++++|||.+...... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GA 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--cc
Confidence 99999998865 3446899999999999999999999 999999999999999999999999999998765321 11
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
......++..|+|||++.+..++.++|+||||+++|+|++|..||.......... .+ .....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~-------------~~-~~~~~---- 217 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL-------------KV-CQGSY---- 217 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH-------------HH-hcCCC----
Confidence 2233567888999999998889999999999999999999999997532111100 00 00000
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...+..++..+.+++.+||+.||.+||++.+++++
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 --KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01122345669999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=289.87 Aligned_cols=258 Identities=23% Similarity=0.330 Sum_probs=208.8
Q ss_pred CCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++.+.||.|++|.||+|.. .+++.+++|.+... .......+.+|+.+++.++|+||+++++++...+..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5799999999999999999975 46899999987643 2234467889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 119 EYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 119 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
|++++++|.+++.. ....+++..++.++.+++.|+.||| +.+++|+||+|+||+++.++.++++|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 2346899999999999999999999 99999999999999999999999999999876532
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
. ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .....
T Consensus 159 ~--~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~ 221 (267)
T cd08229 159 K--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---------------CKKIE 221 (267)
T ss_pred C--CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH---------------hhhhh
Confidence 1 122233467888999999988889999999999999999999999986532211111 00000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
.... .......+++.+.+++.+||+.||++|||+.+|++.+.++.
T Consensus 222 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 222 QCDY--PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cCCC--CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0000 00012345677999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=281.78 Aligned_cols=256 Identities=20% Similarity=0.330 Sum_probs=215.1
Q ss_pred hhcCCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
-..+.|.+-+.||+|.|+.|+++. ..+|+.+++|++... +....+.+.+|+++-+.++||||+++++.+......|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 356789999999999999999984 457999999988643 34467899999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC---CCCcEEEeeccccccc
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLL 193 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~---~~~~v~l~dfg~~~~~ 193 (335)
|||.++|+.|..=|.++ ..+++..+.....||+++|.|.| .++|+|+|++|+|+++- ..--+||+|||++..+
T Consensus 88 vFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999997666554 36889999999999999999999 99999999999999994 3346999999999977
Q ss_pred cCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
. .........||+.|+|||++...+++..+|||+-|+++|-|+.|.+||.+.+. ..+++.
T Consensus 164 ~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----------------~rlye~ 223 (355)
T KOG0033|consen 164 N---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----------------HRLYEQ 223 (355)
T ss_pred C---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----------------HHHHHH
Confidence 4 34445667899999999999999999999999999999999999999987543 233333
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.......-..+..+.++++.++|+++||..||.+|.|+.|.|..=|
T Consensus 224 I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 224 IKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred HhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 3333333333334567888999999999999999999999886543
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=300.47 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=195.9
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|... +++.+|+|++... .......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999765 5889999998754 233445677888888877 799999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+++.... .+++..+..++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccc
Confidence 99998876553 7999999999999999999999 99999999999999999999999999999874321 112223
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...|+..|+|||++.+..++.++|+||||+++|+|++|..||........... .....+...... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~--------~~~~~~~~~i~~----~~~ 222 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLFQVILE----KQI 222 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc--------ccHHHHHHHHhc----CCC
Confidence 45689999999999999999999999999999999999999964321111000 000001111111 111
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCH------HHHHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINA------KEIVTR 317 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~~ 317 (335)
..+..++..+.+++.+||+.||++||++ .++++.
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1233456679999999999999999984 566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=294.73 Aligned_cols=270 Identities=20% Similarity=0.286 Sum_probs=204.6
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.++|.+.+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 478999999999999999999765 57889999987543 2333567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++ +|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...... .
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 158 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--T 158 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCC--c
Confidence 9965 888888766657899999999999999999999 999999999999999999999999999998754211 1
Q ss_pred cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh---HHHH-----
Q 019843 200 KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS---VMEI----- 270 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~----- 270 (335)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......+... .......... ...+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELH-LIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCHHHHhhhcchhh
Confidence 22233457889999998765 468899999999999999999999997654322211 1111000000 0000
Q ss_pred -HHhhhccc-cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 271 -VDANLLSR-EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 271 -~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
.+...... ..........+++++.+++.+||+.||.+|||+.|+++.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 00000000 0000111124577799999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=283.09 Aligned_cols=268 Identities=24% Similarity=0.279 Sum_probs=209.2
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCceEEEeeeeec--CCeeEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIISTCSN--DDFKALV 117 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 117 (335)
+.|..++.|++|+||.||+|+++ +++-||+|.++.+.. ..--.-.+|+.+|.+++|||||.+-++... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 57889999999999999999755 689999999987643 233456789999999999999999998764 4679999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||++. +|.+++.....++...++..+..|++.|+.||| +..|+|+|||++|+|++..|.+|++|||+|+.++ .
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg--s 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG--S 229 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhc--C
Confidence 999955 999999888789999999999999999999999 9999999999999999999999999999999885 3
Q ss_pred cccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh-------HHH
Q 019843 198 QSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS-------VME 269 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~ 269 (335)
........+.|.+|.|||++.+. .|+++.|+||+||++.||+++.+.|.+.++-+.....+..--.|.. ...
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 34556778899999999998874 6999999999999999999999999876543332221111000000 000
Q ss_pred HHHhh-----hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 270 IVDAN-----LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 270 ~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..... .......++... .+++.-.+|+..+|..||.+|.|++|.|..
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~-~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGAL-SLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhcccc-ccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00000 000000111111 145778999999999999999999998864
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=286.58 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=205.2
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|.+.+.||+|++|.||+|..+ +++.|++|.+... .......+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5788999999999999999765 5889999998754 234567788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+++++|.+++... ...+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~ 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--T 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--c
Confidence 9999999998764 457899999999999999999999 999999999999999999999999999998865322 1
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......++..|+|||+..+..++.++|+||||+++|+|++|..||........ ........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------------~~~~~~~~- 217 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL-----------------ILKIIRGV- 217 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHHcCC-
Confidence 122334578889999999988899999999999999999999999976432111 11110000
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
....+..++..+.+++.+||+.+|++||++.++++.
T Consensus 218 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 --FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 011122456679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=297.80 Aligned_cols=241 Identities=23% Similarity=0.301 Sum_probs=192.9
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|... +++.||+|++.... ......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999765 58899999987532 22334556677777654 899999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGKAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC--CCccc
Confidence 99999887654 6899999999999999999999 999999999999999999999999999998754211 12333
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...|+..|+|||++.+..++.++|||||||++|+|++|..||......+. ....... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-----------------~~~i~~~----~~ 213 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-----------------FDSILND----RP 213 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHHcC----CC
Confidence 45689999999999998999999999999999999999999976432111 1110000 11
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCHH-HHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINAK-EIVT 316 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~ 316 (335)
..+..++.++.+++.+||+.||.+||++. +++.
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11233566799999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=293.98 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=202.4
Q ss_pred cCCCCccceeeecCceEEEEEEEcC---------------CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD---------------GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKII 105 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~---------------~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 105 (335)
.++|++.+.||+|+||.||++.... ...|++|.+.... ......+.+|+++++.++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3689999999999999999986432 2348999987542 33446788999999999999999999
Q ss_pred eeeecCCeeEEEEEecCCCChHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCE
Q 019843 106 STCSNDDFKALVLEYMPHGSLEKCLYSSN-----------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNV 174 (335)
Q Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Ni 174 (335)
+++...+..++||||+++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence 99999999999999999999999986431 13688899999999999999999 99999999999999
Q ss_pred EECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCcccccc
Q 019843 175 LLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--KKKPTDKIFAGE 252 (335)
Q Consensus 175 lv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~--g~~pf~~~~~~~ 252 (335)
+++.++.++|+|||++..+.............++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999876532222222333445678999999988889999999999999999988 667776543211
Q ss_pred hhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 253 MTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
... . ......... .......+..+++.+.+++.+||+.||++|||+.+|++.|.
T Consensus 241 ~~~-~---------~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIE-N---------TGEFFRNQG---RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHH-H---------HHHhhhhcc---ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 100 0 000000000 00001112234567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=293.21 Aligned_cols=262 Identities=24% Similarity=0.381 Sum_probs=206.3
Q ss_pred cCCCCccceeeecCceEEEEEEEcC-----------------CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD-----------------GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIK 103 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~-----------------~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~ 103 (335)
.++|++++.||+|+||.||+|.... +..|++|.+.... ......+.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999987542 2458999987553 334577889999999999999999
Q ss_pred EeeeeecCCeeEEEEEecCCCChHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCC
Q 019843 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSN----------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSN 173 (335)
Q Consensus 104 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~N 173 (335)
+++++...+..++++|++++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999999986543 26899999999999999999999 9999999999999
Q ss_pred EEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCccccc
Q 019843 174 VLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--KKKPTDKIFAG 251 (335)
Q Consensus 174 ilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~--g~~pf~~~~~~ 251 (335)
|+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876543332333344556778999999988889999999999999999998 67777653321
Q ss_pred chhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 252 EMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.. . ..................+..++.++.+++.+||+.||++|||+.||+..|+
T Consensus 241 ~~-~------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QV-I------------ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH-H------------HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11 0 0000000000011111122345677999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=294.54 Aligned_cols=255 Identities=24% Similarity=0.422 Sum_probs=205.1
Q ss_pred CCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
.+|++.+.||.|+||.||+|... .+..|++|++..... .....+..|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45888999999999999999753 247799999875533 23466889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC
Q 019843 116 LVLEYMPHGSLEKCLYSS---------------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~ 180 (335)
++++|+.+++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence 999999999999998532 225788889999999999999999 99999999999999999999
Q ss_pred cEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHh
Q 019843 181 VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWV 259 (335)
Q Consensus 181 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~ 259 (335)
.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------- 233 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999999999876532222222334456778999999988889999999999999999998 88887653221
Q ss_pred hhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 260 SNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
.+.+...... ....+..++..+.+++.+||+.+|.+||++++|+.+|+.
T Consensus 234 ---------~~~~~i~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 ---------DVIEMIRNRQ---VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---------HHHHHHHcCC---cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111111111 111234567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.00 Aligned_cols=241 Identities=22% Similarity=0.264 Sum_probs=195.4
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
+|.+.+.||+|+||.||+|... +++.||+|++.... ......+..|..++..+ +|++|+.+++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999765 57899999987542 22334566788888777 5899999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+.+.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..... .
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--D 154 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--C
Confidence 9999999999887654 6899999999999999999999 99999999999999999999999999999874321 1
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||......... ..+...
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~-------------~~i~~~----- 216 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-------------QSIMEH----- 216 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH-------------HHHHhC-----
Confidence 12233456899999999999999999999999999999999999999764321110 011110
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINA 311 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 311 (335)
....+..++.++.+++.+||+.||.+|++.
T Consensus 217 ---~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 ---NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 011123456779999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=290.64 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=202.6
Q ss_pred CCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 45 FSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
|++.+.||.|++|.||+|... ++..+++|.+..........+.+|+++++.++|+|++++++.+...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 788899999999999999765 4778899988765555567788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+++.....++++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||++..... ......
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccc--cccccc
Confidence 9999988765557999999999999999999999 99999999999999999999999999999875431 122233
Q ss_pred cccccccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 204 QTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
...++..|+|||++. +..++.++|+||+|+++|+|++|..||........... ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-------------~~~~----- 223 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK-------------IAKS----- 223 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH-------------Hhhc-----
Confidence 456888999999874 34578899999999999999999999876432111110 0000
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.......+..++..+.+++.+||+.||.+||++.+++..
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 224 EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111223456679999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=293.29 Aligned_cols=262 Identities=24% Similarity=0.407 Sum_probs=204.0
Q ss_pred cCCCCccceeeecCceEEEEEEEc-----------------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-----------------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIK 103 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-----------------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~ 103 (335)
.++|++.+.||+|+||.||++... ++..+++|++.... ......+.+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 367999999999999999998532 23468999987543 334567889999999999999999
Q ss_pred EeeeeecCCeeEEEEEecCCCChHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCC
Q 019843 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSN----------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSN 173 (335)
Q Consensus 104 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~N 173 (335)
+++++...+..+++|||+++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence 9999999999999999999999999987532 24677889999999999999999 9999999999999
Q ss_pred EEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCccccc
Q 019843 174 VLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--KKKPTDKIFAG 251 (335)
Q Consensus 174 ilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~--g~~pf~~~~~~ 251 (335)
|+++.++.++|+|||++..+.........+....+..|+|||...++.++.++|+||||+++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999876532222222233345678999999888889999999999999999998 77888654322
Q ss_pred chhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 252 EMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
+... .......... .....+.+..+++.+.+++.+||+.||.+||++.+|++.|+
T Consensus 241 ~~~~----------~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIE----------NTGEFFRDQG---RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHH----------HHHHHHhhcc---ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 2110 0000111000 00111122345677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=292.30 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=207.9
Q ss_pred hcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
...+|++.+.||.|++|.||+|.. .+++.|++|.+..........+.+|+.+++.++|+|++++++.+...+..++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 445799999999999999999975 4689999999976655566788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++++|.+++... .+++.++..++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 169 (296)
T cd06655 97 YLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-- 169 (296)
T ss_pred ecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--
Confidence 99999999988654 5899999999999999999999 9999999999999999999999999999987653221
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .+.. ..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~--------------~~~~----~~ 231 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------------LIAT----NG 231 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--------------HHHh----cC
Confidence 12233467889999999998889999999999999999999999997643211110 0000 01
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
......+..+++.+.++|.+||..||.+||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 232 TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11112233456779999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=289.35 Aligned_cols=254 Identities=25% Similarity=0.428 Sum_probs=199.0
Q ss_pred CCccceeeecCceEEEEEEEcC-Cc--EEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeec------CCe
Q 019843 45 FSENNLIGRGSFGSVYKARIQD-GM--EVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN------DDF 113 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~~-~~--~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~ 113 (335)
+.+.+.||+|+||.||+|.+.. +. .+++|.++.. .......+..|+++++.++|+||+++++.+.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4678999999999999998654 32 5899987654 23445778899999999999999999997643 235
Q ss_pred eEEEEEecCCCChHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 114 KALVLEYMPHGSLEKCLYS-----SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
.+++++|+++++|.+++.. ....+++..+..++.+++.||.||| +++++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988742 2345889999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhH
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
++..+..............+..|+|||...+..++.++|+||||+++|+|++ |..||........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------------- 223 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI-------------- 223 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--------------
Confidence 9887643222122223345678999999999899999999999999999999 7889865322111
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
...+... .....+..+++.+.+++.+||+.||++|||+.++++.|+++
T Consensus 224 ~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 224 YDYLRQG------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHcC------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111110 01111234566799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.85 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=207.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCC
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDD 112 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 112 (335)
..++|.+.+.||+|+||.||+|... .+..+++|++.... ....+.+.+|+.+++++ +|+||+++++.+...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3468999999999999999999642 24579999886543 33456788999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
..+++|||+.+++|.+++.... ..+++.++..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||++.
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999987543 34899999999999999999999 9999999999999999999999999999987
Q ss_pred cccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 192 LLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
...............++..|+|||.+.+..++.++||||+|+++|+|++ |..||........ ....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-------------~~~~ 256 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-------------FYKL 256 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-------------HHHH
Confidence 6532221122223345678999999998899999999999999999998 9999865432111 1111
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
+.... ....+...++.+.+++.+||+.+|++||++.|+++.|.++
T Consensus 257 ~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGY------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCC------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111 0111223356799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=291.16 Aligned_cols=245 Identities=22% Similarity=0.296 Sum_probs=196.2
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCCh
Q 019843 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL 126 (335)
Q Consensus 51 lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 126 (335)
||+|+||+||++... +++.+|+|++.... ......+..|+++++.++|+||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999755 58899999986432 22345677899999999999999999999999999999999999999
Q ss_pred HHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 127 EKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 127 ~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
.+.+.. ....+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+.... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 887743 3346899999999999999999999 9999999999999999999999999999987653211 1223
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .......... ..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-------------~~~~~~~~~~----~~ 218 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-------------KELKQRILND----SV 218 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-------------HHHHHhhccc----CC
Confidence 356889999999999999999999999999999999999999753321110 1111111110 11
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
..+..++..+.+++.+||+.||++|| +++++++.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 12234577799999999999999999 77888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=302.60 Aligned_cols=260 Identities=22% Similarity=0.276 Sum_probs=204.8
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD 112 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 112 (335)
+.....++|++.+.||+|+||.||+|..+ +++.+|+|++... .......+.+|..+++.++||||+++++.+.+.+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445689999999999999999999765 5889999998642 2233456788999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
..++||||+++++|.+++... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 999999999999999988754 4889999999999999999999 99999999999999999999999999999986
Q ss_pred ccCCccccccccccccccccCccccCCCC----CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......
T Consensus 192 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---------------- 254 (371)
T cd05622 192 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---------------- 254 (371)
T ss_pred cCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH----------------
Confidence 53221 11223456899999999987543 7889999999999999999999997543211
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhcccc--CCCHHHHHHHHH
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQ--RINAKEIVTRLL 319 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~L~ 319 (335)
.............++....++..+.++|.+||..++.+ |++++++++...
T Consensus 255 -~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 255 -TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred -HHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 11111111111112223345777999999999844433 789999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=300.31 Aligned_cols=269 Identities=23% Similarity=0.225 Sum_probs=201.2
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecC-----
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSND----- 111 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 111 (335)
...++|++.+.||.|+||.||+|... +|..||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 56689999999999999999999764 5899999998643 233456788999999999999999999988644
Q ss_pred -CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 112 -DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 112 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
...++||||+++ ++.+.+.. .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 357899999965 66665532 4788999999999999999999 999999999999999999999999999998
Q ss_pred ccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh----
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS---- 266 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 266 (335)
..... ........++..|+|||++.+..++.++||||||+++|+|++|..||....... .............
T Consensus 171 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 171 RTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHH
Confidence 75421 222334567899999999999999999999999999999999999997643211 1111111111000
Q ss_pred ------HHHHHHhhh-cccc-----------ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 267 ------VMEIVDANL-LSRE-----------DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 267 ------~~~~~~~~~-~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
......... .... ..........++.+.+|+.+||..||++|||+.|++..-+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 000000000 0000 0000011123566899999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.01 Aligned_cols=256 Identities=23% Similarity=0.449 Sum_probs=205.7
Q ss_pred CCCCccceeeecCceEEEEEEEcC-C---cEEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQD-G---MEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~-~---~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
+.|++.+.||.|+||.||+|.... + ..|++|.+... .......+..|+.+++.++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 468899999999999999997542 3 36999998754 333457899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
+||+++++|.+++....+.+++..++.++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999876667899999999999999999999 9999999999999999999999999999987653221
Q ss_pred ccccccc-c--cccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 198 QSKSQTQ-T--LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 198 ~~~~~~~-~--~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
....... . ..+..|+|||.+.+..++.++|+||||+++|++++ |..||........ ...+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~--------------~~~i~~ 226 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--------------INAIEQ 226 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH--------------HHHHHc
Confidence 1111111 1 12357999999998899999999999999999886 9999865432111 111110
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
....+.+..++..+.+++.+||+.+|.+||+++++++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 ------DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011122334567799999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.69 Aligned_cols=242 Identities=23% Similarity=0.279 Sum_probs=196.7
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||.|+||.||+|... +++.||+|++... .......+..|.+++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999765 5789999998753 233456677888999888 799999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+.+.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~--~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI--LGGVTTS 154 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecC--cCCCccc
Confidence 99999887654 7999999999999999999999 9999999999999999999999999999886421 1112223
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...++..|+|||++.+..++.++|+|||||++|+|++|..||......... ..+... ..
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-------------~~i~~~--------~~ 213 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-------------QSILED--------EV 213 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-------------HHHHcC--------CC
Confidence 346889999999999999999999999999999999999999754321110 001100 11
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCH-----HHHHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINA-----KEIVTR 317 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~~ 317 (335)
..+..+++.+.+++.+||..||.+||++ .++++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1123456779999999999999999999 777754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=301.02 Aligned_cols=239 Identities=24% Similarity=0.319 Sum_probs=194.1
Q ss_pred cceeeecCceEEEEEEE----cCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 48 NNLIGRGSFGSVYKARI----QDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~----~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
++.||+|+||.||++.. .+|+.+|+|++.... ......+..|++++++++||||+++++++...+..++||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999864 357899999987542 223356778999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
++++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 81 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~ 154 (318)
T cd05582 81 RGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKK 154 (318)
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCc
Confidence 9999999887554 6899999999999999999999 999999999999999999999999999998754211 122
Q ss_pred cccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccccc
Q 019843 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (335)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||........ .......
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-----------------~~~i~~~---- 213 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-----------------MTMILKA---- 213 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-----------------HHHHHcC----
Confidence 3345689999999999988899999999999999999999999976432111 1110000
Q ss_pred chhhHHHHHHHHHHHHHHhchhccccCCCHHH
Q 019843 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKE 313 (335)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 313 (335)
....+..+++.+.+++.+||+.||.+||++.+
T Consensus 214 ~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 214 KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11122345677999999999999999999444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=286.58 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=203.4
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|.+.+.||.|++|.||+|....+..+++|.+.... ...+.+.+|+++++.++|+|++++++++.. +..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 36799999999999999999988777789999876443 234678899999999999999999998754 5678999999
Q ss_pred CCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++++|.+++... ...+++..+..++.+++.||.||| +.+++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~ 158 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YT 158 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-cc
Confidence 999999999754 335889999999999999999999 9999999999999999999999999999997653221 11
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.. ..+...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~--------------~~~~~~----- 219 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL--------------EQVERG----- 219 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--------------HHHHcC-----
Confidence 2222345677999999988889999999999999999999 89998754321110 000000
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
.....+...+..+.+++.+||+.||.+||+++++++.|++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 -YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011123456779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=288.81 Aligned_cols=257 Identities=24% Similarity=0.441 Sum_probs=206.8
Q ss_pred cCCCCccceeeecCceEEEEEEEc----CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.++|++.+.||.|+||.||+|... .+..+++|.+.... ......+.+|+.+++.++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 367899999999999999999753 23478999886542 3345678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+++++|.+++......+++..++.++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++..+...
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999876667899999999999999999999 999999999999999999999999999998865322
Q ss_pred cccc-ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 197 DQSK-SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 197 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
.... .......+..|+|||.+.+..++.++|+||||+++|++++ |..||......+.. ..+.+.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~-------------~~~~~~- 225 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-------------KAIEEG- 225 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH-------------HHHhCC-
Confidence 1111 1111223567999999998889999999999999999886 99998764321110 011100
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
...+.+..+++.+.+++.+||+.+|.+||++.++++.|.++
T Consensus 226 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01111234567799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=288.47 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=203.6
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.++|.+.+.||.|++|.||.|... +++.|++|++..........+.+|+.+++.++||||+++++.+...+..++++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 468999999999999999999754 5889999998876555556788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++++|.+++.... .+++..++.++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~~ 161 (267)
T cd06645 88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIA 161 (267)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--ccc
Confidence 99999999887554 7899999999999999999999 99999999999999999999999999999876531 122
Q ss_pred ccccccccccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 201 SQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
......++..|+|||.+. +..++.++|+||||+++|+|++|..||........... .......
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~-------------~~~~~~~- 227 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------------MTKSNFQ- 227 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh-------------hhccCCC-
Confidence 233456889999999874 45688999999999999999999999865332111100 0000000
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.........++..+.+++.+||+.||++||++++++.
T Consensus 228 --~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 --PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000111124556899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=295.04 Aligned_cols=261 Identities=28% Similarity=0.439 Sum_probs=206.9
Q ss_pred cCCCCccceeeecCceEEEEEEEc--------CCcEEEEEEeecC-CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecC
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ--------DGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSND 111 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 111 (335)
.++|.+.+.||+|++|.||+|... ....+++|.+... .......+..|+++++.+ .||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 368899999999999999999642 2456899987643 233456788999999999 699999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL 176 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv 176 (335)
+..++++||+++++|.+++.... ..+++..+..++.+++.||.||| +.+++|+||+|+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence 99999999999999999986532 35888999999999999999999 9999999999999999
Q ss_pred CCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhh
Q 019843 177 DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTL 255 (335)
Q Consensus 177 ~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 255 (335)
+.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-- 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-- 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999976532221111222234457999999988889999999999999999999 8888865322111
Q ss_pred HhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 256 KYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
...+... .....+..++..+.+++.+||+.||++||++.++++.|.++....
T Consensus 246 ------------~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 246 ------------FKLLREG------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ------------HHHHHcC------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111110 011112345667999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=286.55 Aligned_cols=249 Identities=31% Similarity=0.471 Sum_probs=201.7
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeee-cCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS-NDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~ 120 (335)
.++|.+.+.||+|++|.||+|... +..+++|.+..+. ..+.+.+|+.+++.++|+|++++++++. ..+..++++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 358999999999999999999766 7889999886443 3467889999999999999999999754 56678999999
Q ss_pred cCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+++++|.+++.... ..+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~---- 154 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---- 154 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccc----
Confidence 99999999987643 35889999999999999999999 99999999999999999999999999999875421
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......+..|+|||++.+..++.++|+||||+++|+|++ |..||........ ...+....
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~--------------~~~~~~~~--- 216 (256)
T cd05082 155 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--------------VPRVEKGY--- 216 (256)
T ss_pred -cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHhcCC---
Confidence 1122334567999999998889999999999999999997 9999864321110 01111110
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
....+..+++.+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 217 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 ---KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1111234567799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=284.73 Aligned_cols=247 Identities=29% Similarity=0.453 Sum_probs=199.9
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCChH
Q 019843 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLE 127 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 127 (335)
++||+|++|.||+|...++..+++|.+..... .....+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47899999999999877789999999875432 33457889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccccccc
Q 019843 128 KCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207 (335)
Q Consensus 128 ~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~ 207 (335)
+++......+++..++.++.+++.+|.++| +.+++|+||+|+||+++.++.++|+|||++...... .........+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccc-ccccCCCCCC
Confidence 998766557899999999999999999999 999999999999999999999999999998754211 1111222234
Q ss_pred cccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhH
Q 019843 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286 (335)
Q Consensus 208 ~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (335)
+..|+|||++.+..++.++|+||||+++|++++ |..||......... ..+.... ....+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~--------------~~~~~~~------~~~~~ 216 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR--------------EQVEKGY------RMSCP 216 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH--------------HHHHcCC------CCCCC
Confidence 567999999988889999999999999999998 99998654221110 1111110 11112
Q ss_pred HHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 287 EQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 287 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
..++..+.+++.+||+.+|++||++.|+++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 234667999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=290.19 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=205.6
Q ss_pred cCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
.++|++.+.||.|+||.||+|... ++..|++|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 468999999999999999999754 24679999986442 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEe
Q 019843 115 ALVLEYMPHGSLEKCLYSSN---------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 185 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~ 185 (335)
++||||+++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999986431 24678899999999999999999 9999999999999999999999999
Q ss_pred eccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcC
Q 019843 186 DFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLP 264 (335)
Q Consensus 186 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 264 (335)
|||++..+.............++..|+|||.+.+..++.++||||||+++|++++ |..||......+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~----------- 230 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV----------- 230 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-----------
Confidence 9999876543322223334456788999999988889999999999999999998 8999865322111
Q ss_pred hhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 265 ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...+.. ......+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 231 ---~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 231 ---LKFVID------GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---HHHHhc------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111 0111122334677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=289.67 Aligned_cols=271 Identities=23% Similarity=0.395 Sum_probs=206.9
Q ss_pred CCCCccceeeecCceEEEEEEE-----cCCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecC--Cee
Q 019843 43 DGFSENNLIGRGSFGSVYKARI-----QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSND--DFK 114 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 114 (335)
.-|++.+.||+|+||.||.+.. .++..|++|.+.... ......+.+|+++++.+.|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578999999999999999963 347889999987553 33456789999999999999999999988765 678
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++||||+++++|.+++.+....+++..++.++.+++.||.||| +++++|+||+|+||+++.++.++|+|||++..+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 8999999999999999766557899999999999999999999 9999999999999999999999999999988653
Q ss_pred CCccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 195 GEDQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 195 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
..... .......++..|+|||.+.+..++.++||||||+++|+|+++..|+.......... ................
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKM--IGPTHGQMTVTRLVRV 238 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhh--cccccccccHHHHHHH
Confidence 22211 11223446677999999988889999999999999999999887654321111000 0000000001111111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
.. .....+.+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus 239 ~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LE---EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH---cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 10 0111222334677899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=289.11 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=194.9
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCCh
Q 019843 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL 126 (335)
Q Consensus 51 lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 126 (335)
||+|+||.||++..+ +|+.+++|.+.... ......+..|+++++.++||||+++++.+......++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999755 58999999986421 12234556799999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccccc
Q 019843 127 EKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQT 205 (335)
Q Consensus 127 ~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~ 205 (335)
.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence 9887643 336889999999999999999999 999999999999999999999999999998765321 122335
Q ss_pred cccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhh
Q 019843 206 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAA 285 (335)
Q Consensus 206 ~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (335)
.++..|+|||++.+..++.++|+||+||++|+|++|..||......... ............ .. .
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~~--~~-~ 218 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-------------EELKRRTLEDEV--KF-E 218 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-------------HHHHHHhhcccc--cc-c
Confidence 6888999999999888999999999999999999999998754321111 111111111110 00 1
Q ss_pred HHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 286 KEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 286 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...+++++.+++.+||+.||++||+++|+++.+.
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 1245677999999999999999999977664443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=302.40 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=200.7
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++.+.||+|+||.||+|... +++.||+|++... .......+..|+.++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999765 5899999998643 2344567888999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||++|++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999987654 6899999999999999999999 99999999999999999999999999999875421100
Q ss_pred c---------------------------------cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 019843 199 S---------------------------------KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPT 245 (335)
Q Consensus 199 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf 245 (335)
. .......||+.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011346899999999999999999999999999999999999999
Q ss_pred CcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCC---HHHHHHH
Q 019843 246 DKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN---AKEIVTR 317 (335)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 317 (335)
......... ..+... .....++....+++++.++|.+++. ||.+|++ ++|+++.
T Consensus 237 ~~~~~~~~~-------------~~i~~~----~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQETY-------------RKVMNW----KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHHHH-------------HHHHcC----CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 764322111 111110 0011111112246679999999874 9999985 6676654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=294.01 Aligned_cols=259 Identities=28% Similarity=0.449 Sum_probs=203.7
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCc--EEEEEEeecC-CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGM--EVAVKVFHLQ-CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~--~v~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 116 (335)
.++|++.+.||+|+||.||+|.+. ++. .+++|.+... .......+.+|++++.++ +|+||+++++++...+.+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 368999999999999999999764 344 3577766532 233456788899999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc
Q 019843 117 VLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~ 181 (335)
|+||+++++|.+++.... ..+++..++.++.+++.|+.||| +.+++|+||+|+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 999999999999986432 25789999999999999999999 999999999999999999999
Q ss_pred EEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhh
Q 019843 182 AHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVS 260 (335)
Q Consensus 182 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~ 260 (335)
++|+|||++.... ..........+..|+|||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus 163 ~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------- 232 (303)
T cd05088 163 AKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------- 232 (303)
T ss_pred EEeCccccCcccc---hhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-------
Confidence 9999999986321 1111122234567999999988889999999999999999998 9999865332111
Q ss_pred hhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 261 NLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
.+.... ......+..+++.+.+++.+||+.+|++||++.+++..|..+...-.
T Consensus 233 ----------~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 233 ----------YEKLPQ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ----------HHHHhc---CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 111000 00111122346679999999999999999999999999998755433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=292.61 Aligned_cols=269 Identities=21% Similarity=0.292 Sum_probs=204.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
-++|.+.+.||.|++|.||+|... +++.|++|.+.... ......+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 478999999999999999999765 58899999987543 2334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|++ ++|.+++......+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...... .
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--T 158 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--C
Confidence 996 5898888776667899999999999999999999 999999999999999999999999999998754211 1
Q ss_pred cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc---ChhHHHHHHhhh
Q 019843 200 KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL---PISVMEIVDANL 275 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 275 (335)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||......+. ......... +.....+.....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhcccc
Confidence 12233456888999998765 4578899999999999999999999976543211 111111110 000000110000
Q ss_pred c-----ccccc-c-hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 276 L-----SREDK-H-FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 276 ~-----~~~~~-~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. ..... . ......+++.+.+||.+||+.||.+|||++|++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 00000 0 01112456779999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=286.80 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=207.9
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.+.|+..+.||.|.-|+||++... ++..+|+|++..+ ......+...|-+||..+.||.++.+|+.|+.....|++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 457889999999999999999865 4689999999754 234456778899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 118 LEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+||+|..+++++ .+.+++..+..++.+++-||+||| ..||++|||||+||||-++|++.|+||.++....-.
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999988765 457999999999999999999999 999999999999999999999999999987543210
Q ss_pred -------c------------------------c-c----------------------cccccccccccccCccccCCCCC
Q 019843 197 -------D------------------------Q-S----------------------KSQTQTLATIGYMAPEYGREGRV 222 (335)
Q Consensus 197 -------~------------------------~-~----------------------~~~~~~~~~~~y~aPE~~~~~~~ 222 (335)
. . . ......+||-.|+|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0 01123468999999999999999
Q ss_pred CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhch
Q 019843 223 STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTV 302 (335)
Q Consensus 223 ~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 302 (335)
+.+.|+|+||+++|||+.|..||.+....+.-. +++.+. ..++.....+..+++||+++|.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~-------------NIv~~~------l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR-------------NIVGQP------LKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH-------------HHhcCC------CcCCCCCcchhHHHHHHHHHhc
Confidence 999999999999999999999999875443322 222221 1222223556779999999999
Q ss_pred hccccCCC----HHHHHH
Q 019843 303 ESAEQRIN----AKEIVT 316 (335)
Q Consensus 303 ~dP~~Rps----~~ell~ 316 (335)
.||++|.. +.||-+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999987 666643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=303.23 Aligned_cols=260 Identities=25% Similarity=0.380 Sum_probs=214.5
Q ss_pred CCCCccceeeecCceEEEEEEEcC--C---cEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQD--G---MEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~--~---~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
++-.+.++||+|+||.||.|..+. + .+||+|....+ ..+...++.+|++++++++||||++++|+......+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 455567999999999999997542 2 23899998753 356678899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++|||+|.||+|.++|.+..+.++..+...++.+.+.||.||| +++++||||-..|+|++.++.+||+|||++..-.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999999999988778999999999999999999999 9999999999999999999999999999987431
Q ss_pred CCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
..............|+|||.+....++.++||||||+++||+++ |..||.+....+. ...+.
T Consensus 314 --~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v--------------~~kI~- 376 (474)
T KOG0194|consen 314 --QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV--------------KAKIV- 376 (474)
T ss_pred --ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH--------------HHHHH-
Confidence 11222222346788999999999999999999999999999999 8889877543211 11111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
....+...+...|.++..++.+|+..||+.||++.++.+.|..+.....
T Consensus 377 ----~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 377 ----KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ----hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1122223334567889999999999999999999999999998876544
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=285.32 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=204.8
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
..+|++.+.||.|++|.||+|.+.++..+++|.+..... ....+..|+++++.++|||++++++++......++++||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 357899999999999999999887788999998864322 3367889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
++++|.+++......+++..++.++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 157 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTS 157 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-ccc
Confidence 999999998766557899999999999999999999 9999999999999999999999999999987653221 111
Q ss_pred cccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......... ..+...
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~--------------~~~~~~------ 217 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV--------------ETINAG------ 217 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH--------------HHHhCC------
Confidence 222334578999999988889999999999999999998 99998653321110 000000
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
.....+...++.+.+++.+||+.+|++||++.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 218 FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00011122356799999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=291.53 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=208.5
Q ss_pred hhhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
....++|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+|++++++.+...+..++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 34558999999999999999999985 46899999999866555567788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+++++|.+++... .+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~- 168 (297)
T cd06656 95 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 168 (297)
T ss_pred ecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCC-
Confidence 9999999999988654 4889999999999999999999 999999999999999999999999999998765321
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
........++..|+|||.+.+..++.++|+||||+++|++++|..||............ ..
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------------------~~ 229 (297)
T cd06656 169 -QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------------AT 229 (297)
T ss_pred -ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------------------cc
Confidence 11223346788899999999888999999999999999999999999764321111000 00
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
........+..++..+.+++.+||..||++||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111123345667999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=285.74 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=203.3
Q ss_pred CCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC------CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC------GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
+|++.+.||.|+||.||+|...+++.+++|.+.... ......+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 589999999999999999988788999999987542 12345688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
+||+++++|.+++.+.. .+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999987654 6889999999999999999999 9999999999999999999999999999987542111
Q ss_pred ----cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 198 ----QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 198 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
.........++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-------------~~~~- 222 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-------------YIGA- 222 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-------------Hhhh-
Confidence 1111223457888999999998889999999999999999999999997532111100 0000
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.. ......+..++..+.+++.+||+.+|.+||++.++++
T Consensus 223 --~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 --HR--GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --cc--CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0001112345677999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=297.24 Aligned_cols=237 Identities=29% Similarity=0.339 Sum_probs=189.6
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHH-HHHhCCCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECE-VMKSIRHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|... +++.||+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999765 68999999987432 222234444444 56778999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~--~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI--EHSKTTS 154 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccc--cCCCccc
Confidence 99999887644 7899999999999999999999 9999999999999999999999999999986432 1122233
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...|+..|+|||++.+..++.++|||||||++|+|++|..||......+ ..+...... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----------------~~~~i~~~~----~ 213 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-----------------MYDNILNKP----L 213 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-----------------HHHHHHcCC----C
Confidence 4568999999999999999999999999999999999999997643211 111111111 1
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINAK 312 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 312 (335)
..+...+..+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11223466799999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=295.82 Aligned_cols=240 Identities=22% Similarity=0.296 Sum_probs=192.9
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|..+ +++.||+|++.... .........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999765 58899999987532 23345667788888765 899999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~--~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV--FGDNRAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecc--cCCCcee
Confidence 99999887653 6899999999999999999999 9999999999999999999999999999986431 1112233
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...|+..|+|||++.+..++.++||||||+++|+|++|..||........ ........ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-----------------~~~~~~~~----~ 213 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-----------------FESIRVDT----P 213 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHHhCC----C
Confidence 45689999999999999999999999999999999999999975432111 11000000 0
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCHH-HHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINAK-EIV 315 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell 315 (335)
..+..++.++.+++.+||+.||++||++. +++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11223466799999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=292.90 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=207.0
Q ss_pred hcCCCCccceeeecCceEEEEEEEc--------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeec
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ--------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSN 110 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 110 (335)
..++|.+.+.||+|+||.||.|... ++..+++|...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3578999999999999999999631 24578999886442 33457789999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEE
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVL 175 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nil 175 (335)
....+++|||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence 999999999999999999987531 24788889999999999999999 999999999999999
Q ss_pred ECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchh
Q 019843 176 LDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMT 254 (335)
Q Consensus 176 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~ 254 (335)
++.++.++|+|||.+..+.............++..|+|||++.+..++.++||||||+++|+|++ |..||......+.
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~- 248 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 248 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-
Confidence 99999999999999886632222222223345677999999988889999999999999999998 7888765321111
Q ss_pred hHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 255 LKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
...+... .....+..++..+.+++.+||+.+|.+||++.|+++.|.++..
T Consensus 249 -------------~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 249 -------------FKLLKEG------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred -------------HHHHHcC------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 0111110 0111123456779999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=289.33 Aligned_cols=268 Identities=25% Similarity=0.280 Sum_probs=202.1
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|.+.+.||.|++|.||+|... +|+.+++|.+.... ......+.+|+++++.++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5889999999999999999765 58999999987542 22345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++ ++|.+++......+++..++.++.||++||.||| +.+++|+||+|+||+++.++.++|+|||++..+... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VR 154 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CC
Confidence 96 5888887765567999999999999999999999 999999999999999999999999999998765311 12
Q ss_pred ccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH------HHh
Q 019843 201 SQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI------VDA 273 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 273 (335)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||....+...................+ .+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 22334568889999988764 47899999999999999999998865433322222221111111111000 000
Q ss_pred hhccccccc---hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 274 NLLSREDKH---FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 274 ~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
......... ......+++++.+++.+||+.||.+|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000000 01112356779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=286.90 Aligned_cols=257 Identities=25% Similarity=0.464 Sum_probs=206.1
Q ss_pred cCCCCccceeeecCceEEEEEEEcC-C---cEEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD-G---MEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~-~---~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.++|+..+.||+|++|.||+|.... + ..+++|.+... .....+.+..|+++++.++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578899999999999999997642 3 36899988654 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+++++|.+++......+++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999776567899999999999999999999 999999999999999999999999999998765321
Q ss_pred ccccc-cccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 197 DQSKS-QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 197 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
..... ......+..|+|||++.+..++.++|+||||+++|+|++ |..||....... ....+...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--------------~~~~i~~~ 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--------------VMKAINDG 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--------------HHHHHhcC
Confidence 11111 111223457999999988889999999999999999997 999986532211 01111111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
...+....++..+.+++.+||+.+|++||++.++++.|.++
T Consensus 227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111234567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=295.38 Aligned_cols=241 Identities=23% Similarity=0.320 Sum_probs=193.0
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|... +++.||+|++.... .........|..++... +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999765 47899999987541 23345566777888764 899999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTC 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCcee
Confidence 99999887643 6899999999999999999999 99999999999999999999999999999874311 111223
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...++..|+|||++.+..++.++|+||+||++|+|++|..||......+. ........ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-----------------~~~i~~~~----~ 213 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-----------------FQSIRMDN----P 213 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHHhCC----C
Confidence 45689999999999998999999999999999999999999976432111 11100000 0
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCHH-HHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINAK-EIVT 316 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~ 316 (335)
..+..++.++.+++.+||+.||++||++. +++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01123456699999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=302.89 Aligned_cols=267 Identities=22% Similarity=0.215 Sum_probs=202.6
Q ss_pred hcCCCCccceeeecCceEEEEEEEc---CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ---DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
...+|.+.+.||.|++|.||++... .+..|++|.+... ....+|+++++.++||||+++++.+......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3457999999999999999999643 3678999987643 3456799999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|+++. ++|.+++... ..+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 165 ~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 165 MPKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred ehhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 99984 6888888543 47999999999999999999999 9999999999999999999999999999997664333
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccc--hhhHhHhhhhc------Ch-hHH
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE--MTLKYWVSNLL------PI-SVM 268 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~--~~~~~~~~~~~------~~-~~~ 268 (335)
.........++..|+|||++.+..++.++|||||||++|+|++|..||....... ..+........ +. ...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 3333345678999999999999999999999999999999999999996643221 11111111100 00 000
Q ss_pred HH---HHhhhc-cc---cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 269 EI---VDANLL-SR---EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 269 ~~---~~~~~~-~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.+ ...... .. ...........+.++.++|.+||..||++|||+.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000 00 000011112345678999999999999999999999875
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=288.35 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=208.1
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCc----EEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGM----EVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
..+|++.+.||+|+||.||+|.++ +++ .+++|...... ......+.+|+.+++.++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 368899999999999999999754 233 58899876553 3345678899999999999999999999887 7888
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+++||+++++|.+++......+++..++.++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999876667999999999999999999999 99999999999999999999999999999987642
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
...........++..|+|||.+.+..++.++|+||||+++|++++ |..||......+. ...+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------------~~~~~~~ 227 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI--------------PDLLEKG 227 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH--------------HHHHhCC
Confidence 222111222223567999999988889999999999999999998 9999876432211 1111110
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
.....+..++..+.+++.+||..||+.||++.++++.|..+..+
T Consensus 228 ------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 228 ------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11111223455689999999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=290.31 Aligned_cols=259 Identities=23% Similarity=0.373 Sum_probs=204.0
Q ss_pred hcCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
..++|++.+.||+|+||.||+|..+ .+..|++|.+.... ......+.+|+.+++.++|+||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999643 24579999876442 2234567889999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEE
Q 019843 114 KALVLEYMPHGSLEKCLYSS---------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 184 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l 184 (335)
.++||||+++++|.+++... ....+...+..++.+++.||.||| +++++|+||+|+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999642 124567788999999999999999 999999999999999999999999
Q ss_pred eeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhc
Q 019843 185 SDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLL 263 (335)
Q Consensus 185 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 263 (335)
+|||++................++..|+|||.+.++.++.++|+||||+++|+|++ |..||......+..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~--------- 231 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL--------- 231 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---------
Confidence 99999876532222222223345677999999988889999999999999999998 78888653221110
Q ss_pred ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 264 PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
..+.+.. ....+..+++.+.+++.+||+.||++|||+.++++.|.+..
T Consensus 232 ----~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 ----KFVMDGG-------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ----HHHHcCC-------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0011110 01112234567999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=285.39 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=206.0
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
..++|++.+.||+|++|.||+|...++..+++|.+.... .....+.+|+++++.++|+||+++++.+.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 457899999999999999999987777889999876442 234678899999999999999999999887 778999999
Q ss_pred cCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+++++|.+++... ...+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~ 157 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y 157 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-c
Confidence 9999999999753 346788999999999999999999 9999999999999999999999999999987653221 1
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......++..|+|||.+.+..++.++|+||||+++|++++ |..||........ ...+....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--------------~~~~~~~~--- 220 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--------------IRALERGY--- 220 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH--------------HHHHhCCC---
Confidence 11222334567999999988889999999999999999998 9999875432111 11111110
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
..+.....+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 221 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 221 ---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ---CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 0111233456799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=284.14 Aligned_cols=248 Identities=27% Similarity=0.462 Sum_probs=197.7
Q ss_pred eeeecCceEEEEEEEc---CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCC
Q 019843 50 LIGRGSFGSVYKARIQ---DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGS 125 (335)
Q Consensus 50 ~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 125 (335)
.||.|+||.||+|.+. .+..|++|++..... ...+.+.+|+.++++++|+||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999653 355699999875533 334678899999999999999999998764 56789999999999
Q ss_pred hHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc-cccc
Q 019843 126 LEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK-SQTQ 204 (335)
Q Consensus 126 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~-~~~~ 204 (335)
|.+++......+++..++.++.+++.||.+|| +++++|+||+|+||+++.++.++|+|||++..+....... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999866667999999999999999999999 9999999999999999999999999999987553221111 1111
Q ss_pred ccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 205 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 205 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
..++..|+|||.+.+..++.++|+||||+++|++++ |..||....... ....+... ...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------------~~~~~~~~------~~~ 217 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--------------VMSFIEQG------KRL 217 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--------------HHHHHHCC------CCC
Confidence 223567999999988889999999999999999996 999987643211 11111111 111
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
..+..+++++.+++.+||..||++||++.+|++.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22344577899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=286.78 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=201.5
Q ss_pred CCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 43 DGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
++|.+.+.||+|++|.||+|.. .+++.|++|++.... ......+.+|++++++++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4688999999999999999975 468899999987552 33456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++++|..+. .+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+. ..
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~----~~ 148 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NS 148 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc----cc
Confidence 9999986542 4788899999999999999999 9999999999999999999999999999987653 12
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||........... + ........... .
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-------~---~~~~~~~~~~~-~ 217 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-------P---LQLLQCIVDED-P 217 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-------h---HHHHHHHhccC-C
Confidence 23345688899999999998999999999999999999999999976432221110 0 00000000000 0
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
... .....++++.+++.+||+.||.+||+++|++..-+
T Consensus 218 ~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 218 PVL-PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CCC-CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 000 01223556999999999999999999999987644
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=290.11 Aligned_cols=271 Identities=25% Similarity=0.418 Sum_probs=211.4
Q ss_pred CCCCccceeeecCceEEEEEEEc-----CCcEEEEEEeecCCCc-hhHHHHHHHHHHHhCCCCceEEEeeeeec--CCee
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-----DGMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKIISTCSN--DDFK 114 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 114 (335)
+.|++.+.||+|+||.||+|... ++..+++|++...... ....+.+|+++++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 57888999999999999999743 3688999998766443 56789999999999999999999999877 5688
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
+++|||+++++|.+++......+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999876657999999999999999999999 9999999999999999999999999999998764
Q ss_pred CCccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC-hhHHHHHH
Q 019843 195 GEDQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP-ISVMEIVD 272 (335)
Q Consensus 195 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 272 (335)
..... .......++..|+|||.+.+..++.++|+||||+++|+|++|..|+.......... ...... .....+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~ 237 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM---IGIAQGQMIVTRLLE 237 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccc---cccccccccHHHHHH
Confidence 22111 11222344566999999988889999999999999999999999986543222110 000000 01111111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
... .......+..++..+.+++.+||+.+|++||++.||++.|.+++
T Consensus 238 ~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 LLK---EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHH---cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 111 11122223445677999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=288.77 Aligned_cols=265 Identities=23% Similarity=0.297 Sum_probs=195.1
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhC---CCCceEEEeeeeec-----CC
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSI---RHRNLIKIISTCSN-----DD 112 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~ 112 (335)
+|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999765 58899999987542 22234556677777655 79999999998764 34
Q ss_pred eeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 113 FKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
..++++|++. ++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 6889999996 4888888654 335899999999999999999999 9999999999999999999999999999987
Q ss_pred cccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 192 LLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
.... ........++..|+|||++.+..++.++||||+||++|+|++|.+||.......... .............+.
T Consensus 157 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSC---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG-KIFDLIGLPPEDDWP 232 (288)
T ss_pred cccC---cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH-HHHHHhCCCChhhCc
Confidence 6531 122233567889999999988889999999999999999999999986543322111 111100000000000
Q ss_pred H------hhhccccccc-hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 272 D------ANLLSREDKH-FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 272 ~------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
. .......... ......++..+.+++.+||+.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000000000 0111235667899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=271.52 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=213.6
Q ss_pred cCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
-++|.+++.||.|.||.||+|+. +++.-||+|++... .......+.+|+++-..|+||||++++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 37899999999999999999975 45778999998644 344557889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 118 LEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
+||..+|.+...+..+ ...+++...+.+..|++.|+.|+| .++++|+||+|+|+|++..|.+|+.|||.+...
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~--- 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--- 174 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec---
Confidence 9999999999988843 346999999999999999999999 999999999999999999999999999998753
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
........+||..|.+||...+...+...|+|++|++.||++.|.+||+.....+. + .+...
T Consensus 175 -p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-Y----------------krI~k 236 (281)
T KOG0580|consen 175 -PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-Y----------------KRIRK 236 (281)
T ss_pred -CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-H----------------HHHHH
Confidence 24445567899999999999999999999999999999999999999987552222 1 11111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
.++..+..++....++|.+||..+|.+|.+..|++..-+-
T Consensus 237 ----~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 237 ----VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred ----ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 1112235567779999999999999999999999987654
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=296.10 Aligned_cols=243 Identities=22% Similarity=0.272 Sum_probs=193.6
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|... +++.||+|++... .......+..|..++.++ +||+|+.+++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999765 5788999999754 233456688899999888 699999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTS 154 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCcee
Confidence 99998886544 6999999999999999999999 99999999999999999999999999999874321 112233
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...|+..|+|||++.+..++.++|+||||+++|+|++|..||.......... ....+....... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-----------~~~~~~~~~~~~---~~ 220 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-----------TEDYLFQVILEK---PI 220 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-----------cHHHHHHHHHhC---CC
Confidence 4568999999999999999999999999999999999999997543221110 000111111111 11
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINA 311 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~ 311 (335)
..+..++..+.+++.+||+.||.+|+++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1233456679999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=284.40 Aligned_cols=247 Identities=24% Similarity=0.423 Sum_probs=197.6
Q ss_pred eeeecCceEEEEEEEc---CCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCC
Q 019843 50 LIGRGSFGSVYKARIQ---DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHG 124 (335)
Q Consensus 50 ~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 124 (335)
.||+|+||.||+|.++ ++..+++|++..... ...+.+.+|+.+++.+.|+||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999643 478899999865432 345678899999999999999999998754 4668999999999
Q ss_pred ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc-ccc
Q 019843 125 SLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK-SQT 203 (335)
Q Consensus 125 ~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~-~~~ 203 (335)
+|.+++.... .+++..+..++.|++.|+.+|| +.+++|+||+|.||+++.++.++|+|||++..+....... ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999987554 6899999999999999999999 9999999999999999999999999999988654222111 112
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccc
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKH 282 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (335)
...++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. ...+... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--------------~~~i~~~------~~ 216 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV--------------TQMIESG------ER 216 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHCC------CC
Confidence 2233578999999988889999999999999999998 9999876432111 1111111 11
Q ss_pred hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 283 FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 283 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
.+.+..+++++.++|.+||+.||++||++.+|...|++.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 222345677899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=305.36 Aligned_cols=265 Identities=24% Similarity=0.312 Sum_probs=195.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec--------C
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN--------D 111 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~ 111 (335)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+|+.+++.++||||+++++++.. .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999764 58899999885432 334579999999999999999887643 2
Q ss_pred CeeEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-cEEEeec
Q 019843 112 DFKALVLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDF 187 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~-~v~l~df 187 (335)
..+++||||+++ ++.+++.. ....+++..++.++.||+.||.||| +.+++|+||+|+||+++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 357799999964 77776642 3457999999999999999999999 99999999999999998665 6999999
Q ss_pred cccccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 266 (335)
|++..+... .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||......+... ..........
T Consensus 216 Gla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV-RIIQVLGTPT 291 (440)
T ss_pred ccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCC
Confidence 999865321 22234567899999998766 468999999999999999999999997654322211 1111111111
Q ss_pred HHHH--HHhhh----ccc---cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 267 VMEI--VDANL----LSR---EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 267 ~~~~--~~~~~----~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...+ ..... ... .......+...++++.+|+.+||..||.+|||+.|++..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 1100 00000 000 000111122356789999999999999999999999965
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=284.65 Aligned_cols=249 Identities=25% Similarity=0.402 Sum_probs=201.8
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCc---------hhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGG---------VFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
+|++.+.||.|++|.||.|... +++.+++|.+...... ....+..|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999754 5789999988644221 23568889999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.++++||+++++|.+++.... .+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999997653 6889999999999999999999 999999999999999999999999999998866
Q ss_pred cCCccc----cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 194 TGEDQS----KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 194 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
...... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------------~~ 223 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-------------FK 223 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-------------HH
Confidence 421111 1112235778899999999888999999999999999999999999764221110 00
Q ss_pred HHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 270 IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
... ......+..++..+.+++.+||+.||++||++.++++
T Consensus 224 ~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 IGE-------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred Hhc-------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 0011112345667999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=291.36 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=204.7
Q ss_pred cCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
.++|++.+.||.|+||.||+|... ++..+++|++..... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 468999999999999999999753 467899999875432 3346788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCC
Q 019843 115 ALVLEYMPHGSLEKCLYSSN---------------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSN 173 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~N 173 (335)
++++||+++++|.+++.... ..+++..++.++.+++.||.+|| +.+++|+||+|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999986421 24788889999999999999999 9999999999999
Q ss_pred EEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccc
Q 019843 174 VLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGE 252 (335)
Q Consensus 174 ilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~ 252 (335)
|+++.++.++|+|||++..+..............+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876532222222223344667999999988899999999999999999997 878875432111
Q ss_pred hhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 253 MTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
. ...+... .....+..++..+.+++.+||+.||.+|||+.|++..|++
T Consensus 241 ~--------------~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 V--------------IYYVRDG------NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H--------------HHHHhcC------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 0 0111110 0111123456779999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=284.63 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=200.9
Q ss_pred ceeeecCceEEEEEEEcC--C--cEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQD--G--MEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~--~--~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||.|++|.||+|.+.+ + ..|++|.+..... .....+..|+..+++++|+||+++++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997643 2 3689999876655 566789999999999999999999999988 889999999999
Q ss_pred CChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc-cc
Q 019843 124 GSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS-KS 201 (335)
Q Consensus 124 ~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~-~~ 201 (335)
++|.+++.... ..+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++..+...... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654 57899999999999999999999 999999999999999999999999999999876432211 12
Q ss_pred cccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+... .+.. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~--------------~~~~-----~~ 217 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK--------------KIDK-----EG 217 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------------HHHh-----cC
Confidence 223456778999999998899999999999999999998 999986543221110 0110 00
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.....+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111112334667999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=293.45 Aligned_cols=257 Identities=24% Similarity=0.289 Sum_probs=218.3
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEcC-CcEEEEEEeecCCC---chhHHHHHHHHHHHhCC-CCceEEEeeeeecCC
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCG---GVFKSFDVECEVMKSIR-HRNLIKIISTCSNDD 112 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 112 (335)
.......|.+.+.||.|.||.||.+..+. |+.+|+|++..... .....+.+|+++++++. ||||+.+++.|++.+
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 45567789999999999999999997664 99999999975532 34578999999999998 999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC----CCcEEEeecc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSDFG 188 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~----~~~v~l~dfg 188 (335)
.+++|||+++||.|.+.+... .+++..+..++.+++.++.|+| +.+++|+|++|+|+|+.. ++.++++|||
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999999877 3999999999999999999999 999999999999999953 3579999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
++..... .......+||+.|+|||++....++...|+||+|+++|.|++|.+||..........
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------------- 248 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------------- 248 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------------
Confidence 9998632 445667889999999999999999999999999999999999999998765433222
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.....+..-..+....++..+.++|..||..||.+|+++.++|+.-|
T Consensus 249 ----~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 249 ----AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ----HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 11122222222334556888999999999999999999999999643
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=290.75 Aligned_cols=267 Identities=22% Similarity=0.323 Sum_probs=207.6
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
++|++.+.||.|+||.||++... ++..+++|.+..... .....+.+|+++++.++||||+++++++..++.+++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999755 578899998875532 3445688999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+++++|.+++... ..+++..+..++.+++.||.||| + .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 152 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 152 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence 9999999998765 37899999999999999999999 7 5899999999999999999999999998875421
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc----------------
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL---------------- 263 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------- 263 (335)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .......
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE--AMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH--HhhcCccccccccCCcccccCCC
Confidence 1223456788999999998888999999999999999999999998654321111 1111000
Q ss_pred -----ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 264 -----PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 264 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
........+..... ..+..+ ...++.++.+++.+||..||++||++++++..-.-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNE-PPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred CCccchhhHHHHHHHHhcC-CCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 00011111111111 111111 112566799999999999999999999999886543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=286.14 Aligned_cols=249 Identities=25% Similarity=0.352 Sum_probs=205.5
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
++|++.+.||.|++|.||+|... +++.+++|++.... ......+.+|+++++.++|+|++++++.+.+....++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47999999999999999999765 58899999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++++|.+++... .+++..++.++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST--MS 153 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccc--cc
Confidence 9999999998765 6899999999999999999999 999999999999999999999999999999876322 12
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ..+... ..
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~--------------~~~~~~----~~ 215 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL--------------FLIPKN----NP 215 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH--------------HHhhhc----CC
Confidence 233456788899999999888999999999999999999999999754321110 001110 00
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.... ...++..+.+++.+||..||++||+++++++.
T Consensus 216 ~~~~-~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 216 PSLE-GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCCc-ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1110 11156679999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=286.24 Aligned_cols=266 Identities=25% Similarity=0.327 Sum_probs=200.3
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|++.+.||.|++|.||+|... ++..|++|++.... ......+.+|+.+++.++|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5889999999999999999765 58999999986542 23346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 121 MPHGSLEKCLYSS--NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 121 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
++ ++|.+++... ...+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 154 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-- 154 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence 96 5888887643 257899999999999999999999 999999999999999999999999999998754311
Q ss_pred ccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh------HHHHH
Q 019843 199 SKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS------VMEIV 271 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~ 271 (335)
........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||............ ........ .....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI-FRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HHHhCCCChhhhhcchhhH
Confidence 1222334568889999987654 4788999999999999999999999764322111110 00000000 00000
Q ss_pred --Hhhhccccc-cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 272 --DANLLSRED-KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 272 --~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
......... ........+++++.++|.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 000111235777999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=300.20 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=206.1
Q ss_pred CCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCee
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFK 114 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 114 (335)
++|.+.+.||+|+||.||+|.+. .+..||+|++.... ....+.+..|++++..+. ||||+++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 56889999999999999999753 34679999997543 333457889999999997 99999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCC------------------------------------------------------------
Q 019843 115 ALVLEYMPHGSLEKCLYSSN------------------------------------------------------------ 134 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~------------------------------------------------------------ 134 (335)
++|+||+++|+|.+++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999986421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC
Q 019843 135 -------------------------------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD 177 (335)
Q Consensus 135 -------------------------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~ 177 (335)
..+++..++.++.+++.||.||| +.+++|+||+|.||+++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence 13567788899999999999999 99999999999999999
Q ss_pred CCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhH
Q 019843 178 DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLK 256 (335)
Q Consensus 178 ~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~ 256 (335)
.++.++|+|||++..+.............++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+..
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~-- 351 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF-- 351 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH--
Confidence 999999999999876532221122233456788999999998889999999999999999998 88998654322111
Q ss_pred hHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 257 YWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
...+.... +...+..++.++.+++.+||+.+|.+||++++|+..|+++.
T Consensus 352 -----------~~~~~~~~------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 -----------YNAIKRGY------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -----------HHHHHcCC------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111110 11122345677999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=300.50 Aligned_cols=268 Identities=23% Similarity=0.280 Sum_probs=200.8
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC-----eeE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD-----FKA 115 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 115 (335)
+|.+.+.||.|+||.||+|... +++.||+|++... .......+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5789999999999999999764 6899999998643 2234467889999999999999999999998766 789
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+|+||+. ++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999995 57888776543 7999999999999999999999 99999999999999999999999999999876432
Q ss_pred CccccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH----
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI---- 270 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 270 (335)
. .........++..|+|||.+.+. .++.++||||+||++|+|++|+.||........ ...............+
T Consensus 156 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 156 D-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-LDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred C-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHHHhh
Confidence 1 12222334678899999998774 478999999999999999999999976542211 1111111111111110
Q ss_pred ------HHhhhccccc--cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 271 ------VDANLLSRED--KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 271 ------~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
+......... .........++++.+|+.+||+.||++|||+.|+++.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 0000000000 00011123466799999999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=297.39 Aligned_cols=240 Identities=26% Similarity=0.313 Sum_probs=190.4
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHH-HHHHhCCCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVEC-EVMKSIRHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|... +++.||+|++.... ......+..|. .+++.++|+||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999765 47889999987431 12223334443 456788999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~--~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--EHNGTTS 154 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccc--cCCCCcc
Confidence 99999887654 6888999999999999999999 9999999999999999999999999999987532 1122233
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...|+..|+|||++.+..++.++|||||||++|+|++|..||......+.. ..+.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-------------~~i~~~~--------~ 213 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-------------DNILNKP--------L 213 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH-------------HHHHhCC--------c
Confidence 456899999999999999999999999999999999999999754322110 1111110 1
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCHHHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINAKEIV 315 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 315 (335)
.....+++.+.+++.+||+.||.+||++.+.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 11234567799999999999999999887443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=293.77 Aligned_cols=241 Identities=21% Similarity=0.265 Sum_probs=194.9
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 118 (335)
+|...+.||+|+||.||+|... +++.||+|++... .......+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788899999999999999765 5889999998743 2234456778888988885 677888999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++.... .+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-- 154 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC--
Confidence 9999999999887654 6999999999999999999999 999999999999999999999999999998753211
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........|+..|+|||++.+..++.++|+||+|+++|+|++|..||........ ...+...
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------------~~~i~~~----- 216 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-------------FQSIMEH----- 216 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHhC-----
Confidence 1122345689999999999988999999999999999999999999976432111 0111110
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINA 311 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 311 (335)
....+..++..+.+++.+||+.||.+|++.
T Consensus 217 ---~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 217 ---NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 011123456679999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.84 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=201.8
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.|++.+.||+|+||.||++... +++.+|+|.+.... ......+..|+.+++.++|++++.+++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4788899999999999999755 58899999886432 2223457789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 120 YMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 120 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
|+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-- 155 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC--
Confidence 99999999988643 336899999999999999999999 999999999999999999999999999998754211
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......++..|+|||++.+..++.++|+||+|+++|+|++|..||......... ...........
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~----------~~~~~~~~~~~--- 221 (285)
T cd05630 156 -QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----------EEVERLVKEVQ--- 221 (285)
T ss_pred -ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH----------HHHHhhhhhhh---
Confidence 1222346889999999999989999999999999999999999999754221100 00011111100
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCC-----HHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-----AKEIVTRL 318 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~L 318 (335)
...+..+++++.+|+.+||+.||.+||| ++|+++.=
T Consensus 222 ----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 222 ----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred ----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 0112335667999999999999999999 88998843
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=285.85 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=200.5
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.|+..+.||.|+||+||.|... +++.+|+|.+.... ......+.+|+++++.++|+|++.+.+.+...+..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4788899999999999999764 58899999986432 2233457789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 120 YMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 120 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
|+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~--- 154 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--- 154 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---
Confidence 99999999888643 346999999999999999999999 99999999999999999999999999999875421
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........++..|+|||++.+..++.++|+||||+++|+|++|..||......... ..+.......
T Consensus 155 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--------------~~~~~~~~~~ 220 (285)
T cd05632 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--------------EEVDRRVLET 220 (285)
T ss_pred CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--------------HHHHHhhhcc
Confidence 11223346899999999999888999999999999999999999999754321110 0011111100
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCC-----HHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-----AKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 317 (335)
. ......++..+.+|+.+||+.||++||+ +.+++..
T Consensus 221 ~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 E---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred c---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0 0112334666899999999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=295.58 Aligned_cols=260 Identities=24% Similarity=0.389 Sum_probs=203.4
Q ss_pred cCCCCccceeeecCceEEEEEEE------cCCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeec-CC
Q 019843 42 TDGFSENNLIGRGSFGSVYKARI------QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSN-DD 112 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~------~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 112 (335)
.++|++.+.||.|+||.||+|.+ .+++.||+|++.... ......+..|+.++..+ +|+||+++++++.. ..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36899999999999999999963 246889999987543 23346788899999999 78999999998765 45
Q ss_pred eeEEEEEecCCCChHHHHhcCC----------------------------------------------------------
Q 019843 113 FKALVLEYMPHGSLEKCLYSSN---------------------------------------------------------- 134 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------- 134 (335)
..+++|||+++++|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccccc
Q 019843 135 --------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206 (335)
Q Consensus 135 --------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~ 206 (335)
..+++..+..++.+++.||.||| +.+++|+||+|.||+++.++.++|+|||++..+.............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 23677888999999999999999 9999999999999999999999999999987653222222222334
Q ss_pred ccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhh
Q 019843 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAA 285 (335)
Q Consensus 207 ~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (335)
++..|+|||.+.+..++.++|+||||+++|+|++ |..||......... ...+.... ....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------------~~~~~~~~------~~~~ 303 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-------------CRRLKEGT------RMRA 303 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-------------HHHHhccC------CCCC
Confidence 5667999999988889999999999999999997 89998654321111 01111100 1111
Q ss_pred HHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 286 KEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 286 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
+..+++.+.+++.+||+.||++||++.||++.|+.+.+
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22235569999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=283.88 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=206.6
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
...|+..+.||.|++|.||.|.+. ++..|++|++.... ......+.+|+.+++.+.|+||+++++++.+....++|||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 356889999999999999999765 58899999987543 3456788899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++++|.+++... ++++..+..++.+++.|+.+|| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06640 83 YLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred cCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence 99999999988754 5899999999999999999999 9999999999999999999999999999987653221
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ..+...
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--------------~~~~~~----- 216 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--------------FLIPKN----- 216 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--------------hhhhcC-----
Confidence 1223345788899999998888999999999999999999999998754321110 011100
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
........++..+.+++.+||+.+|++||++.+++..-.
T Consensus 217 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 217 -NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred -CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 011123345777999999999999999999999988744
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=292.78 Aligned_cols=255 Identities=22% Similarity=0.268 Sum_probs=200.6
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++.+.||+|+||.||++... +++.||+|++... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999755 5899999998642 2334466888999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++......+++..+..++.||+.||.||| +++++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG- 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-
Confidence 999999999999875557999999999999999999999 9999999999999999999999999999987653211
Q ss_pred ccccccccccccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 199 SKSQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
........+++.|+|||++.+ ..++.++|||||||++|+|++|..||......+... .+...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~-------------~i~~~ 223 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-------------KIMNH 223 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH-------------HHHcC
Confidence 112223468999999999863 457889999999999999999999997543211100 01100
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhcccc--CCCHHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQ--RINAKEIVTR 317 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 317 (335)
.. ..........+++.+.+++.+||..++++ |++++++++.
T Consensus 224 ~~---~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 224 KE---HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CC---cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 00000111235677999999988765444 7899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=284.60 Aligned_cols=269 Identities=25% Similarity=0.334 Sum_probs=205.4
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC-----eeEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD-----FKAL 116 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 116 (335)
=.|...+++|.|+||.||.|... +++.||||..-.+.+ --..|+++++.+.||||+++..+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35788899999999999999755 479999999865533 2345899999999999999998886422 4458
Q ss_pred EEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC-CcEEEeecccccc
Q 019843 117 VLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKL 192 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~-~~v~l~dfg~~~~ 192 (335)
||||++ .+|.++++. .+..++...+.-+.+||++||.||| +.+|+||||||.|+|+|.+ |.+||+|||.|..
T Consensus 100 VleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 999995 599888874 2446888889999999999999999 9999999999999999966 8999999999998
Q ss_pred ccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
+- ..........+..|.|||.+.| ..|+.+.||||.||++.||+.|++-|.+.+ ...++.....-+..+..+++.
T Consensus 176 L~---~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 176 LV---KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred ec---cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHh
Confidence 73 2333355677888999998887 569999999999999999999999998854 344444444444333333222
Q ss_pred Hhhhc------cccccch---hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH--HHHHHh
Q 019843 272 DANLL------SREDKHF---AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR--LLKIRD 323 (335)
Q Consensus 272 ~~~~~------~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~~~ 323 (335)
.-... .+..... ......+++..+|+.++|..+|.+|.++.|++.. ...+++
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 11111 1111111 1234567889999999999999999999999853 444443
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=297.60 Aligned_cols=269 Identities=23% Similarity=0.223 Sum_probs=201.1
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecC---
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSND--- 111 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 111 (335)
.....++|++.+.||+|+||.||+|... .++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 12 TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 3456789999999999999999999754 5889999998643 233456778899999999999999999988543
Q ss_pred ---CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 112 ---DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 112 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
...++||||+++ ++.+.+.. .++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCc
Confidence 357899999965 67666643 4788999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC----
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP---- 264 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---- 264 (335)
++.... .........++..|+|||++.+..++.++|||||||++|+|++|..||........ ..........
T Consensus 165 ~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 240 (355)
T cd07874 165 LARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPE 240 (355)
T ss_pred ccccCC---CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHH
Confidence 997642 12223345688999999999998999999999999999999999999975432111 1111111100
Q ss_pred ------hhHHHHHHhhhc----------ccc--ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 265 ------ISVMEIVDANLL----------SRE--DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 265 ------~~~~~~~~~~~~----------~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.......+.... ... ..........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 001111110000 000 00000111234568999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=283.87 Aligned_cols=239 Identities=21% Similarity=0.339 Sum_probs=191.2
Q ss_pred ceeeecCceEEEEEEEcC-------------CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 49 NLIGRGSFGSVYKARIQD-------------GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~-------------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
+.||.|++|.||.|.... ...+++|++..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997432 2358899887665555678889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc-------EEEeecc
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-------AHLSDFG 188 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~-------v~l~dfg 188 (335)
++|||+++++|..++......+++..++.++.||+.|+.||| +.+++|+||+|+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988766667999999999999999999999 999999999999999987664 8999999
Q ss_pred ccccccCCccccccccccccccccCccccC-CCCCCCccchhhHHHHHHHHH-hCCCCCCcccccchhhHhHhhhhcChh
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETF-TKKKPTDKIFAGEMTLKYWVSNLLPIS 266 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~ 266 (335)
++.... ......++..|+|||.+. +..++.++||||||+++|+|+ .|..||......+.
T Consensus 158 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------------- 218 (262)
T cd05077 158 IPITVL------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------------- 218 (262)
T ss_pred CCcccc------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------------
Confidence 886542 122345678899999886 466899999999999999998 58888764321111
Q ss_pred HHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
....... . ......++++.+++.+||+.||.+||++.+|+..|
T Consensus 219 -~~~~~~~-~-------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 -ERFYEGQ-C-------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -HHHHhcC-c-------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000000 0 00111245689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=272.62 Aligned_cols=258 Identities=25% Similarity=0.347 Sum_probs=211.4
Q ss_pred HHHhhhcCCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecCCC--------chhHHHHHHHHHHHhC-CCCceEEEe
Q 019843 36 LELFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG--------GVFKSFDVECEVMKSI-RHRNLIKII 105 (335)
Q Consensus 36 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~i~~~~ 105 (335)
..-.+..+.|.-.+.+|.|..+.|-++. ..+|..+++|++..... +..+.-..|+.+|+++ .||+|+++.
T Consensus 10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 3445566788889999999999998885 45688899999864321 2345566799999999 699999999
Q ss_pred eeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEe
Q 019843 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 185 (335)
Q Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~ 185 (335)
++++.+...++|++.++.|-|-|++.+.- .+++.....+..|+++|++||| .++|+|+|+||+||+++++.+++|+
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEe
Confidence 99999999999999999999999998765 7999999999999999999999 9999999999999999999999999
Q ss_pred eccccccccCCccccccccccccccccCccccC------CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHh
Q 019843 186 DFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWV 259 (335)
Q Consensus 186 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 259 (335)
|||+++.+ .........+||++|+|||.+. ...|+...|+|+.|+++|-|+.|.+||..-.. +.
T Consensus 166 DFGFa~~l---~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--ml----- 235 (411)
T KOG0599|consen 166 DFGFACQL---EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--ML----- 235 (411)
T ss_pred ccceeecc---CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--HH-----
Confidence 99999977 3444566789999999999865 23578899999999999999999999875321 11
Q ss_pred hhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 260 SNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.+.-.+..+..-.-+...+++...++||.+||+.||.+|.|++|+|..
T Consensus 236 ----------MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 236 ----------MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ----------HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111111222222223345667889999999999999999999999875
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=279.10 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=205.9
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|++.+.||.|++|.||.+... +++.+++|.+... +......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5899999999999999999754 5889999998754 244556788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+++++|.+++... ...+++..+..++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-- 155 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-- 155 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--
Confidence 9999999999765 446899999999999999999999 9999999999999999999999999999987653221
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||......+. .........
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-----------------~~~~~~~~~ 218 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL-----------------VVKIVQGNY 218 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH-----------------HHHHHcCCC
Confidence 123345678899999999888899999999999999999999999865322111 111111111
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
...+..++..+.+++.+||..+|.+||+++++++.+
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 ---TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 111234567799999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=295.25 Aligned_cols=267 Identities=22% Similarity=0.270 Sum_probs=199.8
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecC---
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSND--- 111 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 111 (335)
.....++|++.+.||.|+||.||+|... +++.||+|++.... ......+.+|+++++.++|+||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3456789999999999999999999754 68899999986432 22345677899999999999999999887542
Q ss_pred ---CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 112 ---DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 112 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
...+++++++ +++|.+++... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence 4568999987 78998887643 5999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcCh--
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI-- 265 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-- 265 (335)
++..... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||....... ............
T Consensus 164 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~ 237 (343)
T cd07878 164 LARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSP 237 (343)
T ss_pred cceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCH
Confidence 9886521 2234568899999999876 568899999999999999999999996533211 111111111000
Q ss_pred hH---------HHHHHhhhccccccch-hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 266 SV---------MEIVDANLLSREDKHF-AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 266 ~~---------~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.. ...... +........ ......++.+.+|+.+||..||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000 000000000 0011234568899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=290.31 Aligned_cols=259 Identities=25% Similarity=0.448 Sum_probs=205.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCc----EEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGM----EVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
.++|++.+.||+|++|.||+|.+. ++. .+++|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 467889999999999999999754 343 578888765432 2344688999999999999999999988754 467
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
++++++++|+|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence 899999999999999876667899999999999999999999 99999999999999999999999999999986642
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ..++...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~--------------~~~~~~~ 227 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI--------------PDLLEKG 227 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHCC
Confidence 222222223345678999999998899999999999999999997 8999865421111 1111111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
.....+..++..+.+++.+||..+|++||+++++++.|..+..+
T Consensus 228 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 228 ------ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111223456699999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=281.19 Aligned_cols=248 Identities=27% Similarity=0.442 Sum_probs=197.7
Q ss_pred ceeeecCceEEEEEEEcC----CcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQD----GMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|.+.. +..+++|.+..... .....+.+|+++++.+.|+|++++++++.. +..++||+|+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 479999999999996432 36899999875533 345678899999999999999999998764 467899999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc-cc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK-SQ 202 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~-~~ 202 (335)
++|.+++.... .+++..++.++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++..+....... ..
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997655 7899999999999999999999 9999999999999999999999999999988653222111 11
Q ss_pred ccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccccc
Q 019843 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281 (335)
Q Consensus 203 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (335)
....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+. ...+... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~--------------~~~~~~~------~ 215 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV--------------IAMLESG------E 215 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH--------------HHHHHcC------C
Confidence 11223457999999998889999999999999999998 9999876432111 1111111 0
Q ss_pred chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
....+..++..+.+++.+||+.||++||++.++++.|+++
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1122334567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=286.45 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=202.4
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
++|++.+.||.|++|.||+|... ++..+++|.+.... ......+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47899999999999999999765 68999999887542 33456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 121 MPHGSLEKCLYSS--NCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 121 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
+++++|..++... ...+++..+..++.+++.|+.||| + .+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-- 155 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-- 155 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC--
Confidence 9999999988764 236899999999999999999999 6 5999999999999999999999999999875521
Q ss_pred cccccccccccccccCccccCCCC------CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGR------VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~------~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
.......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........ ...+
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--------------~~~~ 219 (286)
T cd06622 156 --SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--------------FAQL 219 (286)
T ss_pred --CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--------------HHHH
Confidence 1222345778899999885543 47899999999999999999999865321111 0001
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
...... .....+..++.++.+++.+||+.+|.+||++.+++..-
T Consensus 220 ~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 220 SAIVDG---DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred HHHhhc---CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 110000 01111234677799999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=301.81 Aligned_cols=266 Identities=19% Similarity=0.215 Sum_probs=199.1
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
..+|.+.+.||.|+||.||+|... .++.|++|... ...+.+|++++++++|+||+++++++...+..++||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999765 47889999632 23457899999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+ .++|.+++......+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++..+.......
T Consensus 242 ~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 Y-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9 46888888766557999999999999999999999 9999999999999999999999999999997653222222
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccc------hhhHhHhhhh------cCh---
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE------MTLKYWVSNL------LPI--- 265 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~------~~~--- 265 (335)
......||..|+|||++.+..++.++|||||||++|+|++|..|+....... .......... .+.
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 2234568999999999999999999999999999999999876643221110 0010000000 000
Q ss_pred -hHHHHHHhh-hcc----ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 266 -SVMEIVDAN-LLS----REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 266 -~~~~~~~~~-~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
......... ... .....+......+.++.+||.+||+.||.+|||+.|+|+.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 000 0000111111335579999999999999999999999974
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=314.99 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=205.7
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++.+.||+|+||.||+|.+. +++.||+|++..+. ......+.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999765 58999999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 119 EYMPHGSLEKCLYSS----------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 119 e~~~~~~L~~~l~~~----------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
||++|++|.+++... ....+...++.++.+|+.||.||| +.+++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988632 123566778899999999999999 9999999999999999999999999999
Q ss_pred ccccccCCcc----------------ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccc
Q 019843 189 IAKLLTGEDQ----------------SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252 (335)
Q Consensus 189 ~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~ 252 (335)
++........ ........||+.|+|||.+.+..++.++|||||||++|+|++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976521100 011123468999999999999999999999999999999999999997633211
Q ss_pred hhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCC-CHHHHHHHHHHHH
Q 019843 253 MTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI-NAKEIVTRLLKIR 322 (335)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~~~ 322 (335)
.... ..... .........+++.+.+++.+||+.||++|| +++++++.|+...
T Consensus 239 i~~~-----------------~~i~~-P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 239 ISYR-----------------DVILS-PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hhhh-----------------hhccC-hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1110 00000 001111234567799999999999999996 6777888887664
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=278.64 Aligned_cols=269 Identities=25% Similarity=0.291 Sum_probs=208.5
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCc-eEEEeeeeecCC-----
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRN-LIKIISTCSNDD----- 112 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~----- 112 (335)
...|..++.||+|+||+||+|..+ +|+.||+|++..+.. .......+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456777888999999999999754 689999999987754 35577889999999999999 999999998876
Q ss_pred -eeEEEEEecCCCChHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 113 -FKALVLEYMPHGSLEKCLYSSN---CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 113 -~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
.+++||||+ ..+|..++...+ ..++...+..+..||+.||.||| +++|+||||||.||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 899999999 569999988655 35777899999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhH
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
++..+. -........++|..|.|||++.+. .|+...||||+||++.||+++++.|.+..+-+... ........+..
T Consensus 166 lAra~~--ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~-~If~~lGtP~e 242 (323)
T KOG0594|consen 166 LARAFS--IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF-RIFRLLGTPNE 242 (323)
T ss_pred hHHHhc--CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH-HHHHHcCCCCc
Confidence 999653 233446677899999999998886 69999999999999999999999998765422221 11111111111
Q ss_pred HHH------HHhh-hccccc-cchh--hHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 268 MEI------VDAN-LLSRED-KHFA--AKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 268 ~~~------~~~~-~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..+ -+.. ...... .... ..+...++..+++.+||+.+|.+|.|++.+++.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 110 0110 000000 0000 001122468999999999999999999999986
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=292.61 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=205.1
Q ss_pred CCCCccceeeecCceEEEEEEEc--------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCC
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ--------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDD 112 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~--------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 112 (335)
.+|++++.||+|+||.||.|... ++..+++|++.... ......+..|+++++++ +|+||+++++.+...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 57999999999999999999642 12368999887542 33457889999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC
Q 019843 113 FKALVLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD 177 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~ 177 (335)
..++++||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 9999999999999999987532 24788889999999999999999 99999999999999999
Q ss_pred CCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhH
Q 019843 178 DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLK 256 (335)
Q Consensus 178 ~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~ 256 (335)
.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 245 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--- 245 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---
Confidence 999999999999876532221122222334567999999999899999999999999999998 8888865321111
Q ss_pred hHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 257 YWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
...+... .....+..++..+.+++.+||+.+|.+||++.|+++.|.++..
T Consensus 246 -----------~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 246 -----------FKLLKEG------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred -----------HHHHHcC------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 0111110 0111123446679999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=281.69 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=203.8
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.....+.+.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445566667789999999999999754 578899998876655566789999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC-CCcEEEeeccccccc
Q 019843 117 VLEYMPHGSLEKCLYSSNCVL--DIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLL 193 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~--~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~-~~~v~l~dfg~~~~~ 193 (335)
++||+++++|.+++......+ ++..+..++.+++.|+.||| +.+++|+||+|+||+++. ++.++|+|||.+...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999998654455 88889999999999999999 999999999999999976 679999999998765
Q ss_pred cCCccccccccccccccccCccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
... ........++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||.......... .
T Consensus 160 ~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---------------~ 222 (268)
T cd06624 160 AGI--NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---------------F 222 (268)
T ss_pred ccC--CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---------------h
Confidence 321 11222345788999999986543 7889999999999999999999986532211110 0
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...... .....+..+++.+.+++.+||+.+|.+|||+.|++..
T Consensus 223 ~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 223 KVGMFK---IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhhhhc---cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000000 0111133456779999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=284.04 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=200.5
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeec------C
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSN------D 111 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~ 111 (335)
.+.+.|++.+.||.|+||.||.|... +++.+++|++..... ....+..|+.+++.+ +|+|++++++.+.. .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46788999999999999999999754 588999999875533 346788899999998 79999999999865 3
Q ss_pred CeeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
...++++||+++++|.+++... ...+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4688999999999999998763 346899999999999999999999 999999999999999999999999999998
Q ss_pred ccccCCccccccccccccccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcCh
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI 265 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 265 (335)
..... .........++..|+|||++. +..++.++|+||+|+++|+|++|..||..........
T Consensus 159 ~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~---------- 226 (272)
T cd06637 159 AQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------- 226 (272)
T ss_pred eeccc--ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH----------
Confidence 75421 112233456888999999875 3357889999999999999999999986532211110
Q ss_pred hHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 266 SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.... ..........++..+.+++.+||..||.+|||+.++++
T Consensus 227 ----~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 227 ----LIPR-----NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----HHhc-----CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000 00111112234667999999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=296.39 Aligned_cols=269 Identities=23% Similarity=0.225 Sum_probs=201.3
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecC---
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSND--- 111 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 111 (335)
.....++|++.+.||+|+||.||.|... .++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 19 TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hhchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 3456789999999999999999999754 5889999998643 234456788899999999999999999987543
Q ss_pred ---CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 112 ---DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 112 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 467999999954 77776643 4788999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC--hh
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP--IS 266 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~ 266 (335)
++..... ........++..|+|||++.+..++.++|||||||++|+|++|+.||........ .......... ..
T Consensus 172 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 247 (364)
T cd07875 172 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPE 247 (364)
T ss_pred CccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHH
Confidence 9976421 2222345688999999999999999999999999999999999999976432211 1111111110 00
Q ss_pred HHHHHHh----hhccccc----------------cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 267 VMEIVDA----NLLSRED----------------KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 267 ~~~~~~~----~~~~~~~----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
....+.. .....+. .........+..+.+|+.+||+.||.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 0000000 0000011124568999999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=285.05 Aligned_cols=264 Identities=22% Similarity=0.326 Sum_probs=209.9
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.++|++.+.||+|++|+||+|... +++.+++|++.... ......+.+|+++++.++||||+++++.+...+.+++|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 468999999999999999999765 58889999887553 3345778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
|+++++|.+++.... .+++..+..++.+++.++.||| + .+++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~---- 155 (284)
T cd06620 84 FMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI---- 155 (284)
T ss_pred cCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchh----
Confidence 999999999887643 6899999999999999999999 6 589999999999999999999999999886542
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........++..|+|||.+.+..++.++|+|||||++|+|++|..||.......... ..+..............
T Consensus 156 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 229 (284)
T cd06620 156 NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------DDPMGILDLLQQIVQEP 229 (284)
T ss_pred hhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------hhhhHHHHHHHHHhhcc
Confidence 112234568899999999988899999999999999999999999998654322100 00111112222221111
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
.... ....++..+.+++.+||+.||.+|||+.|++....-+
T Consensus 230 -~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 230 -PPRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred -CCCC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 1111 1123567799999999999999999999999875433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=278.36 Aligned_cols=250 Identities=30% Similarity=0.559 Sum_probs=202.8
Q ss_pred CCccceeeecCceEEEEEEEcC-----CcEEEEEEeecCCCc-hhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 45 FSENNLIGRGSFGSVYKARIQD-----GMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~~-----~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
+++.+.||.|+||.||++.... +..|++|++...... ....+..|++.++.++|+||+++++.+.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4678999999999999997653 388999998765433 5678999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 119 EYMPHGSLEKCLYSSNCV-LDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~-~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|++++++|.+++...... +++..+..++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765434 899999999999999999999 9999999999999999999999999999998664332
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.... ....++..|+|||.+.+..++.++|+||+|+++++|++ |..||........ ...+..
T Consensus 158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~--------------~~~~~~--- 219 (258)
T smart00219 158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV--------------LEYLKK--- 219 (258)
T ss_pred cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHhc---
Confidence 1111 12336788999999988889999999999999999998 7888765321111 011111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
.. ....+..++..+.+++.+||+.||++|||+.++++.|
T Consensus 220 ~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 220 GY---RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC---CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 1111223577799999999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=281.77 Aligned_cols=252 Identities=25% Similarity=0.436 Sum_probs=195.8
Q ss_pred ceeeecCceEEEEEEEc----CCcEEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeee-cCCeeEEEEEecC
Q 019843 49 NLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCS-NDDFKALVLEYMP 122 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 122 (335)
+.||+|+||.||+|... .+..+++|.+... .......+..|+.+++.++||||+++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 2457999987533 2334567888999999999999999999765 4567889999999
Q ss_pred CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc--c
Q 019843 123 HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS--K 200 (335)
Q Consensus 123 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~--~ 200 (335)
+++|.+++.......++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+...... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999866556788888999999999999999 999999999999999999999999999998755322111 1
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
......++..|+|||.+.+..++.++||||||+++|+|++| .+||......+. ...+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~--------------~~~~~~------ 217 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI--------------TVYLLQ------ 217 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--------------HHHHhc------
Confidence 11233456789999999888899999999999999999995 556544221110 001100
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
......+..+++.+.+++.+||+.+|++||++.++++.|+++..
T Consensus 218 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 218 GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 01111123346679999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=284.25 Aligned_cols=248 Identities=28% Similarity=0.491 Sum_probs=199.1
Q ss_pred ceeeecCceEEEEEEEcC-------CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 49 NLIGRGSFGSVYKARIQD-------GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~-------~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+.||.|++|.||+|+..+ +..+++|.+.... ......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999997542 2578999876442 24457788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-----cEEEeeccc
Q 019843 121 MPHGSLEKCLYSS------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM-----VAHLSDFGI 189 (335)
Q Consensus 121 ~~~~~L~~~l~~~------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~-----~v~l~dfg~ 189 (335)
+++++|.+++... ...+++..+..++.+++.||.||| +.+++|+||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998642 234788999999999999999999 99999999999999999877 899999999
Q ss_pred cccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
+.................+..|+|||.+.+..++.++||||||+++|+|++ |..||......+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~--------------~ 223 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV--------------L 223 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH--------------H
Confidence 876543322223333455678999999999899999999999999999998 9999865432111 0
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
..+.. ......+..++..+.+++.+||..+|.+||++.++++.|+
T Consensus 224 ~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 224 QHVTA------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHhc------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111 1111223445778999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=279.55 Aligned_cols=249 Identities=23% Similarity=0.362 Sum_probs=201.8
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeec-CCeeEEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSN-DDFKALVLE 119 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 119 (335)
+|++.+.||.|++|.||.+..+ +++.+++|.+..+. ......+.+|+++++.++|+|++++++.+.. ...+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999755 47889999987543 3345678899999999999999999988764 457889999
Q ss_pred ecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 120 YMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 120 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
++++++|.+++... ...+++.+++.++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~-- 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ-- 155 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc--
Confidence 99999999998763 346899999999999999999999 999999999999999999999999999998765321
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........++..|+|||++.+..++.++|+||||+++++|++|..||......... ..+. .....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-------------~~~~-~~~~~- 220 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV-------------YRII-EGKLP- 220 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-------------HHHH-hcCCC-
Confidence 12223446788999999999999999999999999999999999998753211110 0011 10010
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..+...++.+.+++.+||+.||++||++.++++.
T Consensus 221 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 -----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1123456779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=283.66 Aligned_cols=271 Identities=21% Similarity=0.279 Sum_probs=200.8
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.+.++|++.+.||.|++|.||.|... +++.+++|++..... .....+.+|+.+++.++|+||+++++++...+..++|
T Consensus 2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 45689999999999999999999754 588999999875432 2334677899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
+||+. +++.+.+......+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 156 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP- 156 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCC-
Confidence 99995 6777777655556888899999999999999999 999999999999999999999999999998754211
Q ss_pred cccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH------
Q 019843 198 QSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI------ 270 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 270 (335)
........++..|+|||.+.+. .++.++|+||||+++|+|++|..||.........................
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 157 -SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred -CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 1122334568889999998764 57889999999999999999999997654322211111110000000000
Q ss_pred ---HHhhhccccccchhh---HHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 271 ---VDANLLSREDKHFAA---KEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 271 ---~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
............... ....+..+.+++.+||..||.+|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 0012456899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=285.64 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=206.0
Q ss_pred ccCHHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeee
Q 019843 32 RFSYLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCS 109 (335)
Q Consensus 32 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 109 (335)
.+..+......++|.+.+.||+|++|.||+|... +++.+++|++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 3556677788999999999999999999999764 57899999876432 2336688899999999 6999999999873
Q ss_pred -----cCCeeEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc
Q 019843 110 -----NDDFKALVLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181 (335)
Q Consensus 110 -----~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~ 181 (335)
..+..++||||+++++|.+++.. ....+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCC
Confidence 45678999999999999998753 2346889999999999999999999 999999999999999999999
Q ss_pred EEEeeccccccccCCccccccccccccccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhH
Q 019843 182 AHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK 256 (335)
Q Consensus 182 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 256 (335)
++|+|||++...... ........++..|+|||++.+ ..++.++|+||+|+++|+|++|..||..........
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~- 239 (286)
T cd06638 163 VKLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF- 239 (286)
T ss_pred EEEccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-
Confidence 999999998765321 112233468889999998753 447889999999999999999999986543211100
Q ss_pred hHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 257 YWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
.. . .........+..++..+.+++.+||+.||++|||+.|+++..
T Consensus 240 ------------~~-~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 ------------KI-P----RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ------------hc-c----ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 0 000011111223455699999999999999999999999754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=281.88 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=206.8
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
++|.+.+.||.|++|.||+|..+ +++.+++|.+.... ......+.+|+++++.+.||||+++++.+...+.+++++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47889999999999999999765 58899999987653 34456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+++++|.+++......+++..+..++.+++.|+.+|| + .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 154 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--- 154 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence 9999999999876568999999999999999999999 8 99999999999999999999999999998755211
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .............
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------------~~~~~~~~~~~~~ 221 (265)
T cd06605 155 -LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG------------IFELLQYIVNEPP 221 (265)
T ss_pred -HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc------------HHHHHHHHhcCCC
Confidence 111266788899999999889999999999999999999999998754321111 1111221111111
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. ... ...++..+.++|.+||..||++||++.+++..
T Consensus 222 ~-~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 P-RLP-SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred C-CCC-hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1 111 11256779999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=283.32 Aligned_cols=268 Identities=22% Similarity=0.286 Sum_probs=205.0
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|.+.+.||.|++|.||+|... +|+.|++|++.... ......+.+|+.+++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5899999999999999999864 58999999987653 33456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+ +++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999998766668999999999999999999999 99999999999999999999999999999886632221 1
Q ss_pred ccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH------HHh
Q 019843 201 SQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI------VDA 273 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 273 (335)
......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||...... .................+ .+.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcchh
Confidence 23345688899999988654 4689999999999999999998887654321 111111111110000000 000
Q ss_pred --hhcccccc-c-hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 274 --NLLSREDK-H-FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 274 --~~~~~~~~-~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
........ . .......+..+.+++.+||+.||.+||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 0 00112345779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=281.87 Aligned_cols=248 Identities=29% Similarity=0.480 Sum_probs=195.6
Q ss_pred ceeeecCceEEEEEEEcC-Cc--EEEEEEeecC-CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQD-GM--EVAVKVFHLQ-CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~-~~--~v~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|++|.||+|..++ +. .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998653 43 4688887643 234456788999999999 799999999999999999999999999
Q ss_pred CChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 124 GSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 124 ~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
++|.+++.... ..+++..++.++.+++.|+.||| +.+++|+||+|+||+++.++.++++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 24789999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhH
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
++.... ..........+..|+|||++.+..++.++|+||||+++|+|++ |..||........
T Consensus 158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------------- 220 (270)
T cd05047 158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------------- 220 (270)
T ss_pred Cccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH--------------
Confidence 875321 1111112223567999999988889999999999999999997 9999865321110
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
...+... .....+..++..+.+++.+||+.||.+|||+.+++..|.++.
T Consensus 221 ~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 221 YEKLPQG------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHhCC------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0001110 011112335667999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=294.48 Aligned_cols=239 Identities=28% Similarity=0.338 Sum_probs=189.9
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHH-HHHhCCCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECE-VMKSIRHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|... +|+.+|+|++... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999765 5899999998643 2223344455544 56778999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|..++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~--~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGI--AQSDTTT 154 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCC--CCCCCcc
Confidence 99998887544 7899999999999999999999 9999999999999999999999999999986432 1122233
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...++..|+|||++.+..++.++|||||||++|+|++|..||......+. .+...... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-----------------~~~~~~~~----~ 213 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-----------------YDNILHKP----L 213 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-----------------HHHHHcCC----c
Confidence 45689999999999999999999999999999999999999975432111 11111110 0
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCHHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINAKEI 314 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 314 (335)
......+..+.+++.+||..||.+||++.+.
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 1112345668999999999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=290.55 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=200.5
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|.+.+.||+|+||.||++..+ +++.+|+|++... .......+.+|..++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 57999999999999999999765 4788999998632 2233455788999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++......+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence 999999999999875557999999999999999999999 9999999999999999999999999999987542111
Q ss_pred ccccccccccccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 199 SKSQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
........|+..|+|||++. ...++.++|+|||||++|+|++|..||......+.. ..+..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~-------------~~i~~- 222 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------------GKIMN- 222 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH-------------HHHhC-
Confidence 11223356899999999886 345788999999999999999999999754321111 01111
Q ss_pred hhcccccc-chhhHHHHHHHHHHHHHHhchhcccc--CCCHHHHHHH
Q 019843 274 NLLSREDK-HFAAKEQCVSFVFNLAMECTVESAEQ--RINAKEIVTR 317 (335)
Q Consensus 274 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 317 (335)
..... .......+++++.+++.+||..+|.+ |++++++++.
T Consensus 223 ---~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 223 ---HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00000 01112345777999999999765555 6899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=279.33 Aligned_cols=249 Identities=20% Similarity=0.318 Sum_probs=204.0
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|++.+.||.|++|.+|.+... +++.+++|.+... .......+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 6899999999999999999754 5889999998754 233446789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+.+++|.+.+... ...+++..++.++.+++.|+.+|| +.+++|+||+|+||+++.++.++++|||++..+... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~--~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--V 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc--h
Confidence 9999999988754 335889999999999999999999 999999999999999999999999999998865321 1
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......++..|+|||++.+..++.++|+||||+++++|++|..||......+ ..+.......
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----------------~~~~~~~~~~ 218 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-----------------LVLKIIRGSY 218 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-----------------HHHHHhcCCC
Confidence 11223457888999999998889999999999999999999999986532111 1111111111
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...+..++.++.++|.+||+.+|.+||++.++++.
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 ---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11133456779999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=301.18 Aligned_cols=267 Identities=21% Similarity=0.244 Sum_probs=193.2
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCC------CCceEEEeeeeecC-
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR------HRNLIKIISTCSND- 111 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~- 111 (335)
...++|++.+.||+|+||.||+|... .++.||||++.... ........|+++++.+. |.+++.+++++...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 34678999999999999999999754 57889999986432 22344556777776664 45688898888754
Q ss_pred CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCC----------
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNM---------- 180 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~---------- 180 (335)
..+++||+++ +++|.+++.... .+++..+..++.||+.||.||| + .+|+|+||||+||+++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 5788999988 778988887653 7999999999999999999999 7 5999999999999998765
Q ss_pred ------cEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchh
Q 019843 181 ------VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMT 254 (335)
Q Consensus 181 ------~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~ 254 (335)
.+||+|||.+... ........+|..|+|||++.+..++.++|||||||++|+|++|+.||......+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred cCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 4999999987532 22234567899999999999999999999999999999999999999764422111
Q ss_pred h--Hh--------HhhhhcChhHHHHHHhhhcccccc-----------chhhHHHHHHHHHHHHHHhchhccccCCCHHH
Q 019843 255 L--KY--------WVSNLLPISVMEIVDANLLSREDK-----------HFAAKEQCVSFVFNLAMECTVESAEQRINAKE 313 (335)
Q Consensus 255 ~--~~--------~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 313 (335)
. .. |...........+.+......... .........+.+.+||.+||..||++|||++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 0 00 000000000011111100000000 00000011355889999999999999999999
Q ss_pred HHHH
Q 019843 314 IVTR 317 (335)
Q Consensus 314 ll~~ 317 (335)
+++.
T Consensus 435 ~L~H 438 (467)
T PTZ00284 435 MTTH 438 (467)
T ss_pred HhcC
Confidence 9973
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=279.33 Aligned_cols=247 Identities=26% Similarity=0.354 Sum_probs=202.8
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-----CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-----GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+....+.+|+++++.++|+||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5888999999999999999866 68999999986543 23557789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
+||+++++|.+++.... .+++..++.++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999987654 6899999999999999999999 9999999999999999999999999999987653211
Q ss_pred cccccccccccccccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
......++..|+|||.+.... ++.++|+||||+++|+|++|..||.......... ......
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~-------------~~~~~~-- 218 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF-------------KIGRSK-- 218 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH-------------HHHhcc--
Confidence 233456788899999987766 8999999999999999999999987643111100 000000
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.....+..+++.+.+++.+||+.+|.+||++.+++.
T Consensus 219 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 ----ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 001112334667999999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=286.24 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=203.9
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.+.|++.+.||.|++|.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++.+..++..++|+|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 356788899999999999999754 47889999987443 3455678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++++|.+++... .+++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.++++|||++..+... .
T Consensus 83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~ 155 (277)
T cd06642 83 YLGGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--Q 155 (277)
T ss_pred ccCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCc--c
Confidence 99999999988653 5899999999999999999999 999999999999999999999999999998765321 1
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ..+.....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--------------~~~~~~~~--- 218 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL--------------FLIPKNSP--- 218 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH--------------hhhhcCCC---
Confidence 1222345788899999999888999999999999999999999998654321110 00110000
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
......++..+.+++.+||+.+|.+||++.+++..-
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 219 ---PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred ---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 011223456799999999999999999999999843
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=292.31 Aligned_cols=266 Identities=21% Similarity=0.241 Sum_probs=197.0
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.....+|++.+.||+|+||.||+|... +++.||+|+... .....|+.+++.++|+||+++++++......++|
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 344568999999999999999999765 478899997432 2235689999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
++++ .++|.+++......+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 136 ~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~--- 208 (357)
T PHA03209 136 LPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV--- 208 (357)
T ss_pred EEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccc---
Confidence 9999 46888888776668999999999999999999999 9999999999999999999999999999987432
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCC-Ccccccch-hh-------HhHhhhh------
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPT-DKIFAGEM-TL-------KYWVSNL------ 262 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf-~~~~~~~~-~~-------~~~~~~~------ 262 (335)
.........++..|+|||++.+..++.++|||||||++|+|+++..|+ ........ .. .......
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 209 VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 112223456899999999999999999999999999999999865544 43221100 00 0000000
Q ss_pred cC-----hhHHHHHHhhhc-cccccch--hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 263 LP-----ISVMEIVDANLL-SREDKHF--AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 263 ~~-----~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.+ .....+++.... ......+ .....++.++.++|.+||+.||.+|||+.|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00 000011110000 0000000 0111345667889999999999999999999863
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=292.09 Aligned_cols=237 Identities=26% Similarity=0.316 Sum_probs=188.2
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHH-HHHHhCCCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVEC-EVMKSIRHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|... +++.||+|++.... ......+..|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999865 58899999986431 22233444454 467888999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|...+.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.... .......
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~--~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV--EPEETTS 154 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCC--CCCCccc
Confidence 99988886543 6889999999999999999999 9999999999999999999999999999987432 1122233
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...++..|+|||++.+..++.++|||||||++|+|++|..||....... ..+..... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------------~~~~i~~~----~~ 213 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-----------------MYDNILHK----PL 213 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-----------------HHHHHhcC----CC
Confidence 4568999999999998889999999999999999999999997643111 11111111 01
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINAK 312 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 312 (335)
..+...+..+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11223456699999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=281.90 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=202.2
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCC-----
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDD----- 112 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~----- 112 (335)
...++|++.+.||.|++|.||+|..+ +++.+++|++..... ....+.+|+.+++.+ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999865 578899999875543 346789999999999 7999999999986544
Q ss_pred -eeEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 113 -FKALVLEYMPHGSLEKCLYSS---NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 113 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
.+++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 589999999999999988642 357899999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL 263 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 263 (335)
++..... .........++..|+|||.+.. ..++.++||||||+++|+|++|..||..........
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-------- 228 (275)
T cd06608 159 VSAQLDS--TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF-------- 228 (275)
T ss_pred cceeccc--chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH--------
Confidence 9876531 1222334568889999998753 346789999999999999999999997532211100
Q ss_pred ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 264 PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
... .........+..+++.+.+++.+||..||++|||+.++++
T Consensus 229 -----~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 -----KIP-----RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----Hhh-----ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 0111122223345677999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=282.68 Aligned_cols=254 Identities=24% Similarity=0.423 Sum_probs=204.2
Q ss_pred CCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCCc-hhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
++|++.+.||.|+||.||+|+.+ +.+.+++|.+...... ....+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 68999999999999999999754 2467899988654443 4678999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeec
Q 019843 116 LVLEYMPHGSLEKCLYSSN--------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 187 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~df 187 (335)
+||||+++++|.+++.... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999987543 15899999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChh
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPIS 266 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 266 (335)
|++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~------------- 227 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV------------- 227 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH-------------
Confidence 9886432111 112233345677999999988889999999999999999998 7888865322111
Q ss_pred HHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...+... ...+..+..++..+.+++.+||+.||.+||++.+++..|+
T Consensus 228 -~~~~~~~-----~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 228 -LNRLQAG-----KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -HHHHHcC-----CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0011100 0011112345677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=282.88 Aligned_cols=270 Identities=22% Similarity=0.286 Sum_probs=200.6
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
..++|++.+.||.|++|.||+|... +++.|++|.+..... .....+.+|+++++.++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 4578999999999999999999865 588999999875432 22345678999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++ +|.+++......+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 156 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-- 156 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCC--
Confidence 99975 999988776557899999999999999999999 999999999999999999999999999998653211
Q ss_pred ccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh--
Q 019843 199 SKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL-- 275 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 275 (335)
........++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||........................+.....
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 111222346788999998865 45789999999999999999999999654422222111111110000000000000
Q ss_pred ------cccc-ccch-hhHHHHH--HHHHHHHHHhchhccccCCCHHHHHH
Q 019843 276 ------LSRE-DKHF-AAKEQCV--SFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 276 ------~~~~-~~~~-~~~~~~~--~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.... .... ....... ..+.+++.+||+.||.+|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 0000 0000112 56889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=291.81 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=206.1
Q ss_pred hhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecC--CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 116 (335)
..+..|++.+.||.|+.+.||++...+.+-+++|..... +.....-+.+|+.+|.+| .|.+|++++++-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 345689999999999999999998887788888876533 456678899999999999 59999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
|||+- ..+|..+|.++....+.-.+..++.|++.|+.++| ..||+|.||||.|+++- .|.+||+|||++..+...
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 99975 66999999987655665588999999999999999 99999999999999986 569999999999988766
Q ss_pred ccccccccccccccccCccccCCCC-----------CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcCh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGR-----------VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI 265 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 265 (335)
...-.....+||..|||||.+.... .+++||||||||++|+|+.|+.||....+....+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl---------- 582 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKL---------- 582 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHH----------
Confidence 6666777889999999999865322 5678999999999999999999998753222111
Q ss_pred hHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 266 SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..+.++. ....++.... ..++.++++.||+.||++||++.|+|+
T Consensus 583 --~aI~~P~----~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 583 --HAITDPN----HEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HhhcCCC----ccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1222221 1111111100 122999999999999999999999986
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=296.11 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=221.8
Q ss_pred CCCCccceeeecCceEEEEEEEc---CC--cEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ---DG--MEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~---~~--~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
+..+..+.||.|-||.||.|... .| -.||||..+.++ .+..+.|..|.-+++++.||||++++|++.+.. .++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeE
Confidence 34445689999999999999643 23 348999998753 445788999999999999999999999998765 579
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
|||.++.|-|..+++.....++...+..++.||+.||.||| +..++|+||...||+|.....|||+|||+++.+.+.
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999999988889999999999999999999999 999999999999999999999999999999988655
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
...... ...-...|||||.++-..++.+||||.||+++||++. |..||.+-.+.+ -..
T Consensus 545 ~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------------------VI~ 603 (974)
T KOG4257|consen 545 AYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------------------VIG 603 (974)
T ss_pred chhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc--------------------eEE
Confidence 433333 4445677999999999999999999999999999987 999998743322 122
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
.-..+.+++.|++||+.|..|+.+||+.+|.+||.+.|+...|..+..+=.+
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 3446678888999999999999999999999999999999999988764333
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=281.77 Aligned_cols=258 Identities=28% Similarity=0.343 Sum_probs=211.9
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.....+.|.+.+.||.|++|.||.|... ++..+++|++..... ....+.+|++.++.++|+|++++++.+...+..++
T Consensus 14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 3457788999999999999999999766 689999999976544 45778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
++||+++++|.+++......+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999999999876557999999999999999999999 999999999999999999999999999988765321
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .+..
T Consensus 170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~-------------~~~~---- 230 (286)
T cd06614 170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-------------LITT---- 230 (286)
T ss_pred h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHh----
Confidence 1 12223456788999999988889999999999999999999999987532211100 0000
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...........++..+.+++.+||+.+|.+||++.++++.-.
T Consensus 231 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 231 -KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred -cCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 111112223335677999999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=277.99 Aligned_cols=256 Identities=25% Similarity=0.329 Sum_probs=206.0
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
++|++.+.||.|++|+||+|... ++..+++|++.... ......+.+|++.++.++|+|++++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 57999999999999999999754 57889999986543 33567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 121 MPHGSLEKCLYSS--NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 121 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
+++++|.+++... ...+++..+..++.+++.|+.+|| +.+++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999998754 246899999999999999999999 99999999999999999999999999999887643322
Q ss_pred cc--ccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 199 SK--SQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 199 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
.. ......++..|+|||.+... .++.++|+||||+++|+|++|..||........... .....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~-------------~~~~~- 223 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML-------------TLQND- 223 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH-------------HhcCC-
Confidence 21 22334678899999998776 789999999999999999999999976533211111 11000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
............+++.+.+++.+||..||++||+++++++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 -PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000001245677999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=289.83 Aligned_cols=255 Identities=20% Similarity=0.246 Sum_probs=200.1
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|.+.+.||+|+||.||++... +++.||+|++... .......+.+|..++..++|++|+.+++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999765 5788999998642 2233456788999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||++|++|.+++......+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG- 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-
Confidence 999999999999875557899999999999999999999 9999999999999999999999999999987653221
Q ss_pred ccccccccccccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 199 SKSQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
........|+..|+|||++.+ +.++.++|+||||+++|+|++|..||......+.. ..+...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-------------~~i~~~ 223 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------------GKIMNH 223 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH-------------HHHHcC
Confidence 112233568999999998875 45788999999999999999999999753221110 011110
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhcccc--CCCHHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQ--RINAKEIVTR 317 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 317 (335)
.... ........+++.+.+++.+||..++.+ |++++++++.
T Consensus 224 ~~~~---~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 224 EERF---QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCcc---cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0000 000111234677999999999876654 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=283.64 Aligned_cols=245 Identities=26% Similarity=0.318 Sum_probs=202.8
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++.+.||.|++|.||.+... +++.+++|++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 57999999999999999999765 58999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++.... .+++..+..++.+++.||.+|| +.+++|+||+|.||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999987654 7899999999999999999999 999999999999999999999999999998865322
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ......
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------~~~~~~----- 213 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY-------------EKILEG----- 213 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHhcC-----
Confidence 33446788999999998888899999999999999999999998764311110 001100
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
....+...+..+.+++.+||..||.+|+ +++|++..
T Consensus 214 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 ---KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ---CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0111223456799999999999999999 77777743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=280.70 Aligned_cols=246 Identities=28% Similarity=0.500 Sum_probs=199.8
Q ss_pred CCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecC
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
++|++.+.||.|+||.||.+.. +++.+++|....+. ....+.+|+.+++.++|||++++++++.... .+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence 5699999999999999999875 47889999986542 3467889999999999999999999987654 689999999
Q ss_pred CCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 123 HGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 123 ~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
+++|.+++.... ..+++..++.++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~-----~ 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM-----G 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccc-----c
Confidence 999999987543 35899999999999999999999 99999999999999999999999999999875421 1
Q ss_pred cccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. ...+....
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--------------~~~~~~~~----- 214 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--------------KECVEKGY----- 214 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH--------------HHHHhCCC-----
Confidence 122234567999999988889999999999999999997 9999865432111 11111111
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
....+..++..+.+++.+||+.+|++||+++++++.|++
T Consensus 215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111123456779999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=280.94 Aligned_cols=267 Identities=24% Similarity=0.312 Sum_probs=202.5
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
++|++.+.||.|++|.||+|..+ +++.|++|++.... ......+.+|+++++.++|+|++++++++......++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 57999999999999999999866 58999999986442 2334567899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++++|..++... ..+++..++.++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (286)
T cd07847 81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG-- 154 (286)
T ss_pred ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCc--
Confidence 99998888776543 36899999999999999999999 9999999999999999999999999999998663221
Q ss_pred cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHh--HhhhhcChhHHHHHHh---
Q 019843 200 KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKY--WVSNLLPISVMEIVDA--- 273 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~--- 273 (335)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+..... ......+. .....+.
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-HQQIFSTNQF 233 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH-Hhhhcccccc
Confidence 12223457788999998876 45788999999999999999999999765432221110 00010000 0000000
Q ss_pred ---hhccccccch---hhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 274 ---NLLSREDKHF---AAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 274 ---~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.......... ......+..+.+++.+||+.||++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000 011234677999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=284.24 Aligned_cols=255 Identities=21% Similarity=0.253 Sum_probs=200.5
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|.+.+.||.|++|.||++... +++.|++|.+.... ......+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999765 47899999987543 234467889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc-
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED- 197 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~- 197 (335)
||++|++|.+++.... .+++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999997654 7899999999999999999999 9999999999999999999999999999876321000
Q ss_pred ------------cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcCh
Q 019843 198 ------------QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI 265 (335)
Q Consensus 198 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 265 (335)
.........++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------------- 223 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------------- 223 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------------
Confidence 0001112356778999999988889999999999999999999999986532111
Q ss_pred hHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 266 SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
+......... ........+++.+.+++.+||+.||++||++.++++.|+
T Consensus 224 ----~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 224 ----LFGQVISDDI-EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ----HHHHHHhccc-CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 1111110000 000011235677999999999999999998655554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.50 Aligned_cols=195 Identities=23% Similarity=0.335 Sum_probs=160.3
Q ss_pred cceeeecCceEEEEEEEc---CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec--CCeeEEEEEecC
Q 019843 48 NNLIGRGSFGSVYKARIQ---DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN--DDFKALVLEYMP 122 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 122 (335)
.+.||+|+||.||+|..+ +++.+|+|.+.... ....+.+|+++++.++||||+++++++.. ....++++||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 468999999999999754 46789999886432 23567889999999999999999998854 45788999998
Q ss_pred CCChHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE----CCCCcEEEeecccc
Q 019843 123 HGSLEKCLYSS--------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIA 190 (335)
Q Consensus 123 ~~~L~~~l~~~--------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv----~~~~~v~l~dfg~~ 190 (335)
+++|.+++... ...+++..+..++.||+.||.||| +.+++|+||+|+||++ +.++.+||+|||++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 45888876532 235899999999999999999999 9999999999999999 45678999999999
Q ss_pred ccccCCcc-ccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcc
Q 019843 191 KLLTGEDQ-SKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKI 248 (335)
Q Consensus 191 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~ 248 (335)
..+..... ........+|..|+|||++.+ ..++.++||||+||++|+|++|.+||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 86642211 122334578999999999876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=283.96 Aligned_cols=239 Identities=23% Similarity=0.360 Sum_probs=189.4
Q ss_pred eeeecCceEEEEEEEcC-------------------------CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEE
Q 019843 50 LIGRGSFGSVYKARIQD-------------------------GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKI 104 (335)
Q Consensus 50 ~lg~g~~~~v~~~~~~~-------------------------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 104 (335)
.||+|+||.||+|.... ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999986321 13588898865555455678889999999999999999
Q ss_pred eeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC----
Q 019843 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM---- 180 (335)
Q Consensus 105 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~---- 180 (335)
++++...+..++||||+++++|..++....+.+++..+..++.|++.||.||| +++++|+||+|+||+++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998765567899999999999999999999 99999999999999997543
Q ss_pred ---cEEEeeccccccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHH-hCCCCCCcccccchhh
Q 019843 181 ---VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETF-TKKKPTDKIFAGEMTL 255 (335)
Q Consensus 181 ---~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll-~g~~pf~~~~~~~~~~ 255 (335)
.++++|||.+.... ......++..|+|||.+.+ ..++.++|+||||+++|+|+ +|..||......+.
T Consensus 159 ~~~~~kl~d~g~~~~~~------~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-- 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTAL------SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-- 230 (274)
T ss_pred ccceeeecCCccccccc------cccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence 47999999876432 1122346778999998865 56899999999999999985 68999875432211
Q ss_pred HhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 256 KYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
........ ..+...++.+.+++.+||+.+|++||++.++++.|+
T Consensus 231 ------------~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ------------ERFYEKKH--------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ------------HHHHHhcc--------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 01111100 001112345899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=282.10 Aligned_cols=261 Identities=24% Similarity=0.319 Sum_probs=204.4
Q ss_pred cCHHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeec
Q 019843 33 FSYLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSN 110 (335)
Q Consensus 33 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 110 (335)
+.+.++..+.++|.+.+.||.|++|.||+|... +++.+++|++.... .....+..|+.+++.+ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445667777899999999999999999999764 58899999986432 2346677899999999 89999999999865
Q ss_pred C-----CeeEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcE
Q 019843 111 D-----DFKALVLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 182 (335)
Q Consensus 111 ~-----~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v 182 (335)
. +..++|+||+++++|.+++.. ....+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence 3 468999999999999998763 3447899999999999999999999 9999999999999999999999
Q ss_pred EEeeccccccccCCccccccccccccccccCccccCCC-----CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHh
Q 019843 183 HLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG-----RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKY 257 (335)
Q Consensus 183 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~ 257 (335)
+|+|||++...... ........++..|+|||.+... .++.++|+||||+++|+|++|..||..........
T Consensus 168 kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-- 243 (291)
T cd06639 168 KLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-- 243 (291)
T ss_pred EEeecccchhcccc--cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH--
Confidence 99999998765321 1122334678889999987643 36889999999999999999999986542211100
Q ss_pred HhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 258 WVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.+. .........+...+..+.++|.+||+.||++||++.|++..
T Consensus 244 -----------~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 -----------KIP-----RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -----------HHh-----cCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000 00011111122345569999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=283.81 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=216.6
Q ss_pred CCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecC
Q 019843 44 GFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
-|.++..||+|+||.||+|.+ .+|+.+|+|....++ ..+++..|+.+++++.+|++|++||.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 466789999999999999954 469999999987664 46899999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccc
Q 019843 123 HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202 (335)
Q Consensus 123 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~ 202 (335)
.|++.+++..+++++++.++..++.+.+.||+||| ...-+|+||+..|||++.+|..||.|||.+..+. +.-...
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMAKR 186 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhh--hhHHhh
Confidence 99999999999899999999999999999999999 8889999999999999999999999999998764 333445
Q ss_pred ccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccc
Q 019843 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKH 282 (335)
Q Consensus 203 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (335)
+..+||+-|+|||++..-.|+.++||||||++..||.-|++||....+-..-. ..-..+++.
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------------------MIPT~PPPT 248 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------------------MIPTKPPPT 248 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------------------eccCCCCCC
Confidence 56789999999999999999999999999999999999999987643211000 012334455
Q ss_pred hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 283 FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 283 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
+..+...++++.+++++||-.+|++|.++.++++.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 55577789999999999999999999999999874
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=273.57 Aligned_cols=249 Identities=28% Similarity=0.398 Sum_probs=206.9
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecC
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
+|.+.+.||.|++|.||++... +++.+++|++..........+.+|++.++.++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4888999999999999999865 688999999876655566889999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccc
Q 019843 123 HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202 (335)
Q Consensus 123 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~ 202 (335)
+++|.+++......+++..++.++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999876557999999999999999999999 99999999999999999999999999999886532211 3
Q ss_pred ccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccc
Q 019843 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKH 282 (335)
Q Consensus 203 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (335)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .... .....
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--------------~~~~----~~~~~ 216 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF--------------KIAT----NGPPG 216 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH--------------HHHh----cCCCC
Confidence 44567889999999988889999999999999999999999987643111100 0000 01111
Q ss_pred hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 283 FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 283 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
......++..+.+++.+||+.||++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111223566999999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=276.37 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=207.7
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
++|.+.+.||.|++|.||+|... +++.|++|++..... .....+.+|++.+..++|+|++++++++...+.+++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47899999999999999999766 489999999876544 4567899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+++++|.+++... ..+++..++.++.+++.|+.+|| + .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 154 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-- 154 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--
Confidence 9999999999765 47999999999999999999999 9 999999999999999999999999999988663211
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ............
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--------------~~~~~~~~~~~~ 220 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF--------------FELMQAICDGPP 220 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH--------------HHHHHHHhcCCC
Confidence 111244678889999999988899999999999999999999999876542100 111111110000
Q ss_pred ccchhhHHH-HHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 280 DKHFAAKEQ-CVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 280 ~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...... ++..+.+++.+||+.+|++||++.++++.
T Consensus 221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111222 56779999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=282.16 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=204.3
Q ss_pred cCHHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeee-
Q 019843 33 FSYLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCS- 109 (335)
Q Consensus 33 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~- 109 (335)
.+..+.....+.|++.+.||.|+||.||+|... +++.+++|++..... ....+..|+.+++.+ +|+|++++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 345566667789999999999999999999764 588999999865433 336688899999998 7999999999885
Q ss_pred -----cCCeeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEE
Q 019843 110 -----NDDFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 183 (335)
Q Consensus 110 -----~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~ 183 (335)
..+..+++|||+++++|.+++... ...+++..++.++.||+.|+.||| +.+++|+||+|+||+++.++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 356889999999999999988753 346888999999999999999999 99999999999999999999999
Q ss_pred EeeccccccccCCccccccccccccccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhH
Q 019843 184 LSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYW 258 (335)
Q Consensus 184 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~ 258 (335)
|+|||++..... .........++..|+|||.+. +..++.++|+||||+++|+|++|..||..........
T Consensus 162 l~dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--- 236 (282)
T cd06636 162 LVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--- 236 (282)
T ss_pred EeeCcchhhhhc--cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence 999999875421 112233456888999999875 3457889999999999999999999986532111100
Q ss_pred hhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 259 VSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
. +.. ..........++..+.++|.+||+.||.+||++.|+++
T Consensus 237 ----------~-~~~-----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 ----------L-IPR-----NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----------h-Hhh-----CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000 00011112245677999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=277.37 Aligned_cols=247 Identities=24% Similarity=0.412 Sum_probs=202.1
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|++.+.||.|++|.||.|... +++.+++|.+... .......+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5889999999999999999754 5889999998754 234467889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC-CcEEEeeccccccccCCcc
Q 019843 121 MPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 121 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~-~~v~l~dfg~~~~~~~~~~ 198 (335)
+++++|.+++... ...+++..+..++.+++.++.+|| +.+++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-- 155 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-- 155 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--
Confidence 9999999999764 345899999999999999999999 9999999999999999855 46799999999865322
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .......
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~-------------~~~~~~~---- 217 (256)
T cd08220 156 -SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV-------------LKIMSGT---- 217 (256)
T ss_pred -ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH-------------HHHHhcC----
Confidence 2223356788999999999888999999999999999999999998654321111 1111100
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
....+..++..+.+++.+||+.||.+|||+.|++.
T Consensus 218 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 218 ---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01112235667999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=278.45 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=200.5
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC----------chhHHHHHHHHHHHhCCCCceEEEeeeeecCC
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG----------GVFKSFDVECEVMKSIRHRNLIKIISTCSNDD 112 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 112 (335)
+|.+.+.||.|++|.||+|... +++.+++|.+..... ...+.+..|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5888999999999999999754 588999998864211 12346788999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
..++|+||+++++|.+++.... .+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++++|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999987653 7899999999999999999999 99999999999999999999999999999876
Q ss_pred ccCCccccccccccccccccCccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
..............++..|+|||.+.+.. ++.++|+||||+++|++++|..||.......... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-------------~~ 224 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF-------------KL 224 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH-------------Hh
Confidence 43221112223345788899999987654 8899999999999999999999986432111100 00
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..... ...........++..+.+++.+||+.+|.+||+++++++.
T Consensus 225 ~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 225 GNKRS--APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hcccc--CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000 0000011122356779999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=283.12 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=207.7
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
...++|.+.+.||.|++|.||++... ++..|++|.+........+.+.+|+.+++.++|||++++++.+...+..++|+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 33579999999999999999999754 57899999987655555678899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++.+. .+++..+..++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~-- 168 (293)
T cd06647 96 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 168 (293)
T ss_pred ecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc--
Confidence 999999999998754 4789999999999999999999 999999999999999999999999999988755322
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........++..|+|||.+.+..++.++|+||||+++|++++|..||............ ...
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------------------~~~ 230 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------------ATN 230 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------------------hcC
Confidence 12223346788899999998888999999999999999999999999764321110000 000
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.......+..++..+.+++.+||..+|++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111122233456679999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=295.96 Aligned_cols=245 Identities=27% Similarity=0.375 Sum_probs=207.6
Q ss_pred CCCccceeeecCceEEEEEEE-cCCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.|...+.||.|+||.||-|++ .+.+.||||+..-. +.+-++.+..|++.|+++.|||++.+-|+|......++|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 578889999999999999975 46788999998644 34567899999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|| -|+..|++.-..+++-+..+..|..+.++||+||| +.+.+|+|||..|||+++.|.|||+|||.+.+.
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~------ 176 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIM------ 176 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhc------
Confidence 99 77999999887778999999999999999999999 999999999999999999999999999999764
Q ss_pred cccccccccccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 200 KSQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
......+||+.|||||++. .+.|+-+.||||||+++.+|.-.++|+.+..+ + +.+....+
T Consensus 177 ~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--M---------------SALYHIAQ 239 (948)
T KOG0577|consen 177 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--M---------------SALYHIAQ 239 (948)
T ss_pred CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--H---------------HHHHHHHh
Confidence 3456688999999999875 46799999999999999999999999655321 1 11111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..++ .+ .....++.+..++..||+.-|.+|||.++++..
T Consensus 240 NesP-tL-qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 240 NESP-TL-QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred cCCC-CC-CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1111 11 134567889999999999999999999999875
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=285.99 Aligned_cols=253 Identities=26% Similarity=0.343 Sum_probs=204.3
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC---chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG---GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|.+.+.||.|++|.||+|... +++.+++|.+..... .....+..|+++++.++|+||+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47899999999999999999765 489999999875532 24567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 119 EYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 119 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
||+.+++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998754 347899999999999999999999 9999999999999999999999999999987543111
Q ss_pred cc---------------------------cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccc
Q 019843 198 QS---------------------------KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFA 250 (335)
Q Consensus 198 ~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~ 250 (335)
.. .......++..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 00 011134578889999999988899999999999999999999999976432
Q ss_pred cchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCC----HHHHHHH
Q 019843 251 GEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN----AKEIVTR 317 (335)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 317 (335)
.... ....+.. .........++.+.+++.+||..||++||+ ++|++..
T Consensus 238 ~~~~-------------~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DETF-------------SNILKKE------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHH-------------HHHhcCC------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 2111 1111110 111111225677999999999999999999 7777763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=276.77 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=198.0
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-----CchhHHHHHHHHHHHhCCCCceEEEeeeeec--CCee
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-----GGVFKSFDVECEVMKSIRHRNLIKIISTCSN--DDFK 114 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 114 (335)
.+|.+.+.||+|++|.||+|... ++..|++|++.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 57999999999999999999764 58999999886432 2234568889999999999999999998865 4678
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++++||+++++|.+++.... .+++...+.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999987654 6899999999999999999999 9999999999999999999999999999987542
Q ss_pred CCcc-ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 195 GEDQ-SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 195 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
.... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||........ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~----------------~~~~ 221 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA----------------IFKI 221 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH----------------HHHH
Confidence 1111 1111234578889999999988899999999999999999999999875321111 1111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
... ......+..+++.+.+++ +||..+|++||+++|+++
T Consensus 222 ~~~---~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 222 ATQ---PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hcC---CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000 011112334556688888 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=307.03 Aligned_cols=257 Identities=23% Similarity=0.446 Sum_probs=221.4
Q ss_pred CCCccceeeecCceEEEEEEEcC----CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQD----GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
.-.|.++||.|.||.||.|+.+. ...||||.++... ......|..|+.|+-+++||||+++.|+........+|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 44588999999999999998652 4569999998663 445678999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc-
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED- 197 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~- 197 (335)
|||++|+|+.+|..+.+.++..++..++..|+.|+.||. +.+++|+||...||||+.+-.+|++|||+++.+.+..
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 999999999999999889999999999999999999999 9999999999999999999999999999999774332
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.......-.-..+|.|||.+....++.+|||||+|++|||.++ |..||...++.+ +.+.++
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--------------VIkaIe---- 848 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------------VIKAIE---- 848 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--------------HHHHHH----
Confidence 1112222234678999999999999999999999999999877 999988765322 122222
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
...+++.|.+||..|..|+..||++|-.+||.+.+|.+.|.++..
T Consensus 849 --~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 849 --QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred --hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 345677889999999999999999999999999999999999863
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=285.96 Aligned_cols=252 Identities=25% Similarity=0.313 Sum_probs=203.5
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
..+.|.....||.|++|.||.+... ++..|++|.+..........+.+|+..++.++|+|++++++.+...+..++|||
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3345555678999999999999764 588999999876655566778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++++|.+++... .+++..++.++.+|+.|+.||| +.+++|+||+|+||+++.++.++|+|||++...... .
T Consensus 100 ~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~ 172 (292)
T cd06658 100 FLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--V 172 (292)
T ss_pred CCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--c
Confidence 99999999988654 4899999999999999999999 999999999999999999999999999998754321 1
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ . ..+....
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~-------------~~~~~~~---- 234 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-M-------------RRIRDNL---- 234 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-------------HHHHhcC----
Confidence 222334678899999999888899999999999999999999999875321110 0 0011100
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..........+..+.+++.+||..||.+|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 235 PPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01111122345669999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=276.08 Aligned_cols=252 Identities=27% Similarity=0.393 Sum_probs=204.4
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|.+.+.||.|++|.||+|... +++.+++|.+..... .....+..|+++++.++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 6899999999999999999754 689999999876544 3667899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++++|.+++.... .+++..+..++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999987653 5889999999999999999999 9999999999999999999999999999988764322211
Q ss_pred c--cccccccccccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 201 S--QTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 201 ~--~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
. .....++..|+|||.+.+.. ++.++|+||||+++|++++|..||........ .... +
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~------------~---- 219 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFH------------V---- 219 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHH------------H----
Confidence 1 12345788999999988765 88999999999999999999999975431111 1000 0
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
........+....++..+.+++.+||+.+|.+||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 220 GAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred hcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00111111112234667899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=275.44 Aligned_cols=251 Identities=23% Similarity=0.315 Sum_probs=199.2
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-----CchhHHHHHHHHHHHhCCCCceEEEeeeeec--CCee
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-----GGVFKSFDVECEVMKSIRHRNLIKIISTCSN--DDFK 114 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 114 (335)
++|++.+.||+|++|.||.|... ++..|++|.+.... ......+.+|+.+++.+.|+||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999765 58999999886432 1234678889999999999999999998876 3578
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++++||+++++|.+++.... .+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999987653 5889999999999999999999 9999999999999999999999999999987653
Q ss_pred CCccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 195 GEDQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 195 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
..... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----------------~~~-~ 220 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA----------------AIF-K 220 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH----------------HHH-H
Confidence 21111 11223457888999999988889999999999999999999999987532111 110 1
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.... ......+...+..+.+++.+|+. +|++||++++++..
T Consensus 221 ~~~~--~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 221 IATQ--PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HhcC--CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0000 01111234456678999999995 99999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=276.36 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=191.5
Q ss_pred ceeeecCceEEEEEEEcC---CcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCC
Q 019843 49 NLIGRGSFGSVYKARIQD---GMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHG 124 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~---~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 124 (335)
+.||+|+||.||+|...+ +..+++|.+..... .....+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999997543 46789998865532 23357888999999999999999999999999999999999999
Q ss_pred ChHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 125 SLEKCLYSSN----CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 125 ~L~~~l~~~~----~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+|.+++.... ...++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 24567788889999999999999 9999999999999999999999999999987543222222
Q ss_pred ccccccccccccCccccCCC-------CCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 201 SQTQTLATIGYMAPEYGREG-------RVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~-------~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
......++..|+|||++.+. .++.++|+||||+++|+|++ |..||......+.... .+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-------------~~~ 224 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY-------------TVR 224 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH-------------Hhh
Confidence 22334567889999987642 35789999999999999996 9999976433221110 000
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
........ .......++.+.+++.+|+ .+|++|||++||+..|+
T Consensus 225 ~~~~~~~~--~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 225 EQQLKLPK--PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cccCCCCC--CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000000 0111224556889999998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=286.70 Aligned_cols=267 Identities=20% Similarity=0.260 Sum_probs=197.6
Q ss_pred ccceeeec--CceEEEEEEE-cCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 47 ENNLIGRG--SFGSVYKARI-QDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 47 ~~~~lg~g--~~~~v~~~~~-~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
++++||+| ++++||++.. .+|+.||+|.+.... ......+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56889999 6889999965 468999999987542 334467788999999999999999999999999999999999
Q ss_pred CCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc-
Q 019843 122 PHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS- 199 (335)
Q Consensus 122 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~- 199 (335)
++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+++.||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998753 335899999999999999999999 999999999999999999999999999865433211110
Q ss_pred ----cccccccccccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcCh-------h
Q 019843 200 ----KSQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI-------S 266 (335)
Q Consensus 200 ----~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------~ 266 (335)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||............... ..+. .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG-TVPCLLDTTTIP 237 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC-Cccccccccchh
Confidence 11122346677999999876 45889999999999999999999999754332221111100 0000 0
Q ss_pred HHHHHHhh-------------------hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 267 VMEIVDAN-------------------LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 267 ~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...+.... .........+....+++.+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00000000 0000000011122356779999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=285.00 Aligned_cols=257 Identities=23% Similarity=0.301 Sum_probs=206.2
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
..|.....||.|+||.||.|... +++.|++|++..........+.+|+.+++.+.|||++++++.+...+..++++||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 44555678999999999999764 58999999987655555677889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
++++|.+++... .+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 101 ~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~ 173 (297)
T cd06659 101 QGGALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPK 173 (297)
T ss_pred CCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--ccc
Confidence 999999987653 5899999999999999999999 999999999999999999999999999998754311 122
Q ss_pred cccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccccc
Q 019843 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (335)
.....++..|+|||++.+..++.++|+||||+++|+|++|..||......+. . ..+.. ....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~-------------~~~~~----~~~~ 235 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-M-------------KRLRD----SPPP 235 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-------------HHHhc----cCCC
Confidence 2345688899999999888899999999999999999999999875322111 0 00100 0011
Q ss_pred chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
.......++..+.+++.+||+.+|++||+++++++.-.-+...
T Consensus 236 ~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 236 KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 1111223456699999999999999999999999864444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=281.92 Aligned_cols=267 Identities=24% Similarity=0.305 Sum_probs=201.8
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-----chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-----GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
+|.+.+.||.|++|.||+|... +++.|++|.+..... .....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 5888999999999999999765 589999999875432 2345677899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+ +++|.+++......+++..++.++.||++||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 88999998765457999999999999999999999 9999999999999999999999999999998653221
Q ss_pred cccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 198 QSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||....... ..................+....
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 --RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred --ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhcccc
Confidence 12223346778999998855 457889999999999999999988776543211 11111111100000000000000
Q ss_pred ------c--ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 277 ------S--REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 277 ------~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. ............+..+.++|.+||+.||++|||+.|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 0000001112346779999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=314.92 Aligned_cols=253 Identities=20% Similarity=0.277 Sum_probs=199.0
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeec--CC
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN--DD 112 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 112 (335)
.....++|.+.+.||.|+||+||+|... ++..+++|++... .......+..|+.+++.++||||+++++++.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445679999999999999999999765 4778999988654 23345678899999999999999999998854 46
Q ss_pred eeEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhccCC-------CCeEecCCCCCCEEECC----
Q 019843 113 FKALVLEYMPHGSLEKCLYSS---NCVLDIFQRLNIMIDVAAALEYLHFGYS-------APVIHCDLKPSNVLLDD---- 178 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-------~~i~h~di~p~Nilv~~---- 178 (335)
.+++||||+++++|.++|... ...+++..++.|+.||+.||.||| + .+|+|+||+|+|||++.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH---s~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH---NLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hcccccccCCceeccCcHHHeEeecCccc
Confidence 789999999999999998742 347999999999999999999999 6 45999999999999964
Q ss_pred -------------CCcEEEeeccccccccCCccccccccccccccccCccccCC--CCCCCccchhhHHHHHHHHHhCCC
Q 019843 179 -------------NMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTKKK 243 (335)
Q Consensus 179 -------------~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~ 243 (335)
.+.++|+|||++..+.. ........+++.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 23589999999976532 122234578999999998854 458899999999999999999999
Q ss_pred CCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 244 PTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 244 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
||......... ...+... + .. .....+.++.+||.+||..+|.+||++.|++.
T Consensus 242 PF~~~~~~~ql-------------i~~lk~~----p--~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 242 PFHKANNFSQL-------------ISELKRG----P--DL-PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCcCCcHHHH-------------HHHHhcC----C--CC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99653221110 0111100 0 00 01234667999999999999999999999985
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=277.62 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=202.9
Q ss_pred CCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC------CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 44 GFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC------GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
+|+..+.||+|++|.||.|.. .+++.+++|++.... ......+..|++.++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588999999999999999975 468999999986432 1235678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-cEEEeeccccccccC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTG 195 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~-~v~l~dfg~~~~~~~ 195 (335)
|+||+++++|.+++.... ++++..++.++.|++.||.+|| +.+++|+||+|+||+++.++ .++|+|||.+..+..
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999987654 7899999999999999999999 99999999999999998776 599999999876642
Q ss_pred Ccc--ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 196 EDQ--SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 196 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
... ........++..|+|||.+.+..++.++|+||+|+++++|++|..||......... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--------------~~~~~ 222 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--------------ALIFK 222 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH--------------HHHHH
Confidence 211 11122345788899999998888999999999999999999999998643221110 01111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.... ......+...++.+.+++.+||..+|.+||++.+++.
T Consensus 223 ~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 IASA--TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred Hhcc--CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000 1111223445677999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=278.53 Aligned_cols=261 Identities=23% Similarity=0.261 Sum_probs=202.4
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeec--CCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSN--DDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 118 (335)
++|...+.||.|++|.||.|... +++.+++|.+..... .....+.+|+++++.++||||+++++++.. .+.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47889999999999999999864 588899999875433 345678999999999999999999998864 45789999
Q ss_pred EecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 119 EYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 119 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
||+++++|.+++.. ....+++..+..++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~- 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV- 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccc-
Confidence 99999999988653 3446899999999999999999999 9999999999999999999999999999987542
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||............ ....+....
T Consensus 157 ---~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~ 224 (287)
T cd06621 157 ---NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE---------LLSYIVNMP 224 (287)
T ss_pred ---ccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHH---------HHHHHhcCC
Confidence 11222345678899999999889999999999999999999999999765321111000 001110000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
..............++.+.+++.+||..||.+|||+.|+++.-+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 00000001101123567999999999999999999999998543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=298.83 Aligned_cols=245 Identities=25% Similarity=0.410 Sum_probs=210.7
Q ss_pred ceeeecCceEEEEEEEcC-CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCChH
Q 019843 49 NLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLE 127 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 127 (335)
-+||+|.||+||.|++.+ ...+|||-+...+....+-+.+|+.+-+++.|.|||+++|.+..+++.-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 479999999999998664 6679999998777777789999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCC--CHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC-CCcEEEeeccccccccCCcccccccc
Q 019843 128 KCLYSSNCVL--DIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGEDQSKSQTQ 204 (335)
Q Consensus 128 ~~l~~~~~~~--~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~-~~~v~l~dfg~~~~~~~~~~~~~~~~ 204 (335)
+++...=+++ .+...-.+..||++||.||| ...|+|+|||-+|++++. .|.+||+|||.+..+. ........
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhc--cCCccccc
Confidence 9999876677 78889999999999999999 999999999999999975 5789999999998874 33444556
Q ss_pred ccccccccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccc
Q 019843 205 TLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKH 282 (335)
Q Consensus 205 ~~~~~~y~aPE~~~~~--~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (335)
.-||..|||||++..+ .|+.++|||||||++.||.||++||-....+...+ ..-++ ....
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---------------FkVGm---yKvH 797 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---------------FKVGM---YKVH 797 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---------------hhhcc---eecC
Confidence 7799999999999765 48999999999999999999999998765544332 11122 2334
Q ss_pred hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 283 FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 283 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.+.|..++.+.+.+|.+|+..||.+||+++++|.
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 4557778899999999999999999999999985
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=278.89 Aligned_cols=249 Identities=25% Similarity=0.298 Sum_probs=202.7
Q ss_pred CCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 43 DGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
..|...+.||.|++|.||++.. .+++.+++|++..........+.+|+.+++.++|+|++++++.+...+..++++||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 3566678999999999999975 468899999987655555567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
++++|.+++.. ..++...+..++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~ 171 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPR 171 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Ccc
Confidence 99999999876 35899999999999999999999 999999999999999999999999999987754311 122
Q ss_pred cccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccccc
Q 019843 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (335)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ...+... ...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~--------------~~~~~~~----~~~ 233 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA--------------MKRIRDN----LPP 233 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH--------------HHHHHhc----CCC
Confidence 2335678899999999888899999999999999999999999865321110 0000000 111
Q ss_pred chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
....+..++..+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 234 KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11112224667999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=276.38 Aligned_cols=238 Identities=24% Similarity=0.412 Sum_probs=190.3
Q ss_pred ceeeecCceEEEEEEEcC-C----------cEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 49 NLIGRGSFGSVYKARIQD-G----------MEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~-~----------~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
+.||+|+||.||+|.... + ..+++|++...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999997653 2 24788877654433 5788999999999999999999999888 778999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-------cEEEeecccc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM-------VAHLSDFGIA 190 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~-------~v~l~dfg~~ 190 (335)
+||+++++|.+++......+++..+..++.+|+.||.||| +.+++|+||+|+||+++.++ .++|+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999876657899999999999999999999 99999999999999999887 7999999998
Q ss_pred ccccCCccccccccccccccccCccccCCC--CCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhH
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
..... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.......... .+
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~--------- 219 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FY--------- 219 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-HH---------
Confidence 76431 2234456779999998876 78999999999999999999 577776543211110 00
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
........ .....+.+++.+||..+|.+||++.++++.|+
T Consensus 220 ---~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 ---QDQHRLPM---------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---hcCCCCCC---------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000000 00145899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=282.38 Aligned_cols=240 Identities=24% Similarity=0.351 Sum_probs=191.1
Q ss_pred ceeeecCceEEEEEEEcC--------CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 49 NLIGRGSFGSVYKARIQD--------GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+.||.|+||.||+|.... ..++++|.+........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999997532 234888887655555567889999999999999999999999998999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc--------EEEeecccccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--------AHLSDFGIAKL 192 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~--------v~l~dfg~~~~ 192 (335)
+++++|.+++......+++..+..++.||+.||.||| +.+++|+||+|+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999876657899999999999999999999 999999999999999987764 69999998865
Q ss_pred ccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCC-CCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKK-KPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
.. ......++..|+|||++.+ ..++.++|+||||+++|+|++|. .||........ ...
T Consensus 158 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--------------~~~ 217 (258)
T cd05078 158 VL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--------------LQF 217 (258)
T ss_pred cC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--------------HHH
Confidence 42 1223456788999999886 45789999999999999999985 55543221110 001
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
... ....+...+.++.+++.+||+.||++|||++++++.|+
T Consensus 218 ~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 218 YED--------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHc--------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 110 00111223456999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=279.35 Aligned_cols=247 Identities=25% Similarity=0.319 Sum_probs=204.1
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
+|.+.+.||.|++|.||+|... ++..+++|++.... ......+.+|++++++++||||+++++.+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999765 58999999987442 2456788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+.+++|.+++... .++++..+..++.++++||.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998766 47999999999999999999999 9999999999999999999999999999988653221
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..+......
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~--- 216 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR--------------DQIRAKQET--- 216 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH--------------HHHHHHhcc---
Confidence 23345678889999999888899999999999999999999999886542110 001100000
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCH--HHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINA--KEIV 315 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~--~ell 315 (335)
.....+..++..+.+++.+||..||.+||++ +|++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112233456779999999999999999999 6665
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=272.71 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=207.7
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCceEEEeeeeecC--CeeEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIISTCSND--DFKALVL 118 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 118 (335)
+|...+.||+|++|.||.|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5888999999999999999866 689999999875542 4567899999999999999999999999988 8999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
|++++++|.+++.... .+++..++.++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999988765 8999999999999999999999 99999999999999999999999999999987643322
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........++..|+|||.+.+..++.++|+||||+++++|++|..||.......... ..+..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------------~~~~~------ 218 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL------------YKIGS------ 218 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH------------Hhccc------
Confidence 112344568889999999988889999999999999999999999987654111100 00000
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.......+...+..+.+++.+||+.||.+||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11111123344677999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=278.69 Aligned_cols=255 Identities=27% Similarity=0.453 Sum_probs=199.2
Q ss_pred CCccceeeecCceEEEEEEEc----CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC------
Q 019843 45 FSENNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD------ 112 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 112 (335)
|.+.+.||+|++|.||+|... +++.|++|++..+ .....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999743 3688999998654 2334567889999999999999999999876432
Q ss_pred eeEEEEEecCCCChHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeec
Q 019843 113 FKALVLEYMPHGSLEKCLYSS-----NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 187 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~df 187 (335)
..+++++|+.+++|.+++... ...++...++.++.+++.|+.||| +.+++|+||+|+||+++.++.++++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 346889999999998877432 225788999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChh
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPIS 266 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 266 (335)
|++................++..|++||.+.+..++.++||||||+++|+|++ |.+||........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~------------- 224 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI------------- 224 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH-------------
Confidence 99886532221222223345677999999988889999999999999999999 8888865432111
Q ss_pred HHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
...+... .....+..++..+.+++.+||+.+|++|||+.+++..|++++
T Consensus 225 -~~~~~~~------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 225 -YNYLIKG------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred -HHHHHcC------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 0011000 001111234567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=287.76 Aligned_cols=263 Identities=24% Similarity=0.421 Sum_probs=223.5
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCch-hHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGV-FKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.+...++++||+|.||.|.++....+..||+|+++.+.... ..+|..|+++|.+++||||+.++++|..++.+++++||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 35677899999999999999988878999999998776544 48999999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSSNCV-LDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~-~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
++.|+|..++.++..+ +.......|+.||+.|++||. +.+++||||.+.|+|++.++++|++|||+++-+++.+..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999877423 355677789999999999999 999999999999999999999999999999988877878
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT--KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
...+..+-..+|+|||.+..++++.+||+|+||+++||+++ ...||+....++ ..+.....+..
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--------------vven~~~~~~~ 759 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--------------VVENAGEFFRD 759 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--------------HHHhhhhhcCC
Confidence 88888888999999999999999999999999999999866 678877654322 11111111111
Q ss_pred ccc-cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 278 RED-KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 278 ~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
+.. ..+..|.-|+..+.+++.+||..+-++|||.+++-..|++.
T Consensus 760 ~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 760 QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111 22344567899999999999999999999999999888754
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=279.32 Aligned_cols=267 Identities=23% Similarity=0.255 Sum_probs=200.8
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCceEEEeeeeecC--CeeEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIISTCSND--DFKALV 117 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 117 (335)
++|++.+.||.|++|.||+|... +++.+++|.++.... .....+.+|+.+++.++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57999999999999999999876 588999999875432 2234567899999999999999999998876 899999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
+||++ ++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99996 4999988776657999999999999999999999 9999999999999999999999999999988664221
Q ss_pred cccccccccccccccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH---Hh
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV---DA 273 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 273 (335)
.......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........... ............+. +-
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK-IFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCchHHHHHhhcc
Confidence 2223345678899999887644 68899999999999999999999976432211111 11100000000000 00
Q ss_pred hh--------ccccccchhhHHH-HHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 274 NL--------LSREDKHFAAKEQ-CVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 274 ~~--------~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.. ..........+.. +++.+.++|.+||+.||++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 0000000000111 3667999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=275.90 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=201.3
Q ss_pred CCCccceeeecCceEEEEEEEcC--CcEEEEEEeecC----------CCchhHHHHHHHHHHHh-CCCCceEEEeeeeec
Q 019843 44 GFSENNLIGRGSFGSVYKARIQD--GMEVAVKVFHLQ----------CGGVFKSFDVECEVMKS-IRHRNLIKIISTCSN 110 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~~--~~~v~iK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 110 (335)
.|++.+.||+|++|.||.|.... ++.+++|.+... .......+..|+.++.. ++|+||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999998654 688999987532 12234567778888875 699999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCCcEEEee
Q 019843 111 DDFKALVLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSD 186 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~~v~l~d 186 (335)
.+..+++|||+++++|.+++.. ....+++..++.++.+++.+|.+|| + .+++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 3446899999999999999999999 6 6899999999999999999999999
Q ss_pred ccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh
Q 019843 187 FGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266 (335)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 266 (335)
||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.........
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~------------ 222 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA------------ 222 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH------------
Confidence 99998653221 334456788899999999888999999999999999999999998653221110
Q ss_pred HHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
..+.+..... .....+++.+.+++.+||+.||++||++.|+.+++.
T Consensus 223 -~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 223 -TKIVEAVYEP------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -HHHhhccCCc------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111000 011134567999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=276.73 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=189.8
Q ss_pred ceeeecCceEEEEEEEcC---CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCC
Q 019843 49 NLIGRGSFGSVYKARIQD---GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHG 124 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~---~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 124 (335)
+.||+|+||.||+|.... ...+++|.+.... ......+.+|++.++.++|+||+++++.+.....+++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999996432 4568888765443 233456788999999999999999999999999999999999999
Q ss_pred ChHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 125 SLEKCLYSSN----CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 125 ~L~~~l~~~~----~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+|.+++.... ...++..+..++.||+.|+.||| +.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999987643 23467888999999999999999 9999999999999999999999999999986542222122
Q ss_pred ccccccccccccCccccC-------CCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 201 SQTQTLATIGYMAPEYGR-------EGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~-------~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
......++..|+|||++. ...++.++||||||+++|+|++ |..||......+.. ...+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------------~~~~~ 224 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL-------------KQVVR 224 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH-------------HHHhh
Confidence 223344567799999864 3456889999999999999999 78888654321110 01111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
....... .......+++.+.+++..|+ .||++||++++|++.|.
T Consensus 225 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 225 EQDIKLP--KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCccCC--CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1100000 11112345666888888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=280.10 Aligned_cols=317 Identities=25% Similarity=0.286 Sum_probs=231.6
Q ss_pred eeehhhHHHHhhCCCCCCCCCCCCcccccccCHHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCch
Q 019843 3 VVILLISRYRKRGKQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGV 82 (335)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~ 82 (335)
|.+++-+|+||-.+..+.....|..+.-+..+..... .......++||+|.||.||+|... ++.||||++... .
T Consensus 172 i~~~~~~r~~k~~~~~~e~~~~p~~d~~~~~sspl~~--l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~ 245 (534)
T KOG3653|consen 172 ILAFLGYRQRKNAREEIEPVLIPLEDSGPAPSSPLLE--LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---E 245 (534)
T ss_pred HHHHHHHHHhhcccccCccCcccCCCCCCCCCccccc--CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---H
Confidence 4456667777766664444444433333333322222 456677899999999999999988 699999999755 4
Q ss_pred hHHHHHHHHHHHhC--CCCceEEEeeeeecCC----eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 019843 83 FKSFDVECEVMKSI--RHRNLIKIISTCSNDD----FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL 156 (335)
Q Consensus 83 ~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~L 156 (335)
.+.+.+|-+|++.. +|+||+++++.-.... .+++|++|.+.|+|.++|... .+++.....++..+++||+||
T Consensus 246 kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~L 323 (534)
T KOG3653|consen 246 KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHL 323 (534)
T ss_pred HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHh
Confidence 57888888888865 7999999998876655 889999999999999999876 499999999999999999999
Q ss_pred hc------cCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCC-C-----C
Q 019843 157 HF------GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV-S-----T 224 (335)
Q Consensus 157 h~------~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~-----~ 224 (335)
|+ ..+.+|+|||||+.||||..|++..|+|||++-++............+||.+|||||++.+... . .
T Consensus 324 Hee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afk 403 (534)
T KOG3653|consen 324 HEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFK 403 (534)
T ss_pred cccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHH
Confidence 94 3366899999999999999999999999999999865544455556889999999999876432 1 3
Q ss_pred ccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhH---HHHHHHHHHHHHHhc
Q 019843 225 NGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK---EQCVSFVFNLAMECT 301 (335)
Q Consensus 225 ~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l 301 (335)
+.||||+|.++||+++...-+.....++..+..-..--..+..++..+-...++..+.++.. ..-..-+.+.+..||
T Consensus 404 r~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCW 483 (534)
T KOG3653|consen 404 RIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECW 483 (534)
T ss_pred HHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHc
Confidence 68999999999999997665543222222222211111122233322222222222221111 123455999999999
Q ss_pred hhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 302 VESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 302 ~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
.+||+.|.|+.=+.+++.++......
T Consensus 484 DhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 484 DHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCchhhhhhhHHHHHHHHHHhccCCc
Confidence 99999999999999999998765543
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=277.41 Aligned_cols=265 Identities=25% Similarity=0.308 Sum_probs=199.5
Q ss_pred CCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 45 FSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
|++.+.||.|++|.||+|... +|..|++|++.... ......+.+|+++++.++|+|++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999765 68999999987553 233467888999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+ ++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VR 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cc
Confidence 5 68998886543 46899999999999999999999 999999999999999999999999999998754211 11
Q ss_pred ccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH---------HH
Q 019843 201 SQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM---------EI 270 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~ 270 (335)
......++..|+|||++.+. .++.++|+||||+++|+|++|..||........... ........... +.
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR-IFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChHHhhhhhhchhh
Confidence 22233567889999987654 568899999999999999999999976433221111 11110000000 00
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..................++..+.+++.+||+.||.+||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000001112234567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=280.80 Aligned_cols=267 Identities=25% Similarity=0.329 Sum_probs=201.7
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
++|++.+.||.|++|.||+|..+ +++.+++|++.... ......+.+|+++++.++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 57999999999999999999875 58999999875432 2234668889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++++|.++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-- 154 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 154 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence 99998888876544 35899999999999999999999 9999999999999999999999999999987653221
Q ss_pred cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhH--hHhhhhcChhHHHHHH----
Q 019843 200 KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK--YWVSNLLPISVMEIVD---- 272 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~---- 272 (335)
.......++..|+|||++.+ ..++.++|+||||+++|+|++|.+||......+.... ....... .......+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLI-PRHQEIFQKNPL 233 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCc-hhhHHHhccchH
Confidence 22223457888999998875 4478899999999999999999999865432111100 0000000 00000000
Q ss_pred --hhhccccc---cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 273 --ANLLSRED---KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 273 --~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
........ ........++..+.+++.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 000112245777999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=278.33 Aligned_cols=269 Identities=23% Similarity=0.290 Sum_probs=202.5
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
++|++.+.||.|++|.||+|... +++.|++|.+... .......+.+|+++++.++|+||+++++++...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999765 5889999988643 23445788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|++++.+..+..+ ...+++..++.++.+++.|+.+|| ..+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 9988666655544 346899999999999999999999 99999999999999999999999999999886642221
Q ss_pred cccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhH--hHhhhhcChhHHHHHH-hhh
Q 019843 200 KSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK--YWVSNLLPISVMEIVD-ANL 275 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~ 275 (335)
.......++..|+|||++.+. .++.++|+||||+++|+|++|..||......+.... .......+........ ...
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 122335678889999999887 789999999999999999999999875432211110 0000000000000000 000
Q ss_pred ----ccccccch----hhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 276 ----LSREDKHF----AAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 276 ----~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
........ ..+..++..+.++|.+||..+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 011224677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=290.29 Aligned_cols=241 Identities=23% Similarity=0.268 Sum_probs=187.8
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhC---CCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSI---RHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 51 lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
||+|+||.||+|... +++.||+|++.... .........|..++... .||||+++++.+...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999765 58999999986431 12233444566666655 699999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTN 154 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCcc
Confidence 99999887554 7899999999999999999999 99999999999999999999999999999875321 112233
Q ss_pred cccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccc
Q 019843 204 QTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKH 282 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (335)
...|+..|+|||++.+. .++.++|||||||++|+|++|..||......+. ........ ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-----------------~~~i~~~~--~~ 215 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-----------------YRNIAFGK--VR 215 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-----------------HHHHHcCC--CC
Confidence 45689999999998754 478999999999999999999999876432111 11100000 00
Q ss_pred hhhHHHHHHHHHHHHHHhchhccccCC----CHHHHHHH
Q 019843 283 FAAKEQCVSFVFNLAMECTVESAEQRI----NAKEIVTR 317 (335)
Q Consensus 283 ~~~~~~~~~~l~~li~~~l~~dP~~Rp----s~~ell~~ 317 (335)
++ ...+++++.+++.+||+.||++|| ++.++++.
T Consensus 216 ~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 216 FP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 00 122466789999999999999998 56776653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=277.17 Aligned_cols=266 Identities=25% Similarity=0.335 Sum_probs=199.5
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|++.+.||.|++|.||+|... +++.|++|.+..+. ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4889999999999999999765 58899999887543 23346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+. ++|.+++... ...+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++...... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--V 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--c
Confidence 95 5888887653 346899999999999999999999 999999999999999999999999999998755311 1
Q ss_pred cccccccccccccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc-Ch-hH----HHHHH
Q 019843 200 KSQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL-PI-SV----MEIVD 272 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~-~~----~~~~~ 272 (335)
.......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........... ...... +. .. ..+..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR-IFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhCCCChhhhhhhhHHHH
Confidence 1223334678899999876644 68899999999999999999999975432221111 111110 00 00 00000
Q ss_pred --hhhcccccc-chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 273 --ANLLSREDK-HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 273 --~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
......... .......++..+.++|.+||+.||.+||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000 00011234667899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=275.67 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=200.7
Q ss_pred CCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC-CchhHHHHHHHHHHHhCC---CCceEEEeeeeecCCeeEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIR---HRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~ 118 (335)
.|++.+.||.|++|.||+|.+ .+++.+++|.+.... ......+.+|+.+++.+. |||++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 588899999999999999975 468999999987542 334567888999999986 999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++... .+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+..+....
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 999999999988654 6899999999999999999999 9999999999999999999999999999988764222
Q ss_pred ccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 199 SKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... .+...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--------------~~~~~--- 217 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--------------LIPKS--- 217 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh--------------ccccC---
Confidence 22334468889999998765 457899999999999999999999997543211100 00000
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...... ...++.++.+++.+||+.||++||++.++++.
T Consensus 218 -~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 218 -KPPRLE-DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -CCCCCC-cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 000000 11245679999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=279.49 Aligned_cols=254 Identities=26% Similarity=0.341 Sum_probs=203.0
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
+.|...+.||+|+||.||+|... ++..+++|.+.... ......+.+|+++++.++|+|++++++++...+..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 45888999999999999999754 58899999986432 234457888999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+.+ ++.+.+.....++++..+..++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~---- 176 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS---- 176 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccC----
Confidence 99964 787877665567999999999999999999999 9999999999999999999999999999886542
Q ss_pred ccccccccccccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 199 SKSQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
......++..|+|||.+. ++.++.++|+||||+++|+|++|..||......... ..+.....
T Consensus 177 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-------------~~~~~~~~ 241 (317)
T cd06635 177 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------------YHIAQNES 241 (317)
T ss_pred --CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH-------------HHHHhccC
Confidence 122345788899999873 456889999999999999999999998653211110 01111000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
.......+++.+.+++.+||+.+|.+||++.++++.+..+....
T Consensus 242 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 242 ------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 01112234567999999999999999999999999776554433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=274.37 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=202.2
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+-|++.+.||.|+||.||+|... ++..+++|++.... ......+.+|+.+++.++||||+++++.+..+...++|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45778899999999999999754 58899999876432 33456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++++|.+++... .+++..+..++.+++.++.+|| +.+++|+||+|+||+++.++.++++|||++..+... ..
T Consensus 84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~ 156 (277)
T cd06641 84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QI 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccc--hh
Confidence 9999999988653 5899999999999999999999 999999999999999999999999999998765321 11
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ...+... ..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--------------~~~~~~~----~~ 218 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV--------------LFLIPKN----NP 218 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH--------------HHHHhcC----CC
Confidence 22334578889999999888889999999999999999999999865322111 0011110 00
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. .....++.++.+++.+||..+|.+||++.+++..
T Consensus 219 ~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 P--TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred C--CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 1122346679999999999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=278.55 Aligned_cols=251 Identities=27% Similarity=0.356 Sum_probs=200.9
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
+...+|.+.+.||.|++|.||.|... +++.|++|++.... .+....+.+|+++++.++|||++++++++.+.+..+
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34467999999999999999999765 58999999986432 233457889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+|+||++ +++.+++......+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~- 166 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS- 166 (307)
T ss_pred EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecC-
Confidence 9999996 5777777655557999999999999999999999 9999999999999999999999999999887542
Q ss_pred CccccccccccccccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
......++..|+|||++. ...++.++||||||+++|+|++|..||.......... .+.
T Consensus 167 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-------------~~~- 227 (307)
T cd06607 167 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------------HIA- 227 (307)
T ss_pred -----CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-------------HHh-
Confidence 112345778899999874 4568889999999999999999999986542211100 000
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
. ..... .....++..+.+++.+||+.||++||++.+++...+
T Consensus 228 ---~-~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 228 ---Q-NDSPT-LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred ---c-CCCCC-CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 0 00000 012235667999999999999999999999988543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=282.35 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=215.6
Q ss_pred hhcCCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.++.-|.+.+.||+|.|+.|-+|+ .-+|..||||++... +.-....+.+|++-++.++|||||++|++...+..+|+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 356789999999999999999995 457999999999654 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE-CCCCcEEEeeccccccccC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL-DDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv-~~~~~v~l~dfg~~~~~~~ 195 (335)
|+|.-++|+|.|+|.+....+.+....+++.||+.|+.|.| +..++|+||||+|+.+ ..-|-|||.|||++..+.
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~- 170 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ- 170 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC-
Confidence 99999999999999988778999999999999999999999 9999999999999766 567899999999998873
Q ss_pred CccccccccccccccccCccccCCCCCC-CccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVS-TNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
........+|...|.|||++.|..|+ ++.||||||++||.|.+|++||......+.. ..+
T Consensus 171 --PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL-------------TmI---- 231 (864)
T KOG4717|consen 171 --PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL-------------TMI---- 231 (864)
T ss_pred --CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh-------------hhh----
Confidence 34455667899999999999998886 5789999999999999999999764322211 111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
..=++..|..++.+.++||..||..||++|.+.+||.+.-|
T Consensus 232 ----mDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 232 ----MDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred ----hcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 11234457778999999999999999999999999987544
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=278.75 Aligned_cols=195 Identities=24% Similarity=0.336 Sum_probs=159.3
Q ss_pred cceeeecCceEEEEEEEc---CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeee--cCCeeEEEEEecC
Q 019843 48 NNLIGRGSFGSVYKARIQ---DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS--NDDFKALVLEYMP 122 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~ 122 (335)
.+.||+|+||.||+|... ++..|++|.+.... ....+.+|+++++.++||||+++++++. .....++++||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999854 35789999876432 2356788999999999999999999885 3567889999985
Q ss_pred CCChHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE----CCCCcEEEeecccc
Q 019843 123 HGSLEKCLYSS--------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIA 190 (335)
Q Consensus 123 ~~~L~~~l~~~--------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv----~~~~~v~l~dfg~~ 190 (335)
++|.+++... ...+++..++.++.||+.||.||| +.+++|+||+|+||++ +.++.++|+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5777776421 235889999999999999999999 9999999999999999 56679999999999
Q ss_pred ccccCCcc-ccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcc
Q 019843 191 KLLTGEDQ-SKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKI 248 (335)
Q Consensus 191 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~ 248 (335)
..+..... ........++..|+|||++.+ ..++.++||||||+++|+|++|.+||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 86642211 112234567899999999876 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=273.45 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=201.9
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeee--cCCeeEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCS--NDDFKALVL 118 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 118 (335)
+|.+.+.||.|++|.||+|... +++.+++|.+... .....+.+..|+++++.++|+||+++++.+. .....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5889999999999999999754 5889999998643 2334567888999999999999999999775 356788999
Q ss_pred EecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhccC--CCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 119 EYMPHGSLEKCLYSS---NCVLDIFQRLNIMIDVAAALEYLHFGY--SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 119 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~--~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
||+++++|.+++... ..++++..++.++.+|+.||.+||... +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 457899999999999999999999322 568999999999999999999999999999876
Q ss_pred cCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
.... .......++..|+|||.+.+..++.++|+||||+++++|++|..||........ ...+..
T Consensus 161 ~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~ 224 (265)
T cd08217 161 GHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL--------------ASKIKE 224 (265)
T ss_pred cCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHH--------------HHHHhc
Confidence 4221 112334688899999999988899999999999999999999999876432111 111111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
... ...+...+..+.+++.+||+.+|++||++.+|++
T Consensus 225 ~~~------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 225 GKF------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCC------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 111 1122345677999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=289.65 Aligned_cols=208 Identities=24% Similarity=0.333 Sum_probs=177.4
Q ss_pred cccCHHHHhhhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-C-----CceEE
Q 019843 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-H-----RNLIK 103 (335)
Q Consensus 31 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~ 103 (335)
..+.+-.-.-.+.+|.+.++||+|+||.|.+|.+ ++++.||||+++... ........|+.+|..++ | -|+|+
T Consensus 174 ~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vr 252 (586)
T KOG0667|consen 174 GDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVR 252 (586)
T ss_pred CceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEE
Confidence 3344444455566999999999999999999964 569999999998664 34466677999999986 3 48999
Q ss_pred EeeeeecCCeeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC--CC
Q 019843 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD--NM 180 (335)
Q Consensus 104 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~--~~ 180 (335)
++++|...++.|+|+|.+ ..+|.++++.. ...++...+..++.||+.||..|| ..+|+|+||||+|||+.+ ..
T Consensus 253 m~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~ 328 (586)
T KOG0667|consen 253 MLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRS 328 (586)
T ss_pred eeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcC
Confidence 999999999999999998 77999999864 346999999999999999999999 999999999999999964 34
Q ss_pred cEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcc
Q 019843 181 VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKI 248 (335)
Q Consensus 181 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~ 248 (335)
.||++|||++.... ......+.+..|.|||++.|.+|+.+.|||||||++.||++|.+.|.+.
T Consensus 329 ~vKVIDFGSSc~~~-----q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 329 RIKVIDFGSSCFES-----QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ceeEEecccccccC-----CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 79999999998753 2222567788899999999999999999999999999999998887653
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=275.12 Aligned_cols=250 Identities=27% Similarity=0.354 Sum_probs=194.1
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHH-HHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEV-MKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
++|++.+.||+|+||.||+|..+ +|+.||+|.+.... ......+..|+.. ++.++||||+++++++...+..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47999999999999999999765 58999999987543 2233445556554 566789999999999999999999999
Q ss_pred ecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCC-CeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 120 YMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 120 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~-~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
|++ ++|.+++.. ....+++..++.++.|++.||.||| ++ +++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 688877754 2346899999999999999999999 87 999999999999999999999999999876531
Q ss_pred CccccccccccccccccCccccCC----CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGRE----GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... ....
T Consensus 157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------------~~~~ 221 (283)
T cd06617 157 ---SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL------------KQVV 221 (283)
T ss_pred ---ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH------------HHHH
Confidence 112233457888999998765 446889999999999999999999986532211111 1111
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
... .... ....++.++.+++.+||..+|.+||++.++++.
T Consensus 222 ~~~-----~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 222 EEP-----SPQL-PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred hcC-----CCCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 0001 012356779999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=275.13 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=201.2
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
+|++.+.||.|++|.||+|... ++..|++|++..... .....+.+|+++++.++|+||+++++.+...+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999875 588999999876532 33467778999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 122 PHGSLEKCLYSSN--CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 122 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
++ +|.+++.... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++...... .
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~ 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--V 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--c
Confidence 75 8888876543 46899999999999999999999 999999999999999999999999999998754311 1
Q ss_pred cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh---HHHHHHhhh
Q 019843 200 KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS---VMEIVDANL 275 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 275 (335)
.......++..|++||.+.+ ..++.++|+||||+++|+|++|..||......+. ............ ...+.+...
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCch
Confidence 12233456788999998765 4578899999999999999999999976543222 111111111000 000000000
Q ss_pred cccc------ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 276 LSRE------DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 276 ~~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.... .........+++.+.+++.+||+.||.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0000111234677999999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=316.82 Aligned_cols=271 Identities=26% Similarity=0.445 Sum_probs=208.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
.....|...+.||+|+||.||+|.. .++..||+|.+..... ....|++.+++++||||+++++++.+.+..++||
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3445688889999999999999986 4689999998864322 1234688899999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++. .+++..+..++.+++.|+.|||...+.+++|+||+|+||+++.++..++. ++......
T Consensus 763 Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~---- 833 (968)
T PLN00113 763 EYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC---- 833 (968)
T ss_pred eCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc----
Confidence 9999999999985 37899999999999999999995446699999999999999988887765 55443221
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc-ChhHHHHHHhhhcc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL-PISVMEIVDANLLS 277 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 277 (335)
......++..|+|||++.+..++.++||||||+++|||++|+.||+...........|..... +.....++++....
T Consensus 834 --~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 834 --TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 112235788999999999999999999999999999999999999654433333333333222 11222223322211
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcccc
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICT 329 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 329 (335)
. .........++.+++.+||+.||++||+++|+++.|+++......|.
T Consensus 912 ~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~ 959 (968)
T PLN00113 912 D----VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCV 959 (968)
T ss_pred C----CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccc
Confidence 1 11122334568899999999999999999999999999877665554
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=269.77 Aligned_cols=247 Identities=30% Similarity=0.417 Sum_probs=204.9
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|++.+.||.|++|.||.|... +++.+++|.+..... .....+.+|+++++.+.|+|++++++++...+..++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5889999999999999999765 578999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++++|.+++... ..+++..++.++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~ 154 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--K 154 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc--c
Confidence 9999999998765 47999999999999999999999 9999999999999999999999999999998764221 1
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
......++..|+|||...+..++.++|+||+|+++|+|++|..||.......... ... . .
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~-------------~~~----~---~ 214 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF-------------RIV----Q---D 214 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH-------------HHh----c---c
Confidence 1233467888999999988888999999999999999999999987543111100 000 0 0
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.....+..+++.+.+++.+||..+|++||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111123345677999999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=283.08 Aligned_cols=269 Identities=23% Similarity=0.240 Sum_probs=201.7
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecC---
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSND--- 111 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 111 (335)
.+...++|++.+.||+|++|.||+|... +++.|++|.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 11 ~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 11 TFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 4456799999999999999999999764 6899999998643 233446677899999999999999999987643
Q ss_pred ---CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 112 ---DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 112 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
...++|+||+. ++|.+.+... ++...+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35789999995 5888877543 889999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC--hh
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP--IS 266 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~ 266 (335)
++...... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ........... ..
T Consensus 164 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 239 (353)
T cd07850 164 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDE 239 (353)
T ss_pred cceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHH
Confidence 99865321 12233457888999999999999999999999999999999999997543211 11111111110 00
Q ss_pred HHHHHHh----hhccccc-----------------cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 267 VMEIVDA----NLLSRED-----------------KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 267 ~~~~~~~----~~~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
....++. ....... .........++.+.+++.+||+.||++|||+.|++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000000 0000012346678999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=272.75 Aligned_cols=261 Identities=20% Similarity=0.263 Sum_probs=195.3
Q ss_pred CCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCC-CCceEEEeeeeecC--CeeEEEEE
Q 019843 45 FSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIR-HRNLIKIISTCSND--DFKALVLE 119 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e 119 (335)
|++.+.||.|++|.||+|... +++.+++|.+.... .........|+..+.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678999999999999999754 58899999986542 222234457888888884 99999999999887 89999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|++ +++.+.+......+++..++.++.+++.||.+|| +.+++|+||+|+||+++. +.++|+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--- 152 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--- 152 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccC---
Confidence 996 5888888765557999999999999999999999 999999999999999999 99999999999865322
Q ss_pred cccccccccccccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 200 KSQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......++..|+|||.+. +..++.++|+||||+++|+|++|..||......+. ... ...........+... ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~-~~~-~~~~~~~~~~~~~~~-~~~~ 229 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ-IAK-IHDVLGTPDAEVLKK-FRKS 229 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH-HHH-HHHHcCCCCHHHHHh-hccc
Confidence 1122345788899999764 45578899999999999999999999976432111 111 111111111111000 0000
Q ss_pred cccc-----------hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 279 EDKH-----------FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 279 ~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.... ......++..+.++|.+||+.+|++||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000 0112345788999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=268.74 Aligned_cols=248 Identities=27% Similarity=0.366 Sum_probs=205.8
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|.+.+.||.|++|.||++... ++..+++|++..... .....+.+|+++++.++|+|++++.+.+...+..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999765 589999999876533 4567788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 121 MPHGSLEKCLYSS---NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 121 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
+++++|.+++... ...+++..+..++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998764 368999999999999999999999 9999999999999999999999999999988653221
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
.......++..|+|||...+..++.++|+||+|+++++|++|..||........ .......
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----------------~~~~~~~ 218 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL-----------------ALKILKG 218 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH-----------------HHHHhcC
Confidence 223334678889999999888899999999999999999999999865432111 1111000
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
. ....+..++..+.+++.+||+.+|.+||++.++++
T Consensus 219 ~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 219 Q---YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 00112245677999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=277.79 Aligned_cols=270 Identities=25% Similarity=0.283 Sum_probs=200.5
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCceEEEeeeeecC--CeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIISTCSND--DFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 116 (335)
.++|++.+.||.|++|.||+|... +|+.|++|++..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 478999999999999999999765 589999999875432 2234566899999999999999999998754 56899
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
|+||++ ++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999995 4888888765567999999999999999999999 999999999999999999999999999999866322
Q ss_pred ccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH---HH-
Q 019843 197 DQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME---IV- 271 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~- 271 (335)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........ ............... ..
T Consensus 162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 162 A--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-LDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred c--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChhhchhhhc
Confidence 1 22223345778999998865 5578999999999999999999999975432221 111111000000000 00
Q ss_pred ----Hhhhccccc-cchh-hHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 272 ----DANLLSRED-KHFA-AKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 272 ----~~~~~~~~~-~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
......... .... .....++.+.++|.+||+.||++|||+++++..-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000000000 0000 0012366789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=282.36 Aligned_cols=271 Identities=23% Similarity=0.266 Sum_probs=200.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeeecC-----C
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCSND-----D 112 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 112 (335)
..+++|.+.+.||+|++|.||.|... +|+.|++|++... .......+..|+.+++.++|+||+++++++... .
T Consensus 2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 35689999999999999999999754 6899999998643 233456788899999999999999999886543 3
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
..++++|+++ ++|.+++... .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred eEEEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 5789999995 5888877543 5999999999999999999999 99999999999999999999999999999876
Q ss_pred ccCCcc-ccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc---ChhH
Q 019843 193 LTGEDQ-SKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL---PISV 267 (335)
Q Consensus 193 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---~~~~ 267 (335)
...... ........++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||....... .......... +...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHH
Confidence 532211 112223467889999998654 568999999999999999999999996532111 1111111111 1111
Q ss_pred HHHHHhhh----c-cccccchh---hHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 268 MEIVDANL----L-SREDKHFA---AKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 268 ~~~~~~~~----~-~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..+.+... . ........ .....++.+.+++.+||+.||++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111000 0 00000000 112346679999999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=277.66 Aligned_cols=269 Identities=23% Similarity=0.292 Sum_probs=198.5
Q ss_pred CCCccceeeecCceEEEEEEEc---CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecC--CeeE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ---DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSND--DFKA 115 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 115 (335)
+|.+.+.||+|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5889999999999999999864 47899999987632 44456788899999999999999999999887 8899
Q ss_pred EEEEecCCCChHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC----CCcEEEeec
Q 019843 116 LVLEYMPHGSLEKCLYSS----NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSDF 187 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~----~~~v~l~df 187 (335)
+|+|++++ ++.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++. ++.++|+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 677666432 236899999999999999999999 999999999999999999 999999999
Q ss_pred cccccccCCcc-ccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccch--------hhHh
Q 019843 188 GIAKLLTGEDQ-SKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEM--------TLKY 257 (335)
Q Consensus 188 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~--------~~~~ 257 (335)
|++........ ........++..|+|||.+.+ ..++.++|+||||+++++|++|.+||........ .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886532221 112234467888999998766 4578999999999999999999999976543220 0111
Q ss_pred HhhhhcChhH------------HHHHHhhhccccc-cc--hhhH--HHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 258 WVSNLLPISV------------MEIVDANLLSRED-KH--FAAK--EQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 258 ~~~~~~~~~~------------~~~~~~~~~~~~~-~~--~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
....+..... ....+........ .. .... ...+..+.+++.+||+.||++|||+.|++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1110000000 0000000000000 00 0000 134567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=281.40 Aligned_cols=272 Identities=23% Similarity=0.273 Sum_probs=203.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeec----CCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSN----DDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 113 (335)
..++|.+.+.||.|++|.||+|..+ +++.|++|++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 4589999999999999999999754 58999999987542 2345677889999999999999999988753 457
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.++|+||+. ++|.+++.... .+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 899999995 68998886554 6999999999999999999999 999999999999999999999999999998765
Q ss_pred cCCccc--cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc--C----
Q 019843 194 TGEDQS--KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL--P---- 264 (335)
Q Consensus 194 ~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~---- 264 (335)
...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........ ......... +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-LKLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-HHHHHHHhCCChhHhh
Confidence 322111 11223467889999998765 5688999999999999999999999965432111 111111000 0
Q ss_pred -----hhHHHHHHhhhccccccch-hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 265 -----ISVMEIVDANLLSREDKHF-AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 265 -----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.......+. ........+ ......++.+.++|.+||+.||.+||++++++..-+
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 237 NRIGSDRVRKYIQN-LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhhchhhHHHHHhh-cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 001111110 000001100 011235778999999999999999999999988544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=281.46 Aligned_cols=275 Identities=24% Similarity=0.261 Sum_probs=204.8
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecC-----
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSND----- 111 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 111 (335)
.+.++|.+.+.||.|++|+||.|... +++.|++|.+... .......+..|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 45679999999999999999999754 5899999998643 233345677899999999999999999987643
Q ss_pred CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
...++++||+. ++|.+++.... .+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 35799999995 68988887553 7999999999999999999999 9999999999999999999999999999987
Q ss_pred cccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc-------
Q 019843 192 LLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL------- 263 (335)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~------- 263 (335)
...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... ..........
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDL 233 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHh
Confidence 653211 22233457888999998764 468999999999999999999999996542111 1111110000
Q ss_pred ----ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH--HHHHH
Q 019843 264 ----PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR--LLKIR 322 (335)
Q Consensus 264 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~~ 322 (335)
.........................+++.+.+++.+||+.||++|||++++++. +..++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 001111111100000000011123467789999999999999999999999987 55554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=274.23 Aligned_cols=268 Identities=24% Similarity=0.308 Sum_probs=197.9
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
++|.+.+.||.|++|.||+|..+ +++.|++|.+.... ......+.+|+++++.++|+||+++++++...+.+++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999765 58899999986542 2334678889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC-CCcEEEeeccccccccCCc
Q 019843 120 YMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 120 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~-~~~v~l~dfg~~~~~~~~~ 197 (335)
|++ ++|.+++... ....++..++.++.+|+.||.||| +++++|+||+|+||+++. ++.++|+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 995 5787777543 334688899999999999999999 999999999999999985 567999999998754211
Q ss_pred cccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH------HH
Q 019843 198 QSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM------EI 270 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~ 270 (335)
........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||......+..... .......... .+
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI-FRILGTPNEETWPGVTSL 234 (294)
T ss_pred -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHhCCCChhhccccccc
Confidence 1222334567889999988664 5789999999999999999999999764322211111 0000000000 00
Q ss_pred HHh-hhccc--cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 271 VDA-NLLSR--EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 271 ~~~-~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
-+. ..... ...........++.+.+++.+||+.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00000 000000112346679999999999999999999999863
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=275.57 Aligned_cols=248 Identities=25% Similarity=0.313 Sum_probs=200.4
Q ss_pred CCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 45 FSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
|.....||+|++|.||.+..+ +++.|++|++..........+.+|+.+++.++|+|++++++.+...+..+++|||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 334578999999999999764 6899999998765555567788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+++... .+++..+..++.+++.++.+|| +.+++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 102 ~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~ 174 (292)
T cd06657 102 GALTDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRK 174 (292)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccc--ccccc
Confidence 9999987544 4899999999999999999999 999999999999999999999999999988755321 12223
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...++..|+|||.+.+..++.++|+||+|+++|+|++|..||........ ...+.... ....
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~--------------~~~~~~~~----~~~~ 236 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--------------MKMIRDNL----PPKL 236 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------------HHHHHhhC----Cccc
Confidence 34578889999999888889999999999999999999999875322111 00111110 0111
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.....++..+.+++.+||..||.+||++.++++.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 237 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1122345668999999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=269.74 Aligned_cols=241 Identities=23% Similarity=0.291 Sum_probs=187.6
Q ss_pred ceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHH-HhCCCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVM-KSIRHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||.|++|.||+|... +++.|++|++.... ......+..|..++ ...+|+|++++++.+...+.+++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57899999999999764 58899999986432 11223344454444 445899999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999987654 6899999999999999999999 99999999999999999999999999998875421 23
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ...+... ......
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~---~~~~~~ 214 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--------------FDNILSR---RINWPE 214 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--------------HHHHHhc---ccCCCC
Confidence 34577889999999888889999999999999999999999965432111 0001100 000011
Q ss_pred hhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 284 AAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 284 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.....+++.+.+++.+||+.||++||++.++.+
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 112245677999999999999999997754444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=272.93 Aligned_cols=267 Identities=25% Similarity=0.316 Sum_probs=201.4
Q ss_pred CCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecC--CeeEEEEE
Q 019843 45 FSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSND--DFKALVLE 119 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 119 (335)
|.+.+.||.|++|.||+|... +++.+++|++.... ......+.+|+++++.++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999866 48899999998653 34456788999999999999999999999887 89999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++ +|.+++......+++..++.++.+++.||.+|| +.+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9964 899888776557999999999999999999999 99999999999999999999999999999987642221
Q ss_pred cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH-------
Q 019843 200 KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV------- 271 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------- 271 (335)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........ ...............+.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccccchh
Confidence 12233456788999997765 4578999999999999999999999976442211 11111110000000000
Q ss_pred Hhhhccccccc---hhhHHH-HHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 272 DANLLSREDKH---FAAKEQ-CVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 272 ~~~~~~~~~~~---~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
........... ...... ++..+.+++.+||+.+|.+||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000000 000111 36779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=270.90 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=200.9
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|.+.+.||.|++|.||+|..+ ++..+++|.+.... ......+.+|+++++.++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5889999999999999999765 48889999987542 23446788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-cEEEeeccccccccCCcc
Q 019843 121 MPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 121 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~-~v~l~dfg~~~~~~~~~~ 198 (335)
+++++|.+++.... ..+++..+..++.+++.|+.||| +.+++|+||+|+||++++++ .++++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-- 155 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS-- 155 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--
Confidence 99999999987543 35799999999999999999999 99999999999999999886 4699999998765321
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........++..|+|||...+..++.++|+||||+++++|++|..||.......... .......
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~~~~--- 219 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL-------------KICQGYF--- 219 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH-------------HHhcccC---
Confidence 112223457888999999988889999999999999999999999986532211110 1111000
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
......++..+.+++.+||..+|++|||+.+++..
T Consensus 220 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 ----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00112345669999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=268.34 Aligned_cols=242 Identities=26% Similarity=0.348 Sum_probs=197.4
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCCh
Q 019843 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL 126 (335)
Q Consensus 51 lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 126 (335)
||.|++|.||+|... +++.+++|++.... ....+.+.+|+++++.++||||+++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999865 48999999986432 23457789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccccc
Q 019843 127 EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206 (335)
Q Consensus 127 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~ 206 (335)
.+++.... .+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 99987654 6899999999999999999999 9999999999999999999999999999988663221 223346
Q ss_pred ccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhH
Q 019843 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286 (335)
Q Consensus 207 ~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (335)
++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....+.. ........ .......+
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~~~--~~~~~~~~ 216 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM---------------EIYNDILK--GNGKLEFP 216 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH---------------HHHHHHhc--cCCCCCCC
Confidence 78889999999888899999999999999999999999976542111 11111110 01111122
Q ss_pred HHHHHHHHHHHHHhchhccccCCC-----HHHHHH
Q 019843 287 EQCVSFVFNLAMECTVESAEQRIN-----AKEIVT 316 (335)
Q Consensus 287 ~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~ 316 (335)
..+++++.+++.+||+.||.+||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 333677999999999999999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=270.05 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=187.9
Q ss_pred ceeeecCceEEEEEEEcC---CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCC
Q 019843 49 NLIGRGSFGSVYKARIQD---GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHG 124 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~---~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 124 (335)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 368999999999996433 3346677665443 234568899999999999999999999999999999999999999
Q ss_pred ChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 125 SLEKCLYSS---NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 125 ~L~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
+|.+++.+. ....+...++.++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999998753 234677788899999999999999 99999999999999999999999999998764321111222
Q ss_pred cccccccccccCccccCC-------CCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 202 QTQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
.....++..|+|||++.. ..++.++||||||+++|+|++ |..||......+.. ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------------~~~~~~ 224 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL-------------NHVIKD 224 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH-------------HHHHhh
Confidence 234567888999998743 245789999999999999997 56777543321110 001101
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.... ..+.......++.+.+++..|| .+|++||+++++++.|.
T Consensus 225 ~~~~--~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 225 QQVK--LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cccc--cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0000 0011111234566899999999 78999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=271.65 Aligned_cols=265 Identities=24% Similarity=0.289 Sum_probs=203.3
Q ss_pred CCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 45 FSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
|.+.+.||.|++|.||+|... +++.+++|.+..... .....+..|+++++.++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 678899999999999999765 588999999865432 34567888999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
++ ++.+++......+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 65 888888776568999999999999999999999 9999999999999999999999999999987663221 12
Q ss_pred cccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh---HHHHHH---hh
Q 019843 202 QTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS---VMEIVD---AN 274 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~---~~ 274 (335)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+. ............ .....+ ..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhcccchhhhhhh
Confidence 2334577889999998776 789999999999999999999999865432111 111111100000 000000 00
Q ss_pred ---h-ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 275 ---L-LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 275 ---~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
. .............++..+.++|.+||+.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00000111122356788999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=274.27 Aligned_cols=267 Identities=24% Similarity=0.278 Sum_probs=196.8
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCe-----
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDF----- 113 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~----- 113 (335)
++|++.+.||.|++|.||+|... +++.|++|+..... ......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999765 58999999986543 22346788899999999 56999999999877655
Q ss_pred eEEEEEecCCCChHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC-CCcEEEeecc
Q 019843 114 KALVLEYMPHGSLEKCLYSS----NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFG 188 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~-~~~v~l~dfg 188 (335)
.+++|||+++ +|.+++... ...+++..++.++.+|+.||.||| +.+++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 788887643 236899999999999999999999 999999999999999998 8899999999
Q ss_pred ccccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhH
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
++..+... ........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||............. ........
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF-KLLGTPTE 233 (295)
T ss_pred cceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-HHhCCCCh
Confidence 98765311 112223356788999998765 457899999999999999999999997643322211111 00000000
Q ss_pred ------HHHHHhhhcccccc--chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 268 ------MEIVDANLLSREDK--HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 268 ------~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
....+......... .......++..+.++|.+||..||.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000000000 00011235677999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=292.59 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=214.7
Q ss_pred CCCCccceeeecCceEEEEEEEcC-CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
+-|.|+..||.|+||.||+|..++ +-.-|.|++.....+..+.+.-|++||..+.||+|+++++.|...+.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 457889999999999999998664 4446788888888888899999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
.||.++.++-.-+..+++.++.-++++++.||.||| +.+|+|+||+..|||+..+|.++|.|||.+.... .....
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQK 186 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhh
Confidence 999999998887778999999999999999999999 9999999999999999999999999999987542 23344
Q ss_pred cccccccccccCcccc-----CCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 202 QTQTLATIGYMAPEYG-----REGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~-----~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
....+||+.|||||+. ...+|+.++||||||++|.+|.-+.+|...... ...+-+. .
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----------------MRVllKi-a 248 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------------MRVLLKI-A 248 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----------------HHHHHHH-h
Confidence 5678999999999975 356799999999999999999999999554321 1111111 2
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...++.+..|...+..+.+++.+||..||..||++.+++..
T Consensus 249 KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 249 KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 22344455567778889999999999999999999999864
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=272.10 Aligned_cols=244 Identities=23% Similarity=0.308 Sum_probs=194.2
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCCh
Q 019843 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL 126 (335)
Q Consensus 51 lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 126 (335)
||.|+||.||+|... +|+.+++|++.... ......+..|+++++.++|||++++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999755 58899999986432 22345667899999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccccc
Q 019843 127 EKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQT 205 (335)
Q Consensus 127 ~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~ 205 (335)
.+++.... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+..... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence 99887543 36899999999999999999999 99999999999999999999999999999876521 1222334
Q ss_pred cccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhh
Q 019843 206 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAA 285 (335)
Q Consensus 206 ~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (335)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ..+..... ......
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~----~~~~~~ 217 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-------------EELKRRTL----EMAVEY 217 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-------------HHHHhccc----cccccC
Confidence 5678899999998888999999999999999999999998654321110 01111100 011112
Q ss_pred HHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 286 KEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 286 ~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
+..+++.+.+++.+||+.||.+|| ++.+++..
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 233467799999999999999999 77777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.15 Aligned_cols=246 Identities=25% Similarity=0.339 Sum_probs=203.4
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|++.+.||.|++|.||++... +++.+++|.+.... ......+..|+++++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5889999999999999999654 58899999987542 33456778899999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 121 MPHGSLEKCLYSS---NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 121 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
+++++|.+++... ...+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988652 346899999999999999999999 999999999999999999999999999999876422
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ..+.....
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR--------------YKVQRGKY- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------------HHHhcCCC-
Confidence 222345788899999999888999999999999999999999998764322111 01111100
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
...+..++.++.+++.+||+.+|++||++.+++.
T Consensus 219 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 -----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1112345677999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=279.05 Aligned_cols=271 Identities=24% Similarity=0.285 Sum_probs=202.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhC-CCCceEEEeeeeec--CCe
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSN--DDF 113 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 113 (335)
...++|.+.+.||.|++|.||+|... +++.+++|.+... .......+..|+.+++++ +|+||+++++++.. ...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35678999999999999999999765 5889999987532 233345677899999999 99999999998864 347
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.++|+||++ ++|.+++... .+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 899999996 5998888654 6889999999999999999999 999999999999999999999999999999866
Q ss_pred cCCccc---cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc--Ch--
Q 019843 194 TGEDQS---KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL--PI-- 265 (335)
Q Consensus 194 ~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~-- 265 (335)
...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....+..... ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~ 236 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE-KIIEVIGPPSAED 236 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCHHH
Confidence 432211 12233457888999998754 457889999999999999999999997654332211 1111100 00
Q ss_pred -------hHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 266 -------SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 266 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
......+................++..+.+++.+||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0001111000000011111112257789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=276.64 Aligned_cols=271 Identities=22% Similarity=0.321 Sum_probs=197.8
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC----
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD---- 112 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 112 (335)
..-++|.+.+.||.|++|.||+|... +++.|++|.+.... ......+.+|+++++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34568999999999999999999765 58899999886542 223345678999999999999999999886543
Q ss_pred ----eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 113 ----FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 113 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
..++|+||+. ++|.+.+......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 4589999995 5888888766557999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCccc--cccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc--
Q 019843 189 IAKLLTGEDQS--KSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL-- 263 (335)
Q Consensus 189 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-- 263 (335)
++..+...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~--~~~~~~~~~ 242 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL--TLISQLCGS 242 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCC
Confidence 99866322111 112234567889999987664 4788999999999999999999998754322110 0011100
Q ss_pred -ChhH------HHHHHhhhccccccchh----hHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 264 -PISV------MEIVDANLLSREDKHFA----AKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 264 -~~~~------~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
+... ....+............ .....+..+.++|.+||..||.+|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 00000000000000000 00012345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=268.16 Aligned_cols=250 Identities=21% Similarity=0.260 Sum_probs=196.4
Q ss_pred HHHHhhhcCCCCcccee--eecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeec
Q 019843 35 YLELFQATDGFSENNLI--GRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSN 110 (335)
Q Consensus 35 ~~~~~~~~~~y~~~~~l--g~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 110 (335)
..+.....++|.+.+.+ |.|+||.||.+..+ ++..+++|.+........ |......+ +|+|++++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34455666888888887 99999999999754 588899999865422111 22222222 79999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-cEEEeeccc
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGI 189 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~-~v~l~dfg~ 189 (335)
.+..++||||+++++|.+++.... .+++..++.++.|++.|+.+|| +.+++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999999987664 7999999999999999999999 99999999999999999988 999999999
Q ss_pred cccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
+..... .....++..|+|||++.+..++.++|+||+|+++|+|++|..||............
T Consensus 157 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~------------ 218 (267)
T PHA03390 157 CKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES------------ 218 (267)
T ss_pred ceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHH------------
Confidence 875421 12235788899999999888999999999999999999999999754332211111
Q ss_pred HHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCC-HHHHHH
Q 019843 270 IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-AKEIVT 316 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~ 316 (335)
+.... .........+++.+.+++.+||+.||.+||+ ++++++
T Consensus 219 ~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 219 LLKRQ-----QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHhh-----cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11110 1111222356777999999999999999995 688874
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=292.38 Aligned_cols=273 Identities=16% Similarity=0.183 Sum_probs=192.4
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEcC--CcEEEEE------------------EeecCCCchhHHHHHHHHHHHhCCC
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQD--GMEVAVK------------------VFHLQCGGVFKSFDVECEVMKSIRH 98 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~--~~~v~iK------------------~~~~~~~~~~~~~~~e~~~l~~l~h 98 (335)
....++|++.+.||+|+||.||++..+. +...+.| ... ........+.+|+.+++.++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence 3456799999999999999999986432 2222222 111 112234567899999999999
Q ss_pred CceEEEeeeeecCCeeEEEEEecCCCChHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCE
Q 019843 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSS----NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNV 174 (335)
Q Consensus 99 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Ni 174 (335)
+||+++++++...+..+++++++ +++|.+++... ........+..++.||+.||.||| +++++|+||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHE
Confidence 99999999999999999999998 45777666432 122346677889999999999999 99999999999999
Q ss_pred EECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCC-CCccccc-c
Q 019843 175 LLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP-TDKIFAG-E 252 (335)
Q Consensus 175 lv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~p-f~~~~~~-~ 252 (335)
|++.++.++|+|||++..+.... ........|+..|+|||++.+..++.++|||||||++|+|++|..+ |...... .
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 99999999999999998663221 1222345789999999999999999999999999999999998754 4322111 1
Q ss_pred hhhHhHhhhh------cCh---hHHHHHHhhhccccccc---hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 253 MTLKYWVSNL------LPI---SVMEIVDANLLSREDKH---FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 253 ~~~~~~~~~~------~~~---~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..+....... .+. .....++.......... ......++.++.+++.+||+.||++|||+.|+++.
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111111100 011 11112211111111100 11112345668899999999999999999999874
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=260.55 Aligned_cols=249 Identities=24% Similarity=0.288 Sum_probs=207.5
Q ss_pred CccceeeecCceEEEEEEEc-CCcEEEEEEeecC-CCchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEEEEecC
Q 019843 46 SENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 46 ~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
.++..||.|+.|.|++++.. +|.-.|||..... +.+...++...+.+....+ +|+||+.+|+|..+..+++.||.+
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM- 173 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM- 173 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence 35678999999999999765 4888999998644 5667788888999888775 999999999999999999999987
Q ss_pred CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccc
Q 019843 123 HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202 (335)
Q Consensus 123 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~ 202 (335)
..-++.++....+++++.-+-++...+..||.||.+ +++++|+|+||+|||+|+.|.+||+|||++-.+. .....
T Consensus 174 s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv---dSkAh 248 (391)
T KOG0983|consen 174 STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV---DSKAH 248 (391)
T ss_pred HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceee---ccccc
Confidence 556777777666789999999999999999999996 8899999999999999999999999999998763 34455
Q ss_pred ccccccccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 203 TQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 203 ~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
....|-+.|||||.+.- ..|+.++||||||++++||.||+.||.+..++=.- +...+. ..
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~----------------ltkvln-~e 311 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV----------------LTKVLN-EE 311 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH----------------HHHHHh-cC
Confidence 56678889999998763 46899999999999999999999999886543221 112222 33
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
++.++...++++.+.+++..||..|+.+||...++++.
T Consensus 312 PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 45566666789999999999999999999999999864
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=267.03 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=200.3
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC-----CCchhHHHHHHHHHHHhCCCCceEEEeeeeecC--Cee
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ-----CGGVFKSFDVECEVMKSIRHRNLIKIISTCSND--DFK 114 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 114 (335)
++|++.+.||+|++|.||+|... ++..+++|.+... .......+.+|+++++.++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999764 5899999987532 123446788999999999999999999998763 568
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++++||+++++|.+++.... .+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 89999999999999887544 5889999999999999999999 9999999999999999999999999999987653
Q ss_pred CCcc-ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 195 GEDQ-SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 195 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
.... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~ 221 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----------------AAIFKI 221 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----------------HHHHHH
Confidence 2111 11112345788899999999888999999999999999999999998753211 111111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.. .......+..+++.+.+++.+||. +|..||++.++++
T Consensus 222 ~~---~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 AT---QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred Hc---CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 10 111122244567789999999999 5799999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=274.83 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=204.4
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 117 (335)
++|.+.+.||.|++|.||+|... +++.|++|++... .......+..|+++++.+. |+||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 57999999999999999999765 6899999998643 2233467888999999998 99999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
||++++++|.+++.... .+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999998664 7999999999999999999999 9999999999999999999999999999988764322
Q ss_pred cc------------------cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHh
Q 019843 198 QS------------------KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWV 259 (335)
Q Consensus 198 ~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 259 (335)
.. .......++..|+|||...+..++.++|+||||++++++++|..||........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~---- 231 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-F---- 231 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-H----
Confidence 11 222334578889999998888899999999999999999999999886541110 0
Q ss_pred hhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCH----HHHHH
Q 019843 260 SNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINA----KEIVT 316 (335)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~----~ell~ 316 (335)
.... ......+..+++.+.+++.+||+.||.+||++ ++++.
T Consensus 232 --------~~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 --------QKIL--------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --------HHHH--------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0111 01111223336669999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=272.66 Aligned_cols=260 Identities=18% Similarity=0.259 Sum_probs=188.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEcC----CcEEEEEEeecCCCchhH-----------HHHHHHHHHHhCCCCceEEEe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQD----GMEVAVKVFHLQCGGVFK-----------SFDVECEVMKSIRHRNLIKII 105 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~~i~~~~ 105 (335)
..++|.+.+.||+|+||.||+|...+ +..+++|+.......... ....+...+..+.|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34799999999999999999997653 456677765443322111 112233445566899999999
Q ss_pred eeeecCC----eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc
Q 019843 106 STCSNDD----FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181 (335)
Q Consensus 106 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~ 181 (335)
+++.... ..+++++++ ..++.+.+.... ..++..+..++.|++.||.||| +.+++|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EeeeEecCCceEEEEEEehh-ccCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence 8765433 446777876 446766665432 4678889999999999999999 999999999999999999999
Q ss_pred EEEeeccccccccCCccc-----cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhH
Q 019843 182 AHLSDFGIAKLLTGEDQS-----KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK 256 (335)
Q Consensus 182 v~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 256 (335)
++|+|||++..+...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999865321111 112234689999999999999999999999999999999999999987532221110
Q ss_pred hHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 257 YWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
. ...+++....... .....+++.+.+++..|++.+|++||++.++++.|
T Consensus 245 ~--------~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 A--------AKCDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred H--------hHHHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 0011111111100 01233467799999999999999999999999876
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=276.03 Aligned_cols=268 Identities=25% Similarity=0.296 Sum_probs=201.1
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeec-CCe
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN-DDF 113 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 113 (335)
...++++|++.+.||.|++|.||+|... +++.|++|++... .......+..|+++++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3557899999999999999999999755 6899999987532 23345678889999999999999999998865 567
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.++++|++ +++|.+++... .++...+..++.+++.||.+|| +.+++|+||+|.||+++.++.++|+|||.+...
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 88999998 66898887644 4788889999999999999999 999999999999999999999999999998754
Q ss_pred cCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc--C------
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL--P------ 264 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~------ 264 (335)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... .......... +
T Consensus 159 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 159 D-----PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTPPDDVINT 232 (328)
T ss_pred C-----CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHh
Confidence 2 11223456778999998765 568999999999999999999999996543211 1111110000 0
Q ss_pred ---hhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 265 ---ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 265 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.....+..................+++.+.++|.+||+.+|++||++++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00011111100000000001112356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=278.03 Aligned_cols=269 Identities=23% Similarity=0.282 Sum_probs=201.0
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC-
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD- 112 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 112 (335)
.+....++|++.+.||.|++|.||.|... ++..||+|++... .......+.+|+++++.++|+||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 34456789999999999999999999754 6899999998543 2233456889999999999999999999887543
Q ss_pred -----eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeec
Q 019843 113 -----FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 187 (335)
Q Consensus 113 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~df 187 (335)
..++|++++ +++|.+++... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999998 77999888653 5899999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHh-------
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWV------- 259 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~------- 259 (335)
|++.... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..............
T Consensus 163 g~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTD-----SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccc-----cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9987542 12223456888999998876 4588999999999999999999999975432211111100
Q ss_pred ---hhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 260 ---SNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 260 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.............................+++.+.+++.+||+.||++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000001111100000000001112345667999999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=272.35 Aligned_cols=253 Identities=27% Similarity=0.306 Sum_probs=194.7
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 119 (335)
++|...+.||.|+||.||++... +++.+++|.+.... ......+..|+.++.++. |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 46677889999999999999765 58999999986543 234567888999999995 9999999999999999999999
Q ss_pred ecCCCChHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 120 YMPHGSLEKCLY----SSNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 120 ~~~~~~L~~~l~----~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++. +++.++.. .....+++..+..++.+++.||.||| + .+++|+||+|+||+++.++.++|+|||++..+.
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 985 46555432 22357999999999999999999999 6 599999999999999999999999999987653
Q ss_pred CCccccccccccccccccCccccCCC---CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
. ........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.......... ....
T Consensus 160 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------------~~~~ 224 (288)
T cd06616 160 D---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL------------TQVV 224 (288)
T ss_pred c---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHH------------hhhc
Confidence 1 1122234578889999998765 68999999999999999999999987543100000 0000
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. ...+.........++..+.+|+.+||+.||.+|||++++++.
T Consensus 225 ~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 225 K---GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred C---CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000111112356779999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=268.98 Aligned_cols=242 Identities=23% Similarity=0.287 Sum_probs=188.2
Q ss_pred eeeecCceEEEEEEEc-CCcEEEEEEeecCCC---chhHHHHHHHHHHH---hCCCCceEEEeeeeecCCeeEEEEEecC
Q 019843 50 LIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG---GVFKSFDVECEVMK---SIRHRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 50 ~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~---~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
.||+|+||.||++... +++.+++|.+..... .....+.++..+++ ...|++|+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 588999998864321 11223344444333 3479999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccc
Q 019843 123 HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202 (335)
Q Consensus 123 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~ 202 (335)
+++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~----~~~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKP 152 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc----cCc
Confidence 999999887654 6999999999999999999999 99999999999999999999999999999875421 122
Q ss_pred ccccccccccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccccc
Q 019843 203 TQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281 (335)
Q Consensus 203 ~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (335)
....++..|+|||.+. +..++.++|+||+|+++|+|++|..||.......... +..... ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---------------~~~~~~---~~ 214 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---------------IDRMTL---TV 214 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---------------HHHHhh---cC
Confidence 3346889999999886 4568999999999999999999999997543221110 000000 01
Q ss_pred chhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 282 HFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
....+..+++.+.+++.+||..||.+|| +++|+++.
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1112334577799999999999999999 59998875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=278.89 Aligned_cols=272 Identities=21% Similarity=0.244 Sum_probs=199.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecC-------
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSND------- 111 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 111 (335)
+...+|.+.+.||.|++|.||+|... +++.|++|++..........+.+|+++++.++||||+++++.+...
T Consensus 2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 34689999999999999999999764 5899999998776666667888999999999999999999776543
Q ss_pred -------CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC-CCCcEE
Q 019843 112 -------DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAH 183 (335)
Q Consensus 112 -------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~-~~~~v~ 183 (335)
...++|+||++ ++|.+++... .+++..++.++.||+.||.||| +.+++|+||+|+||+++ .++.++
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEE
Confidence 36789999996 5888877643 5899999999999999999999 99999999999999997 455789
Q ss_pred EeeccccccccCCccc-cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhh
Q 019843 184 LSDFGIAKLLTGEDQS-KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSN 261 (335)
Q Consensus 184 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 261 (335)
++|||.+..+...... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||................
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998765321111 11122356788999997654 568889999999999999999999997543322111110000
Q ss_pred hc--ChhHHHHH---Hhhhc-cccccch---hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 262 LL--PISVMEIV---DANLL-SREDKHF---AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 262 ~~--~~~~~~~~---~~~~~-~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.. +....... ..... ....... .....++.++.+++.+||+.||.+|||+.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 00000000 00000 0000000 0112356779999999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=267.43 Aligned_cols=264 Identities=24% Similarity=0.326 Sum_probs=196.6
Q ss_pred CCccceeeecCceEEEEEEEcC-CcEEEEEEeecCCC--chhHHHHHHHHHHHhC---CCCceEEEeeeeecCCe-----
Q 019843 45 FSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCG--GVFKSFDVECEVMKSI---RHRNLIKIISTCSNDDF----- 113 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 113 (335)
|++.+.||.|++|.||+|..+. ++.+++|.+..... .....+.+|+.+++.+ .|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6788999999999999998764 89999999874422 2234566777777666 59999999999987766
Q ss_pred eEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
.+++||++.+ +|.+++.... ..+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999964 8888886543 36899999999999999999999 99999999999999999999999999999876
Q ss_pred ccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH-
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV- 271 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 271 (335)
+... .......++..|+|||.+.+..++.++|+||||+++|+|++|.+||......+. ...............+-
T Consensus 157 ~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFE---MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ-LDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCC---cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH-HHHHHHHcCCCChHhcCC
Confidence 5322 122233467889999999988899999999999999999999999876443221 11111111000000000
Q ss_pred H----hh-hccccccc-hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 272 D----AN-LLSREDKH-FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 272 ~----~~-~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
. .. ........ .......+..+.+++.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 00 00000000 1111244677899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=284.38 Aligned_cols=264 Identities=26% Similarity=0.409 Sum_probs=221.8
Q ss_pred hcCCCCccceeeecCceEEEEEEEcC-CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
...+.++-++||.|.||.||.|.|+. .-.||||.++.+ ....++|..|+.+++.++|||+|+++|+|...-.+|||.|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 33455667899999999999999875 567999998754 5566899999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 120 YMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 120 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||..|+|.++|.+. ...++.-.++.++.||..|+.||. .++++|+||...|.||.++..||+.|||+++.+.....
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 99999999999864 335777788999999999999999 99999999999999999999999999999998864433
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
.. ...-.-.+.|.|||-+....++.++|||+||++|||+.| |-.||.+..- .++..+++
T Consensus 421 TA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------------SqVY~LLE----- 480 (1157)
T KOG4278|consen 421 TA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------------SQVYGLLE----- 480 (1157)
T ss_pred ec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH--------------HHHHHHHh-----
Confidence 32 222334567999999999999999999999999999998 7788766421 12223333
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcccc
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICT 329 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 329 (335)
...+...+.+||+.+.+|+++||+.+|.+||++.|+-..++.+..+-.++.
T Consensus 481 -kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisd 531 (1157)
T KOG4278|consen 481 -KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISD 531 (1157)
T ss_pred -ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccH
Confidence 345667789999999999999999999999999999999998876555443
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=272.30 Aligned_cols=255 Identities=25% Similarity=0.319 Sum_probs=198.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEcC-CcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 117 (335)
..++|.+.+.||.|++|.||+|.++. ++.+++|.+.... ......+..|+.++... .|+||+++++++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34789999999999999999998764 8899999987542 23345566677777666 599999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
|||+ ++++.+++......+++..+..++.+++.|+.||| + .+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 93 ~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~- 167 (296)
T cd06618 93 MELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD- 167 (296)
T ss_pred eecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccC-
Confidence 9998 45788877765558999999999999999999999 7 5999999999999999999999999999876532
Q ss_pred ccccccccccccccccCccccCCCC----CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........... ....
T Consensus 168 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------------~~~~ 233 (296)
T cd06618 168 --SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT------------KILQ 233 (296)
T ss_pred --CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH------------HHhc
Confidence 11222345678899999987543 78899999999999999999999865322111111 1111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.. .........++.++.+++.+||+.||.+||++++++..-.
T Consensus 234 ~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 234 EE-----PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CC-----CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 10 0111111234667999999999999999999999987754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=277.43 Aligned_cols=273 Identities=24% Similarity=0.258 Sum_probs=206.9
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC-----eeE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD-----FKA 115 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 115 (335)
+|.+.+.||.|++|.||+|... +++.|++|++.... ....+.+..|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6899999999999999999865 48999999987543 344578899999999999999999999988765 789
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
++++|++ ++|.+++.... .+++..++.++.+|+.||.+|| +.+++|+||+|.||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999996 58888887654 8999999999999999999999 99999999999999999999999999999987642
Q ss_pred Ccc-ccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc----------
Q 019843 196 EDQ-SKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL---------- 263 (335)
Q Consensus 196 ~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------- 263 (335)
... ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+.. ........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL-NLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHhcCCCChhHhhhc
Confidence 211 0122334578889999999887 7899999999999999999999999765432211 11111000
Q ss_pred -ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH--HHHHH
Q 019843 264 -PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR--LLKIR 322 (335)
Q Consensus 264 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~~ 322 (335)
.......+.................++..+.+++.+||+.||.+||++++++.. ++.++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 001111111100000000011112356779999999999999999999999985 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=273.48 Aligned_cols=252 Identities=26% Similarity=0.349 Sum_probs=200.5
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.+.|...+.||.|++|.||+|... ++..+++|.+... .......+.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 345888899999999999999865 5788999988643 223446788899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
+||+. +++.+.+......+++..+..++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~--- 166 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--- 166 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeec---
Confidence 99996 5888877655557899999999999999999999 9999999999999999999999999999987542
Q ss_pred cccccccccccccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 198 QSKSQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
......++..|+|||.+. +..++.++||||||+++|+|++|..||.......... .....
T Consensus 167 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------------~~~~~- 229 (308)
T cd06634 167 ---PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------------HIAQN- 229 (308)
T ss_pred ---CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-------------HHhhc-
Confidence 122345778899999874 3567889999999999999999999986542211110 00000
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
. ........++..+.++|.+||+.+|.+||+++++++.-....
T Consensus 230 ~-----~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 230 E-----SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred C-----CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 0 000112245667999999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=267.80 Aligned_cols=245 Identities=27% Similarity=0.357 Sum_probs=195.6
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeecCCC---chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCCh
Q 019843 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG---GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL 126 (335)
Q Consensus 51 lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 126 (335)
||.|++|.||++... +++.+++|++..... .....+.+|+++++.++|+||+++++.+...+..++++|++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 688999999999876 489999999865432 4567788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc------cc
Q 019843 127 EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ------SK 200 (335)
Q Consensus 127 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~------~~ 200 (335)
.+++.... .+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99987655 7899999999999999999999 99999999999999999999999999999875432111 11
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
......++..|+|||...+...+.++|+||||+++|+|++|..||......+. ........
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----------------~~~~~~~~-- 217 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----------------FQNILNGK-- 217 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHhcCC--
Confidence 22345578889999999888899999999999999999999999875432111 11100000
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
...+.....+..+.+++.+||+.+|.+||++.++.+.|
T Consensus 218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 00111111367799999999999999999994444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=270.79 Aligned_cols=271 Identities=25% Similarity=0.311 Sum_probs=200.2
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC----
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD---- 112 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 112 (335)
...++|.+.+.||.|++|.||+|..+ +++.|++|.+.... ......+..|+++++.++|||++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999875 48899999987543 233456778999999999999999999887644
Q ss_pred ------eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEee
Q 019843 113 ------FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 186 (335)
Q Consensus 113 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~d 186 (335)
.+++|+||+++ ++.+.+......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999975 777777765557999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcCh
Q 019843 187 FGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI 265 (335)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 265 (335)
||.+........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...... ..+..........
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Confidence 999886532221 11222345778999998765 45788999999999999999999999753321 1111111110000
Q ss_pred hHHH---HHHhhhc-----cc-c-ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 266 SVME---IVDANLL-----SR-E-DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 266 ~~~~---~~~~~~~-----~~-~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.... +...... .. . .........++..+.+++.+||+.||.+||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000000 00 0 0000011234677999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=273.08 Aligned_cols=270 Identities=19% Similarity=0.217 Sum_probs=196.4
Q ss_pred CccceeeecCceEEEEEEEcCCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 46 SENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 46 ~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
.+.+.+|.|+++.|+.+.. +++.||+|++... .......+..|+++++.++|+||+++++++...+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3444455555555555443 5899999998755 344567899999999999999999999999999999999999999
Q ss_pred CChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc---
Q 019843 124 GSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS--- 199 (335)
Q Consensus 124 ~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~--- 199 (335)
++|.+++... ...+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||.+..+......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999998753 346899999999999999999999 999999999999999999999999999988755322111
Q ss_pred --cccccccccccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc---ChhHHHHHH
Q 019843 200 --KSQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL---PISVMEIVD 272 (335)
Q Consensus 200 --~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 272 (335)
.......++..|+|||++.+ ..++.++|+||+|+++|+|++|..||.................. .........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 11123346778999999865 45889999999999999999999999764332222111100000 000000000
Q ss_pred hh----------hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 273 AN----------LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 273 ~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.. ..............++.++.+++.+||+.||++|||++++++.-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 00 000001112223345678999999999999999999999998543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=273.74 Aligned_cols=269 Identities=22% Similarity=0.300 Sum_probs=197.7
Q ss_pred cceeeec--CceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecC
Q 019843 48 NNLIGRG--SFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 48 ~~~lg~g--~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
...||.| ++|+||+|.+. +++.|++|+..... ....+.+.+|+.+++.++||||+++++++...+..++|+||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3456666 89999999764 68999999987543 2345778899999999999999999999999999999999999
Q ss_pred CCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc-
Q 019843 123 HGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK- 200 (335)
Q Consensus 123 ~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~- 200 (335)
++++.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999988764 235899999999999999999999 9999999999999999999999999998654332111010
Q ss_pred ----ccccccccccccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc--------Chh
Q 019843 201 ----SQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL--------PIS 266 (335)
Q Consensus 201 ----~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------~~~ 266 (335)
......++..|+|||++.+. .++.++|||||||++|+|++|..||.................. +..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 01112345669999998763 4789999999999999999999999765433222111111000 000
Q ss_pred HHHHHHh-----------h-------hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 267 VMEIVDA-----------N-------LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 267 ~~~~~~~-----------~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.....+. . .........+....+++.+.+|+.+||..||++|||+.|+++.-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0000000 0 000011112223456788999999999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=279.48 Aligned_cols=269 Identities=22% Similarity=0.267 Sum_probs=202.3
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
......++|.+.+.||.|++|.||+|... +++.|++|++... .......+..|+.+++.+.|+|++++++++...+.
T Consensus 9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 34567889999999999999999999765 5889999998643 22344667789999999999999999988766544
Q ss_pred ------eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeec
Q 019843 114 ------KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 187 (335)
Q Consensus 114 ------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~df 187 (335)
.++|++++ +++|.+++... .+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 67999988753 5999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc---
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL--- 263 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--- 263 (335)
|++..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... ..........
T Consensus 163 g~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~ 236 (343)
T cd07851 163 GLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPD 236 (343)
T ss_pred cccccccc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCC
Confidence 99886521 1233456788999998765 467899999999999999999999997543211 1111111110
Q ss_pred --------ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 264 --------PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 264 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
......+...................++.+.+++.+||+.||++|||+.+|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000111111110000000011112346779999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=275.25 Aligned_cols=273 Identities=23% Similarity=0.278 Sum_probs=202.4
Q ss_pred cCHHHHhhhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeee
Q 019843 33 FSYLELFQATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCS 109 (335)
Q Consensus 33 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 109 (335)
....++..+.++|.+.+.||+|+||.||.|.. .+++.||+|++.... ......+.+|+.+++.++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 33456667889999999999999999999975 468899999986432 223466788999999999999999999875
Q ss_pred cC------CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEE
Q 019843 110 ND------DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 183 (335)
Q Consensus 110 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~ 183 (335)
.. ...+++++++ +++|.+++... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence 42 3467888876 78999887654 4899999999999999999999 99999999999999999999999
Q ss_pred EeeccccccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh
Q 019843 184 LSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262 (335)
Q Consensus 184 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 262 (335)
|+|||++.... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........ ........
T Consensus 161 l~dfg~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~ 234 (345)
T cd07877 161 ILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLV 234 (345)
T ss_pred Eeccccccccc-----ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh
Confidence 99999987542 22233467888999998766 5688899999999999999999999865332111 11111100
Q ss_pred -----------cChhHHHHHHhhhccccccchh-hHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 263 -----------LPISVMEIVDANLLSREDKHFA-AKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 263 -----------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
.+......... ........+. .....++.+.++|.+||+.||.+||++.++++.=
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQS-LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHH-hcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 00000000000 0000000000 0012466799999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=269.85 Aligned_cols=245 Identities=26% Similarity=0.319 Sum_probs=196.0
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.|...+.||+|++|.||+|+.. +++.|++|++.... ......+.+|+++++.++|+|++++++++.+....++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 3777788999999999999764 58899999986442 2334568889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+. +++.+++.....++++..+..++.+++.++.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~------ 171 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS------ 171 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCccc------
Confidence 995 5788877766667999999999999999999999 999999999999999999999999999987642
Q ss_pred cccccccccccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 200 KSQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.......++..|+|||.+. +..++.++|+||||+++|+|++|..||........... .....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~-------------~~~~~-- 236 (313)
T cd06633 172 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-------------IAQND-- 236 (313)
T ss_pred CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------------HHhcC--
Confidence 1223456788899999874 45688899999999999999999999865432111110 00000
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. .. .....++..+.+++.+||+.+|.+||++.+++..
T Consensus 237 --~-~~-~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 --S-PT-LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --C-CC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00 0112234569999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=274.67 Aligned_cols=273 Identities=21% Similarity=0.246 Sum_probs=201.0
Q ss_pred hhcCCCCc-cceeeecCceEEEEEEEc-CCcEEEEEEeecCCCch--------------hHHHHHHHHHHHhCCCCceEE
Q 019843 40 QATDGFSE-NNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGV--------------FKSFDVECEVMKSIRHRNLIK 103 (335)
Q Consensus 40 ~~~~~y~~-~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~ 103 (335)
...++|.. .+.||.|++|.||+|... +++.||+|++....... ...+.+|+++++.++|+||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 45678875 578999999999999755 58999999986442211 125778999999999999999
Q ss_pred EeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEE
Q 019843 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 183 (335)
Q Consensus 104 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~ 183 (335)
+++++...+..+++||++. ++|.+++.... .+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEE
Confidence 9999999999999999996 58998886543 6899999999999999999999 99999999999999999999999
Q ss_pred EeeccccccccCCc------------cccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccc
Q 019843 184 LSDFGIAKLLTGED------------QSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFA 250 (335)
Q Consensus 184 l~dfg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~ 250 (335)
|+|||.+....... .........++..|+|||.+.+. .++.++|+||||+++|+|++|..||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999987653111 01111223457789999988764 468999999999999999999999976543
Q ss_pred cchhhHhHhhhhcChhHHHHHHhhh--------ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 251 GEMTLKYWVSNLLPISVMEIVDANL--------LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
.+. +..............+-+... ..............++.+.+++.+||+.+|.+||++++++..-
T Consensus 240 ~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 240 IDQ-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHH-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 221 111111110000000000000 0000000111123466799999999999999999999998743
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=267.77 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=198.7
Q ss_pred CCCccceeeecCceEEEEEEE----cCCcEEEEEEeecCC----CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCee
Q 019843 44 GFSENNLIGRGSFGSVYKARI----QDGMEVAVKVFHLQC----GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~----~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 114 (335)
.|++.+.||.|++|.||.|.. .+|..|++|++.... ......+.+|+++++.+ +|+||+.+++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488999999999999999975 358899999987432 23346778899999999 699999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++|+||+++++|.+++.... .+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999987654 6889999999999999999999 9999999999999999999999999999987653
Q ss_pred CCccccccccccccccccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
... ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ ...+.+
T Consensus 157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------------~~~~~~ 222 (290)
T cd05613 157 EDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-------------QAEISR 222 (290)
T ss_pred ccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc-------------HHHHHH
Confidence 221 1122234578889999998753 467899999999999999999999864221110 011111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
...... .+.+..+++.+.+++.+||+.||.+|| ++++++..
T Consensus 223 ~~~~~~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 223 RILKSE----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HhhccC----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 111111 011233566799999999999999997 77888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=273.33 Aligned_cols=268 Identities=22% Similarity=0.290 Sum_probs=197.6
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecC------C
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSND------D 112 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 112 (335)
.++|.+.+.||.|++|.||+|... +|+.||+|++... .......+.+|+.+++.+.|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 579999999999999999999764 5899999998643 223345678999999999999999999988654 3
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
.+++|++|+. .+|.+++. ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 4689999985 47766542 25899999999999999999999 99999999999999999999999999999875
Q ss_pred ccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh--cChhHHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL--LPISVME 269 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~ 269 (335)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........ ........ .......
T Consensus 167 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 167 AD-----AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CC-----CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence 42 12223456788999999876 4688999999999999999999999975432111 11111100 0011111
Q ss_pred HHHhh-------hccc-cccch-hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH--HHHHH
Q 019843 270 IVDAN-------LLSR-EDKHF-AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR--LLKIR 322 (335)
Q Consensus 270 ~~~~~-------~~~~-~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~~ 322 (335)
..... .... ..... ......+..+.+++.+||+.||++||++.+++.. ++.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 01000 0000 00000 0012345678999999999999999999999965 65554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=264.10 Aligned_cols=242 Identities=24% Similarity=0.305 Sum_probs=188.1
Q ss_pred eeeecCceEEEEEEEc-CCcEEEEEEeecCCC---chhHHHHHHHH---HHHhCCCCceEEEeeeeecCCeeEEEEEecC
Q 019843 50 LIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG---GVFKSFDVECE---VMKSIRHRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 50 ~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
.||+|+||.||+|... +++.||+|.+..... .....+..|.. +++...||+|+.+++.+...+..++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999754 588999999864321 11122333433 4444579999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccc
Q 019843 123 HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202 (335)
Q Consensus 123 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~ 202 (335)
|++|.+++.... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..+... ..
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP 152 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CC
Confidence 999999886543 7999999999999999999999 999999999999999999999999999998754311 22
Q ss_pred ccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccccc
Q 019843 203 TQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281 (335)
Q Consensus 203 ~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (335)
....++..|+|||.+.++ .++.++|+||+|+++|+|++|..||......... .. ..... ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--------------~~-~~~~~---~~ 214 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------------EI-DRMTL---TM 214 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--------------HH-HHHhh---cc
Confidence 334688999999998754 6899999999999999999999999764221110 00 00000 00
Q ss_pred chhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 282 HFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
....+..++..+.+++.+||..+|.+|| ++.++++.
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1112233467799999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=256.49 Aligned_cols=257 Identities=21% Similarity=0.256 Sum_probs=204.2
Q ss_pred hhhcCCCCcc-ceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeec----C
Q 019843 39 FQATDGFSEN-NLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSN----D 111 (335)
Q Consensus 39 ~~~~~~y~~~-~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~ 111 (335)
.+++++|++. ++||-|-.|.|-.+.. .+++.+|+|++... +..++|+++--.. .|||||.++++|++ .
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3467788875 7899999999999964 46999999998633 6667788776555 69999999999875 4
Q ss_pred CeeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC---CCcEEEeec
Q 019843 112 DFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDF 187 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~---~~~v~l~df 187 (335)
..+.+|||.++||.|.+.++.+ ...+++.++..|..+|..|+.||| +.+|.|+||||+|+|... |..+||+||
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccc
Confidence 5777999999999999988865 447999999999999999999999 999999999999999964 457999999
Q ss_pred cccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhH
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
|++.... ........+-|+.|.|||++....|+...|+||+|+++|-|++|.+||......... ..-
T Consensus 209 GFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais----------pgM 275 (400)
T KOG0604|consen 209 GFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------PGM 275 (400)
T ss_pred ccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC----------hhH
Confidence 9998642 234445567899999999999999999999999999999999999999654321111 111
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
..-+..+.+. -..+....+++..+++|+.+|..+|.+|.|+.++++.=+
T Consensus 276 k~rI~~gqy~---FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 276 KRRIRTGQYE---FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred HhHhhccCcc---CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 1122222222 222234567888999999999999999999999987543
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=269.88 Aligned_cols=270 Identities=21% Similarity=0.271 Sum_probs=196.4
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecC-------
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSND------- 111 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 111 (335)
.++|++.+.||.|++|.||+|..+ +++.+++|++.... ......+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 479999999999999999999765 58899999986442 22335677899999999999999999887543
Q ss_pred -CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 112 -DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 112 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
...++|++|+. +++.+.+......+++..+..++.++++||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 35689999985 4777777665557999999999999999999999 999999999999999999999999999998
Q ss_pred ccccCCcccc---------ccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhh
Q 019843 191 KLLTGEDQSK---------SQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVS 260 (335)
Q Consensus 191 ~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 260 (335)
.......... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||.......... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~-~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH-LIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHH
Confidence 7653221111 1122346778999998765 457899999999999999999999987543321111 1110
Q ss_pred hhcChhHHHHHHh---------hhccccccch-hhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 261 NLLPISVMEIVDA---------NLLSREDKHF-AAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 261 ~~~~~~~~~~~~~---------~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
...........+. .......... .......+.+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000000000 0000000000 001123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=266.07 Aligned_cols=265 Identities=26% Similarity=0.308 Sum_probs=201.5
Q ss_pred CCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 45 FSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
|++.+.||.|.+|.||.|... +++.+++|++.... ....+.+..|+.+++.++|+|++++++++...+..++|+|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 677889999999999999765 48999999987653 344567888999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
+ ++|.+++......+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRT 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccc
Confidence 6 5999999876457999999999999999999999 999999999999999999999999999998765321 112
Q ss_pred cccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH--------H
Q 019843 202 QTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV--------D 272 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 272 (335)
......+..|+|||.+.+. .++.++|+||||+++|+|++|..||........ ...............+. +
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHHHhCCCcHHHHHhhccccccc
Confidence 2234457789999998766 789999999999999999999999876432211 11111111100000000 0
Q ss_pred hhhccccccch-hhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 273 ANLLSREDKHF-AAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 273 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
........... ......+..+.+++.+||..||++||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 011123667999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=268.87 Aligned_cols=254 Identities=24% Similarity=0.289 Sum_probs=199.1
Q ss_pred CCCccceeeecCceEEEEEEEc----CCcEEEEEEeecCC----CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCee
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQC----GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 114 (335)
+|++.+.||.|++|.||.+... ++..|++|++.... ......+.+|++++..+ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999999642 46889999986432 23345678899999999 699999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++||||+++++|.+++.... .+++..+..++.|++.+|.+|| +.+++|+||+|.||+++.++.++|+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999887543 6899999999999999999999 9999999999999999999999999999987653
Q ss_pred CCccccccccccccccccCccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
... ........++..|+|||.+.+.. .+.++|+||||+++|+|++|..||........ . ..+..
T Consensus 157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~------------~~~~~ 222 (288)
T cd05583 157 AEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-Q------------SEISR 222 (288)
T ss_pred ccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-H------------HHHHH
Confidence 221 11122345788999999987654 78899999999999999999999864321110 0 01111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
..... ....+..++..+.+++.+||+.||++|||+.++.+.|.
T Consensus 223 ~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 223 RILKS----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHHcc----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 10000 11122335667999999999999999999877766555
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=277.59 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=212.1
Q ss_pred hcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
-...|.+.+.||.|.|+.|.+|+. .++..||+|.+.... ....+.+.+|++++..++||||++++.+.+.+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 346899999999999999999964 469999999987542 33446689999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+.+|.+.+++.+.+ ...+..+..++.|+.+|++|+| +++++|+|||++||+++.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--- 206 (596)
T ss_pred EEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec---
Confidence 99999999999998776 5666889999999999999999 9999999999999999999999999999999873
Q ss_pred cccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.......++|++.|.|||++.+..+ ++..|+||+|+++|.|+.|.+||++..-.+.. ++.
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------------~rv-- 267 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------------PRV-- 267 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------------chh--
Confidence 4455667889999999999998775 67999999999999999999999864322211 111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...++..+.-++.+..++|+++|-.+|.+|++++++.+.-+
T Consensus 268 --l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 268 --LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred --eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 11222233445667999999999999999999999987654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=263.62 Aligned_cols=265 Identities=21% Similarity=0.240 Sum_probs=196.9
Q ss_pred CCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEEEEec
Q 019843 45 FSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
|.+.+.||.|++|.||+|... +++.|++|.+..... .......+|+..+..+. |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999875 478899998865432 22234556899999998 999999999999999999999999
Q ss_pred CCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++|.+.+.... ..+++..+..++.+++.+|.||| +.+++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~ 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---P 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---C
Confidence 779988887643 47899999999999999999999 999999999999999999999999999998765321 1
Q ss_pred ccccccccccccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH--------
Q 019843 201 SQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV-------- 271 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 271 (335)
......++..|+|||.+. +..++.++|+||||+++++|++|.+||.......... .............+.
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY-KICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH-HHHHhcCCCChhhhhhHhhhhcc
Confidence 223345788899999874 4567899999999999999999999986653322111 100000000000000
Q ss_pred -Hhhhccccccch-hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 272 -DANLLSREDKHF-AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 272 -~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
+........... ......+..+.+++.+||+.||.+||+++|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 0001124669999999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=280.56 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=201.7
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeec----CCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC--eeE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHL----QCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD--FKA 115 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 115 (335)
.-.+...+||+|+|-+||+|.+. +|-.||--.++. .+....+++..|+++|+.|+||||+++++.+.+.. ...
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 33456689999999999999654 477776444332 23455689999999999999999999999987654 477
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC-CCCcEEEeecccccccc
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~-~~~~v~l~dfg~~~~~~ 194 (335)
+|+|.+..|+|..++.+.+ ..+...+..|+.||+.||.|||. ...+|+|+|||.+||||+ .-|.|||+|+|+|+...
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 8999999999999998765 78899999999999999999993 367999999999999997 56899999999999863
Q ss_pred CCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
.......+||+.|||||+-. ..|+...||||||++++||.|+..||..+.....-++...+...|..+..+.
T Consensus 198 ----~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~--- 269 (632)
T KOG0584|consen 198 ----KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK--- 269 (632)
T ss_pred ----ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC---
Confidence 33334479999999999876 7899999999999999999999999998876544444433333333333322
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.++++++|.+||.. ..+|||+.|+|.
T Consensus 270 ---------------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 ---------------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 23489999999999 899999999986
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=270.36 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=206.4
Q ss_pred hcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..+.|+.-++||+|+||.||.++. .+|+-+|+|.+... .........+|-++|.+++.+.||.+-..|+..+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 346788999999999999999965 46999999987532 33344667889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 117 VLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
|+..|+||+|.-+|...+ ..+++..+..++.+|+.||.+|| +.+|+++|+||+|||+|+.|++.|+|+|++..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~- 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP- 338 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecC-
Confidence 999999999998887643 46999999999999999999999 9999999999999999999999999999999773
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
........+||.+|||||++++..|+...|.|||||++|+|+.|+.||....+... .+-+|+..
T Consensus 339 --~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk--------------~eEvdrr~ 402 (591)
T KOG0986|consen 339 --EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK--------------REEVDRRT 402 (591)
T ss_pred --CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh--------------HHHHHHHH
Confidence 22333445899999999999999999999999999999999999999987543221 11223322
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINA 311 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 311 (335)
..+.. ..+..++++.+++....|+.||.+|...
T Consensus 403 ~~~~~---ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 403 LEDPE---EYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hcchh---hcccccCHHHHHHHHHHHccCHHHhccC
Confidence 22221 1246778899999999999999999643
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=281.25 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=214.9
Q ss_pred cCCCCccceeeecCceEEEEEEEcC--C--cEEEEEEeecCCCc-hhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD--G--MEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~--~--~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.++.+..+.||+|+||.|++|.|.. | -.||||.+..+... ....|.+|+.++.+|+|+|++++||+..+ ....|
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3566778999999999999998763 4 35899999866433 67899999999999999999999999988 66779
Q ss_pred EEEecCCCChHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 117 VLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
|||.+++|+|.+.|.+ ....+....+..++.||+.|+.||. +++++|+|+-..|+++-....|||+|||+.+-+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999999987 5557889999999999999999999 99999999999999999988999999999998753
Q ss_pred Cc-cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 196 ED-QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 196 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
.+ .............|+|||.+....++.+||+|++|+++|||++ |..||-+...- .+...+|
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------------qIL~~iD- 329 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------------QILKNID- 329 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------------HHHHhcc-
Confidence 32 3333444556777999999999999999999999999999999 88998875421 1222222
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...+++.++.|++++++++.+||+++|++||++..|.+.+-
T Consensus 330 -----~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 330 -----AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -----ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 45567778899999999999999999999999999975544
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=305.97 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=207.3
Q ss_pred hcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
..=+|.-...||.|.||.||.|.. .+|.-.|+|-+.... ......+.+|+.++..++|||+++++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 344788889999999999999964 458888999887553 34557788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
||||++|+|.+++...+ ..++....-+..|++.|+.||| +.||||+||||+||+++.+|.+|++|||.+..+.+..
T Consensus 1313 MEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 99999999999887654 6777777778999999999999 9999999999999999999999999999999875432
Q ss_pred --cccccccccccccccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 198 --QSKSQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 198 --~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
....-....||+.|||||++.+.. ...++|||||||++.||.||+.||.+.+.+- ..=+ .
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-aIMy--------------~ 1453 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-AIMY--------------H 1453 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-HHHh--------------H
Confidence 223334678999999999998654 6779999999999999999999998764321 1111 1
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
-+ -+.....|..++++-.+++..||..||++|-++.|+++.
T Consensus 1454 V~----~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 VA----AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred Hh----ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11 111222344478889999999999999999777776653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=258.71 Aligned_cols=239 Identities=29% Similarity=0.346 Sum_probs=195.6
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCCh
Q 019843 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL 126 (335)
Q Consensus 51 lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 126 (335)
||.|++|.||.+... +++.+++|++.... ......+..|+++++.++|+|++++++.+...+..+++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999765 48899999986542 22456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccccc
Q 019843 127 EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206 (335)
Q Consensus 127 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~ 206 (335)
.+++.... .+++..++.++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+....... .......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 99987664 6899999999999999999999 9999999999999999999999999999987653211 2234456
Q ss_pred ccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhH
Q 019843 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286 (335)
Q Consensus 207 ~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (335)
++..|+|||.+.+..++.++|+||||+++|++++|..||....... ....... .....+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----------------~~~~~~~----~~~~~~ 213 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-----------------IYEKILK----DPLRFP 213 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-----------------HHHHHhc----CCCCCC
Confidence 7888999999988888999999999999999999999986543211 1111111 111223
Q ss_pred HHHHHHHHHHHHHhchhccccCCCH---HHHHH
Q 019843 287 EQCVSFVFNLAMECTVESAEQRINA---KEIVT 316 (335)
Q Consensus 287 ~~~~~~l~~li~~~l~~dP~~Rps~---~ell~ 316 (335)
...++.+.+++.+||..||++||++ +++++
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 3346679999999999999999999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=262.09 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=194.5
Q ss_pred CCCccceeeecCceEEEEEEEcC-CcEEEEEEeecC-----CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQ-----CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
+|.+.+.||.|++|.||++.... +..+++|+.+.. .......+..|+.+++.++||||+++++.+.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 68999999999999999997653 444555555421 122334566789999999999999999999999999999
Q ss_pred EEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 118 LEYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
+||+++++|.+++.. ....+++..++.++.+++.|+.+|| +.+++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998863 3447899999999999999999999 999999999999999975 579999999987653
Q ss_pred CCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
.. ........++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .....
T Consensus 157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----------------~~~~~ 217 (260)
T cd08222 157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS-----------------VVLRI 217 (260)
T ss_pred CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----------------HHHHH
Confidence 22 122233457788999999988888999999999999999999999986432111 11111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.. ......+..++.++.++|.+||..||++||++.++++
T Consensus 218 ~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 218 VE---GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred Hc---CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00 0111123456778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=267.46 Aligned_cols=267 Identities=22% Similarity=0.241 Sum_probs=194.3
Q ss_pred CCCccceeeecCceEEEEEEEc-C--CcEEEEEEeecC--CCchhHHHHHHHHHHHhC-CCCceEEEeeeeec----CCe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-D--GMEVAVKVFHLQ--CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSN----DDF 113 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~--~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~ 113 (335)
+|++.+.||.|+||.||++... . +..||+|.+... .....+.+..|+.+++.+ +|+||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5889999999999999999755 3 678999988643 223346778899999999 59999999987532 246
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.+++++++. ++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 778889884 68988886543 7899999999999999999999 999999999999999999999999999999865
Q ss_pred cCCccc--cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc-------
Q 019843 194 TGEDQS--KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL------- 263 (335)
Q Consensus 194 ~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~------- 263 (335)
...... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||....... ..........
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 322111 11223467889999998765 568999999999999999999999987543211 1111111100
Q ss_pred ----ChhHHHHHHhhhccccccchh-hHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 264 ----PISVMEIVDANLLSREDKHFA-AKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 264 ----~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.......... ........+. .....+..+.+++.+||+.||.+|||+.+++..
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRS-LPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHh-ccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 0000001110 011235679999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=255.79 Aligned_cols=278 Identities=23% Similarity=0.260 Sum_probs=205.4
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEE-cC----CcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeee
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARI-QD----GMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCS 109 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~----~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 109 (335)
+..+....|.+...||+|.||.||+|.. ++ ...+|+|+++.+. +..-.+.-+|+.+++.++|||++.+..++.
T Consensus 18 ~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 18 ERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred hhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 4445567899999999999999999943 22 2368999997552 345577888999999999999999999987
Q ss_pred c-CCeeEEEEEecCCCChHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC----C
Q 019843 110 N-DDFKALVLEYMPHGSLEKCLYSS----NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN----M 180 (335)
Q Consensus 110 ~-~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~----~ 180 (335)
. +..++++++|.+. +|..+|.-. ...++...+..++.||+.|+.||| +.-+.|+|+||.||+|..+ |
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG 173 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERG 173 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccC
Confidence 7 7899999999955 888888632 347899999999999999999999 9999999999999999877 8
Q ss_pred cEEEeeccccccccCCcccc-ccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchh----
Q 019843 181 VAHLSDFGIAKLLTGEDQSK-SQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMT---- 254 (335)
Q Consensus 181 ~v~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~---- 254 (335)
.|||+|+|+++.+.+.-.+- .....+.|..|.|||.+.|. .|+.+.|+|+.||++.||++..+.|....+....
T Consensus 174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pf 253 (438)
T KOG0666|consen 174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPF 253 (438)
T ss_pred eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCc
Confidence 99999999999886443332 45567789999999998874 6899999999999999999999988643221111
Q ss_pred ----hHhHhhhhcChhHH------------HHHHhhhcccccc----c-hhhHHHHHHHHHHHHHHhchhccccCCCHHH
Q 019843 255 ----LKYWVSNLLPISVM------------EIVDANLLSREDK----H-FAAKEQCVSFVFNLAMECTVESAEQRINAKE 313 (335)
Q Consensus 255 ----~~~~~~~~~~~~~~------------~~~~~~~~~~~~~----~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 313 (335)
+....+-+..+.-. ..+.......... . +.....-++...+|+.++|+.||.+|.|+++
T Consensus 254 q~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q 333 (438)
T KOG0666|consen 254 QHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ 333 (438)
T ss_pred hHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence 11111111000000 0000000000000 0 0001112344789999999999999999999
Q ss_pred HHHHH
Q 019843 314 IVTRL 318 (335)
Q Consensus 314 ll~~L 318 (335)
.++..
T Consensus 334 Aleh~ 338 (438)
T KOG0666|consen 334 ALEHP 338 (438)
T ss_pred Hhccc
Confidence 98754
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=258.86 Aligned_cols=242 Identities=22% Similarity=0.293 Sum_probs=203.1
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..++|...++||+|.||.|-+++-+ +++.+|+|+++.+ .......-..|-++|+...||.+..+-..|..++.+|.
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3468899999999999999999755 6899999998755 23334555678999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||..||.|.-.+.... .+++.....+...|..||.||| +++|+++|+|.+|.++|.||++||.|||++..- .
T Consensus 246 VMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--I 319 (516)
T ss_pred EEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc--c
Confidence 999999999988777654 7999999999999999999999 999999999999999999999999999999742 2
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.........+||+.|+|||++....|+.+.|.|.+|+++|||++|+.||.+...+.. -+++ +
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL--------------FeLI---l- 381 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL--------------FELI---L- 381 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH--------------HHHH---H-
Confidence 334455668999999999999999999999999999999999999999987432111 1111 1
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCC
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRI 309 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 309 (335)
....-.|..++++...|+..+|..||++|.
T Consensus 382 ---~ed~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 382 ---MEDLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---hhhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 111223566788899999999999999995
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=251.27 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=204.5
Q ss_pred cceeeecCceEEEEEE-EcCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEecCCCC
Q 019843 48 NNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPHGS 125 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 125 (335)
.+.||+|+++.|-.+. ..++..+|||++.........++.+|++++.++ .|+||+.++++|++....|+|||-+.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4789999999998885 678999999999888777788999999999999 59999999999999999999999999999
Q ss_pred hHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC---cEEEeeccccccccC-----Cc
Q 019843 126 LEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLLTG-----ED 197 (335)
Q Consensus 126 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~---~v~l~dfg~~~~~~~-----~~ 197 (335)
|...|.++. .+++.++..+..+|+.||.+|| ++||.|+|+||+|||...-. -|||+||.+..-... ..
T Consensus 163 lLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 163 LLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred HHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 999998765 7999999999999999999999 99999999999999996544 589999988653311 11
Q ss_pred cccccccccccccccCccccC---C--CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc----ChhHH
Q 019843 198 QSKSQTQTLATIGYMAPEYGR---E--GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL----PISVM 268 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~---~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~ 268 (335)
.......++|+..|||||+.. + .-|+.+.|.||||+++|-|+.|.+||.+....+-.+ -.... +...-
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW---drGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW---DRGEVCRVCQNKLF 315 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc---cCCCccHHHHHHHH
Confidence 122333567899999999753 2 348999999999999999999999997654322211 11100 11122
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.-+..+.++-+.+.+ -.++.+..++++.+|..||.+|.++.+++.
T Consensus 316 esIQEGkYeFPdkdW---ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDW---AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHhccCCcCChhhh---HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 222222222222222 357888999999999999999999998876
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=263.03 Aligned_cols=267 Identities=22% Similarity=0.259 Sum_probs=214.5
Q ss_pred CCCCCCCCCCCCcccccccCHHHHhhhcCCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecC---CCchhHHHHHHH
Q 019843 15 GKQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQ---CGGVFKSFDVEC 90 (335)
Q Consensus 15 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~---~~~~~~~~~~e~ 90 (335)
++.++++..+|+....+..+... ..-..+|..+.+||+|+||.|.+|. ..+.+-+|||+++.+ .+...+--..|-
T Consensus 322 ~~s~p~~~~~~~~~~~~~~~~~d-~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EK 400 (683)
T KOG0696|consen 322 GSSKPEKKTMPTDSKFHNSSKRD-RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEK 400 (683)
T ss_pred CcCCCCCCCCCCcccCCCCCccc-ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhh
Confidence 34466677777766666666655 4445789999999999999999995 445778999998754 122234445577
Q ss_pred HHHHhC-CCCceEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCC
Q 019843 91 EVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169 (335)
Q Consensus 91 ~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di 169 (335)
++|... +-|.+++++.+|..-+.+|.||||+.||+|--.|++-+ .+.+..+..++.+|+-||.+|| +++|+++||
T Consensus 401 rvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDL 476 (683)
T KOG0696|consen 401 RVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDL 476 (683)
T ss_pred hheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeec
Confidence 777766 46788899999999999999999999999988887655 7889999999999999999999 999999999
Q ss_pred CCCCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccc
Q 019843 170 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIF 249 (335)
Q Consensus 170 ~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~ 249 (335)
+.+||+++.+|++||.|||++..- ..........+||+.|+|||++..++|+.+.|.||+|++||||+.|++||++.+
T Consensus 477 KLDNvmLd~eGHiKi~DFGmcKEn--i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 477 KLDNVMLDSEGHIKIADFGMCKEN--IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred cccceEeccCCceEeeeccccccc--ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999998742 122334456789999999999999999999999999999999999999999865
Q ss_pred ccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCC
Q 019843 250 AGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI 309 (335)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 309 (335)
+.+. ...+.+. ....++.++.+..++.+..|...|.+|.
T Consensus 555 E~el-------------F~aI~eh--------nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 555 EDEL-------------FQAIMEH--------NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHH-------------HHHHHHc--------cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 4322 1222222 1223556678899999999999999995
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=268.42 Aligned_cols=263 Identities=21% Similarity=0.318 Sum_probs=213.1
Q ss_pred ccCHHHHhhhcCCCCc--cceeeecCceEEEEEE-EcCCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEee
Q 019843 32 RFSYLELFQATDGFSE--NNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIIS 106 (335)
Q Consensus 32 ~~~~~~~~~~~~~y~~--~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 106 (335)
..+..+..++..-|++ .++||.|.||+||-|. .++|+.||||++... .+.....+++|+.||++++||.||.+.-
T Consensus 551 ~~qiqe~vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~ 630 (888)
T KOG4236|consen 551 NCQIQENVDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLEC 630 (888)
T ss_pred chhhhhhhhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 4445555566666666 5899999999999995 567999999999643 2334488999999999999999999999
Q ss_pred eeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC---CcEE
Q 019843 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAH 183 (335)
Q Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~---~~v~ 183 (335)
.|+..+..++|||-+.|--|.-++.+..+.+++.....+..||+.||.||| -++|+|.|+||+|||+... ..+|
T Consensus 631 M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvK 707 (888)
T KOG4236|consen 631 MFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVK 707 (888)
T ss_pred eecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCcee
Confidence 999999999999999664455555556668999999999999999999999 9999999999999999643 4799
Q ss_pred EeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc
Q 019843 184 LSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL 263 (335)
Q Consensus 184 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 263 (335)
|+|||++++++ ........+||+.|+|||++.+..|+..-|+||+|+++|.-+.|..||....
T Consensus 708 lCDFGfARiIg---EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-------------- 770 (888)
T KOG4236|consen 708 LCDFGFARIIG---EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-------------- 770 (888)
T ss_pred eccccceeecc---hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--------------
Confidence 99999999884 3344456789999999999999999999999999999999999999987632
Q ss_pred ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 264 PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
+..+-++....-.+. .....++....+||..+|+..-.+|.|...-++.-|
T Consensus 771 --dIndQIQNAaFMyPp---~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 771 --DINDQIQNAAFMYPP---NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred --chhHHhhccccccCC---CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 122222222222222 223566778999999999999999999998887655
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=252.35 Aligned_cols=219 Identities=20% Similarity=0.156 Sum_probs=176.5
Q ss_pred cCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCChHHHHhc
Q 019843 54 GSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS 132 (335)
Q Consensus 54 g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 132 (335)
|.+|.||++.+. +++.+|+|.+.... ....|...+....||||+++++.+...+..+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999764 58899999987542 233445555556799999999999999999999999999999998876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccccccccccc
Q 019843 133 SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212 (335)
Q Consensus 133 ~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 212 (335)
.. .+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||.+..+.. ......++..|+
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~ 149 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYC 149 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCcccc
Confidence 54 6899999999999999999999 99999999999999999999999999998765421 122234566799
Q ss_pred CccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHH
Q 019843 213 APEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSF 292 (335)
Q Consensus 213 aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (335)
|||.+.+..++.++|+||+|+++|+|++|..|+........ .......+..+++.
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~ 204 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------------------THTTLNIPEWVSEE 204 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------------------cccccCCcccCCHH
Confidence 99999888899999999999999999999988654211000 00001112334667
Q ss_pred HHHHHHHhchhccccCCCH
Q 019843 293 VFNLAMECTVESAEQRINA 311 (335)
Q Consensus 293 l~~li~~~l~~dP~~Rps~ 311 (335)
+.+++.+||+.||++||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 9999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=284.89 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=192.4
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeee---------
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTC--------- 108 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--------- 108 (335)
--.++|...+.||+|+||.||+++.+ +|+.+|||++... +......+.+|+..|.+++|||||+++..+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45568889999999999999999876 7999999999755 455678899999999999999999997322
Q ss_pred ---------------------------------------------------e------------------c---------
Q 019843 109 ---------------------------------------------------S------------------N--------- 110 (335)
Q Consensus 109 ---------------------------------------------------~------------------~--------- 110 (335)
. +
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0 0
Q ss_pred ------------------------C--------CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 019843 111 ------------------------D--------DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHF 158 (335)
Q Consensus 111 ------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~ 158 (335)
+ ..+||=||||+..++.+++..+...-.....|.++.+|++||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH- 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH- 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH-
Confidence 0 2467889999888888877765422257889999999999999999
Q ss_pred cCCCCeEecCCCCCCEEECCCCcEEEeecccccccc----C------------CccccccccccccccccCccccCCC--
Q 019843 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT----G------------EDQSKSQTQTLATIGYMAPEYGREG-- 220 (335)
Q Consensus 159 ~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~----~------------~~~~~~~~~~~~~~~y~aPE~~~~~-- 220 (335)
+.|++||||||.|||+++++.|||+|||+++... + ..........+||.-|+|||++.+.
T Consensus 715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred --hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9999999999999999999999999999998721 0 0111233456799999999998765
Q ss_pred -CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHH
Q 019843 221 -RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAME 299 (335)
Q Consensus 221 -~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 299 (335)
.|+.|.|+||||++++||+.- |...-++...+ .++. ....+.. ......-.+.-..+|.+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~yP---F~TsMERa~iL------------~~LR-~g~iP~~---~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLYP---FGTSMERASIL------------TNLR-KGSIPEP---ADFFDPEHPEEASLIRW 853 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhcc---CCchHHHHHHH------------Hhcc-cCCCCCC---cccccccchHHHHHHHH
Confidence 499999999999999999863 54422111111 1111 1111111 00111123346899999
Q ss_pred hchhccccCCCHHHHHH
Q 019843 300 CTVESAEQRINAKEIVT 316 (335)
Q Consensus 300 ~l~~dP~~Rps~~ell~ 316 (335)
||++||.+||||.|+|.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999985
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=287.92 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=212.4
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
---.++|.++++||+|+||.|..++.+ +++.+|+|+++.. ......-|++|-.++..-+.+=|+.++-.|.++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 345679999999999999999999765 5888999998752 234456788999999988999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
|+||+|++||+|..++.+.. .+++..+..++..|.-||..|| +.|+|||||||+|||+|..|+++|.|||.+-.+.
T Consensus 151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 99999999999999998777 8999999999999999999999 9999999999999999999999999999998875
Q ss_pred CCccccccccccccccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
..+ .......+|||-|.|||++.. +.|+...|.||+|+++|||+.|..||...+ ...
T Consensus 227 ~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----------------lve 288 (1317)
T KOG0612|consen 227 ADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----------------LVE 288 (1317)
T ss_pred CCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----------------HHH
Confidence 333 334556789999999998763 458999999999999999999999998643 223
Q ss_pred HHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCC---HHHHHHHHH
Q 019843 270 IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN---AKEIVTRLL 319 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~L~ 319 (335)
.+.+.+.-+....++....+|....+||.+.+. +|..|.. ++++-..-.
T Consensus 289 TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 289 TYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred HHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence 333333333333343334578889999998775 5677776 887766543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=253.17 Aligned_cols=274 Identities=25% Similarity=0.395 Sum_probs=210.3
Q ss_pred cccCHHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhC--CCCceEEEeeee
Q 019843 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI--RHRNLIKIISTC 108 (335)
Q Consensus 31 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~ 108 (335)
+-.++.---.++.+-++++.||+|.||.||+|.|. |+.||||+|... ...+..+|.++++.. +|+||+.+++.-
T Consensus 199 SGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 199 SGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred CCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 33344444456678889999999999999999999 999999999744 237788899999865 999999999876
Q ss_pred ecC----CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh-----ccCCCCeEecCCCCCCEEECCC
Q 019843 109 SND----DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH-----FGYSAPVIHCDLKPSNVLLDDN 179 (335)
Q Consensus 109 ~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh-----~~~~~~i~h~di~p~Nilv~~~ 179 (335)
..+ ..+++|.+|.+.|||.|+|... .++.+..+.++..++.||++|| ++-+..|.|||||+.||+|..+
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 543 3788999999999999999874 5999999999999999999999 2336679999999999999999
Q ss_pred CcEEEeeccccccccCCc--cccccccccccccccCccccCCCC------CCCccchhhHHHHHHHHHhC----------
Q 019843 180 MVAHLSDFGIAKLLTGED--QSKSQTQTLATIGYMAPEYGREGR------VSTNGDVYSFGIMLMETFTK---------- 241 (335)
Q Consensus 180 ~~v~l~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~------~~~~sDiwslG~~l~~ll~g---------- 241 (335)
|.+.|+|+|++....... ..-..+..+||.+|||||++...- --..+||||||.++||+...
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 999999999998764332 223455678999999999986542 23468999999999999653
Q ss_pred CCCCCcccccchhhHhHhhhhcChhHHHHHHh----hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 242 KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA----NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 242 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
++||...-+.+.. .++..+- .+.+..+.++. ...+-..+..+++.||..||..|.|+=-+-+.
T Consensus 433 ~~Pyyd~Vp~DPs------------~eeMrkVVCv~~~RP~ipnrW~-s~~~l~~m~klMkeCW~~Np~aRltALriKKt 499 (513)
T KOG2052|consen 433 QLPYYDVVPSDPS------------FEEMRKVVCVQKLRPNIPNRWK-SDPALRVMAKLMKECWYANPAARLTALRIKKT 499 (513)
T ss_pred cCCcccCCCCCCC------------HHHHhcceeecccCCCCCcccc-cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence 4555443332222 2222211 12222222222 22344558999999999999999999999988
Q ss_pred HHHHHh
Q 019843 318 LLKIRD 323 (335)
Q Consensus 318 L~~~~~ 323 (335)
|.++.+
T Consensus 500 l~~l~~ 505 (513)
T KOG2052|consen 500 LAKLSN 505 (513)
T ss_pred HHHHhc
Confidence 888764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=279.78 Aligned_cols=146 Identities=28% Similarity=0.430 Sum_probs=132.1
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... ......+..|+.++..++|+||+++++.+...+..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 478999999999999999999766 68999999987432 23346788899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
|||+.+++|.+++.... .+++..++.++.+|+.||.||| ..+|+|+||+|+|||++.++.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999987544 6899999999999999999999 9999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=277.64 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=219.8
Q ss_pred CCCccceeeecCceEEEEEEE-cC----CcEEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARI-QD----GMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~-~~----~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
..+-.++||.|+||+||+|.| .+ +-+|++|++... ..+...++.+|+-++.++.|||++++++++..+. +.+|
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 445678999999999999964 23 456899998644 3445688999999999999999999999998776 7799
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
++|+++|+|.++++..+..+..+..+.|..||++|+.||| .+.++||||-..||||..-..+|+.|||++..+...+
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999988888999999999999999999999 9999999999999999999999999999999876554
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.........-.+.|+|-|.+....++.+|||||||+++||++| |..|+.+....+.. +++
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~--------------dll----- 913 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP--------------DLL----- 913 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh--------------HHH-----
Confidence 4444444455677999999999999999999999999999999 99998886543331 222
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
..+.+++.++.|+-++..++.+||..|+..||+++++.+.+..+..+
T Consensus 914 -e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 914 -EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred -hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 23445777888999999999999999999999999999999987654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=255.47 Aligned_cols=267 Identities=20% Similarity=0.223 Sum_probs=201.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-C-C----ceEEEeeeeecCCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-H-R----NLIKIISTCSNDDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i~~~~~~~~~~~~ 113 (335)
..++|.++..+|+|.||.|..+.+. .+..||||+++.-. ...+...-|+++|.++. + | -++.+.++|...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 4889999999999999999999654 47899999987442 23456677999999993 2 2 37777888999999
Q ss_pred eEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC---------------
Q 019843 114 KALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD--------------- 177 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~--------------- 177 (335)
.|+|+|.+ |.|+.+++..+ -.+++...+..++.||++++.+|| +.+++|.||||+||++.
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999988 88999999864 447999999999999999999999 99999999999999983
Q ss_pred -----CCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccc
Q 019843 178 -----DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252 (335)
Q Consensus 178 -----~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~ 252 (335)
.+..++++|||.++.- .......+.|..|.|||++.+-.++..+||||+||+|+||++|...|....+.+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~-----~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFD-----HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCccee-----ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 1346899999999864 223356788999999999999999999999999999999999999998766333
Q ss_pred hh--hHhHhhhhcCh----h-HHHHHHhhhcc--------------ccccchh----hHHHHHHHHHHHHHHhchhcccc
Q 019843 253 MT--LKYWVSNLLPI----S-VMEIVDANLLS--------------REDKHFA----AKEQCVSFVFNLAMECTVESAEQ 307 (335)
Q Consensus 253 ~~--~~~~~~~~~~~----~-~~~~~~~~~~~--------------~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~ 307 (335)
.. +...+.+.... . ........... +....+. ....-...|.+|+.+||.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 21 12222211100 0 11111111000 0000000 01122445999999999999999
Q ss_pred CCCHHHHHHH
Q 019843 308 RINAKEIVTR 317 (335)
Q Consensus 308 Rps~~ell~~ 317 (335)
|+|+.|+|..
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=267.27 Aligned_cols=245 Identities=24% Similarity=0.261 Sum_probs=198.2
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 117 (335)
.+.+.|.+...+|.|+|+.|-.+.. .+++..++|++.... ....+|..++... +||||++..+.+.+....|+|
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 3577899999999999999998854 468889999987552 2334566565555 799999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE-CCCCcEEEeeccccccccCC
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL-DDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv-~~~~~v~l~dfg~~~~~~~~ 196 (335)
||.+.|+-+.+.+.... .....+..|+.+|+.|+.||| .+|++|||++|+|||+ +..|+++|+|||.+.....
T Consensus 395 ~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~- 468 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER- 468 (612)
T ss_pred ehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCch-
Confidence 99999988877766544 333777889999999999999 9999999999999999 6999999999999986532
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.....+-|..|.|||++....|+.++|+||||++||+||+|+.||.....+. ++......
T Consensus 469 ----~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~----------------ei~~~i~~ 528 (612)
T KOG0603|consen 469 ----SCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI----------------EIHTRIQM 528 (612)
T ss_pred ----hhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH----------------HHHHhhcC
Confidence 2344567888999999999999999999999999999999999998754331 11111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
... ...+++..++|+.+||+.||.+||++.++...=+.
T Consensus 529 ~~~------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 529 PKF------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred Ccc------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 111 15568889999999999999999999999875444
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=274.39 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=211.3
Q ss_pred CCCccceeeecCceEEEEEEEc----C----CcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ----D----GMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDF 113 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~----~----~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 113 (335)
+..+.+.+|.|.||.|++|... . ...||||.++... ....+.+..|+++++.+ .|+||+.++|++...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3456679999999999999632 1 3569999987543 34668899999999999 69999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC
Q 019843 114 KALVLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD 178 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~ 178 (335)
.++|+||+..|+|.+++...+ ..++...++.++.||+.|++||+ +.+++|||+-..||++..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecC
Confidence 999999999999999998765 35899999999999999999999 999999999999999999
Q ss_pred CCcEEEeeccccccccCCcccccc-ccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhH
Q 019843 179 NMVAHLSDFGIAKLLTGEDQSKSQ-TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLK 256 (335)
Q Consensus 179 ~~~v~l~dfg~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~ 256 (335)
+..+|++|||+++........... ....-...|||||.+....++.+|||||+|+++||+++ |..||.+....
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~----- 528 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT----- 528 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH-----
Confidence 999999999999865433322211 11114556999999999999999999999999999999 88888652111
Q ss_pred hHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 257 YWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
.++.. ....+.+...|..|++++.++++.||+.+|++||+..++.+.+....
T Consensus 529 -----------~~l~~---~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 529 -----------EELLE---FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred -----------HHHHH---HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 11111 22344556667888999999999999999999999999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=241.94 Aligned_cols=238 Identities=29% Similarity=0.342 Sum_probs=193.5
Q ss_pred CceEEEEEEEc-CCcEEEEEEeecCCCch-hHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCChHHHHhc
Q 019843 55 SFGSVYKARIQ-DGMEVAVKVFHLQCGGV-FKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS 132 (335)
Q Consensus 55 ~~~~v~~~~~~-~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 132 (335)
++|.||+|... +++.+++|++....... ...+.+|++.++.++|+|++++++.+......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 57999999876 48999999997665443 68899999999999999999999999999999999999999999999876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccccccccccc
Q 019843 133 SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212 (335)
Q Consensus 133 ~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 212 (335)
.. .++...++.++.+++.++.+|| +.+++|+||+|.||+++.++.++++|||.+...... .......++..|+
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~ 153 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYM 153 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCC
Confidence 54 3899999999999999999999 999999999999999999999999999999876322 1334456788899
Q ss_pred CccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHH
Q 019843 213 APEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSF 292 (335)
Q Consensus 213 aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (335)
|||...+..++.++|+||||++++++++|..||........ ..+........ .......++..
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~----------------~~~~~~~~~~~-~~~~~~~~~~~ 216 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE----------------LFKKIGKPKPP-FPPPEWKISPE 216 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----------------HHHHHhccCCC-CccccccCCHH
Confidence 99999888889999999999999999999999866321111 11111000000 00000114567
Q ss_pred HHHHHHHhchhccccCCCHHHHHH
Q 019843 293 VFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 293 l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
+.+++.+||..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=264.47 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=210.8
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCc-EEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGM-EVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
..++..+..||-|+||.|=++..++.. .+|+|+++.. ++...+.+..|-+++..+++|.|+++|-.|.++.++|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 456777889999999999999877533 3788877532 455567889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
||.|-||.|..++..++ .++......++.++++|+.||| +++|+++||||+|.+++.+|-+||.|||++..+.
T Consensus 499 mEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--- 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--- 571 (732)
T ss_pred HHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhc---
Confidence 99999999999988765 8999999999999999999999 9999999999999999999999999999999874
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
.....-..+||+.|.|||++.+...+.+.|.||||+++|||++|.+||+..++-... +++-++
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY--------------n~ILkG--- 634 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY--------------NLILKG--- 634 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH--------------HHHHhh---
Confidence 333444578999999999999999999999999999999999999999886432221 111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCC-----HHHHHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-----AKEIVTRLLKI 321 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~L~~~ 321 (335)
-..+..|..++....+||++++..+|.+|.. +.+|-+.-|-.
T Consensus 635 --id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 635 --IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred --hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 1122334566777999999999999999975 66666665543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=248.80 Aligned_cols=266 Identities=23% Similarity=0.283 Sum_probs=222.0
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeee
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 109 (335)
++.....+++...++-+|.||.||.|.+. +.+.|.+|..+.. +.-....+..|.-++..+.|||+..+.++..
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 33444557888889999999999999544 3456777877644 3334567888888999999999999999875
Q ss_pred -cCCeeEEEEEecCCCChHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc
Q 019843 110 -NDDFKALVLEYMPHGSLEKCLYS-------SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181 (335)
Q Consensus 110 -~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~ 181 (335)
+...+++++.+..-|+|..++.. ....++..++..++.|++.|+.||| +++++|.||...|.++++.-+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhee
Confidence 56788899999999999999972 1236788899999999999999999 999999999999999999999
Q ss_pred EEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhh
Q 019843 182 AHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVS 260 (335)
Q Consensus 182 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~ 260 (335)
|||+|=.+++.+.+.+.............|||||.+.+..++.+||+||||+++|||++ |+.||...++-++..
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~----- 509 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH----- 509 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-----
Confidence 99999999988776666666666777888999999999999999999999999999999 899987755433321
Q ss_pred hhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 261 NLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
....+.++..|.+||+++..++..||+.+|++||+.+++..-|+.+...+
T Consensus 510 ---------------ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 510 ---------------YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ---------------HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 12244566668899999999999999999999999999999999887665
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=262.89 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=216.4
Q ss_pred cccCHHHHhhhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeee
Q 019843 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTC 108 (335)
Q Consensus 31 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 108 (335)
.-...+....-++.|.+.+.||.|.+|.||+++. ++++-.|+|+.....+. -+++..|+++++.. +|||++.+++++
T Consensus 7 ~~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 7 MDIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred cccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 3345566677788999999999999999999974 45888899987755443 37888999999988 699999999998
Q ss_pred ec-----CCeeEEEEEecCCCChHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcE
Q 019843 109 SN-----DDFKALVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 182 (335)
Q Consensus 109 ~~-----~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v 182 (335)
.. .+.+++|||+|.|||.-|+++. .+..+.++.+..|+..++.|+.+|| ...++|+||+-.||+++.++.|
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcE
Confidence 53 6799999999999999999874 2557999999999999999999999 9999999999999999999999
Q ss_pred EEeeccccccccCCccccccccccccccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHh
Q 019843 183 HLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKY 257 (335)
Q Consensus 183 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~ 257 (335)
||+|||.+..++ ......+..+||+.|||||++.- ..|+.++|+||||++..||--|.+|+-...+-....
T Consensus 163 KLvDFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF-- 238 (953)
T KOG0587|consen 163 KLVDFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF-- 238 (953)
T ss_pred EEeeeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc--
Confidence 999999998764 33445566789999999999864 347889999999999999999999965432111100
Q ss_pred HhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 258 WVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
. ....+.+.+-.+...+.++.++|..||..|-.+||++.+++.
T Consensus 239 --------------~--IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 --------------L--IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --------------c--CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0 123345555556777889999999999999999999999875
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=262.88 Aligned_cols=275 Identities=24% Similarity=0.319 Sum_probs=201.4
Q ss_pred hcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecC------C
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSND------D 112 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 112 (335)
...-|..-+.||+|+||.||+|++ .+|+.||||.+.... ....+..-.|++++++++|+|||++.++-+.. .
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 345677789999999999999984 569999999997643 33456777899999999999999999886653 3
Q ss_pred eeEEEEEecCCCChHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC--CCC--cEEEee
Q 019843 113 FKALVLEYMPHGSLEKCLYSS--NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD--DNM--VAHLSD 186 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~--~~~--~v~l~d 186 (335)
...+|||||.||+|...+++. ...+++.+++.+..++..|+.||| .++|+||||||.||++- ++| ..||+|
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 667999999999999999853 346999999999999999999999 99999999999999984 444 469999
Q ss_pred ccccccccCCccccccccccccccccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHh-HhhhhcC
Q 019843 187 FGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKY-WVSNLLP 264 (335)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~ 264 (335)
||.++-+.+ .......+||..|++||+.. ...|+...|.|||||++|++.||..||.....+...... |......
T Consensus 168 fG~Arel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 168 FGAARELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred ccccccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 999997742 33556688999999999988 477889999999999999999999999876554322111 1111111
Q ss_pred h-hHHHHHHhhhc--cccccchhhH----HHHHHHHHHHHHHhchhccccCC--CHHHHHHHHHHH
Q 019843 265 I-SVMEIVDANLL--SREDKHFAAK----EQCVSFVFNLAMECTVESAEQRI--NAKEIVTRLLKI 321 (335)
Q Consensus 265 ~-~~~~~~~~~~~--~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rp--s~~ell~~L~~~ 321 (335)
. .+....++... -.....++.+ ......+-..+..+|.-+|.+|- ...+.-..+..+
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 1 00000000000 0001111112 12233355666778888999987 666665555544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=218.21 Aligned_cols=266 Identities=25% Similarity=0.273 Sum_probs=203.3
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|.-.+.||+|.+|+||+|+.. +++-||+|..+.++ .....+..+|+-+++.++|.||++++++......+.+|+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556689999999999999754 58889999988663 44567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
| ...|..+..+-++.++.+.+..+..|+++||.+.| ++++.|+|++|.|.+++.+|.+|+.|||+++-++ -...
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafg--ipvr 156 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFG--IPVR 156 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcC--CceE
Confidence 9 56899998888889999999999999999999999 9999999999999999999999999999998763 2233
Q ss_pred ccccccccccccCccccCCCC-CCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHH------H
Q 019843 201 SQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIV------D 272 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 272 (335)
-....+.|..|.+|.++.|.. |++..|+||.||++.|+.. |.+.|.+.+-.+. +............+.+- |
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq-lkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH-HHHHHHHhCCCccccCCccccCCC
Confidence 445567899999999988755 8899999999999999988 6666655433222 22222111111111110 1
Q ss_pred hhhccccccchhhH---HHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 273 ANLLSREDKHFAAK---EQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 273 ~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
-...+......... +.+...=++++.+.|.-+|..|.++++.++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11111111111111 122333578999999999999999998875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=238.56 Aligned_cols=252 Identities=25% Similarity=0.254 Sum_probs=195.7
Q ss_pred CCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCC-chhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
..+....||.|+||+|++-.. .+|+..|||.++.... ...+++..|.+...+- ++||||+++|....++..++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 344567899999999999854 5699999999986543 4456777788776665 799999999999999999999999
Q ss_pred cCCCChHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 121 MPHGSLEKCLYS----SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 121 ~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
+ ..|++.+... ....+++.-+-.|......||.||.+ ...++|+|+||+|||++..|.+||||||++..+
T Consensus 145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL--- 218 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL--- 218 (361)
T ss_pred H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhH---
Confidence 8 6688776431 23368999999999999999999996 789999999999999999999999999998765
Q ss_pred ccccccccccccccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
..+.......|-..|+|||.+.. ..|+.+||+||||++|||+.||..||.....-- +-+...
T Consensus 219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf----------------eql~~V 282 (361)
T KOG1006|consen 219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF----------------EQLCQV 282 (361)
T ss_pred HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH----------------HHHHHH
Confidence 23334455667888999998864 348999999999999999999999987653211 111111
Q ss_pred hccccccchhhH--HHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 275 LLSREDKHFAAK--EQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 275 ~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...+++.-.... ...+..+..+|.-||..|-..||+..++++.
T Consensus 283 v~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 283 VIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111121111111 1256779999999999999999999998763
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=247.25 Aligned_cols=261 Identities=26% Similarity=0.413 Sum_probs=204.1
Q ss_pred hhhcCCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecCCC-------chhHHHHHHHHHHHhCCCCceEEEeeeee-
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG-------GVFKSFDVECEVMKSIRHRNLIKIISTCS- 109 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 109 (335)
....++|-+.++||+|+|+.||+|. ..+++.||+|+-..... -.....-+|.+|-+.|.||.||+++++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 3456789999999999999999996 44578899998643321 12234567999999999999999999986
Q ss_pred cCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC---CCCcEEEee
Q 019843 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSD 186 (335)
Q Consensus 110 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~---~~~~v~l~d 186 (335)
+.+.+|-|+|||+|.+|+-++.... .+++.++..|+.||..||.||.. .+.+|+|-||+|.|||+. .-|.+||.|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeee
Confidence 5678889999999999999888665 79999999999999999999993 377999999999999995 346899999
Q ss_pred ccccccccCCcccc-----ccccccccccccCccccCCC----CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHh
Q 019843 187 FGIAKLLTGEDQSK-----SQTQTLATIGYMAPEYGREG----RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKY 257 (335)
Q Consensus 187 fg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~----~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~ 257 (335)
||++.++.+..... ......||.+|++||.+.-+ .++.+.||||+|+++|..+.|+.||+.......-+.
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq- 695 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ- 695 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh-
Confidence 99999986543332 23456799999999976532 368899999999999999999999987543332221
Q ss_pred HhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 258 WVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.........-.++..+.++.+..++|++||++.-++|....++..
T Consensus 696 --------------eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 --------------ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --------------hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111122233444556788999999999999999988877753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=237.11 Aligned_cols=248 Identities=21% Similarity=0.272 Sum_probs=199.6
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 116 (335)
.++|.+.++||+|+|+.|.++..+ +.+-+|+|+++.+ .++.+.-...|-.++.+. +||.++.++.+|...+.+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 358999999999999999999754 5788999998754 344556667788888877 79999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
|.||++||+|--.+++++ .++++.+..+...|+-||.||| ++||+++|+|.+|++++.+|++||.|+|++..- -
T Consensus 329 vieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~--l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--L 402 (593)
T ss_pred EEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcC--C
Confidence 999999999987777665 7999999999999999999999 999999999999999999999999999999742 2
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcc--cccchhhHhHhhhhcChhHHHHHHhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKI--FAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
.........+||+.|.|||++.+..|+...|.|+||++++||+.|+.||+-- .+++.+...++- ..++++.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf-------qvilekq 475 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF-------QVILEKQ 475 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH-------HHHhhhc
Confidence 3344556789999999999999999999999999999999999999999742 222222222211 1122211
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCC
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN 310 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 310 (335)
...+..++-....+++..|+.||++|..
T Consensus 476 --------iriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 476 --------IRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --------ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 1112223334677888889999999853
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=260.18 Aligned_cols=264 Identities=20% Similarity=0.206 Sum_probs=169.1
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-C----CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeee------ee
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-D----GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIIST------CS 109 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~----~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~ 109 (335)
..++|.+.+.||+|+||.||+|... + +..||+|++...... +....+ .++...+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5679999999999999999999764 4 688999987543211 111111 1122222222222111 24
Q ss_pred cCCeeEEEEEecCCCChHHHHhcCCCCC-------------------CHHHHHHHHHHHHHHHHHHhccCCCCeEecCCC
Q 019843 110 NDDFKALVLEYMPHGSLEKCLYSSNCVL-------------------DIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLK 170 (335)
Q Consensus 110 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------------------~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~ 170 (335)
.....++|++|+.+++|.+++.....+. ....+..++.||+.||.||| +.+|+|+|||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 5668899999999999999887543211 23346679999999999999 9999999999
Q ss_pred CCCEEECC-CCcEEEeeccccccccCCccccccccccccccccCccccCCC----------------------CCCCccc
Q 019843 171 PSNVLLDD-NMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG----------------------RVSTNGD 227 (335)
Q Consensus 171 p~Nilv~~-~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~sD 227 (335)
|+|||++. ++.+||+|||++..+... .........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 579999999999755311 12223345688999999964322 2344669
Q ss_pred hhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccccc----chhhHHHHHHHHHHHHHHhchh
Q 019843 228 VYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK----HFAAKEQCVSFVFNLAMECTVE 303 (335)
Q Consensus 228 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~ 303 (335)
||||||++|+|+++..+++.. ........... ......+.... ...... .+...........+|+.+||+.
T Consensus 362 VwSlGviL~el~~~~~~~~~~---~~~~~~~l~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRN-DYDLVAWRKLV-EPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH---HHHHHHHHHhc-CCcHHHHHHhh-ccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999999977664321 11111111110 00111111100 000000 0010111123456899999999
Q ss_pred ccccCCCHHHHHHH
Q 019843 304 SAEQRINAKEIVTR 317 (335)
Q Consensus 304 dP~~Rps~~ell~~ 317 (335)
||.+|||++++++.
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999985
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=223.41 Aligned_cols=264 Identities=20% Similarity=0.299 Sum_probs=204.7
Q ss_pred hhcCCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeeec--CCeeE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSN--DDFKA 115 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~ 115 (335)
...++|.+++.+|+|.++.||.|. ..+++.++||++++- -...+.+|+.+|+.+. ||||++++++..+ +..+.
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 345789999999999999999995 556899999999854 3478999999999996 9999999999876 45778
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC-CcEEEeecccccccc
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLT 194 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~-~~v~l~dfg~~~~~~ 194 (335)
+++|+++..+...+.. .++...+..++.+++.||.|.| +.||.|+|++|.|++++.. -.++|+|+|++.++
T Consensus 112 LiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY- 183 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY- 183 (338)
T ss_pred hHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhc-
Confidence 9999998877766442 4778889999999999999999 9999999999999999954 47999999999987
Q ss_pred CCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH---
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI--- 270 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 270 (335)
......+..+.+..|--||.+.. +.|+.+-|+|||||++..|++.+.||-.-..+..++...+.-+........
T Consensus 184 --Hp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 184 --HPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred --CCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 33444455667777899998765 568899999999999999999999986554444444443333333333332
Q ss_pred ------------HHhhhccccccchhhH---HHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 271 ------------VDANLLSREDKHFAAK---EQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 271 ------------~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
+........ .++... ...+++..+|+.+.|..|.++|+|+.|.+..
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w-~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPW-SRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccH-HHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 222211110 111111 1245789999999999999999999998864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=234.80 Aligned_cols=272 Identities=20% Similarity=0.302 Sum_probs=200.7
Q ss_pred CCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeec--------C
Q 019843 43 DGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN--------D 111 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~ 111 (335)
+.|.-...||+|.||.||+|+. ++|+.|++|+.-.+ ....-....+|+++|..++|+|++.++++|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4566678999999999999964 45888888876443 33445667889999999999999999988743 3
Q ss_pred CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
..+|+||.+|+. +|..++......++...+..+...++.||.|+| ...|+|+|+|+.|++++.+|.+||.|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 468999999955 888888776668999999999999999999999 9999999999999999999999999999997
Q ss_pred cccCC--ccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhh-HhHhh-----hh
Q 019843 192 LLTGE--DQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTL-KYWVS-----NL 262 (335)
Q Consensus 192 ~~~~~--~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~-----~~ 262 (335)
.+.-. .........+.|..|.+||.+.| ..++++.|||+.||++.+|.++.+-+.+..+..... -..+- ..
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 65322 22233456677999999998776 579999999999999999999999987655433211 10010 11
Q ss_pred cCh-hHHHHHHhhhcc-ccccchhhHH------HHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 263 LPI-SVMEIVDANLLS-REDKHFAAKE------QCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 263 ~~~-~~~~~~~~~~~~-~~~~~~~~~~------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
+|. +...+......+ -........+ .-.++..+|+.++|..||.+|+.+.+++..-
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 111 111111111000 0000000001 1134578999999999999999999998654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=250.92 Aligned_cols=264 Identities=19% Similarity=0.257 Sum_probs=181.9
Q ss_pred cCCCCccceeeecCceEEEEEEE-----------------cCCcEEEEEEeecCCCchhHHH--------------HHHH
Q 019843 42 TDGFSENNLIGRGSFGSVYKARI-----------------QDGMEVAVKVFHLQCGGVFKSF--------------DVEC 90 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~-----------------~~~~~v~iK~~~~~~~~~~~~~--------------~~e~ 90 (335)
.++|.+.++||+|+||.||+|.. ..++.||||.+........+.+ ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57999999999999999999853 2356799999876543332333 3356
Q ss_pred HHHHhCCCCce-----EEEeeeeec--------CCeeEEEEEecCCCChHHHHhcCC-----------------------
Q 019843 91 EVMKSIRHRNL-----IKIISTCSN--------DDFKALVLEYMPHGSLEKCLYSSN----------------------- 134 (335)
Q Consensus 91 ~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~----------------------- 134 (335)
..+.+++|.++ +.+++++.. .+..++|+||+++++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 66666665544 556666542 356889999999999999886421
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccccccccccccCc
Q 019843 135 CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAP 214 (335)
Q Consensus 135 ~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 214 (335)
..+++..+..++.+++.+|.||| +.+++|+||+|+||+++.++.++|+|||++....... .........++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeCh
Confidence 12356778899999999999999 9999999999999999999999999999987542111 1111223347899999
Q ss_pred cccCCCCC----------------------CCccchhhHHHHHHHHHhCCC-CCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 215 EYGREGRV----------------------STNGDVYSFGIMLMETFTKKK-PTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 215 E~~~~~~~----------------------~~~sDiwslG~~l~~ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
|.+..... ..+.|+||+||++++|++|.. ||.....-......+ ......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~-----~~~~~~-- 452 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY-----DNDLNR-- 452 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc-----cchHHH--
Confidence 98753221 124699999999999999875 665322111111000 000111
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhcc---ccCCCHHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESA---EQRINAKEIVTR 317 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rps~~ell~~ 317 (335)
+.........+......++...+|+.+||..+| .+|+|++|+|+.
T Consensus 453 -~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 453 -WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111111222233344557789999999999876 689999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=240.71 Aligned_cols=130 Identities=26% Similarity=0.355 Sum_probs=111.9
Q ss_pred CCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-----C---CceEEEeeeeec---
Q 019843 43 DGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-----H---RNLIKIISTCSN--- 110 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~~--- 110 (335)
.+|-++++||+|.|++||+|.+ +..+.||+|+.+.. ....+....|+++|+++. | ..||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6899999999999999999964 55788999997643 445577889999999883 2 469999999864
Q ss_pred -CCeeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE
Q 019843 111 -DDFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL 176 (335)
Q Consensus 111 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv 176 (335)
..++|||+|++ |-+|..+|... -..++...+.+|+.|++.||.|||+ ..+|+|.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 56999999999 88999998754 2359999999999999999999996 7899999999999997
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-31 Score=218.34 Aligned_cols=210 Identities=35% Similarity=0.550 Sum_probs=184.2
Q ss_pred eeecCceEEEEEEEcC-CcEEEEEEeecCCCc-hhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCChHH
Q 019843 51 IGRGSFGSVYKARIQD-GMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEK 128 (335)
Q Consensus 51 lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 128 (335)
||.|.+|.||++...+ ++.+++|++...... ....+.+|++.++.+.|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998654 899999998766432 45789999999999999999999999999999999999999899999
Q ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC-CCcEEEeeccccccccCCccccccccccc
Q 019843 129 CLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207 (335)
Q Consensus 129 ~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~-~~~v~l~dfg~~~~~~~~~~~~~~~~~~~ 207 (335)
++......++...++.++.++++++.+|| +.+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 98876346899999999999999999999 999999999999999999 89999999999986532211 2334557
Q ss_pred cccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhH
Q 019843 208 TIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286 (335)
Q Consensus 208 ~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (335)
...|++||..... .++.++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8889999998877 788999999999999999
Q ss_pred HHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 287 EQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 287 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..+.+++.+|++.||.+||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 228999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=244.27 Aligned_cols=208 Identities=22% Similarity=0.343 Sum_probs=176.2
Q ss_pred CCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
+-|..++.||-|+||.|+++. ..+...+|.|.+...+ .......+.|-.||....++-||+++-.|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 346678999999999999996 4457778999886542 233456778999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc----
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT---- 194 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~---- 194 (335)
+|++||++-.+|-+.+ .+.+..+..++.++..|+.+.| +.|++|+||||+|||+|.+|++||.|||+++-+.
T Consensus 709 dYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999999999887765 8999999999999999999999 9999999999999999999999999999987431
Q ss_pred -----CCccc-------------------------------cccccccccccccCccccCCCCCCCccchhhHHHHHHHH
Q 019843 195 -----GEDQS-------------------------------KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 238 (335)
Q Consensus 195 -----~~~~~-------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~l 238 (335)
..+.. ......+||+.|+|||++....++...|.||.|++||+|
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 10000 011234689999999999999999999999999999999
Q ss_pred HhCCCCCCcccccchh
Q 019843 239 FTKKKPTDKIFAGEMT 254 (335)
Q Consensus 239 l~g~~pf~~~~~~~~~ 254 (335)
+.|++||-.....+..
T Consensus 865 ~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQ 880 (1034)
T ss_pred hhCCCCccCCCCCcce
Confidence 9999999876655544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=241.54 Aligned_cols=268 Identities=22% Similarity=0.264 Sum_probs=203.5
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEcC-CcEEEEEEeecCCCchhHHHHHHHHHHHhCC------CCceEEEeeeeecC
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIR------HRNLIKIISTCSND 111 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 111 (335)
+...++|.+....|+|-|++|..|.+.. |..||||++...... ...=..|+++|++|+ --|+++++-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 3456799999999999999999997654 789999999855322 345567999999995 34789999999999
Q ss_pred CeeEEEEEecCCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-cEEEeecc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSN--CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFG 188 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~-~v~l~dfg 188 (335)
+++|||||.+ ..+|.+++.+.+ -.+....+..++.||+-||..|. ..+++|.||+|+||||++.- .+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCc
Confidence 9999999998 679999998643 35788999999999999999999 99999999999999998654 67999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh--cChh
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL--LPIS 266 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~ 266 (335)
.|.... .....++..+--|.|||++.|-.|+..-|+||+||+||||+||+..|.+..++.+. ..++.-. ++..
T Consensus 583 SA~~~~----eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML-rl~me~KGk~p~K 657 (752)
T KOG0670|consen 583 SASFAS----ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML-RLFMELKGKFPNK 657 (752)
T ss_pred cccccc----cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH-HHHHHhcCCCcHH
Confidence 998653 22333445566699999999999999999999999999999999999876655442 1111111 1110
Q ss_pred ---HHHHHHhhh------------------------cccccc-----------chhhHHHHHHHHHHHHHHhchhccccC
Q 019843 267 ---VMEIVDANL------------------------LSREDK-----------HFAAKEQCVSFVFNLAMECTVESAEQR 308 (335)
Q Consensus 267 ---~~~~~~~~~------------------------~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dP~~R 308 (335)
...+++..+ ...+.. ...........+.+|+.+||..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 001111110 000000 011112345569999999999999999
Q ss_pred CCHHHHHH
Q 019843 309 INAKEIVT 316 (335)
Q Consensus 309 ps~~ell~ 316 (335)
.|..++|.
T Consensus 738 it~nqAL~ 745 (752)
T KOG0670|consen 738 ITVNQALK 745 (752)
T ss_pred CCHHHHhc
Confidence 99999885
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=251.56 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=189.5
Q ss_pred CCccceeeecCce-EEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEecC
Q 019843 45 FSENNLIGRGSFG-SVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 45 y~~~~~lg~g~~~-~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
|.-.+++|.|+.| .||+|... |+.||||.+-.+ ......+|+..|+.. .||||+++++.-.+.+..|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 3445778888766 57889887 899999987543 346778899999999 6999999999999999999999999
Q ss_pred CCChHHHHhcCCCCC---CHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC---C--CcEEEeecccccccc
Q 019843 123 HGSLEKCLYSSNCVL---DIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD---N--MVAHLSDFGIAKLLT 194 (335)
Q Consensus 123 ~~~L~~~l~~~~~~~---~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~---~--~~v~l~dfg~~~~~~ 194 (335)
.-+|.+++....... .....+.+..|++.||++|| +.+|+|+||+|.|||++. + .+++|+|||++..+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 559999998741111 11345788999999999999 999999999999999975 3 478999999999886
Q ss_pred CCccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 195 GEDQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 195 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
..... .......||.+|+|||.+.+...+.+.|||||||++|+.++| .+||+.....+.+...
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~--------------- 727 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT--------------- 727 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc---------------
Confidence 43322 234567799999999999998888899999999999999995 8999876544332210
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.. . ....+.....+ +..+||.+|++++|..||+|.+||.
T Consensus 728 ~~-~--~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 728 GN-Y--TLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred Cc-c--ceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 0 00000001111 5899999999999999999999973
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=241.42 Aligned_cols=198 Identities=24% Similarity=0.360 Sum_probs=172.6
Q ss_pred cCCCCccceeeecCceEEEEEEEcC-CcEEEEEEeecCC--------CchhHHHHHHHHHHHhCC---CCceEEEeeeee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQC--------GGVFKSFDVECEVMKSIR---HRNLIKIISTCS 109 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~ 109 (335)
...|+..+.+|.|+||.|++|.++. +..|++|.+..+. +.....+..|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3569999999999999999997664 6679999886542 222345667999999996 999999999999
Q ss_pred cCCeeEEEEEec-CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 110 NDDFKALVLEYM-PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 110 ~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
+++++|+++|.. +|.+|-++|..+. .+++..+..|+.|++.|+.+|| +.+|+|||||-+|+.++.+|-+||+|||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence 999999999975 4568899998766 7999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCc
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDK 247 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~ 247 (335)
.+.... ........||..|.|||++.|..| +..-|||++|+++|-++....||.+
T Consensus 716 saa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 998652 445566789999999999999887 6678999999999999999999764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=207.88 Aligned_cols=207 Identities=28% Similarity=0.337 Sum_probs=169.2
Q ss_pred CCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecC-CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
+...-...||+|++|.|-.-+ ..+|.-.|+|.+... ..+...+...|+.+.... .+|.++.++|...+....++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 344456889999999988775 457899999998754 234446677788877766 79999999999999999999999
Q ss_pred ecCCCChHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 120 YMPHGSLEKCLY---SSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 120 ~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
-+ ..||+.+.. ..++..++..+-+|+..+.+||.|||. +..++|+|+||+|||++.+|+||+||||.+-.+.+
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d- 201 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD- 201 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh-
Confidence 98 568887754 346689999999999999999999995 67999999999999999999999999999987632
Q ss_pred ccccccccccccccccCccccCC----CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGRE----GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTL 255 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~ 255 (335)
+-......|-..|+|||.+.. ..|+.+|||||||+++.||.+++.||+...++=..+
T Consensus 202 --SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 202 --SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred --hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence 222333456778999998753 368999999999999999999999998765543333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=242.15 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=209.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
.-.++|....++|.|.+|.||+|+++ +++..++|+++.+.......+.+|+-+++.++||||+.+++.+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 44578999999999999999999754 68999999999998888899999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
|||.||+|.++.. ..+++++.++..++...++++.||| +.+-.|||||-.||++++.|.+|+.|||.+..++ ..
T Consensus 92 EycgggslQdiy~-~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqit--at 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT--AT 165 (829)
T ss_pred EecCCCcccceee-ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhh--hh
Confidence 9999999999544 4458999999999999999999999 9999999999999999999999999999987664 33
Q ss_pred ccccccccccccccCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 199 SKSQTQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~---~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
........||+.|+|||+- ..+.|...+|+|++|++..|+--.++|-.... .+ .+..+..+..
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--pm------------r~l~LmTkS~ 231 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--PM------------RALFLMTKSG 231 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--hH------------HHHHHhhccC
Confidence 3445567899999999964 45779999999999999999988887732211 11 1111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
... +....+...++.+.++++.+|..+|++||+++-+|.
T Consensus 232 ~qp--p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 232 FQP--PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCC--CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 111112334667999999999999999999988765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=218.56 Aligned_cols=269 Identities=23% Similarity=0.239 Sum_probs=201.2
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecC--
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSND-- 111 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 111 (335)
..+....+|.-.+.+|.|.. .|..|.+. .+++|++|+.... ......+..+|..++..++|+||++++.+|.-.
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 45667789999999999998 77777543 5899999987533 455668888999999999999999999998543
Q ss_pred ----CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeec
Q 019843 112 ----DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 187 (335)
Q Consensus 112 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~df 187 (335)
...|+|||++ ..+|..++. ..++-..+..++.|++.|+++|| +.+|+|+||||+||++..++.+|+.||
T Consensus 90 l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~df 162 (369)
T KOG0665|consen 90 LEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDF 162 (369)
T ss_pred HHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccc
Confidence 4678999999 569988887 24788899999999999999999 999999999999999999999999999
Q ss_pred cccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc--Ch
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL--PI 265 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~ 265 (335)
|++..- ...-.....+.+..|.|||++.+..+....||||+||++.||++|...|.+.. .-.++........ +.
T Consensus 163 g~ar~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 163 GLARTE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-HIDQWNKIIEQLGTPDP 238 (369)
T ss_pred hhhccc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-HHHHHHHHHHHhcCCCH
Confidence 999864 22345667788999999999999889999999999999999999999886422 1111111111111 11
Q ss_pred hHHHHHHhh------hcccccc--------------chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 266 SVMEIVDAN------LLSREDK--------------HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 266 ~~~~~~~~~------~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...+-+.+. ..++... .......-+..+++++.+||..||++|.|+.++|+.
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111100000 0000000 000011113448999999999999999999999863
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-29 Score=210.59 Aligned_cols=199 Identities=30% Similarity=0.430 Sum_probs=173.8
Q ss_pred CCccceeeecCceEEEEEEEcC-CcEEEEEEeecCCCc-hhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecC
Q 019843 45 FSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
|.+.+.||.|++|.||++.... ++.+++|.+...... ..+.+.+|++.++.++|+|++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6788999999999999998664 899999999866554 56889999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccc
Q 019843 123 HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202 (335)
Q Consensus 123 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~ 202 (335)
+++|.+++......+++..++.++.+++.++.+|| +.+++|+|++|.||+++.++.++|+|||.+..+.... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-cccc
Confidence 99999998866533899999999999999999999 8999999999999999999999999999988763221 1122
Q ss_pred ccccccccccCcccc-CCCCCCCccchhhHHHHHHHHHhCCCCCCc
Q 019843 203 TQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFTKKKPTDK 247 (335)
Q Consensus 203 ~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~~l~~ll~g~~pf~~ 247 (335)
....++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345677889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=213.56 Aligned_cols=268 Identities=20% Similarity=0.251 Sum_probs=200.7
Q ss_pred hhhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeee-eecCCeeE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIIST-CSNDDFKA 115 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~~ 115 (335)
.+..+.|.+.+.+|+|.||.+-++.+ ++++.+|+|.+..... ....|.+|...--.| .|.||+.-+++ |...+.+.
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 45668899999999999999999965 4688899998865533 347788888877777 58999988765 56678888
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC--CCCcEEEeeccccccc
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLL 193 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~--~~~~v~l~dfg~~~~~ 193 (335)
.++||++.|+|.+-+...+ +.+.....++.|+++|+.|+| +++++|+|||.+|||+. +..+|||+|||.....
T Consensus 99 F~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred EeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999999998776554 889999999999999999999 99999999999999994 4558999999998865
Q ss_pred cCCccccccccccccccccCccccCC---C--CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGRE---G--RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~---~--~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
+ ..-.....+..|.+||.... + ...+.+|+|.||++++.+++|+.||.........+..|..-
T Consensus 174 g-----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w------- 241 (378)
T KOG1345|consen 174 G-----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW------- 241 (378)
T ss_pred C-----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH-------
Confidence 2 11222334666999996532 2 24678999999999999999999998554444333332221
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccccc
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICTR 330 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 330 (335)
.... . ......-..+++.+..+.++-|.++|++|-...++...-....-+-.+.+.
T Consensus 242 --~~rk-~---~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~ 297 (378)
T KOG1345|consen 242 --LKRK-N---PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTV 297 (378)
T ss_pred --hccc-C---ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccc
Confidence 1111 0 111111133466689999999999999997777777766666544444443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-31 Score=219.70 Aligned_cols=275 Identities=23% Similarity=0.282 Sum_probs=196.8
Q ss_pred CCccceeeecCceEEEEEEE-cCCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecC-----CeeEE
Q 019843 45 FSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSND-----DFKAL 116 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 116 (335)
..-.+.||.|+||.||.+++ .+|+.|++|++..- +-.....+.+|+++|..++|.|++..+++..-. ...|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34468999999999999975 47999999988643 223457788999999999999999988876533 24556
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
+.|.+ ..+|..+|.+. ..++...+.-..+||++||.||| +.+|.|+||||.|.+|+.+..+||+|||+++... .
T Consensus 135 ~TELm-QSDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee-~ 208 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD-Q 208 (449)
T ss_pred HHHHH-HhhhhheeccC-CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc-h
Confidence 77777 45777766644 47889999999999999999999 9999999999999999999999999999998753 2
Q ss_pred ccccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh--
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA-- 273 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 273 (335)
+........+.|..|.|||++.|. .|+.+.||||+||++.||+..+..|....+-+ .+.....-+.....+.....
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq-QL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE-QLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH-HHHHHHHHhCCCcHHHHHHHhh
Confidence 334445566788999999998874 68999999999999999999998886533211 11111111111111111100
Q ss_pred ----hhccccccc--------hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 274 ----NLLSREDKH--------FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 274 ----~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
.......+. +..+..-..+...+..+++..||.+|.+.++.+..+-.=+-.+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r 352 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLR 352 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccccee
Confidence 011111110 11111223447788899999999999999998876654333333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=218.41 Aligned_cols=271 Identities=25% Similarity=0.328 Sum_probs=204.3
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc----CCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCC
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDD 112 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 112 (335)
.....+.|.++++||.|.|++||+|... .++.|++|.+...+. ...+.+|++.|..+ .+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4556778999999999999999999643 467899998865443 37799999999999 5999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC-CCCcEEEeeccccc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAK 191 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~-~~~~v~l~dfg~~~ 191 (335)
...+|+||++.....++... ++...+..++..++.||.++| ..||+|+||||.|++.+ ..++-.|+|||++.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence 99999999999999987753 668889999999999999999 99999999999999998 45678999999988
Q ss_pred cccCC-------c-----------------------------------cccccccccccccccCccccCC-CCCCCccch
Q 019843 192 LLTGE-------D-----------------------------------QSKSQTQTLATIGYMAPEYGRE-GRVSTNGDV 228 (335)
Q Consensus 192 ~~~~~-------~-----------------------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi 228 (335)
..... . .....-...||++|.|||++.. ...+++.||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 32100 0 0001113458999999998765 557889999
Q ss_pred hhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH----------------------HH-------Hhhhcccc
Q 019843 229 YSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME----------------------IV-------DANLLSRE 279 (335)
Q Consensus 229 wslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~-------~~~~~~~~ 279 (335)
||.|++++.++++..||......-..+...+..+.+..... .. ........
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999999765544444333222211111000 00 00000000
Q ss_pred --ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 280 --DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 280 --~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.......+..+..+.+|+.+||..||.+|.|+++.|..
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 12222233456679999999999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-28 Score=196.34 Aligned_cols=169 Identities=20% Similarity=0.196 Sum_probs=130.2
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
|+|.+++......+++..++.++.|++.||.||| +.+ +|+||+++.++.+++ ||++..... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~ 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTP-------E 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecc-------c
Confidence 6899999876667999999999999999999999 777 999999999999999 999876532 1
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccch
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
...++..|+|||++.+..++.++|||||||++|+|++|..||........... .+......... ...
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~------------~~~~~~~~~~~-~~~ 129 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILE------------ILLNGMPADDP-RDR 129 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHH------------HHHHHhccCCc-ccc
Confidence 12578999999999999999999999999999999999999865432222111 11111111100 001
Q ss_pred hhHHHHHH--HHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 284 AAKEQCVS--FVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 284 ~~~~~~~~--~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
......++ .+.+++.+||+.||.+||++.|+++.+..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11223333 69999999999999999999999999987754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=189.28 Aligned_cols=273 Identities=21% Similarity=0.206 Sum_probs=217.9
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCee
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFK 114 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 114 (335)
+.....++|++++.||.|+||.+|.|. ..+|+.||||+-..... ...+..|.++.+.++ ...|+.+..+..+..+-
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 445567899999999999999999995 56799999999764432 266788999999995 57888888888889999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC---CcEEEeeccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAK 191 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~---~~v~l~dfg~~~ 191 (335)
.+||+.+ |.||.++.+-....++...++.++.|++.-++|+| .++++|+||||+|++..-+ .++.|+|||++.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchh
Confidence 9999988 99999998855557999999999999999999999 9999999999999999633 478999999999
Q ss_pred cccCCccc-----cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh
Q 019843 192 LLTGEDQS-----KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266 (335)
Q Consensus 192 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 266 (335)
.+.+.... .......||.+|.|--.+.+-..+.+.|+-|+|.++.++.-|..||.+..+.....++
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy--------- 233 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY--------- 233 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH---------
Confidence 88643322 2344567999999988888888899999999999999999999999987654332211
Q ss_pred HHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccc
Q 019843 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328 (335)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 328 (335)
+.+.+... ....-..-.++|.++.-.+..|-..--++-|...-+...+..+...++..
T Consensus 234 -EkI~EkK~---s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~ 291 (341)
T KOG1163|consen 234 -EKISEKKM---STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQ 291 (341)
T ss_pred -HHHHHhhc---CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcccc
Confidence 12222111 11112223567888999999999998889999998888888777766543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-26 Score=193.58 Aligned_cols=270 Identities=18% Similarity=0.186 Sum_probs=221.0
Q ss_pred hhcCCCCccceeeecCceEEEEEE-EcCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 117 (335)
-.+-.|+++++||+|+||.++.|+ .-++++||||.-...+ ....++.|++.++.| ..++|..++-+.....+-.+|
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 456689999999999999999996 3469999999754333 347889999999999 589999999888888888899
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC-----CcEEEeecccccc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN-----MVAHLSDFGIAKL 192 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~-----~~v~l~dfg~~~~ 192 (335)
++.+ |.||+|+..-.+..++...+..++.|++.-++++| .+.++++||||+|+|+..- ..+.++|||++..
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9988 99999999866668999999999999999999999 9999999999999999643 3589999999998
Q ss_pred ccCCccc-----cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhH
Q 019843 193 LTGEDQS-----KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 193 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
+.+.... .......||.+||+--.+.|.+.+.+.|+-|||-++++.|-|.+||.+..++....++
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY---------- 248 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY---------- 248 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH----------
Confidence 8654322 2334567999999999999999999999999999999999999999987654443222
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccc
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 328 (335)
+.+ +..++.........++|.++..-+...-..+-.+-|..+-+.+.+.++.+++...
T Consensus 249 eKI---Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t 306 (449)
T KOG1165|consen 249 EKI---GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGET 306 (449)
T ss_pred HHh---ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCc
Confidence 111 1122233334445667888999999888889899999999999888887776543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-26 Score=201.32 Aligned_cols=261 Identities=22% Similarity=0.252 Sum_probs=200.8
Q ss_pred CCCccceeeecCceEEEEEEEcC--CcEEEEEEeecCCCchhHHHHHHHHHHHhCC----CCceEEEeeee-ecCCeeEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQD--GMEVAVKVFHLQCGGVFKSFDVECEVMKSIR----HRNLIKIISTC-SNDDFKAL 116 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~l 116 (335)
+|.+.+.||+|+||.||.+...+ ...+|+|+...........+..|..++..+. .+++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999998654 3578989877654333337888899998886 36899999999 57888999
Q ss_pred EEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC-----CcEEEeecccc
Q 019843 117 VLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN-----MVAHLSDFGIA 190 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~-----~~v~l~dfg~~ 190 (335)
||+.+ |.+|.++..... +.++...+..++.|++.+|.+|| +.|++||||||.|+.+... ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 999999886544 68999999999999999999999 9999999999999999855 36999999999
Q ss_pred c--cccCCcc----cc-c-cccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh
Q 019843 191 K--LLTGEDQ----SK-S-QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262 (335)
Q Consensus 191 ~--~~~~~~~----~~-~-~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 262 (335)
+ .+..... .. . .....||..|+++..+.+...+.+.|+||++.++.+++.|..||...........
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~------ 248 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK------ 248 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH------
Confidence 8 3321111 11 1 2345699999999999999999999999999999999999999976543222110
Q ss_pred cChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 263 LPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
............ .....+..+..+...+-..+...+|....+...|+....+
T Consensus 249 ----~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 249 ----FEKDPRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ----HHHHhhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 000000000000 1122345577777777778999999999999998877654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=234.19 Aligned_cols=194 Identities=15% Similarity=0.192 Sum_probs=135.8
Q ss_pred CceEEEeeee-------ecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCC
Q 019843 99 RNLIKIISTC-------SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKP 171 (335)
Q Consensus 99 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p 171 (335)
+||..+++.+ ........++|++ +++|.+++......+++..++.++.||+.||.||| +++|+|+||||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHrDlKP 108 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVHNVRP 108 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeeccCCc
Confidence 4666666665 2234566788887 66999999866567999999999999999999999 99999999999
Q ss_pred CCEEECCCCc-------------------EEEeeccccccccCCcc--------------ccccccccccccccCccccC
Q 019843 172 SNVLLDDNMV-------------------AHLSDFGIAKLLTGEDQ--------------SKSQTQTLATIGYMAPEYGR 218 (335)
Q Consensus 172 ~Nilv~~~~~-------------------v~l~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~ 218 (335)
+|||++..+. +|++|||++........ ........+|+.|+|||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 9999965444 45555555542210000 00011135788899999999
Q ss_pred CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHH
Q 019843 219 EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAM 298 (335)
Q Consensus 219 ~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 298 (335)
+..++.++|||||||++|||++|..|+..... .. ..+... ... .. .....+....++.
T Consensus 189 ~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~------------~~~~~~-~~~---~~---~~~~~~~~~~~~~ 246 (793)
T PLN00181 189 GSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TM------------SSLRHR-VLP---PQ---ILLNWPKEASFCL 246 (793)
T ss_pred cCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HH------------HHHHHh-hcC---hh---hhhcCHHHHHHHH
Confidence 99999999999999999999998887543211 00 000000 000 00 0011223568889
Q ss_pred HhchhccccCCCHHHHHHHH
Q 019843 299 ECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 299 ~~l~~dP~~Rps~~ell~~L 318 (335)
+||+.||.+||++.|+++.-
T Consensus 247 ~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HhCCCChhhCcChHHHhhch
Confidence 99999999999999998643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-26 Score=186.77 Aligned_cols=267 Identities=20% Similarity=0.323 Sum_probs=202.6
Q ss_pred CCCcccccccCHHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCce
Q 019843 24 MPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNL 101 (335)
Q Consensus 24 ~p~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i 101 (335)
.++.++.++++-... +...+..+|.....|..|+|+++ |..++.|++.... ...-..|.+|.-.|+.+.||||
T Consensus 175 r~rdatlsr~~gid~----~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpni 249 (448)
T KOG0195|consen 175 RTRDATLSRYTGIDV----SSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNI 249 (448)
T ss_pred cccccccccccCcch----hhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCch
Confidence 444444444443222 33456678889999999999999 6677778886542 2233568889999999999999
Q ss_pred EEEeeeeecCCeeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC
Q 019843 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180 (335)
Q Consensus 102 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~ 180 (335)
+++++.|.....+.++.+|++.|+|..++... +...+..++.+.+.++++|++|||. ...-+.--.+++..++++++.
T Consensus 250 lpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedl 328 (448)
T KOG0195|consen 250 LPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDL 328 (448)
T ss_pred hhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchh
Confidence 99999999999999999999999999999865 3357888999999999999999992 122333446889999999998
Q ss_pred cEEEeeccccccccCCccccccccccccccccCccccCCCCC---CCccchhhHHHHHHHHHhCCCCCCcccccchhhHh
Q 019843 181 VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV---STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKY 257 (335)
Q Consensus 181 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~ 257 (335)
+.+|.- +-+ ..+.+.....-.+.|++||.++..+. -.++|+|||++++|||-|...||...++-+..++.
T Consensus 329 tarism-ad~------kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki 401 (448)
T KOG0195|consen 329 TARISM-ADT------KFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI 401 (448)
T ss_pred hhheec-ccc------eeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh
Confidence 776641 111 11222333445778999999887553 45789999999999999999999987766655543
Q ss_pred HhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 258 WVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
.++ +.+...+++++..+..|+.-|++.||.+||.+.++.-.|++++
T Consensus 402 ale-------------------glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 402 ALE-------------------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhc-------------------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 322 2233446677888999999999999999999999999998875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=192.83 Aligned_cols=170 Identities=20% Similarity=0.179 Sum_probs=131.4
Q ss_pred HHHHhhhcCCCCccceeeecCceEEEEEEEc--CCcEEEEEEeecC-----CCchhHHHHHHHHHHHhCCCCceEE-Eee
Q 019843 35 YLELFQATDGFSENNLIGRGSFGSVYKARIQ--DGMEVAVKVFHLQ-----CGGVFKSFDVECEVMKSIRHRNLIK-IIS 106 (335)
Q Consensus 35 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~-~~~ 106 (335)
.++.-...++|.+.+.||+|+||.||+|... +++.+|+|+.... .......+.+|+++++.++|+|+++ +++
T Consensus 10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 3455667889999999999999999999764 4777899986532 1223567899999999999999885 443
Q ss_pred eeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCC-CCCCEEECCCCcEEEe
Q 019843 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL-KPSNVLLDDNMVAHLS 185 (335)
Q Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di-~p~Nilv~~~~~v~l~ 185 (335)
. +..++||||++|++|.. +.. .. ...++.+++++|.+|| +.+++|+|| ||+||+++.++.++|+
T Consensus 90 ~----~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 90 T----GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred c----CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEE
Confidence 2 45789999999999963 211 11 1467889999999999 999999999 9999999999999999
Q ss_pred eccccccccCCccccc------cccccccccccCccccCC
Q 019843 186 DFGIAKLLTGEDQSKS------QTQTLATIGYMAPEYGRE 219 (335)
Q Consensus 186 dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~ 219 (335)
|||++..+........ -....++..|+|||.+..
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999997643221111 124567888999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=206.19 Aligned_cols=258 Identities=19% Similarity=0.218 Sum_probs=191.8
Q ss_pred CCC-CccceeeecCceEEEEEEEc-CCcEEEEEEee-----cCCCc-hhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 43 DGF-SENNLIGRGSFGSVYKARIQ-DGMEVAVKVFH-----LQCGG-VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 43 ~~y-~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~-----~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
+.| ....++|.|++|.|+.+... ....+..|.+. .+... ....+..|+-+-..++|+|++..+..+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 445 46789999999977777532 23334444332 11111 112266677777888999998888877776655
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
.-.|||+++ +|..++... ..+....+..++.||+.|+.|+| +.|+.|+|++++|+++..+|.+|++|||.+..+.
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 566999999 999988765 26888999999999999999999 9999999999999999999999999999998764
Q ss_pred CCccc--cccccccccccccCccccCCCCCCC-ccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 195 GEDQS--KSQTQTLATIGYMAPEYGREGRVST-NGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 195 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~-~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
-.... .......|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||......+.... ...
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------------~~~ 539 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------------TNN 539 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------------hhc
Confidence 33332 4566788999999999999999876 57999999999999999999987654433220 000
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...-.............++..-+.+|.+||+.||.+|.++++|++-
T Consensus 540 ~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 540 YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0000111111222234567779999999999999999999999763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-22 Score=177.19 Aligned_cols=256 Identities=30% Similarity=0.407 Sum_probs=198.5
Q ss_pred CCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCc---hhHHHHHHHHHHHhCCCC-ceEEEeeeeecCCeeEEEEEe
Q 019843 45 FSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGG---VFKSFDVECEVMKSIRHR-NLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~ 120 (335)
|.+.+.||.|+|+.||.+... ..+++|.+...... ....+.+|..++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 788899999999999999876 78899988755322 467899999999999888 799999999888888999999
Q ss_pred cCCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-cEEEeeccccccccCCc
Q 019843 121 MPHGSLEKCLYSSN--CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTGED 197 (335)
Q Consensus 121 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~-~v~l~dfg~~~~~~~~~ 197 (335)
+.++++.+++.... ..+.......+..+++.++.++| ..+++|+|++|+||+++..+ .+++.|||.+..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776553 26899999999999999999999 99999999999999999988 79999999998654222
Q ss_pred ccc----ccccccccccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCccccc--chhhHhHhhhhcChhHH
Q 019843 198 QSK----SQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAG--EMTLKYWVSNLLPISVM 268 (335)
Q Consensus 198 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 268 (335)
... ......++..|+|||.+.+ ...+...|+|++|++++++++|..||...... .... .
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~------------~ 224 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT------------L 224 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH------------H
Confidence 221 3466789999999999987 57889999999999999999999997654431 1111 1
Q ss_pred HHHHhhhcc--ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 269 EIVDANLLS--REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 269 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..+...... ...............+.+++..++..+|..|.+..+....
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 225 KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111100 0000000001223458999999999999999998887765
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=175.14 Aligned_cols=172 Identities=13% Similarity=0.115 Sum_probs=133.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCch---hHH------HHHHHHHHHhCCCCceEEEeeeeec
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGV---FKS------FDVECEVMKSIRHRNLIKIISTCSN 110 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~---~~~------~~~e~~~l~~l~h~~i~~~~~~~~~ 110 (335)
-..++|++.+++|.|+||.||++.. ++..+|+|++....... ... +.+|++.+.++.|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3578999999999999999999866 47789999997553222 222 5789999999999999999887653
Q ss_pred C--------CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcE
Q 019843 111 D--------DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 182 (335)
Q Consensus 111 ~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v 182 (335)
. +..+++|||++|.+|.++.. +++. ...+++.++..+| ..|++|||++|+||+++.+| +
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~~----~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISED----VKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccHH----HHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-E
Confidence 3 35789999999999988632 3332 4569999999999 99999999999999999988 9
Q ss_pred EEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHH
Q 019843 183 HLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF 239 (335)
Q Consensus 183 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll 239 (335)
+|+|||......... .. ..+.....++.++|+|+||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~----a~----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRK----AK----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchh----hH----------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999876441100 00 00333445667999999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-24 Score=201.78 Aligned_cols=248 Identities=22% Similarity=0.240 Sum_probs=181.1
Q ss_pred CCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCC-chhHHHHHHHHH--HHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCG-GVFKSFDVECEV--MKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
+|-..+.||.+.|-.|.+|++.+|. |++|++-...+ -....+.+.++- ....++||.+++.-........|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 7888999999999999999988776 89999865542 223333333333 4455899999999888888888999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc-CCccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~-~~~~~ 199 (335)
+ .-+|.|.+.-++ .+..-+..-|+.||+.||...| ..|++|||||.+|||++.-.-+.|.||......+ ..+.+
T Consensus 103 v-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 V-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred H-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 8 459999887665 5667777779999999999999 9999999999999999999999999998765443 12222
Q ss_pred cccc----cccccccccCccccCCC----------C-CCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhc
Q 019843 200 KSQT----QTLATIGYMAPEYGREG----------R-VSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLL 263 (335)
Q Consensus 200 ~~~~----~~~~~~~y~aPE~~~~~----------~-~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 263 (335)
.... ....-..|.|||.+... . .+++.||||+||++.||++ |++||.... .+.+....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~-- 251 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGN-- 251 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccC--
Confidence 2211 12233459999975431 1 4678999999999999998 788876421 01111110
Q ss_pred ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 264 PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
....+..+...- ...++.++..|++.||.+|.|+++.|..
T Consensus 252 ~~~~e~~Le~Ie--------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKIE--------------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhCc--------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111122222110 1138999999999999999999999987
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-22 Score=168.74 Aligned_cols=231 Identities=20% Similarity=0.261 Sum_probs=148.4
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC---chhHHHHHHHHHHHhCCC----------CceEEEeeeee
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG---GVFKSFDVECEVMKSIRH----------RNLIKIISTCS 109 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h----------~~i~~~~~~~~ 109 (335)
.....+.||.|+++.||.+++. +|+++++|++..... ...+.+++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4556789999999999999876 489999999875542 345566666555544322 22333333221
Q ss_pred ------------cCC-----eeEEEEEecCCCChHHHHhc---C-C--CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEe
Q 019843 110 ------------NDD-----FKALVLEYMPHGSLEKCLYS---S-N--CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166 (335)
Q Consensus 110 ------------~~~-----~~~lv~e~~~~~~L~~~l~~---~-~--~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h 166 (335)
+.+ ..+++|+-+ .++|.+++.. . . ..+.......+..|+++.+++|| +.|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence 111 235677777 5688887642 1 1 12445555667789999999999 999999
Q ss_pred cCCCCCCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCC--------CCCCCccchhhHHHHHHHH
Q 019843 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE--------GRVSTNGDVYSFGIMLMET 238 (335)
Q Consensus 167 ~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~~l~~l 238 (335)
+||+|+|++++.+|.++|+||+.....+. .......+..|.+||.... -.++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999998776431 1111334567899996532 2467889999999999999
Q ss_pred HhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccC
Q 019843 239 FTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQR 308 (335)
Q Consensus 239 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 308 (335)
.+|..||+.......... .+..-.++|+.++.||..+|+.||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~-------------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-------------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-------------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc-------------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999987543222110 111122567779999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-22 Score=161.98 Aligned_cols=140 Identities=17% Similarity=0.182 Sum_probs=108.2
Q ss_pred ccceeeecCceEEEEEEEcCCcEEEEEEeecCCCch--------------------------hHHHHHHHHHHHhCCCCc
Q 019843 47 ENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGV--------------------------FKSFDVECEVMKSIRHRN 100 (335)
Q Consensus 47 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~~ 100 (335)
+...||+|++|.||+|...+|++||+|+++...... ......|++.+..+.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357899999999999987789999999997542210 012234899999997766
Q ss_pred eEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-hccCCCCeEecCCCCCCEEECCC
Q 019843 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL-HFGYSAPVIHCDLKPSNVLLDDN 179 (335)
Q Consensus 101 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~L-h~~~~~~i~h~di~p~Nilv~~~ 179 (335)
+.....+... . .++||||++|+++....... ..++...+..++.+++.+|.++ | +.+++|+||||+||+++ +
T Consensus 81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-C
Confidence 5333222222 2 37999999887776543322 3689999999999999999999 7 88999999999999998 4
Q ss_pred CcEEEeeccccccc
Q 019843 180 MVAHLSDFGIAKLL 193 (335)
Q Consensus 180 ~~v~l~dfg~~~~~ 193 (335)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=154.97 Aligned_cols=139 Identities=23% Similarity=0.251 Sum_probs=110.0
Q ss_pred ccceeeecCceEEEEEEEcCCcEEEEEEeecCCCch--------------------------hHHHHHHHHHHHhCCCCc
Q 019843 47 ENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGV--------------------------FKSFDVECEVMKSIRHRN 100 (335)
Q Consensus 47 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~~ 100 (335)
+...||+|++|.||+|...+|+.||+|++....... ...+..|.+.+..+.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 457899999999999987789999999987652210 122357889999998887
Q ss_pred eEEEeeeeecCCeeEEEEEecCCCChHHH-HhcCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECC
Q 019843 101 LIKIISTCSNDDFKALVLEYMPHGSLEKC-LYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDD 178 (335)
Q Consensus 101 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~ 178 (335)
+.....+.... .++||||++|+++... +.. ..++......++.+++.++.++| . .|++|+||+|+||+++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~- 152 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-
Confidence 64433333222 4799999988755433 332 35788899999999999999999 8 9999999999999999
Q ss_pred CCcEEEeeccccccc
Q 019843 179 NMVAHLSDFGIAKLL 193 (335)
Q Consensus 179 ~~~v~l~dfg~~~~~ 193 (335)
++.++|+|||++...
T Consensus 153 ~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 DGKPYIIDVSQAVEL 167 (190)
T ss_pred CCCEEEEEcccceec
Confidence 889999999999865
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=173.75 Aligned_cols=216 Identities=28% Similarity=0.423 Sum_probs=166.7
Q ss_pred HHhCCCCceEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCe-EecCCCC
Q 019843 93 MKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV-IHCDLKP 171 (335)
Q Consensus 93 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i-~h~di~p 171 (335)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+......+++.....+..+|+.|+.||| +..+ .||.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence 35678999999999999999999999999999999999987778999999999999999999999 5555 9999999
Q ss_pred CCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCC-------CCCccchhhHHHHHHHHHhCCCC
Q 019843 172 SNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGR-------VSTNGDVYSFGIMLMETFTKKKP 244 (335)
Q Consensus 172 ~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~sDiwslG~~l~~ll~g~~p 244 (335)
.|.+++....+|+.|||+....................-|.|||.+.+.. .+.++|+||+|++++|+++...|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999988763211222223333556699999987641 46679999999999999999999
Q ss_pred CCcccccchhhHhHhhhhcChhHHHHHHhhhc-cccccc--hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 245 TDKIFAGEMTLKYWVSNLLPISVMEIVDANLL-SREDKH--FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 245 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
|......... .+++..... .....+ ......+++++..++.+||..+|..||+++++-..+..+
T Consensus 158 ~~~~~~~~~~-------------~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 158 FDLRNLVEDP-------------DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cccccccCCh-------------HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9874322221 111111000 111111 111124555799999999999999999999999999877
Q ss_pred Hhh
Q 019843 322 RDS 324 (335)
Q Consensus 322 ~~~ 324 (335)
...
T Consensus 225 ~~~ 227 (484)
T KOG1023|consen 225 NKG 227 (484)
T ss_pred ccc
Confidence 654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=182.44 Aligned_cols=201 Identities=25% Similarity=0.274 Sum_probs=161.1
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC---CCceEEEeeeeecCCe
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR---HRNLIKIISTCSNDDF 113 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~ 113 (335)
++.--++.|-|.+.+|.|+||.||.|...+|+.||+|+-+...... |.-..+++.+|+ -+-|..+...+...+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 4445667899999999999999999987779999999977665432 222233334443 3445556666666777
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC-------CCCcEEEee
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-------DNMVAHLSD 186 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~-------~~~~v~l~d 186 (335)
.++|++|.+.|+|.++++ ..+..++..+..++.+++..+..|| ..+|+||||||+|+++. ..-.++|+|
T Consensus 769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 889999999999999998 4458999999999999999999999 99999999999999994 234689999
Q ss_pred ccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 019843 187 FGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244 (335)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~p 244 (335)
||-+.-+.--..........+|-.+-.+|...|..++...|.|+++.+++.||+|+.-
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9998765322222344456788899999999999999999999999999999999743
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=160.91 Aligned_cols=198 Identities=19% Similarity=0.232 Sum_probs=143.1
Q ss_pred CCCceEEEeeeee---------------------------cCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHH
Q 019843 97 RHRNLIKIISTCS---------------------------NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDV 149 (335)
Q Consensus 97 ~h~~i~~~~~~~~---------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l 149 (335)
.||||+++.+.|. ++..+|+||..+ .-+|..++-.+. .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC--CchHHHHHHHHHH
Confidence 4999999987661 245888999988 559999887654 6666677799999
Q ss_pred HHHHHHHhccCCCCeEecCCCCCCEEEC--CCC--cEEEeeccccccccCC----ccccccccccccccccCccccCCCC
Q 019843 150 AAALEYLHFGYSAPVIHCDLKPSNVLLD--DNM--VAHLSDFGIAKLLTGE----DQSKSQTQTLATIGYMAPEYGREGR 221 (335)
Q Consensus 150 ~~~l~~Lh~~~~~~i~h~di~p~Nilv~--~~~--~v~l~dfg~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~ 221 (335)
++|+.||| .+++.|+|+|++||++. +|+ .+.+.|||.+---... ..........|...-+|||+.+..+
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 99999999999999994 443 4688999976421110 1112223345677789999876432
Q ss_pred ------CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHH
Q 019843 222 ------VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFN 295 (335)
Q Consensus 222 ------~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 295 (335)
...++|.|+.|.+.||+++...||....+-..+... +. ...-...++.+++.+++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-------------Yq------e~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-------------YQ------ESQLPALPSRVPPVARQ 488 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-------------hh------hhhCCCCcccCChHHHH
Confidence 245899999999999999999999763211111111 11 11112235567888999
Q ss_pred HHHHhchhccccCCCHHHHHHHHH
Q 019843 296 LAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 296 li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
++...|+.||.+|+|..=....|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999887777665
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.1e-20 Score=149.68 Aligned_cols=188 Identities=15% Similarity=0.102 Sum_probs=138.7
Q ss_pred CccceeeecCceEEEEEEEcCCcEEEEEEeecCCCch----hHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEEEEe
Q 019843 46 SENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGV----FKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 46 ~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
-+...|+.|+||+|+.+.. .+.+++.+.+....... ...+.+|+++++++. ++++++++++ +..+++|+|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4678999999999998876 47888888776543311 225789999999994 5789998885 346899999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCC-CCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL-KPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di-~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+.|.+|...+.. ....++.+++.+|.++| +.|++|+|| +|+||+++.+|.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998754321 12357789999999999 999999999 799999999999999999999865322110
Q ss_pred ----cc-------cccccccccccCccccCCC-CCC-CccchhhHHHHHHHHHhCCCCCCccc
Q 019843 200 ----KS-------QTQTLATIGYMAPEYGREG-RVS-TNGDVYSFGIMLMETFTKKKPTDKIF 249 (335)
Q Consensus 200 ----~~-------~~~~~~~~~y~aPE~~~~~-~~~-~~sDiwslG~~l~~ll~g~~pf~~~~ 249 (335)
.. ......++.+++|+-..-. ..+ .+.+.++.|+-+|.++|+..++....
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00 1112245566666643221 223 56799999999999999999876543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-21 Score=177.23 Aligned_cols=225 Identities=24% Similarity=0.261 Sum_probs=180.5
Q ss_pred eeeecCceEEEEEEE----cCCcEEEEEEeecCCC--chhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEEEEecC
Q 019843 50 LIGRGSFGSVYKARI----QDGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 50 ~lg~g~~~~v~~~~~----~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
++|.|++|.|+++.. ..+.-+++|+....+. ........|..++...+ ||.+++++..+......++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 478999999999742 2366678887754321 12225556788888886 9999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccc
Q 019843 123 HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202 (335)
Q Consensus 123 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~ 202 (335)
|+.+-..+.... .+++.....+...++-++.++| +.+++|+|+|++||+++.+|++++.|||++...-..
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------ 150 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------ 150 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhh------
Confidence 988887766554 6778888889999999999999 999999999999999999999999999999865211
Q ss_pred ccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccc
Q 019843 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKH 282 (335)
Q Consensus 203 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (335)
...+||..|+|||+++ ....++|.||+|+++++|++|..||..... . ......
T Consensus 151 ~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~------------------~-------~Il~~~ 203 (612)
T KOG0603|consen 151 KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTM------------------K-------RILKAE 203 (612)
T ss_pred hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHH------------------H-------HHhhhc
Confidence 1128999999999998 667799999999999999999999887111 0 011123
Q ss_pred hhhHHHHHHHHHHHHHHhchhccccCCCH
Q 019843 283 FAAKEQCVSFVFNLAMECTVESAEQRINA 311 (335)
Q Consensus 283 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 311 (335)
+..+..++..+.+++.+++..+|..|.-.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 44466778889999999999999999754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.4e-19 Score=146.89 Aligned_cols=135 Identities=24% Similarity=0.312 Sum_probs=112.7
Q ss_pred cceeeecCceEEEEEEEcCCcEEEEEEeecCCCc--------hhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 48 NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGG--------VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.+.||+|++|.||+|.. .|..+++|+....... ....+.+|++++..+.|+++.....++...+..+++||
T Consensus 1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 36799999999999987 4788999986543211 12357789999999998888776666667778889999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
|++|++|.+++.... . ....++.+++.+|.++| +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999886543 1 78889999999999999 99999999999999999 78999999998763
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.2e-19 Score=145.53 Aligned_cols=137 Identities=18% Similarity=0.305 Sum_probs=107.7
Q ss_pred CCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-----CCCceEEEeeeeecCC---e-eE
Q 019843 45 FSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-----RHRNLIKIISTCSNDD---F-KA 115 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~ 115 (335)
..-.+.||+|+++.||. ...++.. +||++..........+.+|+.+++.+ .||||+++++++.++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34568999999999996 3333444 68998766555567899999999999 5799999999998863 4 33
Q ss_pred EEEEe--cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHhccCCCCeEecCCCCCCEEECC----CCcEEEee-c
Q 019843 116 LVLEY--MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAAL-EYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSD-F 187 (335)
Q Consensus 116 lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l-~~Lh~~~~~~i~h~di~p~Nilv~~----~~~v~l~d-f 187 (335)
+|+|| +.+++|.+++.+. .+++. ..++.+++.++ .||| +.+|+|+||+|+||+++. ++.++|+| |
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 5578999999764 35555 35677778777 9999 999999999999999974 33799999 5
Q ss_pred ccc
Q 019843 188 GIA 190 (335)
Q Consensus 188 g~~ 190 (335)
|..
T Consensus 155 G~~ 157 (210)
T PRK10345 155 GES 157 (210)
T ss_pred CCc
Confidence 543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=148.37 Aligned_cols=153 Identities=19% Similarity=0.171 Sum_probs=117.4
Q ss_pred ccCHHHHhhhcCCCCccceeeecCceEEEEEE--EcCCcEEEEEEeecCCCc------------------------hhHH
Q 019843 32 RFSYLELFQATDGFSENNLIGRGSFGSVYKAR--IQDGMEVAVKVFHLQCGG------------------------VFKS 85 (335)
Q Consensus 32 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~--~~~~~~v~iK~~~~~~~~------------------------~~~~ 85 (335)
+.........+.-|.+.+.||.|++|.||+|. ..+|+.||+|++...... ....
T Consensus 17 ~~~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (237)
T smart00090 17 RLALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLW 96 (237)
T ss_pred HHHHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHH
Confidence 33344445555679999999999999999998 457999999998754211 1123
Q ss_pred HHHHHHHHHhCCC--CceEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCC
Q 019843 86 FDVECEVMKSIRH--RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163 (335)
Q Consensus 86 ~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~ 163 (335)
+..|++.+..+.+ ..++++++. ...++||||++|.++....... .......+..++.+++.++.+|| +.+
T Consensus 97 ~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g 168 (237)
T smart00090 97 AEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEG 168 (237)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcC
Confidence 5679999999965 334444442 2347999999998887654332 24666777899999999999999 999
Q ss_pred -eEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 164 -VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 164 -i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
++|+||+|+||+++ ++.++|+|||.+...
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999999 889999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.4e-18 Score=140.10 Aligned_cols=130 Identities=22% Similarity=0.335 Sum_probs=104.8
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEeecCCC---c-----hhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 50 LIGRGSFGSVYKARIQDGMEVAVKVFHLQCG---G-----VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 50 ~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.||+|++|.||+|.+. +..+++|+...... + ....+.+|++++..+.|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999854 78899998653321 1 1255778999999998776554444445566678999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
+|++|.+++.... . .++.+++.+|.+|| +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~-~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875432 1 78999999999999 99999999999999999 88999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-17 Score=138.25 Aligned_cols=139 Identities=23% Similarity=0.182 Sum_probs=110.0
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCc----------------------hhHHHHHHHHHHHhCCC
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGG----------------------VFKSFDVECEVMKSIRH 98 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h 98 (335)
....|.+.+.||.|++|.||++...+|+.|++|++...... .......|+.++..+.+
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 33458999999999999999998878999999997643210 11235678888888877
Q ss_pred C--ceEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE
Q 019843 99 R--NLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL 176 (335)
Q Consensus 99 ~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv 176 (335)
+ .++.+++ ....+++|||++|++|.++... .....++.+++.++.++| ..+++|+||+|+||++
T Consensus 93 ~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill 158 (198)
T cd05144 93 EGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILV 158 (198)
T ss_pred cCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEE
Confidence 6 3444443 2345899999999999775431 335678899999999999 9999999999999999
Q ss_pred CCCCcEEEeeccccccc
Q 019843 177 DDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 177 ~~~~~v~l~dfg~~~~~ 193 (335)
++++.++|+|||.+...
T Consensus 159 ~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 159 DDDEKIYIIDWPQMVST 175 (198)
T ss_pred cCCCcEEEEECCccccC
Confidence 99999999999999755
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.5e-19 Score=157.79 Aligned_cols=174 Identities=27% Similarity=0.382 Sum_probs=130.1
Q ss_pred CeeEEEEEecCCCChHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSS--NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
.++|+.|++|+..+|.+||..+ ....++.....++.|++.++.| ++.+|+|++|.||+...+..++|+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 3678999999999999999643 4467788888999999999988 7899999999999999999999999999
Q ss_pred cccccCCc----cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcC
Q 019843 190 AKLLTGED----QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLP 264 (335)
Q Consensus 190 ~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 264 (335)
........ .........+|..||+||.+.++.|+.++||||||++++||+. -..+++... .+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----t~--------- 469 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----TL--------- 469 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----hh---------
Confidence 98764332 2234556789999999999999999999999999999999998 334333211 11
Q ss_pred hhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHH
Q 019843 265 ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314 (335)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 314 (335)
.++.+...-+..... .+.-..|+.++|...|.+||++.+.
T Consensus 470 ---~d~r~g~ip~~~~~d-------~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 470 ---TDIRDGIIPPEFLQD-------YPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ---hhhhcCCCChHHhhc-------CcHHHHHHHHhcCCCcccCchHHHH
Confidence 111111100000000 1124689999999999999944443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.3e-18 Score=163.11 Aligned_cols=214 Identities=22% Similarity=0.254 Sum_probs=148.7
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEcC-CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
.....-++|..++.|..|++|.||.+++++ .+++++|+ +.++ .+.+. ++....+|.++
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee-------------
Confidence 566777899999999999999999997664 77888854 3221 11111 33333344433
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
|+=...+.. .++++... +.+++||| +.+|+|+|++|+|.++..-|++|+.|||+...-.-
T Consensus 136 --------gDc~tllk~-~g~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 --------GDCATLLKN-IGPLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred --------chhhhhccc-CCCCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 222222222 22444443 67899999 99999999999999999999999999999775321
Q ss_pred C-------------ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh
Q 019843 196 E-------------DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262 (335)
Q Consensus 196 ~-------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 262 (335)
. ...-.....++|+.|.|||++.-+.|+...|+|++|+++|+.+-|+.||.+..+.+. +...+
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~vi--- 271 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVI--- 271 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhh---
Confidence 0 011122345899999999999999999999999999999999999999988643322 11111
Q ss_pred cChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCC
Q 019843 263 LPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI 309 (335)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 309 (335)
.+.+.+ .+.....+++.++++.++|..+|..|-
T Consensus 272 -----sd~i~w---------pE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 272 -----SDDIEW---------PEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -----hhhccc---------cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 111111 011223466799999999999999995
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.2e-17 Score=154.04 Aligned_cols=141 Identities=20% Similarity=0.246 Sum_probs=113.2
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecC--C------CchhHHHHHHHHHHHhCCCCceEEEeeeee
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQ--C------GGVFKSFDVECEVMKSIRHRNLIKIISTCS 109 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~--~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 109 (335)
.......|...+.||+|+||.||+|.+.. ..+++|+.... . ......+.+|+++++.++|++++....+..
T Consensus 328 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 328 EEEVKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred ccccccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 34445566788999999999999998764 34444443211 1 112356889999999999999888777777
Q ss_pred cCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 110 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
.....++||||++|++|.+++. ....++.+++.+|.+|| +.+++|+|++|+||++ .++.++|+|||+
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 7677889999999999999775 34678999999999999 9999999999999999 677999999999
Q ss_pred ccc
Q 019843 190 AKL 192 (335)
Q Consensus 190 ~~~ 192 (335)
+..
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 874
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.5e-16 Score=127.49 Aligned_cols=136 Identities=24% Similarity=0.240 Sum_probs=97.7
Q ss_pred ccceeeecCceEEEEEEEcCCcEEEEEEeecCCCch--hHH----------------------HHHHHHHHHhCCCC--c
Q 019843 47 ENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGV--FKS----------------------FDVECEVMKSIRHR--N 100 (335)
Q Consensus 47 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~--~ 100 (335)
+.+.||+|++|+||+|...+++.||+|++....... ... ...|.+.+..+.+. .
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 357899999999999987789999999987542211 011 13455555555333 2
Q ss_pred eEEEeeeeecCCeeEEEEEecCCCChHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECC
Q 019843 101 LIKIISTCSNDDFKALVLEYMPHGSLEK-CLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDD 178 (335)
Q Consensus 101 i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~ 178 (335)
+.++++. ...++||||++++++.. .+.... .. .....++.+++.++.++| . .+++|+||+|+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence 3444433 23589999998844321 111111 11 667889999999999999 8 9999999999999999
Q ss_pred CCcEEEeeccccccc
Q 019843 179 NMVAHLSDFGIAKLL 193 (335)
Q Consensus 179 ~~~v~l~dfg~~~~~ 193 (335)
++.++++|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.8e-15 Score=119.56 Aligned_cols=135 Identities=20% Similarity=0.276 Sum_probs=113.0
Q ss_pred ccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCC--CceEEEeeeeecCCeeEEEEEecCCC
Q 019843 47 ENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRH--RNLIKIISTCSNDDFKALVLEYMPHG 124 (335)
Q Consensus 47 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~ 124 (335)
+++.|+.|.++.||++...+ ..+++|....... ...+..|+..++.+.+ .+++++++.....+..++++||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 56889999999999998764 7899999765433 4678899999999965 58899998888888899999999887
Q ss_pred ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 125 SLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 125 ~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
.+..+ +......++.++++++..+|.....+++|+|++|+||+++.++.++++|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77653 5566677899999999999932225799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-17 Score=157.54 Aligned_cols=258 Identities=24% Similarity=0.274 Sum_probs=197.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEcC--CcEEEEEEeecCC--CchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQD--GMEVAVKVFHLQC--GGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~--~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 115 (335)
-...|.+.+.||+|+++.|-...... ...++.|.+.... ......+..|..+-..+. |+|++.+++...+.+..+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 45788899999999999998886532 3445656554432 233345555777777776 999999999999999999
Q ss_pred EEEEecCCCChHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-cEEEeeccccccc
Q 019843 116 LVLEYMPHGSLEKCL-YSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLL 193 (335)
Q Consensus 116 lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~-~v~l~dfg~~~~~ 193 (335)
++.++..|+++.+.+ .......+....-.++.|+..++.|+|. ..++.|+|++|+|.+++..+ ..++.|||++..+
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999998877 3332256667777899999999999995 68999999999999999999 9999999999988
Q ss_pred cC-Cccccccccccc-cccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 194 TG-EDQSKSQTQTLA-TIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 194 ~~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
.. ...........| ++.|.|||...+. -.....|+||.|+++..+++|..||............|....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-------- 247 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-------- 247 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc--------
Confidence 65 444555556677 9999999998884 457789999999999999999999987765444332222211
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
...........+.....++.+++..+|..|.+.+++-.
T Consensus 248 --------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 --------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00012223344556889999999999999999888643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.4e-15 Score=125.86 Aligned_cols=136 Identities=19% Similarity=0.225 Sum_probs=104.2
Q ss_pred cceee-ecCceEEEEEEEcCCcEEEEEEeecCC-------------CchhHHHHHHHHHHHhCCCCce--EEEeeeeecC
Q 019843 48 NNLIG-RGSFGSVYKARIQDGMEVAVKVFHLQC-------------GGVFKSFDVECEVMKSIRHRNL--IKIISTCSND 111 (335)
Q Consensus 48 ~~~lg-~g~~~~v~~~~~~~~~~v~iK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~ 111 (335)
...|| .|+.|+||.+... +..++||.+.... ......+.+|++++..+.|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35676 7888889888776 7889999875321 1223567889999999987764 6666654332
Q ss_pred -C---eeEEEEEecCC-CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEee
Q 019843 112 -D---FKALVLEYMPH-GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 186 (335)
Q Consensus 112 -~---~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~d 186 (335)
. ..++|+|+++| .+|.+++... .++... +.+++.++.+|| +.|++|+||+|.||+++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~~----~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEEQ----WQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHHH----HHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 6898887653 355543 568999999999 99999999999999999999999999
Q ss_pred ccccccc
Q 019843 187 FGIAKLL 193 (335)
Q Consensus 187 fg~~~~~ 193 (335)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.7e-14 Score=126.61 Aligned_cols=273 Identities=14% Similarity=0.100 Sum_probs=179.7
Q ss_pred CCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEE-E---ee--eeec-CCeeEE
Q 019843 45 FSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIK-I---IS--TCSN-DDFKAL 116 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~-~---~~--~~~~-~~~~~l 116 (335)
....+.||+|+-+.+|..- +-...+.|++............ ..|... .||-+-. + .. +..+ +....+
T Consensus 13 i~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecc--hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 3456889999999999652 2233456887755443323222 222222 4542221 0 01 0112 223667
Q ss_pred EEEecCCC-ChHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 117 VLEYMPHG-SLEKCLY-----SSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 117 v~e~~~~~-~L~~~l~-----~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
+|+.+.|. .+..+++ ++-....|..++..+..|+.+...|| ..|.+-||++++|++|++++.|.|.|-...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccce
Confidence 88887665 2333332 12235789999999999999999999 999999999999999999999999986654
Q ss_pred ccccCCccccccccccccccccCccccC-----CCCCCCccchhhHHHHHHHHHhC-CCCCCcccccchhh---H-hHhh
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTL---K-YWVS 260 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g-~~pf~~~~~~~~~~---~-~~~~ 260 (335)
.+. .........++...|++||.-+ +...+..+|.|.||+++++++.| ++||++........ . ....
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 433 2334455678899999999644 45567789999999999999996 99998754222111 0 0111
Q ss_pred hhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchh--ccccCCCHHHHHHHHHHHHhhhccccccc
Q 019843 261 NLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVE--SAEQRINAKEIVTRLLKIRDSLLICTRES 332 (335)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 332 (335)
... ...-+...-.+..+.-....-+++++..+..+|+.. ++.-|||++.++..|..+++++..|++.+
T Consensus 242 g~f----~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a 311 (637)
T COG4248 242 GRF----AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSA 311 (637)
T ss_pred cee----eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcc
Confidence 100 001111111222222233345688899999999975 46789999999999999999999998643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5e-14 Score=130.23 Aligned_cols=168 Identities=20% Similarity=0.249 Sum_probs=133.1
Q ss_pred EEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHH
Q 019843 63 RIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQR 142 (335)
Q Consensus 63 ~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 142 (335)
...++.+|.+...+..+.+......+-++.++.++||||+++++.++..+..|+|+|.+. .|..++.+. +...+
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v 106 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEV 106 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHH
Confidence 344688888888877666666778899999999999999999999999999999999863 566666643 36667
Q ss_pred HHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCC
Q 019843 143 LNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222 (335)
Q Consensus 143 ~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 222 (335)
.--++||+.||.+||+ +.+++|+|++-..|||+..|.-+|++|.++....+... .......-..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 7788999999999985 78999999999999999999999999998876532221 222333444577777654333
Q ss_pred CCccchhhHHHHHHHHHhCC
Q 019843 223 STNGDVYSFGIMLMETFTKK 242 (335)
Q Consensus 223 ~~~sDiwslG~~l~~ll~g~ 242 (335)
-..|.|.||+++++++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 3569999999999999993
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.2e-13 Score=124.72 Aligned_cols=140 Identities=22% Similarity=0.268 Sum_probs=98.2
Q ss_pred cceeeecCceEEEEEEEcCCcEEEEEEeecCCCchh----------------------------------------HHHH
Q 019843 48 NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVF----------------------------------------KSFD 87 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~----------------------------------------~~~~ 87 (335)
.+.||.|++|.||+|+.++|+.||||+.++.-.... -.+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 478999999999999998999999999865421100 0133
Q ss_pred HHHHHHHhC----CCCceEEEeeeee-cCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHhccCC
Q 019843 88 VECEVMKSI----RHRNLIKIISTCS-NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA-ALEYLHFGYS 161 (335)
Q Consensus 88 ~e~~~l~~l----~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~-~l~~Lh~~~~ 161 (335)
.|++.+..+ .+.+-+.+-.++. ..+..++||||++|++|.++........+ ...++..++. .+..+| .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence 344444443 2333333333332 24456899999999999887653221222 2345666665 478889 8
Q ss_pred CCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 162 ~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.|++|+|++|.||+++.++.++++|||++..+
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 99999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.8e-14 Score=122.37 Aligned_cols=203 Identities=19% Similarity=0.278 Sum_probs=142.3
Q ss_pred HHHhCCCCceEEEeeeeecC-----CeeEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCC
Q 019843 92 VMKSIRHRNLIKIISTCSND-----DFKALVLEYMPHGSLEKCLYSS---NCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163 (335)
Q Consensus 92 ~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~ 163 (335)
-+-++-|.|+++++.++.+. ....++.||+..|++..+|++. ...+.+....+|+.||+.||.||| +++..
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCc
Confidence 34445689999999887653 3566889999999999999753 446888888999999999999999 55889
Q ss_pred eEecCCCCCCEEECCCCcEEEeecccccccc--CCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhC
Q 019843 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT--GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK 241 (335)
Q Consensus 164 i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~--~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g 241 (335)
++||++..+.|++..+|-+|++----...-. ............+.++|.+||.-...+.+.++|||++|+...+|-.|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999999886421111100 00111122233467789999987777788899999999999999888
Q ss_pred CCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 242 KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 242 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
...-.+..... ..+..+....+.-.... -+.++.+|++..|+.||+|++++...
T Consensus 279 Eiq~tnseS~~-------------~~ee~ia~~i~~len~l----------qr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 279 EIQSTNSESKV-------------EVEENIANVIIGLENGL----------QRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eeccCCCccee-------------ehhhhhhhheeeccCcc----------ccCcCcccccCCCCCCcchhhhhcCc
Confidence 76532221100 11111111111111111 36788999999999999999987643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.1e-14 Score=128.28 Aligned_cols=248 Identities=21% Similarity=0.204 Sum_probs=183.0
Q ss_pred CCCCccceeee--cCceEEEEEEE---cCCcEEEEEEeecCCC--chhHHHHHHHHHHHhC-CCCceEEEeeeeecCCee
Q 019843 43 DGFSENNLIGR--GSFGSVYKARI---QDGMEVAVKVFHLQCG--GVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 43 ~~y~~~~~lg~--g~~~~v~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 114 (335)
..+.+.+.+|. |.+|.+|.+.. .++..+++|.-+.... ..-..-.+|+.....+ .|++.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 46677899999 99999999965 3477888887543322 2222333455555555 489999988899999999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHhccCCCCeEecCCCCCCEEECCC-CcEEEeeccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA----ALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGI 189 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~----~l~~Lh~~~~~~i~h~di~p~Nilv~~~-~~v~l~dfg~ 189 (335)
++-.|.+ +.+|.++.......++...++..+.+... |+.++| +.+++|.|++|.||+...+ ...+++|||+
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence 9999998 67888877766666899999999999999 999999 9999999999999999999 8899999999
Q ss_pred cccccCCcccccc---ccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccch-hhHhHhhhhcCh
Q 019843 190 AKLLTGEDQSKSQ---TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEM-TLKYWVSNLLPI 265 (335)
Q Consensus 190 ~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~ 265 (335)
...+.+....... ....+...|++||..+ .-++.++|+|++|.++.+-.++..++..-....+ ....+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~------- 341 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG------- 341 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc-------
Confidence 9887644423222 2236778899999885 4678899999999999999988776543211111 11000
Q ss_pred hHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 266 SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
-...+.-.+.+.++...+.+|+..+|-.|++++.+..
T Consensus 342 --------------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 --------------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --------------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000111122444677999999999999998877653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.8e-12 Score=121.38 Aligned_cols=145 Identities=19% Similarity=0.185 Sum_probs=93.3
Q ss_pred cCCCCccceeeecCceEEEEEEEcC-CcEEEEEEeecCCCc----------------------------------hhHH-
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGG----------------------------------VFKS- 85 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~----------------------------------~~~~- 85 (335)
...|.. +.||.|++|.||.|+.++ |+.||||+.++.-.+ ....
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 899999999999999876 999999999754210 0111
Q ss_pred -----HHHHHHHHHhC----CCCceEEEeeeeec-CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHH-HHH
Q 019843 86 -----FDVECEVMKSI----RHRNLIKIISTCSN-DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA-ALE 154 (335)
Q Consensus 86 -----~~~e~~~l~~l----~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~-~l~ 154 (335)
+..|+....++ .+.+.+.+-.++.+ ....++||||++|+.+.++-.-.....+...+ +...+. -+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~l---a~~~v~~~~~ 274 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLL---AERGVEVFFT 274 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHH---HHHHHHHHHH
Confidence 22233333333 23333444344433 45567999999999998753211111222222 222221 233
Q ss_pred HHhccCCCCeEecCCCCCCEEECCCC----cEEEeeccccccc
Q 019843 155 YLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLL 193 (335)
Q Consensus 155 ~Lh~~~~~~i~h~di~p~Nilv~~~~----~v~l~dfg~~~~~ 193 (335)
.+. ..|++|+|++|.||+++.+| .++++|||++..+
T Consensus 275 Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 275 QVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 445 68999999999999999888 9999999998865
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=105.99 Aligned_cols=127 Identities=21% Similarity=0.223 Sum_probs=95.3
Q ss_pred cceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCc-eEEEeeeeecCCeeEEEEEecCCCCh
Q 019843 48 NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN-LIKIISTCSNDDFKALVLEYMPHGSL 126 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L 126 (335)
++.++.|..+.||++... +..+++|+...... ....+..|+.+++.+.+.+ +++++.... +..++|||+++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 467889999999999876 78899999764432 2234678899999885444 344555433 335799999999887
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCC-----eEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 127 EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP-----VIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 127 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~-----i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
.+. . . ....++.++++++..|| ..+ ++|||++|.||+++ ++.++++||+.+.
T Consensus 79 ~~~----~--~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE----D--F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc----c--c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 653 0 1 11245678999999999 776 59999999999999 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.1e-11 Score=99.53 Aligned_cols=136 Identities=19% Similarity=0.190 Sum_probs=98.3
Q ss_pred cceeeecCceEEEEEEEcC-------CcEEEEEEeecCC------------C----------chhHHHH----HHHHHHH
Q 019843 48 NNLIGRGSFGSVYKARIQD-------GMEVAVKVFHLQC------------G----------GVFKSFD----VECEVMK 94 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~-------~~~v~iK~~~~~~------------~----------~~~~~~~----~e~~~l~ 94 (335)
...||.|.-+.||.|...+ +..+|+|+.+... + .....+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999997442 4789999985321 0 0112233 7999999
Q ss_pred hCC--CCceEEEeeeeecCCeeEEEEEecCCCChHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHH-hccCCCCeEecCCC
Q 019843 95 SIR--HRNLIKIISTCSNDDFKALVLEYMPHGSLEK-CLYSSNCVLDIFQRLNIMIDVAAALEYL-HFGYSAPVIHCDLK 170 (335)
Q Consensus 95 ~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~i~~~l~~~l~~L-h~~~~~~i~h~di~ 170 (335)
++. .-+++.++++ ..-++||||+.+..+.. .+... .++......+..+++.++..+ | ..+++||||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 884 3456666654 34568999997643321 12221 355566777889999999998 8 8999999999
Q ss_pred CCCEEECCCCcEEEeeccccccc
Q 019843 171 PSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 171 p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
+.||++. ++.++++|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-11 Score=97.76 Aligned_cols=131 Identities=23% Similarity=0.319 Sum_probs=98.8
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEeecCC---C-----chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQC---G-----GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
..+.+|+-+.++.+.+. |.++++|.-.... + -...+-.+|++++.++.--.|....=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999776 6667777643321 1 1234566799999988644444333344455556699999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
++|..|.+.+... ...++..+-.-+.-|| ..+++|||+.++||+++.++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888765 2456777888889999 99999999999999998764 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.7e-11 Score=94.12 Aligned_cols=142 Identities=18% Similarity=0.188 Sum_probs=106.1
Q ss_pred ccceeeecCceEEEEEEEcCCcEEEEEEeecCC--------CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 47 ENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--------GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 47 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
....+-+|+-+.|+++.+. |+..+||.-.... .-...+..+|+++|.++.--.|.-..=++.+...-.+.|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678899999999999888 8888888653321 123456778999999886444443333444555556899
Q ss_pred EecCC-CChHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC---cEEEeecccccc
Q 019843 119 EYMPH-GSLEKCLYSSNC-VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGIAKL 192 (335)
Q Consensus 119 e~~~~-~~L~~~l~~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~---~v~l~dfg~~~~ 192 (335)
||++| .++.+++..... ....+....++..|-+.+.-|| ..+++||||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 578888765432 3333444789999999999999 99999999999999997655 358999999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.5e-11 Score=100.29 Aligned_cols=143 Identities=18% Similarity=0.193 Sum_probs=109.6
Q ss_pred cceeeecCceEEEEEEEcCCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCC--CceEEEeeeeecC---CeeEEEEEec
Q 019843 48 NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRH--RNLIKIISTCSND---DFKALVLEYM 121 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~ 121 (335)
.+.|+.|..+.+|++...+|+.+++|+...... .....+..|+++++.+.+ .++++++.+.... +..++||+++
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999877668999999764432 235678899999999965 3456677766654 3668999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcc------------------------------------------
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG------------------------------------------ 159 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~------------------------------------------ 159 (335)
+|.++.+.+.. ..++......++.+++++|..||..
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888775532 2467777778888888888888831
Q ss_pred -----------CCCCeEecCCCCCCEEECC--CCcEEEeecccccc
Q 019843 160 -----------YSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKL 192 (335)
Q Consensus 160 -----------~~~~i~h~di~p~Nilv~~--~~~v~l~dfg~~~~ 192 (335)
....++|||++|.||+++. ++.+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0245799999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.7e-09 Score=97.91 Aligned_cols=168 Identities=21% Similarity=0.217 Sum_probs=130.6
Q ss_pred CceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeee----cCCeeEEEEEecCC-CChHH
Q 019843 55 SFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS----NDDFKALVLEYMPH-GSLEK 128 (335)
Q Consensus 55 ~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~ 128 (335)
.-.+.|++.. -+|..+++|.++.+..........-+++++++.|.|++++.+++. ....+++|++|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3467888864 468999999996554444456666789999999999999999876 35678899999876 47776
Q ss_pred HHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 129 CLYS--------------SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 129 ~l~~--------------~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
..-. .+...++..+|.++.||..||.++| +.|+.-.-+.+.+|+++.+.+++|...|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5421 1235788999999999999999999 9999999999999999999999999888877653
Q ss_pred CCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~p 244 (335)
... . |.+.+. .+.|.=.||.++..|.+|..-
T Consensus 445 ~d~--------------~--~~le~~---Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDP--------------T--EPLESQ---QQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC--------------C--cchhHH---hhhhHHHHHHHHHHHhhcccc
Confidence 221 0 111111 257999999999999999654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.1e-11 Score=110.76 Aligned_cols=246 Identities=20% Similarity=0.157 Sum_probs=172.8
Q ss_pred CCCCccceeeecCceEEEEEEEc--CCcEEEEEEeecCCCchhHH--HHHHHHHHHhC-CCCceEEEeeeeecCCeeEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ--DGMEVAVKVFHLQCGGVFKS--FDVECEVMKSI-RHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 117 (335)
.+|..+..||.|.|+.|+..... ++..+++|............ -..|+.+...+ .|.++++....+......|+-
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 47888999999999999998643 46778888765443322222 22455555555 588888888777777777789
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC-CcEEEeeccccccccCC
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~-~~v~l~dfg~~~~~~~~ 196 (335)
.||++++++...+.... .+++...+.+..+++.++.++| +..++|+|++|+||++..+ +..+++|||.+..+
T Consensus 345 ~e~~~~~s~~l~~~~~~-~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~--- 417 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQ-MLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL--- 417 (524)
T ss_pred hhhhcCcchhhhhHHHH-hcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc---
Confidence 99999988876553222 5778889999999999999999 9999999999999999886 77899999988743
Q ss_pred cccccccccccccccc--CccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 197 DQSKSQTQTLATIGYM--APEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
...........++. ++.......+..+.|+++||..+.+.+++...-.... +.
T Consensus 418 --~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-~~---------------------- 472 (524)
T KOG0601|consen 418 --AFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-QS---------------------- 472 (524)
T ss_pred --ceecccccccccccccchhhccccccccccccccccccccccccCcccCcccc-cc----------------------
Confidence 11122222333344 4555556778999999999999999999865422110 00
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
........+...+....+..+.+.+...++..||++.++.....-.
T Consensus 473 -~~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 473 -LTIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -eeeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0001111111222235688999999999999999998876655443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.1e-10 Score=89.93 Aligned_cols=125 Identities=26% Similarity=0.281 Sum_probs=82.7
Q ss_pred EEEEEEEcCCcEEEEEEeecCC--------------C------------chhHHHHHHHHHHHhCCCC--ceEEEeeeee
Q 019843 58 SVYKARIQDGMEVAVKVFHLQC--------------G------------GVFKSFDVECEVMKSIRHR--NLIKIISTCS 109 (335)
Q Consensus 58 ~v~~~~~~~~~~v~iK~~~~~~--------------~------------~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 109 (335)
.||.|...+|..+|+|+..... . .......+|++.|..+..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999985321 0 0123466799999999654 566666543
Q ss_pred cCCeeEEEEEecC--CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HhccCCCCeEecCCCCCCEEECCCCcEEEee
Q 019843 110 NDDFKALVLEYMP--HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEY-LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 186 (335)
Q Consensus 110 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~-Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~d 186 (335)
.-.+||||++ |..+..+.... ++......++.+++..+.. +| ..|++|||+++.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 2359999998 65555433322 1234455677788774444 68 9999999999999999987 999999
Q ss_pred ccccccc
Q 019843 187 FGIAKLL 193 (335)
Q Consensus 187 fg~~~~~ 193 (335)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.6e-09 Score=89.25 Aligned_cols=140 Identities=15% Similarity=0.109 Sum_probs=99.1
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEeecCCCc-hh----------HHHHHHHHHHHhCCCCc--eEEEeeeeec-----
Q 019843 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGG-VF----------KSFDVECEVMKSIRHRN--LIKIISTCSN----- 110 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~-~~----------~~~~~e~~~l~~l~h~~--i~~~~~~~~~----- 110 (335)
+.+.......|+++... |+.+.||........ .. ..+.+|.+.+..+...+ .+.++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 45555555557776654 788999976433211 01 13678888888874322 2333444432
Q ss_pred CCeeEEEEEecCCC-ChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC-------CCc
Q 019843 111 DDFKALVLEYMPHG-SLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD-------NMV 181 (335)
Q Consensus 111 ~~~~~lv~e~~~~~-~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~-------~~~ 181 (335)
....++|+|++++. +|.+++... ..+.+......++.+++..+..|| ..|++|+|++++||+++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23567999999886 899987532 234566777889999999999999 999999999999999975 468
Q ss_pred EEEeecccccc
Q 019843 182 AHLSDFGIAKL 192 (335)
Q Consensus 182 v~l~dfg~~~~ 192 (335)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=8.9e-11 Score=113.69 Aligned_cols=250 Identities=24% Similarity=0.276 Sum_probs=171.2
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..+.+.+.+-+..|.++.++.+.-. +|.-...|+..... ....+....+-.++-...+|.++...-.+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4467778888889999999988533 34333444332211 1122333333333333345666555444555677889
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
+++|..+++|...+...+ ..+.+........+..+..+|| +..+.|+|++|.|.+...+|..++.||+........
T Consensus 882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence 999999999988877655 5666666777788889999999 888999999999999999999999999843332100
Q ss_pred -----------------------------ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCc
Q 019843 197 -----------------------------DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDK 247 (335)
Q Consensus 197 -----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~ 247 (335)
+.........+|+.|.+||...+......+|+|++|+++++.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 000123345689999999999999999999999999999999999999876
Q ss_pred ccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHH
Q 019843 248 IFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAK 312 (335)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 312 (335)
...... .+.. ......-...+...++...+++...+..+|.+|..+.
T Consensus 1038 ~tpq~~-----------------f~ni-~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQI-----------------FENI-LNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhh-----------------hhcc-ccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 543221 1111 1111111122334466789999999999999997665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.9e-09 Score=89.46 Aligned_cols=136 Identities=23% Similarity=0.189 Sum_probs=103.0
Q ss_pred CCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC----------------------CchhHHHHHHHHHHHhCCCC-
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC----------------------GGVFKSFDVECEVMKSIRHR- 99 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~- 99 (335)
.=+.++..||-|.-+.||.|...+|.++++|.=+... .-..-...+|.++|..|...
T Consensus 91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred hHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3456789999999999999999999999999643211 01123466799999998644
Q ss_pred -ceEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC
Q 019843 100 -NLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD 178 (335)
Q Consensus 100 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~ 178 (335)
.+++.++. +.-.+|||+++|..|...- ++.+....++..|+.-+..+- ..|++|||+++-||++++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEec
Confidence 56665533 3345899999987665421 245556667788888888888 899999999999999999
Q ss_pred CCcEEEeeccccc
Q 019843 179 NMVAHLSDFGIAK 191 (335)
Q Consensus 179 ~~~v~l~dfg~~~ 191 (335)
||.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999996554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.4e-10 Score=108.16 Aligned_cols=150 Identities=18% Similarity=0.238 Sum_probs=105.2
Q ss_pred HHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc-------ccccccccccccCccccCCC
Q 019843 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK-------SQTQTLATIGYMAPEYGREG 220 (335)
Q Consensus 148 ~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~ 220 (335)
+.+.|+.++|. +.+++|++|.|++|+++.++..||+.|+++....+..... ...-......|.|||++.+.
T Consensus 107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34489999996 7899999999999999999999999999987654321111 11122356679999999998
Q ss_pred CCCCccchhhHHHHHHHHHhCCCC-CCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHH
Q 019843 221 RVSTNGDVYSFGIMLMETFTKKKP-TDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAME 299 (335)
Q Consensus 221 ~~~~~sDiwslG~~l~~ll~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 299 (335)
..+.++|+||+|+++|.+..|..+ +..... .... .... .............+|.++.+=+.+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~----------~~~~------~~~~~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSY----------SFSR------NLLNAGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCC-cchh----------hhhh------cccccccccccccCcHHHHHHHHH
Confidence 889999999999999999955444 332211 1110 0000 011111111225668889999999
Q ss_pred hchhccccCCCHHHHHH
Q 019843 300 CTVESAEQRINAKEIVT 316 (335)
Q Consensus 300 ~l~~dP~~Rps~~ell~ 316 (335)
++..++..||++.+++.
T Consensus 248 ~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HhcCCcccCcchhhhhc
Confidence 99999999997777653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.2e-08 Score=81.50 Aligned_cols=138 Identities=14% Similarity=0.138 Sum_probs=92.4
Q ss_pred hhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCch------------hHHHHHHHHHHHhCCCCceEEEeee
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGV------------FKSFDVECEVMKSIRHRNLIKIIST 107 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~~~~~ 107 (335)
-..++|.+.+++-......|.+.... |..+++|......... ..++......++...-.....++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 35678888889888888888777766 7999999987654221 1222222333333222222232222
Q ss_pred e-----ecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcE
Q 019843 108 C-----SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 182 (335)
Q Consensus 108 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v 182 (335)
. ......+++|||++|..|.++.. +++ .++..+.+++..|| ..|++|||.+|.|++++.+ .+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cE
Confidence 2 22345568999999988876432 222 24567788899999 9999999999999999865 59
Q ss_pred EEeeccccc
Q 019843 183 HLSDFGIAK 191 (335)
Q Consensus 183 ~l~dfg~~~ 191 (335)
+++|++...
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999997543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.8e-08 Score=94.03 Aligned_cols=140 Identities=21% Similarity=0.222 Sum_probs=92.5
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEeecCCCc----------------------------------hhHH------HHH
Q 019843 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGG----------------------------------VFKS------FDV 88 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----------------------------------~~~~------~~~ 88 (335)
+.|+.++-|.||.|+.++|+.||||+.++.-.+ ..+. +..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 789999999999999999999999998644210 0111 222
Q ss_pred HHHHHHhC----CCCceEEEeeeee-cCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHH-HHHHhccCCC
Q 019843 89 ECEVMKSI----RHRNLIKIISTCS-NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAA-LEYLHFGYSA 162 (335)
Q Consensus 89 e~~~l~~l----~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~-l~~Lh~~~~~ 162 (335)
|+.-+.++ +...-+.+=.++. -.+.-.++|||++|..+.++..-.....+... ++..++++ +..+- ..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~---~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLL---RD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHH---hc
Confidence 33333332 2222222223332 23455699999999999888432223355443 33333333 33444 57
Q ss_pred CeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 163 ~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
|++|+|.+|.||+++.+|++.+.|||+...+.
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 99999999999999999999999999988764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.6e-07 Score=77.12 Aligned_cols=137 Identities=18% Similarity=0.064 Sum_probs=101.1
Q ss_pred eecCceEEEEEEEcCCcEEEEEEeecCC------CchhHHHHHHHHHHHhCCC--CceEEEeeeeec----CCeeEEEEE
Q 019843 52 GRGSFGSVYKARIQDGMEVAVKVFHLQC------GGVFKSFDVECEVMKSIRH--RNLIKIISTCSN----DDFKALVLE 119 (335)
Q Consensus 52 g~g~~~~v~~~~~~~~~~v~iK~~~~~~------~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~----~~~~~lv~e 119 (335)
++|+.+.|+..... |..+-+|.-.... +-....|.+|...+..+.. -+++++...... .-..++|+|
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 45888889988766 4568888754211 2235789999999999843 234444422111 234669999
Q ss_pred ecCC-CChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc--EEEeecccccc
Q 019843 120 YMPH-GSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--AHLSDFGIAKL 192 (335)
Q Consensus 120 ~~~~-~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~--v~l~dfg~~~~ 192 (335)
-++| .+|.+++.... .+.+......++.+++.++.-|| +.|+.|+|+.+.||+++.+|. +.++||.-+..
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 8754 58988886532 25677778899999999999999 999999999999999986677 99999987764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.2e-07 Score=79.05 Aligned_cols=107 Identities=23% Similarity=0.247 Sum_probs=82.6
Q ss_pred hHHHHHHHHHHHhCCC--CceEEEeeeeecC----CeeEEEEEecCCC-ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 019843 83 FKSFDVECEVMKSIRH--RNLIKIISTCSND----DFKALVLEYMPHG-SLEKCLYSSNCVLDIFQRLNIMIDVAAALEY 155 (335)
Q Consensus 83 ~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~ 155 (335)
.....+|...+..+.. -..+.++++.+.. ...++|+|++++. +|.+++.... ..+......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHH
Confidence 3567778888777742 2344455554432 3457999999874 8999887643 26667788899999999999
Q ss_pred HhccCCCCeEecCCCCCCEEECCCC---cEEEeeccccccc
Q 019843 156 LHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLL 193 (335)
Q Consensus 156 Lh~~~~~~i~h~di~p~Nilv~~~~---~v~l~dfg~~~~~ 193 (335)
|| ..|++|+|+++.|||++.++ .+.++||+-+...
T Consensus 134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99 99999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.5e-07 Score=78.13 Aligned_cols=132 Identities=13% Similarity=0.110 Sum_probs=86.3
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCC--ceEEEeeeeecCCeeEEEEEecCCCC-
Q 019843 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHR--NLIKIISTCSNDDFKALVLEYMPHGS- 125 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~- 125 (335)
..|+.|..+.||+. .+..+++|...... ......+|.++++.+..- .+++++++....+...+||++++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999974 25578889876432 335678999999988533 35677888888888889999998863
Q ss_pred hHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc----------------------------------------cCCCCeE
Q 019843 126 LEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHF----------------------------------------GYSAPVI 165 (335)
Q Consensus 126 L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~----------------------------------------~~~~~i~ 165 (335)
+...+. .+......++..+++.+.-||. .....++
T Consensus 82 ~~~~~~-----~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 82 FSRIIS-----DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred hhhhhc-----CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 221111 0001111111112222222220 1134579
Q ss_pred ecCCCCCCEEECCCCcEEEeeccccc
Q 019843 166 HCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 166 h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
|||++|.||++++++ +.++||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.64 E-value=6.1e-07 Score=76.08 Aligned_cols=141 Identities=19% Similarity=0.290 Sum_probs=84.2
Q ss_pred cceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCC--CceEEEeeee---ecCCeeEEEEEecC
Q 019843 48 NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRH--RNLIKIISTC---SNDDFKALVLEYMP 122 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~---~~~~~~~lv~e~~~ 122 (335)
++.++.|..+.||.+...+ ..+++|..... .....+..|..+++.+.. ..++.++... ......+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999999886 69999996544 345678888888888842 2355666533 33456789999999
Q ss_pred CCChHH----------------HHh---cC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHhc
Q 019843 123 HGSLEK----------------CLY---SS---NCVLDIFQ---------RLNI------------MIDVAA-ALEYLHF 158 (335)
Q Consensus 123 ~~~L~~----------------~l~---~~---~~~~~~~~---------~~~i------------~~~l~~-~l~~Lh~ 158 (335)
|.++.. .+. .. ........ .... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 111 10 00111000 0000 001111 2222221
Q ss_pred ----cCCCCeEecCCCCCCEEEC-CCCcEEEeeccccc
Q 019843 159 ----GYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAK 191 (335)
Q Consensus 159 ----~~~~~i~h~di~p~Nilv~-~~~~v~l~dfg~~~ 191 (335)
.....++|||++|.||+++ +++.+.++||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1257799999999999999 66677899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.63 E-value=6.5e-07 Score=76.76 Aligned_cols=133 Identities=17% Similarity=0.131 Sum_probs=83.6
Q ss_pred CceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEEEEecCCCChHHHHh--
Q 019843 55 SFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLY-- 131 (335)
Q Consensus 55 ~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-- 131 (335)
..+.||+.... +..+++|+..... ...+..|+++++.+. +-.+++++++....+..++||++++|.++.....
T Consensus 11 ~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~ 86 (244)
T cd05150 11 SGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEEL 86 (244)
T ss_pred CcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhccc
Confidence 44889999765 4788889875432 356778999998883 4556778888777777889999999987764321
Q ss_pred -----------------cCC---CCCCHH--HHHHHHH--------------------HHHHHHHHHhc----cCCCCeE
Q 019843 132 -----------------SSN---CVLDIF--QRLNIMI--------------------DVAAALEYLHF----GYSAPVI 165 (335)
Q Consensus 132 -----------------~~~---~~~~~~--~~~~i~~--------------------~l~~~l~~Lh~----~~~~~i~ 165 (335)
... .++... ....... .+...+..|-. .....++
T Consensus 87 ~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 166 (244)
T cd05150 87 EPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVT 166 (244)
T ss_pred CHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEE
Confidence 000 011100 0000000 01111112210 1134589
Q ss_pred ecCCCCCCEEECCCCcEEEeeccccc
Q 019843 166 HCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 166 h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
|||+.|.||+++.++.+.|+||+.+.
T Consensus 167 HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 167 HGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCCCCccEEEeCCcEEEEEEccccc
Confidence 99999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.8e-07 Score=76.88 Aligned_cols=170 Identities=22% Similarity=0.246 Sum_probs=108.6
Q ss_pred HhhCCCCCCCCCCCCcccccccCHHHHhhhcCCCCccceee---ecCceEEEEEEEcCCcEEEEEEeecCCCch------
Q 019843 12 RKRGKQLPNDANMPPVATWRRFSYLELFQATDGFSENNLIG---RGSFGSVYKARIQDGMEVAVKVFHLQCGGV------ 82 (335)
Q Consensus 12 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~y~~~~~lg---~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~------ 82 (335)
++++|...+..-.+.+- ...+...+....++..+....| .|.-+.||.|...++..+|+|++.......
T Consensus 16 ~kr~Kd~~~~k~~~~v~--D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Y 93 (268)
T COG1718 16 EKREKDKEDRKVVDEVF--DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRY 93 (268)
T ss_pred HHhhhcchHhhhhhhhh--hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHH
Confidence 44445555555544433 3334555666666766655555 677889999988889999999997543110
Q ss_pred ------------------hHHHHHHHHHHHhCC--CCceEEEeeeeecCCeeEEEEEecCCCCh-HHHHhcCCCCCCHHH
Q 019843 83 ------------------FKSFDVECEVMKSIR--HRNLIKIISTCSNDDFKALVLEYMPHGSL-EKCLYSSNCVLDIFQ 141 (335)
Q Consensus 83 ------------------~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~ 141 (335)
..=...|+.-|+++. +-.+++.+++.. -.+|||++..... .=.| +..++....
T Consensus 94 i~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L--kDv~~e~~e 167 (268)
T COG1718 94 IQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL--KDVPLELEE 167 (268)
T ss_pred HhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc--ccCCcCchh
Confidence 001224666666653 334444444433 3489999844310 0001 111233336
Q ss_pred HHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 142 RLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 142 ~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
...+..++++.+.-|- . .+++||||+.-|||+. ++.+.++|+|-+...
T Consensus 168 ~~~~~~~~v~~~~~l~---~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 168 AEGLYEDVVEYMRRLY---KEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHHHHHHHHHHHHHHH---HhcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 7778888899988888 5 8999999999999999 889999999988754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=6.8e-07 Score=83.42 Aligned_cols=139 Identities=22% Similarity=0.273 Sum_probs=88.7
Q ss_pred cceeeecCceEEEEEEEcCCcEEEEEEeecCCC-------------------------------chhHHHH------HHH
Q 019843 48 NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCG-------------------------------GVFKSFD------VEC 90 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-------------------------------~~~~~~~------~e~ 90 (335)
.+.||..+.|.||+|+.++|+.||||+-++.-. +..+.+. .|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 478999999999999999999999999764321 1111112 222
Q ss_pred HHH----HhCCCCc------eEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccC
Q 019843 91 EVM----KSIRHRN------LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160 (335)
Q Consensus 91 ~~l----~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~ 160 (335)
+-. +.+.|-+ |++++-.+ .....++|||++|..+.|+-.-....++... ++..+.++....=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~---i~~~l~~~~~~qIf-- 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHD---ILNKLVEAYLEQIF-- 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHH---HHHHHHHHHHHHHH--
Confidence 222 2223444 33333222 3456699999999877665432222355554 44444444222211
Q ss_pred CCCeEecCCCCCCEEECC----CCcEEEeeccccccc
Q 019843 161 SAPVIHCDLKPSNVLLDD----NMVAHLSDFGIAKLL 193 (335)
Q Consensus 161 ~~~i~h~di~p~Nilv~~----~~~v~l~dfg~~~~~ 193 (335)
..|++|+|-+|.||++.. ++.+.+.|||+....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 578999999999999983 668999999998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.5e-06 Score=68.75 Aligned_cols=136 Identities=17% Similarity=0.206 Sum_probs=95.8
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEE-EeeeeecCCeeEEE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK-IISTCSNDDFKALV 117 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv 117 (335)
......-++.+.|++|..|.||++.+. |..+++|+-..++. ...+..|+++|..+...++.+ ++.+..+ ++.
T Consensus 18 ~~~~~~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~ 90 (201)
T COG2112 18 EEGKYELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIR 90 (201)
T ss_pred eccchhhhhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhh
Confidence 334445567899999999999999988 67999999776654 378899999999997665543 4433332 244
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCC-CCEEECCCCcEEEeecccccc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKP-SNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p-~Nilv~~~~~v~l~dfg~~~~ 192 (335)
|||++|..|.++-... +-.+ ...+++.-.-|- ..||-|+.|+- ...++..++.+.|+||..++.
T Consensus 91 me~i~G~~L~~~~~~~----~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 91 MEYIDGRPLGKLEIGG----DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcCcchhhhhhcc----cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9999998988754321 2233 334555555566 78999999874 444444455999999998873
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.6e-05 Score=65.32 Aligned_cols=134 Identities=19% Similarity=0.265 Sum_probs=95.6
Q ss_pred ccceeeecCceEEEEEEEcCCcEEEEEEeecCC----------------CchhHHHHHHHHHHHhCC------CCceEEE
Q 019843 47 ENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC----------------GGVFKSFDVECEVMKSIR------HRNLIKI 104 (335)
Q Consensus 47 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~ 104 (335)
-...||.|+.-.||. +.++...+||+..... ........+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999998884 4445667889987665 223456667777776665 7899999
Q ss_pred eeeeecCCeeEEEEEecC------CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC
Q 019843 105 ISTCSNDDFKALVLEYMP------HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD 178 (335)
Q Consensus 105 ~~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~ 178 (335)
+|..+.+....+|+|.+. ..+|.+++.... ++. .....+.+ -..+|- ...|+.+|++|.||++..
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~~L~~---f~~~l~---~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQALDE---FKRYLL---DHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHHHHHH---HHHHHH---HcCCeecCCCcccEEEEe
Confidence 999999999999999753 247888885543 555 44444444 445566 677999999999999953
Q ss_pred CC----cEEEee-ccccc
Q 019843 179 NM----VAHLSD-FGIAK 191 (335)
Q Consensus 179 ~~----~v~l~d-fg~~~ 191 (335)
.. .+.++| ||...
T Consensus 154 ~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred cCCCceEEEEEeCCCCcc
Confidence 22 578887 55433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.4e-05 Score=63.07 Aligned_cols=102 Identities=24% Similarity=0.281 Sum_probs=81.1
Q ss_pred HHHHHHHHhCCC-CceEEEeeeeecCCeeEEEEEecCCCChHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCC
Q 019843 87 DVECEVMKSIRH-RNLIKIISTCSNDDFKALVLEYMPHGSLEKC---LYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162 (335)
Q Consensus 87 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~ 162 (335)
..|.-+++.+++ +++++++|.|.+ .++.|+...+++... +.+- ...+|..+..++.++++.+.+|+++...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 347788888865 699999999853 578999876655421 1111 1478999999999999999999966557
Q ss_pred CeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 163 ~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.+...|++++|+-++++|++|++|.+.+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 7888999999999999999999999887654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.5e-07 Score=87.59 Aligned_cols=188 Identities=18% Similarity=0.180 Sum_probs=135.6
Q ss_pred CCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCc-eEEEeeeeecCCeeEEEEEec
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN-LIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.-|...+-+++++++.+++.+....+....+.+... ....-++++|.+++||| .+..++-+..++..+++++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 334455667889999988876443333444444322 56677899999999999 666666677788889999999
Q ss_pred CCC-ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHG-SLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~-~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
.++ +...-.......+.+.+...+...-++++.++| +..-+|+| ||+..+ +.++..||+....+.. ..
T Consensus 317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~---~~ 385 (829)
T KOG0576|consen 317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR---TM 385 (829)
T ss_pred cCCccccccCChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCc---cc
Confidence 776 333222222234555556666677778899999 66667776 777665 6889999998876632 22
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTD 246 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~ 246 (335)
......+++.++|||+..++.+....|.|++|.-..++--|-+|-.
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4556778999999999999999999999999988788877877744
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.3e-05 Score=68.29 Aligned_cols=73 Identities=8% Similarity=0.145 Sum_probs=45.9
Q ss_pred ceeeecCce-EEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCC---ceEEEeeeeecC---CeeEEEEEec
Q 019843 49 NLIGRGSFG-SVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHR---NLIKIISTCSND---DFKALVLEYM 121 (335)
Q Consensus 49 ~~lg~g~~~-~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e~~ 121 (335)
+.++.|+.. .||.. +..+++|..... .....+..|+++++.+... .+..+++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456655555 58875 235777875432 2345788999999888532 344455443332 2457899999
Q ss_pred CCCChH
Q 019843 122 PHGSLE 127 (335)
Q Consensus 122 ~~~~L~ 127 (335)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.16 E-value=4.9e-05 Score=76.47 Aligned_cols=79 Identities=13% Similarity=0.267 Sum_probs=57.1
Q ss_pred cceeeecCceEEEEEEEcCC---cEEEEEEeecCC-CchhHHHHHHHHHHHhCC-CCc--eEEEeeeeecC---CeeEEE
Q 019843 48 NNLIGRGSFGSVYKARIQDG---MEVAVKVFHLQC-GGVFKSFDVECEVMKSIR-HRN--LIKIISTCSND---DFKALV 117 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~~---~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~---~~~~lv 117 (335)
++.++.|....+|+.....+ ..+++|+..... ......+.+|+++++.+. |.+ +++++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 67788899999999876543 467888754332 122357889999999995 555 47777777654 467899
Q ss_pred EEecCCCCh
Q 019843 118 LEYMPHGSL 126 (335)
Q Consensus 118 ~e~~~~~~L 126 (335)
||+++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988653
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.4e-05 Score=67.58 Aligned_cols=137 Identities=13% Similarity=0.155 Sum_probs=78.6
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCce-EEEeeeeecCCeeEEEEEecCCCChHH
Q 019843 50 LIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNL-IKIISTCSNDDFKALVLEYMPHGSLEK 128 (335)
Q Consensus 50 ~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~ 128 (335)
.+..|-...+|+.... +..+++|..........-....|.++++.+....+ ++++.... -++|++|++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~~-~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHP-GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEeC-CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 4556888899988744 67889998654332221245778999998853322 33444332 258999999876532
Q ss_pred H--------------Hh---cC---CCCCCHH-HHHHHHHHH---------HHHHHHHhc-----cCCCCeEecCCCCCC
Q 019843 129 C--------------LY---SS---NCVLDIF-QRLNIMIDV---------AAALEYLHF-----GYSAPVIHCDLKPSN 173 (335)
Q Consensus 129 ~--------------l~---~~---~~~~~~~-~~~~i~~~l---------~~~l~~Lh~-----~~~~~i~h~di~p~N 173 (335)
- +. .. ..+++.. .+..+..++ ...+..+-. .....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11 00 1112211 111211111 111111210 112468999999999
Q ss_pred EEECCCCcEEEeecccccc
Q 019843 174 VLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 174 ilv~~~~~v~l~dfg~~~~ 192 (335)
|+++.++ +.++||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999988763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.11 E-value=6.8e-05 Score=63.78 Aligned_cols=74 Identities=18% Similarity=0.238 Sum_probs=49.2
Q ss_pred cceeeecCceEEEEEEEcC--CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCC-ceEEEeeeeecCCeeEEEEEecCCC
Q 019843 48 NNLIGRGSFGSVYKARIQD--GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHR-NLIKIISTCSNDDFKALVLEYMPHG 124 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~ 124 (335)
++.|..|-...+|+....+ +..+++|+...... .......|+.+++.+... -.+++++... + .++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCC
Confidence 4567778888999997664 67899998764322 223345788888888432 2344444332 1 3799999987
Q ss_pred Ch
Q 019843 125 SL 126 (335)
Q Consensus 125 ~L 126 (335)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 65
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=0.00011 Score=64.81 Aligned_cols=80 Identities=10% Similarity=0.060 Sum_probs=58.2
Q ss_pred CCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCC---CceEEEeeeeec---CCeeEEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRH---RNLIKIISTCSN---DDFKALV 117 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv 117 (335)
.-.-.+.||.|..+.||.....++ .+++|..+.. .....+..|++.++.+.. -.++++++.+.. .+..++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 334467899999999999976655 4677774431 122678889999998842 467888877654 4668999
Q ss_pred EEecCCCCh
Q 019843 118 LEYMPHGSL 126 (335)
Q Consensus 118 ~e~~~~~~L 126 (335)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.6e-05 Score=77.70 Aligned_cols=201 Identities=21% Similarity=0.256 Sum_probs=135.3
Q ss_pred hhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE----EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 019843 82 VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA----LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH 157 (335)
Q Consensus 82 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh 157 (335)
.......|...+....|+|+..++.+........ +..+++...++.+.+..-. ..+...++.+..++..|+.++|
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHH
Confidence 3455566777888889999999988876543322 4456777777777666544 7889999999999999999999
Q ss_pred ccCCCCeEecCCCCC---CEEECCCCcEEEe--eccccccccCCccccccccccccccccCccccCCCCCC--Cccchhh
Q 019843 158 FGYSAPVIHCDLKPS---NVLLDDNMVAHLS--DFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVS--TNGDVYS 230 (335)
Q Consensus 158 ~~~~~~i~h~di~p~---Nilv~~~~~v~l~--dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~sDiws 230 (335)
+....|.-+..+ +.-++.++.+..+ ||+....+.. .........+..+.+||........ ...|+|+
T Consensus 304 ---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d---~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 ---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD---NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred ---HhccceeEEecccccccccCccceeecchhhhcccccCCC---cccchhhcCccccccccccccccchhhhhhHHHH
Confidence 665555444444 3444556666666 8887776532 2222233345557778876655443 4479999
Q ss_pred HHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCC
Q 019843 231 FGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN 310 (335)
Q Consensus 231 lG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 310 (335)
+|.....+..|..+-.... ....+.+.. +...+.+...+|+.-++++|++
T Consensus 378 lgll~~~~~~~~~i~~~~~----------------~~~~~l~~~--------------~~~~~~d~~~~~~~~~~~~Rl~ 427 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSA----------------VPVSLLDVL--------------STSELLDALPKCLDEDSEERLS 427 (1351)
T ss_pred HHHHHhhhhhcCccccccc----------------chhhhhccc--------------cchhhhhhhhhhcchhhhhccc
Confidence 9999999999876622211 111111111 1113788899999999999999
Q ss_pred HHHHHHHHH
Q 019843 311 AKEIVTRLL 319 (335)
Q Consensus 311 ~~ell~~L~ 319 (335)
+.+++....
T Consensus 428 ~~~ll~~~f 436 (1351)
T KOG1035|consen 428 ALELLTHPF 436 (1351)
T ss_pred hhhhhhchh
Confidence 999987654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00015 Score=64.49 Aligned_cols=158 Identities=20% Similarity=0.221 Sum_probs=90.4
Q ss_pred cccCHHHHhhhcCCCCc-----cceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCC--ceEE
Q 019843 31 RRFSYLELFQATDGFSE-----NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHR--NLIK 103 (335)
Q Consensus 31 ~~~~~~~~~~~~~~y~~-----~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~ 103 (335)
...+.+++....++|.+ .+.++.|....+|..... +..+++|+...... ...+..|.+++..+... .+++
T Consensus 5 ~~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~-~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~ 81 (307)
T TIGR00938 5 TSVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD-VGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPK 81 (307)
T ss_pred ccCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeC-CCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCc
Confidence 34455566666556654 456677777899998765 44688898654321 24455667777776322 2344
Q ss_pred Eeee------eecCCeeEEEEEecCCCChH-----------HHHh---cCCCCCC-------HHHHHH------------
Q 019843 104 IIST------CSNDDFKALVLEYMPHGSLE-----------KCLY---SSNCVLD-------IFQRLN------------ 144 (335)
Q Consensus 104 ~~~~------~~~~~~~~lv~e~~~~~~L~-----------~~l~---~~~~~~~-------~~~~~~------------ 144 (335)
++.. ....+..+++++|++|..+. ..+. .....++ ....|.
T Consensus 82 ~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (307)
T TIGR00938 82 PVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQ 161 (307)
T ss_pred cccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccc
Confidence 4332 12345678999999885432 1111 0000000 000100
Q ss_pred ----HHHHHHHHHHHHhc----cCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 145 ----IMIDVAAALEYLHF----GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 145 ----i~~~l~~~l~~Lh~----~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
....+...+.++.. ....+++|||+++.||+++.++.+.++||+.+.
T Consensus 162 l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 162 LEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 01112233444431 124789999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00038 Score=56.98 Aligned_cols=125 Identities=26% Similarity=0.420 Sum_probs=90.3
Q ss_pred CCCCccceeeecCc-eEEEEEEEcCCcEEEEEEeec---CCC------------------chhHHHHHHHHHHHhCC---
Q 019843 43 DGFSENNLIGRGSF-GSVYKARIQDGMEVAVKVFHL---QCG------------------GVFKSFDVECEVMKSIR--- 97 (335)
Q Consensus 43 ~~y~~~~~lg~g~~-~~v~~~~~~~~~~v~iK~~~~---~~~------------------~~~~~~~~e~~~l~~l~--- 97 (335)
..++..+.||.|.- |.||++... |+.+|+|++.. ... .....|..|.+.+.+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 999999988 78999999431 100 12345778998888874
Q ss_pred CCce--EEEeeeeecC------------------CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 019843 98 HRNL--IKIISTCSND------------------DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH 157 (335)
Q Consensus 98 h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh 157 (335)
+.++ ++++|+..-. ....||.|+.+... .+... -+.+|.+-+..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHH
Confidence 4455 8888886321 13347777765433 12222 3456777788899
Q ss_pred ccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 158 ~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
..+|+-+|+++.|.. .=+|+|||.+
T Consensus 182 ---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 ---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ---HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999988 4468899864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00048 Score=62.87 Aligned_cols=76 Identities=18% Similarity=0.196 Sum_probs=54.5
Q ss_pred cceeeecCceEEEEEEEcCC-cEEEEEEeecCC-------CchhHHHHHHHHHHHhCC---CCceEEEeeeeecCCeeEE
Q 019843 48 NNLIGRGSFGSVYKARIQDG-MEVAVKVFHLQC-------GGVFKSFDVECEVMKSIR---HRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~~-~~v~iK~~~~~~-------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 116 (335)
.+.||.|.+..||++...+| +.++||.-.... +-...+...|.+.|+.+. -.++++++.+.. +..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 46789999999999988766 489999854221 123466778888888863 245677776643 55679
Q ss_pred EEEecCCCC
Q 019843 117 VLEYMPHGS 125 (335)
Q Consensus 117 v~e~~~~~~ 125 (335)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999987643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00027 Score=62.37 Aligned_cols=141 Identities=18% Similarity=0.159 Sum_probs=83.0
Q ss_pred cceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCC--ceEEEeee------eecCCeeEEEEE
Q 019843 48 NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHR--NLIKIIST------CSNDDFKALVLE 119 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~------~~~~~~~~lv~e 119 (335)
.+.+..|....+|+.... +..+++|+.... ....+..|++++..+.+. .+++++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 566777877899998765 457888987642 235567778887777422 24444332 123456789999
Q ss_pred ecCCCChHH----H-------Hh---c--CC--CC------CCHHHH----------HHHHHHHHHHHHHHhc----cCC
Q 019843 120 YMPHGSLEK----C-------LY---S--SN--CV------LDIFQR----------LNIMIDVAAALEYLHF----GYS 161 (335)
Q Consensus 120 ~~~~~~L~~----~-------l~---~--~~--~~------~~~~~~----------~~i~~~l~~~l~~Lh~----~~~ 161 (335)
+++|..+.. . +. . .. .. ..+... ......+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998876532 0 10 0 00 00 000000 0011112233333331 123
Q ss_pred CCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 162 ~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
.+++|||++|.||+++.++.+.++||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 5799999999999999887778999988763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.88 E-value=1.5e-05 Score=69.09 Aligned_cols=135 Identities=20% Similarity=0.196 Sum_probs=97.9
Q ss_pred CCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC-----------------Cc---h--hHHHHHHHHHHHhCC-C-C
Q 019843 44 GFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC-----------------GG---V--FKSFDVECEVMKSIR-H-R 99 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-----------------~~---~--~~~~~~e~~~l~~l~-h-~ 99 (335)
=+.+++.||-|.-+.+|.+-..+|++.++|.=.... .. . .-...+|...++.|. | -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 467889999999999999999989999998632211 00 1 112445777777773 2 2
Q ss_pred ceEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC
Q 019843 100 NLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN 179 (335)
Q Consensus 100 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~ 179 (335)
.+++.+++. .-++||+.+.|..|..+-.-.. .-.+...++..+.-|. .+|++|||++--||++.++
T Consensus 173 pVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v~d-------~~~ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 173 PVPKPIDHN----RHCVVMELVDGYPLRQVRHVED-------PPTLYDDLMGLIVRLA---NHGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCccccc----ceeeHHHhhcccceeeeeecCC-------hHHHHHHHHHHHHHHH---HcCceecccchheeEEecC
Confidence 344444433 3458999999888876432222 3456777778888899 9999999999999999999
Q ss_pred CcEEEeecccccc
Q 019843 180 MVAHLSDFGIAKL 192 (335)
Q Consensus 180 ~~v~l~dfg~~~~ 192 (335)
+.++++||--+..
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 9999999976543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00074 Score=60.29 Aligned_cols=157 Identities=18% Similarity=0.149 Sum_probs=84.4
Q ss_pred ccCHHHHhhhcCCCCc-----cceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCC--ceEEE
Q 019843 32 RFSYLELFQATDGFSE-----NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHR--NLIKI 104 (335)
Q Consensus 32 ~~~~~~~~~~~~~y~~-----~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~ 104 (335)
.++..++......|.+ .+.++.|....+|.....+| .+++|++... ....+..++.+++.+... .++++
T Consensus 6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcc
Confidence 3444555555556654 35566777788999876644 6888987521 123444455555555211 13333
Q ss_pred ee------eeecCCeeEEEEEecCCCChH-----------HHHh---c--CC------CCCC---HHHHHH---------
Q 019843 105 IS------TCSNDDFKALVLEYMPHGSLE-----------KCLY---S--SN------CVLD---IFQRLN--------- 144 (335)
Q Consensus 105 ~~------~~~~~~~~~lv~e~~~~~~L~-----------~~l~---~--~~------~~~~---~~~~~~--------- 144 (335)
+. +....+..++++++++|..+. +.+. . .. .... +.....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 32 122356678999999887431 1111 0 00 0001 111110
Q ss_pred ---HHHH-HHHHHHHHhc----cCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 145 ---IMID-VAAALEYLHF----GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 145 ---i~~~-l~~~l~~Lh~----~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
...+ +...+..+.. ....+++|||++|.||+++.+...-++||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 1111122210 0245899999999999999765568999998763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00024 Score=62.95 Aligned_cols=75 Identities=23% Similarity=0.329 Sum_probs=49.4
Q ss_pred cceeeecCceEEEEEEEcC-------CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCc-eEEEeeeeecCCeeEEEEE
Q 019843 48 NNLIGRGSFGSVYKARIQD-------GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN-LIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e 119 (335)
++.+..|-...+|+....+ ++.+++|+..... ........|.+++..+...+ .+++++.+.. .+|++
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e 77 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE 77 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence 3456667777899887554 5789999976543 23345678888888884322 3345555432 35899
Q ss_pred ecCCCChH
Q 019843 120 YMPHGSLE 127 (335)
Q Consensus 120 ~~~~~~L~ 127 (335)
|++|.++.
T Consensus 78 ~i~G~~l~ 85 (302)
T cd05156 78 FIPSRTLT 85 (302)
T ss_pred eeCCCcCC
Confidence 98887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00066 Score=59.33 Aligned_cols=75 Identities=25% Similarity=0.309 Sum_probs=48.2
Q ss_pred CccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhC---CCCceEEEeeeeecCCeeEEEEEecC
Q 019843 46 SENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI---RHRNLIKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 46 ~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~ 122 (335)
+-.+.++.|....+|+.. .+++.+.+|+-... ....+..|++-|+.+ ..-.+++++++....+..++++||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 335778889999999988 55788999987622 336677788888777 34567888888887777899999987
Q ss_pred CC
Q 019843 123 HG 124 (335)
Q Consensus 123 ~~ 124 (335)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 65
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0012 Score=59.58 Aligned_cols=139 Identities=17% Similarity=0.207 Sum_probs=81.4
Q ss_pred cceeeecCceEEEEEEEcC-----CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCce-EEEeeeeecCCeeEEEEEec
Q 019843 48 NNLIGRGSFGSVYKARIQD-----GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNL-IKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~ 121 (335)
.+.+..|-...+|++...+ ++.+++|+..........+ ..|..+++.+...++ +++++.+... .|.+|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3455557788899987532 3689999887654433333 778999988853333 3455655432 578998
Q ss_pred CCCChHHH-------H----------hcCC----C-CCCHHHHHHHHHHH-----------------HHHHHHH----hc
Q 019843 122 PHGSLEKC-------L----------YSSN----C-VLDIFQRLNIMIDV-----------------AAALEYL----HF 158 (335)
Q Consensus 122 ~~~~L~~~-------l----------~~~~----~-~~~~~~~~~i~~~l-----------------~~~l~~L----h~ 158 (335)
++.++..- + .+.. . ......+..+..++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87766421 0 0001 0 11122222332111 1111111 10
Q ss_pred -cCCCCeEecCCCCCCEEECC-CCcEEEeeccccc
Q 019843 159 -GYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAK 191 (335)
Q Consensus 159 -~~~~~i~h~di~p~Nilv~~-~~~v~l~dfg~~~ 191 (335)
.....++|+|+++.||++++ ++.+.++||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11447899999999999976 4689999998875
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0013 Score=57.97 Aligned_cols=143 Identities=16% Similarity=0.176 Sum_probs=94.6
Q ss_pred CCCCccceeeecCceEEEEEEEcCCcEEEEEEee-cCCCchhHHHHHHHHHHHhCCC--CceEEEeeeeecCC--eeEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFH-LQCGGVFKSFDVECEVMKSIRH--RNLIKIISTCSNDD--FKALV 117 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~-~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv 117 (335)
....+++.+..|-...+|..... +++++++.-. ............|+++++.+.- ......++++.+.. ..+.|
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CCCceeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 44555566655555555555444 7889988221 2234455677788999888742 34555666776655 78999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHH-HHHHHHHHHHhc--------------------------------------
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIM-IDVAAALEYLHF-------------------------------------- 158 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~-~~l~~~l~~Lh~-------------------------------------- 158 (335)
|++++|..+.+...... .+ ...+ ..+++.|..||.
T Consensus 104 ~~~veGe~~~~~~~~~~--~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 104 MEWVEGEVVWSALPPES--LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EEEecceeccCcCCccc--ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 99999865544322111 11 1222 477888888882
Q ss_pred -----------------cCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 159 -----------------GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 159 -----------------~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
.....++|||+++.|++++.++.+-++||+++..
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 1123489999999999999998899999999875
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0006 Score=60.47 Aligned_cols=140 Identities=18% Similarity=0.170 Sum_probs=92.3
Q ss_pred ccceeeecCceEEEEEEEcCCcEEEEEEeecC-----CC---------------------chhHHHHHHHHHHHhCCCCc
Q 019843 47 ENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQ-----CG---------------------GVFKSFDVECEVMKSIRHRN 100 (335)
Q Consensus 47 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-----~~---------------------~~~~~~~~e~~~l~~l~h~~ 100 (335)
+...|..|.-+.||.|...+|..+|||+++.. +. ...-=...|++-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 45677789999999999888999999998522 00 01111334666677775544
Q ss_pred eEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC
Q 019843 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180 (335)
Q Consensus 101 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~ 180 (335)
|+-.--+... ++ .+||+++. ..=.-.-.-+...++...+..+..+++.-+.-|.. ...+||.||+--|+|+- +|
T Consensus 228 IP~PePIlLk-~h-VLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 228 IPCPEPILLK-NH-VLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH-DG 301 (520)
T ss_pred CCCCCceeee-cc-eEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE-CC
Confidence 3221111121 22 38999983 22211111123357777788888888888888875 78999999999999986 66
Q ss_pred cEEEeecccccc
Q 019843 181 VAHLSDFGIAKL 192 (335)
Q Consensus 181 ~v~l~dfg~~~~ 192 (335)
.+.++|.+-+..
T Consensus 302 ~lyiIDVSQSVE 313 (520)
T KOG2270|consen 302 KLYIIDVSQSVE 313 (520)
T ss_pred EEEEEEcccccc
Confidence 999999876653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0035 Score=57.16 Aligned_cols=81 Identities=12% Similarity=0.060 Sum_probs=54.5
Q ss_pred ccceeeecCceEEEEEEEcCCcEEEEEEeecCC----C---chhHHHHHHHHHHHhCC---CCceEEEeeeeecCCeeEE
Q 019843 47 ENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC----G---GVFKSFDVECEVMKSIR---HRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 47 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~----~---~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l 116 (335)
..+.||.|....||+.... ++.++||.-.... . -...+...|++.|+.+. -.++++++.++.+. ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEE
Confidence 4678899999999999865 5679999865221 1 13345555677777663 24778888887744 568
Q ss_pred EEEecCC--CChHHHH
Q 019843 117 VLEYMPH--GSLEKCL 130 (335)
Q Consensus 117 v~e~~~~--~~L~~~l 130 (335)
+||++++ ..+.+-+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 8999976 3454443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0021 Score=56.02 Aligned_cols=31 Identities=32% Similarity=0.606 Sum_probs=25.8
Q ss_pred CCeEecCCCCCCEEECCCCc-EEEeecccccc
Q 019843 162 APVIHCDLKPSNVLLDDNMV-AHLSDFGIAKL 192 (335)
Q Consensus 162 ~~i~h~di~p~Nilv~~~~~-v~l~dfg~~~~ 192 (335)
..++|||++|.||+++.++. .-++||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0053 Score=55.07 Aligned_cols=140 Identities=12% Similarity=0.148 Sum_probs=78.5
Q ss_pred cceeeecCceEEEEEEEcC----CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCce-EEEeeeeecCCeeEEEEEecC
Q 019843 48 NNLIGRGSFGSVYKARIQD----GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNL-IKIISTCSNDDFKALVLEYMP 122 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~ 122 (335)
++.+..|-...+|+....+ +..|++|+....+.. .-.-.+|..+++.+...++ +++++++. ++ +|.+|++
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~ 93 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFIN 93 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhhc
Confidence 3445557777888886442 348999987655433 2334678888888854444 34555553 22 5888887
Q ss_pred CCChHH-------HH-------h---cCC----C-CCCHHHHHHHHHHH----------------------HHHHHH---
Q 019843 123 HGSLEK-------CL-------Y---SSN----C-VLDIFQRLNIMIDV----------------------AAALEY--- 155 (335)
Q Consensus 123 ~~~L~~-------~l-------~---~~~----~-~~~~~~~~~i~~~l----------------------~~~l~~--- 155 (335)
|.++.. .+ . ... . +..+..+..+..++ ..-+..
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 766522 01 0 101 0 11122222222211 111111
Q ss_pred Hhc--cCCCCeEecCCCCCCEEECC-CCcEEEeecccccc
Q 019843 156 LHF--GYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKL 192 (335)
Q Consensus 156 Lh~--~~~~~i~h~di~p~Nilv~~-~~~v~l~dfg~~~~ 192 (335)
+.. ....-++|+|+.+.||++++ ++.++++||+.+..
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 110 11224799999999999974 57899999998753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0082 Score=53.87 Aligned_cols=72 Identities=17% Similarity=0.200 Sum_probs=47.5
Q ss_pred eeeecCceEEEEEEEcCC-cEEEEEEeecC------C-CchhHHHHHHHHHHHhCC--CC-ceEEEeeeeecCCeeEEEE
Q 019843 50 LIGRGSFGSVYKARIQDG-MEVAVKVFHLQ------C-GGVFKSFDVECEVMKSIR--HR-NLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 50 ~lg~g~~~~v~~~~~~~~-~~v~iK~~~~~------~-~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~ 118 (335)
.||.|....||++...++ +.|+||.-... + +-...+..-|.+.|+... .| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 578999999999987644 58999975321 1 223456667888887763 34 34455533 444555899
Q ss_pred EecCC
Q 019843 119 EYMPH 123 (335)
Q Consensus 119 e~~~~ 123 (335)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0025 Score=59.00 Aligned_cols=164 Identities=18% Similarity=0.187 Sum_probs=93.8
Q ss_pred HHHHHHHHHHHhCCCCceEEEeeeeec-CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCC
Q 019843 84 KSFDVECEVMKSIRHRNLIKIISTCSN-DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162 (335)
Q Consensus 84 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~ 162 (335)
..+....++++.+.|+|...++++-.. .....+|+|++ +.|+.+.+..+. +...... -|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s~~------------~~----- 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDESLL------------AH----- 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhhhc------------cc-----
Confidence 556677889999999999999988764 34577899998 779999876554 2111111 12
Q ss_pred CeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCC
Q 019843 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKK 242 (335)
Q Consensus 163 ~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~ 242 (335)
++.| -|++ +..| -++.. . | ....+++|||++|.++.++..|.
T Consensus 87 ~~~~-----~~~~-------~~td-~~~t~---------~-----------~-----~~~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 87 GVLH-----LNII-------YITD-HFLTK---------Y-----------P-----SPIGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred ccce-----ehhh-------hccc-ccccc---------C-----------C-----CCCCcchhhhhHHHHHHHHHHhh
Confidence 2222 2222 2222 01110 0 0 01113999999999999999997
Q ss_pred CCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHH
Q 019843 243 KPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314 (335)
Q Consensus 243 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 314 (335)
..+......+.......-...+.....+.... .....+......+..+|+...|..||...++
T Consensus 129 ~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~---------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 129 SLEAELTESEYLEILLKYYTDDQELLSTAMEH---------LIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHHHHHHHHHHHHHHhccCchhHHHHHHHH---------HHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 76544332221111111111111111111111 2234556668899999999999988855544
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0022 Score=53.53 Aligned_cols=31 Identities=32% Similarity=0.488 Sum_probs=22.1
Q ss_pred CCeEecCCCCCCEEE-CCCCcEEEeecccccc
Q 019843 162 APVIHCDLKPSNVLL-DDNMVAHLSDFGIAKL 192 (335)
Q Consensus 162 ~~i~h~di~p~Nilv-~~~~~v~l~dfg~~~~ 192 (335)
..++|+|+.+.||++ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 468999999999999 8899999999998763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.025 Score=50.25 Aligned_cols=32 Identities=22% Similarity=0.309 Sum_probs=28.6
Q ss_pred CCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 161 ~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
..+++|||+.++|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999988763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.11 Score=46.48 Aligned_cols=94 Identities=10% Similarity=0.085 Sum_probs=58.7
Q ss_pred ccccCHHHHhhhcCCCCcc-----ceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCC--ceE
Q 019843 30 WRRFSYLELFQATDGFSEN-----NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHR--NLI 102 (335)
Q Consensus 30 ~~~~~~~~~~~~~~~y~~~-----~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~ 102 (335)
.+.++.+.+..+.+.+-+. ..| .+.-..||.....++..+++|+..... .....+..|++.+..+... .++
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l-~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~ 85 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLAL-NSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVV 85 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEee-ccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCC
Confidence 4666777777777666542 222 345577999987778889999876332 2346677788888777321 122
Q ss_pred EEe---e--eeecCCeeEEEEEecCCCC
Q 019843 103 KII---S--TCSNDDFKALVLEYMPHGS 125 (335)
Q Consensus 103 ~~~---~--~~~~~~~~~lv~e~~~~~~ 125 (335)
... | ....++..+.++++++|..
T Consensus 86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 86 APLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 211 1 1223567788999998764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.035 Score=49.28 Aligned_cols=30 Identities=27% Similarity=0.282 Sum_probs=26.1
Q ss_pred CCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 161 ~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
..+++|||++++||+++. +.+.++||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 468999999999999987 678999998765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.014 Score=48.32 Aligned_cols=102 Identities=15% Similarity=0.107 Sum_probs=64.8
Q ss_pred EEEEEEeec-CCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHH
Q 019843 69 EVAVKVFHL-QCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMI 147 (335)
Q Consensus 69 ~v~iK~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 147 (335)
+..+|++.. +..-.-..+.++++++.+++ .|+++..- +.-.+.++.|+|..... .... +..
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~~~N----~i~ 148 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------NFSN----FIT 148 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------chhH----HHH
Confidence 445555542 22213355677888887764 46666522 34466689998854222 1111 112
Q ss_pred HHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 148 ~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
.-+.+|..+| +.+.+.+|||-.|+||+.|.+|-+||.|=+.
T Consensus 149 agi~~L~~fH-~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 149 AGIKDLMDFH-SENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HhHHHHHHhh-ccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 2245677788 3378999999999999999999999998543
|
The function of this family is unknown. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.015 Score=52.92 Aligned_cols=74 Identities=16% Similarity=0.165 Sum_probs=50.0
Q ss_pred cceeeecCceEEEEEEEcC-CcEEEEEEeecC-----C-CchhHHHHHHHHHHHhCC--CC-ceEEEeeeeecCCeeEEE
Q 019843 48 NNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQ-----C-GGVFKSFDVECEVMKSIR--HR-NLIKIISTCSNDDFKALV 117 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~-----~-~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv 117 (335)
.+.||.|....||++...+ ++.|+||.-... + +-...+..-|.+.|+... .| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5788999999999998743 567999975321 1 223567777888888763 34 45555543 34445588
Q ss_pred EEecCC
Q 019843 118 LEYMPH 123 (335)
Q Consensus 118 ~e~~~~ 123 (335)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.023 Score=50.66 Aligned_cols=113 Identities=14% Similarity=0.129 Sum_probs=75.7
Q ss_pred cCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 110 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
...+.|++|++. |+++.. +. .....++..++.+.+..+.-+.. +-.+-|+|+...||+++ +|.|.|+||.+
T Consensus 297 e~~y~yl~~kdh-gt~is~-ik----~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI-IK----ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred CceEEEEEEecC-Cceeee-ee----cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeee
Confidence 345667888876 666653 21 34577888888888887777774 56889999999999999 99999999999
Q ss_pred cccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCC
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKK 242 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~ 242 (335)
++.-. .+..+.....-.|-.+.|. -+..-+||-+.-. |+.|+
T Consensus 368 sRl~~-------~q~~isy~rldhp~lF~G~-dd~QFeIYrlMr~---l~~g~ 409 (488)
T COG5072 368 SRLSY-------SQGIISYNRLDHPDLFNGV-DDYQFEIYRLMRR---LLKGR 409 (488)
T ss_pred eeccc-------CCceeeccccCchhhhcCc-cceeeeHHHHHHH---HhcCc
Confidence 88432 1112222233445555543 3667788865443 44454
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.059 Score=49.30 Aligned_cols=76 Identities=21% Similarity=0.291 Sum_probs=46.5
Q ss_pred ccceeeecCceEEEEEEEcCC--c-----EEEEEEeecCCCchhHHHHHHHHHHHhCCCCc-eEEEeeeeecCCeeEEEE
Q 019843 47 ENNLIGRGSFGSVYKARIQDG--M-----EVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN-LIKIISTCSNDDFKALVL 118 (335)
Q Consensus 47 ~~~~lg~g~~~~v~~~~~~~~--~-----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 118 (335)
..+.+..|-...+|++...++ . .|++++... .....-.-..|+++++.+...+ -+++++.+.. +++.
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ 128 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ 128 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence 345565688889999865432 2 244444322 2222233466899999986444 4456666653 5899
Q ss_pred EecCCCChH
Q 019843 119 EYMPHGSLE 127 (335)
Q Consensus 119 e~~~~~~L~ 127 (335)
||++|.++.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999887664
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.074 Score=55.00 Aligned_cols=140 Identities=21% Similarity=0.242 Sum_probs=78.6
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-------CCCceEEEe-e----eeec-CC--e
Q 019843 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-------RHRNLIKII-S----TCSN-DD--F 113 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~-~----~~~~-~~--~ 113 (335)
+.|+ |..-.+|+....+|..+++|+.+.... ......|.+.+..+ .-|.+++-. + .... .+ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 5564 556888999877788999999875432 23444455566544 223333321 1 1111 22 4
Q ss_pred eEEEEEecCCCChHHHH-----------------hc------CC---CCCCHH-----------------HHHHHHHHHH
Q 019843 114 KALVLEYMPHGSLEKCL-----------------YS------SN---CVLDIF-----------------QRLNIMIDVA 150 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l-----------------~~------~~---~~~~~~-----------------~~~~i~~~l~ 150 (335)
.+.+++|++|..+.+.. .. .+ ..+.|. ....++..++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 66789999997775510 00 00 001110 1112222222
Q ss_pred HHHH-----HHhccCCCCeEecCCCCCCEEECCCC--cEE-Eeecccccc
Q 019843 151 AALE-----YLHFGYSAPVIHCDLKPSNVLLDDNM--VAH-LSDFGIAKL 192 (335)
Q Consensus 151 ~~l~-----~Lh~~~~~~i~h~di~p~Nilv~~~~--~v~-l~dfg~~~~ 192 (335)
.... .+. ....+++|+|+++.||+++.++ ++. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 121 2246799999999999999775 555 999998764
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.026 Score=48.34 Aligned_cols=79 Identities=19% Similarity=0.213 Sum_probs=53.8
Q ss_pred cceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec-CCCCh
Q 019843 48 NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM-PHGSL 126 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~L 126 (335)
...+..|..+.|+.+...+|.+.++|+........ .+.. ....|+..+-...+++++.-... -.+++|.+ ++.+|
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~-~E~~-g~~~L~~w~G~GaVrll~~d~~~--~AlLLErl~~g~~L 82 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE-HEAR-GEAALRWWNGRGAVRLLAADPER--GALLLERLDPGRSL 82 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch-hhhh-HHhHhheeCCCCceeeecccccc--chhhhhhccCCCch
Confidence 34566799999999998889999999976442211 1111 12457777878888998776444 34788888 45577
Q ss_pred HHHH
Q 019843 127 EKCL 130 (335)
Q Consensus 127 ~~~l 130 (335)
.++.
T Consensus 83 ~~~~ 86 (253)
T PF04655_consen 83 ASLP 86 (253)
T ss_pred hhcc
Confidence 6554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.11 Score=43.40 Aligned_cols=75 Identities=23% Similarity=0.370 Sum_probs=53.0
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhC---CCCceEEEeeeeecCCeeEEEEEecCCCC
Q 019843 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI---RHRNLIKIISTCSNDDFKALVLEYMPHGS 125 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 125 (335)
+.+..|..-..|...+. ..++.+|+-. .+....|..|+.-|+.+ +.-.+.+++.+....++.|+|++|++.+.
T Consensus 22 ~~v~gG~inea~~v~dg-~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRDG-TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeecC-CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 44555555555555544 5778888743 33446677777777666 44678889999999999999999998866
Q ss_pred hH
Q 019843 126 LE 127 (335)
Q Consensus 126 L~ 127 (335)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 65
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.023 Score=51.45 Aligned_cols=58 Identities=22% Similarity=0.155 Sum_probs=43.0
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD 177 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~ 177 (335)
++-+|..|.++..++.... .++.....++.-..+|+-.+-. -.+++|.|++|.||++.
T Consensus 322 l~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 322 LVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence 5556778889998887654 4555666677766777555442 67999999999999994
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.1 Score=46.54 Aligned_cols=154 Identities=21% Similarity=0.247 Sum_probs=85.6
Q ss_pred CHHHHhhhcCCCCcc-----ceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCC---Cc---eE
Q 019843 34 SYLELFQATDGFSEN-----NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRH---RN---LI 102 (335)
Q Consensus 34 ~~~~~~~~~~~y~~~-----~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h---~~---i~ 102 (335)
...+...+...|.+. ..|.. .-..+|+....+|+. ++|+.... .....+..|...+..+.- +- +.
T Consensus 12 ~~~~~~~~l~~~~~g~~~~~~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~ 87 (331)
T COG2334 12 TSDEAAAALEAYHYGLDGSLRGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLP 87 (331)
T ss_pred ChHHHHHHHHhcCcCcccccccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCcc
Confidence 334444444444432 33444 556799998776666 88987765 344677778888887731 11 22
Q ss_pred EEeeee--ecCC--eeEEEEEecCCCChHH-H-----------H---hc--------CCC---CCCHH----HH------
Q 019843 103 KIISTC--SNDD--FKALVLEYMPHGSLEK-C-----------L---YS--------SNC---VLDIF----QR------ 142 (335)
Q Consensus 103 ~~~~~~--~~~~--~~~lv~e~~~~~~L~~-~-----------l---~~--------~~~---~~~~~----~~------ 142 (335)
..=|-. .-.. ..+.+++|++|..+.. . + .. ++. ...+. ..
T Consensus 88 ~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~ 167 (331)
T COG2334 88 SLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDL 167 (331)
T ss_pred CCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcc
Confidence 211111 1233 7788999999987772 1 1 00 000 01111 00
Q ss_pred ---HHHHHHHHHHHHHHh----ccC-CCC--eEecCCCCCCEEECCCCc-EEEeeccccc
Q 019843 143 ---LNIMIDVAAALEYLH----FGY-SAP--VIHCDLKPSNVLLDDNMV-AHLSDFGIAK 191 (335)
Q Consensus 143 ---~~i~~~l~~~l~~Lh----~~~-~~~--i~h~di~p~Nilv~~~~~-v~l~dfg~~~ 191 (335)
.....++...+..+. ... ..+ ++|+|+.|.||+++.+.. +-++||+-+.
T Consensus 168 ~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 168 VEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 001222222233332 111 233 999999999999998874 8899999775
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 335 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-32 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-22 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-13 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 9e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 4e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 9e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 9e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 2e-85
Identities = 96/304 (31%), Positives = 156/304 (51%), Gaps = 17/304 (5%)
Query: 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVEC 90
R ++L +AT+ F LIG G FG VYK ++DG +VA+K + + F+ E
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 91 EVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSN---CVLDIFQRLNIMI 147
E + RH +L+ +I C + L+ +YM +G+L++ LY S+ + QRL I I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
A L YLH +IH D+K N+LLD+N V ++DFGI+K T DQ+ T
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIF-AGEMTLKYWVSNLLPIS 266
T+GY+ PEY +GR++ DVYSFG++L E + + + L W
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 267 -VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL---LKIR 322
+ +IVD NL + K + A++C S+E R + +++ +L L+++
Sbjct: 264 QLEQIVDPNLADKIRPESLRK------FGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
Query: 323 DSLL 326
+S++
Sbjct: 318 ESVI 321
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 3e-84
Identities = 100/297 (33%), Positives = 143/297 (48%), Gaps = 15/297 (5%)
Query: 30 WRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCG-GVFKSFDV 88
+RFS EL A+D FS N++GRG FG VYK R+ DG VAVK + G F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 89 ECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLY---SSNCVLDIFQRLNI 145
E E++ HRNL+++ C + LV YM +GS+ CL S LD +R I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 146 MIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQT 205
+ A L YLH +IH D+K +N+LLD+ A + DFG+AKL+ + T
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAV 195
Query: 206 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKY---WVSNL 262
TIG++APEY G+ S DV+ +G+ML+E T ++ D WV L
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 263 LPI-SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
L + +VD +L + + +A+ CT S +R E+V L
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQ------LIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-75
Identities = 88/310 (28%), Positives = 138/310 (44%), Gaps = 31/310 (10%)
Query: 31 RRFSYLELFQATDGFSE------NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFK 84
FS+ EL T+ F E N +G G FG VYK + + VAVK L
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK--LAAMVDIT 69
Query: 85 S------FDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLY--SSNCV 136
+ FD E +VM +H NL++++ S+ D LV YMP+GSL L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 137 LDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196
L R I A + +LH IH D+K +N+LLD+ A +SDFG+A+
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK 256
Q+ ++ + T YMAPE R G ++ D+YSFG++L+E T D+ L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLL 244
Query: 257 YWVSNLL--PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
+ ++ + +D + D + E ++A +C E +R + K++
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMY----SVASQCLHEKKNKRPDIKKV 297
Query: 315 VTRLLKIRDS 324
L ++ S
Sbjct: 298 QQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-66
Identities = 70/310 (22%), Positives = 126/310 (40%), Gaps = 28/310 (9%)
Query: 33 FSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEV 92
L+ + + RG FG V+KA++ VAVK+F +Q +S+ E EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD---KQSWQNEYEV 69
Query: 93 --MKSIRHRNLIKIISTCSNDDFKA----LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIM 146
+ ++H N+++ I L+ + GSL L ++ V+ + +I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIA 127
Query: 147 IDVAAALEYLH-------FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199
+A L YLH G+ + H D+K NVLL +N+ A ++DFG+A +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 200 KSQTQTLATIGYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTKKKPTDKIFAGEMT 254
+ T YMAPE D+Y+ G++L E ++ D M
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 255 LKYWVSNLLPISVMEIVDANLLSREDKHFAA---KEQCVSFVFNLAMECTVESAEQRINA 311
P S+ ++ + + ++ K ++ + EC AE R++A
Sbjct: 248 PFEEEIGQHP-SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 312 KEIVTRLLKI 321
+ R+ ++
Sbjct: 307 GCVGERITQM 316
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-58
Identities = 68/289 (23%), Positives = 119/289 (41%), Gaps = 46/289 (15%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGG-------VFKSFDVECEVMKSIRHRNLI 102
IG+G FG V+K R ++D VA+K L F+ F E +M ++ H N++
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
K+ N +V+E++P G L L + +L +M+D+A +EY+ +
Sbjct: 87 KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 163 PVIHCDLKPSNVLLD-----DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE-- 215
P++H DL+ N+ L + A ++DFG+++ S + L +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETI 198
Query: 216 YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL---LPISVMEIVD 272
E + D YSF ++L T + P D+ G++ + I
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP------ 252
Query: 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
E C + N+ C ++R + IV L ++
Sbjct: 253 --------------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 4e-58
Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 27/280 (9%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTC 108
IG GSFG+V++A G +VAVK+ Q F E +MK +RH N++ +
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNC--VLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
+ ++V EY+ GSL + L+ S LD +RL++ DVA + YLH + P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG 226
+LK N+L+D + DFG+++L S T +MAPE R+ +
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 227 DVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286
DVYSFG++L E T ++P + NL P V+ V + K
Sbjct: 221 DVYSFGVILWELATLQQP------------W--GNLNPAQVVAAV-----GFKCKRLEIP 261
Query: 287 EQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326
V + C +R + I+ L + S +
Sbjct: 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-57
Identities = 78/324 (24%), Positives = 123/324 (37%), Gaps = 37/324 (11%)
Query: 33 FSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEV 92
+ E D LIGRG +G+VYK + D VAVKVF ++F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNI 58
Query: 93 MK--SIRHRNLIKIISTCSNDDFKA-----LVLEYMPHGSLEKCLYSSNCVLDIFQRLNI 145
+ + H N+ + I LV+EY P+GSL K L D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRL 116
Query: 146 MIDVAAALEYLH------FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199
V L YLH Y + H DL NVL+ ++ +SDFG++ LTG
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 200 KSQTQTLA------TIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFTKKK--- 243
+ + A TI YMAPE D+Y+ G++ E F +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 244 PTDKIFAGEMTLKYWVSNLLPISVME--IVDANLLSREDKHFAAKEQCVSFVFNLAMECT 301
P + + +M + V N M+ + + + + V + +C
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 302 VESAEQRINAKEIVTRLLKIRDSL 325
+ AE R+ A+ R+ ++
Sbjct: 297 DQDAEARLTAQXAEERMAELMMIW 320
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-56
Identities = 74/280 (26%), Positives = 115/280 (41%), Gaps = 35/280 (12%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110
+GRG+FG V KA +VA+K + K+F VE + + H N++K+ C N
Sbjct: 16 VGRGAFGVVCKA-KWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 111 DDFKALVLEYMPHGSLEKCLYSSN--CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
LV+EY GSL L+ + ++ + + + YLH +IH D
Sbjct: 73 P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 169 LKPSNVLLDDNM-VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGD 227
LKP N+LL V + DFG A D T + +MAPE S D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 228 VYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSN--LLPISVMEIVDANLLSREDKHFAA 285
V+S+GI+L E T++KP D+I + + V N P+
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI------------------- 226
Query: 286 KEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ + +L C + QR + +EIV + +
Sbjct: 227 -KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 4e-56
Identities = 64/281 (22%), Positives = 115/281 (40%), Gaps = 36/281 (12%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTC 108
+ G ++K R Q G ++ VKV ++ + F+ EC ++ H N++ ++ C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 109 SN--DDFKALVLEYMPHGSLEKCLYSSNC-VLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
+ L+ +MP+GSL L+ V+D Q + +D+A + +LH +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTN 225
L +V++D++M A +S + S + ++APE ++ TN
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 226 G---DVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKH 282
D++SF ++L E T++ P FA +S MEI ++ E
Sbjct: 189 RRSADMWSFAVLLWELVTREVP----FAD-------------LSNMEIGMK--VALEGLR 229
Query: 283 FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323
V L C E +R IV L K++D
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 6e-56
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTC 108
IG GSFG+VYK + +VAVK+ ++ ++F E V++ RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ A+V ++ SL L++S ++ + ++I A ++YLH + +IH D
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE---YGREGRVSTN 225
LK +N+ L ++ + DFG+A + S Q +I +MAPE S
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 226 GDVYSFGIMLMETFTKKKP 244
DVY+FGI+L E T + P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-54
Identities = 55/287 (19%), Positives = 114/287 (39%), Gaps = 39/287 (13%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIIS 106
LIG+G FG VY R EVA+++ ++ K+F E + RH N++ +
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
C + A++ +L + + VLD+ + I ++ + YLH + ++H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA---TIGYMAPEYGREGRVS 223
DLK NV D+ V ++DFG+ + + + + + ++APE R+
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 224 TNG---------DVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274
T DV++ G + E ++ P + +++ +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP------------F--KTQPAEAIIWQMGTG 258
Query: 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
+ K ++ + ++ + C E+R +++ L K+
Sbjct: 259 M-----KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-53
Identities = 66/297 (22%), Positives = 113/297 (38%), Gaps = 26/297 (8%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEV--MKSIRHRNLIKIIS 106
IG+G +G V+ + + G +VAVKVF S+ E E+ +RH N++ I+
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98
Query: 107 TCSNDDFK----ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH----- 157
L+ +Y +GSL L S+ LD L + + L +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA--TIGYMAPE 215
+ H DLK N+L+ N ++D G+A + T YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 216 ------YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269
+ D+YSFG++L E + + ++ V + M
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 270 IVDANLLSR-EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ R + + ++C+ + L EC + R+ A + L K+ +S
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 7e-53
Identities = 65/288 (22%), Positives = 113/288 (39%), Gaps = 34/288 (11%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
+G+G FG K + G + +K ++F E +VM+ + H N++K I
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169
D + EY+ G+L + S + QR++ D+A+ + YLH S +IH DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 170 KPSNVLLDDNMVAHLSDFGIAKLLTGED------------QSKSQTQTLATIGYMAPEYG 217
N L+ +N ++DFG+A+L+ E K + + +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 218 REGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277
DV+SFGI+L E + + LP ++ ++
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADP--------------DYLPRTMDFGLNVRGFL 240
Query: 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
C F + + C E+R + ++ L +R L
Sbjct: 241 DRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-52
Identities = 68/286 (23%), Positives = 112/286 (39%), Gaps = 44/286 (15%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQC----GGVFKSFDVECEVMKSIRHRNLIKIIS 106
IG G FG VY+A G EVAVK ++ E ++ ++H N+I +
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
C + LV+E+ G L + L + +N + +A + YLH P+IH
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 167 CDLKPSNVLLD--------DNMVAHLSDFGIAKLLTGEDQSKSQTQTLA---TIGYMAPE 215
DLK SN+L+ N + ++DFG+A+ +T ++ +MAPE
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLARE-------WHRTTKMSAAGAYAWMAPE 184
Query: 216 YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275
R S DV+S+G++L E T + P + + ++V V
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP------------F--RGIDGLAVAYGV---- 226
Query: 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
+ C L +C R + I+ +L I
Sbjct: 227 -AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-52
Identities = 68/293 (23%), Positives = 113/293 (38%), Gaps = 26/293 (8%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEV--MKSIRHRNLIKIIS 106
+G+G +G V++ Q G VAVK+F + KS+ E E+ +RH N++ I+
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIA 69
Query: 107 TCSNDDFKA----LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH----- 157
+ + L+ Y GSL L LD L I++ +A+ L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA--TIGYMAPE 215
+ H DLK N+L+ N ++D G+A + + T YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 216 ------YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269
D+++FG++L E + + + V N M
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 270 IVDANLLSR-EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
V R + + ++ + L EC ++ R+ A I L KI
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 1e-47
Identities = 63/296 (21%), Positives = 113/296 (38%), Gaps = 26/296 (8%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEV--MKSIRHRNLIKIIS 106
IG+G FG V++ + + G EVAVK+F + +S+ E E+ +RH N++ I+
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103
Query: 107 TCSNDDFKA----LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH----- 157
+ D+ LV +Y HGSL L + + + + + A+ L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA--TIGYMAPE 215
+ H DLK N+L+ N ++D G+A + T YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 216 ------YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269
+ D+Y+ G++ E + ++ V + + M
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 270 IVDANLLSR-EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
V R + + + + + EC + R+ A I L ++
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-40
Identities = 81/276 (29%), Positives = 118/276 (42%), Gaps = 28/276 (10%)
Query: 51 IGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKIISTC 108
IGRG+FG V+ R++ D VAVK K+ F E ++K H N++++I C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ +V+E + G L + L + L ++ D AA +EYL S IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
L N L+ + V +SDFG+++ + S + + APE GR S+ DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 229 YSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSREDKHFAAK 286
+SFGI+L ETF+ P Y +SN E V+ R
Sbjct: 299 WSFGILLWETFSLGASP------------YPNLSNQ---QTREFVEKGG--RLPCP---- 337
Query: 287 EQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322
E C VF L +C QR + I L IR
Sbjct: 338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 74/287 (25%), Positives = 133/287 (46%), Gaps = 23/287 (8%)
Query: 51 IGRGSFGSVYKARI-----QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKII 105
+G+G+FGSV R G VAVK + F+ E E++KS++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 106 STCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
C + + L++EY+P+GSL L +D + L + +EYL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSKSQTQTLATIGYMAPEYGREGRV 222
IH DL N+L+++ + DFG+ K+L ++ K + + I + APE E +
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225
Query: 223 STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK----YWVSNLLPISVMEIVDANLLSR 278
S DV+SFG++L E FT + + A M + + V +++ L +
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-----QMIVFHLIE---LLK 277
Query: 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ + C ++ + EC + QR + +++ R+ +IRD +
Sbjct: 278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-40
Identities = 74/287 (25%), Positives = 134/287 (46%), Gaps = 23/287 (8%)
Query: 51 IGRGSFGSVYKARI-----QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKII 105
+G+G+FGSV R G VAVK + F+ E E++KS++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 106 STCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
C + + L++EY+P+GSL L +D + L + +EYL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSKSQTQTLATIGYMAPEYGREGRV 222
IH DL N+L+++ + DFG+ K+L ++ K + + I + APE E +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 223 STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK----YWVSNLLPISVMEIVDANLLSR 278
S DV+SFG++L E FT + + A M + + V +++ L +
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-----QMIVFHLIE---LLK 246
Query: 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ + C ++ + EC + QR + +++ R+ +IRD++
Sbjct: 247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-40
Identities = 75/282 (26%), Positives = 120/282 (42%), Gaps = 36/282 (12%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKIISTCS 109
IG G FG V+ + +VA+K ++ G + + F E EVM + H L+++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGYSAPVIH 166
LV E+M HG L L + + L + +DV + YL IH
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IH 127
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG 226
DL N L+ +N V +SDFG+ + + +DQ S T T + + +PE R S+
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 227 DVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSREDKHFA 284
DV+SFG+++ E F++ K P Y SN V+E +
Sbjct: 187 DVWSFGVLMWEVFSEGKIP------------YENRSNS---EVVEDIS------TGFRLY 225
Query: 285 AKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326
+ V+ + C E E R ++ +L +I +S L
Sbjct: 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-39
Identities = 64/283 (22%), Positives = 121/283 (42%), Gaps = 23/283 (8%)
Query: 51 IGRGSFGSVYKAR-----IQDGMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKI 104
+G G FG V R G +VAVK + GG E E+++++ H N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 105 ISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
C+ D L++E++P GSL++ L + +++ Q+L + + ++YL S
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSKSQTQTLATIGYMAPEYGREGR 221
+H DL NVL++ + DFG+ K + T ++ + + + + APE + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 222 VSTNGDVYSFGIMLMETFT---KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278
DV+SFG+ L E T +F + + ++V +V+ +
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ-----MTVTRLVN---TLK 257
Query: 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
E K C V+ L +C R + + ++ +
Sbjct: 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-39
Identities = 67/286 (23%), Positives = 122/286 (42%), Gaps = 25/286 (8%)
Query: 51 IGRGSFGSVYKARIQD-----GMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKI 104
+G G FG V G VAVK G + E ++++++ H ++IK
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 105 ISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
C + + LV+EY+P GSL L + + + Q L + + YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSKSQTQTLATIGYMAPEYGREGR 221
IH DL NVLLD++ + + DFG+AK + G + + + + + + APE +E +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213
Query: 222 VSTNGDVYSFGIMLMETFT---KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278
DV+SFG+ L E T + F + + ++V+ + + L
Sbjct: 214 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ-----MTVLRLTE---LLE 265
Query: 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
+ ++C + V++L C A R + ++ L + +
Sbjct: 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-39
Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 32/278 (11%)
Query: 49 NLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKIIS 106
+ +G G +G VY+ + + VAVK L+ + F E VMK I+H NL++++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
C+ + ++ E+M +G+L L N + L + +++A+EYL I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 340
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTN 225
H +L N L+ +N + ++DFG+++L+T D + I + APE + S
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 226 GDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSREDKHF 283
DV++FG++L E T P Y + V E+++ +D
Sbjct: 400 SDVWAFGVLLWEIATYGMSP------------YPGIDL---SQVYELLE------KDYRM 438
Query: 284 AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
E C V+ L C + R + EI +
Sbjct: 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 64/280 (22%), Positives = 121/280 (43%), Gaps = 36/280 (12%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKIISTCS 109
+G G FG V + + +VA+K+ ++ G + + F E +VM ++ H L+++ C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGYSAPVIH 166
++ EYM +G L L Q L + DV A+EYL F +H
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LH 143
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG 226
DL N L++D V +SDFG+++ + +D+ S + + + PE + S+
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 227 DVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSREDKHFA 284
D+++FG+++ E ++ K P Y +N E + +
Sbjct: 203 DIWAFGVLMWEIYSLGKMP------------YERFTNS---ETAEHIA------QGLRLY 241
Query: 285 AKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
V+ + C E A++R K +++ +L + D
Sbjct: 242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 64/242 (26%), Positives = 113/242 (46%), Gaps = 16/242 (6%)
Query: 7 LISRYRKRGKQL------PNDANMPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVY 60
L++ Y K L + P + ++ E+ + + +G+G FG V+
Sbjct: 228 LVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAW-EIPR--ESLRLEVKLGQGCFGEVW 284
Query: 61 KARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120
VA+K ++F E +VMK +RH L+++ + S + +V EY
Sbjct: 285 MGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEY 342
Query: 121 MPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN 179
M GSL L L + Q +++ +A+ + Y+ +H DL+ +N+L+ +N
Sbjct: 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGEN 399
Query: 180 MVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF 239
+V ++DFG+A+L+ + + Q I + APE GR + DV+SFGI+L E
Sbjct: 400 LVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
Query: 240 TK 241
TK
Sbjct: 459 TK 460
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-38
Identities = 68/289 (23%), Positives = 108/289 (37%), Gaps = 40/289 (13%)
Query: 51 IGRGSFGSVYKAR----IQDGMEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIK 103
+G GSFG V + + VAVK L F E M S+ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGY 160
+ K +V E P GSL L + + VA + YL F
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSKSQTQTLATIGYMAPEYGRE 219
IH DL N+LL + + DFG+ + L +D Q + APE +
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 220 GRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLS 277
S D + FG+ L E FT ++P + ++ +I+ +
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP------------WIGLNG------SQILHK--ID 238
Query: 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326
+E + E C ++N+ ++C E R + LL+ + + +
Sbjct: 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-38
Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 40/290 (13%)
Query: 49 NLIGRGSFGSVYKARIQDG----MEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIK 103
+IGRG FG VY + D + AVK + G F E +MK H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 104 IISTCSNDDFKAL-VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFG 159
++ C + L VL YM HG L + + + + + VA ++YL F
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT--IGYMAPEYG 217
+H DL N +LD+ ++DFG+A+ + ++ +T A + +MA E
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 218 REGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANL 275
+ + +T DV+SFG++L E T+ P Y V+ + +
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPP------------YPDVNT---FDITVYL---- 245
Query: 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ + E C ++ + ++C AE R + E+V+R+ I +
Sbjct: 246 --LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 18/283 (6%)
Query: 51 IGRGSFGSVYKARI-----QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKII 105
+G+G+FGSV R G VAVK + F E +++K++ ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 106 STCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
++ LV+EY+P G L L LD + L + +EYL S
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSKSQTQTLATIGYMAPEYGREGRV 222
+H DL N+L++ ++DFG+AKLL +D + + I + APE +
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 223 STNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281
S DV+SFG++L E FT K + ++E++ E +
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL------EEGQ 261
Query: 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
A C + V L C S + R + + +L +
Sbjct: 262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-38
Identities = 65/297 (21%), Positives = 121/297 (40%), Gaps = 50/297 (16%)
Query: 51 IGRGSFGSVYKARIQDG----MEVAVKVFHLQCGGV--FKSFDVECEVMKSIRHRNLIKI 104
+G G FGSV + ++ ++VAVK L + F E MK H N+I++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 105 ISTCSNDDFKA-----LVLEYMPHGSL-----EKCLYSSNCVLDIFQRLNIMIDVAAALE 154
+ C + ++L +M +G L L + + + L M+D+A +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 155 YL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY 211
YL +F +H DL N +L D+M ++DFG++K + D + + +
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 212 MAPEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVME 269
+A E + ++ DV++FG+ + E T+ P Y V N + +
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP------------YPGVQNH---EMYD 260
Query: 270 IVDA-NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ + L + E C+ ++ + C R + +L K+ +SL
Sbjct: 261 YLLHGHRLKQ-------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 81/280 (28%), Positives = 124/280 (44%), Gaps = 36/280 (12%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110
IG+G FG V + G +VAVK ++ ++F E VM +RH NL++++
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 111 DDFKA-LVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ +V EYM GSL L S VL L +DV A+EYL +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
L NVL+ ++ VA +SDFG+ K + S +Q + + APE RE + ST DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 229 YSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSREDKHFAAK 286
+SFGI+L E ++ + P Y + V+ V+ + A
Sbjct: 370 WSFGILLWEIYSFGRVP------------YPRIPL---KDVVPRVE------KGYKMDAP 408
Query: 287 EQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326
+ C V+++ C A R ++ +L IR L
Sbjct: 409 DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
+G+G FG V+ VA+K ++F E +VMK +RH L+++ +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
S + +V EYM GSL L L + Q +++ +A+ + Y+ +H
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGD 227
DL+ +N+L+ +N+V ++DFG+A+L+ + + Q I + APE GR + D
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSD 363
Query: 228 VYSFGIMLMETFTK 241
V+SFGI+L E TK
Sbjct: 364 VWSFGILLTELTTK 377
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-38
Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 36/279 (12%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKIISTCS 109
+G G FG V + + +VAVK+ ++ G + + F E + M + H L+K CS
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKM--IKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGYSAPVIH 166
+ +V EY+ +G L L S L+ Q L + DV + +L F IH
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IH 127
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG 226
DL N L+D ++ +SDFG+ + + +DQ S T + + APE + S+
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 227 DVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSREDKHFA 284
DV++FGI++ E F+ K P Y +N V+ V +
Sbjct: 187 DVWAFGILMWEVFSLGKMP------------YDLYTNS---EVVLKVS------QGHRLY 225
Query: 285 AKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323
++ + C E E+R +++++ + +R+
Sbjct: 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 9e-38
Identities = 66/276 (23%), Positives = 120/276 (43%), Gaps = 30/276 (10%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
+G G FG V+ A +VAVK ++F E VMK+++H L+K+ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
+ + ++ E+M GSL L S + + ++ +A + ++ IH
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308
Query: 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGD 227
DL+ +N+L+ ++V ++DFG+A+++ + + + I + APE G + D
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSD 367
Query: 228 VYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSREDKHFAA 285
V+SFGI+LME T + P Y +SN V+ ++
Sbjct: 368 VWSFGILLMEIVTYGRIP------------YPGMSN---PEVIRALE------RGYRMPR 406
Query: 286 KEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
E C ++N+ M C E+R + I + L
Sbjct: 407 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-38
Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 17/204 (8%)
Query: 51 IGRGSFGSVYKARIQDGME-----VAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKI 104
+G G+FG+VYK E VA+K K E VM S+ + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGYS 161
+ C + L+ + MP G L + + LN + +A + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGR 221
+H DL NVL+ ++DFG+AKLL E++ I +MA E
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 222 VSTNGDVYSFGIMLMETFTK-KKP 244
+ DV+S+G+ + E T KP
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 61/278 (21%), Positives = 97/278 (34%), Gaps = 38/278 (13%)
Query: 49 NLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIIST 107
+GRGSFG V++ + Q G + AVK L+ E + ++ +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGA 118
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
+ + +E + GSL + + C L + L + LEYLH + ++H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLH---TRRILHG 174
Query: 168 DLKPSNVLLDDN-MVAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPEYGREGRVS 223
D+K NVLL + A L DFG A L + KS G +MAPE
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 224 TNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM-EIVDANLLSREDKH 282
D++S M++ P W + + +I RE
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHP-------------W-TQYFRGPLCLKIASEPPPIREIPP 280
Query: 283 FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320
A + E + R +A E L +
Sbjct: 281 SCAPL-TAQAI----QEGLRKEPVHRASAME----LRR 309
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 65/287 (22%), Positives = 122/287 (42%), Gaps = 42/287 (14%)
Query: 51 IGRGSFGSVYKARIQDG---MEVAVKVFHLQCGGVFKS---FDVECEVMKSIRHRNLIKI 104
+G G+FGSV + + ++VA+KV L+ G E ++M + + ++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGYS 161
I C + LV+E G L K L + + ++ V+ ++YL +F
Sbjct: 76 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 131
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS-KSQTQTLATIGYMAPEYGREG 220
+H DL NVLL + A +SDFG++K L +D +++ + + APE
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 221 RVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSR 278
+ S+ DV+S+G+ + E + +KP Y + VM ++
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKP------------YKKMKGP---EVMAFIE------ 227
Query: 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ K +C ++ L +C + E R + + R+ SL
Sbjct: 228 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-37
Identities = 66/298 (22%), Positives = 125/298 (41%), Gaps = 51/298 (17%)
Query: 51 IGRGSFGSVYKARIQDG----MEVAVKVFHLQCGGV--FKSFDVECEVMKSIRHRNLIKI 104
+G+G FGSV +A+++ ++VAVK+ + F E MK H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 105 ISTCSNDDFKA------LVLEYMPHGSLEKCLYSS-----NCVLDIFQRLNIMIDVAAAL 153
+ K ++L +M HG L L +S L + + M+D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 154 EYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG 210
EYL +F IH DL N +L ++M ++DFG+++ + D + + +
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 211 YMAPEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVM 268
++A E + + + DV++FG+ + E T+ + P Y + N +
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP------------YAGIEN---AEIY 249
Query: 269 EIVDA-NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ N L + +C+ V++L +C +QR + + L I L
Sbjct: 250 NYLIGGNRLKQ-------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 60/292 (20%), Positives = 117/292 (40%), Gaps = 40/292 (13%)
Query: 47 ENNLIGRGSFGSVYKARIQDG----MEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNL 101
+ +IG+G FG VY D ++ A+K ++F E +M+ + H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 102 IKIISTCSNDD-FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---H 157
+ +I + ++L YM HG L + + S + ++ + VA +EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED--QSKSQTQTLATIGYMAPE 215
F +H DL N +LD++ ++DFG+A+ + + + + + A E
Sbjct: 145 F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 216 YGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDA 273
+ R +T DV+SFG++L E T+ P Y + + +
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP------------YRHIDP---FDLTHFL-- 241
Query: 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ + E C ++ + +C R + +V + +I +L
Sbjct: 242 ----AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-37
Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 51 IGRGSFGSVYKARIQDGME-----VAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKI 104
+G G FG+V+K E V +KV + G F++ + S+ H +++++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGYS 161
+ C + LV +Y+P GSL + L LN + +A + YL
Sbjct: 81 LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM--- 136
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGR 221
+H +L NVLL ++DFG+A LL +D+ ++ I +MA E G+
Sbjct: 137 ---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 222 VSTNGDVYSFGIMLMETFT 240
+ DV+S+G+ + E T
Sbjct: 194 YTHQSDVWSYGVTVWELMT 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 40/290 (13%)
Query: 49 NLIGRGSFGSVYKARIQDG----MEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIK 103
+IGRG FG VY + D + AVK + G F E +MK H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 104 IISTCSNDDFKAL-VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFG 159
++ C + L VL YM HG L + + + + + VA +++L F
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT--IGYMAPEYG 217
+H DL N +LD+ ++DFG+A+ + ++ +T A + +MA E
Sbjct: 214 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 218 REGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANL 275
+ + +T DV+SFG++L E T+ P Y V+ + +
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPP------------YPDVNT---FDITVYL---- 309
Query: 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ + E C ++ + ++C AE R + E+V+R+ I +
Sbjct: 310 --LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-37
Identities = 79/280 (28%), Positives = 123/280 (43%), Gaps = 36/280 (12%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
IG+G FG V + G +VAVK ++ ++F E VM +RH NL++++
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 109 SNDDFKA-LVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
+ +V EYM GSL L S VL L +DV A+EYL +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG 226
DL NVL+ ++ VA +SDFG+ K + S +Q + + APE RE + ST
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 227 DVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSREDKHFA 284
DV+SFGI+L E ++ + P Y + V+ V+ +
Sbjct: 196 DVWSFGILLWEIYSFGRVP------------YPRIPLK---DVVPRVE------KGYKMD 234
Query: 285 AKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
A + C V+ + C A R + ++ +L I+
Sbjct: 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 9/193 (4%)
Query: 51 IGRGSFGSVYKARIQDG-MEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKIISTC 108
+G G +G VY+ + + VAVK L+ + F E VMK I+H NL++++ C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
+ + ++ E+M +G+L L N + L + +++A+EYL IH
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135
Query: 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGD 227
DL N L+ +N + ++DFG+++L+T D + I + APE + S D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 228 VYSFGIMLMETFT 240
V++FG++L E T
Sbjct: 195 VWAFGVLLWEIAT 207
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 49/210 (23%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 45 FSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMK-SIRHRNLIK 103
F +++G G+ G++ + D +VAVK +C F D E ++++ S H N+I+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
T + F+ + +E +L++ + + + + ++ + L +LH S
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 164 VIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYMAPEY- 216
++H DLKP N+L+ + A +SDFG+ K L S S+ + T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 217 --GREGRVSTNGDVYSFGIMLMETFTKKKP 244
+ + D++S G + ++
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 64/287 (22%), Positives = 122/287 (42%), Gaps = 42/287 (14%)
Query: 51 IGRGSFGSVYKARIQDG---MEVAVKVFHLQCGGVFKS---FDVECEVMKSIRHRNLIKI 104
+G G+FGSV + + ++VA+KV L+ G E ++M + + ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGYS 161
I C + LV+E G L K L + + ++ V+ ++YL +F
Sbjct: 402 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 457
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS-KSQTQTLATIGYMAPEYGREG 220
+H +L NVLL + A +SDFG++K L +D +++ + + APE
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 221 RVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSR 278
+ S+ DV+S+G+ + E + +KP Y + VM ++
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKP------------YKKMKGP---EVMAFIE------ 553
Query: 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ K +C ++ L +C + E R + + R+ SL
Sbjct: 554 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-36
Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 55/301 (18%)
Query: 51 IGRGSFGSVYKARI------QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKI 104
+G G+FG V+ A +D M VAVK K F E E++ +++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 105 ISTCSNDDFKALVLEYMPHGSL---------------EKCLYSSNCVLDIFQRLNIMIDV 149
C + D +V EYM HG L + + L + Q L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 150 AAALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206
A+ + YL HF +H DL N L+ N++ + DFG+++ + D + T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLP 264
I +M PE + +T DV+SFG++L E FT K+P ++ +SN
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP------------WFQLSNT-- 242
Query: 265 ISVMEIVDA-NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323
V+E + +L R C V+++ + C +QR+N KEI L +
Sbjct: 243 -EVIECITQGRVLER-------PRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
Query: 324 S 324
+
Sbjct: 295 A 295
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-36
Identities = 69/288 (23%), Positives = 119/288 (41%), Gaps = 44/288 (15%)
Query: 51 IGRGSFGSVYKARIQDG---MEVAVKVFHLQCG----GVFKSFDVECEVMKSIRHRNLIK 103
+G G+FG+V K Q VAVK+ L+ + E VM+ + + +++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGY 160
+I C + + LV+E G L K L N + + ++ V+ ++YL +F
Sbjct: 83 MIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF-- 138
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSKSQTQTLATIGYMAPEYGRE 219
+H DL NVLL A +SDFG++K L E+ K+QT + + APE
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 220 GRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLS 277
+ S+ DV+SFG+++ E F+ +KP Y + V +++
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKP------------YRGMKGS---EVTAMLEKG--- 236
Query: 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ C +++L C E R + RL +
Sbjct: 237 ---ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-36
Identities = 66/282 (23%), Positives = 113/282 (40%), Gaps = 39/282 (13%)
Query: 48 NNLIGRGSFGSVYKAR-IQDGMEVAVKVFHL--QCGGVFKSFDVECEVMKSIRHRNLIKI 104
+ IGRGSF +VYK + +EVA + F E E++K ++H N+++
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 105 I----STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
ST LV E M G+L K V+ I + + L++LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTL-KTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 161 SAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYMAPEYGR 218
+ P+IH DLK N+ + + D G+A L S + + T +MAPE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-----SFAKAVIGTPEFMAPEMYE 203
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278
E + DVY+FG+ ++E T + P + + V++ + + + +
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASFD----KVAIP 257
Query: 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320
E K C ++ ++R + K+ LL
Sbjct: 258 EVKEIIEG-------------CIRQNKDERYSIKD----LLN 282
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-36
Identities = 68/298 (22%), Positives = 118/298 (39%), Gaps = 54/298 (18%)
Query: 51 IGRGSFGSVYKARIQDG------MEVAVKVFHLQCGGVFKS---FDVECEVMKSIRHRNL 101
+G G+FG VY+ ++ ++VAVK L + F +E ++ H+N+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSS------NCVLDIFQRLNIMIDVAAALEY 155
++ I + +++E M G L+ L + L + L++ D+A +Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 156 L---HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
L HF IH D+ N LL VA + DFG+A+ + + + +
Sbjct: 156 LEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 210 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISV 267
+M PE EG ++ D +SFG++L E F+ P Y SN V
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------------YPSKSNQ---EV 254
Query: 268 MEIVDA-NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
+E V + + + C V+ + +C E R N I+ R+
Sbjct: 255 LEFVTSGGRMDP-------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-36
Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 16/199 (8%)
Query: 51 IGRGSFGSVYKARIQDGME-----VAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKI 104
+G G+FG+VYK E VA+K K E VM S+ + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGYS 161
+ C + L+ + MP G L + + LN + +A + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGR 221
+H DL NVL+ ++DFG+AKLL E++ I +MA E
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 222 VSTNGDVYSFGIMLMETFT 240
+ DV+S+G+ + E T
Sbjct: 196 YTHQSDVWSYGVTVWELMT 214
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-36
Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 38/282 (13%)
Query: 51 IGRGSFGSVYKARIQDG----MEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKII 105
IG G G V R++ + VA+K + F E +M H N+I++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGYSA 162
+ +V EYM +GSL+ L + + I Q + ++ V A + YL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-EDQSKSQTQTLATIGYMAPEYGREGR 221
+H DL NVL+D N+V +SDFG++++L D + + T I + APE
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 222 VSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSRE 279
S+ DV+SFG+++ E ++P YW ++N V+ V+ E
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERP------------YWNMTNR---DVISSVE------E 269
Query: 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
A C + L ++C + QR +IV+ L +
Sbjct: 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 54/193 (27%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKIISTCS 109
+G G FG V+ +VAVK L+ G + F E +MK ++H+ L+++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 110 NDDFKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ ++ EYM +GSL L + + L I + L++ +A + ++ IH D
Sbjct: 79 QEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDV 228
L+ +N+L+ D + ++DFG+A+L+ +++ ++ I + APE G + DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 229 YSFGIMLMETFTK 241
+SFGI+L E T
Sbjct: 194 WSFGILLTEIVTH 206
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 66/282 (23%), Positives = 127/282 (45%), Gaps = 38/282 (13%)
Query: 51 IGRGSFGSVYKARIQ----DGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKII 105
+G G FG V R++ + VA+K + + F E +M H N+I++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGYSA 162
+ +V EYM +GSL+ L + + Q + ++ +A+ ++YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSKSQTQTLATIGYMAPEYGREGR 221
+H DL N+L++ N+V +SDFG+ ++L + + + I + +PE +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 222 VSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSRE 279
++ DV+S+GI+L E + ++P YW +SN V++ VD E
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERP------------YWEMSNQ---DVIKAVD------E 265
Query: 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
C + ++ L ++C + R ++IV+ L K+
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 60/284 (21%), Positives = 115/284 (40%), Gaps = 45/284 (15%)
Query: 51 IGRGSFGSVYKARIQDG----MEVAVKVFHLQCGGVFKS---FDVECEVMKSIRHRNLIK 103
+G G FG VY+ + + VAVK + + F E +MK++ H +++K
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKT--CKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGY 160
+I + +++E P+G L L + L + + + + A+ YL +
Sbjct: 78 LIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC-- 134
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG 220
+H D+ N+L+ L DFG+++ + ED K+ T I +M+PE
Sbjct: 135 ----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-VTRLPIKWMSPESINFR 189
Query: 221 RVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDAN-LLS 277
R +T DV+ F + + E + K+P ++ + N V+ +++ L
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP------------FFWLENK---DVIGVLEKGDRLP 234
Query: 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
+ + C ++ L C R E+V L +
Sbjct: 235 K-------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 39/283 (13%)
Query: 51 IGRGSFGSVYKARIQDG-----MEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKI 104
IG G FG VYK ++ + VA+K + F E +M H N+I++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGYS 161
S ++ EYM +G+L+K L + + Q + ++ +AA ++YL ++
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQ-TLATIGYMAPEYGREG 220
+H DL N+L++ N+V +SDFG++++L + ++ T I + APE
Sbjct: 169 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 221 RVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSR 278
+ ++ DV+SFGI++ E T ++P YW +SN VM+ ++
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERP------------YWELSN---HEVMKAIN------ 264
Query: 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
+ C S ++ L M+C + +R +IV+ L K+
Sbjct: 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 60/284 (21%), Positives = 107/284 (37%), Gaps = 39/284 (13%)
Query: 51 IGRGSFGSVYKARIQDG----MEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKII 105
IG G FG V++ + VA+K + F E M+ H +++K+I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGYSA 162
+ + +++E G L L LD+ + ++ AL YL F
Sbjct: 83 GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222
+H D+ NVL+ N L DFG+++ + K+ + I +MAPE R
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPESINFRRF 194
Query: 223 STNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSRED 280
++ DV+ FG+ + E KP + V N V+ ++
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP------------FQGVKNN---DVIGRIE------NG 233
Query: 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
+ C +++L +C +R E+ +L I +
Sbjct: 234 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 60/293 (20%), Positives = 120/293 (40%), Gaps = 44/293 (15%)
Query: 51 IGRGSFGSVYKARIQDG------MEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIK 103
+G+GSFG VY+ + VA+K + + F E VMK ++++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 104 IISTCSNDDFKALVLEYMPHGSL---------EKCLYSSNCVLDIFQRLNIMIDVAAALE 154
++ S +++E M G L + + + + ++A +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 155 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAP 214
YL+ + +H DL N ++ ++ + DFG+ + + D + + L + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 215 EYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVD 272
E ++G +T DV+SFG++L E T ++P Y +SN V+ V
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQP------------YQGLSNE---QVLRFVM 254
Query: 273 A-NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
LL + + C +F L C + + R + EI++ + + +
Sbjct: 255 EGGLLDK-------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 69/298 (23%), Positives = 118/298 (39%), Gaps = 54/298 (18%)
Query: 51 IGRGSFGSVYKARIQDG------MEVAVKVFHLQCGGVFKS---FDVECEVMKSIRHRNL 101
+G G+FG VY+ ++ ++VAVK L + F +E ++ H+N+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSS------NCVLDIFQRLNIMIDVAAALEY 155
++ I + ++LE M G L+ L + L + L++ D+A +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 156 L---HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
L HF IH D+ N LL VA + DFG+A+ + + + +
Sbjct: 197 LEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 210 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISV 267
+M PE EG ++ D +SFG++L E F+ P Y SN V
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------------YPSKSNQ---EV 295
Query: 268 MEIVDA-NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
+E V + + + C V+ + +C E R N I+ R+
Sbjct: 296 LEFVTSGGRMDP-------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 72/300 (24%), Positives = 124/300 (41%), Gaps = 54/300 (18%)
Query: 51 IGRGSFGSVYKARIQDG------MEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKI 104
+G G+FG V+ A + M VAVK + F E E++ ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 105 ISTCSNDDFKALVLEYMPHGSL--------------EKCLYSSNCVLDIFQRLNIMIDVA 150
C+ +V EYM HG L + L + Q L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 151 AALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
A + YL HF +H DL N L+ +V + DFG+++ + D + +T+
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPI 265
I +M PE + +T DV+SFG++L E FT K+P ++ +SN
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP------------WYQLSNT--- 267
Query: 266 SVMEIVDA-NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
++ + L R C V+ + C +QR + K++ RL + +
Sbjct: 268 EAIDCITQGRELER-------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 44/212 (20%), Positives = 82/212 (38%), Gaps = 28/212 (13%)
Query: 50 LIGRGSFGSVYKAR--IQDGMEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKIIS 106
I G G +Y A +G V +K ++ E + + + H ++++I +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 107 TCSNDDFKA-----LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS 161
+ D +V+EY+ SL++ L + + + ++++ AL YLH S
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---S 200
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQT-LATIGYMAPEYGREG 220
+++ DLKP N++L + + L D G + T G+ APE R
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK-LIDLGAVSRIN-------SFGYLYGTPGFQAPEIVR-T 251
Query: 221 RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
+ D+Y+ G L G
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
++G+G++G VY R + + + +A+K + + E + K ++H+N+++ + +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL--NIMIDVAAALEYLHFGYSAPVIH 166
S + F + +E +P GSL L S L ++ + L+YLH ++H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 167 CDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYMAPE---YGREGR 221
D+K NVL++ + V +SDFG +K L G T+T T+ YMAPE G G
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 222 VSTNGDVYSFGIMLMETFTKKKP 244
D++S G ++E T K P
Sbjct: 203 -GKAADIWSLGCTIIEMATGKPP 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-35
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGG--VFKS-FDVECEVMKSIRHRNLIKII 105
+G G +VY A ++VA+K + F+ E + H+N++ +I
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
DD LV+EY+ +L S+ L + +N + +++ H ++
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIV 133
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPEYGREGRV 222
H D+KP N+L+D N + DFGIAK L+ S TQT +G Y +PE +
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALS----ETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 223 STNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
D+YS GI+L E + P F GE
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP----FNGE 215
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 70/300 (23%), Positives = 125/300 (41%), Gaps = 54/300 (18%)
Query: 51 IGRGSFGSVYKARIQDG------MEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIK 103
+G FG VYK + VA+K + G + F E + ++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 104 IISTCSNDDFKALVLEYMPHGSL---------------EKCLYSSNCVLDIFQRLNIMID 148
++ + D +++ Y HG L + L+ ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 149 VAAALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQT 205
+AA +EYL H +H DL NVL+ D + +SD G+ + + D K +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 206 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLL 263
L I +MAPE G+ S + D++S+G++L E F+ +P Y SN
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP------------YCGYSNQ- 237
Query: 264 PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323
V+E++ R + + C ++V+ L +EC E +R K+I +RL +
Sbjct: 238 --DVVEMI------RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 289
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 50 LIGRGSFGSVYKARIQD---GMEVAVKVFHLQCGG--VFKS-FDVECEVMKSIRHRNLIK 103
L+GRG G VY+A D VA+K+ VF++ E ++ +++
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
I D + + + L L L + + I+ + +AL+ H +A
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPEYGREG 220
H D+KP N+L+ + A+L DFGIA T + TQ T+G YMAPE E
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT----DEKLTQLGNTVGTLYYMAPERFSES 210
Query: 221 RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
+ D+Y+ +L E T P + G+
Sbjct: 211 HATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 5e-34
Identities = 61/284 (21%), Positives = 108/284 (38%), Gaps = 39/284 (13%)
Query: 51 IGRGSFGSVYKARIQDG----MEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIKII 105
IG G FG V++ M VA+K + F E M+ H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFGYSA 162
+ + +++E G L L LD+ + ++ AL YL F
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222
+H D+ NVL+ N L DFG+++ + K+ ++ I +MAPE R
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRF 569
Query: 223 STNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VSNLLPISVMEIVDANLLSRED 280
++ DV+ FG+ + E KP + V N V+ ++
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKP------------FQGVKNN---DVIGRIE------NG 608
Query: 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
+ C +++L +C +R E+ +L I +
Sbjct: 609 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 33/215 (15%)
Query: 51 IGRGSFGSVYKARIQD--------GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLI 102
+G+G+F ++K ++ EV +KV +SF +M + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL---HFG 159
C D LV E++ GSL+ L + ++I +L + +AAA+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134
Query: 160 YSAPVIHCDLKPSNVLLD--------DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY 211
IH ++ N+LL + LSD GI+ + +D + I +
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ------ERIPW 183
Query: 212 MAPEYGREGRV-STNGDVYSFGIMLMETFTK-KKP 244
+ PE + + D +SFG L E + KP
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-33
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 28/218 (12%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
F E LIG G FG V+KA+ DG +K + + E + + + H N++
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68
Query: 104 IISTCSNDDFKA----------------LVLEYMPHGSLEKCLYSSNCV-LDIFQRLNIM 146
D+ + +E+ G+LE+ + LD L +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 147 IDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206
+ ++Y+H S +I+ DLKPSN+ L D + DFG+ L + + TL
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
YM+PE D+Y+ G++L E
Sbjct: 186 R---YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 72/310 (23%), Positives = 126/310 (40%), Gaps = 64/310 (20%)
Query: 51 IGRGSFGSVYKARIQDG------MEVAVKVFHLQCGGVFKS-FDVECEVMKSIRHRNLIK 103
IG G+FG V++AR VAVK+ + ++ F E +M + N++K
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 104 IISTCSNDDFKALVLEYMPHGSL-----------------------EKCLYSSNCVLDIF 140
++ C+ L+ EYM +G L + L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 141 QRLNIMIDVAAALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197
++L I VAA + YL F +H DL N L+ +NMV ++DFG+++ + D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLK 256
K+ I +M PE R +T DV+++G++L E F+ +P
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP------------ 276
Query: 257 YW-VSNLLPISVME-IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
Y+ +++ V+ + D N+L+ E C ++NL C + R + I
Sbjct: 277 YYGMAHE---EVIYYVRDGNILAC-------PENCPLELYNLMRLCWSKLPADRPSFCSI 326
Query: 315 VTRLLKIRDS 324
L ++ +
Sbjct: 327 HRILQRMCER 336
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGG--VFKS-FDVECEVMKSIRHRNLIKII 105
++G G V+ AR ++D +VAVKV F F E + ++ H ++ +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 106 STCSNDDFKA----LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS 161
T + +V+EY+ +L + + + + + + ++ D AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALNFSH---Q 134
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPEYGR 218
+IH D+KP+N+++ + DFGIA+ + D S TQT A IG Y++PE R
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
V DVYS G +L E T + P F G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV-----ECEVMKSI 96
F IGRG F VY+A + DG+ VA+K +Q + + E +++K +
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKK--VQIFDLMDAKARADCIKEIDLLKQL 89
Query: 97 RHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIF---QRLNIMIDVAAAL 153
H N+IK ++ D+ +VLE G L + + + + + +AL
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYM 212
E++H S V+H D+KP+NV + V L D G+ + + + + +L T YM
Sbjct: 150 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYM 203
Query: 213 APEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
+PE E + D++S G +L E + P
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 44/200 (22%), Positives = 89/200 (44%), Gaps = 11/200 (5%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIIS 106
IG GSFG + +DG + +K ++ + E V+ +++H N+++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 107 TCSNDDFKALVLEYMPHGSL-EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
+ + +V++Y G L ++ + Q L+ + + AL+++H ++
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYMAPEYGREGRVST 224
H D+K N+ L + L DFGIA++L + + + T Y++PE +
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYYLSPEICENKPYNN 204
Query: 225 NGDVYSFGIMLMETFTKKKP 244
D+++ G +L E T K
Sbjct: 205 KSDIWALGCVLYELCTLKHA 224
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 66/302 (21%), Positives = 116/302 (38%), Gaps = 59/302 (19%)
Query: 51 IGRGSFGSVYKARIQD--------GMEVAVKVFHLQCGGV-FKSFDVECEVMKSI-RHRN 100
+G G FG V A + VAVK+ E E+MK I +H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSL---------------EKCLYSSNCVLDIFQRLNI 145
+I ++ C+ D +++EY G+L + ++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 146 MIDVAAALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202
+A +EYL IH DL NVL+ +N V ++DFG+A+ + D K
Sbjct: 209 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYW-VS 260
T + +MAPE + + DV+SFG+++ E FT P Y +
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP------------YPGIP 310
Query: 261 NLLPISVMEIVDA-NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319
+ +++ + + + C + ++ + +C QR K++V L
Sbjct: 311 VE---ELFKLLKEGHRMDK-------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360
Query: 320 KI 321
+I
Sbjct: 361 RI 362
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-32
Identities = 53/206 (25%), Positives = 80/206 (38%), Gaps = 12/206 (5%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEV---MKSIRH 98
F + +G GS+G V+K R +DG AVK G EV K +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHF 158
+++ L E SL++ + L Q + D AL +LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH- 174
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR 218
S ++H D+KP+N+ L L DFG+ L + Q YMAPE +
Sbjct: 175 --SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPELLQ 229
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKP 244
T DV+S G+ ++E +
Sbjct: 230 GSY-GTAADVFSLGLTILEVACNMEL 254
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 39/223 (17%)
Query: 51 IGRGSFGSVYKARIQDG------MEVAVKVFHLQCGGV-FKSFDVECEVMKSIRHRNLIK 103
+G G FG V KA VAVK+ + E V+K + H ++IK
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 104 IISTCSNDDFKALVLEYMPHGSL-----------------------EKCLYSSNCVLDIF 140
+ CS D L++EY +GSL + L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 141 QRLNIMIDVAAALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197
++ ++ ++YL +H DL N+L+ + +SDFG+++ + ED
Sbjct: 151 DLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
++Q + +MA E + +T DV+SFG++L E T
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 54/235 (22%), Positives = 89/235 (37%), Gaps = 23/235 (9%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
+G G F V + DG A+K + E ++ + H N++++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 109 SNDDFKA----LVLEYMPHGSLEKCLYSSNCVLDIF---QRLNIMIDVAAALEYLHFGYS 161
+ L+L + G+L + + Q L +++ + LE +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-------TIGYMAP 214
H DLKP+N+LL D L D G + Q TL TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 215 E----YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI 265
E + DV+S G +L + P D +F ++ V N L I
Sbjct: 213 ELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 48/211 (22%), Positives = 88/211 (41%), Gaps = 21/211 (9%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNL--IKI 104
IG G V++ + A+K +L+ S+ E + ++ + I++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
D + +V+E + L L +D ++R + ++ A+ +H +
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 148
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE--------- 215
+H DLKP+N L+ D M+ L DFGIA + + S + + T+ YM PE
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 216 --YGREGRVSTNGDVYSFGIMLMETFTKKKP 244
+ ++S DV+S G +L K P
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 21/211 (9%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGG--VFKSFDVECEVMKSIRHRNL--IKI 104
IG G V++ + A+K +L+ S+ E + ++ + I++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
D + +V+E + L L +D ++R + ++ A+ +H +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 176
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE--------- 215
+H DLKP+N L+ D M+ L DFGIA + + S + + + YM PE
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 216 --YGREGRVSTNGDVYSFGIMLMETFTKKKP 244
+ ++S DV+S G +L K P
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 71/302 (23%), Positives = 116/302 (38%), Gaps = 59/302 (19%)
Query: 51 IGRGSFGSVYKARIQD--------GMEVAVKVFHLQCGGV-FKSFDVECEVMKSI-RHRN 100
+G G+FG V A + VAVK+ E E+MK I +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSL---------------EKCLYSSNCVLDIFQRLNI 145
+I ++ C+ D +++EY G+L + ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 146 MIDVAAALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202
+A +EYL IH DL NVL+ +N V ++DFG+A+ + D K
Sbjct: 163 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262
T + +MAPE + + DV+SFG+++ E FT G
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL---------GGS--------- 258
Query: 263 LP---ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319
P I V E+ L +E C + ++ + +C QR K++V L
Sbjct: 259 -PYPGIPVEELFK---LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 320 KI 321
+I
Sbjct: 315 RI 316
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 60/297 (20%), Positives = 107/297 (36%), Gaps = 48/297 (16%)
Query: 51 IGRGSFGSVYKARI------QDGMEVAVKVFHLQCGGV-FKSFDVECEVMKSI-RHRNLI 102
+G G+FG V +A M VAVK+ ++ E +V+ + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 103 KIISTCSNDDFKALVLEYMPHGSL-----------------EKCLYSSNCVLDIFQRLNI 145
++ C+ ++ EY +G L + LD+ L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 146 MIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQT 205
VA + +L S IH DL N+LL + + DFG+A+ + + +
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 206 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYWVSNLLP 264
+ +MAPE + DV+S+GI L E F+ P + K
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM------- 260
Query: 265 ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
I + + E + ++++ C +R K+IV + K
Sbjct: 261 -----IKEGFRMLS-------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 14/206 (6%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIIS 106
IG GS+G K R DG + K + E +++ ++H N+++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 107 TCSNDDFKAL--VLEYMPHGSLEKCLYSSNCVLDIF---QRLNIMIDVAAALEYLH--FG 159
+ L V+EY G L + L +M + AL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYMAPEYGR 218
V+H DLKP+NV LD L DFG+A++L + S +T T YM+PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKTFVGTPYYMSPEQMN 189
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKP 244
+ D++S G +L E P
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-31
Identities = 49/216 (22%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 49 NLIGRGSFGSVYKARIQD------GMEVAVKVFHLQCGGV-FKSFDVECEVMKSI-RHRN 100
+G G+FG V +A ++VAVK+ ++ E ++M + +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSL-------------EKCLYSSNCVLDIFQRLNIMI 147
++ ++ C++ ++ EY +G L + +N L+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 148 DVAAALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQ 204
VA + +L + IH D+ NVLL + VA + DFG+A+ + + +
Sbjct: 172 QVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 205 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ +MAPE + + DV+S+GI+L E F+
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 54/249 (21%), Positives = 94/249 (37%), Gaps = 44/249 (17%)
Query: 45 FSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVM-KSIRHRNLIK 103
++G GS G+V G VAVK + +E +++ +S H N+I+
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 104 IISTCSNDDFKALVLEYMPHGSLE------KCLYSSNCVLDIFQRLNIMIDVAAALEYLH 157
+ + D F + LE +L+ + + + ++++ +A+ + +LH
Sbjct: 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 158 FGYSAPVIHCDLKPSNVLLD-------------DNMVAHLSDFGIAKLLTGEDQSKSQTQ 204
S +IH DLKP N+L+ +N+ +SDFG+ K L S
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 205 TLA--TIGYMAPEYGREGRVSTNG-------DVYSFGIMLMETFTKKKP--------TDK 247
T G+ APE E D++S G + +K K
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 248 IFAGEMTLK 256
I G +L
Sbjct: 250 IIRGIFSLD 258
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-31
Identities = 48/211 (22%), Positives = 88/211 (41%), Gaps = 21/211 (9%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNL--IKI 104
IG G V++ + A+K +L+ S+ E + ++ + I++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
D + +V+E + L L +D ++R + ++ A+ +H +
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 129
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE--------- 215
+H DLKP+N L+ D M+ L DFGIA + + S + + T+ YM PE
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 216 --YGREGRVSTNGDVYSFGIMLMETFTKKKP 244
+ ++S DV+S G +L K P
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 8e-31
Identities = 72/302 (23%), Positives = 118/302 (39%), Gaps = 59/302 (19%)
Query: 51 IGRGSFGSVYKARIQD--------GMEVAVKVFHLQCGGV-FKSFDVECEVMKSI-RHRN 100
+G G+FG V A +VAVK+ E E+MK I +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSL---------------EKCLYSSNCVLDIFQRLNI 145
+I ++ C+ D +++EY G+L ++ L ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 146 MIDVAAALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202
VA +EYL IH DL NVL+ ++ V ++DFG+A+ + D K
Sbjct: 197 AYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262
T + +MAPE + + DV+SFG++L E FT G
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL---------GGS--------- 292
Query: 263 LP---ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319
P + V E+ L +E C + ++ + +C QR K++V L
Sbjct: 293 -PYPGVPVEELFK---LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348
Query: 320 KI 321
+I
Sbjct: 349 RI 350
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 36/217 (16%)
Query: 49 NLIGRGSFGSVYKARIQDG---MEVAVKVFHLQCGGV---FKSFDVECEVMKSI-RHRNL 101
++IG G+FG V KARI+ M+ A+K ++ + F E EV+ + H N+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 102 IKIISTCSNDDFKALVLEYMPHGSL---------------EKCLYSSNCVLDIFQRLNIM 146
I ++ C + + L +EY PHG+L S+ L Q L+
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 147 IDVAAALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203
DVA ++YL F IH DL N+L+ +N VA ++DFG+++ G++ +T
Sbjct: 149 ADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 199
Query: 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ +MA E +TN DV+S+G++L E +
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
++ IG+G+ G+VY A + G EVA++ +LQ + E VM+ ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
+ + D +V+EY+ GSL + + +D Q + + ALE+LH S
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPEYGREG 220
VIH D+K N+LL + L+DFG +T +QSK T +G +MAPE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKRST----MVGTPYWMAPEVVTRK 191
Query: 221 RVSTNGDVYSFGIMLME 237
D++S GIM +E
Sbjct: 192 AYGPKVDIWSLGIMAIE 208
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 27/214 (12%)
Query: 51 IGRGSFGSVYKARIQD------GMEVAVKVFHLQCGGV-FKSFDVECEVMKSI-RHRNLI 102
+GRG+FG V +A VAVK+ ++ E +++ I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 103 KIISTCSNDDFKA-LVLEYMPHGSL---------------EKCLYSSNCVLDIFQRLNIM 146
++ C+ +++E+ G+L L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 147 IDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206
VA +E+L S IH DL N+LL + V + DFG+A+ + + +
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 207 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ +MAPE + + DV+SFG++L E F+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
IG GS G V AR G +VAVK+ L+ + E +M+ +H N+++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
+ + + +++E++ G+L + S L+ Q + V AL YLH +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQG 161
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPEYGREG 220
VIH D+K ++LL + LSDFG ++ +D K ++ +G +MAPE
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKS----LVGTPYWMAPEVISRS 216
Query: 221 RVSTNGDVYSFGIMLME 237
+T D++S GIM++E
Sbjct: 217 LYATEVDIWSLGIMVIE 233
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-30
Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 47/238 (19%)
Query: 49 NLIGRGSFGSVYKAR-IQDGMEVAVKVFH---LQCGGVFKSFDVECEVMKSIRHRNLIKI 104
+G+G FG+VY AR Q +A+KV L+ GV E E+ +RH N++++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLN------IMIDVAAALEYLHF 158
+ L+LEY P G++ + L + + + ++A AL Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCH- 126
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYMAPE-- 215
S VIH D+KP N+LL ++DFG + S+ L T+ Y+ PE
Sbjct: 127 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTDLCGTLDYLPPEMI 179
Query: 216 ----YGREGRVSTNGDVYSFGIMLMETFTKKKPTD---------KIFAGEMTLKYWVS 260
+ + D++S G++ E K P + +I E T +V+
Sbjct: 180 EGRMHDEK------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 231
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-30
Identities = 58/237 (24%), Positives = 104/237 (43%), Gaps = 44/237 (18%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFH---LQCGGVFKSFDVECEVMKSIRHRNLIKII 105
L+G+GSF VY+A I G+EVA+K+ + G+ + E ++ ++H +++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
+ + ++ LVLE +G + + L + + + M + + YLH S ++
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYMAPE------YGR 218
H DL SN+LL NM ++DFG+A L + TL T Y++PE +G
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISPEIATRSAHGL 191
Query: 219 EGRVSTNGDVYSFGIML---------------METFTKKKPTDKIFAGEMTLKYWVS 260
E DV+S G M T K+ + + ++S
Sbjct: 192 E------SDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVVLADYEMPSFLS 236
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-30
Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
+ +G G+FG VYKA+ + G A KV + + + VE E++ + H ++K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
++ +D +++E+ P G+++ + + L Q + + AL +LH S
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPE----- 215
+IH DLK NVL+ L+DFG++ K + IG +MAPE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQKRDS----FIGTPYWMAPEVVMCE 192
Query: 216 YGREGRVSTNGDVYSFGIMLME 237
++ D++S GI L+E
Sbjct: 193 TMKDTPYDYKADIWSLGITLIE 214
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 52/257 (20%), Positives = 93/257 (36%), Gaps = 50/257 (19%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
F E ++G+G+FG V KAR D A+K + E ++ S+ H+ +++
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVR 66
Query: 104 IISTCSNDDFKA-------------LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVA 150
+ + +EY +G+L ++S N + + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 151 AALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA--- 207
AL Y+H S +IH DLKP N+ +D++ + DFG+AK +
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 208 ---------TIGYMAPE-------YGREGRVSTNGDVYSFGIMLME-------TFTKKKP 244
T Y+A E Y + D+YS GI+ E +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 245 TDKIFAGEMTLKYWVSN 261
K+ + + +
Sbjct: 238 LKKLRSVSIEFPPDFDD 254
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 51/211 (24%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFH-LQCGGVFKSFDVECEVMKSIRHRN 100
+ ++++G+G+ +V++ R + G A+KVF+ + E EV+K + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 101 LIKIIST--CSNDDFKALVLEYMPHGSLEKCLYS--SNCVLDIFQRLNIMIDVAAALEYL 156
++K+ + + K L++E+ P GSL L + L + L ++ DV + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 157 HFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212
++H ++KP N++ D V L+DFG A+ L ++Q S T Y+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYL 182
Query: 213 APE-YGREGRVSTNG-------DVYSFGIML 235
P+ Y R + D++S G+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 33/220 (15%)
Query: 51 IGRGSFGSVYKARIQDG------MEVAVKVFHLQCGGV-FKSFDVECEVMKSI-RHRNLI 102
+G G+FG V A ++VAVK+ + ++ E ++M + H N++
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 103 KIISTCSNDDFKALVLEYMPHGSL----------------------EKCLYSSNCVLDIF 140
++ C+ L+ EY +G L VL
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 141 QRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200
L VA +E+L +H DL NVL+ V + DFG+A+ + +
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ + +MAPE EG + DV+S+GI+L E F+
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 44/221 (19%), Positives = 90/221 (40%), Gaps = 29/221 (13%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFK-SFDVECEVMKSIRHRN 100
F +GRG FG V++A+ D A+K L + + E + + + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 101 LIKIISTCSNDDFKA------------LVLEYMPHGSLEKCLYSSNCV--LDIFQRLNIM 146
+++ + + + ++ +L+ + + + L+I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 147 IDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206
+ +A A+E+LH S ++H DLKPSN+ + V + DFG+ + +++ ++ +
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 207 ATIG----------YMAPEYGREGRVSTNGDVYSFGIMLME 237
YM+PE S D++S G++L E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 9e-29
Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 11/205 (5%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHL-QCGGVFKSFDVECEVMKSIRHRN 100
D F + + +G G+ G V+K G+ +A K+ HL + E +V+
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
++ +D ++ +E+M GSL++ + + + I V L YL +
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYMAPEYGRE 219
++H D+KPSN+L++ L DFG++ L S + T YM+PE +
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-----DSMANSFVGTRSYMSPERLQG 204
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKP 244
S D++S G+ L+E + P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-29
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
F +G GS+GSVYKA + G VA+K ++ + E +M+ +++K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
+ + +V+EY GS+ + N L + I+ LEYLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPEYGREG 220
IH D+K N+LL+ A L+DFG+A LT +K T IG +MAPE +E
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-MAKRNT----VIGTPFWMAPEVIQEI 200
Query: 221 RVSTNGDVYSFGIMLME 237
+ D++S GI +E
Sbjct: 201 GYNCVADIWSLGITAIE 217
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-29
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFH-LQCGGVFKSFDVECEVMKSIRHRNLIKIIST 107
++G+G+ +V++ R + G A+KVF+ + E EV+K + H+N++K+ +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 108 --CSNDDFKALVLEYMPHGSLEKCLYS--SNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
+ K L++E+ P GSL L + L + L ++ DV + +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 164 VIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE-YGR 218
++H ++KP N++ D V L+DFG A+ L ++Q S T Y+ P+ Y R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDMYER 189
Query: 219 EGRVSTNG-------DVYSFGIML 235
+ D++S G+
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 47/237 (19%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIKII 105
+G+G FG+VY AR Q+ +A+KV L+ GV E E+ +RH N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLN------IMIDVAAALEYLHFG 159
+ + L+LE+ P G L K L R + M ++A AL Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH-- 131
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYMAPE--- 215
VIH D+KP N+L+ ++DFG + + +T+ T+ Y+ PE
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRTMCGTLDYLPPEMIE 185
Query: 216 ---YGREGRVSTNGDVYSFGIMLMETFTKKKPTD---------KIFAGEMTLKYWVS 260
+ + D++ G++ E P D +I ++ ++S
Sbjct: 186 GKTHDEK------VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLS 236
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 32/303 (10%), Positives = 71/303 (23%), Gaps = 57/303 (18%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFH---LQCGGVFKSFDVECEVMKSIRHRNLIKII 105
+ G V+ R ++ + A+KVF + + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 106 STC----------------------SNDDFKA----LVLEYM-----PHGSLEKCLYSSN 134
DD+ L++ S +Y
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 135 CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194
I + + L S ++H P N+ + + L D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV- 244
Query: 195 GEDQSKSQTQTLATIGYMAPEY--GREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
G S + Y E+ + + + G+ + + P
Sbjct: 245 GTRGPASSV----PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP-------- 292
Query: 253 MTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAK 312
+ + + + + F + FV L +R+
Sbjct: 293 ----FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348
Query: 313 EIV 315
E +
Sbjct: 349 EAM 351
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-28
Identities = 32/244 (13%), Positives = 71/244 (29%), Gaps = 49/244 (20%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGG--------------------------- 81
++G+ + +A + G V V +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 82 -VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM-PHGSLEKCL------YSS 133
V F +++K + + +I++ + + Y +L+ S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 134 NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193
+ L RL + + V L LH ++H L+P +++LD L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 194 TGEDQSKSQTQTLATIGYMAPE-----YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKI 248
G + A A ++ D ++ G+ + + P
Sbjct: 262 -GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316
Query: 249 FAGE 252
+
Sbjct: 317 NTDD 320
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 40/248 (16%), Positives = 78/248 (31%), Gaps = 31/248 (12%)
Query: 42 TDGFSENNLIGRGSFGSVYKAR------IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKS 95
+ ++L+G G+F VY+A ++ + +KV F E +K
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 96 IRHRNLIKIISTCSNDDFKALVLEYMPHGSL----EKCLYSSNCVLDIFQRLNIMIDVAA 151
+K S + LV E +G+L + V+ ++ + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH-----------LSDFGIAKLLTGEDQSK 200
+E +H +IH D+KP N +L + + L D G + + +
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 201 SQTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTKKKPTDKIFAGEMTLK--- 256
T T G+ E + D + + K GE +
Sbjct: 241 IFTAKCETSGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 257 --YWVSNL 262
++
Sbjct: 300 RRLPHLDM 307
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 52/272 (19%), Positives = 90/272 (33%), Gaps = 47/272 (17%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFH-----------------LQCGGVFKSFDVECEVM 93
+ +G F + +D A+K + + + F E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 94 KSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL-------EKCLYSSNCVLDIFQRLNIM 146
I++ + +N D ++ EYM + S+ + C + I I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 147 IDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL 206
V + Y+H + H D+KPSN+L+D N LSDFG ++ + + +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD-----KKIKGS 210
Query: 207 A-TIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTKKKPTD----------KIFAGEM 253
T +M PE D++S GI L F P I +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270
Query: 254 TL--KYWVSNLLPISVMEIVDANLLSREDKHF 283
+ N LS ED F
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF 302
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHL-QCGGVFKSFDVECEVMKSIRHRNLI 102
F++ IG+GSFG V+K + VA+K+ L + + E V+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
K + D +++EY+ GS L LD Q I+ ++ L+YLH S
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH---SE 138
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPEYGRE 219
IH D+K +NVLL ++ L+DFG+A LT Q K T +G +MAPE ++
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNT----FVGTPFWMAPEVIKQ 193
Query: 220 GRVSTNGDVYSFGIMLME 237
+ D++S GI +E
Sbjct: 194 SAYDSKADIWSLGITAIE 211
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 6e-28
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV---ECEVMKSIRHRNLIKII- 105
+G G FG V + G +VA+K + K+ + E ++MK + H N++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 106 -----STCSNDDFKALVLEYMPHGSLEKCL--YSSNCVLDIFQRLNIMIDVAAALEYLHF 158
+ +D L +EY G L K L + + C L ++ D+++AL YLH
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH- 138
Query: 159 GYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
+IH DLKP N++L ++ + D G AK L + + T+ Y+APE
Sbjct: 139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAPE 193
Query: 216 YGREGRVSTNGDVYSFGIML 235
+ + + D +SFG +
Sbjct: 194 LLEQKKYTVTVDYWSFGTLA 213
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-28
Identities = 48/237 (20%), Positives = 93/237 (39%), Gaps = 45/237 (18%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFH---LQCGGVFKSFDVECEVMKSIRHRNLIKII 105
+G+G F ++ A K+ L + +E + +S+ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
++DF +VLE SL + + + R + + +YLH VI
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYMAPE------YGR 218
H DLK N+ L++++ + DFG+A + + + K + L T Y+APE +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHSF 220
Query: 219 EGRVSTNGDVYSFGIML---------------METFTKKKPTDKIFAGEMTLKYWVS 260
E DV+S G ++ ET+ +I E ++ ++
Sbjct: 221 E------VDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIKKNEYSIPKHIN 265
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 48/231 (20%), Positives = 93/231 (40%), Gaps = 33/231 (14%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIKII 105
+G+G F ++ A K+ L + +E + +S+ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
++DF +VLE SL + + + R + + +YLH VI
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYMAPE------YGR 218
H DLK N+ L++++ + DFG+A + + + K + L T Y+APE +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHSF 194
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKPTD---------KIFAGEMTLKYWVS 260
E DV+S G ++ K P + +I E ++ ++
Sbjct: 195 E------VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN 239
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 57/200 (28%), Positives = 83/200 (41%), Gaps = 21/200 (10%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG-GVFKSFDVECEV-MKSIRHRNLIKIIST 107
IGRG++GSV K G +AVK K ++ +V M+S +++
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLN------IMIDVAAALEYLHFGYS 161
+ + +E M S +K VLD + I + AL +L
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLD--DVIPEEILGKITLATVKALNHLKENLK 146
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE----YG 217
+IH D+KPSN+LLD + L DFGI+ L S ++T+ YMAPE
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSA 201
Query: 218 REGRVSTNGDVYSFGIMLME 237
DV+S GI L E
Sbjct: 202 SRQGYDVRSDVWSLGITLYE 221
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-27
Identities = 63/245 (25%), Positives = 95/245 (38%), Gaps = 49/245 (20%)
Query: 23 NMPPVATWRRFSYLELFQATD---GFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQ 78
+M + R ++L D F L+G G++G VYK R ++ G A+KV +
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 79 CGGVFKSFDVECEVMKSI-RHRNLIKII------STCSNDDFKALVLEYMPHGSLEKCLY 131
G + E ++K HRN+ + DD LV+E+ GS
Sbjct: 61 -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGS------ 113
Query: 132 SSNCVLDIFQRLN-----------IMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180
V D+ + I ++ L +LH VIH D+K NVLL +N
Sbjct: 114 ----VTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENA 166
Query: 181 VAHLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPEYGREGRVSTNG-----DVYSFG 232
L DFG++ L + T IG +MAPE D++S G
Sbjct: 167 EVKLVDFGVSAQLDRT-VGRRNT----FIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221
Query: 233 IMLME 237
I +E
Sbjct: 222 ITAIE 226
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 39/270 (14%), Positives = 87/270 (32%), Gaps = 65/270 (24%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVF----------------------------HLQCG 80
++G+ + +A + G V V + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 81 GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM-PHGSLEKCL------YSS 133
V F +++K + + +I++ + + Y +L+ S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 134 NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193
+ L RL + + V L LH ++H L+P +++LD L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 194 TGEDQSKSQTQTLATIGYMAPEY-----------GREGRVSTNGDVYSFGIMLMETFTKK 242
D ++ + + G+ PE R ++ + D ++ G+++ +
Sbjct: 255 --RDGARVVSSV--SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 243 KP---------TDKIFAGEMTLKYWVSNLL 263
P ++ IF + V LL
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALL 340
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 41/201 (20%), Positives = 78/201 (38%), Gaps = 18/201 (8%)
Query: 51 IGRG--SFGSVYKAR-IQDGMEVAVKVFHL--QCGGVFKSFDVECEVMKSIRHRNLIKII 105
IG+G +V AR G V V+ +L + E V K H N++
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 106 STCSNDDFKALVLEYMPHGSLEKCL-YSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
+T D+ +V +M +GS + + ++ I+ V AL+Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGY 149
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT---IG---YMAPEYGR 218
+H +K S++L+ + +LS + + + + +++PE +
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMI-SHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208
Query: 219 EGRVSTNG--DVYSFGIMLME 237
+ + D+YS GI E
Sbjct: 209 QNLQGYDAKSDIYSVGITACE 229
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 16/208 (7%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHL-QCGGVFKSFDVECEVMKSIRHRN 100
D + +IG G+ V A +VA+K +L +C E + M H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSL-------EKCLYSSNCVLDIFQRLNIMIDVAAAL 153
++ ++ D LV++ + GS+ + VLD I+ +V L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG--- 210
EYLH IH D+K N+LL ++ ++DFG++ L +G
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 211 YMAPEYGREGRV-STNGDVYSFGIMLME 237
+MAPE + R D++SFGI +E
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 63/241 (26%), Positives = 99/241 (41%), Gaps = 32/241 (13%)
Query: 16 KQLPNDANMPPVATWRRFSYLELFQATDGFSENN---------LIGRGSFGSVYKAR-IQ 65
+ L M P+ R L+ + F +++ IG GSFG+VY AR ++
Sbjct: 18 ENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVR 77
Query: 66 DGMEVAVKVFHL---QCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMP 122
+ VA+K Q ++ E ++ +RH N I+ + LV+EY
Sbjct: 78 NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137
Query: 123 HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 182
GS L L + + L YLH S +IH D+K N+LL + +
Sbjct: 138 -GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLV 193
Query: 183 HLSDFGIAKLLTGEDQSKSQTQTLATIG---YMAPE---YGREGRVSTNGDVYSFGIMLM 236
L DFG A ++ + + +G +MAPE EG+ DV+S GI +
Sbjct: 194 KLGDFGSASIMA-----PANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 244
Query: 237 E 237
E
Sbjct: 245 E 245
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 45/227 (19%), Positives = 86/227 (37%), Gaps = 36/227 (15%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV--ECEVMKSI-RHRN 100
F E IG G FGSV+K DG A+K G + E + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIF---QRLNIMIDVAAALEYLH 157
+++ S + DD + EY GSL + + ++ F + ++++ V L Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 158 FGYSAPVIHCDLKPSNVLLDDN-------------------MVAHLSDFGIAKLLTGEDQ 198
S ++H D+KPSN+ + ++ + D G +
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----- 184
Query: 199 SKSQTQTLATIGYMAPEYGREGRVSTN-GDVYSFGIMLMETFTKKKP 244
S Q + ++A E +E D+++ + ++ +
Sbjct: 185 SSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 14/195 (7%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHL-QCGGVFKSFDVECEV-MKSIRHRNLIKIIST 107
+G G+ G V+K R + G +AVK K ++ +V +KS +++ T
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
+ + +E M EK + + + + AL YL + VIH
Sbjct: 93 FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHR 149
Query: 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE-----YGREGRV 222
D+KPSN+LLD+ L DFGI+ L K++ ++ YMAPE +
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 223 STNGDVYSFGIMLME 237
DV+S GI L+E
Sbjct: 207 DIRADVWSLGISLVE 221
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 22/200 (11%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG-GVFKSFDVECEV-MKSIRHRNLIKIIST 107
+GRG++G V K R + G +AVK K ++ ++ M+++ +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLN------IMIDVAAALEYLHFGYS 161
+ + +E M SL+K Y V+D Q + I + + ALE+LH S
Sbjct: 75 LFREGDVWICMELMD-TSLDK-FYKQ--VIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE----YG 217
VIH D+KPSNVL++ + DFGI+ L ++ YMAPE
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAPERINPEL 185
Query: 218 REGRVSTNGDVYSFGIMLME 237
+ S D++S GI ++E
Sbjct: 186 NQKGYSVKSDIWSLGITMIE 205
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 54/232 (23%), Positives = 87/232 (37%), Gaps = 31/232 (13%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIIST 107
++ G F VY+A+ + G E A+K ++ E MK + H N+++ S
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 108 CS-------NDDFKALVLEYMPHGSLEKCL--YSSNCVLDIFQRLNIMIDVAAALEYLHF 158
S + L+L + G L + L S L L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA----------T 208
P+IH DLK N+LL + L DFG A ++ Q A T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 209 IGYMAPE----YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK 256
Y PE Y + D+++ G +L ++ P F L+
Sbjct: 214 PMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP----FEDGAKLR 260
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 44/206 (21%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
++G G+F V+ + G A+K S + E V+K I+H N++ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 109 SNDDFKALVLEYMPHGSL-----EKCLYS----SNCVLDIFQRLNIMIDVAAALEYLHFG 159
+ LV++ + G L E+ +Y+ S + + A++YLH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS----------AVKYLH-- 123
Query: 160 YSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYMAPE 215
++H DLKP N+L ++N ++DFG++K+ T T GY+APE
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPE 177
Query: 216 ------YGREGRVSTNGDVYSFGIML 235
Y + D +S G++
Sbjct: 178 VLAQKPYSKA------VDCWSIGVIT 197
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 60/233 (25%)
Query: 40 QATDGFSEN----NLIGRGSFGSVYKAR-IQDGMEVAVKVF---------HLQCGGVFKS 85
+T GF EN ++GRG V + E AVK+ + + ++
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 86 FDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEYMPHGSL-----EKCLYS----SNC 135
E ++++ + H N+I++ T + F LV + M G L EK S
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 136 VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195
+ + + + LH ++H DLKP N+LLDD+M L+DFG + L
Sbjct: 130 MRALLE----------VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 196 EDQSKSQTQTLA-TIGYMAPE------------YGREGRVSTNGDVYSFGIML 235
+ + + + T Y+APE YG+E D++S G+++
Sbjct: 177 GE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 48/207 (23%), Positives = 91/207 (43%), Gaps = 44/207 (21%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV--ECEVMKSIRHRNLIKIIST 107
+G+G+F V + + G E A + + + + E + + ++H N++++ +
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 108 CSNDDFKALVLEYMPHGSL-----EKCLYS----SNCVLDIFQRLNIMIDVAAALEYLHF 158
S + L+ + + G L + YS S+C+ I + A+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE----------AVLHCH- 127
Query: 159 GYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYMAP 214
V+H +LKP N+LL L+DFG+A + GE Q+ A T GY++P
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGYLSP 182
Query: 215 E------YGREGRVSTNGDVYSFGIML 235
E YG+ D+++ G++L
Sbjct: 183 EVLRKDPYGKP------VDLWACGVIL 203
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-24
Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 51/224 (22%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVF--------------------HLQCGGVFKSFDV 88
IG+GS+G V A D A+KV GG +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 89 ------ECEVMKSIRHRNLIK---IISTCSNDDFKALVLEYMPHGSL----EKCLYSSNC 135
E ++K + H N++K ++ + D +V E + G + S +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 136 VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195
FQ D+ +EYLH +IH D+KPSN+L+ ++ ++DFG++ G
Sbjct: 139 ARFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 196 EDQSKSQTQTLA-TIGYMAPEYGREGRVSTNG---DVYSFGIML 235
D + T +MAPE E R +G DV++ G+ L
Sbjct: 190 SD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 49/213 (23%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKV-----FHLQCGGVFKSFDVECEVMKSIRHRNLIKI 104
IG+G F V + + G + AVK+ F G + E + ++H +++++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 105 ISTCSNDDFKALVLEYMPHGSL---------EKCLYS----SNCVLDIFQRLNIMIDVAA 151
+ T S+D +V E+M L +YS S+ + I +
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE---------- 141
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
AL Y H +IH D+KP VLL +++ L FG+A L + T
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGT 196
Query: 209 IGYMAPE------YGREGRVSTNGDVYSFGIML 235
+MAPE YG+ DV+ G++L
Sbjct: 197 PHFMAPEVVKREPYGKP------VDVWGCGVIL 223
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 63/266 (23%), Positives = 104/266 (39%), Gaps = 65/266 (24%)
Query: 9 SRYRKRGKQLPNDANMPPVATWRRFSYLELFQATDGFSEN----NLIGRGSFGSVYKAR- 63
+ +K P + L + A F + ++IGRG V +
Sbjct: 56 AEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVH 115
Query: 64 IQDGMEVAVKVF--------HLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFK 114
G E AVK+ Q V ++ E +++ + H ++I +I + + F
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 115 ALVLEYMPHGSL-----EKCLYS----SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
LV + M G L EK S + + + + A+ +LH + ++
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE----------AVSFLH---ANNIV 222
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI----GYMAPE------ 215
H DLKP N+LLDDNM LSDFG + L + L + GY+APE
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHL-------EPGEKLRELCGTPGYLAPEILKCSM 275
Query: 216 ------YGREGRVSTNGDVYSFGIML 235
YG+E D+++ G++L
Sbjct: 276 DETHPGYGKE------VDLWACGVIL 295
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 25/236 (10%)
Query: 13 KRGKQLPNDANMPPVATWRRFSYLELFQATDGFSEN----NLIGRGSFGSVYKAR-IQDG 67
K ND + W+++ + + +G G+FG V++ G
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76
Query: 68 MEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL- 126
K + + E +M + H LI + + L+LE++ G L
Sbjct: 77 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136
Query: 127 -----EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181
E S V +N M L+++H ++H D+KP N++ +
Sbjct: 137 DRIAAEDYKMSEAEV------INYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKA 187
Query: 182 AHL--SDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 235
+ + DFG+A L + + T AT + APE V D+++ G++
Sbjct: 188 SSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-24
Identities = 47/206 (22%), Positives = 92/206 (44%), Gaps = 43/206 (20%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFH--LQCGGVFKSFDVECEVMKSIRHRNLIKIIST 107
+G+G+F V + G+E A K+ + F+ + E + + ++H N++++ +
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 108 CSNDDFKALVLEYMPHGSL-----EKCLYS----SNCVLDIFQRLNIMIDVAAALEYLHF 158
+ F LV + + G L + YS S+C+ I + ++ Y H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE----------SIAYCH- 145
Query: 159 GYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
S ++H +LKP N+LL L+DFG+A + + S++ T GY++PE
Sbjct: 146 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSPE 200
Query: 216 ------YGREGRVSTNGDVYSFGIML 235
Y + D+++ G++L
Sbjct: 201 VLKKDPYSKP------VDIWACGVIL 220
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 35/202 (17%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIKIIS 106
+G+GSFG V + G E AVKV ++ +S E +++K + H N++K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 107 TCSNDDFKALVLEYMPHGSL-----EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS 161
+ + LV E G L + +S I ++ V + + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYMH---K 144
Query: 162 APVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE--- 215
++H DLKP N+LL + + DFG++ + SK + T Y+APE
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEVLH 201
Query: 216 --YGREGRVSTNGDVYSFGIML 235
Y + DV+S G++L
Sbjct: 202 GTYDEK------CDVWSTGVIL 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-23
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECE-----------VMKSIRH 98
IG G++G+V+KA+ + VA+K L D + E ++K ++H
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRL---------DDDDEGVPSSALREICLLKELKH 60
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHF 158
+N++++ +D LV E+ L+K S N LD + + + L + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH- 118
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE--Y 216
S V+H DLKP N+L++ N L++FG+A+ + + + T+ Y P+ +
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG--IPVRCYSAEVVTLWYRPPDVLF 174
Query: 217 GREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
G + ST+ D++S G + E +P +F G
Sbjct: 175 GAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 47/212 (22%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFH---LQCGGVFKSFDV-----ECEVMKSIRHRNL 101
+G G+ G V A + +VA+++ G ++ E E++K + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 102 IKIISTCSNDDFKALVLEYMPHGSL-----EKCLYSSNCVLDIFQRLNIMIDVAAALEYL 156
IKI + +D+ +VLE M G L F + A++YL
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 255
Query: 157 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYM 212
H +IH DLKP NVLL +++ + ++DFG +K+L S +TL T Y+
Sbjct: 256 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTPTYL 308
Query: 213 APE---------YGREGRVSTNGDVYSFGIML 235
APE Y R V D +S G++L
Sbjct: 309 APEVLVSVGTAGYNRA--V----DCWSLGVIL 334
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 34/201 (16%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV--ECEVMKSIRHRNLIKIIST 107
+G G++G V R +E A+K+ + + E V+K + H N++K+
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 108 CSNDDFKALVLEYMPHGSL-----EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
+ LV+E G L + ++ I + V + + YLH
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK------QVLSGVTYLH---KH 155
Query: 163 PVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE---- 215
++H DLKP N+LL + + + + DFG++ + + K + L T Y+APE
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPEVLRK 212
Query: 216 -YGREGRVSTNGDVYSFGIML 235
Y + DV+S G++L
Sbjct: 213 KYDEK------CDVWSIGVIL 227
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 47/206 (22%), Positives = 93/206 (45%), Gaps = 43/206 (20%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIIST 107
+G+G+F V + G+E A K+ + + F+ + E + + ++H N++++ +
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 108 CSNDDFKALVLEYMPHGSL-----EKCLYS----SNCVLDIFQRLNIMIDVAAALEYLHF 158
+ F LV + + G L + YS S+C+ I + ++ Y H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE----------SIAYCH- 122
Query: 159 GYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
S ++H +LKP N+LL L+DFG+A + + S++ T GY++PE
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSPE 177
Query: 216 ------YGREGRVSTNGDVYSFGIML 235
Y + D+++ G++L
Sbjct: 178 VLKKDPYSKP------VDIWACGVIL 197
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-23
Identities = 56/231 (24%), Positives = 91/231 (39%), Gaps = 52/231 (22%)
Query: 41 ATDGFSEN---------NLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVEC 90
+TD FS +++G G+ V + E AVK+ Q G + E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 91 EVMKSIR-HRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL------ 143
E++ + HRN++++I +D LV E M GS+ +
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHF 108
Query: 144 ------NIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLT 194
++ DVA+AL++LH + + H DLKP N+L + + DF + +
Sbjct: 109 NELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165
Query: 195 -GEDQSKSQTQTLATI----GYMAPEYGREGRVSTNG-----DVYSFGIML 235
D S T L T YMAPE + D++S G++L
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-23
Identities = 49/212 (23%), Positives = 79/212 (37%), Gaps = 58/212 (27%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEV---MKSIRHRNLIKIIS 106
IG GS+ + ME AVK+ D E+ ++ +H N+I +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL------------NIMIDVAAALE 154
+ + +V E M G L ++ ++ + +E
Sbjct: 84 VYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLFTITKTVE 130
Query: 155 YLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TI 209
YLH + V+H DLKPSN+L + + DFG AK L E+ T T
Sbjct: 131 YLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL---LMTPCYTA 184
Query: 210 GYMAPE------YGREGRVSTNGDVYSFGIML 235
++APE Y D++S G++L
Sbjct: 185 NFVAPEVLERQGYDAA--C----DIWSLGVLL 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-23
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 47/212 (22%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFH---LQCGGVFKSFDV-----ECEVMKSIRHRNL 101
+G G+ G V A + +VA+K+ G ++ E E++K + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 102 IKIISTCSNDDFKALVLEYMPHGSL-----EKCLYSSNCVLDIFQRLNIMIDVAAALEYL 156
IKI + +D+ +VLE M G L F + A++YL
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 130
Query: 157 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYM 212
H +IH DLKP NVLL +++ + ++DFG +K+L S +TL T Y+
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTPTYL 183
Query: 213 APE---------YGREGRVSTNGDVYSFGIML 235
APE Y R V D +S G++L
Sbjct: 184 APEVLVSVGTAGYNRA--V----DCWSLGVIL 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 9e-23
Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 48/208 (23%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFH--LQCGGVFKSFDVECEVMKSIRHRNLIKIIST 107
+G+GSFG V K + E AVKV + + E E++K + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL------------NIMIDVAAALEY 155
+ +V E G L F + I+ V + + Y
Sbjct: 90 LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 156 LHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212
+H ++H DLKP N+LL + + + DFG++ Q+ + T Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYI 190
Query: 213 APE-----YGREGRVSTNGDVYSFGIML 235
APE Y + DV+S G++L
Sbjct: 191 APEVLRGTYDEK------CDVWSAGVIL 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 48/208 (23%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV--ECEVMKSIRHRNLIKIIST 107
+G+GSFG V K + E AVKV + + + E E++K + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL------------NIMIDVAAALEY 155
+ +V E G L F + I+ V + + Y
Sbjct: 90 LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 156 LHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212
+H ++H DLKP N+LL + + + DFG++ Q+ + T Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYI 190
Query: 213 APE-----YGREGRVSTNGDVYSFGIML 235
APE Y + DV+S G++L
Sbjct: 191 APEVLRGTYDEK------CDVWSAGVIL 212
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 62/245 (25%), Positives = 95/245 (38%), Gaps = 57/245 (23%)
Query: 19 PNDANMPPVATWRRFSYLELFQATDGFSEN----NLIGRGSFGSVYKAR-IQDGMEVAVK 73
A+ P Y D S+ + +GRG+ VY+ + A+K
Sbjct: 25 SVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK 84
Query: 74 VFHLQCGGVFKSFDV-----ECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL-- 126
V K+ D E V+ + H N+IK+ +LVLE + G L
Sbjct: 85 VLK-------KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFD 137
Query: 127 ---EKCLYS----SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL--- 176
EK YS ++ V I + A+ YLH ++H DLKP N+L
Sbjct: 138 RIVEKGYYSERDAADAVKQILE----------AVAYLH---ENGIVHRDLKPENLLYATP 184
Query: 177 DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE------YGREGRVSTNGDVYS 230
+ ++DFG++K++ + T GY APE YG E V D++S
Sbjct: 185 APDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAPEILRGCAYGPE--V----DMWS 235
Query: 231 FGIML 235
GI+
Sbjct: 236 VGIIT 240
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 50/234 (21%), Positives = 86/234 (36%), Gaps = 31/234 (13%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFH----LQCGGVFKSFDVECEVMKSIRHRNLIK- 103
L+G GS+G V + + AVK+ + + E ++++ +RH+N+I+
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 104 --IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS 161
++ +V+EY G E + Q + LEYLH S
Sbjct: 72 VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---S 127
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI----GYMAPE-- 215
++H D+KP N+LL +S G+A+ L + T T + PE
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL----HPFAADDTCRTSQGSPAFQPPEIA 183
Query: 216 YGREGRVSTNGDVYSFGIMLMETFTKKKPTD---------KIFAGEMTLKYWVS 260
G + D++S G+ L T P + I G +
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCG 237
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 59/221 (26%)
Query: 49 NLIGRGSFGSVYKAR-IQDGMEVAVKV-------------FHLQCGGVFKSFDVECEVMK 94
+G G++G V + E A+KV + + E ++K
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 95 SIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL----------- 143
S+ H N+IK+ + + LV E+ G L F+++
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-------------FEQIINRHKFDECDA 148
Query: 144 -NIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQS 199
NIM + + + YLH ++H D+KP N+LL + + + DFG++ +
Sbjct: 149 ANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKD 202
Query: 200 KSQTQTLATIGYMAPE-----YGREGRVSTNGDVYSFGIML 235
L T Y+APE Y + DV+S G+++
Sbjct: 203 YKLRDRLGTAYYIAPEVLKKKYNEK------CDVWSCGVIM 237
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 48/237 (20%), Positives = 88/237 (37%), Gaps = 25/237 (10%)
Query: 12 RKRGKQLPNDANMPPVATWRRFSYLELFQATDGFSE----NNLIGRGSFGSVYKAR-IQD 66
+ + ++ + W+++ + D + + +G G+FG V++
Sbjct: 122 VRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERAT 181
Query: 67 GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSL 126
G A K ++ E + M +RH L+ + +D+ ++ E+M G L
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241
Query: 127 ------EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180
E S + + M V L ++H +H DLKP N++
Sbjct: 242 FEKVADEHNKMSEDEA------VEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKR 292
Query: 181 VAHL--SDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 235
L DFG+ L D +S T T + APE V D++S G++
Sbjct: 293 SNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 33/223 (14%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECE----------- 91
+ + + +G G++G VYKA+ G VA+K L D E E
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL---------DAEDEGIPSTAIREIS 71
Query: 92 VMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA 151
++K + H N++ +I ++ LV E+M L+K L + L Q + +
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY 211
+ + H ++H DLKP N+L++ + L+DFG+A+ +S T + T+ Y
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFG--IPVRSYTHEVVTLWY 185
Query: 212 MAPE--YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
AP+ G + + ST+ D++S G + E T KP +F G
Sbjct: 186 RAPDVLMGSK-KYSTSVDIWSIGCIFAEMIT-GKP---LFPGV 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-22
Identities = 56/199 (28%), Positives = 81/199 (40%), Gaps = 32/199 (16%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS 109
IGRGS+G V A + A K F E E+MKS+ H N+I++ T
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 110 NDDFKALVLEYMPHGSL-----EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
++ LV+E G L K ++ + I + DV +A+ Y H V
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCH---KLNV 127
Query: 165 IHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE-----Y 216
H DLKP N L + L DFG+A K + T Y++P+ Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGTPYYVSPQVLEGLY 184
Query: 217 GREGRVSTNGDVYSFGIML 235
G E D +S G+M+
Sbjct: 185 GPE------CDEWSAGVMM 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 3e-22
Identities = 51/236 (21%), Positives = 82/236 (34%), Gaps = 54/236 (22%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV-----ECEVMKSIRHRNLIKI 104
IG+GS+G V A Q A+K+ + DV E +MK + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 105 ISTCSNDDFKALVLEYMPHGSL-----EKCLYSSNCVLDIFQRL---------------- 143
++ + LV+E G L S+ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 144 ------------------NIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL- 184
NIM + +AL YLH + + H D+KP N L N +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 185 -SDFGIAKLLTGEDQSKSQ--TQTLATIGYMAPE--YGREGRVSTNGDVYSFGIML 235
DFG++K + + T T ++APE D +S G++L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 51/212 (24%), Positives = 83/212 (39%), Gaps = 58/212 (27%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSF--DV--ECEVMKSIR-HRNLIKI 104
+G GSF K + AVK+ + K + E +K H N++K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKI-------ISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL------------NIMIDVAAA 152
+ LV+E + G L F+R+ IM + +A
Sbjct: 72 HEVFHDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSA 118
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
+ ++H V+H DLKP N+L +DN+ + DFG A+L ++Q T+
Sbjct: 119 VSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTL 173
Query: 210 GYMAPE------YGREGRVSTNGDVYSFGIML 235
Y APE Y D++S G++L
Sbjct: 174 HYAAPELLNQNGYDES------CDLWSLGVIL 199
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-22
Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 51/242 (21%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVEC-----EVMKSIRHRNLIK 103
++G GSF +V AR + E A+K+ L+ + K V +VM + H +K
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVA--------AALEY 155
+ T +D+ L Y +G L K + +ALEY
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEY 145
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATIGYMAP 214
LH +IH DLKP N+LL+++M ++DFG AK+L+ + +++ + T Y++P
Sbjct: 146 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANSFVGTAQYVSP 201
Query: 215 EYGREGRVSTNGDVYSFGI----ML-----------METFTKKKPTDKIFAGEMTLKYWV 259
E E + D+++ G ++ F KI E
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF------QKIIKLEYDFPEKF 255
Query: 260 SN 261
Sbjct: 256 FP 257
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-22
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 40/232 (17%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDV-ECEVMKSIR 97
Q ++ +IG GSFG V++A++ + EVA+K K F E ++M+ ++
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVK 90
Query: 98 HRNLIK----IISTCSNDDFKA--LVLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMID 148
H N++ S D LVLEY+P ++ + + + M
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
+ +L Y+H S + H D+KP N+LLD + V L DFG AK+L + +
Sbjct: 150 LLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL---IAGEPNVSYIC 203
Query: 208 TIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
+ Y APE Y +TN D++S G ++ E +P +F GE
Sbjct: 204 SRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQ-GQP---LFPGE 245
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-22
Identities = 51/229 (22%), Positives = 84/229 (36%), Gaps = 36/229 (15%)
Query: 37 ELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVK--VFHLQCGGVFKSFDV------ 88
EL ++ I GS+G+V +G+ VA+K + G
Sbjct: 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 89 ---ECEVMKSIRHRNLIK---IISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIF 140
E ++ H N++ I LV E M L + ++ V+
Sbjct: 76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQ 134
Query: 141 QRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200
M + L LH A V+H DL P N+LL DN + DF +A+ +
Sbjct: 135 HIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADA 188
Query: 201 SQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTKK 242
++T + Y APE + + D++S G ++ E F +K
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRK 231
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 8e-22
Identities = 47/200 (23%), Positives = 84/200 (42%), Gaps = 21/200 (10%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
S+ ++G G FG V+K G+++A K+ + + E VM + H NLI+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 104 IISTCSNDDFKALVLEYMPHGSL------EKCLYSSNCVLDIFQRLNIMIDVAAALEYLH 157
+ + + LV+EY+ G L E + + M + + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL------FMKQICEGIRHMH 204
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
Y ++H DLKP N+L + + DFG+A+ + T ++APE
Sbjct: 205 QMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPEFLAPE 258
Query: 216 YGREGRVSTNGDVYSFGIML 235
VS D++S G++
Sbjct: 259 VVNYDFVSFPTDMWSVGVIA 278
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-21
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFK-SFDV----ECEVMKSIRHRNLIKI 104
+G G F +VYKAR VA+K L K + E ++++ + H N+I +
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
+ + +LV ++M LE + ++ VL M+ LEYLH +
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 133
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE--YGREGRV 222
+H DLKP+N+LLD+N V L+DFG+AK +++ T + T Y APE +G
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGAR-MY 190
Query: 223 STNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
D+++ G +L E + P G+
Sbjct: 191 GVGVDMWAVGCILAELLL-RVP---FLPGD 216
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-21
Identities = 45/208 (21%), Positives = 74/208 (35%), Gaps = 42/208 (20%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHL-QCGGVFKSFDV-----ECEVMKSIRHRNLIK 103
+G G F V K R G+E A K Q + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL------------NIMIDVAA 151
+ N L+LE + G L F L + + +
Sbjct: 80 LHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEATSFIKQILD 126
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
+ YLH + + H DLKP N++L L DFG+A + +
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFG 180
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIML 235
T ++APE + D++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 50/208 (24%), Positives = 76/208 (36%), Gaps = 42/208 (20%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHL-QCGGVFKSFDV-----ECEVMKSIRHRNLIK 103
+G G F V K R G E A K + + E +++ IRH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL------------NIMIDVAA 151
+ N L+LE + G L F L + +
Sbjct: 73 LHDIFENKTDVVLILELVSGGEL-------------FDFLAEKESLTEDEATQFLKQILD 119
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLTGEDQSKSQTQTLA 207
+ YLH S + H DLKP N++L D V + L DFGIA + +
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFKNIFG 173
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIML 235
T ++APE + D++S G++
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 2e-21
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 33/223 (14%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECE----------- 91
+ + IG G++G VYKA+ G A+K L + E E
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL---------EKEDEGIPSTTIREIS 52
Query: 92 VMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA 151
++K ++H N++K+ LV E++ L+K L L+ + ++ +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY 211
+ Y H V+H DLKP N+L++ ++DFG+A+ + T + T+ Y
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWY 166
Query: 212 MAPE--YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
AP+ G + + ST D++S G + E P +F G
Sbjct: 167 RAPDVLMGSK-KYSTTIDIWSVGCIFAEMVN-GTP---LFPGV 204
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-21
Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 26/212 (12%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIIST 107
IG GS+G V+K R G VA+K F + K E ++K ++H NL+ ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
LV EY H ++ L + +I A+ + H IH
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126
Query: 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE-------YGREG 220
D+KP N+L+ + V L DFG A+LLTG S +AT Y +PE Y
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATRWYRSPELLVGDTQY---- 180
Query: 221 RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
DV++ G + E + P ++ G+
Sbjct: 181 --GPPVDVWAIGCVFAELLS-GVP---LWPGK 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 59/241 (24%), Positives = 94/241 (39%), Gaps = 55/241 (22%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVF---HLQCGGVFKSFDV-----ECEVMKSIRHRNL 101
+G G+FG V+ A + EV VK + + + E ++ + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIF------QRLN------IMIDV 149
IK++ N F LV+E G LD+F RL+ I +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG------------LDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
+A+ YL +IH D+K N+++ ++ L DFG A L E T TI
Sbjct: 140 VSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTI 193
Query: 210 GYMAPE------Y-GREGRVSTNGDVYSFGIMLMETFTKKKP---TDKIFAGEMTLKYWV 259
Y APE Y G E +++S G+ L ++ P ++ + Y V
Sbjct: 194 EYCAPEVLMGNPYRGPE------LEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV 247
Query: 260 S 260
S
Sbjct: 248 S 248
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-21
Identities = 51/261 (19%), Positives = 93/261 (35%), Gaps = 71/261 (27%)
Query: 51 IGRGSFGSVYKARI------QDGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSI-RHRNLI 102
+GRG+FG V +A VAVK+ ++ E +++ I H N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 103 KIISTCSNDDFKALV-LEYMPHGSLEKCL----------------------YSSNCVLDI 139
++ C+ +V +E+ G+L L Y +D+
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 140 FQRLNIMI------------------------------DVAAALEYLHFGY--------- 160
+RL+ + D + + +
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 161 -SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE 219
S IH DL N+LL + V + DFG+A+ + + + + +MAPE +
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269
Query: 220 GRVSTNGDVYSFGIMLMETFT 240
+ DV+SFG++L E F+
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFS 290
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 46/201 (22%), Positives = 76/201 (37%), Gaps = 28/201 (13%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFH-LQCGGVFKSFDV-----ECEVMKSIRHRNLIK 103
+G G F V K R G++ A K + + E ++K I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 104 IISTCSNDDFKALVLEYMPHGSL-----EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHF 158
+ N L+LE + G L EK + + + + + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQILNGVYYLH- 131
Query: 159 GYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAP 214
S + H DLKP N++L + DFG+A + D T ++AP
Sbjct: 132 --SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 186
Query: 215 EYGREGRVSTNGDVYSFGIML 235
E + D++S G++
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-21
Identities = 45/208 (21%), Positives = 74/208 (35%), Gaps = 42/208 (20%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFH-LQCGGVFKSFDV-----ECEVMKSIRHRNLIK 103
+G G F V K R G+E A K Q + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL------------NIMIDVAA 151
+ N L+LE + G L F L + + +
Sbjct: 80 LHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEATSFIKQILD 126
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
+ YLH + + H DLKP N++L L DFG+A + +
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFG 180
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIML 235
T ++APE + D++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 6e-21
Identities = 32/201 (15%), Positives = 57/201 (28%), Gaps = 43/201 (21%)
Query: 50 LIGRGSFGSVYKARIQD---GMEVAVKVFHLQCG---GVFKSFDVECEVMKSIRHRNLIK 103
G ++A D +VA+ Q V + + I + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
++ +V E++ GSL++ +S + M +AAA + H A
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVS 223
V PS V + + G LA M ++
Sbjct: 150 VALSIDHPSRVRVSID--------GDVV--------------LAYPATMPDANPQD---- 183
Query: 224 TNGDVYSFGIMLMETFTKKKP 244
D+ G L + P
Sbjct: 184 ---DIRGIGASLYALLVNRWP 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-21
Identities = 67/234 (28%), Positives = 107/234 (45%), Gaps = 43/234 (18%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKARIQD-GMEVAVK-VFHLQCGGVFKSFDV-ECEVMKS 95
+++ +IG GSFG VY+A++ D G VA+K V K F E ++M+
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRK 103
Query: 96 IRHRNLIK----IISTCSNDDFKAL--VLEYMPHGSLEKCLYS---SNCVLDIFQRLNIM 146
+ H N+++ S+ D L VL+Y+P ++ + + L + M
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 147 IDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSKSQTQT 205
+ +L Y+H S + H D+KP N+LLD D V L DFG AK L + + S
Sbjct: 163 YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 216
Query: 206 LATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
+ + Y APE Y +++ DV+S G +L E +P IF G+
Sbjct: 217 ICSRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLL-GQP---IFPGD 260
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-21
Identities = 58/245 (23%), Positives = 89/245 (36%), Gaps = 59/245 (24%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFH----LQCGGVFKSFDVECEV--MKSIR----H 98
L+G+G FG+V+ + D ++VA+KV L + S EV + + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIF------QRL------NIM 146
+I+++ + LVLE D+F L
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQ------------DLFDYITEKGPLGEGPSRCFF 145
Query: 147 IDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSKSQTQT 205
V AA+++ H S V+H D+K N+L+D A L DFG LL E +
Sbjct: 146 GQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD--- 199
Query: 206 LATIGYMAPEY-------GREGRVSTNGDVYSFGIMLMETFTKKKP---TDKIFAGEMTL 255
T Y PE+ V+S GI+L + P +I E+
Sbjct: 200 -GTRVYSPPEWISRHQYHALP------ATVWSLGILLYDMVCGDIPFERDQEILEAELHF 252
Query: 256 KYWVS 260
VS
Sbjct: 253 PAHVS 257
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-21
Identities = 52/211 (24%), Positives = 84/211 (39%), Gaps = 51/211 (24%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFH-LQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
+G G+FG V+ G+E +K + + + + E EV+KS+ H N+IKI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL----------------NIMIDVAAA 152
+ +V+E G L +R+ +M + A
Sbjct: 90 EDYHNMYIVMETCEGGEL-------------LERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
L Y H S V+H DLKP N+L + + DFG+A+L + T T
Sbjct: 137 LAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF---KSDEHSTNAAGTA 190
Query: 210 GYMAPE-----YGREGRVSTNGDVYSFGIML 235
YMAPE + D++S G+++
Sbjct: 191 LYMAPEVFKRDVTFK------CDIWSAGVVM 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-21
Identities = 39/200 (19%), Positives = 76/200 (38%), Gaps = 34/200 (17%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV-----ECEVMKSIRHRNLIKI 104
+GRG FG V++ K + K D E ++ RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISILNIARHRNILHL 66
Query: 105 ISTCSNDDFKALVLEYMPHGSL------EKCLYS-SNCVLDIFQRLNIMIDVAAALEYLH 157
+ + + ++ E++ + + V + + V AL++LH
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV-------SYVHQVCEALQFLH 119
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
+ H D++P N++ + + +FG A+ L + Y APE
Sbjct: 120 SHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPE 173
Query: 216 YGREGRVSTNGDVYSFGIML 235
+ VST D++S G ++
Sbjct: 174 VHQHDVVSTATDMWSLGTLV 193
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHL-QCGGVFKSFDV-ECEVMKS 95
FQ+ + + L+G GS+G V K R G VA+K F + K + E +++K
Sbjct: 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 96 IRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEY 155
+RH NL+ ++ C LV E++ H ++ L LD + + + +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
H S +IH D+KP N+L+ + V L DFG A+ L + +AT Y APE
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA--APGEVYDDEVATRWYRAPE 194
Query: 216 --YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
G + + DV++ G ++ E F +P +F G+
Sbjct: 195 LLVG-DVKYGKAVDVWAIGCLVTEMFM-GEP---LFPGD 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 43/199 (21%), Positives = 82/199 (41%), Gaps = 26/199 (13%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV--ECEVMKSIRHR-NLIKIIS 106
+GRG F V + G E A K + G ++ E V++ + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 107 TCSNDDFKALVLEYMPHGSL-EKCLYSSNCVLDIFQRL------NIMIDVAAALEYLHFG 159
N L+LEY G + C + ++ + + ++ + + YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAH---LSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY 216
++H DLKP N+LL + DFG+++ + + + + T Y+APE
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELREIMGTPEYLAPEI 204
Query: 217 GREGRVSTNGDVYSFGIML 235
++T D+++ GI+
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-20
Identities = 50/214 (23%), Positives = 98/214 (45%), Gaps = 15/214 (7%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRN 100
+ + + + +G G++ +VYK + VA+K L+ G + E ++K ++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
++ + + LV EY+ L++ L ++++ + + L Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--- 117
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE--YGR 218
V+H DLKP N+L+++ L+DFG+A+ + +K+ + T+ Y P+ G
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKS--IPTKTYDNEVVTLWYRPPDILLGS 175
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
ST D++ G + E T +P +F G
Sbjct: 176 T-DYSTQIDMWGVGCIFYEMAT-GRP---LFPGS 204
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 60/215 (27%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEV---MKSIRHRNLIKII 105
++G G G V + + G + A+K+ + S EV ++ +++ I+
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88
Query: 106 STCSNDDFKA----LVLEYMPHGSLEKCLYSSNCVLD-IFQRLN----------IMIDVA 150
N +++E M G L I +R + IM D+
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138
Query: 151 AALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA 207
A+++LH S + H D+KP N+L + + V L+DFG AK T QT
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPC 190
Query: 208 -TIGYMAPE------YGREGRVSTNGDVYSFGIML 235
T Y+APE Y + D++S G+++
Sbjct: 191 YTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 219
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 3e-20
Identities = 36/165 (21%), Positives = 72/165 (43%), Gaps = 15/165 (9%)
Query: 85 SFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCV--LDIFQR 142
+ V+ M +N + + S + + ++ +L+ + + +
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 143 LNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202
L+I I +A A+E+LH S ++H DLKPSN+ + V + DFG+ + +++ ++
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 203 TQTLA----------TIGYMAPEYGREGRVSTNGDVYSFGIMLME 237
+ T YM+PE S D++S G++L E
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 14/91 (15%), Positives = 31/91 (34%), Gaps = 2/91 (2%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVK-VFHLQCGGVFKSFDVECEVMKSIRHRNLI 102
F +GRG FG V++A+ D A+K + + E + + + H ++
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSS 133
+ + + E ++
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-20
Identities = 58/235 (24%), Positives = 91/235 (38%), Gaps = 41/235 (17%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFH----LQCGGVFKSFDVECEV--MKSIRHR--N 100
L+G G FGSVY + D + VA+K G + V EV +K +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLY---SSNCVLDIFQRLNIMIDVAAALEYLH 157
+I+++ D L+LE P + L+ + L + V A+ + H
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 158 FGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYMAPE 215
+ V+H D+K N+L+D N L DFG LL + T Y PE
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFDGTRVYSPPE 218
Query: 216 Y-------GREGRVSTNGDVYSFGIMLMETFTKKKP---TDKIFAGEMTLKYWVS 260
+ GR V+S GI+L + P ++I G++ + VS
Sbjct: 219 WIRYHRYHGRS------AAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 267
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-20
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 45/237 (18%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIK-- 103
+G G+FG V G +VAVK+ ++ V E + +K RH ++IK
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 104 -IISTCSNDDFKALVLEYMPHGSL-----EKCLYSSNCVLDIFQRLNIMIDVAAALEYLH 157
+IST D F +V+EY+ G L + +FQ++ +A++Y H
Sbjct: 78 QVIST-PTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------LSAVDYCH 128
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI----GYMA 213
V+H DLKP NVLLD +M A ++DFG++ +++ + L T Y A
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-------LRTSCGSPNYAA 178
Query: 214 PE-YGREGRVSTNGDVYSFGIMLMETFTKKKPTD---------KIFAGEMTLKYWVS 260
PE D++S G++L P D KI G + +++
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 8e-20
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 33/221 (14%)
Query: 38 LFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV------EC 90
F + IG G+ G V A VA+K + F++ E
Sbjct: 20 TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK----KLSRPFQNQTHAKRAYREL 75
Query: 91 EVMKSIRHRNLIKI----ISTCSNDDFKA--LVLEYMP---HGSLEKCLYSSNCVLDIFQ 141
+MK + H+N+I + S ++F+ +V+E M ++ L ++Q
Sbjct: 76 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 135
Query: 142 RLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201
L +++LH SA +IH DLKPSN+++ + + DFG+A+ S
Sbjct: 136 MLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFM 182
Query: 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKK 242
T + T Y APE N D++S G ++ E
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 42/226 (18%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECE-----------VMKSIRH 98
IG+G+FG V+KAR + G +VA+K + + E E +++ ++H
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLM---------ENEKEGFPITALREIKILQLLKH 75
Query: 99 RN---LIKIISTCSNDDFKA-----LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVA 150
N LI+I T ++ + LV ++ H L L + + + +M +
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 151 AALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ--TQTLAT 208
L Y+H ++H D+K +NVL+ + V L+DFG+A+ + S+ T + T
Sbjct: 135 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 209 IGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
+ Y PE G E D++ G ++ E +T + P I G
Sbjct: 192 LWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWT-RSP---IMQGN 232
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 46/217 (21%), Positives = 82/217 (37%), Gaps = 65/217 (29%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEV---MKSIRHRNLIKIIS 106
+G G G V + + + A+K+ + EV ++ + ++++I+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKM-------LQDCPKARREVELHWRASQCPHIVRIVD 122
Query: 107 TC----SNDDFKALVLEYMPHGSLEKCLYSSNCVLD-IFQRLN----------IMIDVAA 151
+ +V+E + G L I R + IM +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
A++YLH S + H D+KP N+L N + L+DFG AK T +L T
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-------NSLTT 222
Query: 209 I----GYMAPE------YGREGRVSTNGDVYSFGIML 235
Y+APE Y + D++S G+++
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 253
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 60/243 (24%), Positives = 93/243 (38%), Gaps = 53/243 (21%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIKII 105
IG G+FG R VAVK V + E +S+RH N+++
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82
Query: 106 STCSNDDFKALVLEYMPHGSL-----EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
A+++EY G L +S + FQ+L + + Y H
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LSGVSYCH--- 133
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLTGEDQSKSQTQTLATIGYMAPE--Y 216
S + H DLK N LLD + L DFG +K Q KS T A Y+APE
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 190
Query: 217 GRE--GRVSTNGDVYSFGIML---------------METFTKKKPTDKIFAGEMTL--KY 257
+E G+++ DV+S G+ L + +K +I + + ++
Sbjct: 191 RQEYDGKIA---DVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSVKYSIPDDI 245
Query: 258 WVS 260
+S
Sbjct: 246 RIS 248
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVEC-----EVMKSI 96
D F + ++GRG FG V+ +++ ++ A K L + K + +++ +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 97 RHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIF--QRLNIMI-DVAAAL 153
R ++ + LV+ M G + +Y+ + F R + + L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYM 212
E+LH +I+ DLKP NVLLDD+ +SD G+A L ++T+ A T G+M
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFM 356
Query: 213 APEYGREGRVSTNGDVYSFGIMLME 237
APE + D ++ G+ L E
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYE 381
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 55/242 (22%), Positives = 93/242 (38%), Gaps = 53/242 (21%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDV--------- 88
+ D F + G+G+FG+V + + GM VA+K K
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK----------KVIQDPRFRNRELQ 68
Query: 89 ECEVMKSIRHRNLIKII-------STCSNDDFKALVLEYMP---HGSLEKCLYSSNCVLD 138
+ + + H N++++ D + +V+EY+P H
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPP 128
Query: 139 IFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGED 197
I ++ + + ++ LH S V H D+KP NVL++ + L DFG AK L
Sbjct: 129 ILIKV-FLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL---S 183
Query: 198 QSKSQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFA 250
S+ + + Y APE Y +T D++S G + E +P IF
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMML-GEP---IFR 233
Query: 251 GE 252
G+
Sbjct: 234 GD 235
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 46/212 (21%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVEC-----EVMKSIRHRNLIK 103
+IGRG+FG V R + +V A+K+ L + K D ++M +++
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVA--------AALEY 155
+ +D + +V+EYMP G L +++ ++ A AL+
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
+H S IH D+KP N+LLD + L+DFG + E + T + T Y++PE
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPE 239
Query: 216 ----------YGREGRVSTNGDVYSFGIMLME 237
YGRE D +S G+ L E
Sbjct: 240 VLKSQGGDGYYGRE--C----DWWSVGVFLYE 265
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 56/216 (25%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVEC-----EVMKSIRHRNLIK 103
IG+GSFG V + D ++ A+K + + +V ++M+ + H L+
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKY--MNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMI------------DVAA 151
+ + +++ +V++ + G D+ L + ++
Sbjct: 80 LWYSFQDEEDMFMVVDLLLGG-------------DLRYHLQQNVHFKEETVKLFICELVM 126
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIG 210
AL+YL + +IH D+KP N+LLD++ H++DF IA +L E Q T+A T
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTKP 179
Query: 211 YMAPE---------YGREGRVSTNGDVYSFGIMLME 237
YMAPE Y V D +S G+ E
Sbjct: 180 YMAPEMFSSRKGAGYSFA--V----DWWSLGVTAYE 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-19
Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 49/210 (23%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV------ECEVMKSIRHRNLI 102
+G G++G V A VAVK+ ++ ++ D E + K + H N++
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINKMLNHENVV 68
Query: 103 KIISTCSNDDFKALVLEYMPHGSL-------------EKCLYSSNCVLDIFQRLNIMIDV 149
K + + L LEY G L + + F +L
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--------FHQL------ 114
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
A + YLH + H D+KP N+LLD+ +SDFG+A + ++ + + T+
Sbjct: 115 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 210 GYMAPE--YGRE--GRVSTNGDVYSFGIML 235
Y+APE RE DV+S GI+L
Sbjct: 172 PYVAPELLKRREFHAEPV---DVWSCGIVL 198
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 8e-19
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 45 FSENNLIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVEC--------EVMKS 95
FS + +IGRG FG VY R D ++ A+K L + ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVST 248
Query: 96 IRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEY 155
++ + D + +L+ M G L L + R ++ LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYMAP 214
+H + V++ DLKP+N+LLD++ +SD G+A D SK + T GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAP 359
Query: 215 E-YGREGRVSTNGDVYSFGIMLMETFTKKKP 244
E + ++ D +S G ML + P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-19
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQC--GGVFKSFDV----ECEVMKSIRHRNLIK 103
+G G++ +VYK G+ VA+K L G E +MK ++H N+++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG-----TPSTAIREISLMKELKHENIVR 67
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCV-----LDIFQRLNIMIDVAAALEYLHF 158
+ ++ LV E+M + L+K + S L++ + L + H
Sbjct: 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE--Y 216
++H DLKP N+L++ L DFG+A+ + + + T+ Y AP+
Sbjct: 127 NK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG--IPVNTFSSEVVTLWYRAPDVLM 181
Query: 217 GREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
G ST+ D++S G +L E T KP +F G
Sbjct: 182 GSR-TYSTSIDIWSCGCILAEMIT-GKP---LFPGT 212
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 33 FSYLELFQAT-DGFSENNLIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVEC 90
+ +LE T + F + ++G+G FG V +++ ++ A K L+ + K
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAM 230
Query: 91 -----EVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNI 145
++++ + R ++ + D LVL M G L+ +Y + F
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARA 288
Query: 146 MI---DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202
+ ++ LE LH +++ DLKP N+LLDD+ +SD G+A
Sbjct: 289 VFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQT 341
Query: 203 TQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLME 237
+ T+GYMAPE + R + + D ++ G +L E
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 40/221 (18%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECE-----------VMKSIRH 98
+G G++G VYKA VA+K L + E E ++K ++H
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRL---------EHEEEGVPGTAIREVSLLKELQH 92
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHF 158
RN+I++ S ++ L+ EY + L+K + N + + + + + + + H
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH- 149
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAH-----LSDFGIAKLLTGEDQSKSQTQTLATIGYMA 213
S +H DLKP N+LL + + + DFG+A+ + T + T+ Y
Sbjct: 150 --SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG--IPIRQFTHEIITLWYRP 205
Query: 214 PE--YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
PE G ST+ D++S + E K P +F G+
Sbjct: 206 PEILLGSR-HYSTSVDIWSIACIWAEMLM-KTP---LFPGD 241
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 39/224 (17%)
Query: 38 LFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV-------- 88
F + IG G+ G V A VA+K + + F
Sbjct: 57 TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-------KLSRPFQNQTHAKRAY 109
Query: 89 -ECEVMKSIRHRNLIKII----STCSNDDFKA--LVLEYMP---HGSLEKCLYSSNCVLD 138
E +MK + H+N+I ++ + ++F+ LV+E M ++ L
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 139 IFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198
++Q L +++LH SA +IH DLKPSN+++ + + DFG+A+
Sbjct: 170 LYQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGT 216
Query: 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKK 242
S T + T Y APE N D++S G ++ E K
Sbjct: 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 49/210 (23%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV------ECEVMKSIRHRNLI 102
+G G++G V A VAVK+ ++ ++ D E + K + H N++
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINKMLNHENVV 68
Query: 103 KIISTCSNDDFKALVLEYMPHGSL-------------EKCLYSSNCVLDIFQRLNIMIDV 149
K + + L LEY G L + + F +L
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--------FHQL------ 114
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
A + YLH + H D+KP N+LLD+ +SDFG+A + ++ + + T+
Sbjct: 115 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 210 GYMAPE--YGRE--GRVSTNGDVYSFGIML 235
Y+APE RE DV+S GI+L
Sbjct: 172 PYVAPELLKRREFHAEPV---DVWSCGIVL 198
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 46/211 (21%), Positives = 88/211 (41%), Gaps = 41/211 (19%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVEC-----EVMKSIRHRNLIK 103
+IGRG+FG V ++++ +V A+K+ L + K + C +V+ + + +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMID----------VAAAL 153
+ +D+ LV++Y G L L + + + + A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDL----------LTLLSKFEDRLPEEMARFYLAEMVIAI 188
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSKSQTQTLATIGY 211
+ +H +H D+KP N+L+D N H L+DFG L + +S + T Y
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV-AVGTPDY 242
Query: 212 MAPEYGREGRVSTNG-----DVYSFGIMLME 237
++PE + D +S G+ + E
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 38 LFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV------EC 90
+++ + + + +G G++GSV A + G+ VAVK + F+S E
Sbjct: 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 79
Query: 91 EVMKSIRHRNLIKI----ISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLN 144
++K ++H N+I + S ++F LV M L + D Q
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ--F 136
Query: 145 IMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQ 204
++ + L+Y+H SA +IH DLKPSN+ ++++ + DFG+A+ E T
Sbjct: 137 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTG 188
Query: 205 TLATIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTKK 242
+AT Y APE + D++S G ++ E T +
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 38 LFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV------EC 90
++ + +G G++GSV A + G +VA+K + F+S E
Sbjct: 19 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK----KLSRPFQSEIFAKRAYREL 74
Query: 91 EVMKSIRHRNLIKI----ISTCSNDDFKA--LVLEYMP---HGSLEKCLYSSNCVLDIFQ 141
++K ++H N+I + S +F LV+ +M + ++Q
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQ 134
Query: 142 RLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201
L L+Y+H SA V+H DLKP N+ ++++ + DFG+A+ E
Sbjct: 135 MLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----- 179
Query: 202 QTQTLATIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTKK 242
T + T Y APE + D++S G ++ E T K
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 38/232 (16%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVF---HLQCGGVFKSFDVECEVMKSIRHRNLIK--- 103
IG+G+F V AR I G EVA+K+ L + K F E +MK + H N++K
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLD-----IFQRLNIMIDVAAALEYLHF 158
+I T + L++EY G + L + + + F+++ +A++Y H
Sbjct: 82 VIET-EKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCH- 131
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE-YG 217
++H DLK N+LLD +M ++DFG + T + + Y APE +
Sbjct: 132 --QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP---YAAPELFQ 186
Query: 218 REGRVSTNGDVYSFGIML---------METFTKKKPTDKIFAGEMTLKYWVS 260
+ DV+S G++L + K+ +++ G+ + +++S
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 238
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 45/237 (18%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFH---LQCGGVFKSFDVECEVMKSIRHRNLIK-- 103
+G G+FG V + G +VAVK+ + ++ V E + +K RH ++IK
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 104 -IISTCSNDDFKALVLEYMPHGSL-----EKCLYSSNCVLDIFQRLNIMIDVAAALEYLH 157
+IST +D F +V+EY+ G L + +FQ++ + ++Y H
Sbjct: 83 QVIST-PSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------LSGVDYCH 133
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI----GYMA 213
V+H DLKP NVLLD +M A ++DFG++ +++ + L T Y A
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-------FLRTSCGSPNYAA 183
Query: 214 PE-YGREGRVSTNGDVYSFGIMLMETFTKKKPTD---------KIFAGEMTLKYWVS 260
PE D++S G++L P D KI G +++
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLN 240
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 41/202 (20%), Positives = 85/202 (42%), Gaps = 27/202 (13%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV--------- 88
+Q D + +LIG GS+G V +A + VA+K + + F+
Sbjct: 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK-------KILRVFEDLIDCKRILR 101
Query: 89 ECEVMKSIRHRNLIK---IISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRL 143
E ++ + H +++K I+ + F +VLE +K + + ++ +
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT 160
Query: 144 NIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203
++ ++ ++Y+H SA ++H DLKP+N L++ + + DFG+A+ + + SQ
Sbjct: 161 -LLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 204 QTLATIGYMAPEYGREGRVSTN 225
M +
Sbjct: 217 PISPREDDMNLVTFPHTKNLKR 238
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 50/230 (21%), Positives = 91/230 (39%), Gaps = 39/230 (16%)
Query: 47 ENNLIGRGSFGSVYKAR---IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
E +GRG++G VYKA+ +D + A+K G+ S E +++ ++H N+I
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVIS 82
Query: 104 IISTCSNDDFKA--LVLEYMPH-------GSLEKCLYSSNCVLDIFQRLNIMIDVAAALE 154
+ + + L+ +Y H L +++ + +
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 155 YLHFGYSAPVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLTGEDQSKSQ-TQTLATI 209
YLH + V+H DLKP+N+L+ ++D G A+L + + + T
Sbjct: 143 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 210 GYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
Y APE Y + D+++ G + E T +P IF
Sbjct: 200 WYRAPELLLGARHY------TKAIDIWAIGCIFAELLT-SEP---IFHCR 239
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 60/241 (24%), Positives = 102/241 (42%), Gaps = 54/241 (22%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFH---LQCGGVFKSFDVECEVMKSIRHRNLIK-- 103
+G GSFG V A + +VA+K L+ + + E +K +RH ++IK
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 104 -IISTCSNDDFKALVLEY---------MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAAL 153
+I+T D +V+EY + + + + FQ++ A+
Sbjct: 76 DVITT-PTDIV--MVIEYAGGELFDYIVEKKRM-----TEDEGRRFFQQI------ICAI 121
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI---- 209
EY H ++H DLKP N+LLDDN+ ++DFG++ ++T + L T
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-------LKTSCGSP 171
Query: 210 GYMAPE-YGREGRVSTNGDVYSFGIMLMETFTKKKPTD---------KIFAGEMTLKYWV 259
Y APE + DV+S GI+L + P D K+ + + ++
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL 231
Query: 260 S 260
S
Sbjct: 232 S 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 1e-17
Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 61/216 (28%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVEC-----EVMKSIRHRNLIK 103
+G GSFG V+ R + A+KV L+ V + VE ++ + H +I+
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 104 IISTCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNCVLDIFQRLNIMIDVA 150
+ T + ++++Y+ G L Y++ L
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL------------- 117
Query: 151 AALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSKSQTQTL-A 207
ALEYLH S +I+ DLKP N+LLD N H ++DFG AK T TL
Sbjct: 118 -ALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAK------YVPDVTYTLCG 165
Query: 208 TIGYMAPE------YGREGRVSTNGDVYSFGIMLME 237
T Y+APE Y + + D +SFGI++ E
Sbjct: 166 TPDYIAPEVVSTKPYNKS--I----DWWSFGILIYE 195
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 46/213 (21%), Positives = 86/213 (40%), Gaps = 43/213 (20%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVEC-----EVMKSIRHRNLIK 103
+IGRG+F V +++ +V A+K+ + + K +V C +V+ + R + +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMID----------VAAAL 153
+ ++++ LV+EY G L L + + I + A+
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDL----------LTLLSKFGERIPAEMARFYLAEIVMAI 175
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSKSQTQTLATIGY 211
+ +H +H D+KP N+LLD H L+DFG L + +S + T Y
Sbjct: 176 DSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV-AVGTPDY 229
Query: 212 MAPEYGREGRVSTNGDVY-------SFGIMLME 237
++PE + Y + G+ E
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 60/244 (24%), Positives = 104/244 (42%), Gaps = 36/244 (14%)
Query: 19 PNDANMPPVATWRRFS-YLELFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVK--- 73
+ +M A ++F ++ + IG G++G V A + + VA+K
Sbjct: 2 HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61
Query: 74 VF--HLQCGGVFKSFDVECEVMKSIRHRNLIK---IISTCSNDDFKA--LVLEYMPHGSL 126
F C + E +++ RH N+I II + + K +V + M L
Sbjct: 62 PFEHQTYCQRTLR----EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDL 116
Query: 127 EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 186
K L + + D + + L+Y+H SA V+H DLKPSN+LL+ + D
Sbjct: 117 YKLLKTQHLSNDHIC--YFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICD 171
Query: 187 FGIAKLLTGEDQSKSQ-TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMET 238
FG+A++ + T+ +AT Y APE Y + + D++S G +L E
Sbjct: 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY------TKSIDIWSVGCILAEM 225
Query: 239 FTKK 242
+ +
Sbjct: 226 LSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-17
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 42/230 (18%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVK---VF--HLQCGGVFKSFDVECEV 92
+ + F +L+G G++G V A G VA+K F L + E ++
Sbjct: 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKI 62
Query: 93 MKSIRHRNLIK---IISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMI 147
+K +H N+I I S ++F ++ E M L + + S+ + D + +
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI-STQMLSDDHIQY-FIY 119
Query: 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ----- 202
A++ LH + VIH DLKPSN+L++ N + DFG+A+++ S+
Sbjct: 120 QTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 203 ---TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTKK 242
+ +AT Y APE Y S DV+S G +L E F ++
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRR 220
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 57/214 (26%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVEC-----EVMKSIRHRNLIK 103
+G GSFG V + ++ A+K+ L V K +E +++++ L+K
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 104 IISTCSNDDFKALVLEYMPHGSL-------------EKCLYSSNCVLDIFQRLNIMIDVA 150
+ + ++ +V+EY+ G + Y++ VL
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL------------- 152
Query: 151 AALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATI 209
EYLH S +I+ DLKP N+L+D ++DFG AK + K +T TL T
Sbjct: 153 -TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTP 202
Query: 210 GYMAPE------YGREGRVSTNGDVYSFGIMLME 237
+APE Y + V D ++ G+++ E
Sbjct: 203 EALAPEIILSKGYNKA--V----DWWALGVLIYE 230
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 42/203 (20%), Positives = 79/203 (38%), Gaps = 27/203 (13%)
Query: 33 FSYLELFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV--- 88
F ++ D + +LIGRGS+G VY A VA+K V + F+
Sbjct: 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-------KVNRMFEDLID 68
Query: 89 ------ECEVMKSIRHRNLIK---IISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVL 137
E ++ ++ +I+ +I F +VLE L+K + +
Sbjct: 69 CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLT 127
Query: 138 DIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197
+ + I+ ++ ++H + +IH DLKP+N LL+ + + DFG+A+ + E
Sbjct: 128 EEHIKT-ILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183
Query: 198 QSKSQTQTLATIGYMAPEYGREG 220
+ +
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKK 206
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 58/240 (24%), Positives = 97/240 (40%), Gaps = 48/240 (20%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECE------ 91
AT + IG G++G+VYKAR G VA+K +
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV---------PNGGGGGGGLP 55
Query: 92 -----------VMKSIRHRN---LIKIISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNC 135
+++ H N L+ + +T D LV E++ L L +
Sbjct: 56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP 114
Query: 136 V-LDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194
L ++M L++LH + ++H DLKP N+L+ L+DFG+A++ +
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
Query: 195 GEDQSKSQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
+ + T + T+ Y APE +T D++S G + E F +KP +F G
Sbjct: 172 YQ---MALTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFR-RKP---LFCGN 222
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 51/235 (21%), Positives = 94/235 (40%), Gaps = 50/235 (21%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVK--VFHLQCGGVFKSFDV-----EC 90
F + + +G G G V+ A VA+K V V E
Sbjct: 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-------DPQSVKHALREI 59
Query: 91 EVMKSIRHRNLIKII------------STCSNDDFKA--LVLEYMPHGSLEKCLYSSNCV 136
++++ + H N++K+ S + + +V EYM L L +
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLL 118
Query: 137 LDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTG 195
+ + M + L+Y+H SA V+H DLKP+N+ ++ +++V + DFG+A+++
Sbjct: 119 EEHAR--LFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
Query: 196 EDQSKSQ-TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTKK 242
K ++ L T Y +P Y + D+++ G + E T K
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTGK 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 54/253 (21%), Positives = 95/253 (37%), Gaps = 73/253 (28%)
Query: 51 IGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDV-ECEVMKSIRHRNLIKII--- 105
+G GSFG V + + G A+K + E ++MK + H N+IK++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNIIKLVDYF 69
Query: 106 ---------------------------------STCSNDDFKA--LVLEYMP---HGSLE 127
+ K +++EY+P H L+
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129
Query: 128 KCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSD 186
+ S + + + + A+ ++H S + H D+KP N+L++ + L D
Sbjct: 130 SFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 187 FGIAKLLTGEDQSKSQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETF 239
FG AK L + S + + Y APE Y + + D++S G + E
Sbjct: 186 FGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEY------TPSIDLWSIGCVFGELI 236
Query: 240 TKKKPTDKIFAGE 252
KP +F+GE
Sbjct: 237 L-GKP---LFSGE 245
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-16
Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 46/237 (19%)
Query: 40 QATDGFSENNLIGRGSFGSVYKAR--IQDGMEVAVKVFHLQCGGVFKSFDVECE------ 91
+A + IG G++G V+KAR G VA+K + E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---------QTGEEGMPLST 58
Query: 92 --------VMKSIRHRN---LIKIISTCSNDDFKA--LVLEYMPHGSLEKCLYS-SNCVL 137
+++ H N L + + D LV E++ L L +
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 117
Query: 138 DIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197
++M + L++LH S V+H DLKP N+L+ + L+DFG+A++ + +
Sbjct: 118 PTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ- 173
Query: 198 QSKSQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252
+ T + T+ Y APE +T D++S G + E F +KP +F G
Sbjct: 174 --MALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFR-RKP---LFRGS 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV------ECE 91
++ + + +G G++G+V A + G +VA+K + F+S E
Sbjct: 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK----KLYRPFQSELFAKRAYRELR 76
Query: 92 VMKSIRHRNLIKII----STCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNI 145
++K +RH N+I ++ + DDF LV+ +M L K + D Q +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF--L 133
Query: 146 MIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQT 205
+ + L Y+H +A +IH DLKP N+ ++++ + DFG+A+ T
Sbjct: 134 VYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-----ADSEMTGY 185
Query: 206 LATIGYMAPEY-GREGRVSTNGDVYSFGIMLMETFTKK 242
+ T Y APE R + D++S G ++ E T K
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 38/171 (22%), Positives = 67/171 (39%), Gaps = 48/171 (28%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEV---MKSIRHRNLIKII- 105
+G G G V + + + A+K+ + EV ++ + ++++I+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKM-------LQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 106 ---STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRL--------------NIMID 148
+ + +V+E + G L F R+ IM
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKS 125
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGE 196
+ A++YLH S + H D+KP N+L N + L+DFG AK TGE
Sbjct: 126 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-16
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 53/214 (24%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVEC-----EVMKSIRHRNLIK 103
L+G+G+FG V + + A+K+ L+ + +V V+++ RH L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 104 IISTCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNCVLDIFQRLNIMIDVA 150
+ + D V+EY G L E Y + V
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS------------- 259
Query: 151 AALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATI 209
AL+YLH + V++ DLK N++LD + ++DFG+ K + + +T T
Sbjct: 260 -ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTP 313
Query: 210 GYMAPE------YGREGRVSTNGDVYSFGIMLME 237
Y+APE YGR V D + G+++ E
Sbjct: 314 EYLAPEVLEDNDYGRA--V----DWWGLGVVMYE 341
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 54/214 (25%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVEC-----EVMKSIRHRNLIK 103
L+G+G+FG V R + A+K+ L+ + +V V+++ RH L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 104 IISTCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNCVLDIFQRLNIMIDVA 150
+ D V+EY G L E+ Y + V
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS------------- 116
Query: 151 AALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-ATI 209
ALEYLH S V++ D+K N++LD + ++DFG+ K + + +T T
Sbjct: 117 -ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTP 169
Query: 210 GYMAPE------YGREGRVSTNGDVYSFGIMLME 237
Y+APE YGR V D + G+++ E
Sbjct: 170 EYLAPEVLEDNDYGRA--V----DWWGLGVVMYE 197
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 51/243 (20%), Positives = 100/243 (41%), Gaps = 58/243 (23%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV--------- 88
+ +G+G++G V+K+ + G VAVK +F +F
Sbjct: 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-------KIFDAFQNSTDAQRTFR 57
Query: 89 ECEVMKSIR-HRNLIKIISTCSNDDFKA--LVLEYMPHGSLEKCLYSSNCVLDIFQRLNI 145
E ++ + H N++ +++ D+ + LV +YM L + ++ +L+ + +
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYV 114
Query: 146 MIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ--- 202
+ + ++YLH S ++H D+KPSN+LL+ ++DFG+++ + +
Sbjct: 115 VYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 203 ----------------TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETF 239
T +AT Y APE Y + D++S G +L E
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEIL 225
Query: 240 TKK 242
K
Sbjct: 226 CGK 228
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 55/244 (22%), Positives = 104/244 (42%), Gaps = 52/244 (21%)
Query: 30 WRRFSYLELFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV 88
W S++ + D + +GRG + V++A I + +V VK+ K
Sbjct: 23 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--------KPVKK 74
Query: 89 -----ECEVMKSIR-HRNLIKIISTCSNDDFK--ALVLEYMPHGSLEKCLYSSNCVLDI- 139
E ++++++R N+I + + + ALV E++ + ++ LY + DI
Sbjct: 75 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIR 133
Query: 140 ---FQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTG 195
++ L AL+Y H S ++H D+KP NV++D ++ L D+G+A+
Sbjct: 134 FYMYEILK-------ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE---F 180
Query: 196 EDQSKSQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKI 248
+ +A+ + PE Y + D++S G ML +K+P
Sbjct: 181 YHPGQEYNVRVASRYFKGPELLVDYQMY------DYSLDMWSLGCMLASMIFRKEP---F 231
Query: 249 FAGE 252
F G
Sbjct: 232 FHGH 235
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 60/254 (23%), Positives = 101/254 (39%), Gaps = 75/254 (29%)
Query: 50 LIGRGSFGSVYKARIQDGMEV----AVKVF---HLQCGGVFKSFDVEC-----EVMKSIR 97
++G+G +G V++ R G A+KV + V + D +++ ++
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI----VRNAKDTAHTKAERNILEEVK 79
Query: 98 HRNLIKIISTCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNCVLDIFQRLN 144
H ++ +I L+LEY+ G L E C Y + +
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM------- 132
Query: 145 IMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSKSQ 202
AL +LH +I+ DLKP N++L+ H L+DFG+ K +
Sbjct: 133 -------ALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV--- 177
Query: 203 TQTLA-TIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFT---------KKKPTD 246
T T TI YMAPE + R V D +S G ++ + T +KK D
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRA--V----DWWSLGALMYDMLTGAPPFTGENRKKTID 231
Query: 247 KIFAGEMTLKYWVS 260
KI ++ L +++
Sbjct: 232 KILKCKLNLPPYLT 245
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 59/217 (27%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVM------KSIRHRNLI 102
+IG+GSFG V AR + AVKV LQ + K + + + K+++H L+
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 103 KIISTCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNCVLDIFQRLNIMIDV 149
+ + D VL+Y+ G L E Y++
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIAS------------ 150
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSKSQTQTL- 206
AL YLH S +++ DLKP N+LLD H L+DFG+ K + + T T
Sbjct: 151 --ALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFC 200
Query: 207 ATIGYMAPE------YGREGRVSTNGDVYSFGIMLME 237
T Y+APE Y R V D + G +L E
Sbjct: 201 GTPEYLAPEVLHKQPYDRT--V----DWWCLGAVLYE 231
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 37/150 (24%), Positives = 67/150 (44%), Gaps = 17/150 (11%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLI-KIISTC 108
IG G+FG + + + VA+K+ ++ +E K + + I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 109 SNDDFKALVLEYMPHG-SLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
+ A+VLE + G SLE + + L I I + + +EY+H S +I+
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129
Query: 168 DLKPSNVLL------DDNMVAHLSDFGIAK 191
D+KP N L+ ++ H+ DF +AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-14
Identities = 56/251 (22%), Positives = 105/251 (41%), Gaps = 69/251 (27%)
Query: 50 LIGRGSFGSVYKARIQDGMEV----AVKVFHLQCGGVFKSFDVEC----EVMKSIRHRNL 101
++G+GSFG V+ + G + A+KV L+ + V +++ + H +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 102 IKIISTCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNCVLDIFQRLNIMID 148
+K+ + L+L+++ G L E+ Y + L
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL----------- 137
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSKSQTQTL 206
AL++LH S +I+ DLKP N+LLD+ H L+DFG++K ++ +
Sbjct: 138 ---ALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSF 186
Query: 207 -ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFT---------KKKPTDKIFA 250
T+ YMAPE + + D +SFG+++ E T +K+ I
Sbjct: 187 CGTVEYMAPEVVNRRGHTQS--A----DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240
Query: 251 GEMTLKYWVSN 261
++ + ++S
Sbjct: 241 AKLGMPQFLSP 251
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 55/215 (25%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVM------KSIRHRNLI 102
++G+GSFG V AR+++ ++ AVKV L+ + + DVEC + + H L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 103 KIISTCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNCVLDIFQRLNIMIDV 149
++ D V+E++ G L E Y++ +
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS------------ 135
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-AT 208
AL +LH +I+ DLK NVLLD L+DFG+ K + T T T
Sbjct: 136 --ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGT 187
Query: 209 IGYMAPE------YGREGRVSTNGDVYSFGIMLME 237
Y+APE YG V D ++ G++L E
Sbjct: 188 PDYIAPEILQEMLYGPA--V----DWWAMGVLLYE 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 58/232 (25%), Positives = 95/232 (40%), Gaps = 60/232 (25%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVM------KSIRHRNLI 102
++G+GSFG V + + E+ AVK+ L+ V + DVEC ++ + L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 103 KIISTCSNDDFKALVLEYMPHGSL-------------EKCLYSSNCVLDIFQRLNIMIDV 149
++ S D V+EY+ G L Y++ +
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI------------ 453
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-T 208
L +L S +I+ DLK NV+LD ++DFG+ K + T+T T
Sbjct: 454 --GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTTKTFCGT 505
Query: 209 IGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTKKKP-----TDKIF 249
Y+APE YG+ V D ++FG++L E + P D++F
Sbjct: 506 PDYIAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 31/149 (20%), Positives = 59/149 (39%), Gaps = 15/149 (10%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLI-KIISTC 108
IG GSFG +++ + + +VA+K + E K + I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
LV++ + SLE L + + A ++ +H +++ D
Sbjct: 76 QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131
Query: 169 LKPSNVLL------DDNMVAHLSDFGIAK 191
+KP N L+ + NM+ ++ DFG+ K
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVK 159
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 49/212 (23%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVM-------KSIRHRNL 101
++G+GSFG V+ A + + A+K L+ V DVEC M + H L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVEC-TMVEKRVLSLAWEHPFL 80
Query: 102 IKIISTCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNCVLDIFQRLNIMID 148
+ T + V+EY+ G L Y++ +L
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL----------- 129
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSKSQTQTL 206
L++LH S +++ DLK N+LLD + H ++DFG+ K D ++T T
Sbjct: 130 ---GLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGD---AKTNTF 178
Query: 207 -ATIGYMAPEYGREGRVSTNGDVYSFGIMLME 237
T Y+APE + + + D +SFG++L E
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 55/215 (25%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVM------KSIRHRNLI 102
++G+GSFG V + + E+ AVK+ L+ V + DVEC ++ + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 103 KIISTCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNCVLDIFQRLNIMIDV 149
++ S D V+EY+ G L E Y++ ++
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 130
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-AT 208
A L +L S +I+ DLK NV+LD ++DFG+ K + T+T T
Sbjct: 131 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGT 184
Query: 209 IGYMAPE------YGREGRVSTNGDVYSFGIMLME 237
Y+APE YG+ V D ++FG++L E
Sbjct: 185 PDYIAPEIIAYQPYGKS--V----DWWAFGVLLYE 213
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-13
Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 11/146 (7%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLI-KIISTC 108
IG GSFG +Y I G EVA+K+ ++ +E ++ K ++ I I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ D+ +V+E + SLE + + L + + + +EY+H S IH D
Sbjct: 75 AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 130
Query: 169 LKPSNVLL---DDNMVAHLSDFGIAK 191
+KP N L+ + ++ DFG+AK
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 56/219 (25%)
Query: 50 LIGRGSFGSVYKARIQDGMEV----AVKVF---HLQCGGVFKSFDVEC-----EVMKSIR 97
++G G++G V+ R G + A+KV + V K+ E +V++ IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI----VQKAKTTEHTRTERQVLEHIR 116
Query: 98 HRN-LIKIISTCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNCVLDIFQRL 143
L+ + + L+L+Y+ G L E +Y VL
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL------ 170
Query: 144 NIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSKS 201
ALE+LH +I+ D+K N+LLD N H L+DFG++K ++ +
Sbjct: 171 --------ALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETER- 216
Query: 202 QTQTLA-TIGYMAPEYGREGRVSTNGDV--YSFGIMLME 237
TI YMAP+ R G + V +S G+++ E
Sbjct: 217 -AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 7e-13
Identities = 56/216 (25%), Positives = 86/216 (39%), Gaps = 57/216 (26%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVM-------KSIRHRNL 101
+IGRGS+ V R++ + A+KV ++ V D++ V ++ H L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDW-VQTEKHVFEQASNHPFL 72
Query: 102 IKIISTCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNCVLDIFQRLNIMID 148
+ + S + V+EY+ G L E+ YS+ L
Sbjct: 73 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL----------- 121
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-A 207
AL YLH +I+ DLK NVLLD L+D+G+ K T T
Sbjct: 122 ---ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCG 172
Query: 208 TIGYMAPE------YGREGRVSTNGDVYSFGIMLME 237
T Y+APE YG V D ++ G+++ E
Sbjct: 173 TPNYIAPEILRGEDYGFS--V----DWWALGVLMFE 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 11/146 (7%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLI-KIISTC 108
IG GSFG +Y IQ EVA+K+ +++ E ++ + ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
D+ LV++ + SLE + L + L + + +E++H S +H D
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128
Query: 169 LKPSNVLLDDNMVAH---LSDFGIAK 191
+KP N L+ A+ + DFG+AK
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 54/215 (25%), Positives = 85/215 (39%), Gaps = 55/215 (25%)
Query: 50 LIGRGSFGSVYKARIQDGMEV-AVKVFHLQCGGVFKSFDVECEVM------KSIRHRNLI 102
+IGRGS+ V R++ + A++V ++ V D++ ++ H L+
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 103 KIISTCSNDDFKALVLEYMPHGSL-----------EK--CLYSSNCVLDIFQRLNIMIDV 149
+ S + V+EY+ G L E+ YS+ L
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------------ 164
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL-AT 208
AL YLH +I+ DLK NVLLD L+D+G+ K T T T
Sbjct: 165 --ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCGT 216
Query: 209 IGYMAPE------YGREGRVSTNGDVYSFGIMLME 237
Y+APE YG V D ++ G+++ E
Sbjct: 217 PNYIAPEILRGEDYGFS--V----DWWALGVLMFE 245
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 45/241 (18%), Positives = 89/241 (36%), Gaps = 48/241 (19%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
+G G F +V+ A+ + + VA+K+ ++ + E ++++ + + K S
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 109 SN------DDFKA---------LVLEYMPHGSLEKCLYSSNCVLDIFQRLN------IMI 147
+N D F +V E + +L + + + I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-----HRGIPLIYVKQISK 138
Query: 148 DVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH------LSDFGIAKLLTGEDQSKS 201
+ L+Y+H +IH D+KP NVL++ ++D G A D+ +
Sbjct: 139 QLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYT 193
Query: 202 QT-QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVS 260
+ QT Y +PE D++S ++ E T D +F + Y
Sbjct: 194 NSIQTRE---YRSPEVLLGAPWGCGADIWSTACLIFELIT----GDFLFEPDEGHSYTKD 246
Query: 261 N 261
+
Sbjct: 247 D 247
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 37/177 (20%), Positives = 67/177 (37%), Gaps = 51/177 (28%)
Query: 50 LIGRGSFGSVYKAR------IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
IG+G FG +Y A + VKV G +F E + + I+
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF----TELKFYQRAAKPEQIQ 97
Query: 104 IIST-------------------CSNDDFKALVLEYMPHG-SLEKCLYSSN------CVL 137
+ ++ ++++ G L+K ++ VL
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVL 155
Query: 138 DIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 191
+ R ++D+ LEY+H +H D+K SN+LL + + V +L D+G+A
Sbjct: 156 QLSLR---ILDI---LEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 37/170 (21%), Positives = 71/170 (41%), Gaps = 40/170 (23%)
Query: 50 LIGRGSFGSVYKA-RIQDGMEVAVKVFHLQCGG---------VFKSFDVECEVMKSIRHR 99
IG G FG +Y A + A V ++ ++ + + K I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 100 NLIKI---------ISTCSNDDFKALVLEYMPHG-SLEKCL-----YSSNCVLDIFQRLN 144
L + ++ ++ +V+E + G L+K + + VL + R
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIR-- 159
Query: 145 IMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 191
M+DV LEY+H +H D+K +N+LL + + V +L+D+G++
Sbjct: 160 -MLDV---LEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 42/212 (19%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKV------FHLQCGGVFKSFDVECEVMKSIRHR--- 99
+IG+GSFG V KA + VA+K+ FH Q E +++ +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-------AEEIRILEHLRKQDKD 156
Query: 100 NLIKIISTCSNDDFKA---LVLEYMPHGSLEKCLYSSNCVLDIFQRLN------IMIDVA 150
N + +I N F+ + E + +L + + + FQ + +
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNK-----FQGFSLPLVRKFAHSIL 210
Query: 151 AALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSKSQTQTLAT 208
L+ LH +IHCDLKP N+LL + + DFG + + + + +
Sbjct: 211 QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-----YEHQRVYTYIQS 262
Query: 209 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
Y APE R D++S G +L E T
Sbjct: 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 2e-10
Identities = 46/286 (16%), Positives = 77/286 (26%), Gaps = 75/286 (26%)
Query: 39 FQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHL--------QCGGVFKSFDVEC 90
T+ IG G FG V++ D VA+K+ + F+ E
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 91 EVMKSI---------RHRNLIKIISTC------------------------------SND 111
+ K + R I + S D
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 112 DFKALVLEYMPHG-SLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLK 170
D +VLE+ G LE+ + + +I+ + A+L H DL
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 171 PSNVLLDDNMVAHLSDFGIAKLLT---------GEDQSKSQTQTLATIGYMAPEYGRE-- 219
NVLL + L K T D + S+ + + + +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF 249
Query: 220 -GRVSTNGDVYSF-GIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL 263
G D+Y + + P + W+ L
Sbjct: 250 TGDGDYQFDIYRLMKKENNNRWGEYHP--------YSNVLWLHYLT 287
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 36/173 (20%), Positives = 64/173 (36%), Gaps = 45/173 (26%)
Query: 51 IGRGSFGSVYKAR---------IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNL 101
R + G +Y+A + ++K+ G +F + K ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKW 108
Query: 102 IKIIST------------CSNDDFKALVLEYMPHG-SLEKCLYSSN-------CVLDIFQ 141
K+ ST D ++ LVL + G SL+ L S VL +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVAC 166
Query: 142 RLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 191
R ++D ALE+LH +H ++ N+ + D + V L+ +G A
Sbjct: 167 R---LLD---ALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 38/213 (17%)
Query: 48 NNLIGRGSFGSVYKAR-IQDGMEVAVKV------FHLQCGGVFKSFDVECEVMKSIRHR- 99
++LIG+GSFG V KA + VA+K+ F Q +E +++ +
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-------QIEVRLLELMNKHD 111
Query: 100 --NLIKIISTCSNDDFKA---LVLEYMPHGSLEKCLY-----SSNCVLDIFQRLNIMIDV 149
I+ + F+ LV E L LY ++ + + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSKSQTQTLA 207
AL +L +IHCDLKP N+LL + + + DFG + + Q +
Sbjct: 167 CTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC-----QLGQRIYQYIQ 220
Query: 208 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 240
+ Y +PE D++S G +L+E T
Sbjct: 221 SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 50/246 (20%), Positives = 78/246 (31%), Gaps = 88/246 (35%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKV------FHLQCGGVFKSFDVECEVMKSIRHR--- 99
+G G+FG V + I + AVKV + +E +++K I++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-------KIEADILKKIQNDDIN 94
Query: 100 --NLIKIISTCSNDDFK-----ALVLEYMPHGSLEKCLYSSNCVLDIFQRLN-------- 144
N++K F L+ E L LY N
Sbjct: 95 NNNIVKYH-----GKFMYYDHMCLIFE-----PLGPSLYE-------IITRNNYNGFHIE 137
Query: 145 ----IMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200
I++ AL YL + H DLKP N+LLDD + Q
Sbjct: 138 DIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 201 S----------------QTQTLATI----GYMAPE------YGREGRVSTNGDVYSFGIM 234
++ +I Y APE + + D++SFG +
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCV 248
Query: 235 LMETFT 240
L E +T
Sbjct: 249 LAELYT 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 45/235 (19%), Positives = 82/235 (34%), Gaps = 70/235 (29%)
Query: 50 LIGRGSFGSVYKA--RIQDGMEVAVKV------FHLQCGGVFKSFDVECEVMKSIRHR-- 99
+G G+FG V + + +VA+K+ + +E V+K I+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-------RLEINVLKKIKEKDK 78
Query: 100 -NLIKIISTCSNDDFKA---LVLEYMPHGSLEKCLY-----SSNCVLDIFQRLNIMIDVA 150
N + +F + E L K + ++ + ++ +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 151 AALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH-------------------LSDFGIAK 191
AL +LH + H DLKP N+L ++ ++DFG A
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 192 LLTGEDQSKSQTQTLATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFT 240
T + + T +AT Y PE + + DV+S G +L E +
Sbjct: 190 --TFDHE--HHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 41/237 (17%), Positives = 74/237 (31%), Gaps = 74/237 (31%)
Query: 50 LIGRGSFGSVYKA--RIQDGMEVAVKV------FHLQCGGVFKSFDVECEVMKSIRHR-- 99
+G G+FG V + G VAVK+ + E +V++ +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEIQVLEHLNTTDP 73
Query: 100 -NLIKIISTCSNDDFKA---LVLEYMPHGSLEKCLYSSNCVLDIFQRLN----------- 144
+ + + + +V E L Y F + N
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFE-----LLGLSTYD-------FIKENGFLPFRLDHIR 121
Query: 145 -IMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK--- 200
+ + ++ +LH S + H DLKP N+L + + I +
Sbjct: 122 KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 201 -------SQTQTLATI----GYMAPE------YGREGRVSTNGDVYSFGIMLMETFT 240
+ +T+ Y APE + S DV+S G +L+E +
Sbjct: 179 VDFGSATYDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYL 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 55/257 (21%), Positives = 86/257 (33%), Gaps = 80/257 (31%)
Query: 51 IGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-----HRNLIKI 104
+G G F +V+ + IQ VA+KV + D E ++KS+R N +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNREMV 103
Query: 105 ISTCSNDDFK---------ALVLEYMPHGSLEKCLYSSNCV---LDIFQRLNIMIDVAAA 152
+ DDFK +V E + H L K + SN L ++ I+ V
Sbjct: 104 VQLL--DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQQVLQG 158
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLL------------------------------------ 176
L+YLH +IH D+KP N+LL
Sbjct: 159 LDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 177 -------------DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVS 223
+ + ++D G A + QT+ Y + E +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYN 271
Query: 224 TNGDVYSFGIMLMETFT 240
T D++S M E T
Sbjct: 272 TPADIWSTACMAFELAT 288
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 2e-04
Identities = 45/274 (16%), Positives = 80/274 (29%), Gaps = 87/274 (31%)
Query: 11 YRKRGKQL---PNDANMPP---VATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARI 64
YRK +L P A++P W ++ + + +L+ + S I
Sbjct: 371 YRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI--SI 428
Query: 65 QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLI---KIISTCSNDDFKALVLE-Y 120
+ V+ E ++ HR+++ I T +DD L+ Y
Sbjct: 429 PS----------IYL-----ELKVKLENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLDQY 472
Query: 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180
Y H G+ H LK +
Sbjct: 473 F---------------------------------YSHIGH-----H--LKNIEHPERMTL 492
Query: 181 VAHL-SDFGI--AKLL---TGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 234
+ DF K+ T + S S TL + + Y + + N Y +
Sbjct: 493 FRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF----Y--KPYICDNDPKYERLVN 546
Query: 235 LMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268
+ F K E + ++LL I++M
Sbjct: 547 AILDFLPK-------IEENLICSKYTDLLRIALM 573
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 7e-04
Identities = 47/345 (13%), Positives = 100/345 (28%), Gaps = 96/345 (27%)
Query: 15 GKQ-LPNDA--------NMPPVATWRRFSY-------LELFQATDGFSENNLIGRGSFGS 58
GK + D M W LE+ Q + N R S
Sbjct: 162 GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS 221
Query: 59 VYKARIQDGMEVAVKVF----HLQC---------GGVFKSFDVECEVMKSIRHRNLIKII 105
K RI ++ + C + +F++ C+++ + R + + +
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFL 281
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQR-LNIMIDVAAALEYLHFGYSAPV 164
S + L++ L V + + L+ L P
Sbjct: 282 ---SAATTTHISLDHHSMT-----LTPDE-VKSLLLKYLDCRPQ---DL---------PR 320
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIA-----KLLTGEDQSKSQTQTLATIGYMAPEYGRE 219
P +++A G+A K + + + +L + P R+
Sbjct: 321 EVLTTNP----RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL---EPAEYRK 373
Query: 220 GRVSTNGDVY-SFGIMLMETFTKKKPTD-KIFAGEMTLK-YWVSNLLPISVMEIVD---- 272
++ + F P I + L W +++ VM +V+
Sbjct: 374 --------MFDRLSV-----F----PPSAHI--PTILLSLIW-FDVIKSDVMVVVNKLHK 413
Query: 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317
+L+ ++ K + ++ +E V+ + + IV
Sbjct: 414 YSLVEKQPKES------TISIPSIYLELKVKLENEYALHRSIVDH 452
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 335 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.04 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.64 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.56 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.54 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.47 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.28 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.19 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.09 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.09 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.9 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.73 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.73 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.69 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.63 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.58 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.47 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.42 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.26 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.23 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.56 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.72 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.7 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.63 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-58 Score=401.26 Aligned_cols=259 Identities=29% Similarity=0.474 Sum_probs=218.6
Q ss_pred CCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
++|.+.+.||+|+||.||+|.+. ++..||||+++..+....+.|.+|++++++++||||+++++++.+.+.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 67889999999999999999753 477899999987666667889999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEE
Q 019843 117 VLEYMPHGSLEKCLYSS------------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 184 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l 184 (335)
||||+++|+|.+++... ...+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999753 246999999999999999999999 999999999999999999999999
Q ss_pred eeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhc
Q 019843 185 SDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLL 263 (335)
Q Consensus 185 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 263 (335)
+|||++................+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---------- 239 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---------- 239 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----------
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH----------
Confidence 99999987644433344445678999999999999999999999999999999998 8999976532211
Q ss_pred ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 264 PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
...+... .....+..+|+++.+|+.+||+.||++|||++||.+.|+++...
T Consensus 240 ----~~~i~~~------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 240 ----IECITQG------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ----HHHHHHT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHcC------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111111 11223456788899999999999999999999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-57 Score=401.37 Aligned_cols=259 Identities=27% Similarity=0.466 Sum_probs=211.7
Q ss_pred CCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
++|.+.+.||+|+||.||+|.+. +++.||||+++..+....+.|.+|++++++++||||+++++++.+.+.+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999754 478899999987666667889999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcE
Q 019843 117 VLEYMPHGSLEKCLYSS--------------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 182 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v 182 (335)
||||+++|+|.+++... ..++++..++.++.|++.||.||| +++|+||||||+|||++.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 99999999999998753 246999999999999999999999 9999999999999999999999
Q ss_pred EEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhh
Q 019843 183 HLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSN 261 (335)
Q Consensus 183 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 261 (335)
||+|||++..+.............+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~-------- 269 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-------- 269 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH--------
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH--------
Confidence 9999999987644443444456679999999999999999999999999999999999 8999976432111
Q ss_pred hcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 262 LLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
...+... .+...+..+++++.+|+.+||+.||++|||++||++.|+.+.+.
T Consensus 270 ------~~~i~~g------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 270 ------IDCITQG------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ------HHHHHHT------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------HHHHHcC------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111111 12233456788899999999999999999999999999988653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=393.11 Aligned_cols=265 Identities=28% Similarity=0.430 Sum_probs=211.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
..+++.+.+.||+|+||+||+|+++ ..||||+++... ....+.|.+|++++++++||||+++++++.+ +.+++||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3478899999999999999999865 369999987542 3456789999999999999999999998865 5688999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++|+|.+++......+++..+..++.|++.||.||| +++|+||||||+|||+++++.+||+|||++........
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999999877678999999999999999999999 99999999999999999999999999999987643333
Q ss_pred ccccccccccccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 199 SKSQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...+....
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~-------------~~~~~~~~ 254 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI-------------IFMVGRGY 254 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-------------HHHHHTTC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH-------------HHHHhcCC
Confidence 333455689999999999864 35899999999999999999999999764322111 11111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
.. +.....+..+++.+.+|+.+||+.||++|||+.||++.|+.++..+-
T Consensus 255 ~~--p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 255 AS--PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp CC--CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CC--CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 10 11112234577889999999999999999999999999999987663
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=397.59 Aligned_cols=250 Identities=24% Similarity=0.293 Sum_probs=214.1
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
+.|++.+.||+|+||.||+|.++ +|+.||||++........+.+.+|+++++.++||||+++++++.+.+.+|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999865 69999999998766666678899999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
+||+|.+++... .+++..+..++.||+.||.||| +++|+||||||+|||++.+|.+||+|||++..+... ...
T Consensus 154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPR 226 (346)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCC
T ss_pred CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC--CCc
Confidence 999999999764 5999999999999999999999 999999999999999999999999999999876422 223
Q ss_pred cccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccccc
Q 019843 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (335)
....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||......+. ...+.. ....
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--------------~~~i~~----~~~~ 288 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--------------MKMIRD----NLPP 288 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------------HHHHHH----SSCC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--------------HHHHHc----CCCC
Confidence 4456899999999999999999999999999999999999999976432111 111111 1122
Q ss_pred chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.......+++++.+||.+||..||++|||++|+++.
T Consensus 289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 223345678889999999999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-57 Score=398.04 Aligned_cols=256 Identities=26% Similarity=0.453 Sum_probs=215.2
Q ss_pred CCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
+++++.+.||+|+||+||+|.+. +++.||||+++... ....+.|.+|+.++++++||||++++|++.+.+.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 46778899999999999999752 46789999997543 334578999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC
Q 019843 116 LVLEYMPHGSLEKCLYSS---------------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~ 180 (335)
+||||+++|+|.++|... ...+++..++.++.||+.||.||| +++++||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence 999999999999999643 235899999999999999999999 99999999999999999999
Q ss_pred cEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHh
Q 019843 181 VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWV 259 (335)
Q Consensus 181 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~ 259 (335)
.+||+|||++..+.............||+.|+|||++.++.++.++|||||||++|||+| |..||......+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~------ 256 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV------ 256 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence 999999999987654444444556789999999999999999999999999999999998 8999976532211
Q ss_pred hhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 260 SNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
...+.. ....+.+..+|+.+.+|+.+||+.||++|||++||++.|+.+
T Consensus 257 --------~~~i~~------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 --------VEMIRN------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --------HHHHHT------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --------HHHHHc------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111 112233556788899999999999999999999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=397.73 Aligned_cols=252 Identities=19% Similarity=0.310 Sum_probs=206.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.-++|++++.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3479999999999999999999765 69999999997552 33457899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 118 LEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
|||++||+|.+++... ...+++..++.++.||+.||.||| +++|+||||||+|||++.+|.+||+|||++..+..
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~- 177 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS- 177 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH-
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC-
Confidence 9999999999999754 446799999999999999999999 99999999999999999999999999999987631
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
........+||+.|+|||++.+..|+.++|||||||++|+|++|..||......+. +.....
T Consensus 178 -~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-----------------~~~i~~ 239 (350)
T 4b9d_A 178 -TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL-----------------VLKIIS 239 (350)
T ss_dssp -HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----------------HHHHHH
T ss_pred -CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-----------------HHHHHc
Confidence 11223446799999999999999999999999999999999999999976432211 111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.... ..+..+++++.+||.+||+.||++|||++|+++.
T Consensus 240 ~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 240 GSFP---PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 1123467789999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=393.75 Aligned_cols=258 Identities=22% Similarity=0.288 Sum_probs=213.1
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.+.|.+.++||+|+||.||+|.++ +|+.||||+++.+.. ..+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999999999999865 589999999986532 24699999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-cEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~-~v~l~dfg~~~~~~~~~~~ 199 (335)
++||+|.+++...+ .+++..+..++.||+.||.||| +++|+||||||+|||++.+| .+||+|||++..+......
T Consensus 132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 99999999998654 7999999999999999999999 99999999999999999988 6999999999876432211
Q ss_pred c---ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 200 K---SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 200 ~---~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+... .+...
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-------------~i~~~--- 271 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-------------KIASE--- 271 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH-------------HHHHS---
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------------HHHcC---
Confidence 1 2234579999999999999999999999999999999999999997654332211 11111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
.......+..+++.+.++|.+||+.||.+|||+.|+++.|.....+..
T Consensus 272 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 272 --PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp --CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 111112244568889999999999999999999999999998776654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-57 Score=394.22 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=213.0
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++.+.||+|+||+||+|... +|+.||+|++... .....+.+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999765 6899999999743 2344578999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||++||+|.+++.+.+ .+++..+..++.||+.||.||| +++|+||||||+|||++.+|.+||+|||++..+.....
T Consensus 112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999998654 7999999999999999999999 99999999999999999999999999999998754333
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||......+ +.......
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----------------~~~~i~~~- 249 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-----------------IFAKIIKL- 249 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHHHHHHT-
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHcC-
Confidence 344556789999999999999999999999999999999999999997643211 11111111
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.+..+..+++++.+||.+||..||++|||++|++..
T Consensus 250 ---~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 250 ---EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred ---CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 111234567789999999999999999999997544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=399.35 Aligned_cols=251 Identities=24% Similarity=0.291 Sum_probs=214.4
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.+.|++.+.||+|+||.||+|.+. +|+.||||++........+.+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999865 6999999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++||+|.+++... .+++..+..++.||+.||.||| +++|+||||||+|||++.+|.+||+|||++..+... ..
T Consensus 230 ~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VP 302 (423)
T ss_dssp CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--CC
T ss_pred CCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC--Cc
Confidence 9999999999765 4999999999999999999999 999999999999999999999999999999876422 22
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+....+. ...+.. ...
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--------------~~~i~~----~~~ 364 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--------------MKMIRD----NLP 364 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------------HHHHHH----SCC
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--------------HHHHHc----CCC
Confidence 34456899999999999999999999999999999999999999976432111 111111 111
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
........+++++.+||.+||..||++|||++|+++.
T Consensus 365 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 365 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1222234567889999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=379.20 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=194.7
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999764 6999999999744 2334567999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+ +|+|.+++.+.. .+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--- 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC---
Confidence 999 679999887654 7999999999999999999999 99999999999999999999999999999986532
Q ss_pred ccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
........||+.|+|||++.+..+ +.++||||+||++|+|++|+.||........ ...+...
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~--------------~~~i~~~--- 227 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL--------------FKNISNG--- 227 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------------HHHHHHT---
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH--------------HHHHHcC---
Confidence 223345679999999999998876 5799999999999999999999976432111 0111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
....+..+++++.+||.+||+.||++|||++|+++.
T Consensus 228 ----~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 228 ----VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111234467789999999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=377.12 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=201.4
Q ss_pred CCC-CccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeec----CCee
Q 019843 43 DGF-SENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN----DDFK 114 (335)
Q Consensus 43 ~~y-~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 114 (335)
.+| ++.+.||+|+||+||+|.+. ++..||+|++... .....+.+.+|++++++++||||+++++++.+ .+.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 67889999999999999765 5899999998754 23345779999999999999999999999865 4568
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCC--eEecCCCCCCEEEC-CCCcEEEeeccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP--VIHCDLKPSNVLLD-DNMVAHLSDFGIAK 191 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~--i~h~di~p~Nilv~-~~~~v~l~dfg~~~ 191 (335)
|+||||++||+|.+++.+.. .+++..+..++.||+.||.||| +++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999999998654 7999999999999999999999 888 99999999999997 58999999999997
Q ss_pred cccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 192 LLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||......... .
T Consensus 181 ~~~----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~----------------~ 239 (290)
T 3fpq_A 181 LKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------------Y 239 (290)
T ss_dssp GCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH----------------H
T ss_pred eCC----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH----------------H
Confidence 542 223345689999999999865 6999999999999999999999999754322111 1
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
...... ......+..+++++.+||.+||+.||++|||++|+++
T Consensus 240 ~~i~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 240 RRVTSG--VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHTTT--CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHcC--CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111110 1111223445677999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-55 Score=383.34 Aligned_cols=247 Identities=24% Similarity=0.305 Sum_probs=200.3
Q ss_pred CCCCccceeeecCceEEEEEEEc----CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 67999999999999999999752 47889999986432 2233568889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||++||+|.+++.+.. .+++..+..++.||+.||.||| +++|+||||||+|||++.+|.+||+|||++.....
T Consensus 104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~- 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID- 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC-
Confidence 999999999999998654 7999999999999999999999 99999999999999999999999999999986532
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||......+. ......
T Consensus 179 -~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-----------------~~~i~~ 240 (304)
T 3ubd_A 179 -HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-----------------MTMILK 240 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHHH
T ss_pred -CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-----------------HHHHHc
Confidence 12233456899999999999999999999999999999999999999976432211 111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCH-----HHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINA-----KEIVT 316 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~ 316 (335)
. ....+..+++++.+||.+||+.||++|||+ +|+++
T Consensus 241 ~----~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 241 A----KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp C----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C----CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 112234567889999999999999999984 67765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-54 Score=378.51 Aligned_cols=274 Identities=22% Similarity=0.300 Sum_probs=203.9
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC----eeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD----FKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv 117 (335)
.++|.+.+.||+|+||+||+|++. |+.||||++...... ......|+..+..++||||+++++++.+.+ .+++|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 457889999999999999999885 899999998754321 122334555566789999999999997643 67999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCC--------CeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA--------PVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~--------~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
|||+++|+|.+++... .+++..+..++.+++.||.||| +. +|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH---~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH---MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---CCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 9999999999999865 4999999999999999999999 66 999999999999999999999999999
Q ss_pred cccccCCccc--cccccccccccccCccccCCC------CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhh
Q 019843 190 AKLLTGEDQS--KSQTQTLATIGYMAPEYGREG------RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSN 261 (335)
Q Consensus 190 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 261 (335)
+......... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||......+.........
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 9876432211 123345799999999998764 36779999999999999999998876543322221111100
Q ss_pred hcChhHHHHHHhhhccccc---cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 262 LLPISVMEIVDANLLSRED---KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
......+.......... +.......+++.+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus 235 --~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 235 --DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp --SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11112222111111111 11111234567899999999999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-54 Score=384.07 Aligned_cols=262 Identities=23% Similarity=0.375 Sum_probs=216.5
Q ss_pred hhcCCCCccceeeecCceEEEEEEEcC------CcEEEEEEeecCCC-chhHHHHHHHHHHHhCC-CCceEEEeeeeec-
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQD------GMEVAVKVFHLQCG-GVFKSFDVECEVMKSIR-HRNLIKIISTCSN- 110 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~~------~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~- 110 (335)
...++|++.+.||+|+||.||+|.+.. ++.||+|++..... .....+.+|++++.++. ||||+++++++..
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 345789999999999999999997542 35799999875533 34567999999999995 5899999999865
Q ss_pred CCeeEEEEEecCCCChHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEE
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSS---------------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVL 175 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nil 175 (335)
.+.+++||||+++|+|.++|... ...+++..+..++.||+.||.||| +++++||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCcccee
Confidence 56789999999999999999753 235899999999999999999999 999999999999999
Q ss_pred ECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchh
Q 019843 176 LDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMT 254 (335)
Q Consensus 176 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~ 254 (335)
++.++.+||+|||++..+.............+|+.|+|||++.+..++.++|||||||++|||+| |..||......+.
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~- 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999987654433344456678999999999999999999999999999999998 8999976543221
Q ss_pred hHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 255 LKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
....+... .+...+..+++++.+++.+||+.||++|||+.||++.|+++.+
T Consensus 297 ------------~~~~i~~g------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 297 ------------FCRRLKEG------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp ------------HHHHHHHT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------HHHHHHcC------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 11122211 1223345667889999999999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=362.97 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=190.4
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCC--------
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDD-------- 112 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 112 (335)
++|++++.||+|+||.||+|.++ +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999865 689999999976543 34567899999999999999999999986543
Q ss_pred ----eeEEEEEecCCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEee
Q 019843 113 ----FKALVLEYMPHGSLEKCLYSSN--CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 186 (335)
Q Consensus 113 ----~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~d 186 (335)
.+|+||||+++|+|.+++.... ...++..++.++.||+.||.||| +++|+||||||+|||++.+|.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 4789999999999999998653 23556778899999999999999 99999999999999999999999999
Q ss_pred ccccccccCCccc----------cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhH
Q 019843 187 FGIAKLLTGEDQS----------KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK 256 (335)
Q Consensus 187 fg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 256 (335)
||++..+...... ......+||+.|+|||++.+..++.++|||||||++|+|++ ||.........
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~-- 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT-- 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH--
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH--
Confidence 9999876432211 11234579999999999999999999999999999999996 77543211100
Q ss_pred hHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 257 YWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
+..... ....+.....++.+.+||.+||+.||++|||+.|+++
T Consensus 237 --------------~~~~~~---~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 --------------LTDVRN---LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --------------HHHHHT---TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------------HHHHhc---CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000 0111122344556789999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-51 Score=369.37 Aligned_cols=271 Identities=24% Similarity=0.265 Sum_probs=206.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeec------
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSN------ 110 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 110 (335)
...++|.+++.||+|+||.||+|.+. +|+.||||++.... ......+.+|+++++.++||||+++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 34578999999999999999999765 69999999996543 2344678899999999999999999998753
Q ss_pred CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
.+.+|+||||++ |+|.+++.... .+++..+..++.||+.||.||| +++|+|+||||+|||++.+|.+||+|||++
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeeccee
Confidence 467899999995 67999887654 8999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCc--cccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcCh--
Q 019843 191 KLLTGED--QSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI-- 265 (335)
Q Consensus 191 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-- 265 (335)
..+.... ........+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+....+... .........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~-~I~~~~g~p~~ 284 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ-LIMMVLGTPSP 284 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH-HHHHHHCCCCG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHH-HHHHhcCCCCh
Confidence 8663221 12233456899999999998875 46899999999999999999999997654322211 111111000
Q ss_pred ---------hHHHHHHhhhccccccch-hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 266 ---------SVMEIVDANLLSREDKHF-AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 266 ---------~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.....+.. ........+ .....+++++.+||.+||..||++|||++|+|+.
T Consensus 285 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQS-LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHS-SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhc-CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00011110 000000000 1112356779999999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=361.45 Aligned_cols=271 Identities=20% Similarity=0.251 Sum_probs=204.7
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEc----CCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeecC
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSND 111 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 111 (335)
.+....++|++.+.||+|+||+||+|+.+ +++.||+|++.... ....+.+|+++++.+ +||||+++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 34456789999999999999999999753 46789999986543 336788999999998 699999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC-CcEEEeecccc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIA 190 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~-~~v~l~dfg~~ 190 (335)
+.+|+||||++|++|.+++. .+++..+..++.||+.||.||| +++|+||||||+|||++.+ +.+||+|||++
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999999884 4899999999999999999999 9999999999999999876 79999999999
Q ss_pred ccccCCccc--------------------------cccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCC
Q 019843 191 KLLTGEDQS--------------------------KSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKK 243 (335)
Q Consensus 191 ~~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~ 243 (335)
....+.... ......+||+.|+|||++.+. .++.++||||+||++|+|++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 765322110 112235799999999998875 58999999999999999999999
Q ss_pred CCCcccccchhhHhHhhhhcChh----------------------HHHHHHhhhc------------cccccchhhHHHH
Q 019843 244 PTDKIFAGEMTLKYWVSNLLPIS----------------------VMEIVDANLL------------SREDKHFAAKEQC 289 (335)
Q Consensus 244 pf~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~------------~~~~~~~~~~~~~ 289 (335)
||....+....+........... .......... ............+
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 99654433332222111111000 0000000000 0000001112245
Q ss_pred HHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 290 VSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 290 ~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
++++.+||.+||..||++|||++|+++
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 678999999999999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=380.55 Aligned_cols=252 Identities=19% Similarity=0.251 Sum_probs=214.2
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.++|.+.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+++|+.++||||+++++++.+.+.+|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999765 6999999999876655667889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC--CcEEEeeccccccccCCcc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN--MVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~--~~v~l~dfg~~~~~~~~~~ 198 (335)
++||+|.+++....+.+++..+..++.||+.||.||| +++|+|+||||+||+++.+ +.+||+|||++..+..
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--- 309 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 309 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC---
Confidence 9999999999876668999999999999999999999 9999999999999999854 8999999999987642
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||......+. +.......
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-----------------~~~i~~~~ 372 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-----------------LRNVKSCD 372 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-----------------HHHHHTTC
T ss_pred CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-----------------HHHHHhCC
Confidence 2233446799999999999999999999999999999999999999976532211 11111111
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..........+++++.+||.+||..||.+|||+.|+++
T Consensus 373 ~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 373 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112223456788999999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=372.65 Aligned_cols=250 Identities=23% Similarity=0.305 Sum_probs=203.4
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHH---HHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSF---DVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
-++|.+.++||+|+||.||+|..+ +|+.||+|++... ........ ..++.+++.++||||+++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999765 5999999999643 11222233 3446677778999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
|+||||++||+|.++|.+.+ .+++..+..++.||+.||.||| +++|+||||||+|||++.+|.+||+|||++..+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999998654 7999999999999999999999 9999999999999999999999999999998764
Q ss_pred CCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
. ......+||+.|+|||++.+ ..|+.++|+|||||++|+|++|.+||......... .+...
T Consensus 344 ~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--------------~i~~~ 405 (689)
T 3v5w_A 344 K----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------------EIDRM 405 (689)
T ss_dssp S----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--------------HHHHH
T ss_pred C----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--------------HHHHh
Confidence 2 22344689999999999964 57999999999999999999999999765432211 11111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCC-----HHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-----AKEIVTR 317 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 317 (335)
... .....+..+++++.+||.+||..||.+|++ ++||++.
T Consensus 406 i~~----~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 406 TLT----MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHH----CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred hcC----CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 111 111223456788999999999999999998 6887653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=337.57 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=214.1
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
...++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 4557999999999999999999975 468999999998776666788999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++... .+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 97 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 169 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (297)
T ss_dssp ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred ECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--
Confidence 999999999999765 4999999999999999999999 999999999999999999999999999998866422
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........+++.|+|||++.+..++.++||||||+++|+|++|..||.......... .... .
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------------~~~~-----~ 231 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-------------LIAT-----N 231 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------------HHHH-----H
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHh-----C
Confidence 223345679999999999999999999999999999999999999997643221111 0000 0
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.......+..+++.+.+++.+||+.||.+|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 232 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111222244567789999999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=340.71 Aligned_cols=284 Identities=32% Similarity=0.524 Sum_probs=229.2
Q ss_pred cccCHHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec
Q 019843 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110 (335)
Q Consensus 31 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 110 (335)
.+++..++....++|++.+.||+|+||.||+|...+++.||+|++........+.+.+|+++++.++||||+++++++..
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 45566677788999999999999999999999988899999999887766677889999999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeec
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSSN---CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 187 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~df 187 (335)
.+..++||||+++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999986542 35899999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchh-hHhHhhhhc-Ch
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMT-LKYWVSNLL-PI 265 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~~-~~ 265 (335)
|++................++..|+|||++.+..++.++||||||+++|+|++|..||......... ...+..... ..
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 9998654333333334456899999999998889999999999999999999999999765433221 111110000 00
Q ss_pred hHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 266 SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
.....+ ...........++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 264 ~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 264 QLEQIV------DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCCSSS------SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHhc------ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 000000 0111112235678889999999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=340.60 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=220.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.++|++.+.||+|+||+||+|.+. +++.||+|++..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 478999999999999999999865 5899999998766666778899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+.......
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999886668999999999999999999999 9999999999999999999999999999998764222111
Q ss_pred ------------ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 201 ------------SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 201 ------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
......||+.|+|||++.+..++.++||||||+++|+|++|..||........... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~--------~~~~ 237 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--------LNVR 237 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS--------BCHH
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh--------hhhh
Confidence 11145689999999999999999999999999999999999999876443322211 0111
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
...+.. .+..+++.+.+++.+||+.||++|||+.++++.|+.++..+.
T Consensus 238 ~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 238 GFLDRY----------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp HHHHHT----------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cccccc----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111111 123345669999999999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=340.14 Aligned_cols=272 Identities=27% Similarity=0.386 Sum_probs=209.6
Q ss_pred CHHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecC
Q 019843 34 SYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSND 111 (335)
Q Consensus 34 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 111 (335)
.........++|++.+.||+|+||.||+|... ++.||+|++.... ......+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 33444455679999999999999999999875 8899999987553 33456788999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHhccCCCC--eEecCCCCCCEEECCCCcEEEeec
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSNC--VLDIFQRLNIMIDVAAALEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDF 187 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~~~~--i~h~di~p~Nilv~~~~~v~l~df 187 (335)
+..++||||+++++|.+++..... .+++..++.++.|++.||.||| +.+ ++|+||+|+||+++.++.++|+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999999999986532 4899999999999999999999 899 999999999999999999999999
Q ss_pred cccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhH
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
|++..... .........+++.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 184 g~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~------------ 249 (309)
T 3p86_A 184 GLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA------------ 249 (309)
T ss_dssp C-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------------
T ss_pred CCCccccc--cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 99975421 1222344678999999999999999999999999999999999999997643221110
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccccc
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICTR 330 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 330 (335)
.+. . .......+..+++.+.++|.+||+.||.+|||++++++.|+.+..+..-.+.
T Consensus 250 --~~~---~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 250 --AVG---F--KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp --HHH---H--SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred --HHH---h--cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 000 0 1111222345677899999999999999999999999999998876544433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=341.65 Aligned_cols=278 Identities=23% Similarity=0.311 Sum_probs=216.4
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC----ee
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD----FK 114 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~ 114 (335)
.-..++|++.+.||+|+||.||+|... ++.||+|++..... .......|+.+++.++||||+++++++.... .+
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 344579999999999999999999877 79999999875533 2345566888899999999999999998743 47
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCC----------CeEecCCCCCCEEECCCCcEEE
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA----------PVIHCDLKPSNVLLDDNMVAHL 184 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~----------~i~h~di~p~Nilv~~~~~v~l 184 (335)
++||||+++++|.+++.... +++..++.++.|++.||.||| +. +++|+||+|+||+++.++.+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 99999999999999997654 999999999999999999999 88 9999999999999999999999
Q ss_pred eeccccccccCCccccccccccccccccCccccCCC-----CCCCccchhhHHHHHHHHHhCCCCCCcccccchhh-HhH
Q 019843 185 SDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG-----RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTL-KYW 258 (335)
Q Consensus 185 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~-~~~ 258 (335)
+|||++..+.............+|+.|+|||++.+. .++.++||||||+++|+|++|..||.......... ...
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999876543333334456789999999998863 45668899999999999999999997654322211 111
Q ss_pred hhhhcChhHHHHHHhhhccc---cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 259 VSNLLPISVMEIVDANLLSR---EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
... ......+.+...... ..........+++.+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 253 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 253 IGQ--HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HCS--SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hcc--CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111 111122222111111 11111223345777999999999999999999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=342.01 Aligned_cols=263 Identities=25% Similarity=0.419 Sum_probs=215.6
Q ss_pred hcCCCCccceeeecCceEEEEEEEc----CCcEEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
..++|++.+.||+|+||.||+|.+. .+..||+|++... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3468999999999999999999864 3456999999765 3334567899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999877668999999999999999999999 99999999999999999999999999999987643
Q ss_pred Ccc-ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 196 EDQ-SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 196 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
... ........++..|+|||++.+..++.++||||||+++|+|++ |..||........ ...+..
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--------------~~~~~~ 269 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV--------------ISSVEE 269 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--------------HHHHHT
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH--------------HHHHHc
Confidence 211 112233445778999999998899999999999999999999 9999976432211 111111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
. .....+..+++.+.+++.+||+.||.+|||+.++++.|+.+..+..
T Consensus 270 ~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 270 G------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp T------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred C------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 1 1112234567789999999999999999999999999999876544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=331.89 Aligned_cols=258 Identities=28% Similarity=0.423 Sum_probs=217.2
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 468999999999999999999988889999999975533 3467899999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
++++|.+++......+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 163 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS 163 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc-cccc
Confidence 999999999877778999999999999999999999 999999999999999999999999999999865322 1223
Q ss_pred cccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ..+....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~--------------~~~~~~~----- 224 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV--------------EDISTGF----- 224 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--------------HHHHTTC-----
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH--------------HHHhcCc-----
Confidence 334556778999999998899999999999999999999 99998764322111 1111110
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
....+..+++.+.+++.+||+.||.+|||++++++.|+++.++
T Consensus 225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 225 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 1111233466799999999999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=341.66 Aligned_cols=284 Identities=36% Similarity=0.558 Sum_probs=227.3
Q ss_pred cccccccCHHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEe
Q 019843 27 VATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKII 105 (335)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 105 (335)
......++..+.....++|++.+.||+|+||.||+|...+++.||+|++..... .....+.+|+++++.++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 455678999999999999999999999999999999887899999999875532 2334789999999999999999999
Q ss_pred eeeecCCeeEEEEEecCCCChHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhccCCC---CeEecCCCCCCEEECCC
Q 019843 106 STCSNDDFKALVLEYMPHGSLEKCLYSSN---CVLDIFQRLNIMIDVAAALEYLHFGYSA---PVIHCDLKPSNVLLDDN 179 (335)
Q Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~~l~~Lh~~~~~---~i~h~di~p~Nilv~~~ 179 (335)
+++...+..++||||+++++|.+++.... ..+++..++.++.+++.||.||| +. +++|+||+|+||+++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTT
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCC
Confidence 99999999999999999999999998643 35999999999999999999999 77 99999999999999999
Q ss_pred CcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccc---cchhhH
Q 019843 180 MVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFA---GEMTLK 256 (335)
Q Consensus 180 ~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~---~~~~~~ 256 (335)
+.++|+|||++...... .........+|+.|+|||++.+..++.++||||||+++|+|++|..||..... ......
T Consensus 171 ~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 249 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249 (326)
T ss_dssp CCEEECCCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred CCEEeccCccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence 99999999999876322 22233445689999999999888899999999999999999999999964321 111122
Q ss_pred hHhhhhc-ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 257 YWVSNLL-PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 257 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
.+..... ........+. ..........++.+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 250 DWVKGLLKEKKLEALVDV------DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHTTTTSSCCSTTSSCT------TCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHHhhchhhhhhcCh------hhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 2222111 1111111111 11112234567889999999999999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=332.11 Aligned_cols=259 Identities=26% Similarity=0.401 Sum_probs=216.7
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
..++|++.+.||+|+||.||+|..+++..||+|++..... ....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4578999999999999999999988888999999975543 346789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 160 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YV 160 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hh
Confidence 9999999999876667999999999999999999999 9999999999999999999999999999998664222 22
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||........... +...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~--------------~~~~----- 221 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK--------------VSQG----- 221 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH--------------HHTT-----
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH--------------HHcC-----
Confidence 2334456778999999988889999999999999999999 9999876443221110 1110
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
.....+..+++.+.+++.+||+.||.+|||+.++++.|+.++++
T Consensus 222 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 222 -HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 01111233466799999999999999999999999999988764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=335.79 Aligned_cols=255 Identities=18% Similarity=0.256 Sum_probs=213.2
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
..++|++.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 5689999999999999999999865 58899999987543 344678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC--CCcEEEeeccccccccCCc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~--~~~v~l~dfg~~~~~~~~~ 197 (335)
|+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++. ++.++|+|||++..+..
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 99999999999877668999999999999999999999 999999999999999987 78999999999987632
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
........+++.|+|||++.+..++.++||||||+++|+|++|..||........ .......
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----------------~~~i~~~ 218 (321)
T 1tki_A 157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----------------IENIMNA 218 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------HHHHHHT
T ss_pred -CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-----------------HHHHHcC
Confidence 2223445689999999999988899999999999999999999999976432211 1111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...........+++++.+++.+||..||.+|||+.|+++.-+
T Consensus 219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 111111223356778999999999999999999999998654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=328.89 Aligned_cols=283 Identities=30% Similarity=0.467 Sum_probs=227.6
Q ss_pred cccccCHHHHhhhcCCCCcc------ceeeecCceEEEEEEEcCCcEEEEEEeecC----CCchhHHHHHHHHHHHhCCC
Q 019843 29 TWRRFSYLELFQATDGFSEN------NLIGRGSFGSVYKARIQDGMEVAVKVFHLQ----CGGVFKSFDVECEVMKSIRH 98 (335)
Q Consensus 29 ~~~~~~~~~~~~~~~~y~~~------~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h 98 (335)
..+.|+..+...+++.|... +.||+|+||.||+|... ++.|++|++... .....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45788999999999988877 99999999999999874 889999998643 23456789999999999999
Q ss_pred CceEEEeeeeecCCeeEEEEEecCCCChHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE
Q 019843 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSS--NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL 176 (335)
Q Consensus 99 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv 176 (335)
|||+++++++.+.+..++||||+++++|.+++... ...+++..++.++.+++.||.||| +.+++|+||+|+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence 99999999999999999999999999999998743 346999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhH
Q 019843 177 DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK 256 (335)
Q Consensus 177 ~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 256 (335)
+.++.++|+|||++................++..|+|||.+.+ .++.++||||||+++|+|++|..||...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 9999999999999987643332333445678999999998865 588999999999999999999999987544332211
Q ss_pred hHhhhh-cChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 257 YWVSNL-LPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 257 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
...... ........++... ...+..++..+.+++.+||+.||.+|||++++++.|+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhhhhhhhhhhhccccc-------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 100000 0111122222111 11234567789999999999999999999999999998865
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=339.08 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=210.5
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
.....++|++.+.||+|+||.||+|.+ .+|+.||+|++... .....+.+.+|+++++.++||||+++++++...+..
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 344567999999999999999999986 57999999999754 334557788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999999987654 6999999999999999999999 9999999999999999999999999999998653
Q ss_pred CCccccccccccccccccCccccCCCCCC-CccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGRVS-TNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
. ........+|+.|+|||++.+..++ .++|||||||++|+|++|..||........ ...
T Consensus 166 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----------------~~~ 225 (328)
T 3fe3_A 166 V---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL-----------------RER 225 (328)
T ss_dssp S---SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHH
T ss_pred C---CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH-----------------HHH
Confidence 2 2234456799999999999887765 789999999999999999999976432211 111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.... ....+..+++++.+|+.+||..||.+|||++|+++.
T Consensus 226 i~~~----~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 226 VLRG----KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHC----CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHhC----CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111 111123356779999999999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=342.89 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=215.6
Q ss_pred cCCCCccceeeecCceEEEEEEEc--------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeecC
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ--------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSND 111 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 111 (335)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+++++.+ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999752 34579999987553 23456789999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL 176 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv 176 (335)
+.+++||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+++|+||+|+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 99999999999999999997643 24789999999999999999999 9999999999999999
Q ss_pred CCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhh
Q 019843 177 DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTL 255 (335)
Q Consensus 177 ~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 255 (335)
+.++.+||+|||++..+.............+++.|+|||++.+..++.++||||||+++|+|++ |..||......+.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999999999987643333333444567889999999999999999999999999999999 9999876432211
Q ss_pred HhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 256 KYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
...+.... ....+..+++.+.+++.+||+.||.+||++.|+++.|+++...
T Consensus 315 ------------~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 315 ------------FKLLKEGH------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp ------------HHHHHTTC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------HHHHhcCC------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111 1122345677899999999999999999999999999988654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=349.48 Aligned_cols=262 Identities=29% Similarity=0.440 Sum_probs=217.7
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
...++|.+.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34578999999999999999999876 68999999987543 23345788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999999876667999999999999999999999 9999999999999999999999999999997653222
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.........++..|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+...
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--------------~~~~~~~-- 331 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--------------REFVEKG-- 331 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--------------HHHHHTT--
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcC--
Confidence 2222223345778999999988889999999999999999998 9999876432211 1112111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
.+.+.+..+++.+.+++.+||+.||++|||++++++.|++++..
T Consensus 332 ----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 332 ----GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 12222445677899999999999999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=334.36 Aligned_cols=276 Identities=27% Similarity=0.436 Sum_probs=217.0
Q ss_pred hcCCCCccceeeecCceEEEEEEE-----cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec--CCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI-----QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN--DDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 113 (335)
..++|++.+.||+|+||.||+|.+ .+++.||+|++..........+.+|+++++.++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 457899999999999999999974 3588999999987766667889999999999999999999999854 456
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.++||||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 89999999999999999887667999999999999999999999 999999999999999999999999999999876
Q ss_pred cCCcc-ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc-Chh-HHHH
Q 019843 194 TGEDQ-SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL-PIS-VMEI 270 (335)
Q Consensus 194 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~-~~~~ 270 (335)
..... ........++..|+|||.+.+..++.++||||||+++|+|++|..||......... ...... ... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR---MIGNDKQGQMIVFHL 241 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHH---HHCTTCCTHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHh---hhcCccccchhHHHH
Confidence 42221 12233445677899999999899999999999999999999999998764322111 011110 000 1111
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
..... .......+..+++.+.+++.+||+.||++|||+.|+++.|+.+++++
T Consensus 242 ~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 242 IELLK---NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHH---TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHh---ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11111 11122334567788999999999999999999999999999998875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=333.24 Aligned_cols=261 Identities=24% Similarity=0.408 Sum_probs=215.2
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
....++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 345679999999999999999999988888999999975533 3477899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 999999999999876667999999999999999999999 9999999999999999999999999999998653221
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
........++..|+|||++.+..++.++||||||+++|+|++ |..||......... ..+....
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~--------------~~~~~~~-- 238 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--------------EHIAQGL-- 238 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--------------HHHHTTC--
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH--------------HHHhccc--
Confidence 222334456788999999998889999999999999999998 99999764322111 1111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
....+..+++.+.+++.+||+.||.+|||++++++.|+++.++
T Consensus 239 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 ----RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1111233466799999999999999999999999999988754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=336.52 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=210.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC------chhHHHHHHHHHHHhCCCCceEEEeeeeecCC
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG------GVFKSFDVECEVMKSIRHRNLIKIISTCSNDD 112 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 112 (335)
...++|.+.+.||+|+||.||+|..+ +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 45678999999999999999999865 589999999975432 13578899999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC----cEEEeecc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFG 188 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~----~v~l~dfg 188 (335)
..++||||++|++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++ .++|+|||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 9999999999999999997654 7999999999999999999999 99999999999999998777 79999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
++..+.. ........||+.|+|||++.+..++.++||||||+++|+|++|..||......+.
T Consensus 165 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--------------- 226 (361)
T 2yab_A 165 LAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--------------- 226 (361)
T ss_dssp SCEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---------------
T ss_pred CceEcCC---CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---------------
Confidence 9987632 2223446799999999999999999999999999999999999999976432211
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..................+++.+.+||.+||..||.+|||+.|+++
T Consensus 227 --~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 227 --LANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111111111223455777999999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=331.12 Aligned_cols=265 Identities=23% Similarity=0.364 Sum_probs=212.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
...++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 34689999999999999999999765 58999999986543 234567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||+++++|.+++.... ++++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 88 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999997654 7999999999999999999999 99999999999999999999999999999986532
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
. .........+|+.|+|||.+.+..++.++||||||+++|+|++|..||............. .
T Consensus 164 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~----------------~ 226 (294)
T 4eqm_A 164 T-SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI----------------Q 226 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH----------------S
T ss_pred c-cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh----------------h
Confidence 1 1223344568999999999999999999999999999999999999997654322211110 0
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCC-CHHHHHHHHHHHHhhh
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI-NAKEIVTRLLKIRDSL 325 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~~~~~~ 325 (335)
.............+++.+.+++.+||+.||.+|| +++++.+.|..+..+-
T Consensus 227 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 227 DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0001111112234577899999999999999998 9999999998775443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=330.71 Aligned_cols=263 Identities=23% Similarity=0.288 Sum_probs=217.4
Q ss_pred ccCHHHHhhhcCC----------CCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCc
Q 019843 32 RFSYLELFQATDG----------FSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN 100 (335)
Q Consensus 32 ~~~~~~~~~~~~~----------y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~ 100 (335)
.++..++..+.+. |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4566666655543 777889999999999999876 69999999998776666788999999999999999
Q ss_pred eEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC
Q 019843 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180 (335)
Q Consensus 101 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~ 180 (335)
|+++++++...+..++||||+++++|.+++... .+++..++.++.+++.||.||| +.+++|+||+|+||+++.++
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCC
Confidence 999999999999999999999999999988754 5999999999999999999999 99999999999999999999
Q ss_pred cEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhh
Q 019843 181 VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVS 260 (335)
Q Consensus 181 ~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 260 (335)
.++|+|||++...... ........+|+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 179 ~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~------ 250 (321)
T 2c30_A 179 RVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------ 250 (321)
T ss_dssp CEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------
T ss_pred cEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------
Confidence 9999999998866422 22234567899999999999999999999999999999999999999754321110
Q ss_pred hhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 261 NLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
..+.. ...........+++.+.+++.+||+.||++|||+.|+++.-.
T Consensus 251 -------~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 251 -------KRLRD-----SPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp -------HHHHH-----SSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred -------HHHhc-----CCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 01111 111112223445777999999999999999999999987543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=330.02 Aligned_cols=254 Identities=20% Similarity=0.289 Sum_probs=210.1
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC------chhHHHHHHHHHHHhCCCCceEEEeeeeecCC
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG------GVFKSFDVECEVMKSIRHRNLIKIISTCSNDD 112 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 112 (335)
...++|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34567999999999999999999865 589999999875432 13577999999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC----cEEEeecc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFG 188 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~----~v~l~dfg 188 (335)
..++||||+++++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++ .++|+|||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999987654 7999999999999999999999 99999999999999999887 89999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
++..... ........+|+.|+|||++.+..++.++||||||+++|+|++|..||......+...
T Consensus 164 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------------- 227 (326)
T 2y0a_A 164 LAHKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------- 227 (326)
T ss_dssp TCEECCT---TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-------------
T ss_pred CCeECCC---CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------------
Confidence 9987632 222334578999999999999999999999999999999999999997643221110
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. +. .............+++.+.+++.+||..||.+|||+.|+++.
T Consensus 228 ~-~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 228 N-VS---AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp H-HH---HTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred H-HH---hcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00 011111112223456779999999999999999999999974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=324.49 Aligned_cols=271 Identities=15% Similarity=0.142 Sum_probs=220.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 117 (335)
...++|++.+.||+|++|.||+|.. .+++.||+|++.... ....+.+|+++++.+ +|+|++++++++......++|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 3567899999999999999999985 468999999986443 235688899999999 799999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc-----EEEeecccccc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-----AHLSDFGIAKL 192 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~-----v~l~dfg~~~~ 192 (335)
||++ +++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++. ++|+|||++..
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999 99999999877667999999999999999999999 999999999999999987776 99999999987
Q ss_pred ccCCccc-----cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhH
Q 019843 193 LTGEDQS-----KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 193 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
....... .......+|..|+|||++.+..++.++||||||+++|+|++|..||........... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~----------~ 230 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK----------Y 230 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH----------H
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH----------H
Confidence 6432221 123456789999999999999999999999999999999999999987543221110 0
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcccc
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICT 329 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 329 (335)
..+..... ..........+++.+.+++.+||+.||.+||++++|++.|+++..++....
T Consensus 231 ~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 231 ERIGEKKQ---STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp HHHHHHHH---HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred HHHHhhcc---CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 01111100 000111122457789999999999999999999999999999988776543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=340.64 Aligned_cols=273 Identities=22% Similarity=0.352 Sum_probs=220.6
Q ss_pred ccccCHHHHhhhcCCCCccceeeecCceEEEEEEE------cCCcEEEEEEeecCCC-chhHHHHHHHHHHHhC-CCCce
Q 019843 30 WRRFSYLELFQATDGFSENNLIGRGSFGSVYKARI------QDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSI-RHRNL 101 (335)
Q Consensus 30 ~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i 101 (335)
.-.+.........++|++.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|++++..+ +||||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 34445556666779999999999999999999973 2367899999975432 3456789999999999 79999
Q ss_pred EEEeeeeecCC-eeEEEEEecCCCChHHHHhcCCC---------------------------------------------
Q 019843 102 IKIISTCSNDD-FKALVLEYMPHGSLEKCLYSSNC--------------------------------------------- 135 (335)
Q Consensus 102 ~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------- 135 (335)
+++++++...+ ..++||||+++++|.+++.....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 99999988754 58999999999999999976432
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 136 --------------------VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 136 --------------------~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
.+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 2899999999999999999999 99999999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
...........+|..|+|||++.+..++.++||||||+++|+|++ |..||.......... ..+...
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------------~~~~~~ 312 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-------------RRLKEG 312 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-------------HHHHHT
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH-------------HHHHcC
Confidence 333344455678899999999998899999999999999999998 999997654322211 111111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
. ....+..+++.+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 313 ~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 313 T------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp C------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1 1111234567799999999999999999999999999988754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=327.81 Aligned_cols=273 Identities=23% Similarity=0.301 Sum_probs=210.5
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
......++|++.+.||+|+||+||+|.+.+++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 3345678999999999999999999998889999999987542 33457788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++||||+++ +|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 999999975 888888877667999999999999999999999 9999999999999999999999999999998753
Q ss_pred CCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc---ChhH---
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL---PISV--- 267 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---~~~~--- 267 (335)
. .........++..|+|||++.+ ..++.++||||||+++|+|++|..||......+.... ...... +...
T Consensus 171 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 171 I--PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK-IFSILGTPNPREWPQV 247 (311)
T ss_dssp S--CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH-HHHHHCCCCTTTSGGG
T ss_pred C--CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHHCCCChHHhhhh
Confidence 1 1223344578999999999876 5689999999999999999999999976544332211 111110 0000
Q ss_pred ---HHHHHhhhcc-ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 268 ---MEIVDANLLS-REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 268 ---~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..+.+..... ...........+++++.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000 000001112345677999999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=333.96 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=209.7
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
...++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35689999999999999999999865 68999999987543 22346688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+++++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999999887553 6999999999999999999999 9999999999999999999999999999998664333
Q ss_pred cccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.........+|+.|+|||++.+..+ +.++||||||+++|+|++|..||............+.. .
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------------~--- 224 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------K--- 224 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT------------T---
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc------------c---
Confidence 3333445679999999999987765 77899999999999999999999865433222211111 1
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
.........+++.+.+|+.+||+.||.+|||++|+++.-
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 225 ---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp ---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ---cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 011111234567799999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=336.74 Aligned_cols=253 Identities=22% Similarity=0.304 Sum_probs=204.0
Q ss_pred cCCCCc--cceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 42 TDGFSE--NNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 42 ~~~y~~--~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
.+.|.+ .+.||+|+||.||+|... +|+.||+|++........+.+.+|+++++.++||||+++++++...+..++||
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 344555 578999999999999764 58999999998765556678999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE--CCCCcEEEeeccccccccCC
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL--DDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv--~~~~~v~l~dfg~~~~~~~~ 196 (335)
||+++++|.+++......+++..++.++.||+.||.||| +.+++|+||+|+||++ +.++.++|+|||++..+...
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 999999999998876667999999999999999999999 9999999999999999 56789999999999876322
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.......+|+.|+|||++.+..++.++|||||||++|+|++|..||......+.. ..+...
T Consensus 243 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------------~~i~~~--- 303 (373)
T 2x4f_A 243 ---EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL-------------NNILAC--- 303 (373)
T ss_dssp ---CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------------HHHHHT---
T ss_pred ---cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHHhc---
Confidence 2233456899999999999889999999999999999999999999764322111 111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...........+++++.+||.+||+.||.+|||+.|+++.
T Consensus 304 -~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 304 -RWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -CCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111123457779999999999999999999999984
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=337.24 Aligned_cols=255 Identities=18% Similarity=0.240 Sum_probs=211.8
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
...++|.+.+.||+|+||.||+|... +++.||+|++..........+.+|+++++.++||||+++++++.+.+..++||
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 34578999999999999999999765 58999999998665555678899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC--CCcEEEeeccccccccCC
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~--~~~v~l~dfg~~~~~~~~ 196 (335)
||+++++|.+++......+++..++.++.||+.||.||| +.+++|+||+|+||+++. ++.++|+|||++......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999999877667999999999999999999999 999999999999999974 568999999999876322
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.......+|+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+. .
T Consensus 205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-------------~~i~-~--- 264 (387)
T 1kob_A 205 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-------------QNVK-R--- 264 (387)
T ss_dssp ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------------HHHH-H---
T ss_pred ---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH-------------HHHH-h---
Confidence 2233456899999999999999999999999999999999999999764321110 0111 1
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
............+++++.++|.+||+.||.+|||+.|+++.
T Consensus 265 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 265 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 01111111123457779999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=323.56 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=216.2
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|++.+.||+|++|.||+|.+.+++.|++|++..... ..+.+.+|+++++.++||||+++++++.+.+..++|||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 468999999999999999999988888999999976543 3478899999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
++++|.+++......+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~ 161 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS 161 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc-cccc
Confidence 999999999877668999999999999999999999 999999999999999999999999999999865321 1222
Q ss_pred cccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||........ ...+....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------------~~~i~~~~----- 222 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--------------VEDISTGF----- 222 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------------HHHHHTTC-----
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH--------------HHHHhcCC-----
Confidence 334556788999999988889999999999999999999 8999876432111 01111110
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
....+..+++.+.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 223 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111233466799999999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=337.21 Aligned_cols=266 Identities=27% Similarity=0.400 Sum_probs=217.1
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeec
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 110 (335)
.....++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445689999999999999999999864 34789999997653 3345778999999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEec
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSSN-----------------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~ 167 (335)
.+..++||||+++++|.+++.... ..+++..++.++.+|+.||.||| +.+++|+
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 999999999999999999997632 47999999999999999999999 9999999
Q ss_pred CCCCCCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q 019843 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTD 246 (335)
Q Consensus 168 di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~ 246 (335)
||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987643333334445667889999999988889999999999999999999 999987
Q ss_pred cccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 247 KIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
.....+.. ..+.... ....+..+++.+.+++.+||+.||.+|||+.++++.|+++..++.
T Consensus 279 ~~~~~~~~--------------~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHEEVI--------------YYVRDGN------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHHHHH--------------HHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChHHHH--------------HHHhCCC------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 64321110 1111110 011233556779999999999999999999999999999887654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=332.23 Aligned_cols=261 Identities=25% Similarity=0.400 Sum_probs=216.8
Q ss_pred hcCCCCccceeeecCceEEEEEEE------cCCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI------QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++++.++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 467899999999999999999975 235789999987543 3445778999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCC
Q 019843 114 KALVLEYMPHGSLEKCLYSSN-----------------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLK 170 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~ 170 (335)
.++||||+++++|.+++.... ..+++..++.++.+|+.||.||| +.+++|+||+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence 999999999999999997643 24899999999999999999999 9999999999
Q ss_pred CCCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccc
Q 019843 171 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIF 249 (335)
Q Consensus 171 p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~ 249 (335)
|+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987643333333444567888999999988889999999999999999999 999987643
Q ss_pred ccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 250 AGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
.... ...+.... ....+..+++.+.+++.+||+.||.+|||+.++++.|+++..+
T Consensus 258 ~~~~--------------~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PERL--------------FNLLKTGH------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGGH--------------HHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHH--------------HHHhhcCC------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 2211 11111111 1112234577799999999999999999999999999988764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=339.40 Aligned_cols=265 Identities=27% Similarity=0.408 Sum_probs=218.8
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc--------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeee
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ--------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCS 109 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 109 (335)
...++|.+.+.||+|+||.||+|... .+..||+|++.... ......+.+|+++++.+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578999999999999999999752 23579999987653 33457788999999999 8999999999999
Q ss_pred cCCeeEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCE
Q 019843 110 NDDFKALVLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNV 174 (335)
Q Consensus 110 ~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Ni 174 (335)
..+..++||||+++++|.+++.... ..+++..++.++.+|+.||.||| +.+++|+||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceE
Confidence 9999999999999999999998653 35999999999999999999999 99999999999999
Q ss_pred EECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccch
Q 019843 175 LLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEM 253 (335)
Q Consensus 175 lv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~ 253 (335)
+++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......+.
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987644333344445567889999999999999999999999999999999 9999876432111
Q ss_pred hhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 254 TLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
...+.... ....+..+++.+.+++.+||+.||.+|||++|+++.|+.+......
T Consensus 303 --------------~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 303 --------------FKLLKEGH------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp --------------HHHHHTTC------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred --------------HHHHHcCC------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11111111 1111234577799999999999999999999999999999765543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=334.39 Aligned_cols=260 Identities=19% Similarity=0.315 Sum_probs=211.1
Q ss_pred HHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecC
Q 019843 35 YLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSND 111 (335)
Q Consensus 35 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 111 (335)
+.......++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 21 MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE 100 (362)
T ss_dssp ---CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 3334455678999999999999999999765 58999999997553 23456788999999999999999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC---cEEEeecc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFG 188 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~---~v~l~dfg 188 (335)
+..++||||+++++|.+.+.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++ .+||+|||
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence 99999999999999999887654 7999999999999999999999 99999999999999998654 59999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
++..... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||........ .
T Consensus 177 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------------~ 239 (362)
T 2bdw_A 177 LAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--------------Y 239 (362)
T ss_dssp TCBCCTT---CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------------H
T ss_pred cceEecC---CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--------------H
Confidence 9986632 2223346789999999999998999999999999999999999999976432111 1
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
..+...... ........+++++.+||.+||+.||.+||++.|+++.-
T Consensus 240 ~~i~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 240 AQIKAGAYD---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp HHHHHTCCC---CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred HHHHhCCCC---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 111111111 11111234577899999999999999999999998753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=331.10 Aligned_cols=249 Identities=23% Similarity=0.294 Sum_probs=208.8
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.++|++.+.||+|+||.||+|..+ +|+.||+|++... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999865 5899999999753 233457788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||++|++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.+|.++|+|||++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--
Confidence 99999999999887654 7999999999999999999999 99999999999999999999999999999875321
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
.........||+.|+|||++.+..++.++|+||||+++|+|++|..||......... ..+...
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------------~~i~~~---- 220 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------------ELILME---- 220 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------------HHHHHC----
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH-------------HHHHcC----
Confidence 122334567999999999999999999999999999999999999999764321110 111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
....+..+++++.++|.+||+.||++|| +++|+++.
T Consensus 221 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 ----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1111234577899999999999999999 89999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=329.24 Aligned_cols=268 Identities=19% Similarity=0.198 Sum_probs=216.7
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 117 (335)
...++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+..|+++++.+ +||||+++++++...+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 3568999999999999999999986 4689999999875532 35688999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc-----EEEeecccccc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-----AHLSDFGIAKL 192 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~-----v~l~dfg~~~~ 192 (335)
||++ +++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++. ++|+|||++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999 99999999876668999999999999999999999 999999999999999998887 99999999987
Q ss_pred ccCCcccc-----ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhH
Q 019843 193 LTGEDQSK-----SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 193 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~----------~ 229 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER----------Y 229 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH----------H
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH----------H
Confidence 64322111 12456799999999999999999999999999999999999999987543222110 0
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
..+....... ........++ .+.+++.+||+.||.+||++.+|.+.|+++..+...
T Consensus 230 ~~i~~~~~~~---~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 230 QKIGDTKRAT---PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HHHHHHHHHS---CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHhhhccC---CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 0111110000 0000112234 799999999999999999999999999988776543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=338.80 Aligned_cols=262 Identities=23% Similarity=0.456 Sum_probs=205.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEc----CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
..++|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3468999999999999999999764 47789999987653 334567999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||+++++|.+++......+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999999877668999999999999999999999 99999999999999999999999999999987642
Q ss_pred Ccc-ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 196 EDQ-SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 196 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
... ........++..|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~--------------~~~i~~ 265 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVDE 265 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH--------------HHHHHT
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHc
Confidence 211 111222335678999999998899999999999999999998 9999876432111 111111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
.. ..+.+..++..+.+++.+||+.||.+||++.++++.|+++..+.
T Consensus 266 ~~------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 266 GY------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp TE------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CC------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 11 11123345677999999999999999999999999999987653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=326.16 Aligned_cols=284 Identities=21% Similarity=0.305 Sum_probs=211.6
Q ss_pred CCCcccccccCHHHHhhhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCC
Q 019843 24 MPPVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHR 99 (335)
Q Consensus 24 ~p~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~ 99 (335)
.|.................++|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.+++.++||
T Consensus 13 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 92 (310)
T 2wqm_A 13 VPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92 (310)
T ss_dssp -------CCCCGGGTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCT
T ss_pred CCCcChhhcCCCCcccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCC
Confidence 33334445555555566778999999999999999999986 46899999998753 233456788999999999999
Q ss_pred ceEEEeeeeecCCeeEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE
Q 019843 100 NLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL 176 (335)
Q Consensus 100 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv 176 (335)
||+++++++...+..++|||++++++|.+++.. ....+++..++.++.+++.||.||| +.+++|+||+|+||++
T Consensus 93 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~ 169 (310)
T 2wqm_A 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFI 169 (310)
T ss_dssp TBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred CEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEE
Confidence 999999999999999999999999999999864 3457999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhH
Q 019843 177 DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK 256 (335)
Q Consensus 177 ~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~ 256 (335)
+.++.++|+|||++...... ........++..|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus 170 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 247 (310)
T 2wqm_A 170 TATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 247 (310)
T ss_dssp CTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH
T ss_pred cCCCCEEEEeccceeeecCC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH
Confidence 99999999999998765321 2222345688999999999999999999999999999999999999875432211111
Q ss_pred hHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcccc
Q 019843 257 YWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICT 329 (335)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 329 (335)
..+...... ......+++.+.+++.+||+.||.+|||++++++.|+++++......
T Consensus 248 ------------~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 248 ------------KKIEQCDYP-----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp ------------HHHHTTCSC-----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred ------------HHhhcccCC-----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 111111000 00113456779999999999999999999999999999998766544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=334.17 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=213.6
Q ss_pred hcCCCCccceeeecCceEEEEEEE------cCCcEEEEEEeecC-CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCC
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI------QDGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDD 112 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 112 (335)
..++|.+.+.||+|+||.||+|.. .++..||+|++... .......+.+|+.+++.+ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999975 23568999998754 234457899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCC
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNC----------------------VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLK 170 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~----------------------~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~ 170 (335)
..++||||+++++|.+++..... .+++..++.++.+|+.||.||| +.+++|+||+
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 99999999999999999976532 3789999999999999999999 9999999999
Q ss_pred CCCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccc
Q 019843 171 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIF 249 (335)
Q Consensus 171 p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~ 249 (335)
|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987643333333445667889999999988899999999999999999998 999997654
Q ss_pred ccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 250 AGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
.... ....+.... ....+..+++.+.+++.+||..||.+|||+.++++.|+.+..+.
T Consensus 280 ~~~~-------------~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VDAN-------------FYKLIQNGF------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CSHH-------------HHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cHHH-------------HHHHHhcCC------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 3221 111121111 11112345677999999999999999999999999999886554
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=332.88 Aligned_cols=269 Identities=25% Similarity=0.441 Sum_probs=200.9
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEcC-C---cEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeec
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQD-G---MEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~---~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 110 (335)
+.....++|++.+.||+|+||.||+|.... + ..||+|++... .......+.+|+++++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 445566899999999999999999997653 3 27999998754 34456789999999999999999999999987
Q ss_pred CCee------EEEEEecCCCChHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC
Q 019843 111 DDFK------ALVLEYMPHGSLEKCLYSS-----NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN 179 (335)
Q Consensus 111 ~~~~------~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~ 179 (335)
.... ++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCC
Confidence 6654 8999999999999998643 225899999999999999999999 9999999999999999999
Q ss_pred CcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhH
Q 019843 180 MVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYW 258 (335)
Q Consensus 180 ~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~ 258 (335)
+.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......+...
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~--- 250 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN--- 250 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH---
Confidence 9999999999987643333333444556788999999998899999999999999999999 999997654322211
Q ss_pred hhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccc
Q 019843 259 VSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328 (335)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 328 (335)
.+.... ....+..+++.+.+++.+||+.||++|||+.++++.|+++.......
T Consensus 251 ----------~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 251 ----------YLIGGN-------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp ----------HHHTTC-------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred ----------HHhcCC-------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 111110 11112345677999999999999999999999999999987655443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=322.54 Aligned_cols=268 Identities=24% Similarity=0.274 Sum_probs=206.2
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 68999999999999999999865 58999999997553 3345778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++ ++.+.+......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PV 155 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--cc
Confidence 9965 666666665568999999999999999999999 99999999999999999999999999999986531 22
Q ss_pred cccccccccccccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh---
Q 019843 200 KSQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL--- 275 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 275 (335)
.......+|..|+|||++.+.. ++.++||||||+++|+|++|..||........................+.....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 3334557899999999987765 799999999999999999988886443322222222111111000000000000
Q ss_pred ------ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 276 ------LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 276 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.............+++.+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000011112245677999999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=341.17 Aligned_cols=256 Identities=19% Similarity=0.280 Sum_probs=209.4
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
....++|++.+.||+|+||.||+|... +|+.+|+|++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 445678999999999999999999764 68999999987553 234567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC---CCCcEEEeecccccc
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKL 192 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~---~~~~v~l~dfg~~~~ 192 (335)
+||||++|++|.+.+.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++ .++.+||+|||++..
T Consensus 87 lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999999888664 7999999999999999999999 99999999999999998 567899999999976
Q ss_pred ccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
.... ........||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...+.
T Consensus 163 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~--------------~~~i~ 226 (444)
T 3soa_A 163 VEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL--------------YQQIK 226 (444)
T ss_dssp CCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------------HHHHH
T ss_pred ecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH--------------HHHHH
Confidence 5322 2223446799999999999999999999999999999999999999976432211 11111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
... .....+....+++++.+||.+||+.||.+|||+.|+++.
T Consensus 227 ~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 227 AGA---YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HTC---CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hCC---CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111 111111123457789999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=340.28 Aligned_cols=263 Identities=24% Similarity=0.382 Sum_probs=215.6
Q ss_pred cCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 478999999999999999999843 4678999998644 233455788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC---cEEEe
Q 019843 115 ALVLEYMPHGSLEKCLYSSN------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLS 185 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~---~v~l~ 185 (335)
++||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+++|+||+|+||+++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997542 35899999999999999999999 99999999999999999555 59999
Q ss_pred eccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcC
Q 019843 186 DFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLP 264 (335)
Q Consensus 186 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 264 (335)
|||++..+.............+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+.
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~----------- 295 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV----------- 295 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-----------
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------
Confidence 9999986533333334445667899999999988899999999999999999998 9999876432211
Q ss_pred hhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 265 ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
...+.... ....+..+++.+.+|+.+||+.||.+|||+.++++.|+.+..+...
T Consensus 296 ---~~~i~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 296 ---LEFVTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp ---HHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred ---HHHHHcCC------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 11111111 1112344567799999999999999999999999999998776543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=328.75 Aligned_cols=263 Identities=23% Similarity=0.354 Sum_probs=217.9
Q ss_pred hcCCCCccceeeecCceEEEEEEE------cCCcEEEEEEeecCCC-chhHHHHHHHHHHHhC-CCCceEEEeeeeecCC
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI------QDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSI-RHRNLIKIISTCSNDD 112 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 112 (335)
..++|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+.+|+.+++.+ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 457899999999999999999974 2467899999975543 3457789999999999 9999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEE
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNC-----------------VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVL 175 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nil 175 (335)
..++||||+++++|.+++..... .+++..++.++.+|+.||.||| +.+++|+||+|+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence 99999999999999999976532 4899999999999999999999 999999999999999
Q ss_pred ECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchh
Q 019843 176 LDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMT 254 (335)
Q Consensus 176 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~ 254 (335)
++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence 99999999999999987654333333445567888999999988899999999999999999998 9999876432221
Q ss_pred hHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 255 LKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
....+...... ..+..+++.+.+++.+||+.||.+|||+.|+++.|+++..+.
T Consensus 257 ------------~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 ------------FYKMIKEGFRM------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp ------------HHHHHHHTCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ------------HHHHhccCCCC------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 11122211111 112345677999999999999999999999999999887654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=321.82 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=208.9
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCc-------hhHHHHHHHHHHHhCCCCceEEEeeeeecC
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGG-------VFKSFDVECEVMKSIRHRNLIKIISTCSND 111 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 111 (335)
...++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+++++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34589999999999999999999864 6899999998654321 126788999999999999999999999776
Q ss_pred CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCC--eEecCCCCCCEEECCCCc-----EEE
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP--VIHCDLKPSNVLLDDNMV-----AHL 184 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~--i~h~di~p~Nilv~~~~~-----v~l 184 (335)
. ++||||+++++|.+.+......+++..++.++.+++.||.||| +.+ ++|+||+|+||+++.++. ++|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 6 5999999999999998877778999999999999999999999 899 999999999999988776 999
Q ss_pred eeccccccccCCccccccccccccccccCccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh
Q 019843 185 SDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR--EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262 (335)
Q Consensus 185 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 262 (335)
+|||++... ........+++.|+|||++. +..++.++||||||+++|+|++|..||............
T Consensus 171 ~Dfg~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----- 240 (287)
T 4f0f_A 171 ADFGLSQQS-----VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN----- 240 (287)
T ss_dssp CCCTTCBCC-----SSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH-----
T ss_pred CCCCccccc-----cccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH-----
Confidence 999998754 22344567899999999984 456788999999999999999999999765433221111
Q ss_pred cChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 263 LPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
..... ......+..+++.+.+++.+||+.||.+|||++|+++.|+++
T Consensus 241 ------~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 ------MIREE------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ------HHHHS------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ------HHhcc------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 01111 111122345677899999999999999999999999999753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=332.07 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=207.7
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCc----EEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGM----EVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
.++|++.+.||+|+||.||+|.+. +++ +|++|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 478999999999999999999754 344 3688887543 2345578999999999999999999999998765 67
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
++++++.+++|.+++......+++..++.++.+|+.||.||| +.+++|+||||+||+++.++.+||+|||++..+..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 899999999999999887778999999999999999999999 99999999999999999999999999999987654
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ...+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--------------~~~~~~~ 235 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------------SSILEKG 235 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------------HHHHHTT
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--------------HHHHHcC
Confidence 333333444556889999999999999999999999999999999 9999976543221 1222221
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
. ....+..++..+.+++.+||+.||.+||++.++++.|+.+..+
T Consensus 236 ~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 236 E------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp C------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred C------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1 1112334566799999999999999999999999999988654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=331.68 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=207.8
Q ss_pred hcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..++|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+++++.++||||+++++++...+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 457899999999999999999986 46899999998643 22334678999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+ +|+|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 87 v~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~- 160 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD- 160 (336)
T ss_dssp EECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT-
T ss_pred EEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccC-
Confidence 99999 778888887554 6999999999999999999999 99999999999999999999999999999986532
Q ss_pred ccccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
........|++.|+|||++.+..+ +.++||||||+++|+|++|..||..........
T Consensus 161 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------------------- 218 (336)
T 3h4j_B 161 --GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------------------- 218 (336)
T ss_dssp --SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------------------
T ss_pred --CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------------------
Confidence 223344578999999999988776 789999999999999999999997643221110
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.........+..+++.+.+|+.+||+.||.+|||++|+++.-+
T Consensus 219 -~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 219 -KVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp -CCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred -HHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 0011111223345677999999999999999999999987544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=322.45 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=198.5
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC----CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC----GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.++|++.+.||+|+||.||+|.+. ++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 478999999999999999999876 8999999986543 23357789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCC---eEecCCCCCCEEECC--------CCcEEEee
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP---VIHCDLKPSNVLLDD--------NMVAHLSD 186 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~---i~h~di~p~Nilv~~--------~~~v~l~d 186 (335)
|||+++++|.+++... .+++..++.++.+++.||.||| +.+ ++|+||+|+||+++. ++.++|+|
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999988644 6999999999999999999999 888 999999999999986 77899999
Q ss_pred ccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh
Q 019843 187 FGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266 (335)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 266 (335)
||++..... .......++..|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus 160 fg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---------- 225 (271)
T 3dtc_A 160 FGLAREWHR----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG---------- 225 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH----------
T ss_pred CCccccccc----ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh----------
Confidence 999986532 222345689999999999888899999999999999999999999976432221110
Q ss_pred HHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
... .......+..+++.+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 226 ---~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 226 ---VAM------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---HHT------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---hhc------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 000 0111112345567799999999999999999999999999754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=323.78 Aligned_cols=272 Identities=23% Similarity=0.411 Sum_probs=213.9
Q ss_pred cCCCCccceeeecCceEEEEEEE-----cCCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecC--Ce
Q 019843 42 TDGFSENNLIGRGSFGSVYKARI-----QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSND--DF 113 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 113 (335)
.++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+++++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35699999999999999999983 358899999987543 34557899999999999999999999999876 67
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.++||||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 89999999999999999766667999999999999999999999 999999999999999999999999999999876
Q ss_pred cCCccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc-ChhHHHHH
Q 019843 194 TGEDQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL-PISVMEIV 271 (335)
Q Consensus 194 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~ 271 (335)
...... .......++..|+|||++.+..++.++||||||+++|+|++|..|+.......... ..... ......+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM---IGPTHGQMTVTRLV 253 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH---HCSCCGGGHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhc---cCCcccccCHHHHH
Confidence 432211 23345567888999999998889999999999999999999999865432211110 00111 11111111
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
.... .......+..+++.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 254 ~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLK---EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHH---TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHh---ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111 11122223456778999999999999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=332.38 Aligned_cols=255 Identities=21% Similarity=0.282 Sum_probs=208.0
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC-----CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ-----CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
...++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34578999999999999999999765 5899999998642 12245789999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc---EEEeec
Q 019843 114 KALVLEYMPHGSLEKCLYSS---NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDF 187 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~---v~l~df 187 (335)
.++||||+++++|.+.+... ...+++..++.++.||+.||.||| +.+++|+||+|+||+++.++. ++|+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999998887642 335899999999999999999999 999999999999999986654 999999
Q ss_pred cccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhH
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
|++...... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||...... . .
T Consensus 178 g~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~------------~ 241 (351)
T 3c0i_A 178 GVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--L------------F 241 (351)
T ss_dssp TTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--H------------H
T ss_pred cceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH--H------------H
Confidence 999876422 22234457999999999999999999999999999999999999999763210 0 0
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..+.. ............+++.+.+||.+||+.||++|||+.|+++.
T Consensus 242 ~~i~~----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 242 EGIIK----GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHH----TCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHc----CCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111 11111111223457789999999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=321.18 Aligned_cols=252 Identities=22% Similarity=0.365 Sum_probs=209.7
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecC--CeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSND--DFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 117 (335)
.++|++.+.||+|+||.||+|.+. ++.||+|++.... ......+.+|+.+++.++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 478999999999999999999986 8999999997653 33456789999999999999999999999887 788999
Q ss_pred EEecCCCChHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhccCCCC--eEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 118 LEYMPHGSLEKCLYSSNC-VLDIFQRLNIMIDVAAALEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~~~~--i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
|||+++++|.+++..... .+++..++.++.|++.||.||| +.+ ++|+||+|+||+++.++.+++.|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~- 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF- 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT-
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee-
Confidence 999999999999986543 5899999999999999999999 888 999999999999999999999998887543
Q ss_pred CCccccccccccccccccCccccCCCCCCC---ccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGRVST---NGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
......+|+.|+|||.+.+..++. ++||||||+++|+|++|..||.......... ...
T Consensus 164 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------------~~~ 224 (271)
T 3kmu_A 164 ------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM-------------KVA 224 (271)
T ss_dssp ------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH-------------HHH
T ss_pred ------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH-------------HHH
Confidence 223356789999999988765554 7999999999999999999997643322111 111
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
... .....+..+++.+.+++.+||+.||++|||++++++.|+++.+
T Consensus 225 ~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 225 LEG------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HSC------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred hcC------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111 1111234467779999999999999999999999999999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=322.32 Aligned_cols=278 Identities=25% Similarity=0.376 Sum_probs=213.8
Q ss_pred cccCHHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhC--CCCceEEEeeee
Q 019843 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI--RHRNLIKIISTC 108 (335)
Q Consensus 31 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~ 108 (335)
...+........++|++.+.||+|+||.||+|... ++.||+|++.... ......|.+++... +||||+++++++
T Consensus 25 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 25 SGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp SSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CCCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 34445566677789999999999999999999887 8999999986442 24455566666655 899999999998
Q ss_pred ecC----CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCC--------CeEecCCCCCCEEE
Q 019843 109 SND----DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA--------PVIHCDLKPSNVLL 176 (335)
Q Consensus 109 ~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~--------~i~h~di~p~Nilv 176 (335)
... ...++||||+++++|.+++... .+++..++.++.+++.||.||| +. +++|+||+|+||++
T Consensus 101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 101 IKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp EESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEE
T ss_pred ccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEE
Confidence 876 7899999999999999999765 4999999999999999999999 88 99999999999999
Q ss_pred CCCCcEEEeeccccccccCCccc--cccccccccccccCccccCCCCCCCc------cchhhHHHHHHHHHhC-------
Q 019843 177 DDNMVAHLSDFGIAKLLTGEDQS--KSQTQTLATIGYMAPEYGREGRVSTN------GDVYSFGIMLMETFTK------- 241 (335)
Q Consensus 177 ~~~~~v~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~------sDiwslG~~l~~ll~g------- 241 (335)
+.++.+||+|||++..+...... .......+|..|+|||++.+...+.. +||||||+++|+|++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 99999999999999765322211 11234578999999999987766665 9999999999999999
Q ss_pred ---CCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 242 ---KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 242 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
..||........... .......................+++.+.+++.+||+.||.+|||+.++++.|
T Consensus 256 ~~~~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYE---------DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp CCCCCTTTTTSCSSCCHH---------HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccccccHhhhcCCCCchh---------hhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 555544322221111 11111111111111112222346788899999999999999999999999999
Q ss_pred HHHHhhhc
Q 019843 319 LKIRDSLL 326 (335)
Q Consensus 319 ~~~~~~~~ 326 (335)
+++.++-.
T Consensus 327 ~~l~~~~~ 334 (337)
T 3mdy_A 327 AKMSESQD 334 (337)
T ss_dssp HHHHHTTT
T ss_pred HHHHhhcc
Confidence 99987654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=326.92 Aligned_cols=275 Identities=19% Similarity=0.284 Sum_probs=212.1
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC--eeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD--FKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 116 (335)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++...+ ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 4578999999999999999999866 48999999987543 334577889999999999999999999988655 7899
Q ss_pred EEEecCCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE----CCCCcEEEeecccc
Q 019843 117 VLEYMPHGSLEKCLYSSN--CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIA 190 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv----~~~~~v~l~dfg~~ 190 (335)
||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+++|+||+|+||++ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999998643 23999999999999999999999 9999999999999999 78888999999999
Q ss_pred ccccCCccccccccccccccccCccccC--------CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGR--------EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 262 (335)
..+... .......++..|+|||++. +..++.++||||||+++|+|++|..||.................
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 876322 2233456899999999875 56789999999999999999999999975433222211110000
Q ss_pred c--Chh-HHHH---HHhh--hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 263 L--PIS-VMEI---VDAN--LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 263 ~--~~~-~~~~---~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
. +.. ...+ .... ..............+++.+.+++.+||+.||++|||++|+++..++-
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 0 000 0000 0000 00001111123456788899999999999999999999999988753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=334.40 Aligned_cols=273 Identities=16% Similarity=0.194 Sum_probs=211.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEcC------CcEEEEEEeecCCCch-----------hHHHHHHHHHHHhCCCCceEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQD------GMEVAVKVFHLQCGGV-----------FKSFDVECEVMKSIRHRNLIK 103 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~------~~~v~iK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~ 103 (335)
..++|++.+.||+|+||.||+|.+.. ++.||+|++....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 56799999999999999999998654 4789999987554211 112334555667778999999
Q ss_pred EeeeeecC----CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC--
Q 019843 104 IISTCSND----DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-- 177 (335)
Q Consensus 104 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~-- 177 (335)
+++++... ...++||||+ +++|.+++......+++..++.++.||+.||.||| +.+++|+||+|+||+++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence 99998764 5689999999 99999999887678999999999999999999999 99999999999999998
Q ss_pred CCCcEEEeeccccccccCCccc-----cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccc
Q 019843 178 DNMVAHLSDFGIAKLLTGEDQS-----KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252 (335)
Q Consensus 178 ~~~~v~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~ 252 (335)
.++.++|+|||++..+...... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999876422211 11233459999999999999999999999999999999999999998643332
Q ss_pred hhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 253 MTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
..... ...........+.+..+. ...+++++.+++.+||+.||.+||++.+|++.|+++..+...
T Consensus 269 ~~~~~-~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 269 KYVRD-SKIRYRENIASLMDKCFP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp HHHHH-HHHHHHHCHHHHHHHHSC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHH-HHHHhhhhHHHHHHHhcc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 22111 111111122222222211 123467799999999999999999999999999998876544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=321.87 Aligned_cols=268 Identities=22% Similarity=0.310 Sum_probs=204.7
Q ss_pred CCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
++|++.+.||+|+||.||+|...+++.||+|++.... ......+.+|+++++.++||||+++++++...+..++|||+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 6899999999999999999988889999999986543 23346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+++ +|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++..... ...
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVR 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCc--ccc
Confidence 965 999998876668999999999999999999999 99999999999999999999999999999986531 122
Q ss_pred ccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH---HHH-----
Q 019843 201 SQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM---EIV----- 271 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~----- 271 (335)
......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||............ .......... ...
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI-FRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHHCCCChhhchhhhccccc
Confidence 2334568999999999876 45899999999999999999999999765432221111 1100000000 000
Q ss_pred Hhhhcc-ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 272 DANLLS-REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 272 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
+..... ...........+++.+.+|+.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 0000001113456779999999999999999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=328.33 Aligned_cols=279 Identities=23% Similarity=0.379 Sum_probs=218.8
Q ss_pred hhhcCCC-CccceeeecCceEEEEEEEc-----CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeec-
Q 019843 39 FQATDGF-SENNLIGRGSFGSVYKARIQ-----DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSN- 110 (335)
Q Consensus 39 ~~~~~~y-~~~~~lg~g~~~~v~~~~~~-----~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 110 (335)
....++| ++++.||+|+||.||++.+. +++.||+|++..... .....+.+|+++++.++||||+++++++.+
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 3345566 99999999999999988642 588899999986533 345778999999999999999999999987
Q ss_pred -CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 111 -DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 111 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
....++||||+++++|.+++.... +++..++.++.+|+.||.+|| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred CCceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccc
Confidence 468899999999999999997654 999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc-ChhH
Q 019843 190 AKLLTGEDQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL-PISV 267 (335)
Q Consensus 190 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~ 267 (335)
+......... .......++..|+|||++.+..++.++||||||+++|+|++|..||............+..... ....
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 9876432211 2233456788899999999888999999999999999999999998764332211111000000 0011
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccc
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 328 (335)
...+... .....+..+++.+.+++.+||+.||.+|||+.|+++.|+.+.+++...
T Consensus 261 ~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 261 TELLERG------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHHHhcc------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 1111111 122223456778999999999999999999999999999999887643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=330.70 Aligned_cols=281 Identities=24% Similarity=0.322 Sum_probs=217.7
Q ss_pred cCCCCccceeeecCceEEEEEEE-----cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeee--cCCee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARI-----QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS--NDDFK 114 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 114 (335)
.++|++.+.||+|+||.||+|.+ .+++.||+|++..........+.+|+++++.++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 47899999999999999999984 358899999998776666678999999999999999999999886 56678
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++||||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999999875557999999999999999999999 9999999999999999999999999999998764
Q ss_pred CCccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 195 GEDQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 195 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
..... .......++..|+|||++.+..++.++||||||+++|+|++|..||............... .........+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 256 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER--DVPALSRLLEL 256 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc--ccccHHHHHHH
Confidence 22211 2233456788899999998888999999999999999999999998764332111110000 01111111111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccccc
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICTR 330 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 330 (335)
.. .......+..+++.+.+++.+||+.||.+|||++|+++.|+.+......|..
T Consensus 257 ~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 257 LE---EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp HH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred hh---cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 11 1111222445678899999999999999999999999999999876665543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=325.87 Aligned_cols=265 Identities=27% Similarity=0.415 Sum_probs=201.9
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
.....++|++.+.||+|+||.||+|... ..+++|++.... ....+.+.+|+++++.++||||++++++. .....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 3445679999999999999999999865 359999987553 33457789999999999999999999965 455688
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999999877778999999999999999999999 99999999999999999999999999999986543
Q ss_pred CccccccccccccccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
...........++..|+|||++. +..++.++||||||+++|+|++|..||......... ...+.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------------~~~~~ 239 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-------------IEMVG 239 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH-------------HHHHH
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH-------------HHHhc
Confidence 22233334567899999999986 566888999999999999999999999765432211 11111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
........ ......+++.+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 240 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 240 RGSLSPDL--SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HTSCCCCT--TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccccCcch--hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11111110 11123457789999999999999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=317.82 Aligned_cols=254 Identities=25% Similarity=0.276 Sum_probs=210.2
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
....++|++.+.||+|+||.||+|... ++..+++|++........+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 345678999999999999999999765 4788999999876666678899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE---CCCCcEEEeecccccccc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv---~~~~~v~l~dfg~~~~~~ 194 (335)
|||+++++|.+++.... .+++..++.++.+++.||.||| +.+++|+||+|+||++ +.++.++|+|||++..+.
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 85 MELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999887654 6999999999999999999999 9999999999999999 788899999999998663
Q ss_pred CCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
. ........+++.|+|||++.+. ++.++||||||+++|+|++|..||......+.... +..
T Consensus 161 ~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------------~~~- 221 (277)
T 3f3z_A 161 P---GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK--------------IRE- 221 (277)
T ss_dssp T---TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------------HHH-
T ss_pred C---ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH--------------HHh-
Confidence 2 2233445689999999998764 89999999999999999999999976433221110 111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
............+++.+.+++.+||+.||.+|||+.++++.
T Consensus 222 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 222 --GTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp --CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --CCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111112457779999999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=323.45 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=203.6
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEcC----CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQD----GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
....++|++.+.||+|+||.||+|.... +..|++|++.... ....+.+.+|+.+++.++||||+++++++. .+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 3455799999999999999999997642 4569999986543 344567899999999999999999999985 456
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.++||||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 78999999999999999877667999999999999999999999 999999999999999999999999999999876
Q ss_pred cCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
.... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||......+.. ..+.
T Consensus 167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~--------------~~i~ 231 (281)
T 1mp8_A 167 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--------------GRIE 231 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--------------HHHH
T ss_pred Cccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH--------------HHHH
Confidence 3221 112233456778999999988889999999999999999997 99999765432211 1111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
.. .....+..+++.+.+++.+||+.||.+|||+.|+++.|+++..+
T Consensus 232 ~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 232 NG------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cC------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11 01112345677899999999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=325.13 Aligned_cols=266 Identities=25% Similarity=0.416 Sum_probs=221.5
Q ss_pred hhcCCCCccceeeecCceEEEEEEEcC-CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
...++|++.+.||+|++|.||+|.+.. +..||+|++..+ ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 356789999999999999999998764 888999998754 334578899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 119 EYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 119 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|++++++|.+++... ...+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~- 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 164 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS-
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCC-
Confidence 999999999999763 346999999999999999999999 999999999999999999999999999999876422
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ...+....
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--------------~~~~~~~~- 229 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------------YELLEKDY- 229 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--------------HHHHHTTC-
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHhccC-
Confidence 2233344556788999999998899999999999999999999 9999876432221 11111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccccc
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICTR 330 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 330 (335)
....+..+++.+.+++.+||+.||.+|||++++++.|+.+..+.....+
T Consensus 230 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~~~ 278 (288)
T 3kfa_A 230 -----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 278 (288)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccccch
Confidence 1112344567799999999999999999999999999999877665544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=317.64 Aligned_cols=256 Identities=19% Similarity=0.325 Sum_probs=210.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 35689999999999999999999765 58999999997543 3345778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc---EEEeeccccccc
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFGIAKLL 193 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~---v~l~dfg~~~~~ 193 (335)
||||+++++|.+.+.... .+++..++.++.+++.||.||| +.+++|+||+|+||+++.++. ++|+|||++...
T Consensus 83 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999988887654 6999999999999999999999 999999999999999986655 999999999765
Q ss_pred cCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
.. ........+++.|+|||++.+..++.++||||||+++|+|++|..||......... ..+..
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------------~~~~~ 221 (284)
T 3kk8_A 159 ND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY--------------AQIKA 221 (284)
T ss_dssp CS---SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------------HHHHH
T ss_pred cc---CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH--------------HHHHh
Confidence 32 22234467899999999999999999999999999999999999999764322111 11111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.... ........+++.+.+++.+||+.||.+|||++|+++.-+
T Consensus 222 ~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 222 GAYD---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp TCCC---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred cccc---CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 1111 111112345677999999999999999999999998543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=320.21 Aligned_cols=266 Identities=25% Similarity=0.372 Sum_probs=204.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHh--CCCCceEEEeeeeec----CCee
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKS--IRHRNLIKIISTCSN----DDFK 114 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~ 114 (335)
..++|++.+.||+|+||+||+|... ++.||+|++... ....+..|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEEC-CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 5679999999999999999999874 899999998644 33556667777776 789999999998654 4568
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcc-----CCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG-----YSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~-----~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
++||||+++++|.+++... .+++..++.++.+++.||.|||.. .+.+++|+||+|+||+++.++.+||+|||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 8999999999999999654 599999999999999999999921 157999999999999999999999999999
Q ss_pred cccccCCccc--cccccccccccccCccccCCC------CCCCccchhhHHHHHHHHHhC----------CCCCCccccc
Q 019843 190 AKLLTGEDQS--KSQTQTLATIGYMAPEYGREG------RVSTNGDVYSFGIMLMETFTK----------KKPTDKIFAG 251 (335)
Q Consensus 190 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~sDiwslG~~l~~ll~g----------~~pf~~~~~~ 251 (335)
+......... .......+|+.|+|||++.+. .++.++||||||+++|+|++| ..||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 9765322211 112334789999999998876 455789999999999999999 7777554332
Q ss_pred chhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 252 EMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
....... .....................+++.+.+++.+||+.||++|||+.++++.|+++
T Consensus 240 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFEDM---------RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHHHH---------HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccchhhh---------hHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2221110 111111111111111112345678899999999999999999999999999976
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=346.54 Aligned_cols=267 Identities=24% Similarity=0.394 Sum_probs=219.3
Q ss_pred HHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 36 LELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 36 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
.......++|.+.+.||+|+||.||+|.++++..||||++.... ...+.+.+|+++++.++||||+++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 34455667899999999999999999998888999999997654 34678999999999999999999999987 56789
Q ss_pred EEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 116 LVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
+||||+++++|.+++.... ..+++..++.++.||+.||.||| +++++|+||+|+||+++.++.+||+|||++....
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 9999999999999997542 36889999999999999999999 9999999999999999999999999999998753
Q ss_pred CCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
... ........++..|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+..
T Consensus 336 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~--------------~~~i~~ 400 (454)
T 1qcf_A 336 DNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--------------IRALER 400 (454)
T ss_dssp CHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--------------HHHHHH
T ss_pred CCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHc
Confidence 211 112233446778999999988899999999999999999999 9999976432211 111111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccc
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 328 (335)
. .+.+.+..+++.+.+++.+||+.||++|||+++|++.|+.+.......
T Consensus 401 ~------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 401 G------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp T------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred C------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 1 112223456788999999999999999999999999999887655443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=340.48 Aligned_cols=254 Identities=31% Similarity=0.457 Sum_probs=211.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC-eeEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD-FKALVL 118 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~ 118 (335)
...++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34578999999999999999999887 7899999987553 4578999999999999999999999987654 789999
Q ss_pred EecCCCChHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 119 EYMPHGSLEKCLYSSNC-VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
||+++++|.+++..... .+++..++.++.|++.||.||| +++++|+||+|+||+++.++.+||+|||++....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~--- 340 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--- 340 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc---
Confidence 99999999999986543 4799999999999999999999 9999999999999999999999999999987542
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+...
T Consensus 341 --~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--------------~~~i~~~-- 402 (450)
T 1k9a_A 341 --STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--------------VPRVEKG-- 402 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--------------HHHHHTT--
T ss_pred --ccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcC--
Confidence 11222356788999999999999999999999999999998 9999976432221 1111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
.+...+..+++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 403 ----~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 ----YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 12223456778899999999999999999999999999988753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=328.19 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=206.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcE----EEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGME----VAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~----v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
.++|++.+.||+|+||.||+|.+. +++. |++|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 578999999999999999999754 3444 577776533 3445678999999999999999999999998765 77
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
++++++.+++|.+++......+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 899999999999999887778999999999999999999999 99999999999999999999999999999987643
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ...+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--------------~~~~~~~ 235 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------------SSILEKG 235 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------------HHHHHTT
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--------------HHHHHcC
Confidence 333333444556888999999999999999999999999999999 9999976543221 1122211
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
. ....+..++..+.+++.+||+.||.+|||+.|+++.|+++..+
T Consensus 236 ~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 236 E------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp C------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred C------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1 1112334567799999999999999999999999999998744
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=322.88 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=209.6
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC------chhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG------GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
..++|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4578999999999999999999865 589999999975432 135779999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC----cEEEeeccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGI 189 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~----~v~l~dfg~ 189 (335)
.++||||+++++|.+++.... .+++..++.++.+++.||.||| +.+++|+||+|+||+++.++ .++|+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 999999999999999997654 7899999999999999999999 99999999999999999888 799999999
Q ss_pred cccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
+..... ........+++.|+|||++.+..++.++||||||+++|+|++|..||......+..
T Consensus 166 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--------------- 227 (321)
T 2a2a_A 166 AHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--------------- 227 (321)
T ss_dssp CEECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---------------
T ss_pred ceecCc---cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH---------------
Confidence 987632 22234456899999999999999999999999999999999999999764322111
Q ss_pred HHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 270 IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.................+++.+.+++.+||+.||.+|||+.|+++.
T Consensus 228 --~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 228 --ANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --HHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1100111111111223456779999999999999999999999873
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=324.62 Aligned_cols=246 Identities=25% Similarity=0.312 Sum_probs=207.7
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.++|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 368999999999999999999865 6899999999754 223456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||++|++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.+|.++|+|||++....
T Consensus 85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~--- 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--- 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS---
T ss_pred EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecC---
Confidence 99999999999998654 7999999999999999999999 9999999999999999999999999999998653
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
.......||+.|+|||++.+..++.++|+||||+++|+|++|..||........ ...+....
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------------~~~i~~~~--- 219 (318)
T 1fot_A 158 --DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------------YEKILNAE--- 219 (318)
T ss_dssp --SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHHCC---
T ss_pred --CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHhCC---
Confidence 223345789999999999999999999999999999999999999976432111 11111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
...+..+++++.+++.+||..||.+|| +++++++.
T Consensus 220 -----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 -----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 111234567799999999999999999 88888854
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=331.50 Aligned_cols=259 Identities=23% Similarity=0.398 Sum_probs=209.7
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcE----EEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGME----VAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~----v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
.++|++.+.||+|+||.||+|.+. +++. |++|.+.... ......+.+|+.+++.++||||+++++++.. +..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence 478999999999999999999764 3443 7888775432 3445677889999999999999999999874 5678
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+|++|+++++|.+++......+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+..
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999877668999999999999999999999 99999999999999999999999999999987754
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ...+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------------~~~~~~~ 233 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--------------PDLLEKG 233 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--------------HHHHHTT
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--------------HHHHHcC
Confidence 433334455667889999999998899999999999999999999 9999976432221 1112111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
. ....+..++..+.+++.+||+.||.+|||+.++++.|+.+..+
T Consensus 234 ~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 234 E------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp C------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred C------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1 1111223455689999999999999999999999999988643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=335.08 Aligned_cols=253 Identities=21% Similarity=0.261 Sum_probs=202.5
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 115 (335)
..++|.+.+.||+|+||.||+|..+ +++.||+|++... .......+..|..++.++ +||||+++++++.+.+.++
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3478999999999999999999865 5788999999754 233446688899999887 8999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||++|++|.+++.... .+++..++.++.+|+.||.||| +.+++||||||+||+++.+|.+||+|||++....
T Consensus 130 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~- 204 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL- 204 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC-
T ss_pred EEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc-
Confidence 9999999999999987654 7999999999999999999999 9999999999999999999999999999997532
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
..........||+.|+|||++.+..++.++|+|||||++|+|++|..||........... .....+.....
T Consensus 205 -~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~--------~~~~~~~~~i~ 275 (396)
T 4dc2_A 205 -RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLFQVIL 275 (396)
T ss_dssp -CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHHHHHHHHH
T ss_pred -cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch--------hhHHHHHHHHh
Confidence 122334456799999999999999999999999999999999999999965322111000 00011111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINA 311 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 311 (335)
. .....+..+++++.+||.+||+.||.+||++
T Consensus 276 ~----~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 276 E----KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp H----CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred c----cccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 1111234467779999999999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=326.27 Aligned_cols=271 Identities=23% Similarity=0.357 Sum_probs=219.2
Q ss_pred cCHHHHhhhcCCCCccceeeecCceEEEEEEE------cCCcEEEEEEeecCCC-chhHHHHHHHHHHHhC-CCCceEEE
Q 019843 33 FSYLELFQATDGFSENNLIGRGSFGSVYKARI------QDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSI-RHRNLIKI 104 (335)
Q Consensus 33 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~ 104 (335)
+.........++|++.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|+.++..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34445556678999999999999999999974 2468899999875533 3446788999999999 79999999
Q ss_pred eeeeecC-CeeEEEEEecCCCChHHHHhcCCC---------------CCCHHHHHHHHHHHHHHHHHHhccCCCCeEecC
Q 019843 105 ISTCSND-DFKALVLEYMPHGSLEKCLYSSNC---------------VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168 (335)
Q Consensus 105 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~d 168 (335)
++++... ...++||||+++++|.+++..... .+++..++.++.+++.||.||| +.+++|+|
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 9998765 458999999999999999986542 2899999999999999999999 99999999
Q ss_pred CCCCCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCc
Q 019843 169 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDK 247 (335)
Q Consensus 169 i~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~ 247 (335)
|+|+||+++.++.++|+|||++..+.............++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987643333334445667889999999988899999999999999999998 9999976
Q ss_pred ccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 248 IFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
........ ..+.... ....+..+++.+.+++.+||+.||.+|||+.|+++.|+.+....
T Consensus 254 ~~~~~~~~-------------~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDEEFC-------------RRLKEGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSHHHH-------------HHHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhHHHH-------------HHhccCc------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 44222111 1111111 11112334667999999999999999999999999999887653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=320.88 Aligned_cols=267 Identities=23% Similarity=0.389 Sum_probs=218.1
Q ss_pred hcCCCCccc-eeeecCceEEEEEEEc---CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 41 ATDGFSENN-LIGRGSFGSVYKARIQ---DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 41 ~~~~y~~~~-~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
..++|.+.+ .||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+++++.++||||+++++++ ..+..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 346777776 9999999999999753 57889999997653 33567789999999999999999999999 455689
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+|||++++++|.+++......+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999999877668999999999999999999999 99999999999999999999999999999987642
Q ss_pred Cccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 196 EDQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 196 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
.... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--------------~~~i~~ 228 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--------------MAFIEQ 228 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--------------HHHHHT
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--------------HHHHhc
Confidence 2211 22233456788999999988889999999999999999998 9999976432211 111111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcccccc
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICTRE 331 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 331 (335)
.. ....+..+++.+.+++.+||+.||.+||++.++++.|+.+..+....+..
T Consensus 229 ~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 229 GK------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp TC------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred CC------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 11 11123456778999999999999999999999999999998877665543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=328.03 Aligned_cols=262 Identities=27% Similarity=0.439 Sum_probs=215.0
Q ss_pred hcCCCCccceeeecCceEEEEEEEc--------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeec
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ--------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSN 110 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 110 (335)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+++++.+ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3579999999999999999999753 46789999987553 23456789999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEE
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVL 175 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nil 175 (335)
.+..++||||+++++|.+++.... ..+++..++.++.+|+.||.||| +.+++|+||+|+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence 999999999999999999997643 24899999999999999999999 999999999999999
Q ss_pred ECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchh
Q 019843 176 LDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMT 254 (335)
Q Consensus 176 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~ 254 (335)
++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......+.
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 268 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence 99999999999999987643333333344557788999999988889999999999999999999 9999876432111
Q ss_pred hHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 255 LKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
...+.... ....+..+++.+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 269 -------------~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 269 -------------FKLLKEGH------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp -------------HHHHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------------HHHHhcCC------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11111111 11112345677999999999999999999999999999886543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=332.23 Aligned_cols=248 Identities=23% Similarity=0.288 Sum_probs=202.7
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 116 (335)
.++|++.+.||+|+||.||+|..+ +++.||+|++... .......+..|..++..+ +||||+++++++.+.+.+++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 479999999999999999999865 5899999999753 233456788899999988 79999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||++|++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||||+||+++.+|.+||+|||++....
T Consensus 102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~-- 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI-- 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC--
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc--
Confidence 999999999999987654 6999999999999999999999 9999999999999999999999999999987532
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||......+.. ..+...
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-------------~~i~~~--- 239 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF-------------EAILND--- 239 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------------HHHHHC---
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH-------------HHHHcC---
Confidence 1223344567999999999999888999999999999999999999999765322111 111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCH------HHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINA------KEIVT 316 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~ 316 (335)
....+..+++.+.+++.+||+.||.+||++ +|+++
T Consensus 240 -----~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 -----EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111123356779999999999999999998 77765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=327.74 Aligned_cols=254 Identities=21% Similarity=0.270 Sum_probs=194.5
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
....++|.+.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|+++++.++||||+++++++...+..++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 445678999999999999999999876 58899999987543 236688899999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC---CCcEEEeecccccccc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLT 194 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~---~~~v~l~dfg~~~~~~ 194 (335)
|||+++++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++. ++.++|+|||++....
T Consensus 127 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp ECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999987654 6999999999999999999999 999999999999999975 8899999999998653
Q ss_pred CCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
. ........+++.|+|||++.+..++.++|||||||++|+|++|..||............ +...
T Consensus 203 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------------i~~~- 266 (349)
T 2w4o_A 203 H---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR------------ILNC- 266 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH------------HHTT-
T ss_pred c---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH------------HHhC-
Confidence 2 22233456899999999999999999999999999999999999999764332211111 1111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...........++..+.+|+.+||+.||++|||+.|+++.
T Consensus 267 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 267 ---EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111123456779999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=317.96 Aligned_cols=255 Identities=22% Similarity=0.376 Sum_probs=191.5
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD 112 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 112 (335)
.+....++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84 (278)
T ss_dssp HHCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred ccccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence 3455567899999999999999999986 468999999986432 234578899999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 999999999999999999877668999999999999999999999 99999999999999999999999999999986
Q ss_pred ccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
.... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 162 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------------- 222 (278)
T 3cok_A 162 LKMP--HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------------- 222 (278)
T ss_dssp CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------
T ss_pred ccCC--CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-----------------
Confidence 5311 122234568999999999998889999999999999999999999997643221100
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.... .....+..++..+.+++.+||+.||++|||++++++.
T Consensus 223 ~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 223 KVVL----ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -CCS----SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHhh----cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0000 0111123356679999999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=330.88 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=206.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.++|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 378999999999999999999765 5889999998643 233457788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+.|++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.+|.++|+|||++..+.
T Consensus 94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~--- 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--- 166 (384)
T ss_dssp ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeecc---
Confidence 99999999999988654 7999999999999999999999 9999999999999999999999999999998763
Q ss_pred cccccccccccccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 198 QSKSQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ....+...
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~-----------~~~~~~~~ 235 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE-----------IVHTFETT 235 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH-----------HHHHHHHC
T ss_pred CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH-----------HHHHHhhc
Confidence 2233445679999999999864 458999999999999999999999997543221110 00111111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCC-HHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-AKEIVT 316 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~ 316 (335)
....+..+++.+.+||.+||+.||.+||+ ++++++
T Consensus 236 -------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 -------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11112345677999999999999999998 777664
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=322.24 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=199.0
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--------------------------chhHHHHHHHHHHH
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--------------------------GVFKSFDVECEVMK 94 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--------------------------~~~~~~~~e~~~l~ 94 (335)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 579999999999999999999764 588999999865421 12367889999999
Q ss_pred hCCCCceEEEeeeeec--CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCC
Q 019843 95 SIRHRNLIKIISTCSN--DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPS 172 (335)
Q Consensus 95 ~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~ 172 (335)
.++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..++.++.||+.||.||| +.+++|+||+|+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 9999999999999986 6789999999999999886543 36999999999999999999999 999999999999
Q ss_pred CEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCccc
Q 019843 173 NVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTKKKPTDKIF 249 (335)
Q Consensus 173 Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~~l~~ll~g~~pf~~~~ 249 (335)
||+++.++.++|+|||++..+... ........+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999876422 12233457899999999998765 3778999999999999999999997543
Q ss_pred ccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 250 AGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.... ...+.... ...+....+++.+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~--------------~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IMCL--------------HSKIKSQA-----LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHH--------------HHHHHHCC-----CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHH--------------HHHHhccc-----CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 2111 01111100 0111123456779999999999999999999999763
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=332.30 Aligned_cols=257 Identities=22% Similarity=0.258 Sum_probs=199.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
...++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 45689999999999999999999876 689999999975433 3367889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc--EEEeeccccccccCC
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--AHLSDFGIAKLLTGE 196 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~--v~l~dfg~~~~~~~~ 196 (335)
||+++++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++. +||+|||++....
T Consensus 96 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~-- 169 (361)
T 3uc3_A 96 EYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-- 169 (361)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc--
Confidence 9999999999987644 6999999999999999999999 999999999999999987765 9999999987432
Q ss_pred ccccccccccccccccCccccCCCCCCCc-cchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTN-GDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
.........+|+.|+|||++.+..++.+ +||||||+++|+|++|..||.......... ..+....
T Consensus 170 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-------------~~~~~~~ 235 (361)
T 3uc3_A 170 -LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR-------------KTIQRIL 235 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH-------------HHHHHHH
T ss_pred -ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH-------------HHHHHHh
Confidence 2223344579999999999988777655 899999999999999999998654322211 1111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
... ...+....+++.+.+||.+||+.||.+|||+.|+++.=+
T Consensus 236 ~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 236 SVK--YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp TTC--CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred cCC--CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 110 111112234677999999999999999999999998644
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=319.83 Aligned_cols=262 Identities=23% Similarity=0.396 Sum_probs=214.0
Q ss_pred hhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
...++|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|+++++.++||||+++++++.. +..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 34578999999999999999999988888999999875433 35788999999999999999999999874 45889999
Q ss_pred ecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 120 YMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
|+++++|.+++.... ..+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 163 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-
Confidence 999999999987542 26899999999999999999999 9999999999999999999999999999998764221
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+. ...+....
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--------------~~~~~~~~-- 227 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--------------IQNLERGY-- 227 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------------HHHHHTTC--
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH--------------HHHHhccc--
Confidence 222334456788999999988889999999999999999999 9999876432211 11111110
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
....+..+++.+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 228 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 228 ----RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred ----CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 1111234567799999999999999999999999999998876543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=321.17 Aligned_cols=266 Identities=20% Similarity=0.217 Sum_probs=204.1
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
.....++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 3445689999999999999999999865 68899999987542 2334778899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.++|+|++++++|.+++.... .+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999999997654 6999999999999999999999 999999999999999999999999999998765
Q ss_pred cCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
.... ........++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...+.
T Consensus 185 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------~~~~~- 248 (309)
T 2h34_A 185 TDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM--------------GAHIN- 248 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH--------------HHHHH-
T ss_pred cccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH--------------HHHhc-
Confidence 3221 2223345689999999999999999999999999999999999999976432110 01111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCC-CHHHHHHHHHHHHhhhc
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI-NAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~~~~~~~ 326 (335)
.........+..+++.+.+++.+||+.||++|| +++++++.|+++.....
T Consensus 249 ---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 249 ---QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp ---SCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ---cCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 111111122345677799999999999999999 99999999998765443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=324.81 Aligned_cols=268 Identities=23% Similarity=0.387 Sum_probs=206.3
Q ss_pred HHHHhhhcCCCCccceeeecCceEEEEEEEc----CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeee
Q 019843 35 YLELFQATDGFSENNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTC 108 (335)
Q Consensus 35 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 108 (335)
..+.....++|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3455556789999999999999999999654 34579999987553 33456789999999999999999999998
Q ss_pred ecCC-----eeEEEEEecCCCChHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC
Q 019843 109 SNDD-----FKALVLEYMPHGSLEKCLYS-----SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD 178 (335)
Q Consensus 109 ~~~~-----~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~ 178 (335)
...+ ..++||||+++++|.+++.. ....+++..++.++.+|+.||.||| +.+++|+||+|+||+++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcC
Confidence 7654 45899999999999999842 3347999999999999999999999 999999999999999999
Q ss_pred CCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHh
Q 019843 179 NMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKY 257 (335)
Q Consensus 179 ~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~ 257 (335)
++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-- 260 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD-- 260 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH--
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--
Confidence 99999999999987643332333344567888999999999899999999999999999999 889987654322111
Q ss_pred HhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 258 WVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
.+.... ....+..+++.+.+++.+||+.||.+|||+.++++.|+++.+++
T Consensus 261 ------------~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 261 ------------YLLHGH------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ------------HHHTTC------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------------HHHcCC------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111100 11112345677999999999999999999999999999998765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=325.24 Aligned_cols=278 Identities=27% Similarity=0.439 Sum_probs=219.7
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-----cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC--
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-----QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD-- 112 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 112 (335)
...++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+++++.++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 3456799999999999999999973 358899999998776667788999999999999999999999987643
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
..++|||++++++|.+++......+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 789999999999999999887667999999999999999999999 99999999999999999999999999999987
Q ss_pred ccCCccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC-hhH-HH
Q 019843 193 LTGEDQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP-ISV-ME 269 (335)
Q Consensus 193 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~-~~ 269 (335)
....... .......++..|+|||.+.+..++.++||||||+++|+|++|..||......-.. ....... ... ..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR---MIGNDKQGQMIVFH 271 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHH---HHCTTCCTHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHH---hhccccchhhhHHH
Confidence 6432211 1223345677899999998888999999999999999999999997643211100 0000000 000 01
Q ss_pred HHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 270 IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
+.+. ... ....+.+..+++.+.+++.+||+.||.+|||+.|+++.|+++++++.
T Consensus 272 ~~~~-~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 272 LIEL-LKN--NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHH-HHT--TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHH-hhc--CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1111 110 11122234567889999999999999999999999999999998763
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=328.17 Aligned_cols=266 Identities=23% Similarity=0.358 Sum_probs=216.7
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEcC-C-----cEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeee
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQD-G-----MEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCS 109 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~-----~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 109 (335)
.....++|.+.+.||+|+||.||+|.... + ..|++|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456899999999999999999998642 2 479999987553 23457789999999999 8999999999999
Q ss_pred cCCeeEEEEEecCCCChHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE
Q 019843 110 NDDFKALVLEYMPHGSLEKCLYSS-------------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL 176 (335)
Q Consensus 110 ~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv 176 (335)
..+..++||||+++++|.+++... ...+++..++.++.+++.||.||| +.+++|+||+|+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence 999999999999999999998743 235799999999999999999999 9999999999999999
Q ss_pred CCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhh
Q 019843 177 DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTL 255 (335)
Q Consensus 177 ~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 255 (335)
+.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-- 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-- 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--
Confidence 9999999999999986643333333444567888999999988889999999999999999998 9999876432221
Q ss_pred HhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 256 KYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
........... ..+..+++.+.+++.+||+.||.+|||+.++++.|+++..+.
T Consensus 276 -----------~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 276 -----------FYKLVKDGYQM------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp -----------HHHHHHHTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------HHHHHhcCCCC------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 11122211111 112234667999999999999999999999999999887654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=327.63 Aligned_cols=262 Identities=21% Similarity=0.374 Sum_probs=201.9
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC---
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD--- 112 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 112 (335)
...++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+++++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 4568999999999999999999986 468999999997653 234567889999999999999999999987654
Q ss_pred -eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 113 -FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 113 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 3489999999999999997654 7999999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 192 LLTGEDQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 192 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
.+...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~-------------- 230 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-------------- 230 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--------------
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--------------
Confidence 66422211 223345689999999999999999999999999999999999999976433221111
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHH-HHHHHHHHH
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKE-IVTRLLKIR 322 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e-ll~~L~~~~ 322 (335)
...............+++++.+++.+||+.||.+||++.+ +...|..+.
T Consensus 231 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 231 ---HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ---HHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---HhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1111111111122346778999999999999999996555 445555543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=328.60 Aligned_cols=269 Identities=22% Similarity=0.369 Sum_probs=218.2
Q ss_pred ccCHHHHhhhcCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEE
Q 019843 32 RFSYLELFQATDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKI 104 (335)
Q Consensus 32 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~ 104 (335)
.+...+.....++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+++++.++||||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3444455567789999999999999999999654 367899999875432 344578899999999999999999
Q ss_pred eeeeecCCeeEEEEEecCCCChHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEE
Q 019843 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSN---------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVL 175 (335)
Q Consensus 105 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nil 175 (335)
++++.+.+..++|||++++++|.+++.... ..+++..++.++.+|+.||.||| +.+++|+||+|+||+
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEE
Confidence 999999999999999999999999987531 35799999999999999999999 999999999999999
Q ss_pred ECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchh
Q 019843 176 LDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMT 254 (335)
Q Consensus 176 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~ 254 (335)
++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 250 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence 99999999999999986643333333344567889999999988889999999999999999999 88998764322111
Q ss_pred hHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 255 LKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
..+.... ....+..+++.+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 251 --------------~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 251 --------------RFVMEGG------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --------------HHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --------------HHHHcCC------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111110 111123456779999999999999999999999999987643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=315.97 Aligned_cols=255 Identities=23% Similarity=0.326 Sum_probs=210.7
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
..++|++.+.||+|++|.||+|... +++.|++|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4578999999999999999999865 68999999987543 345578899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++... ..+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+..+.....
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999988654 37999999999999999999999 99999999999999999999999999999986542222
Q ss_pred ccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
........++..|+|||.+.+..+ +.++||||||+++|+|++|..||............+.. ..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------~~--- 225 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------KK--- 225 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT------------TC---
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh------------cc---
Confidence 233345678999999999987665 77899999999999999999999875433222211111 00
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
........+++.+.+++.+||+.||.+|||++|+++.
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 226 ---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0111123456779999999999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=320.49 Aligned_cols=255 Identities=28% Similarity=0.399 Sum_probs=204.0
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|.+.+.||+|+||.||+|.+. ++.|++|++... ...+.+.+|+++++.++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 468999999999999999999876 789999998643 345788999999999999999999998874 478999999
Q ss_pred CCCChHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHhccCC---CCeEecCCCCCCEEECCCCc-EEEeeccccccccC
Q 019843 122 PHGSLEKCLYSSNC--VLDIFQRLNIMIDVAAALEYLHFGYS---APVIHCDLKPSNVLLDDNMV-AHLSDFGIAKLLTG 195 (335)
Q Consensus 122 ~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~~---~~i~h~di~p~Nilv~~~~~-v~l~dfg~~~~~~~ 195 (335)
++++|.+++..... .++...++.++.++++||.||| + ++++|+||+|+||+++.++. +||+|||++....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~- 157 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH---SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ- 157 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH---TCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH---hCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc-
Confidence 99999999986542 4789999999999999999999 7 89999999999999998886 7999999987542
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
.......++..|+|||++.+..++.++||||||+++|+|++|..||........... ......
T Consensus 158 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------------~~~~~~- 220 (307)
T 2eva_A 158 ----THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM------------WAVHNG- 220 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH------------HHHHTT-
T ss_pred ----cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH------------HHHhcC-
Confidence 122334689999999999999999999999999999999999999976432221110 000000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
........+++.+.+++.+||+.||.+|||++++++.|+.+...+..
T Consensus 221 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 221 -----TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp -----CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred -----CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 11111234567799999999999999999999999999999876643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=320.73 Aligned_cols=266 Identities=26% Similarity=0.433 Sum_probs=211.8
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEcC----CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeee-ecC
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQD----GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTC-SND 111 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 111 (335)
+.....+|++.+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.++++++||||+++++++ ...
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 44555689999999999999999997542 2358889886543 34457789999999999999999999985 456
Q ss_pred CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
+..++||||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccc
Confidence 7889999999999999999877667999999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCcc--ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 192 LLTGEDQ--SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 192 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
....... ........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||..........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~------------- 243 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------- 243 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH-------------
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH-------------
Confidence 7643221 122334567788999999998899999999999999999999 556655433222111
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
.+.... ....+..+++.+.+++.+||+.||.+|||++|+++.|+.+..++.
T Consensus 244 -~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 244 -YLLQGR------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -HHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -HHhcCC------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111110 111123356679999999999999999999999999999987664
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=330.75 Aligned_cols=276 Identities=18% Similarity=0.253 Sum_probs=209.9
Q ss_pred hhhcCCCCccceeeec--CceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 39 FQATDGFSENNLIGRG--SFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g--~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
....++|++.+.||+| +||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 3456789999999999 99999999876 68999999997553 3445778889999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
.++||||+++++|.+++... ...+++..++.++.||+.||.||| +.+++|+||||+||+++.++.++|+|||.+..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999999764 346999999999999999999999 99999999999999999999999999998865
Q ss_pred ccCCcc-----ccccccccccccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC-
Q 019843 193 LTGEDQ-----SKSQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP- 264 (335)
Q Consensus 193 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~- 264 (335)
...... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||...................
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 432111 112233478899999999987 578999999999999999999999997654333322111110000
Q ss_pred --h---hHHHH-------------HH------hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 265 --I---SVMEI-------------VD------ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 265 --~---~~~~~-------------~~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. ..... .+ .............+..+++.+.+||.+||+.||.+|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 00000 00 000000011112234567789999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=327.38 Aligned_cols=257 Identities=21% Similarity=0.259 Sum_probs=205.6
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 116 (335)
.++|++.+.||+|+||.||+|..+ +++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 367999999999999999999865 58899999997542 23456688899999988 89999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+++++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.+|.++|+|||++.....
T Consensus 88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~- 162 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 162 (345)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC-
Confidence 999999999999987654 6999999999999999999999 99999999999999999999999999999975321
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.........||+.|+|||++.+..++.++|+|||||++|+|++|..||........... .....+......
T Consensus 163 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--------~~~~~~~~~i~~ 233 (345)
T 3a8x_A 163 -PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLFQVILE 233 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHHHHHHH
T ss_pred -CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--------ccHHHHHHHHHc
Confidence 12233456799999999999999999999999999999999999999975322111000 000111111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCH------HHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINA------KEIVT 316 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~------~ell~ 316 (335)
. ....+..++..+.++|.+||+.||.+||++ +|+++
T Consensus 234 ~----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 234 K----QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp C----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred C----CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 1 111233457779999999999999999985 56654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=320.62 Aligned_cols=256 Identities=20% Similarity=0.287 Sum_probs=207.5
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.....++|.+.+.||+|+||.||+|... +|+.||+|++..........+.+|+.+++.++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 3456789999999999999999999865 689999999986654455778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE---CCCCcEEEeeccccccc
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv---~~~~~v~l~dfg~~~~~ 193 (335)
||||+++++|.+++.... .+++..++.++.+++.||.||| +.+++|+||+|+||++ +.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 84 VMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999999887654 6899999999999999999999 9999999999999999 78889999999998754
Q ss_pred cCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
. ........+++.|+|||++.+..++.++||||||+++|+|++|..||........ ...+..
T Consensus 160 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------~~~i~~ 221 (304)
T 2jam_A 160 Q----NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL--------------FEKIKE 221 (304)
T ss_dssp C----CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------------HHHHHH
T ss_pred C----CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--------------HHHHHc
Confidence 2 1223345689999999999999999999999999999999999999976432111 011111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
.. ..........+++.+.+++.+||..||.+|||++|+++.-
T Consensus 222 ~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 222 GY---YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp CC---CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CC---CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 11 1111112234567799999999999999999999998743
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=327.82 Aligned_cols=246 Identities=22% Similarity=0.258 Sum_probs=207.9
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.++|.+.+.||+|+||.||+|... +|+.||+|++... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999865 5899999998643 223457788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||++|++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.+|.++|+|||++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccC--
Confidence 99999999999998654 6999999999999999999999 99999999999999999999999999999986532
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
......||+.|+|||++.+..++.++|+||||+++|+|++|..||......... ..+...
T Consensus 194 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------------~~i~~~---- 253 (350)
T 1rdq_E 194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-------------EKIVSG---- 253 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------------HHHHHC----
T ss_pred ---CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH-------------HHHHcC----
Confidence 233457899999999999999999999999999999999999999764321110 111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCC-----HHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-----AKEIVTR 317 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 317 (335)
....+..+++.+.++|.+||+.||.+||+ ++++++.
T Consensus 254 ----~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 254 ----KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 01112345777999999999999999998 8888764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=313.74 Aligned_cols=257 Identities=22% Similarity=0.298 Sum_probs=208.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC------chhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG------GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999876 589999999875421 2357899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC----cEEEeecccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIA 190 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~----~v~l~dfg~~ 190 (335)
++|||++++++|.+++.... .+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++ .++|+|||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 99999999999999997643 6999999999999999999999 99999999999999998877 8999999999
Q ss_pred ccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
..... ........+++.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 160 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------- 220 (283)
T 3bhy_A 160 HKIEA---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---------------- 220 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------
T ss_pred eeccC---CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH----------------
Confidence 86532 12233456899999999999999999999999999999999999999764321110
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH--HHHHH
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR--LLKIR 322 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~~ 322 (335)
.................+++.+.+++.+||+.||.+|||+.++++. ++.++
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 221 -TNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp -HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred -HHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0000111111112233456779999999999999999999999984 44444
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=317.08 Aligned_cols=270 Identities=19% Similarity=0.229 Sum_probs=210.0
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEee-eeecCCeeEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIIS-TCSNDDFKALV 117 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv 117 (335)
...++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+..|+++++.++|++++..+. ++...+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 4568999999999999999999986 5689999998765432 246788999999998777665554 45678889999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE---CCCCcEEEeecccccccc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv---~~~~~v~l~dfg~~~~~~ 194 (335)
||++ +++|.+++......+++..++.++.||+.||.||| +.+++|+||+|+||++ +.++.++|+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 99999999876668999999999999999999999 9999999999999999 788999999999998764
Q ss_pred CCccc-----cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 195 GEDQS-----KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 195 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
..... .......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~ 229 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ----------KYER 229 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS----------HHHH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh----------hhhh
Confidence 32221 12335678999999999999999999999999999999999999998654322111 0111
Q ss_pred HHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccc
Q 019843 270 IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 328 (335)
+....... ........+++.+.+++.+||+.||++|||++++++.|+++..+....
T Consensus 230 ~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 230 ISEKKMST---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHHHHS---CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hhcccccc---hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 11111000 000111334677999999999999999999999999999998776644
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=325.49 Aligned_cols=263 Identities=21% Similarity=0.270 Sum_probs=208.3
Q ss_pred HHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC-----CCchhHHHHHHHHHHHhCCCCceEEEeeee
Q 019843 35 YLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ-----CGGVFKSFDVECEVMKSIRHRNLIKIISTC 108 (335)
Q Consensus 35 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 108 (335)
-..+....++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+++++.++||||+++++++
T Consensus 18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 3456778899999999999999999999764 5889999998643 345567899999999999999999999999
Q ss_pred ecCCeeEEEEEecCCCChHHHHhcC---------------------------------------CCCCCHHHHHHHHHHH
Q 019843 109 SNDDFKALVLEYMPHGSLEKCLYSS---------------------------------------NCVLDIFQRLNIMIDV 149 (335)
Q Consensus 109 ~~~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~l 149 (335)
.+.+..++||||+++++|.+++... ...+++..++.++.+|
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999999999988521 1134678889999999
Q ss_pred HHHHHHHhccCCCCeEecCCCCCCEEECCCC--cEEEeeccccccccCCcc--ccccccccccccccCccccCC--CCCC
Q 019843 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNM--VAHLSDFGIAKLLTGEDQ--SKSQTQTLATIGYMAPEYGRE--GRVS 223 (335)
Q Consensus 150 ~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~--~v~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~ 223 (335)
+.||.||| +.+++|+||+|+||+++.++ .++|+|||++..+..... ........+++.|+|||++.+ ..++
T Consensus 178 ~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 178 FSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence 99999999 99999999999999998777 899999999986532211 112345678999999999875 6789
Q ss_pred CccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchh
Q 019843 224 TNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVE 303 (335)
Q Consensus 224 ~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 303 (335)
.++||||||+++|+|++|..||......+.. ..+.. .......+....+++.+.++|.+||+.
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~-------------~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTI-------------SQVLN----KKLCFENPNYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------------HHHHH----CCCCTTSGGGGGSCHHHHHHHHHHSCS
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChHHHH-------------HHHHh----cccccCCcccccCCHHHHHHHHHHcCC
Confidence 9999999999999999999999765432211 11111 111111122234577899999999999
Q ss_pred ccccCCCHHHHHHH
Q 019843 304 SAEQRINAKEIVTR 317 (335)
Q Consensus 304 dP~~Rps~~ell~~ 317 (335)
||.+||++.++++.
T Consensus 318 ~p~~Rps~~~~l~h 331 (345)
T 3hko_A 318 NVDERFDAMRALQH 331 (345)
T ss_dssp CTTTSCCHHHHHHS
T ss_pred ChhHCCCHHHHhcC
Confidence 99999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=334.75 Aligned_cols=259 Identities=23% Similarity=0.285 Sum_probs=210.0
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
.....++|.+.+.||+|+||.||+|..+ +++.||+|++... .......+.+|..+++.++||||+++++++.+.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3445679999999999999999999866 5889999998642 12233568899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
+++||||++||+|.+++... .+++..++.++.+|+.||.||| +.+++|+||||+||+++.+|.+||+|||++...
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 99999999999999998765 4899999999999999999999 999999999999999999999999999999866
Q ss_pred cCCccccccccccccccccCccccCCCC----CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGREGR----VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
.... ........||+.|+|||++.+.. ++.++||||||+++|+|++|..||......... ..
T Consensus 219 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------------~~ 284 (410)
T 3v8s_A 219 NKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-------------SK 284 (410)
T ss_dssp CTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------------HH
T ss_pred ccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH-------------HH
Confidence 3221 12233567999999999987655 789999999999999999999999764322111 11
Q ss_pred HHHhhhccccccchhhHHHHHHHHHHHHHHhchhcccc--CCCHHHHHHHHH
Q 019843 270 IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQ--RINAKEIVTRLL 319 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~L~ 319 (335)
+... .....++....+++++.+||.+||..+|.+ ||+++||++.-+
T Consensus 285 i~~~----~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 285 IMNH----KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp HHTH----HHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred HHhc----cccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 1111 111111112345677999999999999998 999999987643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=318.60 Aligned_cols=259 Identities=23% Similarity=0.406 Sum_probs=209.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEcC----CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQD----GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
..++|++.+.||+|+||.||+|.+.. +..|++|++.... ....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 45789999999999999999997542 3459999987653 33457789999999999999999999998754 468
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+|||++++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999999876667999999999999999999999 99999999999999999999999999999986532
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
.. ........++..|+|||++.+..++.++||||||+++|+|++ |..||........ ...+...
T Consensus 166 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--------------~~~~~~~ 230 (281)
T 3cc6_A 166 ED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--------------IGVLEKG 230 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--------------HHHHHHT
T ss_pred cc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--------------HHHHhcC
Confidence 21 122334456788999999988889999999999999999998 9999975432221 1111111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
. ....+..+++.+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 231 ~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 231 D------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp C------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1 1111234567799999999999999999999999999988654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=324.16 Aligned_cols=265 Identities=25% Similarity=0.438 Sum_probs=210.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEcC-----CcEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQD-----GMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
..++|++.+.||+|+||.||+|.... +..||+|++..... .....+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 45688899999999999999997542 24599999875532 3456788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++||||+++++|.+++......+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999999877668999999999999999999999 9999999999999999999999999999998764
Q ss_pred CCcc-ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 195 GEDQ-SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 195 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
.... ........++..|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--------------~~~~~ 264 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--------------MKAIN 264 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------------HHHHH
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH--------------HHHHH
Confidence 2211 111223345778999999998899999999999999999998 9999875432111 11111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccc
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 328 (335)
.. .....+..+++.+.+++.+||+.||.+||++.++++.|+++.......
T Consensus 265 ~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 265 DG------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp TT------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred CC------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 11 111123345677999999999999999999999999999987665543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=326.71 Aligned_cols=280 Identities=25% Similarity=0.345 Sum_probs=206.2
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHH--HhCCCCceEEEeeeee-----cCCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVM--KSIRHRNLIKIISTCS-----NDDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l--~~l~h~~i~~~~~~~~-----~~~~ 113 (335)
..++|++.+.||+|+||.||+|... ++.||+|++.... ...+..|.++. ..++||||+++++.+. ....
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 4589999999999999999999774 8999999987543 24444455554 4579999999997543 3446
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCC---------CeEecCCCCCCEEECCCCcEEE
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA---------PVIHCDLKPSNVLLDDNMVAHL 184 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~---------~i~h~di~p~Nilv~~~~~v~l 184 (335)
+++||||+++++|.+++.... .++..++.++.||+.||.||| +. +++|+||+|+||+++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEE
Confidence 789999999999999997665 689999999999999999999 88 9999999999999999999999
Q ss_pred eeccccccccCCcc------ccccccccccccccCccccCC-------CCCCCccchhhHHHHHHHHHhCCCCCCcccc-
Q 019843 185 SDFGIAKLLTGEDQ------SKSQTQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFTKKKPTDKIFA- 250 (335)
Q Consensus 185 ~dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~- 250 (335)
+|||++..+..... ........+|..|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987643221 112234568999999999887 3466789999999999999999777643322
Q ss_pred cchhhHhHhhhhcChhHHHH---H-HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 251 GEMTLKYWVSNLLPISVMEI---V-DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
.................... . .................+++.+.++|.+||+.||++|||++|+++.|+++...+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 11111111111111111111 1 1111111122222234567789999999999999999999999999999998877
Q ss_pred ccc
Q 019843 327 ICT 329 (335)
Q Consensus 327 ~~~ 329 (335)
...
T Consensus 322 ~~~ 324 (336)
T 3g2f_A 322 RNK 324 (336)
T ss_dssp C--
T ss_pred hcc
Confidence 644
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=328.01 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=206.2
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCe
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDF 113 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 113 (335)
....++|.+.+.||+|+||.||+|..+ +++.||+|++.... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345689999999999999999999875 58999999997542 33456778899999877 89999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.++||||++|++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.+|.++|+|||++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999997644 6999999999999999999999 999999999999999999999999999998754
Q ss_pred cCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
.. .........||+.|+|||++.+..++.++|+||||+++|+|++|..||........ ...
T Consensus 169 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----------------~~~ 229 (345)
T 1xjd_A 169 ML--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----------------FHS 229 (345)
T ss_dssp CC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHH
T ss_pred cc--CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH-----------------HHH
Confidence 21 12233456799999999999999999999999999999999999999976432111 111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHH-HHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAK-EIVT 316 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~ 316 (335)
..... ...+..+++++.+||.+||..||++||++. ++++
T Consensus 230 i~~~~----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 230 IRMDN----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHCC----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHhCC----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11111 111234567799999999999999999997 6653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=343.33 Aligned_cols=263 Identities=19% Similarity=0.237 Sum_probs=212.0
Q ss_pred HHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeec
Q 019843 35 YLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110 (335)
Q Consensus 35 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 110 (335)
..+.....++|.+.+.||+|+||.||+|..+ +++.||+|++... .......+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4445556789999999999999999999876 4788999998742 12233458899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
.+.+++||||++||+|.+++......+++..++.++.+|+.||.||| +.+++|+||||+||+++.+|.+||+|||++
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999999876668999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCccccccccccccccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcCh
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI 265 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 265 (335)
....... ........||+.|+|||++. +..++.++|||||||++|+|++|..||......+..
T Consensus 223 ~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~----------- 290 (437)
T 4aw2_A 223 LKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY----------- 290 (437)
T ss_dssp EECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----------
T ss_pred hhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH-----------
Confidence 7653221 22233467999999999986 567899999999999999999999999764322211
Q ss_pred hHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhcccc--CCCHHHHHHH
Q 019843 266 SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQ--RINAKEIVTR 317 (335)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rps~~ell~~ 317 (335)
..+........... ....+++++.+||.+||..+|++ ||+++|+++.
T Consensus 291 --~~i~~~~~~~~~p~---~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 291 --GKIMNHKERFQFPT---QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --HHHHTHHHHCCCCS---SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --HhhhhccccccCCc---ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11111110000000 01235677999999999999988 9999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=318.46 Aligned_cols=253 Identities=27% Similarity=0.363 Sum_probs=205.4
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
...++|.+.+.||.|+||.||+|... +|+.||+|++.... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 45678999999999999999999865 58999999987653 3477899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-- 178 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence 999999999999765567999999999999999999999 999999999999999999999999999999865321
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........++..|+|||++.+..++.++||||||+++|+|++|..||......... ..+. ..
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------------~~~~----~~ 240 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI--------------FMIP----TN 240 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--------------HHHH----HS
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH--------------HHHh----cC
Confidence 22334457899999999999989999999999999999999999999754321110 0000 01
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.......+..+++.+.+++.+||+.||.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 241 PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111222234457779999999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=320.13 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=200.0
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC-------
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD------- 112 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 112 (335)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999876 69999999997543 345678999999999999999999999875433
Q ss_pred --------------------------------------------------eeEEEEEecCCCChHHHHhcCC--CCCCHH
Q 019843 113 --------------------------------------------------FKALVLEYMPHGSLEKCLYSSN--CVLDIF 140 (335)
Q Consensus 113 --------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~--~~~~~~ 140 (335)
..++||||+++++|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 3789999999999999998643 245667
Q ss_pred HHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc----------cccccccccccc
Q 019843 141 QRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ----------SKSQTQTLATIG 210 (335)
Q Consensus 141 ~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~----------~~~~~~~~~~~~ 210 (335)
.++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++........ ........+|+.
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999 99999999999999999999999999999987643221 122334579999
Q ss_pred ccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHH
Q 019843 211 YMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCV 290 (335)
Q Consensus 211 y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (335)
|+|||++.+..++.++||||||+++|+|++|..|+.... ........ ..........+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------------------~~~~~~~~---~~~~~~~~~~~ 299 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------------------RIITDVRN---LKFPLLFTQKY 299 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------------------HHHHHHHT---TCCCHHHHHHC
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------------------HHHHHhhc---cCCCcccccCC
Confidence 999999999999999999999999999999877632210 01111000 01112234456
Q ss_pred HHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 291 SFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 291 ~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
+.+.+++.+||+.||.+|||++|+++.
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 678999999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=317.93 Aligned_cols=270 Identities=22% Similarity=0.286 Sum_probs=203.0
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
.++|++.+.||+|++|.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 478999999999999999999875 589999999865432 23567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|.+++.... .+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-- 155 (311)
T ss_dssp ECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--
Confidence 9999999998776543 7999999999999999999999 999999999999999999999999999999876321
Q ss_pred ccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhH--hHhhhhcChhHHHHHHhhh
Q 019843 199 SKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK--YWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 275 (335)
........++..|+|||++.+ ..++.++||||||+++|+|++|..||......+.... .......+...........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 222344578999999999876 5679999999999999999999999976543322211 1111111111110000000
Q ss_pred c-----cccc---cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 276 L-----SRED---KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 276 ~-----~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. .... ........+++.+.+|+.+||+.||.+|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0000 0000112457779999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=339.63 Aligned_cols=256 Identities=21% Similarity=0.279 Sum_probs=209.9
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
....++|++.+.||+|+||+||+|... +++.||+|++... .......+.+|+++++.++||||+++++++.+.+..+
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 456789999999999999999999865 6899999998643 2334578899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC---CCCcEEEeecccccc
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKL 192 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~---~~~~v~l~dfg~~~~ 192 (335)
+||||+++++|.+.+.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++ .++.++|+|||++..
T Consensus 98 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999999887654 7999999999999999999999 99999999999999995 556799999999986
Q ss_pred ccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
+.. ........+|+.|+|||++.+ .++.++|||||||++|+|++|..||......+ .+.
T Consensus 174 ~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----------------~~~ 232 (486)
T 3mwu_A 174 FQQ---NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-----------------ILK 232 (486)
T ss_dssp BCC---C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----------------HHH
T ss_pred CCC---CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHH
Confidence 532 223345679999999999876 58999999999999999999999997643211 111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...........+....+++.+.+||.+||+.||.+|||+.++++.-+
T Consensus 233 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 233 RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp HHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred HHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 11111122222333456788999999999999999999999998633
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=323.20 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=198.0
Q ss_pred hcCCCCccceeeecCceEEEEEEE----cCCcEEEEEEeecCC----CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI----QDGMEVAVKVFHLQC----GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD 112 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~----~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 112 (335)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 347899999999999999999986 468999999987542 234466788999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
..++||||+++++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999999987654 6899999999999999999999 99999999999999999999999999999875
Q ss_pred ccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
... .........|++.|+|||++.+..++.++||||||+++|+|++|..||........ ...+..
T Consensus 171 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------~~~i~~ 235 (327)
T 3a62_A 171 SIH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-------------IDKILK 235 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------------HHHHHH
T ss_pred ccc--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHh
Confidence 421 12223345789999999999998999999999999999999999999976432111 011111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
. ....+..+++.+.+++.+||..||.+|| ++.|+++.
T Consensus 236 ~--------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 236 C--------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp T--------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred C--------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1 0111234567799999999999999999 78888764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=323.85 Aligned_cols=256 Identities=20% Similarity=0.263 Sum_probs=188.0
Q ss_pred CCCCc---cceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEE
Q 019843 43 DGFSE---NNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 43 ~~y~~---~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 117 (335)
++|.+ .+.||+|+||.||+|... +++.||+|++... ....+.+|+.+++.+. ||||+++++++.+....++|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 34555 388999999999999865 5899999998743 3467788999999996 99999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC---cEEEeecccccccc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLLT 194 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~---~v~l~dfg~~~~~~ 194 (335)
|||+++++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++ .++|+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 85 MELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp ECCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 99999999999998764 7999999999999999999999 99999999999999998766 89999999998653
Q ss_pred CCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
.. ........+|..|+|||++.+..++.++||||||+++|+|++|..||......... .....+....
T Consensus 161 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----------~~~~~~~~~i 228 (325)
T 3kn6_A 161 PD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC----------TSAVEIMKKI 228 (325)
T ss_dssp C------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C----------CCHHHHHHHH
T ss_pred CC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc----------ccHHHHHHHH
Confidence 21 22234456799999999999999999999999999999999999999764321110 1112222222
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..............+++++.+||.+||+.||.+|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 2222222233335578889999999999999999999998743
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=320.38 Aligned_cols=271 Identities=21% Similarity=0.273 Sum_probs=205.3
Q ss_pred hcCCCCcc-ceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEE
Q 019843 41 ATDGFSEN-NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 41 ~~~~y~~~-~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 117 (335)
..++|++. +.||+|+||.||+|... +++.||+|++..........+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45789885 88999999999999754 6899999999877666678899999999995 799999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc---EEEeecccccccc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFGIAKLLT 194 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~---v~l~dfg~~~~~~ 194 (335)
|||+++++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++. ++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999997654 6999999999999999999999 999999999999999998776 9999999987653
Q ss_pred CCcc-----ccccccccccccccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC
Q 019843 195 GEDQ-----SKSQTQTLATIGYMAPEYGRE-----GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP 264 (335)
Q Consensus 195 ~~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 264 (335)
.... ........++..|+|||++.+ ..++.++||||||+++|+|++|..||............ ....+
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~ 243 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR--GEACP 243 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------CCH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc--cccch
Confidence 1111 111223458999999999865 45789999999999999999999999765432211100 00000
Q ss_pred hhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 265 ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.....+..................+++.+.+|+.+||+.||.+|||++|+++.
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00111111111111111111123457789999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=314.93 Aligned_cols=270 Identities=19% Similarity=0.229 Sum_probs=214.7
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEee-eeecCCeeEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIIS-TCSNDDFKALV 117 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv 117 (335)
...++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+|+.+++.+.|++++..+. +....+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 3568999999999999999999986 5689999999875543 357889999999998877555444 44677888999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE---CCCCcEEEeecccccccc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv---~~~~~v~l~dfg~~~~~~ 194 (335)
|||+ +++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||++ +.++.++|+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999 99999999866668999999999999999999999 9999999999999999 488899999999998764
Q ss_pred CCccc-----cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 195 GEDQS-----KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 195 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
..... .......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~ 229 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ----------KYER 229 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS----------HHHH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh----------hhhh
Confidence 32211 12345678999999999999999999999999999999999999998643221110 0111
Q ss_pred HHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccc
Q 019843 270 IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 328 (335)
+....... ........+++.+.+++.+||+.||.+|||++++++.|+++..+....
T Consensus 230 ~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 230 ISEKKMST---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHHHHS---CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hcccccCC---chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 11111100 001112345677999999999999999999999999999998776553
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=315.57 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=205.8
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..++|++.+.||+|++|.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3478999999999999999999765 47889999986432 2334678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+++++|.+++.... .+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~-- 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCC--
Confidence 999999999999987654 6999999999999999999999 9999999999999999999999999999886542
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
........++..|+|||.+.+..++.++||||||+++|+|++|..||......... ..+...
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------------~~~~~~-- 222 (279)
T 3fdn_A 161 --SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY--------------KRISRV-- 222 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--------------HHHHHT--
T ss_pred --cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH--------------HHHHhC--
Confidence 22234457899999999999999999999999999999999999999764322111 111110
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
....+..+++.+.+++.+||+.||.+|||++|+++.-+
T Consensus 223 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 223 -----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred -----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 11112335667999999999999999999999998755
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=344.38 Aligned_cols=261 Identities=25% Similarity=0.414 Sum_probs=217.2
Q ss_pred hcCCCCccceeeecCceEEEEEEEcC-CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
..++|++.+.||+|+||.||+|.++. +..||+|++..... ..+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 45678999999999999999998764 88999999875543 45789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 120 YMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 120 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
|+++++|.+++... ...+++..++.++.||+.||.||| +++++|+||+|+||+++.++.+||+|||++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence 99999999999863 346899999999999999999999 9999999999999999999999999999998763221
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
........++..|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+...
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~--------------~~~~~~~--- 435 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------------YELLEKD--- 435 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--------------HHHHHTT---
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcC---
Confidence 222334456788999999998889999999999999999999 9999876432211 1112211
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
.+...+..+++.+.+||.+||+.||.+|||+.+|++.|+.+..+..
T Consensus 436 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~ 481 (495)
T 1opk_A 436 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481 (495)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSC
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccc
Confidence 1122234567789999999999999999999999999998754433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=322.72 Aligned_cols=253 Identities=22% Similarity=0.336 Sum_probs=206.4
Q ss_pred cCCCCccceeeecCceEEEEEEEcC-C-------cEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD-G-------MEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~-~-------~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
.++|.+.+.||+|+||.||+|.... + ..|++|++........+.+.+|+++++.++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4789999999999999999997542 3 4799999977666677889999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc--------EEEe
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--------AHLS 185 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~--------v~l~ 185 (335)
.++||||+++++|.+++......+++..++.++.||+.||.||| +.+++|+||+|+||+++.++. ++|+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999999887666999999999999999999999 999999999999999998876 9999
Q ss_pred eccccccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC
Q 019843 186 DFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP 264 (335)
Q Consensus 186 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 264 (335)
|||++.... ......++..|+|||++.+ ..++.++||||||+++|+|++|..|+..........
T Consensus 164 Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~--------- 228 (289)
T 4fvq_A 164 DPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL--------- 228 (289)
T ss_dssp CCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---------
T ss_pred cCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH---------
Confidence 999987542 1233457888999999887 678999999999999999999654433222111111
Q ss_pred hhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 265 ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
...... . ..+...++.+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 229 ----~~~~~~-~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 229 ----QFYEDR-H-------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp ----HHHHTT-C-------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred ----HHhhcc-C-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 011100 0 00112244589999999999999999999999999987653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=321.37 Aligned_cols=245 Identities=21% Similarity=0.219 Sum_probs=196.2
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--chhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 117 (335)
.++|++.+.||+|+||+||+|... +++.||||++..... ........|+..+..+ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 368999999999999999999876 689999999865432 2233444555555554 899999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
||++ +++|.+++......+++..++.++.+|+.||.||| +.+++|+||||+||+++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~-- 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-- 209 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeeccc--
Confidence 9999 77999988876668999999999999999999999 99999999999999999999999999999876532
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
........||+.|+|||++.+ .++.++||||||+++|+|++|..|+..... . ..+..
T Consensus 210 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----~------------~~~~~----- 266 (311)
T 3p1a_A 210 -AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----W------------QQLRQ----- 266 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----H------------HHHTT-----
T ss_pred -CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----H------------HHHhc-----
Confidence 223344568999999999876 789999999999999999999766543211 0 00000
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.......+..+++.+.+++.+||+.||++|||++|+++
T Consensus 267 -~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 267 -GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00111223445778999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=316.98 Aligned_cols=262 Identities=23% Similarity=0.374 Sum_probs=210.0
Q ss_pred CCCccceeeecCceEEEEEEEcC-C---cEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCee-EEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQD-G---MEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK-ALV 117 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~~-~---~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv 117 (335)
.|.+.+.||+|+||.||+|.+.+ + ..+++|++..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667999999999999997532 2 3699999875433 3457788999999999999999999999866554 899
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
++++.+++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999886678999999999999999999999 9999999999999999999999999999998654322
Q ss_pred --cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 198 --QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 198 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
.........++..|+|||.+.+..++.++||||||+++|+|++|..|+........ ....+....
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-------------~~~~~~~~~ 245 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------------LTHFLAQGR 245 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-------------HHHHHHTTC
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-------------HHHHhhcCC
Confidence 12233345678899999999999999999999999999999996555433221111 111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
....+..+++.+.+++.+||+.||.+|||++++++.|+++..++..
T Consensus 246 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 ------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 1111334567799999999999999999999999999999887643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=340.94 Aligned_cols=264 Identities=25% Similarity=0.407 Sum_probs=212.2
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.....++|++.+.||+|+||.||+|.++.+..||+|++..... ..+.+.+|+++++.++||||+++++++.+ +..++|
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 3445678999999999999999999988778899999876543 34789999999999999999999999876 678899
Q ss_pred EEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 118 LEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
|||+++++|.+++... ...+++..++.++.|++.||.||| +++++|+||+|+||+++.++.+||+|||++......
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999999999753 346899999999999999999999 999999999999999999999999999999865322
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
. ........++..|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+...
T Consensus 334 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--------------~~~i~~~- 397 (452)
T 1fmk_A 334 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERG- 397 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------------HHHHHTT-
T ss_pred c-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcC-
Confidence 1 122233456788999999988899999999999999999999 9999876432211 1111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
.+.+.+..+++.+.+++.+||+.||++|||++++++.|+.+..+..-
T Consensus 398 -----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 398 -----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 11222345678899999999999999999999999999988765443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=318.99 Aligned_cols=270 Identities=23% Similarity=0.323 Sum_probs=192.1
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3578999999999999999999765 58999999997553 334477889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 119 EYMPHGSLEKCLYSS-----NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 119 e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
||++ ++|.+++... ...+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 5999988643 235899999999999999999999 999999999999999999999999999999865
Q ss_pred cCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC--hhH-HH
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP--ISV-ME 269 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~-~~ 269 (335)
... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......+.. ......... ... ..
T Consensus 159 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 159 GIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL-KLIFDIMGTPNESLWPS 235 (317)
T ss_dssp TSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCTTTCGG
T ss_pred CCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChhHhhh
Confidence 321 222344578999999999876 46899999999999999999999999765432211 111110000 000 00
Q ss_pred HHH-----hhhccccccc------hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 270 IVD-----ANLLSREDKH------FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 270 ~~~-----~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
... .......... ......+++.+.+|+.+||+.||.+|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000 0000000000 00012346679999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=320.78 Aligned_cols=271 Identities=24% Similarity=0.381 Sum_probs=215.3
Q ss_pred HHHhhhcCCCCccc-eeeecCceEEEEEEEc---CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeee
Q 019843 36 LELFQATDGFSENN-LIGRGSFGSVYKARIQ---DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCS 109 (335)
Q Consensus 36 ~~~~~~~~~y~~~~-~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 109 (335)
.+.....++|.+.+ .||+|+||.||+|.+. +++.|++|++.... ....+.+.+|+++++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 34455567899988 9999999999999542 36889999987543 33467899999999999999999999999
Q ss_pred cCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 110 NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 110 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
..+..++|||++++++|.+++.... .+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 5667889999999999999998754 6999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhH
Q 019843 190 AKLLTGEDQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 190 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
+......... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------------- 229 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------------- 229 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------------
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--------------
Confidence 9876422211 12223345688999999988889999999999999999999 9999876432211
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcccccc
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICTRE 331 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 331 (335)
...+.... ....+..+++.+.+++.+||+.||.+|||+.++++.|+++..+.-..+++
T Consensus 230 ~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~ 287 (291)
T 1xbb_A 230 TAMLEKGE------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 287 (291)
T ss_dssp HHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHcCC------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcccc
Confidence 11111111 11123456778999999999999999999999999999998776555443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=321.93 Aligned_cols=264 Identities=20% Similarity=0.259 Sum_probs=210.7
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeee----cCCee
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS----NDDFK 114 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~ 114 (335)
...++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++||||+++++++. .....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3457899999999999999999986 468999999987766666788999999999999999999999986 34588
Q ss_pred EEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 115 ALVLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
++|+||+++++|.+++.. ....+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 899999999999999875 3557999999999999999999999 9999999999999999999999999999887
Q ss_pred cccCCccc-------cccccccccccccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhh
Q 019843 192 LLTGEDQS-------KSQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSN 261 (335)
Q Consensus 192 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~---~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 261 (335)
........ .......++..|+|||++.+.. ++.++||||||+++|+|++|..||..........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------ 256 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV------ 256 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH------
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh------
Confidence 64211100 0112345689999999987654 6889999999999999999999986532211111
Q ss_pred hcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 262 LLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
....... ...+....+++.+.+++.+||+.||.+|||++++++.|+++...
T Consensus 257 ------~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 257 ------ALAVQNQ------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp ------HHHHHCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred ------hHHhhcc------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 1111110 01111234566799999999999999999999999999988643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=337.98 Aligned_cols=264 Identities=20% Similarity=0.300 Sum_probs=212.9
Q ss_pred cccCHHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-------------CchhHHHHHHHHHHHhC
Q 019843 31 RRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-------------GGVFKSFDVECEVMKSI 96 (335)
Q Consensus 31 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-------------~~~~~~~~~e~~~l~~l 96 (335)
..+.........++|++++.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.+++.+
T Consensus 24 ~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 103 (504)
T 3q5i_A 24 GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103 (504)
T ss_dssp GGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC
T ss_pred hheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC
Confidence 33444455567899999999999999999999865 58899999987542 13457789999999999
Q ss_pred CCCceEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE
Q 019843 97 RHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL 176 (335)
Q Consensus 97 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv 176 (335)
+||||+++++++.+.+..++||||+++++|.+.+.... .+++..++.++.||+.||.||| +.+++|+||+|+||++
T Consensus 104 ~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~ 179 (504)
T 3q5i_A 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILL 179 (504)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEE
Confidence 99999999999999999999999999999999887654 6999999999999999999999 9999999999999999
Q ss_pred CCCC---cEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccch
Q 019843 177 DDNM---VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEM 253 (335)
Q Consensus 177 ~~~~---~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~ 253 (335)
+.++ .++|+|||++..+.. ........+|+.|+|||++. ..++.++||||+|+++|+|++|..||......+
T Consensus 180 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~- 254 (504)
T 3q5i_A 180 ENKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD- 254 (504)
T ss_dssp SSTTCCSSEEECCCTTCEECCT---TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred ecCCCCccEEEEECCCCEEcCC---CCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 8776 699999999987632 22334567999999999987 468999999999999999999999998643221
Q ss_pred hhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 254 TLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
++.................+++.+.+||.+||..||.+|||++|+++.-+
T Consensus 255 ----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 255 ----------------IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp ----------------HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ----------------HHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 11111111111222223456788999999999999999999999987543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=340.33 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=212.4
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
....++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 345678999999999999999999865 68999999986542 34567899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE---CCCCcEEEeeccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 191 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv---~~~~~v~l~dfg~~~ 191 (335)
++||||+.+++|.+.+.... .+++..++.++.||+.||.||| +.+++|+||+|+||++ +.++.++|+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999999887654 7999999999999999999999 9999999999999999 567899999999998
Q ss_pred cccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 192 LLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
.+.. ........+|+.|+|||++.+ .++.++||||||+++|+|++|.+||......+. .
T Consensus 178 ~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----------------~ 236 (484)
T 3nyv_A 178 HFEA---SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI-----------------L 236 (484)
T ss_dssp HBCC---CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------H
T ss_pred Eccc---ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-----------------H
Confidence 7632 223344578999999999876 689999999999999999999999976432111 1
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
............+....+++.+.+||.+||+.||.+|||++|+++.-+
T Consensus 237 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 237 KKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp HHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred HHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 111111112222333456788999999999999999999999997544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=326.63 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=205.1
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--------chhHHHHHHHHHHHhCCCCceEEEeeeeec
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--------GVFKSFDVECEVMKSIRHRNLIKIISTCSN 110 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 110 (335)
...++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45679999999999999999999754 588999999975531 133567789999999999999999999999
Q ss_pred CCeeEEEEEecCCC-ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 111 DDFKALVLEYMPHG-SLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 111 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
.+..++|||++.++ +|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 99999999998666 9999887654 7999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCccccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
+..... ........+|+.|+|||++.+..+ +.++||||||+++|+|++|..||........
T Consensus 177 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--------------- 238 (335)
T 3dls_A 177 AAYLER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE--------------- 238 (335)
T ss_dssp CEECCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT---------------
T ss_pred ceECCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh---------------
Confidence 987632 222334568999999999988776 7899999999999999999999975321100
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. ....+..+++.+.+|+.+||+.||++|||++++++.
T Consensus 239 ----~--------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 ----A--------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----T--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----h--------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 001122246679999999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=325.40 Aligned_cols=250 Identities=21% Similarity=0.252 Sum_probs=206.8
Q ss_pred hcCCCCccceeeecCceEEEEEEEcC-CcEEEEEEeecC---CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQ---CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 115 (335)
..++|.+.+.||+|+||.||+|..+. ++.||+|++... .......+..|..++..+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34789999999999999999998764 788999999754 233456788899999988 8999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||++|++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.+|.++|+|||++.....
T Consensus 98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999997654 6999999999999999999999 99999999999999999999999999999975321
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
.........||+.|+|||++.+..++.++|+||||+++|+|++|..||......+.. ..+...
T Consensus 174 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-------------~~i~~~-- 236 (353)
T 2i0e_A 174 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-------------QSIMEH-- 236 (353)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------------HHHHHC--
T ss_pred --CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH-------------HHHHhC--
Confidence 122334567999999999999999999999999999999999999999764321110 111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCC-----HHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-----AKEIVTR 317 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 317 (335)
....+..+++++.+||.+||..||.+||+ ++++++.
T Consensus 237 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 ------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11112345778999999999999999995 5777654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=318.83 Aligned_cols=254 Identities=30% Similarity=0.446 Sum_probs=203.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec-CCeeEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN-DDFKALVL 118 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 118 (335)
...++|++.+.||+|++|.||+|... ++.||+|++.... ..+.+.+|+++++.++||||+++++++.. .+..++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 34578999999999999999999876 8899999987543 45788999999999999999999998654 45789999
Q ss_pred EecCCCChHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 119 EYMPHGSLEKCLYSSNC-VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
||+++++|.+++..... .+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~--- 168 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--- 168 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccc---
Confidence 99999999999976432 3899999999999999999999 9999999999999999999999999999987542
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ..+...
T Consensus 169 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~--------------~~~~~~-- 230 (278)
T 1byg_A 169 --STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--------------PRVEKG-- 230 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH--------------HHHTTT--
T ss_pred --ccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH--------------HHHhcC--
Confidence 12223456788999999988889999999999999999998 99998764322111 111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
.....+..+++.+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus 231 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 231 ----YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 11122345577799999999999999999999999999998753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=321.99 Aligned_cols=261 Identities=28% Similarity=0.456 Sum_probs=210.1
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcE--EEEEEeecC-CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGME--VAVKVFHLQ-CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~--v~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 117 (335)
++|++.+.||+|+||.||+|... ++.. +++|.+... .......+.+|+++++.+ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 78999999999999999999754 4554 489988743 334557789999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcE
Q 019843 118 LEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 182 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v 182 (335)
|||+++++|.+++.... ..+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 99999999999997543 46999999999999999999999 9999999999999999999999
Q ss_pred EEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhh
Q 019843 183 HLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSN 261 (335)
Q Consensus 183 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 261 (335)
+|+|||++.... .........++..|+|||++.+..++.++||||||+++|+|++ |..||......+.
T Consensus 182 kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------- 250 (327)
T 1fvr_A 182 KIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------- 250 (327)
T ss_dssp EECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------
T ss_pred EEcccCcCcccc---ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH--------
Confidence 999999987432 1222333456788999999988889999999999999999998 9999976432111
Q ss_pred hcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcccc
Q 019843 262 LLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICT 329 (335)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 329 (335)
...+... .....+..+++.+.+++.+||+.||.+|||++++++.|+++..+.....
T Consensus 251 ------~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 251 ------YEKLPQG------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp ------HHHGGGT------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred ------HHHhhcC------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 0111111 1111223456779999999999999999999999999999987665443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=335.64 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=208.7
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..++|.+.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3478999999999999999999865 6999999999744 22345688999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+++++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++......
T Consensus 94 v~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999999987654 7999999999999999999999 999999999999999999999999999999876322
Q ss_pred ccccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
.......|++.|+|||++.+..+ +.++||||||+++|+|++|..||......... ..+.+. .
T Consensus 170 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-------------~~i~~~-~ 232 (476)
T 2y94_A 170 ---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF-------------KKICDG-I 232 (476)
T ss_dssp ---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH-------------HHHHTT-C
T ss_pred ---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH-------------HHHhcC-C
Confidence 22334578999999999988765 68999999999999999999999764321111 111111 1
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...+..+++.+.+|+.+||+.||.+|||++|+++.
T Consensus 233 -------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 -------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 11123356679999999999999999999999974
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=316.35 Aligned_cols=258 Identities=23% Similarity=0.357 Sum_probs=207.8
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec--------
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN-------- 110 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 110 (335)
...++|++.+.||+|+||.||+|... +++.||+|++.... ..+.+|+++++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34578999999999999999999876 68999999987553 456789999999999999999998754
Q ss_pred --------CCeeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc
Q 019843 111 --------DDFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181 (335)
Q Consensus 111 --------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~ 181 (335)
....++||||+++++|.+++... ...+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCC
Confidence 45688999999999999999754 347999999999999999999999 999999999999999999999
Q ss_pred EEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhh
Q 019843 182 AHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSN 261 (335)
Q Consensus 182 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 261 (335)
++|+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 161 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----------- 226 (284)
T 2a19_B 161 VKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----------- 226 (284)
T ss_dssp EEECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----------
T ss_pred EEECcchhheecccc---ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----------
Confidence 999999998876322 223345689999999999988899999999999999999999988543110
Q ss_pred hcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccccccc
Q 019843 262 LLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICTRES 332 (335)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 332 (335)
....+.... . +..++..+.+++.+||+.||.+|||+.|+++.|+.+..+.....+.+
T Consensus 227 -----~~~~~~~~~---~------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~~t 283 (284)
T 2a19_B 227 -----FFTDLRDGI---I------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHT 283 (284)
T ss_dssp -----HHHHHHTTC---C------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---------
T ss_pred -----HHHHhhccc---c------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcccccC
Confidence 000011100 0 12345669999999999999999999999999999988877665543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=330.16 Aligned_cols=279 Identities=21% Similarity=0.245 Sum_probs=206.1
Q ss_pred CHHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeec
Q 019843 34 SYLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110 (335)
Q Consensus 34 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 110 (335)
+....+...++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+++++.++||||+++++++..
T Consensus 17 Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 17 QGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIP 96 (432)
T ss_dssp TCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred cCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEec
Confidence 34456778899999999999999999999765 5889999999753 23345678899999999999999999999876
Q ss_pred C-----CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEe
Q 019843 111 D-----DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 185 (335)
Q Consensus 111 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~ 185 (335)
. ...|+|||+++ ++|.+++... ..+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+
T Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~ 171 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVC 171 (432)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred CCCCcCCeEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEc
Confidence 5 57899999985 5999988764 37999999999999999999999 9999999999999999999999999
Q ss_pred eccccccccCCccc--------------------cccccccccccccCcccc-CCCCCCCccchhhHHHHHHHHHhCCCC
Q 019843 186 DFGIAKLLTGEDQS--------------------KSQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFTKKKP 244 (335)
Q Consensus 186 dfg~~~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~~l~~ll~g~~p 244 (335)
|||++......... .......+|..|+|||++ .+..++.++|||||||++|+|++|..|
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 99999876432211 123456789999999985 566799999999999999999986666
Q ss_pred CCcccccch---------------------------hhHhHhhhhc-----------ChhHHHHHHhhhccccccchhhH
Q 019843 245 TDKIFAGEM---------------------------TLKYWVSNLL-----------PISVMEIVDANLLSREDKHFAAK 286 (335)
Q Consensus 245 f~~~~~~~~---------------------------~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~ 286 (335)
|........ .+........ .......+...............
T Consensus 252 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (432)
T 3n9x_A 252 HINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY 331 (432)
T ss_dssp TCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS
T ss_pred cccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC
Confidence 543211110 0000000000 00111111111111100001111
Q ss_pred HHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 287 EQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 287 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..+++.+.+|+.+||..||.+|||++|+++.
T Consensus 332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 332 PSISDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 3467889999999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=326.95 Aligned_cols=256 Identities=22% Similarity=0.343 Sum_probs=201.7
Q ss_pred hhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCC--CceEEEeeeeecCCeeE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRH--RNLIKIISTCSNDDFKA 115 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~ 115 (335)
...++|++.+.||+|+||.||+|...+++.||+|++.... ......+.+|+.+++.+.| +||+++++++...+..+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 3567899999999999999999988889999999997553 3345778999999999976 99999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+|||+ .+++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++ ++.+||+|||++..+..
T Consensus 86 lv~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99994 5889999998754 7999999999999999999999 99999999999999997 67899999999987643
Q ss_pred CccccccccccccccccCccccCC-----------CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGRE-----------GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP 264 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 264 (335)
...........||+.|+|||++.+ ..++.++||||||+++|+|++|..||..........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--------- 230 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL--------- 230 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH---------
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH---------
Confidence 333333445679999999999754 668889999999999999999999997543221111
Q ss_pred hhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 265 ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...++... ....+...++.+.+++.+||+.||.+|||+.|+++.-+
T Consensus 231 ---~~~~~~~~------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 231 ---HAIIDPNH------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp ---HHHHCTTS------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ---HHHhcCCc------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 11111111 11112233556999999999999999999999987644
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=317.98 Aligned_cols=265 Identities=20% Similarity=0.282 Sum_probs=208.4
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeeec--CCeeE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSN--DDFKA 115 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~ 115 (335)
...++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+|+++++.+. ||||+++++++.+ ....+
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 3457899999999999999999975 46899999998743 3477899999999996 9999999999987 67889
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-cEEEeecccccccc
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLT 194 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~-~v~l~dfg~~~~~~ 194 (335)
+||||+++++|.+++. .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++ .++|+|||++..+.
T Consensus 110 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999999874 3889999999999999999999 99999999999999999776 89999999998653
Q ss_pred CCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
. ........++..|+|||++.+ ..++.++||||||+++|+|++|..||.........................++.
T Consensus 183 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 P---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp T---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred C---CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 2 223344578899999999877 678999999999999999999999996544333333322222222222222222
Q ss_pred hhcccc-----------------ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 274 NLLSRE-----------------DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 274 ~~~~~~-----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...... .........+++.+.+||.+||+.||.+|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111000 00111123367889999999999999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=323.78 Aligned_cols=264 Identities=24% Similarity=0.392 Sum_probs=210.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEE------cCCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI------QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD 112 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 112 (335)
...++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3457999999999999999999973 247789999986442 334567889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC---CCcEE
Q 019843 113 FKALVLEYMPHGSLEKCLYSSN------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAH 183 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~---~~~v~ 183 (335)
..++||||+++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++. +..++
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999998653 35899999999999999999999 999999999999999984 44699
Q ss_pred EeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhh
Q 019843 184 LSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNL 262 (335)
Q Consensus 184 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 262 (335)
|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--------- 254 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------- 254 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---------
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---------
Confidence 999999986543333333445567889999999988889999999999999999998 9999876432111
Q ss_pred cChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 263 LPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
...+.... ....+..+++.+.+++.+||+.||.+||++.++++.|+.+..+-.
T Consensus 255 -----~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 255 -----LEFVTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp -----HHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -----HHHHhcCC------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 11111111 111123456779999999999999999999999999998876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=315.10 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=201.4
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
...++|++.+.||+|+||.||+|... ++..+|+|++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 45578999999999999999999865 58899999987653 33457899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE---CCCCcEEEeeccccc
Q 019843 118 LEYMPHGSLEKCLYSS---NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 191 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv---~~~~~v~l~dfg~~~ 191 (335)
|||+++++|.+.+... ...+++..++.++.+++.||.||| +.+++|+||+|+||++ +.++.++|+|||++.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999988642 357999999999999999999999 9999999999999999 456789999999998
Q ss_pred cccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 192 LLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
.+.. ........++..|+|||++. ..++.++||||||+++|+|++|..||..........
T Consensus 176 ~~~~---~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~---------------- 235 (285)
T 3is5_A 176 LFKS---DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ---------------- 235 (285)
T ss_dssp C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------
T ss_pred ecCC---cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh----------------
Confidence 6532 22334566899999999986 568899999999999999999999997643222111
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
......... ......+++.+.+++.+||+.||.+|||+.|+++
T Consensus 236 -~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 236 -KATYKEPNY-AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -HHHHCCCCC-CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -hhccCCccc-ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000 0011224567999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=325.99 Aligned_cols=268 Identities=17% Similarity=0.191 Sum_probs=204.2
Q ss_pred hcCCCCccceeeecCceEEEEEEEc----CCcEEEEEEeecCCCc-----------hhHHHHHHHHHHHhCCCCceEEEe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQCGG-----------VFKSFDVECEVMKSIRHRNLIKII 105 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~ 105 (335)
..++|++.+.||+|+||.||+|... ++..+|+|+....... ....+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 4579999999999999999999865 5788999998765432 123466788889999999999999
Q ss_pred eeeec----CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-
Q 019843 106 STCSN----DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM- 180 (335)
Q Consensus 106 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~- 180 (335)
+++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSST
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCC
Confidence 99887 78999999999 999999987655 7999999999999999999999 99999999999999999887
Q ss_pred -cEEEeeccccccccCCccc-----cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchh
Q 019843 181 -VAHLSDFGIAKLLTGEDQS-----KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMT 254 (335)
Q Consensus 181 -~v~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~ 254 (335)
.++|+|||++..+...... .......++..|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999876422111 1124457899999999999989999999999999999999999999653322222
Q ss_pred hHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 255 LKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
...............+.. ......+++.+.+++.+||+.||++||++++|++.|+++..
T Consensus 270 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLK----------WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHTTTHHHHH----------HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHhhcccccHHHHh----------hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 211111100000000000 00011456779999999999999999999999999987653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=318.45 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=205.9
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
....++|++.+.||.|+||.||+|... +++.|++|++..........+.+|+++++.++||||+++++++...+..++|
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 356689999999999999999999876 5899999999877666778899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.... .
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~--~ 169 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL--K 169 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH--H
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccc--c
Confidence 9999999999998876567999999999999999999999 9999999999999999999999999999876431 1
Q ss_pred cccccccccccccccCcccc-----CCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 198 QSKSQTQTLATIGYMAPEYG-----REGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
.........++..|+|||++ .+..++.++||||||+++|+|++|..||.......... ....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~ 236 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-------------KIAK 236 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------------HHHH
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH-------------HHhc
Confidence 11223345689999999987 46778999999999999999999999987643211110 0000
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
........+..++..+.+++.+||+.||.+|||+.++++
T Consensus 237 -----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 237 -----SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----SCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----cCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011112223455777999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=316.61 Aligned_cols=282 Identities=22% Similarity=0.349 Sum_probs=217.9
Q ss_pred ccccCHHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHh--CCCCceEEEeee
Q 019843 30 WRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKS--IRHRNLIKIIST 107 (335)
Q Consensus 30 ~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~ 107 (335)
.+..+........++|++.+.||+|+||.||+|... ++.||+|++... ....+..|.+++.. ++||||++++++
T Consensus 29 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 29 GSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAA 104 (342)
T ss_dssp CSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred CCCCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence 345555566677889999999999999999999875 899999998643 34667888999987 689999999999
Q ss_pred eecCC----eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcc-----CCCCeEecCCCCCCEEECC
Q 019843 108 CSNDD----FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG-----YSAPVIHCDLKPSNVLLDD 178 (335)
Q Consensus 108 ~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~-----~~~~i~h~di~p~Nilv~~ 178 (335)
+.... ..++||||+++++|.+++... .+++..++.++.+++.||.|||.. .+.+++|+||+|+||+++.
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC
Confidence 98765 889999999999999999765 499999999999999999999921 1468999999999999999
Q ss_pred CCcEEEeeccccccccCCcccc--ccccccccccccCccccCCCC------CCCccchhhHHHHHHHHHhC---------
Q 019843 179 NMVAHLSDFGIAKLLTGEDQSK--SQTQTLATIGYMAPEYGREGR------VSTNGDVYSFGIMLMETFTK--------- 241 (335)
Q Consensus 179 ~~~v~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~------~~~~sDiwslG~~l~~ll~g--------- 241 (335)
++.++|+|||++.......... ......++..|+|||++.+.. ++.++||||||+++|+|++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 9999999999998664222111 234457899999999987653 33689999999999999999
Q ss_pred -CCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 242 -KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 242 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
..||............+.. .+............+ ....+++.+.+++.+||+.||.+|||+.++++.|++
T Consensus 263 ~~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 263 YQLPYYDLVPSDPSVEEMRK--------VVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCTTTTTSCSSCCHHHHHH--------HHTTSCCCCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccCccccCcCcccHHHHHH--------HHHHHHhCCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 6777654332221111110 011111111111111 123567789999999999999999999999999999
Q ss_pred HHhhhc
Q 019843 321 IRDSLL 326 (335)
Q Consensus 321 ~~~~~~ 326 (335)
+..+..
T Consensus 334 i~~~~~ 339 (342)
T 1b6c_B 334 LSQQEG 339 (342)
T ss_dssp HHHTTC
T ss_pred HHHHhc
Confidence 987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=322.37 Aligned_cols=254 Identities=25% Similarity=0.361 Sum_probs=207.2
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--------chhHHHHHHHHHHHhC-CCCceEEEeeee
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--------GVFKSFDVECEVMKSI-RHRNLIKIISTC 108 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 108 (335)
....++|.+.+.||.|++|.||+|... +|+.||||++..... .....+.+|+.+++.+ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 445578999999999999999999875 699999999876532 2245678899999999 799999999999
Q ss_pred ecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 019843 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 109 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
...+..++||||+++++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecC
Confidence 99999999999999999999987643 6999999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCccccCC------CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGRE------GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 262 (335)
++..+.. ........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||........ .
T Consensus 246 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~------- 314 (365)
T 2y7j_A 246 FSCHLEP---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM-L------- 314 (365)
T ss_dssp TCEECCT---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H-------
T ss_pred cccccCC---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH-H-------
Confidence 9987632 222344678999999998753 3588899999999999999999999976422111 0
Q ss_pred cChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 263 LPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..+.. .......+....+++.+.+++.+||+.||++|||++|+++
T Consensus 315 ------~~i~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 ------RMIME---GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ------HHHHH---TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------HHHHh---CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111 1111111112345677999999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=321.00 Aligned_cols=277 Identities=23% Similarity=0.251 Sum_probs=214.6
Q ss_pred ccccccCHHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-----CCce
Q 019843 28 ATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-----HRNL 101 (335)
Q Consensus 28 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i 101 (335)
+....++..+.....++|++.+.||+|+||.||+|... +++.||+|++... ......+..|+.+++.+. ||||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 34466677777788899999999999999999999864 5899999998643 334466788999999986 9999
Q ss_pred EEEeeeeecCCeeEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC--
Q 019843 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD-- 178 (335)
Q Consensus 102 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~-- 178 (335)
+++++++...+..++|||++ +++|.+++.... ..+++..++.++.||+.||.||| +.+++|+||||+||+++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPY 174 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTT
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccc
Confidence 99999999999999999999 999999998653 36999999999999999999999 999999999999999975
Q ss_pred -----------------------CCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHH
Q 019843 179 -----------------------NMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 235 (335)
Q Consensus 179 -----------------------~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l 235 (335)
++.++|+|||++.... .......+|+.|+|||++.+..++.++|||||||++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS-----DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT-----SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecC-----CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 7899999999998642 223456789999999999999999999999999999
Q ss_pred HHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc----------------cc-----------chhhHHH
Q 019843 236 METFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE----------------DK-----------HFAAKEQ 288 (335)
Q Consensus 236 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~-----------~~~~~~~ 288 (335)
|+|++|..||......+. .........+.... .......... .. .......
T Consensus 250 ~ell~g~~pf~~~~~~~~-~~~~~~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 327 (360)
T 3llt_A 250 AELYTGSLLFRTHEHMEH-LAMMESIIQPIPKN-MLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII 327 (360)
T ss_dssp HHHHHSSCSCCCSSHHHH-HHHHHHHTCCCCHH-HHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred HHHHHCCCCCCCCcHHHH-HHHHHHhcCCCCHH-HHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence 999999999976433221 11111111111111 1100000000 00 0000111
Q ss_pred HHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 289 CVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 289 ~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.++.+.+|+.+||+.||.+|||++|+++
T Consensus 328 ~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 328 KHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 2366889999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=324.55 Aligned_cols=268 Identities=24% Similarity=0.290 Sum_probs=203.3
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC-
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD- 112 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 112 (335)
..+...++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+++++.++||||+++++++...+
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 44567889999999999999999999864 6899999998543 2334567889999999999999999999987653
Q ss_pred -----eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeec
Q 019843 113 -----FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 187 (335)
Q Consensus 113 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~df 187 (335)
.+++|||++ +++|.+++... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.+||+||
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred cccCceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEee
Confidence 469999999 88999998764 5999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc---
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL--- 263 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--- 263 (335)
|++.... .......+|..|+|||++.+ ..++.++||||+||++|+|++|..||........ +........
T Consensus 173 g~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~~~ 246 (367)
T 1cm8_A 173 GLARQAD-----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPP 246 (367)
T ss_dssp TTCEECC-----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCC
T ss_pred ecccccc-----cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCC
Confidence 9998653 12344578999999998876 6799999999999999999999999976543221 111111111
Q ss_pred --------ChhHHHHHHhhhccccccc-hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 264 --------PISVMEIVDANLLSREDKH-FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 264 --------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.......... +....... ......+++.+.+|+.+||..||.+|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKG-LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHTCSCHHHHHHHHH-SCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhhhHHHHHHHHh-CCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 1111111111 11111111 11123457789999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=328.73 Aligned_cols=262 Identities=26% Similarity=0.432 Sum_probs=202.8
Q ss_pred CCCCccceeeecCceEEEEEEEc--C--CcEEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeee-cCCeeEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ--D--GMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCS-NDDFKAL 116 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~--~--~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~l 116 (335)
..|.+.+.||+|+||.||+|... + +..|++|.+... .......+.+|+.+++.++||||+++++++. ..+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35777899999999999999753 2 235899988644 3345678999999999999999999999865 4568899
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+++++|.+++......+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++..+...
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999999877767999999999999999999999 999999999999999999999999999999865322
Q ss_pred ccc--cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 197 DQS--KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 197 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
... .......++..|+|||.+.+..++.++||||||+++|+|++ |.+||......+... .+..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~--------------~~~~ 311 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV--------------YLLQ 311 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH--------------HHHT
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH--------------HHHc
Confidence 211 12234456788999999998999999999999999999999 677776543322111 1111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
. .....+..+++.+.+++.+||+.||++|||+.|+++.|+++...+..
T Consensus 312 ~------~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 312 G------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp T------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred C------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 1 11112334567799999999999999999999999999999877653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=317.12 Aligned_cols=270 Identities=24% Similarity=0.305 Sum_probs=201.8
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC-----CchhHHHHHHHHHHHhC---CCCceEEEeeeeec
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC-----GGVFKSFDVECEVMKSI---RHRNLIKIISTCSN 110 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~ 110 (335)
...++|++.+.||+|+||+||+|.+ .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3468999999999999999999986 468999999987432 22235667777777766 49999999999977
Q ss_pred CC-----eeEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEE
Q 019843 111 DD-----FKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 184 (335)
Q Consensus 111 ~~-----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l 184 (335)
.. ..++|||+++ ++|.+++.... ..+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence 54 5889999996 59999988654 34999999999999999999999 999999999999999999999999
Q ss_pred eeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC
Q 019843 185 SDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP 264 (335)
Q Consensus 185 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 264 (335)
+|||++.... .........+|+.|+|||++.+..++.++||||||+++|+|++|..||........... .......
T Consensus 162 ~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-i~~~~~~ 237 (308)
T 3g33_A 162 ADFGLARIYS---YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK-IFDLIGL 237 (308)
T ss_dssp CSCSCTTTST---TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH-HHHHHCC
T ss_pred eeCccccccC---CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCC
Confidence 9999998653 22233456789999999999989999999999999999999999999976543222111 1110000
Q ss_pred hhHHHHH------Hhhhccc-cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 265 ISVMEIV------DANLLSR-EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 265 ~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.....+. ....... ..........+++.+.+||.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000000 0000000 000011112456779999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=330.56 Aligned_cols=253 Identities=22% Similarity=0.344 Sum_probs=200.7
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCC--CCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIR--HRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv 117 (335)
.++|++.+.||+|+||.||+|...+++.||+|++.... ......+.+|+.+++.+. ||||+++++++...+.+++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 45699999999999999999988889999999997553 334577899999999995 59999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|| +.+++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++ ++.+||+|||++..+....
T Consensus 135 ~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred Ee-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 99 56889999998765 7899999999999999999999 99999999999999995 5899999999998764332
Q ss_pred cccccccccccccccCccccCC-----------CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh
Q 019843 198 QSKSQTQTLATIGYMAPEYGRE-----------GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 266 (335)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----------- 277 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----------- 277 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-----------
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH-----------
Confidence 2223345679999999998864 368889999999999999999999997543211111
Q ss_pred HHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 267 VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
..+++... ....+...+..+.+||.+||+.||.+|||+.|+++.-
T Consensus 278 -~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 278 -HAIIDPNH------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp -HHHHCTTS------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -HHHhCccc------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 11111111 1111222355699999999999999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=321.61 Aligned_cols=268 Identities=21% Similarity=0.287 Sum_probs=200.2
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCc-hhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999875 6899999998754322 222455799999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++ ++|.+++......+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK 155 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence 96 5999988877768999999999999999999999 99999999999999999999999999999976431 122
Q ss_pred ccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc---ChhHH------HH
Q 019843 201 SQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL---PISVM------EI 270 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~------~~ 270 (335)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+... ....... +.... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH-FIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCCCCTTTSTTGGGCHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChHhchhhhcchhh
Confidence 3334568999999999876 568999999999999999999999997754322211 1111000 00000 00
Q ss_pred HHhhhcc-ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 271 VDANLLS-REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 271 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
....... ...........+++++.+|+.+||+.||.+|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 0001111223456779999999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=312.11 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=207.6
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.++|.+.+.||+|++|.||+|... +++.|++|++... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 378999999999999999999865 5788999998643 233456789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+++++|.+++.... .+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-- 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-- 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS--
T ss_pred EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc--
Confidence 99999999999987654 6999999999999999999999 99999999999999999999999999999876431
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
.......++..|+|||++.+..++.++||||||+++|+|++|..||......... ..+...
T Consensus 167 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------------~~~~~~---- 227 (284)
T 2vgo_A 167 --LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-------------RRIVNV---- 227 (284)
T ss_dssp --SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------------HHHHTT----
T ss_pred --cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH-------------HHHhcc----
Confidence 2233456899999999999999999999999999999999999999764322111 001110
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
....+..+++.+.+++.+||+.||.+|||++++++.-
T Consensus 228 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 228 ----DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred ----ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 0111234567799999999999999999999998743
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=321.82 Aligned_cols=277 Identities=21% Similarity=0.236 Sum_probs=206.9
Q ss_pred cCHHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCC-----------chhHHHHHHHHHHHhCCCCce
Q 019843 33 FSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCG-----------GVFKSFDVECEVMKSIRHRNL 101 (335)
Q Consensus 33 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i 101 (335)
....+.....++|++.+.||+|+||.||+|...+++.||+|++..... ...+.+.+|+++++.++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 345677888999999999999999999999888899999999864321 123778999999999999999
Q ss_pred EEEeeeeec-----CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE
Q 019843 102 IKIISTCSN-----DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL 176 (335)
Q Consensus 102 ~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv 176 (335)
+++++++.. ....++||||++ ++|.+.+......+++..++.++.||+.||.||| +.+++|+||+|+||++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL 167 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence 999999843 447899999996 6888888877668999999999999999999999 9999999999999999
Q ss_pred CCCCcEEEeeccccccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhh
Q 019843 177 DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTL 255 (335)
Q Consensus 177 ~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~ 255 (335)
+.++.++|+|||++.... .........++..|+|||++.+ ..++.++||||||+++|+|++|..||.........
T Consensus 168 ~~~~~~kl~Dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~- 243 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDT---ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL- 243 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-
T ss_pred cCCCCEEEEecCcccccc---cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH-
Confidence 999999999999997542 2223344678899999998876 67899999999999999999999999865432221
Q ss_pred HhHhhhhcChhH-----------HHHHHhhhccccccc-hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 256 KYWVSNLLPISV-----------MEIVDANLLSREDKH-FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 256 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
............ ............... ......+++.+.+|+.+||+.||.+|||++|+++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111111111 111111111111111 11123446779999999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=330.01 Aligned_cols=262 Identities=22% Similarity=0.270 Sum_probs=209.6
Q ss_pred HHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeec
Q 019843 35 YLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110 (335)
Q Consensus 35 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 110 (335)
..+.....++|++.+.||+|+||.||+|..+ +++.||+|++... .......+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3344556789999999999999999999875 6899999999743 12234568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
.+.+|+||||++|++|.+++...+..+++..++.++.+|+.||.||| +.+++|+||||+||+++.+|.+||+|||++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999999876557999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCccccccccccccccccCccccC-------CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGR-------EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL 263 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 263 (335)
....... ........||+.|+|||++. +..++.++|+|||||++|+|++|..||......+..
T Consensus 210 ~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~--------- 279 (412)
T 2vd5_A 210 LKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY--------- 279 (412)
T ss_dssp EECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---------
T ss_pred eeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH---------
Confidence 8663221 11223457999999999986 356899999999999999999999999764322211
Q ss_pred ChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccC---CCHHHHHHH
Q 019843 264 PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQR---INAKEIVTR 317 (335)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---ps~~ell~~ 317 (335)
..+........ .......+++++.+||.+||. +|.+| |+++|+++.
T Consensus 280 ----~~i~~~~~~~~---~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 ----GKIVHYKEHLS---LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ----HHHHTHHHHCC---CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ----HHHHhcccCcC---CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11111100000 001123467789999999999 99998 589998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=336.21 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=204.3
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
....++|++++.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 345568999999999999999999865 68899999987542 334578899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC---CcEEEeecccccc
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKL 192 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~---~~v~l~dfg~~~~ 192 (335)
+||||+++++|.+.+.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.. +.+||+|||++..
T Consensus 113 lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999999887654 6999999999999999999999 9999999999999999764 4599999999987
Q ss_pred ccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
+.. ........+|+.|+|||++. ..++.++||||+||++|+|++|..||......+.. ..+.
T Consensus 189 ~~~---~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--------------~~i~ 250 (494)
T 3lij_A 189 FEN---QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL--------------RKVE 250 (494)
T ss_dssp CBT---TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------------HHHH
T ss_pred CCC---CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------------HHHH
Confidence 632 22334567999999999986 46899999999999999999999999765332111 1111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.. ......+....+++.+.+||.+||+.||.+|||+.|+++.
T Consensus 251 ~~---~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 251 KG---KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HT---CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hC---CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11 1111111223467789999999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=309.49 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=202.5
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeec----CCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN----DDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 113 (335)
....|++.+.||+|+||.||+|... ++..|++|++... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3456899999999999999999765 5888999998754 23456778999999999999999999998765 467
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCC--eEecCCCCCCEEEC-CCCcEEEeecccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP--VIHCDLKPSNVLLD-DNMVAHLSDFGIA 190 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~--i~h~di~p~Nilv~-~~~~v~l~dfg~~ 190 (335)
.++||||+++++|.+++.... .+++..++.++.+|+.||.||| +.+ ++|+||+|+||+++ .++.++|+|||++
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 899999999999999997643 6999999999999999999999 888 99999999999997 8899999999999
Q ss_pred ccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
.... ........+++.|+|||++.+ .++.++||||||+++|+|++|..||..............
T Consensus 180 ~~~~----~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----------- 243 (290)
T 1t4h_A 180 TLKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT----------- 243 (290)
T ss_dssp GGCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT-----------
T ss_pred cccc----ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHh-----------
Confidence 7542 223334568999999998864 589999999999999999999999976433222111110
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.. ......+...++.+.+++.+||+.||.+|||++|+++.
T Consensus 244 -----~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 244 -----SG--VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----TT--CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----cc--CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00 01111223345679999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=323.88 Aligned_cols=268 Identities=15% Similarity=0.149 Sum_probs=211.1
Q ss_pred cCCCCccceeeecCceEEEEEEEcC---------CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEE---------
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD---------GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK--------- 103 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~--------- 103 (335)
.++|++.+.||+|+||.||+|.... ++.||+|++... ..+.+|+++++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 5899999999999999999998653 789999998754 56789999999999999887
Q ss_pred ------Eeeeeec-CCeeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEE
Q 019843 104 ------IISTCSN-DDFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVL 175 (335)
Q Consensus 104 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nil 175 (335)
+++++.. .+..++||||+ +++|.+++... ...+++..++.++.||+.||.||| +.+++|+||+|+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence 5566655 78899999999 99999999865 357999999999999999999999 999999999999999
Q ss_pred ECCCC--cEEEeeccccccccCCccc-----cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcc
Q 019843 176 LDDNM--VAHLSDFGIAKLLTGEDQS-----KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKI 248 (335)
Q Consensus 176 v~~~~--~v~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~ 248 (335)
++.++ .++|+|||++..+...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 9999999999876422211 1123447899999999999999999999999999999999999999875
Q ss_pred cccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccc
Q 019843 249 FAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328 (335)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 328 (335)
............ .+... .............+++.+.+++.+||+.||.+|||++++++.|+++..+....
T Consensus 272 ~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 272 LPNTEDIMKQKQ--------KFVDK--PGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp TTCHHHHHHHHH--------HHHHS--CCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CcCHHHHHHHHH--------hccCC--hhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 422221111000 00000 00000000001234667999999999999999999999999999998877654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=331.17 Aligned_cols=278 Identities=19% Similarity=0.264 Sum_probs=213.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC--eeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD--FKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~l 116 (335)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+++++.++||||+++++++...+ ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4678999999999999999999876 48999999997543 334577889999999999999999999988654 7899
Q ss_pred EEEecCCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE----CCCCcEEEeecccc
Q 019843 117 VLEYMPHGSLEKCLYSSN--CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIA 190 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv----~~~~~v~l~dfg~~ 190 (335)
||||+++++|.+++.... ..+++..++.++.+|+.||.||| +.+++|+||+|+||++ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999997643 23999999999999999999999 9999999999999999 77888999999999
Q ss_pred ccccCCccccccccccccccccCccccCC--------CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGRE--------GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 262 (335)
..... ........++..|+|||++.+ ..++.++||||||+++|+|++|..||.................
T Consensus 164 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 87632 222334568999999998764 4577899999999999999999999975443222211111100
Q ss_pred cChhHHHH--H----Hhh--hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 263 LPISVMEI--V----DAN--LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 263 ~~~~~~~~--~----~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
.......+ . ... ..............+++.+.+++.+||+.||++||++.++++.+..+...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 00000000 0 000 00000111122356788899999999999999999999999999987643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=325.01 Aligned_cols=258 Identities=23% Similarity=0.295 Sum_probs=205.4
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 116 (335)
....++|.+.+.||.|+||.||+|..+ +++.||+|++..... ...+|++++..+ +||||+++++++.+.+..++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 345678999999999999999999765 588999999975533 235678888887 79999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC----CcEEEeecccccc
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN----MVAHLSDFGIAKL 192 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~----~~v~l~dfg~~~~ 192 (335)
||||++|++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||++..+ +.++|+|||++..
T Consensus 94 v~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999999987654 7999999999999999999999 9999999999999998533 3599999999986
Q ss_pred ccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
.... ........+|+.|+|||++.+..++.++||||||+++|+|++|..||........ ..+..
T Consensus 170 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--------------~~~~~ 233 (342)
T 2qr7_A 170 LRAE--NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP--------------EEILA 233 (342)
T ss_dssp CBCT--TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH--------------HHHHH
T ss_pred CcCC--CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH--------------HHHHH
Confidence 5322 2223345789999999999888889999999999999999999999975321111 11111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
................+++.+.+||.+||..||++|||+.++++.=+-
T Consensus 234 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 234 RIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp HHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred HHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 111111111111123457789999999999999999999999886543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=321.02 Aligned_cols=283 Identities=21% Similarity=0.211 Sum_probs=213.4
Q ss_pred ccccccCHHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEe
Q 019843 28 ATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKII 105 (335)
Q Consensus 28 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 105 (335)
+..+.....+++...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||++++
T Consensus 12 ~~~~~~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 91 (364)
T 3qyz_A 12 AAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91 (364)
T ss_dssp ---CCBCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCC
T ss_pred hcceEEEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccce
Confidence 44556666777888899999999999999999999765 58889999987543 33457788999999999999999999
Q ss_pred eeeecC-----CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC
Q 019843 106 STCSND-----DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM 180 (335)
Q Consensus 106 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~ 180 (335)
+++... ...++|+|+++ ++|.+++... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++
T Consensus 92 ~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~ 165 (364)
T 3qyz_A 92 DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTC 165 (364)
T ss_dssp EEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTC
T ss_pred eEEecCCccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCC
Confidence 998654 47899999996 5999988765 4999999999999999999999 99999999999999999999
Q ss_pred cEEEeeccccccccCCccc-cccccccccccccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhH
Q 019843 181 VAHLSDFGIAKLLTGEDQS-KSQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYW 258 (335)
Q Consensus 181 ~v~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~ 258 (335)
.++|+|||++......... .......+|+.|+|||++. +..++.++||||||+++|+|++|..||......+... ..
T Consensus 166 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~i 244 (364)
T 3qyz_A 166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN-HI 244 (364)
T ss_dssp CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH-HH
T ss_pred CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH-HH
Confidence 9999999999876422211 1234457899999999865 4558999999999999999999999997654332211 11
Q ss_pred hhhhcChh-----------HHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 259 VSNLLPIS-----------VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 259 ~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
........ ......................+++.+.+|+.+||+.||.+|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111110 011111100011111111113456779999999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=327.49 Aligned_cols=248 Identities=26% Similarity=0.314 Sum_probs=196.1
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHH-HHhCCCCceEEEeeeeecCCeeE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEV-MKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
..++|.+.+.||+|+||.||+|..+ +++.||+|++.... ......+..|..+ ++.++||||+++++++.+.+.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 4578999999999999999999865 58899999997542 2233455666666 46679999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||++|++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.+|.+||+|||++....
T Consensus 116 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~- 190 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI- 190 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB-
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccc-
Confidence 9999999999999987654 6899999999999999999999 9999999999999999999999999999997532
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
..........||+.|+|||++.+..++.++|+|||||++|+|++|..||......+.. ..+....
T Consensus 191 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-------------~~i~~~~- 255 (373)
T 2r5t_A 191 -EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-------------DNILNKP- 255 (373)
T ss_dssp -CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH-------------HHHHHSC-
T ss_pred -cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-------------HHHHhcc-
Confidence 1122344567999999999999999999999999999999999999999764322111 1111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIV 315 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 315 (335)
...+..++..+.+||.+||+.||.+||++.+.+
T Consensus 256 -------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 256 -------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp -------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred -------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 111234567799999999999999999985433
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=313.46 Aligned_cols=252 Identities=20% Similarity=0.294 Sum_probs=209.8
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..++|.+.+.||+|+||.||+|... +++.+++|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 4578999999999999999999876 48889999987542 2345678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+++++|.+++.... .+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999999999887644 7999999999999999999999 999999999999999999999999999999865321
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||......+... .+. ..
T Consensus 169 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------------~~~-~~-- 230 (294)
T 2rku_A 169 --GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-------------RIK-KN-- 230 (294)
T ss_dssp --TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------------HHH-TT--
T ss_pred --ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHh-hc--
Confidence 222344568999999999998889999999999999999999999997643221110 000 00
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
....+..+++.+.+++.+||+.||++|||++++++.-.
T Consensus 231 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 231 -----EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred -----cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 01112345667999999999999999999999998543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=312.66 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=212.5
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
...++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 34577999999999999999999764 58999999997653 34567899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+++++|.+++... .+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 99 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 172 (303)
T 3a7i_A 99 MEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT- 172 (303)
T ss_dssp EECCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT-
T ss_pred EEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcc-
Confidence 9999999999998653 5999999999999999999999 999999999999999999999999999999876322
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
........++..|+|||++.+..++.++||||||+++|+|++|..||........ ...+......
T Consensus 173 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~ 237 (303)
T 3a7i_A 173 -QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--------------LFLIPKNNPP 237 (303)
T ss_dssp -BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------------HHHHHHSCCC
T ss_pred -ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH--------------HHHhhcCCCC
Confidence 2223445789999999999999999999999999999999999999876432111 0111111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
..+..++..+.+++.+||+.||.+|||+.++++...-..
T Consensus 238 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 238 ------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp ------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred ------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 112344667999999999999999999999998765433
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=310.71 Aligned_cols=255 Identities=23% Similarity=0.313 Sum_probs=207.0
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC---------chhHHHHHHHHHHHhCC-CCceEEEee
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG---------GVFKSFDVECEVMKSIR-HRNLIKIIS 106 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~i~~~~~ 106 (335)
.....++|++.+.||+|++|.||+|... +++.||+|++..... .....+.+|+++++++. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 3456789999999999999999999875 589999999975531 23456788999999995 999999999
Q ss_pred eeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEee
Q 019843 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 186 (335)
Q Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~d 186 (335)
++...+..++||||+++++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999999997653 7999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCccccccccccccccccCccccC------CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhh
Q 019843 187 FGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVS 260 (335)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 260 (335)
||++..... ........++..|+|||++. ...++.++||||||+++|+|++|..||.........
T Consensus 168 fg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------ 238 (298)
T 1phk_A 168 FGFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML------ 238 (298)
T ss_dssp CTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------
T ss_pred ccchhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH------
Confidence 999986532 22234456899999999874 456889999999999999999999999764321110
Q ss_pred hhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 261 NLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..+... ......+....+++.+.+++.+||+.||.+|||+.|+++
T Consensus 239 -------~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 -------RMIMSG----NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -------HHHHHT----CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -------HHHhcC----CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 011111 111111122456778999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=324.42 Aligned_cols=256 Identities=20% Similarity=0.245 Sum_probs=197.0
Q ss_pred hcCCCCcc-ceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHh-CCCCceEEEeeeeec----CCe
Q 019843 41 ATDGFSEN-NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKS-IRHRNLIKIISTCSN----DDF 113 (335)
Q Consensus 41 ~~~~y~~~-~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~ 113 (335)
..++|.+. +.||.|+||.||+|... +++.||+|++... ..+.+|+.++.+ .+||||+++++++.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 44567776 78999999999999765 5899999998632 567788888754 589999999998875 667
Q ss_pred eEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC---CCcEEEeeccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGI 189 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~---~~~v~l~dfg~ 189 (335)
+++||||++|++|.+++.... ..+++..++.++.+|+.||.||| +.+++|+||+|+||+++. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 899999999999999998653 36999999999999999999999 999999999999999987 78999999999
Q ss_pred cccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
+..... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||.......... ....
T Consensus 211 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----------~~~~ 277 (400)
T 1nxk_A 211 AKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----------GMKT 277 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC----------SHHH
T ss_pred ccccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH----------HHHH
Confidence 986531 222345678999999999999999999999999999999999999997643222110 0011
Q ss_pred HHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 270 IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
.+........ ......+++++.+||.+||+.||.+|||+.|+++.-+-
T Consensus 278 ~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 278 RIRMGQYEFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp HHHHTCCCCC---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHcCcccCC---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 1111111111 11123457779999999999999999999999986543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=336.43 Aligned_cols=250 Identities=23% Similarity=0.297 Sum_probs=198.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+..|+++++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3468999999999999999999765 5899999999753 33445677889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
||||+++++|.+++.... .+++..+..++.||+.||.||| + .+++|+||+|+||+++.++.++|+|||++....
T Consensus 226 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~- 300 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI- 300 (446)
T ss_dssp EECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC-
T ss_pred EEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceecc-
Confidence 999999999999887654 7999999999999999999999 8 899999999999999999999999999987542
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
..........||+.|+|||++.+..++.++||||||+++|+|++|..||........ .....
T Consensus 301 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----------------~~~i~ 362 (446)
T 4ejn_A 301 -KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----------------FELIL 362 (446)
T ss_dssp -C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHH
T ss_pred -CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-----------------HHHHH
Confidence 112233456799999999999999999999999999999999999999976432111 11111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
.. ....+..+++.+.+||.+||+.||.+|| +++|+++.
T Consensus 363 ~~----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 363 ME----EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HC----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hC----CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11 0111234567799999999999999999 99999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=318.99 Aligned_cols=276 Identities=25% Similarity=0.338 Sum_probs=207.8
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
-.+...++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++.+.+.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 34556789999999999999999999865 489999999865433 234567899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.++||||+++++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEEEEecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 999999999988888765443 6999999999999999999999 999999999999999999999999999999765
Q ss_pred cCCccccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh-cChhHHHHH
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL-LPISVMEIV 271 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~ 271 (335)
... ........++..|+|||++.+. .++.++||||||+++|+|++|..||......+.......... .........
T Consensus 175 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 175 AAP--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cCC--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 321 2223445689999999998875 689999999999999999999999977543322211111100 011111111
Q ss_pred Hhh-h-----ccc---cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 272 DAN-L-----LSR---EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 272 ~~~-~-----~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
... . ... ..........+++.+.+|+.+||+.||.+|||++|+++.=
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 110 0 000 0001111124577899999999999999999999998753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=324.34 Aligned_cols=268 Identities=22% Similarity=0.350 Sum_probs=211.0
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999865 68999999998653 3445778999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCC-CeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~-~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
|+++++|.+++.... .+++..++.++.+++.||.||| +. +++|+||+|+||+++.++.++|+|||++....
T Consensus 112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~---- 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 183 (360)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc----
Confidence 999999999997654 6999999999999999999999 75 89999999999999999999999999987542
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHh-------------------
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWV------------------- 259 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~------------------- 259 (335)
........++..|+|||++.+..++.++||||||+++|+|++|..||..............
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 184 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 1223345789999999999999999999999999999999999999976543322110000
Q ss_pred ------hhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 260 ------SNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 260 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
............+......... .....++.++.+|+.+||+.||.+|||++|+++.-+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0000011112222221111111 112235677999999999999999999999998654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=317.43 Aligned_cols=260 Identities=19% Similarity=0.263 Sum_probs=208.7
Q ss_pred HHHHhhhcCCCCcc-ceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhC-CCCceEEEeeeee
Q 019843 35 YLELFQATDGFSEN-NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSI-RHRNLIKIISTCS 109 (335)
Q Consensus 35 ~~~~~~~~~~y~~~-~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 109 (335)
+.......++|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33445667788888 89999999999999765 58999999987542 33457889999999999 5799999999999
Q ss_pred cCCeeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC---CCcEEEe
Q 019843 110 NDDFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLS 185 (335)
Q Consensus 110 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~---~~~v~l~ 185 (335)
+.+..++||||+++++|.+++... ...+++..++.++.+|+.||.||| +.+++|+||+|+||+++. ++.++|+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999988643 357999999999999999999999 999999999999999987 7899999
Q ss_pred eccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcCh
Q 019843 186 DFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI 265 (335)
Q Consensus 186 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 265 (335)
|||++..... ........+++.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 177 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--------- 244 (327)
T 3lm5_A 177 DFGMSRKIGH---ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN--------- 244 (327)
T ss_dssp CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------
T ss_pred eCccccccCC---ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH---------
Confidence 9999987632 2223345789999999999999999999999999999999999999976432221110
Q ss_pred hHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 266 SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
+.. ............+++.+.+++.+||+.||.+|||++++++.
T Consensus 245 -----i~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 -----ISQ---VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -----HHH---TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -----HHh---cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111 11111112223457779999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.35 Aligned_cols=268 Identities=23% Similarity=0.219 Sum_probs=200.9
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecC----
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSND---- 111 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 111 (335)
+...++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 58 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 355789999999999999999999765 5899999999754 334567788999999999999999999998654
Q ss_pred --CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 112 --DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 112 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
...++||||+++ ++.+.+.. .+++..+..++.||+.||.||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred cCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 467999999965 56666643 4899999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC-----
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP----- 264 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 264 (335)
+.... .........+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+. +.........
T Consensus 211 a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 211 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEF 286 (464)
T ss_dssp C--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHH
T ss_pred eeecC---CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHH
Confidence 98653 22233456789999999999999999999999999999999999999976542221 1111111110
Q ss_pred -----hhHHHHHHhhhc----------cc--cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 265 -----ISVMEIVDANLL----------SR--EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 265 -----~~~~~~~~~~~~----------~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
......+..... .. ...........++++.+|+.+||..||++|||++|+++.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001111110000 00 000111122347789999999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=321.18 Aligned_cols=249 Identities=26% Similarity=0.349 Sum_probs=204.4
Q ss_pred cCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCC---chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCG---GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999986 4689999999975432 3346788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+. |+|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~--- 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--- 205 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS---
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecC---
Confidence 99996 5888888765568999999999999999999999 9999999999999999999999999999997652
Q ss_pred cccccccccccccccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 198 QSKSQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
......+|+.|+|||++. +..++.++||||||+++|+|++|..||......... ..+....
T Consensus 206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------------~~~~~~~ 269 (348)
T 1u5q_A 206 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------------YHIAQNE 269 (348)
T ss_dssp ---SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------------HHHHHSC
T ss_pred ---CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-------------HHHHhcC
Confidence 123457899999999874 567899999999999999999999998764321110 0111110
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
. .......+++.+.+++.+||+.||++|||++++++...
T Consensus 270 ----~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 270 ----S--PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp ----C--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred ----C--CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 0 00112334667999999999999999999999987544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=309.43 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=199.8
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..++|++.+.||+|++|.||.|... +++.|++|++... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4579999999999999999999876 6899999998754 23345688999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
|||++++++|.+++.... .+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 999999999999997654 6899999999999999999999 999999999999999999999999999999865321
Q ss_pred ccccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
.......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||........ ...+....
T Consensus 165 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------------~~~~~~~~ 227 (276)
T 2h6d_A 165 ---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL--------------FKKIRGGV 227 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------------HHHHHHCC
T ss_pred ---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--------------HHHhhcCc
Confidence 22234568899999999987765 6899999999999999999999976432111 11111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...+..++..+.+++.+||+.||.+|||++++++.
T Consensus 228 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 -------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01123346679999999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=330.64 Aligned_cols=273 Identities=21% Similarity=0.241 Sum_probs=189.9
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeec-----C
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN-----D 111 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 111 (335)
...++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+++++.++||||+++++++.. .
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 45689999999999999999999755 6899999998653 23345678899999999999999999999843 3
Q ss_pred CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
..+|+|||++ +++|.+++... ..+++..++.++.||+.||.||| +.+++|+||||+|||++.++.+||+|||++.
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred ceEEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence 6789999998 57999988755 37999999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCccc-------------------------cccccccccccccCcccc-CCCCCCCccchhhHHHHHHHHHh-----
Q 019843 192 LLTGEDQS-------------------------KSQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFT----- 240 (335)
Q Consensus 192 ~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~~l~~ll~----- 240 (335)
........ .......+|..|+|||++ .+..++.++|||||||++|+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 76422111 122345689999999975 56679999999999999999999
Q ss_pred ------CCCCCCcccccc-------------------hhhHhHhhhhcChh-----------HHHHHHhhhccccccchh
Q 019843 241 ------KKKPTDKIFAGE-------------------MTLKYWVSNLLPIS-----------VMEIVDANLLSREDKHFA 284 (335)
Q Consensus 241 ------g~~pf~~~~~~~-------------------~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~ 284 (335)
|.++|.+...-. ..+........... ....+.............
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 556664432100 00000000000000 000000000000000011
Q ss_pred hHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 285 AKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 285 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
....+++++.+||.+||..||++|||++|+++.
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 113347779999999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=325.84 Aligned_cols=271 Identities=21% Similarity=0.305 Sum_probs=196.4
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCC-CCceEEEeeeeecC--Ce
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIR-HRNLIKIISTCSND--DF 113 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~ 113 (335)
...++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.+. ||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34689999999999999999999764 6899999998543 3345567889999999996 99999999999754 47
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
+|+||||++ ++|.+++... .+++..+..++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 899999996 5899988764 5999999999999999999999 999999999999999999999999999999865
Q ss_pred cCCc-------------------cccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccch
Q 019843 194 TGED-------------------QSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEM 253 (335)
Q Consensus 194 ~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~ 253 (335)
.... .........+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3211 0112234579999999999876 6789999999999999999999999976543222
Q ss_pred hhHhHhhhhcChhHH-----------HHHHhhhc------cccccch----------hhHHHHHHHHHHHHHHhchhccc
Q 019843 254 TLKYWVSNLLPISVM-----------EIVDANLL------SREDKHF----------AAKEQCVSFVFNLAMECTVESAE 306 (335)
Q Consensus 254 ~~~~~~~~~~~~~~~-----------~~~~~~~~------~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~ 306 (335)
+............. ..+..... ......+ .....+++++.+|+.+||..||.
T Consensus 240 -~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 240 -LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp -HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred -HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 11111111100000 00000000 0000000 00114567799999999999999
Q ss_pred cCCCHHHHHHH
Q 019843 307 QRINAKEIVTR 317 (335)
Q Consensus 307 ~Rps~~ell~~ 317 (335)
+|||++|+++.
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=319.64 Aligned_cols=265 Identities=22% Similarity=0.258 Sum_probs=196.6
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeee-----
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCS----- 109 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----- 109 (335)
.+.....+|++.+.||+|+||.||+|.+. +++.||+|++..........+.+|+.++..+. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 34444568999999999999999999864 68999999987766666778999999999995 999999999983
Q ss_pred ---cCCeeEEEEEecCCCChHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhccCCCC--eEecCCCCCCEEECCCCcE
Q 019843 110 ---NDDFKALVLEYMPHGSLEKCLYS--SNCVLDIFQRLNIMIDVAAALEYLHFGYSAP--VIHCDLKPSNVLLDDNMVA 182 (335)
Q Consensus 110 ---~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~--i~h~di~p~Nilv~~~~~v 182 (335)
....+++++||++ ++|.+++.. ....+++..++.++.+|+.||.||| +.+ ++|+||+|+||+++.++.+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCE
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCE
Confidence 4456889999995 689888864 3457999999999999999999999 888 9999999999999999999
Q ss_pred EEeeccccccccCCccc----------cccccccccccccCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCccc
Q 019843 183 HLSDFGIAKLLTGEDQS----------KSQTQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMETFTKKKPTDKIF 249 (335)
Q Consensus 183 ~l~dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~---~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~ 249 (335)
+|+|||++......... .......+++.|+|||++ .+..++.++||||||+++|+|++|..||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999999876422111 111234589999999998 56678899999999999999999999986532
Q ss_pred ccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccc
Q 019843 250 AGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328 (335)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 328 (335)
... ....... .......+..+.+++.+||+.||.+|||+.|+++.|+.+.......
T Consensus 258 ~~~-----------------~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 258 KLR-----------------IVNGKYS------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp -------------------------CC------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred HHH-----------------hhcCccc------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 211 1111110 1111222344899999999999999999999999999998765443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=315.99 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=203.2
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc--CCc--EEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ--DGM--EVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD 112 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~--~~~--~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 112 (335)
...++|++.+.||+|+||.||+|.+. +++ .|++|++... .....+.+.+|+++++.++||||+++++++....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 34578999999999999999999753 233 6899998754 3345678899999999999999999999998765
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
.++|+|++++++|.+++......+++..++.++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 78999999999999999876667999999999999999999999 99999999999999999999999999999987
Q ss_pred ccCCccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 193 LTGEDQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 193 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------------- 233 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----------------- 233 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----------------
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH-----------------
Confidence 6422211 12234457778999999988889999999999999999999 9999976432211
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
...... .......+..+++.+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 234 ~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 234 LHKIDK--EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHT--SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHc--cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 111100 011112234567789999999999999999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=343.25 Aligned_cols=263 Identities=24% Similarity=0.399 Sum_probs=211.0
Q ss_pred CCCCccc-eeeecCceEEEEEEEc---CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 43 DGFSENN-LIGRGSFGSVYKARIQ---DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 43 ~~y~~~~-~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....+.+.+|+++++.++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 8999999999999754 46679999997653 3456789999999999999999999999976 568999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+++++|.+++......+++..++.++.||+.||.||| +++++|+||+|+||+++.++.+||+|||++..+....
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999999877668999999999999999999999 9999999999999999999999999999998653221
Q ss_pred c-ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 198 Q-SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 198 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
. ........++..|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+...
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--------------~~~i~~~- 555 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--------------MAFIEQG- 555 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH--------------HHHHHTT-
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--------------HHHHHcC-
Confidence 1 111222345678999999998899999999999999999998 9999976543211 1112111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcccc
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICT 329 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 329 (335)
.+...+..+++.+.++|.+||+.||.+||++.+|++.|+.+..++....
T Consensus 556 -----~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 556 -----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred -----CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 1222344577889999999999999999999999999999887766544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=319.40 Aligned_cols=275 Identities=23% Similarity=0.295 Sum_probs=202.0
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-----chhHHHHHHHHHHHhCCCCceEEEeeeeec
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-----GVFKSFDVECEVMKSIRHRNLIKIISTCSN 110 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 110 (335)
++....++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+++++.++||||+++++++.+
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 34556789999999999999999999865 589999999875321 223578899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
.+..++||||+++ +|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999999975 899988877667999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCccccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
..+... ........+|+.|+|||++.+. .++.++||||||+++|+|++|.+||........... ............
T Consensus 160 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~-i~~~~~~~~~~~ 236 (346)
T 1ua2_A 160 KSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR-IFETLGTPTEEQ 236 (346)
T ss_dssp STTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCTTT
T ss_pred eeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHcCCCChhh
Confidence 866322 2233446789999999998764 588999999999999999999999876543222111 111100000000
Q ss_pred HHHhhhcc-----ccccc---hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 270 IVDANLLS-----REDKH---FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 270 ~~~~~~~~-----~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
+-+..... ..... ......+++.+.+||.+||+.||.+|||++|+++.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00000000 00000 001134567799999999999999999999998753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=318.90 Aligned_cols=273 Identities=22% Similarity=0.283 Sum_probs=197.3
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
......++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+.
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 34556679999999999999999999754 68999999987543 2234567899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC-----CCCcEEEeecc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-----DNMVAHLSDFG 188 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~-----~~~~v~l~dfg 188 (335)
.++||||+++ +|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++ .++.++|+|||
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEEEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999999974 9999887665 6999999999999999999999 99999999999999994 55569999999
Q ss_pred ccccccCCccccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh-
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS- 266 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~- 266 (335)
++..+.. .........+|..|+|||++.+. .++.++||||||+++|+|++|..||..................+..
T Consensus 183 ~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 183 LARAFGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CccccCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 9986531 12233445679999999998874 4899999999999999999999999765432221111100000000
Q ss_pred -HHHHH---Hh--hh--ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 267 -VMEIV---DA--NL--LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 267 -~~~~~---~~--~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..... +. .. .............+++++.+||.+||+.||.+|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 00 00 00000011112235677999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=319.05 Aligned_cols=252 Identities=20% Similarity=0.293 Sum_probs=209.6
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
...++|.+.+.||+|+||.||+|... +++.|++|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 44578999999999999999999865 47899999987542 234577889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||+++++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 118 lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999999887643 7999999999999999999999 99999999999999999999999999999986532
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
. ........++..|+|||++.+..++.++||||||+++|+|++|..||......+... .+. ..
T Consensus 194 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------------~~~-~~- 256 (335)
T 2owb_A 194 D--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-------------RIK-KN- 256 (335)
T ss_dssp T--TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------------HHH-HT-
T ss_pred C--cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------------HHh-cC-
Confidence 1 222344568999999999998889999999999999999999999997643211110 011 10
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 318 (335)
....+..+++.+.+++.+||+.||++|||++|+++.-
T Consensus 257 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 257 ------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 0111234466799999999999999999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=342.33 Aligned_cols=265 Identities=25% Similarity=0.405 Sum_probs=217.2
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
......++|++.+.||+|+||.||+|.+..+..||||++..... ..+.+.+|+++++.++|+||+++++++.+ +..++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 33445678999999999999999999988778899999976543 34789999999999999999999999876 67899
Q ss_pred EEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 117 VLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
||||+++++|.+++... ...+++..++.++.||+.||.||| +++++|+||+|+|||++.++.+||+|||++.....
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999999999753 346899999999999999999999 99999999999999999999999999999986532
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
.. ........++..|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+...
T Consensus 416 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~--------------~~~i~~~ 480 (535)
T 2h8h_A 416 NE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERG 480 (535)
T ss_dssp HH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH--------------HHHHHTT
T ss_pred Cc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcC
Confidence 11 112233456788999999988899999999999999999999 9999876432111 1111111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
.+...+..+++.+.+||.+||+.||++|||+++|++.|+.+.....-
T Consensus 481 ------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 481 ------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 11222345677899999999999999999999999999988665443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=317.86 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=203.6
Q ss_pred ccccccCHHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEe
Q 019843 28 ATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKII 105 (335)
Q Consensus 28 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 105 (335)
.....+...+.....++|++.+.||.|+||.||+|... +++.||+|++..... ....+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp -------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred CcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeee
Confidence 34455666677778899999999999999999999864 689999999875533 347888999999999 799999999
Q ss_pred eeeec------CCeeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC
Q 019843 106 STCSN------DDFKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD 178 (335)
Q Consensus 106 ~~~~~------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~ 178 (335)
+++.. .+..++||||+++++|.+++... ...+++..++.++.+|+.||.||| +.+++|+||+|+||+++.
T Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~ 164 (326)
T 2x7f_A 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTE 164 (326)
T ss_dssp EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECT
T ss_pred eEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcC
Confidence 99876 56889999999999999999864 347999999999999999999999 999999999999999999
Q ss_pred CCcEEEeeccccccccCCccccccccccccccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCcccccch
Q 019843 179 NMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEM 253 (335)
Q Consensus 179 ~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~ 253 (335)
++.++|+|||++..... .........++..|+|||++. +..++.++||||||+++|+|++|..||........
T Consensus 165 ~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 242 (326)
T 2x7f_A 165 NAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242 (326)
T ss_dssp TCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCCEEEeeCcCceecCc--CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH
Confidence 99999999999876531 112233456899999999986 55688999999999999999999999865432111
Q ss_pred hhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 254 TLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.. .+.... . . ......+++.+.++|.+||..||.+||++.++++.
T Consensus 243 ~~-------------~~~~~~-~----~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 243 LF-------------LIPRNP-A----P-RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HH-------------HHHHSC-C----C-CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HH-------------HhhcCc-c----c-cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000 0 0 00122346679999999999999999999999873
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=320.55 Aligned_cols=257 Identities=16% Similarity=0.152 Sum_probs=209.8
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEE------EcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC---CCceEEEeee
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKAR------IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR---HRNLIKIIST 107 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~------~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~ 107 (335)
+.....++|.+.+.||+|+||.||+|. ..+++.||+|++.... ...+..|.++++.++ |+||+.++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 334456789999999999999999993 4468899999987543 356777888888886 9999999999
Q ss_pred eecCCeeEEEEEecCCCChHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC-----
Q 019843 108 CSNDDFKALVLEYMPHGSLEKCLYS----SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD----- 178 (335)
Q Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~----- 178 (335)
+...+..++||||+++++|.+++.. ....+++..++.++.||+.||.||| +.+++|+||||+||+++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999974 3457999999999999999999999 999999999999999998
Q ss_pred ------CCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccc
Q 019843 179 ------NMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252 (335)
Q Consensus 179 ------~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~ 252 (335)
++.+||+|||++..+.............||..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999976532233334455679999999999999999999999999999999999999986543322
Q ss_pred hhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccC-CCHHHHHHHHHHHHhh
Q 019843 253 MTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQR-INAKEIVTRLLKIRDS 324 (335)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-ps~~ell~~L~~~~~~ 324 (335)
.... ...... ..++.+.+++.+||+.+|.+| |++.++.+.|+++...
T Consensus 293 ~~~~---------------------~~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 CKPE---------------------GLFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp EEEC---------------------SCCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred eeec---------------------hhcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 2110 000111 114458899999999999999 6888888888877544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=325.71 Aligned_cols=254 Identities=22% Similarity=0.276 Sum_probs=195.8
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--------CchhHHHHHHHHHHHhCCCCceEEEeeeeec
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--------GGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 110 (335)
...++|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45689999999999999999999765 58999999987532 1223357899999999999999999999865
Q ss_pred CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC---cEEEeec
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDF 187 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~---~v~l~df 187 (335)
+..++||||+++++|.+++.... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++ .+||+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence 45789999999999999887554 7999999999999999999999 99999999999999997544 5999999
Q ss_pred cccccccCCccccccccccccccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP 264 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 264 (335)
|++.... .........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...........
T Consensus 287 G~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~-------- 355 (419)
T 3i6u_A 287 GHSKILG---ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD-------- 355 (419)
T ss_dssp STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH--------
T ss_pred ccceecC---CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH--------
Confidence 9998763 2223344678999999999853 5678899999999999999999999976433222111
Q ss_pred hhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 265 ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.+.... ..........+++.+.+++.+||+.||.+|||++|+++.
T Consensus 356 -----~i~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 356 -----QITSGK---YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -----HHHTTC---CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----HHhcCC---CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111111 111111223457779999999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=316.17 Aligned_cols=272 Identities=21% Similarity=0.322 Sum_probs=204.3
Q ss_pred cCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeec--------
Q 019843 42 TDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSN-------- 110 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 110 (335)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 47899999999999999999987 468999999986543 2334678899999999999999999999876
Q ss_pred CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
.+..++||||+++ +|.+.+......+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4568999999965 888888776667999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCc--cccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHh--hhhcCh
Q 019843 191 KLLTGED--QSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWV--SNLLPI 265 (335)
Q Consensus 191 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~--~~~~~~ 265 (335)
..+.... .........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.............. ....+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 8764221 1223344578999999998876 4579999999999999999999999986543222111100 000000
Q ss_pred hHHH-----HHHhhhcccc-ccch---hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 266 SVME-----IVDANLLSRE-DKHF---AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 266 ~~~~-----~~~~~~~~~~-~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.... ..+....... .... ......++.+.+||.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000 0000000000 0000 0001125668999999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=307.62 Aligned_cols=256 Identities=21% Similarity=0.293 Sum_probs=208.7
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
......++|++.+.||+|++|.||+|... +++.|++|++.... ......+.+|+++++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 45566789999999999999999999875 68999999987542 3456789999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC---CcEEEeecccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIA 190 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~---~~v~l~dfg~~ 190 (335)
.++|+|++++++|.+.+.... .+++..++.++.+|+.||.+|| +.+++|+||+|+||+++.+ +.++|+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999999887544 6999999999999999999999 9999999999999999754 46999999998
Q ss_pred ccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
..... ........++..|+|||.+.+ .++.++||||||+++|+|++|..||........ ...
T Consensus 172 ~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------------~~~ 233 (287)
T 2wei_A 172 TCFQQ---NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI--------------LKR 233 (287)
T ss_dssp GTBCC---CSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------------HHH
T ss_pred eeecC---CCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH--------------HHH
Confidence 86532 122234458889999999876 489999999999999999999999976432111 011
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
+.. .......+....+++.+.+++.+||+.||.+|||+.|+++.
T Consensus 234 ~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 234 VET---GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHH---CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHc---CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 111 11111122224557789999999999999999999999984
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=314.83 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=205.6
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeee--cCCeeE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCS--NDDFKA 115 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~ 115 (335)
..++|++.+.||+|+||.||+|... +++.|++|++.... ....+.+.+|+++++.++||||+++++++. .....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 3578999999999999999999875 58999999997543 334567899999999999999999999874 467899
Q ss_pred EEEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCC-----eEecCCCCCCEEECCCCcEEEeec
Q 019843 116 LVLEYMPHGSLEKCLYSS---NCVLDIFQRLNIMIDVAAALEYLHFGYSAP-----VIHCDLKPSNVLLDDNMVAHLSDF 187 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~-----i~h~di~p~Nilv~~~~~v~l~df 187 (335)
+||||+++++|.+++... ...+++..++.++.+++.||.||| +.+ ++|+||+|+||+++.++.++|+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 999999999999998753 335999999999999999999999 888 999999999999999999999999
Q ss_pred cccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhH
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
|++...... ........++..|+|||.+.+..++.++||||||+++|+|++|..||........
T Consensus 161 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------- 224 (279)
T 2w5a_A 161 GLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------------- 224 (279)
T ss_dssp CHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------------
T ss_pred chheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH--------------
Confidence 999865321 1122345689999999999988899999999999999999999999976532111
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...+...... ..+..+++.+.+++.+||+.||.+|||+.|+++.++
T Consensus 225 ~~~i~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 225 AGKIREGKFR------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHTCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHhhcccc------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1111111111 112345677999999999999999999999998665
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=320.45 Aligned_cols=268 Identities=22% Similarity=0.282 Sum_probs=191.7
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecC--
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSND-- 111 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 111 (335)
..+...++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+++++.++||||+++++++...
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 23 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp EEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 45667799999999999999999999754 6899999998654 233456788999999999999999999998654
Q ss_pred ----CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeec
Q 019843 112 ----DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 187 (335)
Q Consensus 112 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~df 187 (335)
...++|++++ +++|.+++... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+||
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred cccCCeEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeec
Confidence 5679999998 78999988753 5999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc---
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL--- 263 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--- 263 (335)
|++.... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..||........ +........
T Consensus 177 G~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~ 250 (367)
T 2fst_X 177 GLARHTA-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPG 250 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCC
T ss_pred ccccccc-----ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCC
Confidence 9998642 22344678999999999877 6789999999999999999999999976543211 111111111
Q ss_pred --------ChhHHHHHHhhhccccccch-hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 264 --------PISVMEIVDANLLSREDKHF-AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 264 --------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.......+... .......+ .....+++.+.+|+.+||..||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTS-CCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhcc-CCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 11111111111 11111111 1112346779999999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=309.08 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=201.4
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
++|.....||+|+||.||+|.+. +++.|++|++........+.+.+|+.+++.++||||+++++++...+..++|||++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 45666679999999999999864 58899999998776666788999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC-CCcEEEeeccccccccCCcc
Q 019843 122 PHGSLEKCLYSSN--CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 122 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~-~~~v~l~dfg~~~~~~~~~~ 198 (335)
++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++. ++.++|+|||++......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~-- 176 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-- 176 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence 9999999998653 25678999999999999999999 999999999999999987 899999999999865321
Q ss_pred ccccccccccccccCccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
........++..|+|||++.+.. ++.++||||||+++|+|++|..||.......... ......
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---------------~~~~~~ 241 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---------------FKVGMF 241 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---------------HHHHHH
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---------------Hhhccc
Confidence 22233456899999999987643 7889999999999999999999997543221111 000000
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
. .....+..+++.+.+++.+||+.||++|||++++++
T Consensus 242 ~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 242 K---VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp C---CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred c---ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 011112345677999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.38 Aligned_cols=267 Identities=19% Similarity=0.221 Sum_probs=214.7
Q ss_pred hcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCC-CceEEEeeeeecCCeeEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRH-RNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 118 (335)
..++|++.+.||+|+||.||+|.+ .+++.||||++...... ..+..|+++++.+.| +++..+..++...+..++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 468999999999999999999986 46899999998755432 457889999999976 56666777777888999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE---CCCCcEEEeeccccccccC
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv---~~~~~v~l~dfg~~~~~~~ 195 (335)
||+ +++|.+++......+++..++.++.||+.||.||| +.+++|+||||+|||+ +.++.+||+|||++..+..
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999 99999999876668999999999999999999999 9999999999999999 5888999999999987643
Q ss_pred Cccc-----cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 196 EDQS-----KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 196 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
.... .......+|..|+|||++.+..++.++|||||||++|+|++|..||........... ...+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~----------~~~i 228 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK----------YEKI 228 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH----------HHHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH----------HHHH
Confidence 2221 122356799999999999999999999999999999999999999987543222111 0111
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
...... .........+++++.+++.+||+.||++||++.+|++.|+++.....
T Consensus 229 ~~~~~~---~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 229 SEKKVA---TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HHHHHH---SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hhcccc---ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 111110 00111123557789999999999999999999999999998876543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=316.11 Aligned_cols=269 Identities=22% Similarity=0.206 Sum_probs=198.7
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC----
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD---- 112 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 112 (335)
...++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 45689999999999999999999765 58899999997542 334567889999999999999999999987654
Q ss_pred --eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 113 --FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 113 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ccceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999965 78887752 4899999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc-------
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL------- 263 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~------- 263 (335)
..... ........+|..|+|||++.+..++.++||||||+++|+|++|..||........ .........
T Consensus 175 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 175 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFM 250 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHH
T ss_pred ccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHH
Confidence 86531 2223346789999999999999999999999999999999999999976543221 111111100
Q ss_pred ---ChhHHHHHHhhh----------cc--ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 264 ---PISVMEIVDANL----------LS--REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 264 ---~~~~~~~~~~~~----------~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
............ .. ............++.+.+|+.+||..||.+|||++|+++.=.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 000001110000 00 000111123345778999999999999999999999998543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=333.66 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=209.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..++|.+.+.||+|+||.||+|... +|+.||+|++... .......+.+|+++++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999865 6899999998643 23344678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 117 VLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
||||++|++|.+++.... ..+++..++.++.+|+.||.||| +.+++|+||+|+||+++.+|.+||+|||++..+..
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999987643 35999999999999999999999 99999999999999999999999999999987632
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
. .......||+.|+|||++.+..++.++|+|||||++|+|++|..||.......... .....+....
T Consensus 339 ~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~----------~i~~~i~~~~ 405 (576)
T 2acx_A 339 G---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE----------EVERLVKEVP 405 (576)
T ss_dssp T---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH----------HHHHHHHHCC
T ss_pred C---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH----------HHHHHhhccc
Confidence 2 22234579999999999999999999999999999999999999997643221110 0111111110
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
...+..+++++.+||.+||+.||.+|| +++|+++.
T Consensus 406 -------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 -------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 011234577799999999999999999 78888864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=328.24 Aligned_cols=250 Identities=16% Similarity=0.161 Sum_probs=195.4
Q ss_pred cCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecC---CCchhHHHHHHHH---HHHhCCCCceEEEe-------ee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQ---CGGVFKSFDVECE---VMKSIRHRNLIKII-------ST 107 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~i~~~~-------~~ 107 (335)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47899999999999999999985 46899999999743 3445678889995 45555799999988 55
Q ss_pred eecCC-----------------eeEEEEEecCCCChHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHhccCCCCe
Q 019843 108 CSNDD-----------------FKALVLEYMPHGSLEKCLYSSN------CVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164 (335)
Q Consensus 108 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i 164 (335)
+...+ ..++||||+ +|+|.+++.... ..+++..++.++.||+.||.||| +.++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 55443 378999999 679999997542 12335888899999999999999 9999
Q ss_pred EecCCCCCCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCC-----------CCCCccchhhHHH
Q 019843 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG-----------RVSTNGDVYSFGI 233 (335)
Q Consensus 165 ~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~sDiwslG~ 233 (335)
+|+||||+||+++.++.+||+|||++.... .......| ..|+|||++.+. .++.++||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999998542 22334456 899999999877 7999999999999
Q ss_pred HHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHH
Q 019843 234 MLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKE 313 (335)
Q Consensus 234 ~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 313 (335)
++|+|++|..||........... . .. ....+++.+.+||.+||+.||.+|||+.|
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~-----------------~-~~-------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEW-----------------I-FR-------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHHHHHSSCCC------CCSGG-----------------G-GS-------SCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred HHHHHHHCCCCCcccccccchhh-----------------h-hh-------hccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 99999999999976432211100 0 00 01234667999999999999999999999
Q ss_pred HHH--HHHHHHhhhc
Q 019843 314 IVT--RLLKIRDSLL 326 (335)
Q Consensus 314 ll~--~L~~~~~~~~ 326 (335)
+++ .++.+++.+.
T Consensus 357 ~l~hp~f~~~~~~~~ 371 (377)
T 3byv_A 357 AMETPEYEQLRTELS 371 (377)
T ss_dssp HHTSHHHHHHHHHHH
T ss_pred HhhChHHHHHHHHHH
Confidence 997 5556655543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=307.55 Aligned_cols=245 Identities=20% Similarity=0.267 Sum_probs=200.2
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 116 (335)
..++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999875 6899999998754 234456788899999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-------------
Q 019843 117 VLEYMPHGSLEKCLYSS---NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM------------- 180 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~------------- 180 (335)
||||+++++|.+++... ...+++..++.++.||+.||.||| +.+++|+||+|+||+++.++
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999754 246899999999999999999999 99999999999999998444
Q ss_pred ------cEEEeeccccccccCCccccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccch
Q 019843 181 ------VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEM 253 (335)
Q Consensus 181 ------~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~ 253 (335)
.++|+|||.+..... .....++..|+|||++.+. .++.++||||||+++|+|++|.+|+.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred ccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 799999999986532 2234589999999998765 566899999999999999999887643211
Q ss_pred hhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 254 TLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...+.. .... ..+..+++.+.+++.+||+.||.+|||+.|+++.
T Consensus 237 -------------~~~~~~-~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -------------WHEIRQ-GRLP------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -------------HHHHHT-TCCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------------HHHHHc-CCCC------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 011111 1111 1123456779999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=330.55 Aligned_cols=253 Identities=22% Similarity=0.303 Sum_probs=207.5
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
.++|.+.+.||+|+||.||+|..+ +|+.||+|++... .......+..|+++++.++||||+++++++.+.+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 368999999999999999999875 5899999999643 223456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 118 LEYMPHGSLEKCLYSS---NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
|||++|++|.+++... ...+++..++.++.||+.||.||| +.+++|+||||+||+++.+|.+||+|||++..+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999998753 346999999999999999999999 9999999999999999999999999999998763
Q ss_pred CCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
.. ........||+.|+|||++.+..++.++|+|||||++|+|++|..||......... ..+....
T Consensus 341 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-------------~~~~~~i 405 (543)
T 3c4z_A 341 AG--QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-------------KELKQRV 405 (543)
T ss_dssp TT--CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-------------HHHHHHH
T ss_pred CC--CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-------------HHHHHHH
Confidence 22 12233457999999999999999999999999999999999999999764321111 1111111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCH-----HHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINA-----KEIVT 316 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~ 316 (335)
... ....+..+++.+.+||.+||+.||.+||++ +++++
T Consensus 406 ~~~----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 406 LEQ----AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHC----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred hhc----ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 110 111124557789999999999999999965 66664
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=320.59 Aligned_cols=277 Identities=20% Similarity=0.301 Sum_probs=208.8
Q ss_pred ccccCHHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeee
Q 019843 30 WRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIIST 107 (335)
Q Consensus 30 ~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 107 (335)
.......+.....++|++.+.||+|+||.||+|..+. .+++|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 20 ~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 97 (319)
T 2y4i_B 20 QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97 (319)
T ss_dssp --CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred ccccccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 3334445555667899999999999999999998763 49999987542 3344667889999999999999999999
Q ss_pred eecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeec
Q 019843 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 187 (335)
Q Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~df 187 (335)
+.+.+..++|+||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++ ++.++|+||
T Consensus 98 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 98 CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp EECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCC
T ss_pred EecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeec
Confidence 99999999999999999999999877667999999999999999999999 99999999999999998 679999999
Q ss_pred cccccccCCc---cccccccccccccccCccccCC---------CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhh
Q 019843 188 GIAKLLTGED---QSKSQTQTLATIGYMAPEYGRE---------GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTL 255 (335)
Q Consensus 188 g~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~ 255 (335)
|++....... .........++..|+|||++.+ ..++.++||||||+++|+|++|..||..........
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 253 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW 253 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9987542111 1122334458899999998864 347889999999999999999999997643221110
Q ss_pred HhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcccccc
Q 019843 256 KYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLICTRE 331 (335)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 331 (335)
.+....... .....++..+.+++.+||+.||.+|||+.++++.|+++..+....+..
T Consensus 254 --------------~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~ 310 (319)
T 2y4i_B 254 --------------QMGTGMKPN-----LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310 (319)
T ss_dssp --------------HHHTTCCCC-----CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------
T ss_pred --------------HhccCCCCC-----CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCC
Confidence 011100000 001134556999999999999999999999999999998776665544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=317.68 Aligned_cols=265 Identities=20% Similarity=0.283 Sum_probs=206.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCc-----------------hhHHHHHHHHHHHhCCCCceEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGG-----------------VFKSFDVECEVMKSIRHRNLIK 103 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~~i~~ 103 (335)
..++|++.+.||+|+||.||+|.. +++.||+|++...... ....+.+|+.+++.++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999999988 7999999998744211 1178999999999999999999
Q ss_pred EeeeeecCCeeEEEEEecCCCChHHH------HhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEE
Q 019843 104 IISTCSNDDFKALVLEYMPHGSLEKC------LYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVL 175 (335)
Q Consensus 104 ~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nil 175 (335)
+++++.+.+..++||||+++++|.++ +... ...+++..++.++.+++.||.||| + .+++|+||+|+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence 99999999999999999999999998 5542 457999999999999999999999 8 99999999999999
Q ss_pred ECCCCcEEEeeccccccccCCccccccccccccccccCccccCCC-CCCC-ccchhhHHHHHHHHHhCCCCCCcccccch
Q 019843 176 LDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG-RVST-NGDVYSFGIMLMETFTKKKPTDKIFAGEM 253 (335)
Q Consensus 176 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~sDiwslG~~l~~ll~g~~pf~~~~~~~~ 253 (335)
++.++.++|+|||.+..... .......++..|+|||++.+. .++. ++||||||+++|+|++|..||........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 99999999999999987532 234456789999999999887 5666 99999999999999999999986543221
Q ss_pred hhHhHhhhhcChh--HHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 254 TLKYWVSNLLPIS--VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 254 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..........+.. ....... . ...........+++.+.+++.+||+.||.+|||+.|+++
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYP-L--TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTT-T--CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCcCCccchhhhhcc-c--cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111000000 0000000 0 000000111445778999999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=317.70 Aligned_cols=271 Identities=20% Similarity=0.235 Sum_probs=205.1
Q ss_pred HHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecC
Q 019843 35 YLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSND 111 (335)
Q Consensus 35 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 111 (335)
........++|.+.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 34 ~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 34 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp TTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred ccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 3344557789999999999999999999765 58999999987543 23457788999999999999999999999877
Q ss_pred Cee------EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEe
Q 019843 112 DFK------ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 185 (335)
Q Consensus 112 ~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~ 185 (335)
+.. ++||||++ ++|.+++.. .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.++|+
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~ 186 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKIL 186 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred CCcccceeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEE
Confidence 654 99999996 588877642 4899999999999999999999 9999999999999999999999999
Q ss_pred eccccccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHh-----
Q 019843 186 DFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWV----- 259 (335)
Q Consensus 186 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~----- 259 (335)
|||++.... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......+.......
T Consensus 187 Dfg~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 187 DFGLARHAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 261 (371)
T ss_dssp STTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecCcccccc-----cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999998652 22334568999999999877 6789999999999999999999999986543222111100
Q ss_pred -----hhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 260 -----SNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 260 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.............................+++.+.+||.+||+.||.+|||++|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0001111111111111111111111123457789999999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=311.98 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=199.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--------CchhHHHHHHHHHHHhCCCCceEEEeeeeecC
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--------GGVFKSFDVECEVMKSIRHRNLIKIISTCSND 111 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 111 (335)
..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4578999999999999999999765 58899999986432 12234578999999999999999999998776
Q ss_pred CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc---EEEeecc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFG 188 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~---v~l~dfg 188 (335)
+ .++||||+++++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++. ++|+|||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 5 789999999999999887543 7999999999999999999999 999999999999999987664 9999999
Q ss_pred ccccccCCccccccccccccccccCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcCh
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI 265 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 265 (335)
++..... ........++..|+|||++ .+..++.++||||||+++|+|++|..||..........
T Consensus 163 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---------- 229 (322)
T 2ycf_A 163 HSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---------- 229 (322)
T ss_dssp TCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH----------
T ss_pred cceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH----------
Confidence 9986532 1222345689999999986 35678999999999999999999999997643322111
Q ss_pred hHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 266 SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..+..... .........+++.+.+++.+||+.||++|||+.++++
T Consensus 230 ---~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 230 ---DQITSGKY---NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---HHHHHTCC---CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHhCcc---ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11111100 0111112345677999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=307.91 Aligned_cols=254 Identities=20% Similarity=0.298 Sum_probs=202.1
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC----CchhHHHHHHHHHHHhCCCCceEEEeeee--ecCCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC----GGVFKSFDVECEVMKSIRHRNLIKIISTC--SNDDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 113 (335)
..++|++.+.||+|+||.||+|... +++.|++|++.... ......+.+|+++++.++||||+++++++ .+.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4589999999999999999999864 58899999986432 34457899999999999999999999998 45568
Q ss_pred eEEEEEecCCCChHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 114 KALVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
.++||||++++ |.+++.. ....+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999776 7676654 3457999999999999999999999 99999999999999999999999999999987
Q ss_pred ccCCccccccccccccccccCccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
..............++..|+|||++.+.. ++.++||||||+++|+|++|..||........ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~ 224 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL--------------FEN 224 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------------HHH
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH--------------HHH
Confidence 64333333334566899999999987654 37799999999999999999999976432111 111
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
+.... ...+..+++.+.+++.+||+.||.+|||++|+++.-.
T Consensus 225 i~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 225 IGKGS-------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp HHHCC-------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred HhcCC-------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 11111 1112345677999999999999999999999997643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=319.59 Aligned_cols=266 Identities=21% Similarity=0.217 Sum_probs=202.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCC--------CCceEEEeeeee--
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR--------HRNLIKIISTCS-- 109 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~-- 109 (335)
..++|++.+.||+|+||.||+|... +++.||+|++... ......+.+|+++++.+. |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 3589999999999999999999764 5889999998743 334567889999999885 788999999987
Q ss_pred --cCCeeEEEEEecCCCChHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhccCCC-CeEecCCCCCCEEECCCC-----
Q 019843 110 --NDDFKALVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFGYSA-PVIHCDLKPSNVLLDDNM----- 180 (335)
Q Consensus 110 --~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~-~i~h~di~p~Nilv~~~~----- 180 (335)
.....++|||++ ++++.+.+.. ....+++..++.++.||+.||.||| ++ +++|+||||+||+++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhh
Confidence 567899999999 5566665554 3357999999999999999999999 88 999999999999999776
Q ss_pred --------------------------------------------cEEEeeccccccccCCccccccccccccccccCccc
Q 019843 181 --------------------------------------------VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY 216 (335)
Q Consensus 181 --------------------------------------------~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 216 (335)
.++|+|||++.... .......+|..|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~-----~~~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-----KHFTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT-----BCSCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc-----ccCccCCCCCcccCChh
Confidence 79999999998653 22344578999999999
Q ss_pred cCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchh-----hHhHhhhhcChhHHHHHHhhhc---------------
Q 019843 217 GREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMT-----LKYWVSNLLPISVMEIVDANLL--------------- 276 (335)
Q Consensus 217 ~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~--------------- 276 (335)
+.+..++.++|||||||++|+|++|..||......... ...............+......
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99989999999999999999999999999765432211 1111111111000000000000
Q ss_pred -------cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 277 -------SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 277 -------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.........+...++.+.+||.+||+.||++|||++|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000111223456788999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=319.23 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=205.3
Q ss_pred CCCCccceeeecCceEEEEEEE----cCCcEEEEEEeecCC----CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCe
Q 019843 43 DGFSENNLIGRGSFGSVYKARI----QDGMEVAVKVFHLQC----GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDF 113 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~----~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 113 (335)
++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+..|+++++.+ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6899999999999999999986 368999999986432 23346677899999999 79999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.++||||+++++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 999999999999999997654 6999999999999999999999 999999999999999999999999999999865
Q ss_pred cCCccccccccccccccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
.... ........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......... ..+.
T Consensus 210 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------------~~~~ 275 (355)
T 1vzo_A 210 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-------------AEIS 275 (355)
T ss_dssp CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-------------HHHH
T ss_pred ccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-------------HHHH
Confidence 3221 222334578999999999886 34789999999999999999999999754322111 1111
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTRLL 319 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~L~ 319 (335)
....... ...+..++..+.+||.+||..||.+|| +++|+++...
T Consensus 276 ~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 276 RRILKSE----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp HHHHHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred HHHhccC----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 1111111 111234567799999999999999999 9999988654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=315.47 Aligned_cols=272 Identities=23% Similarity=0.297 Sum_probs=202.7
Q ss_pred hhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec--------
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN-------- 110 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 110 (335)
...++|++.+.||+|+||.||+|.. .+|+.||+|++..+... ..+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4568999999999999999999976 46899999998754322 2369999999999999999999843
Q ss_pred ------------------------------CCeeEEEEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 019843 111 ------------------------------DDFKALVLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLH 157 (335)
Q Consensus 111 ------------------------------~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh 157 (335)
....++||||++ ++|.+.+.. ....+++..++.++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345889999997 487777653 3457999999999999999999999
Q ss_pred ccCCCCeEecCCCCCCEEEC-CCCcEEEeeccccccccCCccccccccccccccccCccccCCC-CCCCccchhhHHHHH
Q 019843 158 FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIML 235 (335)
Q Consensus 158 ~~~~~~i~h~di~p~Nilv~-~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l 235 (335)
+.+++|+||+|+||+++ .++.++|+|||++..+.. ........++..|+|||++.+. .++.++||||+||++
T Consensus 159 ---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 ---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp ---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred ---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999997 688999999999986632 2233445679999999988765 489999999999999
Q ss_pred HHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh------cc---ccccchhhHHHHHHHHHHHHHHhchhccc
Q 019843 236 METFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL------LS---REDKHFAAKEQCVSFVFNLAMECTVESAE 306 (335)
Q Consensus 236 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 306 (335)
|+|++|..||......+. ...............+..... .. ...-....+..+++++.+|+.+||+.||.
T Consensus 233 ~ell~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999987543222 222222111111111111100 00 00001112234577799999999999999
Q ss_pred cCCCHHHHHHH--HHHHHh
Q 019843 307 QRINAKEIVTR--LLKIRD 323 (335)
Q Consensus 307 ~Rps~~ell~~--L~~~~~ 323 (335)
+|||+.|+++. ++.+++
T Consensus 312 ~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GSCCHHHHHTSGGGHHHHH
T ss_pred hCCCHHHHhcCHHHHHHHh
Confidence 99999999853 444444
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=309.49 Aligned_cols=272 Identities=20% Similarity=0.271 Sum_probs=201.4
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeee--------
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS-------- 109 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-------- 109 (335)
....++|++.+.||+|++|.||+|... +++.||+|++..........+.+|+++++.++||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 456789999999999999999999876 48999999998776666788999999999999999999998873
Q ss_pred ------cCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC-CCCcE
Q 019843 110 ------NDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVA 182 (335)
Q Consensus 110 ------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~-~~~~v 182 (335)
.....++||||++ ++|.+++... .+++..++.++.|++.||.||| +.+++|+||+|+||+++ .++.+
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeE
Confidence 4478899999997 5999988653 5999999999999999999999 99999999999999997 56799
Q ss_pred EEeeccccccccCCcc-ccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhh
Q 019843 183 HLSDFGIAKLLTGEDQ-SKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVS 260 (335)
Q Consensus 183 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 260 (335)
+|+|||++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ......
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~ 239 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLILE 239 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH
Confidence 9999999986532211 122234557889999998765 6789999999999999999999999986543221 111111
Q ss_pred hhcC---hhHHHH-------HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 261 NLLP---ISVMEI-------VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 261 ~~~~---~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.... .....+ ..................+++.+.+++.+||+.||.+|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1100 000000 00000000111111123467789999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=313.21 Aligned_cols=265 Identities=23% Similarity=0.299 Sum_probs=189.1
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
....++|++.+.||+|++|.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345689999999999999999999754 58999999986543 3345678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 117 VLEYMPHGSLEKCLYS-------SNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
||||+++++|.+++.. ....+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999874 2446999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCcc---ccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcCh
Q 019843 190 AKLLTGEDQ---SKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI 265 (335)
Q Consensus 190 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 265 (335)
+........ ........+++.|+|||++.+ ..++.++||||||+++|+|++|..||............. ....+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~ 246 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-QNDPPS 246 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-TSSCCC
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh-ccCCCc
Confidence 876532211 112234568999999999865 568999999999999999999999997654322211110 000000
Q ss_pred hHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 266 SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. ............+++.+.+++.+||+.||.+|||+.++++.
T Consensus 247 ~----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 247 L----------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp T----------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred c----------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 00000001112345679999999999999999999999873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=314.16 Aligned_cols=269 Identities=21% Similarity=0.319 Sum_probs=205.2
Q ss_pred cccccccCHHHHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCC--CCceE
Q 019843 27 VATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIR--HRNLI 102 (335)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~ 102 (335)
....+.+.........++|++.+.||+|+||.||+|...+++.||+|++.... ......+.+|+++++.+. |+||+
T Consensus 12 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv 91 (313)
T 3cek_A 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91 (313)
T ss_dssp --------CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred cCCCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceE
Confidence 34445566666777788999999999999999999998889999999997543 335578899999999996 59999
Q ss_pred EEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcE
Q 019843 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 182 (335)
Q Consensus 103 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v 182 (335)
++++++...+..++||| +.+++|.+++.... .+++..++.++.+++.||.||| +.+++|+||+|+||+++ ++.+
T Consensus 92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~-~~~~ 165 (313)
T 3cek_A 92 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGML 165 (313)
T ss_dssp CEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEE
T ss_pred EEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE-CCeE
Confidence 99999999999999999 55889999998654 7899999999999999999999 99999999999999996 4899
Q ss_pred EEeeccccccccCCccccccccccccccccCccccCC-----------CCCCCccchhhHHHHHHHHHhCCCCCCccccc
Q 019843 183 HLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE-----------GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAG 251 (335)
Q Consensus 183 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~ 251 (335)
+|+|||++..+.............++..|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus 166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (313)
T 3cek_A 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245 (313)
T ss_dssp EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence 9999999987643322223345578999999999865 46788999999999999999999999754322
Q ss_pred chhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 252 EMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.... ....+... ....+...+..+.+++.+||+.||.+|||+.|+++.-.
T Consensus 246 ~~~~------------~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 246 ISKL------------HAIIDPNH------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HHHH------------HHHHCTTS------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHH------------HHHHhccc------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 1111 11111111 11112223566999999999999999999999997644
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=309.04 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=190.0
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC--chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4578999999999999999999864 689999999875432 2233445555667888999999999999999999999
Q ss_pred EEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCC-CeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 118 LEYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~-~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
|||+++ +|.+++.. ....+++..++.++.|++.||.||| +. +++|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999964 88777653 4457999999999999999999999 87 9999999999999999999999999999865
Q ss_pred cCCccccccccccccccccCcccc----CCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYG----REGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
.. ........+++.|+|||++ .+..++.++||||||+++|+|++|..||........... .
T Consensus 161 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------------~ 225 (290)
T 3fme_A 161 VD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK------------Q 225 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH------------H
T ss_pred cc---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH------------H
Confidence 32 2223334689999999996 556789999999999999999999999975432222111 1
Q ss_pred HHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 270 IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
........ .....+++.+.+++.+||+.||++|||+.|+++.
T Consensus 226 ~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 226 VVEEPSPQ------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHHSCCCC------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhccCCCC------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 11111111 1123456779999999999999999999999884
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=337.78 Aligned_cols=253 Identities=25% Similarity=0.413 Sum_probs=204.2
Q ss_pred ceeeecCceEEEEEEEc---CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ---DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||.||+|.+. .++.||||+++... ....+.+.+|+++++.++||||+++++++... ..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence 47999999999999643 46789999997543 33467899999999999999999999999754 57899999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc-cccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ-SKSQ 202 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~-~~~~ 202 (335)
++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.+||+|||++..+..... ....
T Consensus 454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999997654 7999999999999999999999 99999999999999999999999999999987642221 1222
Q ss_pred ccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccccc
Q 019843 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281 (335)
Q Consensus 203 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (335)
....++..|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+... .
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--------------~~~i~~~------~ 589 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--------------TAMLEKG------E 589 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------------HHHHHTT------C
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcC------C
Confidence 33446788999999998899999999999999999998 9999976533211 1112111 1
Q ss_pred chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhc
Q 019843 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326 (335)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 326 (335)
....+..+++++.++|.+||+.||++||++++|++.|+++..++.
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 122234567889999999999999999999999999999887653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=312.58 Aligned_cols=272 Identities=23% Similarity=0.270 Sum_probs=205.4
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecC-----
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSND----- 111 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 111 (335)
....++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 346789999999999999999999865 58999999986543 33456788999999999999999999987653
Q ss_pred CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
...++|||+++ ++|.+++... .+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 67899999996 5899988764 5999999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCcccc--------ccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh
Q 019843 192 LLTGEDQSK--------SQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262 (335)
Q Consensus 192 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 262 (335)
......... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||............ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~ 239 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI-FGII 239 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH-HHHh
Confidence 764221111 1223468999999998654 67899999999999999999999999865432211110 0000
Q ss_pred ------------cChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 263 ------------LPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 263 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..........................+++.+.+|+.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0011111111110000001111123567789999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=304.57 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=196.1
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec---------
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN--------- 110 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------- 110 (335)
..++|++.+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4578999999999999999999865 6899999998643 3345778899999999999999999998754
Q ss_pred ----CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEee
Q 019843 111 ----DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 186 (335)
Q Consensus 111 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~d 186 (335)
.+..++||||+++++|.+++......+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence 46788999999999999999877667899999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCc------------cccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccch
Q 019843 187 FGIAKLLTGED------------QSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEM 253 (335)
Q Consensus 187 fg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~ 253 (335)
||++....... .........++..|+|||++.+. .++.++||||||+++|+|++ ||........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99998653211 01122345688999999998764 68999999999999999998 5443211111
Q ss_pred hhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 254 TLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.. ..+... ............++.+.+++.+||+.||.+|||+.++++.
T Consensus 237 ~~-------------~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 IL-------------KKLRSV---SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HH-------------HHHHST---TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HH-------------Hhcccc---ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00 001110 0011111123446669999999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.27 Aligned_cols=249 Identities=21% Similarity=0.246 Sum_probs=207.6
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 115 (335)
..++|.+.+.||+|+||.||+|..+ +++.||+|++... .......+..|..++..+ +||+|+.+++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3468999999999999999999765 5888999999743 234457788899999988 7999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||++|++|.+++.... .+++..++.++.||+.||.||| +.+|+|+||||+|||++.+|.+||+|||++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 9999999999999998654 6999999999999999999999 99999999999999999999999999999985421
Q ss_pred CccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||......+. .....
T Consensus 495 --~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~-----------------~~~i~ 555 (674)
T 3pfq_A 495 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----------------FQSIM 555 (674)
T ss_dssp --TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHH
T ss_pred --CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH-----------------HHHHH
Confidence 12234456799999999999999999999999999999999999999976432211 11111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCH-----HHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINA-----KEIVT 316 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-----~ell~ 316 (335)
.. ....+..+++++.+||.+||+.||.+||++ +||++
T Consensus 556 ~~----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 556 EH----NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SS----CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred hC----CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11 111234567789999999999999999987 66664
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=321.10 Aligned_cols=255 Identities=11% Similarity=0.084 Sum_probs=186.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC---chhHHHHHHHHHHHhC--CCCceEEEe-------eee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG---GVFKSFDVECEVMKSI--RHRNLIKII-------STC 108 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~ 108 (335)
..+|.+.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999865 689999999986542 3455677785544444 699988855 343
Q ss_pred ecC-----------------CeeEEEEEecCCCChHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHhccCCCCeE
Q 019843 109 SND-----------------DFKALVLEYMPHGSLEKCLYSSNCVLDIFQR------LNIMIDVAAALEYLHFGYSAPVI 165 (335)
Q Consensus 109 ~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~------~~i~~~l~~~l~~Lh~~~~~~i~ 165 (335)
... ...++||||++ ++|.+++......++...+ +.++.||+.||.||| +.+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence 322 34799999998 8999999865445566666 778899999999999 99999
Q ss_pred ecCCCCCCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCC--CCCCCccchhhHHHHHHHHHhCCC
Q 019843 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTKKK 243 (335)
Q Consensus 166 h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~ 243 (335)
|+||||+||+++.++.+||+|||++.... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998652 11224556799999999987 679999999999999999999999
Q ss_pred CCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 244 PTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 244 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
||............ . ..................+++.+.+||.+||+.||++|||+.++++.
T Consensus 292 Pf~~~~~~~~~~~~--~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIKGSWK--R----------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCTTCCC--B----------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCcccccchh--h----------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99875432211000 0 00000011111122223567789999999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=307.94 Aligned_cols=269 Identities=23% Similarity=0.309 Sum_probs=203.3
Q ss_pred hhcCCCCccceeeecCceEEEEEEE--cCCcEEEEEEeecCC--CchhHHHHHHHHHHHhC---CCCceEEEeeeee---
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARI--QDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSI---RHRNLIKIISTCS--- 109 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~--~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~--- 109 (335)
...++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.+ .||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4568999999999999999999987 357889999987542 22234566777777666 8999999999987
Q ss_pred --cCCeeEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEee
Q 019843 110 --NDDFKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 186 (335)
Q Consensus 110 --~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~d 186 (335)
.....++|||+++ ++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence 5678899999997 59999987643 35999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh
Q 019843 187 FGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266 (335)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 266 (335)
||++.... .........++..|+|||++.+..++.++||||||+++|+|++|..||.......... ..........
T Consensus 164 fg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~i~~~~~~~~ 239 (326)
T 1blx_A 164 FGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG-KILDVIGLPG 239 (326)
T ss_dssp CCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCCCC
T ss_pred Cccccccc---CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHHcCCCC
Confidence 99998653 1223344678999999999999899999999999999999999999998654322111 1111000000
Q ss_pred HHHHH------Hhhhccc-cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 267 VMEIV------DANLLSR-EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 267 ~~~~~------~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
...+. ....... ..........+++.+.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0000000 00001112345777999999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.23 Aligned_cols=260 Identities=22% Similarity=0.371 Sum_probs=209.4
Q ss_pred hhcCCCCccceeeecCceEEEEEEEcC----CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQD----GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
...++|.+.+.||+|+||.||+|.+.. +..|++|++.... ....+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 345678999999999999999997642 4579999886543 3345778999999999999999999999854 568
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 8999999999999999877667999999999999999999999 9999999999999999999999999999998763
Q ss_pred CCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 195 GEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 195 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+..
T Consensus 543 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--------------~~~i~~ 607 (656)
T 2j0j_A 543 DST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--------------IGRIEN 607 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------------HHHHHH
T ss_pred CCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH--------------HHHHHc
Confidence 222 122233456788999999988899999999999999999997 9999876432211 111111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
. .....+..+++.+.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 608 ~------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 608 G------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp T------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1 11112345677899999999999999999999999999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=305.60 Aligned_cols=265 Identities=19% Similarity=0.248 Sum_probs=205.2
Q ss_pred hcCCCCccceeeecCceEEEEEEE-c-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCC------ceEEEeeeeecCC
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI-Q-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHR------NLIKIISTCSNDD 112 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~-~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~ 112 (335)
..++|++.+.||+|+||.||+|.. . +++.||+|++... ......+.+|+++++.++|+ +++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 467999999999999999999976 3 5889999998643 33457788899999888654 5999999999999
Q ss_pred eeEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC-------------
Q 019843 113 FKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD------------- 178 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~------------- 178 (335)
..++||||+ +++|.+++.... ..+++..++.++.||+.||.||| +.+++|+||+|+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 889999987653 36899999999999999999999 999999999999999987
Q ss_pred ------CCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccc
Q 019843 179 ------NMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252 (335)
Q Consensus 179 ------~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~ 252 (335)
++.++|+|||++.... .......+|..|+|||++.+..++.++||||||+++|+|++|..||......+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDD-----EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETT-----SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCc-----cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6689999999997642 22334578999999999999999999999999999999999999997654322
Q ss_pred hhhHhHhhhhc--ChhHHH-----------------------HHHhhhccccccchhhHHHHHHHHHHHHHHhchhcccc
Q 019843 253 MTLKYWVSNLL--PISVME-----------------------IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQ 307 (335)
Q Consensus 253 ~~~~~~~~~~~--~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 307 (335)
.. ........ +..... ..... ..............++.+.+|+.+||+.||.+
T Consensus 242 ~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 242 HL-AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA-CKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HH-HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHH-CCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HH-HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhc-CcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 11 11111110 100000 00000 00001111112345778999999999999999
Q ss_pred CCCHHHHHHH
Q 019843 308 RINAKEIVTR 317 (335)
Q Consensus 308 Rps~~ell~~ 317 (335)
|||+.|+++.
T Consensus 320 Rpt~~ell~h 329 (339)
T 1z57_A 320 RITLREALKH 329 (339)
T ss_dssp SCCHHHHTTS
T ss_pred ccCHHHHhcC
Confidence 9999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=313.80 Aligned_cols=266 Identities=24% Similarity=0.312 Sum_probs=197.7
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC------ee
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD------FK 114 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~ 114 (335)
...+|++.+.||+|+||.||+|....+..+|+|++..... ...+|+++++.++||||+++++++...+ ..
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4568999999999999999999987777799998864432 2236999999999999999999985433 48
Q ss_pred EEEEEecCCCChHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC-CCCcEEEeeccccc
Q 019843 115 ALVLEYMPHGSLEKCLY--SSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAK 191 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~-~~~~v~l~dfg~~~ 191 (335)
++||||++++.+..... .....+++..++.++.||+.||.||| +.+++|+||+|+||+++ .++.+||+|||++.
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 89999997654433322 23457999999999999999999999 99999999999999998 79999999999998
Q ss_pred cccCCccccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 192 LLTGEDQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
.+.. ........++..|+|||++.+. .++.++|||||||++|+|++|..||......+. +..............+
T Consensus 191 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 191 ILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVLGTPSREQI 266 (394)
T ss_dssp ECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHH
T ss_pred cccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHH
Confidence 7632 2223345689999999998764 589999999999999999999999987543222 1111111111111111
Q ss_pred H--Hhhhcccc-----cc--chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 271 V--DANLLSRE-----DK--HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 271 ~--~~~~~~~~-----~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. ........ .. ....+..+++++.+|+.+||..||.+|||+.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 1 11000000 00 001112356789999999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=309.68 Aligned_cols=265 Identities=21% Similarity=0.248 Sum_probs=201.0
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe---
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF--- 113 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 113 (335)
...++|.+.+.||.|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 45689999999999999999999865 58999999986542 2335678899999999999999999999987654
Q ss_pred ---eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 114 ---KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 114 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
.++|||+++ ++|.+++.. .+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred ceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 489999996 588876643 4899999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhh---------
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVS--------- 260 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--------- 260 (335)
.... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||........ ......
T Consensus 174 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 174 RHAD-----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEF 247 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHH
T ss_pred cCCC-----CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHH
Confidence 7642 22334568999999999876 6789999999999999999999999976542211 111111
Q ss_pred --hhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 261 --NLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 261 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..........+.................+++.+.+|+.+||+.||.+|||++++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001111111111110000000011123457789999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=316.69 Aligned_cols=267 Identities=21% Similarity=0.270 Sum_probs=204.5
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhC------CCCceEEEeeeeecC
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSI------RHRNLIKIISTCSND 111 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 111 (335)
....++|++.+.||+|+||.||+|... +++.||+|++... ......+.+|+++++.+ +|+||+++++.+...
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 345678999999999999999999765 5899999998754 23345677788888776 577999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc--EEEeecc
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--AHLSDFG 188 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~--v~l~dfg 188 (335)
+..++|||++. ++|.+++.... ..+++..++.++.||+.||.||| +.+++|+||||+||+++.++. +||+|||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999995 68999887653 35999999999999999999999 999999999999999999887 9999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
++.... .......+|+.|+|||++.+..++.++|||||||++|+|++|.+||......+. +......... ...
T Consensus 248 ~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~-l~~i~~~~~~-p~~ 320 (429)
T 3kvw_A 248 SSCYEH-----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ-LACMIELLGM-PSQ 320 (429)
T ss_dssp TCEETT-----CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCC-CCH
T ss_pred cceecC-----CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCC-CCH
Confidence 997542 223345789999999999998999999999999999999999999976543222 1111111110 001
Q ss_pred HHHHhh----------hccc----------------------------cccch--hhHHHHHHHHHHHHHHhchhccccC
Q 019843 269 EIVDAN----------LLSR----------------------------EDKHF--AAKEQCVSFVFNLAMECTVESAEQR 308 (335)
Q Consensus 269 ~~~~~~----------~~~~----------------------------~~~~~--~~~~~~~~~l~~li~~~l~~dP~~R 308 (335)
.+.+.. .... ....+ ......++.+.+||.+||+.||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 111100 0000 00000 0011225679999999999999999
Q ss_pred CCHHHHHHH
Q 019843 309 INAKEIVTR 317 (335)
Q Consensus 309 ps~~ell~~ 317 (335)
||++|+++.
T Consensus 401 pta~e~L~H 409 (429)
T 3kvw_A 401 MTPGQALRH 409 (429)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhCC
Confidence 999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=310.30 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=192.8
Q ss_pred HHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC------chhHHHHHHHHHHHhC----CCCceEE
Q 019843 35 YLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG------GVFKSFDVECEVMKSI----RHRNLIK 103 (335)
Q Consensus 35 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l----~h~~i~~ 103 (335)
..+.....++|++.+.||+|+||.||+|... +++.||+|++..... .....+..|+.++..+ +|+||++
T Consensus 23 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp ----------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred ccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 3455667789999999999999999999764 588999999865432 1234456789999888 8999999
Q ss_pred EeeeeecCCeeEEEEEe-cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC-CCCc
Q 019843 104 IISTCSNDDFKALVLEY-MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMV 181 (335)
Q Consensus 104 ~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~-~~~~ 181 (335)
+++++...+..++|+|+ +.+++|.+++.... .+++..++.++.+|+.||.||| +.+++|+||+|+||+++ .++.
T Consensus 103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 103 LLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEEEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTE
T ss_pred EEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCe
Confidence 99999999999999999 78999999998654 6999999999999999999999 99999999999999999 8899
Q ss_pred EEEeeccccccccCCccccccccccccccccCccccCCCCCC-CccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhh
Q 019843 182 AHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVS-TNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVS 260 (335)
Q Consensus 182 v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 260 (335)
++|+|||++..... .......++..|+|||++.+..+. .++||||||+++|+|++|..||.....
T Consensus 179 ~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------- 244 (312)
T 2iwi_A 179 AKLIDFGSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------- 244 (312)
T ss_dssp EEECCCSSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred EEEEEcchhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------
Confidence 99999999987642 223345689999999998766654 589999999999999999999875311
Q ss_pred hhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 261 NLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..... ...+..+++.+.+++.+||+.||++|||++|+++.
T Consensus 245 ---------~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ---------ILEAE--------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---------HHHTC--------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------Hhhhc--------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110 01123356679999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=307.73 Aligned_cols=257 Identities=19% Similarity=0.245 Sum_probs=178.9
Q ss_pred hhhcCCCCccc-eeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec----CC
Q 019843 39 FQATDGFSENN-LIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN----DD 112 (335)
Q Consensus 39 ~~~~~~y~~~~-~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 112 (335)
....++|.+.+ .||+|+||.||+|... +++.||+|++.... ....+....++.+.||||+++++++.. ..
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 35678899954 6999999999999876 68999999986431 222333344566799999999999876 55
Q ss_pred eeEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC---CCcEEEeecc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFG 188 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~---~~~v~l~dfg 188 (335)
..++||||+++++|.+++.... ..+++..++.++.+|+.||.||| +.+++|+||+|+||+++. ++.++|+|||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 6899999999999999998653 46999999999999999999999 999999999999999976 4459999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
++.... ........+++.|+|||++.+..++.++||||||+++|+|++|..||........... ..
T Consensus 177 ~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----------~~ 242 (336)
T 3fhr_A 177 FAKETT----QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG----------MK 242 (336)
T ss_dssp TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred cceecc----ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh----------HH
Confidence 998653 2223345679999999999888899999999999999999999999976443221100 00
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
..+. .............+++.+.+|+.+||+.||.+|||++|+++.-+
T Consensus 243 ~~~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 243 RRIR---LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp -----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred Hhhh---ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 0000 00011111112345777999999999999999999999998544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=313.87 Aligned_cols=273 Identities=19% Similarity=0.235 Sum_probs=186.4
Q ss_pred hhcCCCCc-cceeeecCceEEEEEEEc---CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeee--cCCe
Q 019843 40 QATDGFSE-NNLIGRGSFGSVYKARIQ---DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCS--NDDF 113 (335)
Q Consensus 40 ~~~~~y~~-~~~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 113 (335)
...+.|.+ .++||+|+||.||+|... +++.||+|++.... ....+.+|+.+++.++||||+++++++. ....
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34456776 568999999999999865 57889999986443 2357889999999999999999999994 4778
Q ss_pred eEEEEEecCCCChHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE----CCCCc
Q 019843 114 KALVLEYMPHGSLEKCLYSS--------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL----DDNMV 181 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv----~~~~~ 181 (335)
.++||||++ ++|.+++... ...+++..++.++.||+.||.||| +.+++|+||+|+||++ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCc
Confidence 999999995 5888777521 225999999999999999999999 9999999999999999 67889
Q ss_pred EEEeeccccccccCCcc-ccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccc-------
Q 019843 182 AHLSDFGIAKLLTGEDQ-SKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE------- 252 (335)
Q Consensus 182 v~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~------- 252 (335)
++|+|||++..+..... ........+|+.|+|||++.+. .++.++|||||||++|+|++|..||.......
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999999987642211 1233456789999999998874 58999999999999999999999997543211
Q ss_pred -hhhHhHhhhhcCh------------hHHHHHHhhhccccccchhhH-------HHHHHHHHHHHHHhchhccccCCCHH
Q 019843 253 -MTLKYWVSNLLPI------------SVMEIVDANLLSREDKHFAAK-------EQCVSFVFNLAMECTVESAEQRINAK 312 (335)
Q Consensus 253 -~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~ 312 (335)
..+.......... ........ ............ ...++.+.+||.+||..||.+|||++
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKD-FRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHH-CCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhh-ccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 0111111000000 00000000 000000000000 01145689999999999999999999
Q ss_pred HHHHHHH
Q 019843 313 EIVTRLL 319 (335)
Q Consensus 313 ell~~L~ 319 (335)
|+++.=+
T Consensus 330 e~L~hp~ 336 (405)
T 3rgf_A 330 QAMQDPY 336 (405)
T ss_dssp HHHTSGG
T ss_pred HHhcChh
Confidence 9987533
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=311.41 Aligned_cols=263 Identities=23% Similarity=0.312 Sum_probs=196.2
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec------CCeeE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN------DDFKA 115 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~ 115 (335)
.+|++.+.||+|+||.||+|.+. +++.||||++..+.. ...+|+++++.++||||+++++++.. ...++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46999999999999999999875 589999999875432 23469999999999999999998843 22467
Q ss_pred EEEEecCCCChHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC-CcEEEeeccccc
Q 019843 116 LVLEYMPHGSLEKCLY---SSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAK 191 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~-~~v~l~dfg~~~ 191 (335)
+||||+++ ++.+++. .....+++..++.++.||+.||.||| +.+++|+||||+|||++.+ +.+||+|||++.
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999965 6666554 23457999999999999999999999 9999999999999999965 578999999998
Q ss_pred cccCCccccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 192 LLTGEDQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
.+... .......+|..|+|||++.+. .++.++|||||||++|+|++|+.||......+ .+..............+
T Consensus 206 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHH
T ss_pred hcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 65322 223345789999999998764 78999999999999999999999998754322 22222221111111111
Q ss_pred HHhh--hc----cccc-cch--hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 271 VDAN--LL----SRED-KHF--AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 271 ~~~~--~~----~~~~-~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.... .. .... ..+ .....+++++.+||.+||..||.+||++.|+++.
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 1100 00 0000 000 0112346789999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=309.21 Aligned_cols=249 Identities=23% Similarity=0.272 Sum_probs=202.3
Q ss_pred CHHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCc------hhHHHHHHHHHHHhCC--CCceEEE
Q 019843 34 SYLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGG------VFKSFDVECEVMKSIR--HRNLIKI 104 (335)
Q Consensus 34 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~ 104 (335)
...+.....++|++.+.||+|+||.||+|... +++.||+|++...... ....+..|+.+++.+. |+||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 34556667889999999999999999999754 6899999999755321 2355678999999995 5999999
Q ss_pred eeeeecCCeeEEEEEecCC-CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC-CCCcE
Q 019843 105 ISTCSNDDFKALVLEYMPH-GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVA 182 (335)
Q Consensus 105 ~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~-~~~~v 182 (335)
++++...+..++|+|++.+ ++|.+++.... .+++..++.++.||+.||.||| +.+++|+||+|+||+++ .++.+
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEE
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCE
Confidence 9999999999999999976 89999987644 7999999999999999999999 99999999999999999 78999
Q ss_pred EEeeccccccccCCccccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhh
Q 019843 183 HLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSN 261 (335)
Q Consensus 183 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 261 (335)
+|+|||++..... .......++..|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 190 kL~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------- 254 (320)
T 3a99_A 190 KLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------- 254 (320)
T ss_dssp EECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred EEeeCcccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----------
Confidence 9999999987642 22334568999999999876665 6789999999999999999999865311
Q ss_pred hcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 262 LLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...... ..+..+++.+.+++.+||+.||++|||++|+++.
T Consensus 255 --------~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 --------IIRGQV--------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --------HHHCCC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------hhcccc--------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011000 0122346679999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=303.33 Aligned_cols=265 Identities=21% Similarity=0.246 Sum_probs=201.5
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CC-cEEEEEEeecCCCchhHHHHHHHHHHHhCCCCc------eEEEeeeeecCC
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DG-MEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN------LIKIISTCSNDD 112 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~-~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~ 112 (335)
..++|++.+.||+|+||.||+|... ++ +.||+|++... ......+..|+.+++.+.|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4689999999999999999999865 34 68999998643 334567888999999886554 899999999999
Q ss_pred eeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE---------------
Q 019843 113 FKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL--------------- 176 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv--------------- 176 (335)
..++|||++ ++++.+.+... ...+++..++.++.||+.||.||| +.+++|+||+|+||++
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999 56666666544 357999999999999999999999 9999999999999999
Q ss_pred ----CCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccc
Q 019843 177 ----DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE 252 (335)
Q Consensus 177 ----~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~ 252 (335)
+.++.++|+|||++.... .......+|..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 567899999999997642 22334578999999999999999999999999999999999999998654322
Q ss_pred hhhHhHhhhhcChhHHHHHHhh-------------------------hccccccchhhHHHHHHHHHHHHHHhchhcccc
Q 019843 253 MTLKYWVSNLLPISVMEIVDAN-------------------------LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQ 307 (335)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 307 (335)
... .......+.. ....... ...............+..+.+|+.+||+.||.+
T Consensus 247 ~~~-~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 247 HLV-MMEKILGPIP-SHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHH-HHHHHHCCCC-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHH-HHHHHcCCCc-HHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 111 1011000000 0000000 000000011112234667999999999999999
Q ss_pred CCCHHHHHHH
Q 019843 308 RINAKEIVTR 317 (335)
Q Consensus 308 Rps~~ell~~ 317 (335)
|||+.|+++.
T Consensus 325 Rpt~~e~l~h 334 (355)
T 2eu9_A 325 RITLAEALLH 334 (355)
T ss_dssp SCCHHHHTTS
T ss_pred CcCHHHHhcC
Confidence 9999999853
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=303.84 Aligned_cols=276 Identities=20% Similarity=0.241 Sum_probs=193.9
Q ss_pred HHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC-
Q 019843 35 YLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD- 112 (335)
Q Consensus 35 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 112 (335)
........++|++.+.||+|+||.||+|... +++.||+|++..+. .......++++.+..++||||+++++++...+
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3456677789999999999999999999875 58999999986543 33456778888899999999999999986533
Q ss_pred ------eeEEEEEecCCCChHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC-CCcE
Q 019843 113 ------FKALVLEYMPHGSLEKCLY---SSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVA 182 (335)
Q Consensus 113 ------~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~-~~~v 182 (335)
..++||||+++ +|.+.+. .....+++..++.++.+++.||.||| ..+.+++|+||+|+||+++. ++.+
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcE
Confidence 37899999976 5544443 24457899999999999999999999 33689999999999999996 8999
Q ss_pred EEeeccccccccCCccccccccccccccccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhh
Q 019843 183 HLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSN 261 (335)
Q Consensus 183 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 261 (335)
+|+|||++..+.. ........+|..|+|||++.+.. ++.++||||||+++|+|++|..||......... ......
T Consensus 172 kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-~~~~~~ 247 (360)
T 3e3p_A 172 KLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL-HEIVRV 247 (360)
T ss_dssp EECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHH
T ss_pred EEeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH-HHHHHH
Confidence 9999999987632 22233456899999999986654 899999999999999999999999875432221 111111
Q ss_pred hcCh--hHHHHHHhhhc-----cccccch-----hhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 262 LLPI--SVMEIVDANLL-----SREDKHF-----AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 262 ~~~~--~~~~~~~~~~~-----~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.... ......+.... ......+ ......++.+.+|+.+||+.||.+|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111 11111100000 0000000 0011246789999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=304.43 Aligned_cols=256 Identities=25% Similarity=0.293 Sum_probs=181.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-chhHHHHHHHH-HHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-GVFKSFDVECE-VMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3489999999999999999999875 689999999976532 23344555555 67778999999999999999999999
Q ss_pred EEecCCCChHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhccCCC-CeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 118 LEYMPHGSLEKCLYS----SNCVLDIFQRLNIMIDVAAALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~-~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
|||+++ +|.+++.. ....+++..++.++.+++.||.||| +. +++|+||+|+||+++.++.++|+|||++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999975 88877753 2457999999999999999999999 88 999999999999999999999999999976
Q ss_pred ccCCccccccccccccccccCcccc----CCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYG----REGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
... ........++..|+|||++ .+..++.++||||||+++|+|++|..||...........
T Consensus 176 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------------ 240 (327)
T 3aln_A 176 LVD---SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT------------ 240 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C------------
T ss_pred ccc---ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH------------
Confidence 532 1222334689999999998 456789999999999999999999999975422111100
Q ss_pred HHHHhhhccc-cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 269 EIVDANLLSR-EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 269 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...... ..........+++.+.+++.+||+.||.+|||+.++++.-.
T Consensus 241 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 241 ----QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp ----CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred ----HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 000000 00000111235667999999999999999999999987543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=303.50 Aligned_cols=253 Identities=23% Similarity=0.288 Sum_probs=185.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCc--hhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGG--VFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
..++|++.+.||+|+||.||+|... +++.||+|++...... ....+.++..+++.++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3478999999999999999999875 6899999999765332 223445555678888999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCC-CeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~-~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
|||+ ++.+..+.......+++..++.++.+++.||.||| +. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~- 177 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD- 177 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC-
Confidence 9999 66777666654557999999999999999999999 85 999999999999999999999999999876532
Q ss_pred ccccccccccccccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 197 DQSKSQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
........++..|+|||++. +..++.++||||||+++|+|++|..||........... ...
T Consensus 178 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------------~~~ 243 (318)
T 2dyl_A 178 --DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT------------KVL 243 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH------------HHH
T ss_pred --CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH------------HHh
Confidence 22233456899999999984 45688999999999999999999999976432211111 111
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.. .....+....+++.+.+++.+||+.||.+||+++++++.
T Consensus 244 ~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 244 QE-----EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HS-----CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cc-----CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11 111111122356779999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=308.23 Aligned_cols=267 Identities=16% Similarity=0.226 Sum_probs=200.5
Q ss_pred hcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-----------CCceEEEeeee
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-----------HRNLIKIISTC 108 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~ 108 (335)
..++|++.+.||+|+||.||+|.. .+++.||+|++... ......+.+|+.+++.+. |+||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 347999999999999999999986 46899999998743 234467888999998875 78999999998
Q ss_pred ecCC----eeEEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCC-CeEecCCCCCCEEEC-----
Q 019843 109 SNDD----FKALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSA-PVIHCDLKPSNVLLD----- 177 (335)
Q Consensus 109 ~~~~----~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~-~i~h~di~p~Nilv~----- 177 (335)
...+ ..++|||++ +++|.+++... ...+++..++.++.||+.||.||| ++ +++|+||+|+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCC
Confidence 7654 788999999 88999998763 346999999999999999999999 87 999999999999994
Q ss_pred -CCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccch---
Q 019843 178 -DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEM--- 253 (335)
Q Consensus 178 -~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~--- 253 (335)
..+.++|+|||++.... .......+|..|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccC-----CCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 44589999999998653 223345789999999999999999999999999999999999999986542211
Q ss_pred --hhHhHhhhhcChhHHHHHHhh----------h------------ccccccchhhHHHHHHHHHHHHHHhchhccccCC
Q 019843 254 --TLKYWVSNLLPISVMEIVDAN----------L------------LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI 309 (335)
Q Consensus 254 --~~~~~~~~~~~~~~~~~~~~~----------~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 309 (335)
..................... . ..........+..+++.+.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 111111111000000000000 0 0000011122356788899999999999999999
Q ss_pred CHHHHHHH
Q 019843 310 NAKEIVTR 317 (335)
Q Consensus 310 s~~ell~~ 317 (335)
|++|+++.
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=310.60 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=190.6
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
..+.|.+.+.||+|+||+||.+...+|+.||||++..+ ..+.+.+|+++++.+ +||||+++++++.+.+..++|||
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 34566678999999999998876677999999998754 235678899999876 89999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCC------CCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC-------------C
Q 019843 120 YMPHGSLEKCLYSSNCV------LDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN-------------M 180 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~------~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~-------------~ 180 (335)
+++ ++|.+++...... .++..++.++.||+.||.||| +.+++|+||+|+||+++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCce
Confidence 995 5999999765321 123345779999999999999 9999999999999999754 4
Q ss_pred cEEEeeccccccccCCccc--cccccccccccccCccccCC-------CCCCCccchhhHHHHHHHHHh-CCCCCCcccc
Q 019843 181 VAHLSDFGIAKLLTGEDQS--KSQTQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFT-KKKPTDKIFA 250 (335)
Q Consensus 181 ~v~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~ 250 (335)
.++|+|||++..+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999876432211 12234579999999999865 568999999999999999999 9999975432
Q ss_pred cchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 251 GEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
... .++... .............+++++.++|.+||+.||.+|||+.++++
T Consensus 246 ~~~---------------~i~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RES---------------NIIRGI-FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH---------------HHHHTC-CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHH---------------HHhcCC-CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 211 111111 11111111123456788999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=305.84 Aligned_cols=207 Identities=24% Similarity=0.299 Sum_probs=174.8
Q ss_pred HHHHhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CC-----ceEEEeee
Q 019843 35 YLELFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HR-----NLIKIIST 107 (335)
Q Consensus 35 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~ 107 (335)
........++|++.+.||+|+||.||+|... +++.||+|++... ......+..|+++++.+. |+ +|+.++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3444556789999999999999999999765 5889999998743 234466778888888874 44 49999999
Q ss_pred eecCCeeEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC--CCCcEEE
Q 019843 108 CSNDDFKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHL 184 (335)
Q Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~--~~~~v~l 184 (335)
+...+..++|||+++ ++|.+++.... ..+++..++.++.|++.||.|||. ...+++|+||||+||+++ .++.+||
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 999999999999995 59999987653 469999999999999999999991 136899999999999995 4778999
Q ss_pred eeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCccc
Q 019843 185 SDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIF 249 (335)
Q Consensus 185 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~ 249 (335)
+|||++.... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 203 ~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 203 VDFGSSCQLG-----QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCCTTCEETT-----CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeccCceecc-----cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998653 22334678999999999999999999999999999999999999998654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=309.36 Aligned_cols=251 Identities=20% Similarity=0.333 Sum_probs=191.9
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
...+|.+.+.||+|+||+|+.....+++.||||++..+.. ..+.+|+++++.+ +||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3457999999999999997766666799999999865432 3456799999999 79999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC-----CcEEEeecccccccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN-----MVAHLSDFGIAKLLT 194 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~-----~~v~l~dfg~~~~~~ 194 (335)
+++ ++|.+++.......+...++.++.||+.||.||| +.+++|+||+|+||+++.+ ..++|+|||++....
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 995 5999999877656666677899999999999999 9999999999999999532 358899999998764
Q ss_pred CCcc-ccccccccccccccCccccC---CCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 195 GEDQ-SKSQTQTLATIGYMAPEYGR---EGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 195 ~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
.... ........||+.|+|||++. +..++.++|||||||++|+|++ |..||..........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------------- 240 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------------- 240 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--------------
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--------------
Confidence 2211 12334467999999999987 4567889999999999999999 999986532211110
Q ss_pred HHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 270 IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
... .............+..+.+||.+||+.||.+|||++|+++
T Consensus 241 ~~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 241 LLG----ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HTT----CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Hhc----cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 0011111112334666899999999999999999999994
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.78 Aligned_cols=235 Identities=14% Similarity=0.058 Sum_probs=188.1
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC---chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG---GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 4578999999999999999999875 489999999976532 334778999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||++|++|.+++... .....+..++.|++.||.||| +.+++|+||||+||+++.+|.++|++++
T Consensus 109 v~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999998543 355678889999999999999 9999999999999999999999997443
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
|++ .++.++||||||+++|+|++|..||............. ....
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--------------~~~~ 219 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------------RDTA 219 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--------------BCTT
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--------------HHhc
Confidence 222 36789999999999999999999998754322110000 0000
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
............+++.+.+++.+||+.||.+| |+.|+++.|.++...-
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00000111123457779999999999999999 9999999999887543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=320.93 Aligned_cols=273 Identities=25% Similarity=0.307 Sum_probs=202.4
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeeec------C
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN------D 111 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 111 (335)
...++|++.+.||.|+||.||+|.+. +|+.||+|++... .......+.+|+++++.++||||+++++++.. .
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 34489999999999999999999764 5899999998754 33445778999999999999999999998765 6
Q ss_pred CeeEEEEEecCCCChHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCc---EEEee
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSN--CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSD 186 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~---v~l~d 186 (335)
+..++||||+++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++.++. ++|+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 78899999999999999998643 26899999999999999999999 999999999999999997765 99999
Q ss_pred ccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh
Q 019843 187 FGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS 266 (335)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 266 (335)
||++..... ........++..|+|||++.+..++.++||||||+++|+|++|..||........ |........
T Consensus 168 FG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~----~~~~i~~~~ 240 (676)
T 3qa8_A 168 LGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ----WHGKVREKS 240 (676)
T ss_dssp CCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH----SSTTCC---
T ss_pred ccccccccc---ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh----hhhhhhccc
Confidence 999987632 2233446789999999999999999999999999999999999999975322110 111000000
Q ss_pred HHHH-HHhh------hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHH-----HHHHHHHHH
Q 019843 267 VMEI-VDAN------LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKE-----IVTRLLKIR 322 (335)
Q Consensus 267 ~~~~-~~~~------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e-----ll~~L~~~~ 322 (335)
.... .... ..............+++.+.+++.+||..||++|||+++ +.+.+..+.
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 0000 0000 000000011123446888999999999999999999988 445555544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=318.19 Aligned_cols=243 Identities=21% Similarity=0.295 Sum_probs=197.5
Q ss_pred hcCCCCccceeeecCceEEEEEEEc--CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe----
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ--DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF---- 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 113 (335)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ......+..|++++..++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4589999999999999999999875 58999999986543 3445678899999999999999999999987654
Q ss_pred -eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 114 -KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 114 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
.|+||||++|++|.+++.. .+++..++.++.+|+.||.||| +.+++|+||||+||+++.+ .+||+|||++..
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999987654 5999999999999999999999 9999999999999999975 999999999986
Q ss_pred ccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 193 LTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
... .....||+.|+|||++.+. ++.++||||||+++|+|++|..||.........
T Consensus 231 ~~~------~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------ 285 (681)
T 2pzi_A 231 INS------FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------ 285 (681)
T ss_dssp TTC------CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------
T ss_pred ccc------CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc------------------
Confidence 532 1456789999999998765 488999999999999999999887653211100
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCC-CHHHHHHHHHHHHhh
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI-NAKEIVTRLLKIRDS 324 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~~~~~ 324 (335)
........++.+.++|.+||+.||.+|| +++++...|..+..+
T Consensus 286 ---------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 286 ---------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp ---------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred ---------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 0001122356699999999999999999 677777777766443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=284.94 Aligned_cols=236 Identities=19% Similarity=0.254 Sum_probs=185.1
Q ss_pred hhhcCCCCcc-ceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHH-HhCCCCceEEEeeeeec----C
Q 019843 39 FQATDGFSEN-NLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVM-KSIRHRNLIKIISTCSN----D 111 (335)
Q Consensus 39 ~~~~~~y~~~-~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~ 111 (335)
....++|.+. +.||+|+||.||+|... +++.||+|++... ..+.+|+.++ +..+||||+++++++.. .
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 3455778887 88999999999999764 6899999998642 5677888888 55699999999999876 6
Q ss_pred CeeEEEEEecCCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC---CCcEEEeec
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDF 187 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~---~~~v~l~df 187 (335)
...++||||+++++|.+++.... ..+++..++.++.+++.||.||| +.+++|+||+|+||+++. ++.++|+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 78899999999999999998653 46999999999999999999999 999999999999999997 789999999
Q ss_pred cccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhH
Q 019843 188 GIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISV 267 (335)
Q Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
|++.... +..++.++||||||+++|+|++|..||...........
T Consensus 165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~----------- 209 (299)
T 3m2w_A 165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----------- 209 (299)
T ss_dssp TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-----------
T ss_pred ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-----------
Confidence 9986542 23467789999999999999999999976432211000
Q ss_pred HHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 268 MEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
...................+++++.+++.+||+.||.+|||++|+++.-.
T Consensus 210 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 210 --MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp --SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 00000000011111112346778999999999999999999999998544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=300.11 Aligned_cols=248 Identities=17% Similarity=0.162 Sum_probs=184.9
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCC-Cce---------------
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRH-RNL--------------- 101 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i--------------- 101 (335)
...|+..+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.+.| ++.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345788899999999999999854 68999999987432 2336789999999999976 211
Q ss_pred EE------Eeeeeec-----CCeeEEEEEecCCCChHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCe
Q 019843 102 IK------IISTCSN-----DDFKALVLEYMPHGSLEKCLY------SSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164 (335)
Q Consensus 102 ~~------~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~------~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i 164 (335)
+. +..++.. ...++++|+.. +++|.+++. .....+++..++.++.||+.||.||| +.++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 11 1111111 22456777765 789999884 23446888899999999999999999 9999
Q ss_pred EecCCCCCCEEECCCCcEEEeeccccccccCCccccccccccccccccCcccc----------CCCCCCCccchhhHHHH
Q 019843 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYG----------REGRVSTNGDVYSFGIM 234 (335)
Q Consensus 165 ~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~sDiwslG~~ 234 (335)
+|+||||+||+++.++.+||+|||++.... .......| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecC-----CccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999987653 12344556 999999998 55668889999999999
Q ss_pred HHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHH
Q 019843 235 LMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314 (335)
Q Consensus 235 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 314 (335)
+|+|++|..||.......... .... ....+++.+.+||.+||+.||++||++.++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~-----------------~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSE-----------------WIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSG-----------------GGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHH-----------------HHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999999997643221110 0000 011345679999999999999999998888
Q ss_pred HHH--HHHHHhh
Q 019843 315 VTR--LLKIRDS 324 (335)
Q Consensus 315 l~~--L~~~~~~ 324 (335)
++. ++.+.+.
T Consensus 362 l~~~~~~~~~~~ 373 (413)
T 3dzo_A 362 METPEYEQLRTE 373 (413)
T ss_dssp TTSHHHHHHHHH
T ss_pred HhCHHHHHHHHH
Confidence 654 3444433
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=282.21 Aligned_cols=244 Identities=18% Similarity=0.208 Sum_probs=187.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC--------CchhHHHHHHHHHHHhCC---------CCceEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--------GGVFKSFDVECEVMKSIR---------HRNLIK 103 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~i~~ 103 (335)
..++|++.+.||+|+||.||+|.+ +|+.||+|++.... ......+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 357899999999999999999987 58999999997653 233477889999998885 666666
Q ss_pred Eeee-----------------eec-------------CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHH
Q 019843 104 IIST-----------------CSN-------------DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAAL 153 (335)
Q Consensus 104 ~~~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l 153 (335)
+.++ +.. .+..++||||+++|++.+.+.. ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 6554 333 7889999999999976666644 3589999999999999999
Q ss_pred HHHhccCCCCeEecCCCCCCEEECCCC--------------------cEEEeeccccccccCCccccccccccccccccC
Q 019843 154 EYLHFGYSAPVIHCDLKPSNVLLDDNM--------------------VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMA 213 (335)
Q Consensus 154 ~~Lh~~~~~~i~h~di~p~Nilv~~~~--------------------~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 213 (335)
.|||. +.+++|+||||+|||++.++ .+||+|||++..... ....||+.|+|
T Consensus 175 ~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMD 245 (336)
T ss_dssp HHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTC
T ss_pred HHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccC
Confidence 99993 48999999999999999887 899999999986531 23478999999
Q ss_pred ccccCCCCCCCccchhhHHHH-HHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHH
Q 019843 214 PEYGREGRVSTNGDVYSFGIM-LMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSF 292 (335)
Q Consensus 214 PE~~~~~~~~~~sDiwslG~~-l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (335)
||++.+.. +.++||||+|++ .++++.|..||.... |.. .....+.... .............++++
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--------~~~----~~~~~~~~~~-~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--------WLH----YLTDKMLKQM-TFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--------HHH----HHHHHHHHTC-CCSSCCCSHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--------hhh----HHHHhhhhhh-ccCcccchhhhhhcCHH
Confidence 99998766 889999998777 777888999874321 000 0011111111 11122223345678899
Q ss_pred HHHHHHHhchhccccCCCHHHHH
Q 019843 293 VFNLAMECTVESAEQRINAKEIV 315 (335)
Q Consensus 293 l~~li~~~l~~dP~~Rps~~ell 315 (335)
+.+||.+||+.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999977 899988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-31 Score=251.45 Aligned_cols=182 Identities=19% Similarity=0.126 Sum_probs=129.5
Q ss_pred ecCceEEEEEE-EcCCcEEEEEEeecCC----------CchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEEEEe
Q 019843 53 RGSFGSVYKAR-IQDGMEVAVKVFHLQC----------GGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 53 ~g~~~~v~~~~-~~~~~~v~iK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.|+.|....++ .-.|+.+++|++..+. ....+.+.+|+++|+++ +|+||+++++++++++.+||||||
T Consensus 244 ~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEy 323 (569)
T 4azs_A 244 AGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEK 323 (569)
T ss_dssp --------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEEC
T ss_pred cCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEec
Confidence 34444444332 2247889999997542 12345689999999999 799999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++|++|.++|...+ +++.. .|+.||+.||.|+| ++||+||||||+|||++.+|.+||+|||++...... ..
T Consensus 324 v~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~ 394 (569)
T 4azs_A 324 LPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CS 394 (569)
T ss_dssp CCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred CCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--Cc
Confidence 99999999998664 67665 47899999999999 999999999999999999999999999999865322 22
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~p 244 (335)
.....+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 3345679999999999976 466789999999998887766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.9e-27 Score=220.73 Aligned_cols=185 Identities=17% Similarity=0.186 Sum_probs=143.5
Q ss_pred CccceeeecCceEEEEEEEcCCcEEEEEEeecCCC--------chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEE
Q 019843 46 SENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCG--------GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 46 ~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
...+.||+|+||.||+|... ++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 45679999999999999544 78899998653321 1234578999999999999999655555567777999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+++++|.+++.. +..++.|++.+|.||| +++++|+||||+||+++. .+||+|||++.......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999998865 5689999999999999 999999999999999998 99999999998764221
Q ss_pred ccc-----ccccccccccccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCC
Q 019843 198 QSK-----SQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTKKKPT 245 (335)
Q Consensus 198 ~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~~l~~ll~g~~pf 245 (335)
... ......+|+.|+|||++.+ ..|+...|+|+..+-..+-+.++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 111 1235678999999999986 56788899999999888887776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.4e-24 Score=184.40 Aligned_cols=139 Identities=15% Similarity=0.167 Sum_probs=112.3
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCC------------------chhHHHHHHHHHHHhCCCC
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCG------------------GVFKSFDVECEVMKSIRHR 99 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~ 99 (335)
.......|.+.+.||.|++|.||+|.+.+|+.||+|++..... .....+.+|+++++.++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344556667799999999999999887799999999864321 13456889999999998
Q ss_pred ceEEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC
Q 019843 100 NLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN 179 (335)
Q Consensus 100 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~ 179 (335)
| +++.+++.. +..++||||++|++|.+ +.. .....++.+++.||.+|| +.+++|+||+|+||+++ +
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-T
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-C
Confidence 4 566665543 55689999999999988 422 224469999999999999 99999999999999999 9
Q ss_pred CcEEEeecccccc
Q 019843 180 MVAHLSDFGIAKL 192 (335)
Q Consensus 180 ~~v~l~dfg~~~~ 192 (335)
+.++|+|||++..
T Consensus 229 ~~vkl~DFG~a~~ 241 (282)
T 1zar_A 229 EGIWIIDFPQSVE 241 (282)
T ss_dssp TEEEECCCTTCEE
T ss_pred CcEEEEECCCCeE
Confidence 9999999999863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.2e-19 Score=155.80 Aligned_cols=138 Identities=22% Similarity=0.261 Sum_probs=106.1
Q ss_pred CCCccceeeecCceEEEEEEE-cCCcE--EEEEEeecCCCc------------------------hhHHHHHHHHHHHhC
Q 019843 44 GFSENNLIGRGSFGSVYKARI-QDGME--VAVKVFHLQCGG------------------------VFKSFDVECEVMKSI 96 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~-~~~~~--v~iK~~~~~~~~------------------------~~~~~~~e~~~l~~l 96 (335)
-|.+.+.||.|+||.||+|.. .+|+. ||||++...... ....+..|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999987 67888 999997543211 113678899999999
Q ss_pred CCCce--EEEeeeeecCCeeEEEEEecCC-C----ChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCC
Q 019843 97 RHRNL--IKIISTCSNDDFKALVLEYMPH-G----SLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDL 169 (335)
Q Consensus 97 ~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di 169 (335)
.|+++ +.+++. +..++||||+.+ | +|.++... .++..+..++.+++.+|.+||. +.+++|+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence 77653 333332 356799999942 3 67665432 2344577899999999999994 579999999
Q ss_pred CCCCEEECCCCcEEEeeccccccc
Q 019843 170 KPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 170 ~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
+|+||+++. .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999998753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=6.2e-18 Score=151.33 Aligned_cols=138 Identities=17% Similarity=0.174 Sum_probs=99.9
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCC--------------chhHH--------HHHHHHHHHhCCCC
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCG--------------GVFKS--------FDVECEVMKSIRHR 99 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--------------~~~~~--------~~~e~~~l~~l~h~ 99 (335)
..-|++.+.||.|++|.||+|...+|+.||||+++.... ..... ...|...+..+.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 344999999999999999999988899999999753210 00011 23456666666433
Q ss_pred ce--EEEeeeeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC
Q 019843 100 NL--IKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD 177 (335)
Q Consensus 100 ~i--~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~ 177 (335)
++ ...++. ...++||||++|.+|.++... +....++.||+.+|.+|| ..|++||||||.|||++
T Consensus 174 gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 174 GFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIR 239 (397)
T ss_dssp TCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred CCCCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEe
Confidence 32 222221 123699999999888764321 124568899999999999 99999999999999998
Q ss_pred CCC----------cEEEeeccccccc
Q 019843 178 DNM----------VAHLSDFGIAKLL 193 (335)
Q Consensus 178 ~~~----------~v~l~dfg~~~~~ 193 (335)
++| .+.++||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 776 4899999977643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.8e-13 Score=116.27 Aligned_cols=145 Identities=17% Similarity=0.118 Sum_probs=113.8
Q ss_pred hhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 118 (335)
..-.+|++...++.|+.+.||++... ++.+++|+...........+..|+++++.+. +..++++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 44567999999999999999999865 6899999986532222356888999999884 677888999998889999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcc---------------------------------------
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG--------------------------------------- 159 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~--------------------------------------- 159 (335)
|+++|.+|.+.+. +......++.++++++..||.-
T Consensus 90 e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 90 SEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp ECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 9999999987532 1122346788999999999940
Q ss_pred -----------------CCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 160 -----------------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 160 -----------------~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
....++|||++|.||++++++.+.++||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 00458999999999999876666799998775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.37 E-value=2.3e-12 Score=110.15 Aligned_cols=142 Identities=15% Similarity=0.105 Sum_probs=103.9
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCc--eEEEeeeeecCCeeEE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN--LIKIISTCSNDDFKAL 116 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~l 116 (335)
.....+|.+....+.|..+.||++...+|..+++|+.... ....+..|+.+++.+.+.+ +++++++....+..++
T Consensus 16 ~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 16 VERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred HHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 3445567665555567779999998777788999997543 2356788999998885433 5668888888888899
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccC------------------------------------
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY------------------------------------ 160 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~------------------------------------ 160 (335)
|||+++|.++. ... .+ ...++.+++..+..||...
T Consensus 93 v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 99999998884 211 12 1256777888888888211
Q ss_pred -------------------CCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 161 -------------------SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 161 -------------------~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
...++|||++|.||+++.++.+.|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=2e-10 Score=103.07 Aligned_cols=145 Identities=13% Similarity=0.165 Sum_probs=107.4
Q ss_pred CCCccceeeecCceEEEEEEEcCCcEEEEEEee--cCC-CchhHHHHHHHHHHHhCC--CCceEEEeeeeecC---CeeE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQDGMEVAVKVFH--LQC-GGVFKSFDVECEVMKSIR--HRNLIKIISTCSND---DFKA 115 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~ 115 (335)
.....+.++.|.++.||++... +..+++|+.. ... ......+..|+.+++.+. +..+++++..+.+. +..+
T Consensus 39 ~~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 39 GPLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCCEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CCceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3445788899999999999876 4688888865 322 122356788999999986 45578888887766 4588
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccC-----------------------------------
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY----------------------------------- 160 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~----------------------------------- 160 (335)
+|||+++|.++.+.. ...++......++.+++..|..||...
T Consensus 118 ~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999999998875411 124678888889999999999999410
Q ss_pred --------------------CCCeEecCCCCCCEEECCCCc--EEEeecccccc
Q 019843 161 --------------------SAPVIHCDLKPSNVLLDDNMV--AHLSDFGIAKL 192 (335)
Q Consensus 161 --------------------~~~i~h~di~p~Nilv~~~~~--v~l~dfg~~~~ 192 (335)
...++|||+++.||+++.++. +.++||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.04 E-value=2.3e-10 Score=100.26 Aligned_cols=186 Identities=16% Similarity=0.137 Sum_probs=119.8
Q ss_pred cceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhC-CCCc--eEEEeeeeecCC---eeEEEEEec
Q 019843 48 NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSI-RHRN--LIKIISTCSNDD---FKALVLEYM 121 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~--i~~~~~~~~~~~---~~~lv~e~~ 121 (335)
++.++.|....||++. ..+++|+.... .....+..|+++++.+ .+.. ++.++......+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4668999999999864 56888985432 3456788999999887 3322 444554443333 457899999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcc------------------------------------------
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG------------------------------------------ 159 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~------------------------------------------ 159 (335)
+|.++.+... ..++......++.+++..+..||..
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988875332 1367777778888888888888831
Q ss_pred -------------CCCCeEecCCCCCCEEECC--CCcEEEeeccccccccCCccccccccccccccccCccccC----C-
Q 019843 160 -------------YSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR----E- 219 (335)
Q Consensus 160 -------------~~~~i~h~di~p~Nilv~~--~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~- 219 (335)
....++|||++|.||+++. ++.+.++||+.+..-... ...........-.+|+... .
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---NDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---HHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---HHHHHHHhhccccCHHHHHHHHHHc
Confidence 0135799999999999998 556789999987643110 0000000000001222110 0
Q ss_pred CCC---------CCccchhhHHHHHHHHHhCCCCC
Q 019843 220 GRV---------STNGDVYSFGIMLMETFTKKKPT 245 (335)
Q Consensus 220 ~~~---------~~~sDiwslG~~l~~ll~g~~pf 245 (335)
+.. ....+.|++|.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000 11258999999999999998774
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=1.1e-07 Score=81.40 Aligned_cols=140 Identities=19% Similarity=0.110 Sum_probs=100.5
Q ss_pred CCCccceeeecCc-eEEEEEEEcC-CcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEEEEe
Q 019843 44 GFSENNLIGRGSF-GSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 44 ~y~~~~~lg~g~~-~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.|+.. .+..|.. +.||+..... +..+++|+-... ....+..|...++.+. +-.+.++++++.+.+..++||++
T Consensus 26 g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~ 101 (272)
T 4gkh_A 26 GYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA 101 (272)
T ss_dssp TCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred CCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence 34443 3344544 4799887553 667999986533 3467888999999884 44577888888888999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcc-----------------------------------------
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG----------------------------------------- 159 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~----------------------------------------- 159 (335)
++|.++.+...... .....+..++...|..||..
T Consensus 102 l~G~~~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 102 IPGKTAFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCSEEHHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eCCccccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 99988887654321 22345677777888888820
Q ss_pred --------------CCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 160 --------------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 160 --------------~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
....++|||+++.||+++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 011279999999999999887778999998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=2.7e-07 Score=80.64 Aligned_cols=136 Identities=15% Similarity=0.128 Sum_probs=93.7
Q ss_pred cceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCC---ceEEEeeeee-cCCeeEEEEEecCC
Q 019843 48 NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHR---NLIKIISTCS-NDDFKALVLEYMPH 123 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~ 123 (335)
++.++.|....||+. +..+++|+.. .......+..|+++++.+.+. .+++++.+.. ..+..++||++++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 467888888899988 5778889842 223456789999999998642 3556666653 45667899999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcc--------------------------------------------
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG-------------------------------------------- 159 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~-------------------------------------------- 159 (335)
.++.+..-. .++......++.++...|..||..
T Consensus 98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 888763211 234444445555555555555520
Q ss_pred -------------CCCCeEecCCCCCCEEECC---CCc-EEEeecccccc
Q 019843 160 -------------YSAPVIHCDLKPSNVLLDD---NMV-AHLSDFGIAKL 192 (335)
Q Consensus 160 -------------~~~~i~h~di~p~Nilv~~---~~~-v~l~dfg~~~~ 192 (335)
....++|||+++.||+++. ++. +.++||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1345799999999999987 455 48999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=4.6e-07 Score=80.85 Aligned_cols=80 Identities=8% Similarity=-0.012 Sum_probs=55.3
Q ss_pred ccee-eecCceEEEEEEEc-------CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCC-C--CceEEEeeeeecC--
Q 019843 48 NNLI-GRGSFGSVYKARIQ-------DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIR-H--RNLIKIISTCSND-- 111 (335)
Q Consensus 48 ~~~l-g~g~~~~v~~~~~~-------~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~-- 111 (335)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+. + -.+++++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 78888999988654 26789999865432 101256778888888773 2 3567777776654
Q ss_pred -CeeEEEEEecCCCChH
Q 019843 112 -DFKALVLEYMPHGSLE 127 (335)
Q Consensus 112 -~~~~lv~e~~~~~~L~ 127 (335)
+..++|||+++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 4578999999887664
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.28 E-value=4e-06 Score=68.07 Aligned_cols=103 Identities=14% Similarity=0.053 Sum_probs=70.9
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQT 203 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~ 203 (335)
.+|.++|...+.+++++++|.++.|.+.+|..+-. .+.-...=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 48999999888899999999999999999888731 11112334567999999999998763 1110
Q ss_pred cccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 019843 204 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244 (335)
Q Consensus 204 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~p 244 (335)
.....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1223466888763 3445678899999999999987666
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=8.9e-06 Score=73.63 Aligned_cols=76 Identities=13% Similarity=0.148 Sum_probs=50.1
Q ss_pred ccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-------chhHHHHHHHHHHHhCCC--C-ceEEEeeeeecCCeeE
Q 019843 47 ENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-------GVFKSFDVECEVMKSIRH--R-NLIKIISTCSNDDFKA 115 (335)
Q Consensus 47 ~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-~i~~~~~~~~~~~~~~ 115 (335)
..+.+|.|..+.||++... +++.+++|....... .....+..|.++++.+.. + .+++++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3578999999999999654 468899998643211 233567789999887732 3 34455544 334567
Q ss_pred EEEEecCCC
Q 019843 116 LVLEYMPHG 124 (335)
Q Consensus 116 lv~e~~~~~ 124 (335)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.09 E-value=3.2e-05 Score=68.16 Aligned_cols=138 Identities=17% Similarity=0.127 Sum_probs=78.0
Q ss_pred ceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC--CCceEEEee------eeecCCeeEEEEEe
Q 019843 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR--HRNLIKIIS------TCSNDDFKALVLEY 120 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~------~~~~~~~~~lv~e~ 120 (335)
+.|+.|..+.||++...+ ..+++|+.... ...+..|+.+++.+. .-.+++++. +....+..++++++
T Consensus 38 ~~l~gG~~n~~~~v~~~~-~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDS-GAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETT-EEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCC-CCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 456667788999998764 45899988642 133444555555552 112333332 12346678899999
Q ss_pred cCCCChH-----------HHH---hc--CCC--C---------CCHHH-------------------------------H
Q 019843 121 MPHGSLE-----------KCL---YS--SNC--V---------LDIFQ-------------------------------R 142 (335)
Q Consensus 121 ~~~~~L~-----------~~l---~~--~~~--~---------~~~~~-------------------------------~ 142 (335)
++|.++. +.+ .. ... + ..+.. +
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 111 10 000 0 01111 0
Q ss_pred HHHHHHHHHHHHHHhc----------cCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 143 LNIMIDVAAALEYLHF----------GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 143 ~~i~~~l~~~l~~Lh~----------~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
..+...+..++..|+. .....++|||+++.||+++.++.+.++||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111123334555541 025789999999999999888899999999765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.09 E-value=1.8e-05 Score=68.22 Aligned_cols=81 Identities=12% Similarity=0.118 Sum_probs=59.8
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-C--CceEEEeeeeecCCeeEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-H--RNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~lv~ 118 (335)
+.+..-++.+|.|..+.||+.+..+|+++++|+...........+..|+..|+.+. . -.++++++.. ..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 45566678899999999999999999999999876554444567888999998884 2 2344555432 236899
Q ss_pred EecCCCCh
Q 019843 119 EYMPHGSL 126 (335)
Q Consensus 119 e~~~~~~L 126 (335)
|+++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99877643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.90 E-value=0.00013 Score=63.55 Aligned_cols=76 Identities=13% Similarity=0.138 Sum_probs=60.6
Q ss_pred ccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC---CCceEEEeeeeecCCeeEEEEEecCC
Q 019843 47 ENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR---HRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 47 ~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
-.+.|+.|....+|+.... +..+++|+.... ....+..|+..++.+. ...+++++......+..++|||+++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3577899999999999864 678999987643 3467888999888883 35678888888778889999999998
Q ss_pred CCh
Q 019843 124 GSL 126 (335)
Q Consensus 124 ~~L 126 (335)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00014 Score=66.29 Aligned_cols=77 Identities=14% Similarity=0.113 Sum_probs=47.5
Q ss_pred CCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccccccccc--ccccccCccccCCC---CCCCccchhhHHHHH
Q 019843 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTL--ATIGYMAPEYGREG---RVSTNGDVYSFGIML 235 (335)
Q Consensus 161 ~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~---~~~~~sDiwslG~~l 235 (335)
...++|||+++.||+++.++ +.++||+.+..-. ....-.... -...|++|+..... ......++.+....+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~---p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP---MGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC---HHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc---hHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 78899999999999998776 9999999887421 000001111 12345666554311 112234556777777
Q ss_pred HHHHhC
Q 019843 236 METFTK 241 (335)
Q Consensus 236 ~~ll~g 241 (335)
|..+.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877665
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00014 Score=63.10 Aligned_cols=74 Identities=8% Similarity=0.074 Sum_probs=46.1
Q ss_pred CCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCce-EEEeeeeecCCeeEEEEEec-C
Q 019843 45 FSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNL-IKIISTCSNDDFKALVLEYM-P 122 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~-~ 122 (335)
+.-.+.|+.|....+|+. +.+++|+........ .....|+.+++.+...++ +++++... +.-+++++|+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCC
Confidence 444788999999999998 568889876542221 223567777776632222 45555443 3346899999 6
Q ss_pred CCCh
Q 019843 123 HGSL 126 (335)
Q Consensus 123 ~~~L 126 (335)
|.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6555
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00035 Score=61.40 Aligned_cols=140 Identities=13% Similarity=0.109 Sum_probs=72.4
Q ss_pred cceeeecCceE-EEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC--CCceEEEeeeeecCCeeEEEEEecCCC
Q 019843 48 NNLIGRGSFGS-VYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR--HRNLIKIISTCSNDDFKALVLEYMPHG 124 (335)
Q Consensus 48 ~~~lg~g~~~~-v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~ 124 (335)
.+.|+.|.... +|+....++..+++|....... ..+..|+.+++.+. .-.+++++.+....+ +++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34565554444 6677654467788886543321 23345566666553 223455665544333 6899999776
Q ss_pred ChHHHHhcCC-------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHHh--
Q 019843 125 SLEKCLYSSN-------------------------CVLDIFQRL-------NIM-------------IDVAAALEYLH-- 157 (335)
Q Consensus 125 ~L~~~l~~~~-------------------------~~~~~~~~~-------~i~-------------~~l~~~l~~Lh-- 157 (335)
++.+++.... ..++..... .+. ..+...+..+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6654432110 011111110 000 01111122221
Q ss_pred -ccCCCCeEecCCCCCCEEECCC----CcEEEeecccccc
Q 019843 158 -FGYSAPVIHCDLKPSNVLLDDN----MVAHLSDFGIAKL 192 (335)
Q Consensus 158 -~~~~~~i~h~di~p~Nilv~~~----~~v~l~dfg~~~~ 192 (335)
......++|||+++.||+++.+ +.+.++||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1115689999999999999875 6899999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00048 Score=60.14 Aligned_cols=158 Identities=15% Similarity=0.149 Sum_probs=87.8
Q ss_pred cccCHHHHhhhcCCCCcc-----ceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCc--eEE
Q 019843 31 RRFSYLELFQATDGFSEN-----NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN--LIK 103 (335)
Q Consensus 31 ~~~~~~~~~~~~~~y~~~-----~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~ 103 (335)
..++..++.....+|.+. +.|+.|....+|+....++ .+++|+..... ....+..|+.+++.+...+ +++
T Consensus 5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 345666777777777652 4455687889999977644 68899876521 1245566777777663212 333
Q ss_pred Eeee------eecCCeeEEEEEecCCCChHH-----------H---Hhc--CC--CC----CC---HHHHHH--------
Q 019843 104 IIST------CSNDDFKALVLEYMPHGSLEK-----------C---LYS--SN--CV----LD---IFQRLN-------- 144 (335)
Q Consensus 104 ~~~~------~~~~~~~~lv~e~~~~~~L~~-----------~---l~~--~~--~~----~~---~~~~~~-------- 144 (335)
++.. ....+..++++++++|..+.. . +.. .. .+ .. +...+.
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 122456789999998865321 0 110 00 00 11 111000
Q ss_pred ----HHHHHHHHHHHHhc----cCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 145 ----IMIDVAAALEYLHF----GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 145 ----i~~~l~~~l~~Lh~----~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
+...+...+..+.. .....++|+|+++.||+++.++.+.++||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00112333444431 113579999999999999987666899998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00096 Score=58.33 Aligned_cols=157 Identities=13% Similarity=0.095 Sum_probs=88.9
Q ss_pred cccCHHHHhhhcCCCCc-----cceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCC--CceEE
Q 019843 31 RRFSYLELFQATDGFSE-----NNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRH--RNLIK 103 (335)
Q Consensus 31 ~~~~~~~~~~~~~~y~~-----~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~ 103 (335)
..++...+....+.|.+ ...++ |....||++...+|+.+++|....... ....+..|..+++.+.. -.+++
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecc
Confidence 44555555544444432 34566 778899998776677899999864321 23566778888877732 12344
Q ss_pred Eeee-----eecCCeeEEEEEecCCCChH-----HH------H---hc--C------CCCCCHHHH--------------
Q 019843 104 IIST-----CSNDDFKALVLEYMPHGSLE-----KC------L---YS--S------NCVLDIFQR-------------- 142 (335)
Q Consensus 104 ~~~~-----~~~~~~~~lv~e~~~~~~L~-----~~------l---~~--~------~~~~~~~~~-------------- 142 (335)
++.. ....+..++++++++|.++. .. + .. . ....+....
T Consensus 87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 166 (328)
T 1zyl_A 87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 166 (328)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence 4433 12245667899999875432 11 1 00 0 001121110
Q ss_pred --------HHHHHHHHHHHHHHhc-cCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 143 --------LNIMIDVAAALEYLHF-GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 143 --------~~i~~~l~~~l~~Lh~-~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
...+..++..+..+.. .....++|||+++.||+++ + .+.++||+.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 1111222222222210 0156789999999999999 4 89999998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00025 Score=63.46 Aligned_cols=140 Identities=12% Similarity=0.138 Sum_probs=82.1
Q ss_pred cceeeecCceEEEEEEEc--------CCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEEE
Q 019843 48 NNLIGRGSFGSVYKARIQ--------DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++.+..|-...+|++... +++.+++|+..... .......+|.++++.+. +.-.+++++.+.+ .+|+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 456777888889998764 25789999864322 23456678999998874 3223556666554 2899
Q ss_pred EecCCCChHHH--------------Hh---cC----CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 019843 119 EYMPHGSLEKC--------------LY---SS----NCVLD--IFQRLNIMIDVAA-------------------ALEYL 156 (335)
Q Consensus 119 e~~~~~~L~~~--------------l~---~~----~~~~~--~~~~~~i~~~l~~-------------------~l~~L 156 (335)
+|++|.++..- +. .. ..... +.++..+..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99988655310 10 11 11122 3445545443321 12222
Q ss_pred ----h-ccCCCCeEecCCCCCCEEECCC----CcEEEeecccccc
Q 019843 157 ----H-FGYSAPVIHCDLKPSNVLLDDN----MVAHLSDFGIAKL 192 (335)
Q Consensus 157 ----h-~~~~~~i~h~di~p~Nilv~~~----~~v~l~dfg~~~~ 192 (335)
. ......++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 1123568999999999999876 7899999988763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00035 Score=63.76 Aligned_cols=73 Identities=18% Similarity=0.238 Sum_probs=48.9
Q ss_pred cceeeecCceEEEEEEEcC--------CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCc-eEEEeeeeecCCeeEEEE
Q 019843 48 NNLIGRGSFGSVYKARIQD--------GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN-LIKIISTCSNDDFKALVL 118 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 118 (335)
.+.|+.|....+|++...+ +..+++|+..... ....+..|..+++.+...+ .+++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4677788889999997652 5789999874321 1245557888888874322 3556665542 3899
Q ss_pred EecCCCCh
Q 019843 119 EYMPHGSL 126 (335)
Q Consensus 119 e~~~~~~L 126 (335)
+|++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00057 Score=62.81 Aligned_cols=74 Identities=14% Similarity=0.178 Sum_probs=48.0
Q ss_pred cceeeecCceEEEEEEEcC-CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCce-EEEeeeeecCCeeEEEEEecCCCC
Q 019843 48 NNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNL-IKIISTCSNDDFKALVLEYMPHGS 125 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~ 125 (335)
.+.|+.|-...+|++...+ +..+++|+........ -.-..|..+++.+...++ +++++.+. + .+|++|++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4567788889999998764 4789999875433222 122578899988864444 46666663 2 35999998754
Q ss_pred h
Q 019843 126 L 126 (335)
Q Consensus 126 L 126 (335)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00068 Score=60.51 Aligned_cols=74 Identities=14% Similarity=0.221 Sum_probs=44.2
Q ss_pred cceeeecCceEEEEEEEcC---------CcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCc-eEEEeeeeecCCeeEEE
Q 019843 48 NNLIGRGSFGSVYKARIQD---------GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN-LIKIISTCSNDDFKALV 117 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~---------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv 117 (335)
.+.++.|....+|+....+ ++.+++|+....... ......|.++++.+...+ .+++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567778888999997653 268999987543222 223467888888774222 34555444 2 2589
Q ss_pred EEecCCCCh
Q 019843 118 LEYMPHGSL 126 (335)
Q Consensus 118 ~e~~~~~~L 126 (335)
+++++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0045 Score=54.48 Aligned_cols=32 Identities=22% Similarity=0.330 Sum_probs=28.0
Q ss_pred CCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 161 ~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
...++|||+++.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45799999999999999888999999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0069 Score=54.97 Aligned_cols=74 Identities=16% Similarity=0.243 Sum_probs=48.1
Q ss_pred cceeeecCceEEEEEEEcC--------CcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEEE
Q 019843 48 NNLIGRGSFGSVYKARIQD--------GMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++.+..|-...+|+....+ ++.+++++...... ..-...+|.++++.+. +.-.+++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4667778888999997653 57899998654332 2223457888888774 222344554332 26899
Q ss_pred EecCCCCh
Q 019843 119 EYMPHGSL 126 (335)
Q Consensus 119 e~~~~~~L 126 (335)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99988654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.72 E-value=0.012 Score=52.96 Aligned_cols=30 Identities=27% Similarity=0.371 Sum_probs=25.2
Q ss_pred CeEecCCCCCCEEE------CCCCcEEEeecccccc
Q 019843 163 PVIHCDLKPSNVLL------DDNMVAHLSDFGIAKL 192 (335)
Q Consensus 163 ~i~h~di~p~Nilv------~~~~~v~l~dfg~~~~ 192 (335)
.++|+|+.+.||++ +++..+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4566799999998764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.70 E-value=0.47 Score=38.35 Aligned_cols=122 Identities=12% Similarity=0.217 Sum_probs=81.3
Q ss_pred CCCceEEEeeeeecCCeeEEEEEecC-CCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEE
Q 019843 97 RHRNLIKIISTCSNDDFKALVLEYMP-HGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVL 175 (335)
Q Consensus 97 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nil 175 (335)
.||+.++. .+-...+.+.+.++.-+ +.++.. +. ..+....+.++.+|+....+++ .-+|--++|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence 57888866 56666677666565433 223333 22 4778899999999998775544 3356679999999
Q ss_pred ECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccch
Q 019843 176 LDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEM 253 (335)
Q Consensus 176 v~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~ 253 (335)
++.++.+++.-.|+-..+ +|. ..+...=+-.+=|++..+++++..|+....+..
T Consensus 112 f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~l 165 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGNL 165 (215)
T ss_dssp ECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSCG
T ss_pred EcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcChH
Confidence 999999999887765432 111 111122344567899999999999876544433
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.63 E-value=1.2 Score=36.09 Aligned_cols=116 Identities=9% Similarity=0.118 Sum_probs=77.5
Q ss_pred CCCceEEEeeeeecCCeeEEEEEecCC-CChHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHhccCCCCeEecCCCCCCE
Q 019843 97 RHRNLIKIISTCSNDDFKALVLEYMPH-GSLEKCLYSSNCVLDIFQRLNIMIDVAAALE-YLHFGYSAPVIHCDLKPSNV 174 (335)
Q Consensus 97 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~-~Lh~~~~~~i~h~di~p~Ni 174 (335)
.||++ -..+-.+.+.+.+.++.-++ .++.. +. ..+....+.++.+|+.... +++ .-+|--++|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i~----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-IR----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-HH----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-HH----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence 57777 44455777887777776533 34443 32 4778889999999888665 444 445667999999
Q ss_pred EECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcc
Q 019843 175 LLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKI 248 (335)
Q Consensus 175 lv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~ 248 (335)
+++.++.+++.-.|+-..+ +|.- .+...=+-++=|++..++.++..|+..
T Consensus 116 ~f~~~~~p~i~hRGi~~~l-------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe~l 165 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESL-------------------PPDE-----WDDERLLREVKATVLALTEGEYRFDEY 165 (219)
T ss_dssp EECTTCCEEESCCEETTTB-------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred EEeCCCcEEEEEcCCcccC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 9999999999988765432 1211 111122345668888899998886653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 335 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-65
Identities = 68/282 (24%), Positives = 123/282 (43%), Gaps = 26/282 (9%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGG--VFKSFDVECEVMKSIRHRNLIKIIS 106
IG GSFG+VYK + +VAVK+ ++ ++F E V++ RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
+ A+V ++ SL L+ ++ + ++I A ++YLH +IH
Sbjct: 72 YSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY---GREGRVS 223
DLK +N+ L +++ + DFG+A + + S Q +I +MAPE + S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 224 TNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHF 283
DVY+FGI+L E T + P I + + L + ++
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV------------- 234
Query: 284 AAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ C + L EC + ++R +I+ + + SL
Sbjct: 235 --RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (488), Expect = 7e-60
Identities = 66/306 (21%), Positives = 125/306 (40%), Gaps = 39/306 (12%)
Query: 33 FSYLELFQATDGFSEN---------NLIGRGSFGSVYKARI----QDGMEVAVKVFHLQ- 78
F++ + +A F++ +IG G FG V + + + VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 79 CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLD 138
+ F E +M H N+I + + ++ E+M +GSL+ L ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 139 IFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198
+ Q + ++ +AA ++YL +H DL N+L++ N+V +SDFG+++ L +
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 199 SKSQTQTL---ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTL 255
+ T L I + APE + + ++ DV+S+GI++ E + +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER----------- 232
Query: 256 KYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIV 315
P M D +D C S + L ++C + R +IV
Sbjct: 233 --------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 316 TRLLKI 321
L K+
Sbjct: 285 NTLDKM 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 9e-58
Identities = 71/280 (25%), Positives = 117/280 (41%), Gaps = 24/280 (8%)
Query: 45 FSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKI 104
+ IG G FG V+ + +VA+K + F E EVM + H L+++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQL 65
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
C LV E+M HG L L + + L + +DV + YL A V
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 122
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVST 224
IH DL N L+ +N V +SDFG+ + + +DQ S T T + + +PE R S+
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 225 NGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFA 284
DV+SFG+++ E F++ K + + ++ + + L S
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------RLYKPRLASTH----- 230
Query: 285 AKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
V+ + C E E R ++ +L +I +S
Sbjct: 231 --------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-57
Identities = 60/277 (21%), Positives = 114/277 (41%), Gaps = 26/277 (9%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLI 102
+ +G G FG V+ +VAVK +F E +MK ++H+ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFGYS 161
++ + + + ++ EYM +GSL L + S L I + L++ +A + ++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGR 221
IH DL+ +N+L+ D + ++DFG+A+L+ +++ ++ I + APE G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 222 VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281
+ DV+SFGI+L E T + ++ +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR--------------- 231
Query: 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
+ C ++ L C E E R + + L
Sbjct: 232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-57
Identities = 62/277 (22%), Positives = 119/277 (42%), Gaps = 24/277 (8%)
Query: 45 FSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKI 104
+ +G G FG V + + +VA+K+ F E +VM ++ H L+++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQL 64
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
C+ ++ EYM +G L L Q L + DV A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVST 224
+H DL N L++D V +SDFG+++ + +D+ S + + + PE + S+
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 225 NGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFA 284
D+++FG+++ E ++ K + F T ++ L + +L S +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK----- 229
Query: 285 AKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
V+ + C E A++R K +++ +L +
Sbjct: 230 --------VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-56
Identities = 62/296 (20%), Positives = 117/296 (39%), Gaps = 29/296 (9%)
Query: 37 ELFQATDGFS-ENNLIGRGSFGSVYKARIQ---DGMEVAVKVFHLQCG-GVFKSFDVECE 91
+LF D + +G G+FGSV + + ++VA+KV + E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 92 VMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA 151
+M + + ++++I C + LV+E G L K L + + ++ V+
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIG 210
++YL +H DL NVLL + A +SDFG++K L +D + +
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 211 YMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270
+ APE + S+ DV+S+G+ + E + + P M+
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-------------------PYKKMKG 218
Query: 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326
+ + K +C ++ L +C + E R + + R+ SL
Sbjct: 219 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-55
Identities = 64/277 (23%), Positives = 121/277 (43%), Gaps = 26/277 (9%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLI 102
+ +G+G FG V+ VA+K ++F E +VMK +RH L+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIF-QRLNIMIDVAAALEYLHFGYS 161
++ + S + +V EYM GSL L Q +++ +A+ + Y+
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGR 221
+H DL+ +N+L+ +N+V ++DFG+A+L+ +++ ++ I + APE GR
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 222 VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281
+ DV+SFGI+L E TK + ++ V++ V+
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRV-------------PYPGMVNREVLDQVE------RGY 231
Query: 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
+C + +L +C + E+R + + L
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-55
Identities = 61/294 (20%), Positives = 114/294 (38%), Gaps = 18/294 (6%)
Query: 36 LELFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQ-CGGVFKSFDVECEVM 93
+EL D F + + +G G+ G V+K G+ +A K+ HL+ + E +V+
Sbjct: 1 MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 94 KSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAAL 153
++ +D ++ +E+M GSL++ L + + + I V L
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMA 213
YL ++H D+KPSN+L++ L DFG++ L + T YM+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMS 171
Query: 214 PEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273
PE + S D++S G+ L+E + P A E+ L + + +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF-GCQVEGDAAETPPRP 230
Query: 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN------AKEIVTRLLKI 321
R + + +F L E + + ++ V + L
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-55
Identities = 77/276 (27%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
IG+G FG V G +VAVK ++F E VM +RH NL++++
Sbjct: 13 QTIGKGEFGDVMLGD-YRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 109 SNDDFK-ALVLEYMPHGSLEKCLYSSNC-VLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
+ +V EYM GSL L S VL L +DV A+EYL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG 226
DL NVL+ ++ VA +SDFG+ K S +Q + + APE RE + ST
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKS 181
Query: 227 DVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286
DV+SFGI+L E ++ + P + + D + A
Sbjct: 182 DVWSFGILLWEIYSFGRV-------------------PYPRIPLKDVVPRVEKGYKMDAP 222
Query: 287 EQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322
+ C V+ + C A R + ++ +L I+
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-54
Identities = 67/287 (23%), Positives = 126/287 (43%), Gaps = 29/287 (10%)
Query: 45 FSENNLIGRGSFGSVYKARIQDG-----MEVAVKVFHLQCG-GVFKSFDVECEVMKSIRH 98
+ +IG G FG VYK ++ + VA+K F E +M H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHF 158
N+I++ S ++ EYM +G+L+K L + + Q + ++ +AA ++YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSKSQTQTLATIGYMAPEYG 217
+ +H DL N+L++ N+V +SDFG++++L + + + + I + APE
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 218 REGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277
+ ++ DV+SFGI++ E T + L VM+ ++
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGER-------------PYWELSNHEVMKAIN----- 227
Query: 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
+ C S ++ L M+C + +R +IV+ L K+ +
Sbjct: 228 -DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 7e-54
Identities = 67/287 (23%), Positives = 123/287 (42%), Gaps = 30/287 (10%)
Query: 48 NNLIGRGSFGSVYKARIQD----GMEVAVKVFH-LQCGGVFKSFDVECEVMKSIRHRNLI 102
N +IGRG FG VY + D + AVK + + G F E +MK H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 103 KIISTCSNDDFKA-LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS 161
++ C + +VL YM HG L + + + + + VA +++L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 148
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED--QSKSQTQTLATIGYMAPEYGRE 219
+H DL N +LD+ ++DFG+A+ + ++ ++T + +MA E +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279
+ +T DV+SFG++L E T+ P P + D + +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 249
Query: 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLL 326
+ E C ++ + ++C AE R + E+V+R+ I + +
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-53
Identities = 61/292 (20%), Positives = 112/292 (38%), Gaps = 22/292 (7%)
Query: 51 IGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN 110
IG+G FG V++ + G EVAVK+F + + + E +RH N++ I+ +
Sbjct: 11 IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 111 DDFKA----LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH-----FGYS 161
D+ LV +Y HGSL L + + + + + A+ L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ--SKSQTQTLATIGYMAPEY--- 216
+ H DLK N+L+ N ++D G+A + + T YMAPE
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 217 ---GREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM-EIVD 272
+ D+Y+ G++ E + ++ V + + M ++V
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324
L + + + + + EC + R+ A I L ++
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-53
Identities = 64/278 (23%), Positives = 116/278 (41%), Gaps = 30/278 (10%)
Query: 47 ENNLIGRGSFGSVYKARIQD---GMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNL 101
E+ +G G+FG+V K Q VAVK+ + + E VM+ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS 161
+++I C + + LV+E G L K L + + + ++ V+ ++YL
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125
Query: 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSKSQTQTLATIGYMAPEYGREG 220
+ +H DL NVLL A +SDFG++K L + + K+QT + + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 221 RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280
+ S+ DV+SFG+++ E F+ + P M+ + + +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQK-------------------PYRGMKGSEVTAMLEKG 226
Query: 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
+ C +++L C E R + RL
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (442), Expect = 3e-53
Identities = 68/281 (24%), Positives = 119/281 (42%), Gaps = 26/281 (9%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNL 101
+ + +G G +G VY+ + + VAVK V + F E VMK I+H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGY 160
++++ C+ + ++ E+M +G+L L N + L + +++A+EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG 220
IH DL N L+ +N + ++DFG+++L+TG D + I + APE
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 191
Query: 221 RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280
+ S DV++FG++L E T + V E+++ +D
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMS-------------PYPGIDLSQVYELLE------KD 232
Query: 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
E C V+ L C + R + EI +
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-52
Identities = 62/292 (21%), Positives = 118/292 (40%), Gaps = 30/292 (10%)
Query: 36 LELFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKV-----FHLQCGGVFKSFDVE 89
L + + T+ F + ++G G+FG+VYK I +G +V + V K E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 90 CEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDV 149
VM S+ + ++ +++ C + L+ + MP G L + + LN + +
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 150 AAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATI 209
A + YL ++H DL NVL+ ++DFG+AKLL E++ I
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 210 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269
+MA E + DV+S+G+ + E T P +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-------------------PYDGIP 218
Query: 270 IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
+ + + + + C V+ + ++C + A+ R +E++ K+
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 1e-51
Identities = 58/272 (21%), Positives = 110/272 (40%), Gaps = 29/272 (10%)
Query: 49 NLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIIST 107
+G G+FG VYKA+ + + A KV + + + VE +++ S H N++K++
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
++ +++E+ G+++ + L Q + AL YLH +IH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY-----GREGRV 222
DLK N+L + L+DFG++ T Q + + T +MAPE ++
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 223 STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKH 282
DV+S GI L+E + P + M ++ + E
Sbjct: 193 DYKADVWSLGITLIEMAEIEPP----HHEL-------------NPMRVLL-KIAKSEPPT 234
Query: 283 FAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
A + S + +C ++ + R ++
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-51
Identities = 59/275 (21%), Positives = 106/275 (38%), Gaps = 25/275 (9%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHL-QCGGVFKSFDVECEVMKSIRHRN 100
+ + +G G++G V A VAVK+ + + ++ E + K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
++K + + L LEY G L + + + + A + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG 220
+ H D+KP N+LLD+ +SDFG+A + ++ + + T+ Y+APE +
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 221 RVSTNG-DVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279
DV+S GI+L + P D+ W ++ + +D+ L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL--- 237
Query: 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
L + VE+ RI +I
Sbjct: 238 ---------------ALLHKILVENPSARITIPDI 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 2e-51
Identities = 73/320 (22%), Positives = 123/320 (38%), Gaps = 54/320 (16%)
Query: 32 RFSYLELFQATDGFSENNLIGRGSFGSVYKAR------IQDGMEVAVKVFHLQC-GGVFK 84
+ LE + IG G+FG V++AR + VAVK+ + +
Sbjct: 4 KLLSLEY--PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 85 SFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNC--------- 135
F E +M + N++K++ C+ L+ EYM +G L + L S +
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 136 --------------VLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 181
L ++L I VAA + YL +H DL N L+ +NMV
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMV 178
Query: 182 AHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK 241
++DFG+++ + D K+ I +M PE R +T DV+++G++L E F+
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 242 KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECT 301
+ V+ V R+ A E C ++NL C
Sbjct: 239 GLQ-------------PYYGMAHEEVIYYV------RDGNILACPENCPLELYNLMRLCW 279
Query: 302 VESAEQRINAKEIVTRLLKI 321
+ R + I L ++
Sbjct: 280 SKLPADRPSFCSIHRILQRM 299
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (430), Expect = 4e-51
Identities = 64/281 (22%), Positives = 107/281 (38%), Gaps = 36/281 (12%)
Query: 42 TDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHL---QCGGVFKSFDVECEVMKSIR 97
FS+ IG GSFG+VY AR +++ VA+K Q ++ E ++ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 98 HRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH 157
H N I+ + LV+EY + + L + + L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY- 216
S +IH D+K N+LL + + L DFG A ++ + T +MAPE
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVI 183
Query: 217 --GREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274
EG+ DV+S GI +E +K P + A + I
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------LYHIAQNE 230
Query: 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIV 315
+ + H++ N C + + R ++ ++
Sbjct: 231 SPALQSGHWSEY------FRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-51
Identities = 58/299 (19%), Positives = 109/299 (36%), Gaps = 51/299 (17%)
Query: 50 LIGRGSFGSVYKA------RIQDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSI-RHRNL 101
++G G+FG V A + ++VAVK+ + ++ E ++M + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 102 IKIISTCSNDDFKALVLEYMPHGSLEKCLYSSN----------------------CVLDI 139
+ ++ C+ L+ EY +G L L S VL
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 140 FQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199
L VA +E+L +H DL NVL+ V + DFG+A+ + +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWV 259
+ + +MAPE EG + DV+S+GI+L E F+ + G
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGIPVDA--- 274
Query: 260 SNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
+ +++ + ++ + C + +R + + + L
Sbjct: 275 ------NFYKLI------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-50
Identities = 63/276 (22%), Positives = 115/276 (41%), Gaps = 33/276 (11%)
Query: 48 NNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKI 104
+ IGRGSF +VYK + +EVA + + F E E++K ++H N+++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 105 I----STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
ST LV E M G+L+ L V+ I + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-R 131
Query: 161 SAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE 219
+ P+IH DLK N+ + + D G+A L ++ + T +MAPE E
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEM-YE 186
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279
+ + DVY+FG+ ++E T + P + + S + P S ++ +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK--- 243
Query: 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIV 315
+ C ++ ++R + K+++
Sbjct: 244 ---------------EIIEGCIRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-50
Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 33/277 (11%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFH---LQCGGVFKSFDVECEVMKSIRH 98
+ F +G+G FG+VY AR Q +A+KV L+ GV E E+ +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHF 158
N++++ + L+LEY P G++ + L + D + + ++A AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH- 123
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR 218
S VIH D+KP N+LL ++DFG + S +T T+ Y+ PE
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIE 177
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278
D++S G++ E K P F + IS +E + ++
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP----FEANT----YQETYKRISRVEFTFPDFVTE 229
Query: 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIV 315
+ ++ + QR +E++
Sbjct: 230 GARDLISR-------------LLKHNPSQRPMLREVL 253
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-50
Identities = 68/280 (24%), Positives = 104/280 (37%), Gaps = 30/280 (10%)
Query: 51 IGRGSFGSVYKARI----QDGMEVAVKVFH---LQCGGVFKSFDVECEVMKSIRHRNLIK 103
+G GSFG V + + VAVK L F E M S+ HRNLI+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 104 IISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP 163
+ K +V E P GSL L + + VA + YL S
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 164 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSKSQTQTLATIGYMAPEYGREGRV 222
IH DL N+LL + + DFG+ + L +D Q + APE +
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 223 STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKH 282
S D + FG+ L E FT + + G + +I+ + +E +
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQE---PWIGL-------------NGSQILHK--IDKEGER 233
Query: 283 FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322
E C ++N+ ++C E R + LL+ +
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 8e-50
Identities = 60/304 (19%), Positives = 108/304 (35%), Gaps = 46/304 (15%)
Query: 43 DGFSENNLIGRGSFGSVYKARI------QDGMEVAVKVFHL-QCGGVFKSFDVECEVMKS 95
+ S +G G+FG V +A M VAVK+ ++ E +V+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 96 I-RHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSS-----------------NCVL 137
+ H N++ ++ C+ ++ EY +G L L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 138 DIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197
D+ L+ VA + +L S IH DL N+LL + + DFG+A+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKY 257
+ + +MAPE + DV+S+GI L E F+ +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 258 WVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317
+ +E + E + ++++ C +R K+IV
Sbjct: 260 MI------------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 318 LLKI 321
+ K
Sbjct: 302 IEKQ 305
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-49
Identities = 61/283 (21%), Positives = 100/283 (35%), Gaps = 32/283 (11%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHR 99
+ + IG GS+G K R DG + K + E +++ ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 100 NLIKIISTC--SNDDFKALVLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALE 154
N+++ + +V+EY G L + LD L +M + AL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 155 YLH--FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212
H V+H DLKP+NV LD L DFG+A++L + + T YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYM 181
Query: 213 APEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272
+PE + D++S G +L E P F S E+
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF-------------SQKELAG 224
Query: 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIV 315
RE K + + + R + +EI+
Sbjct: 225 KI---REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-49
Identities = 67/267 (25%), Positives = 115/267 (43%), Gaps = 26/267 (9%)
Query: 49 NLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIIST 107
IG+G+ G+VY A + G EVA++ +LQ + E VM+ ++ N++ + +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 108 CSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHC 167
D +V+EY+ GSL + + D Q + + ALE+LH S VIH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHR 140
Query: 168 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGD 227
D+K N+LL + L+DFG +T E + + + T +MAPE D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 228 VYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKE 287
++S GIM +E + P + E P+ + ++ + E
Sbjct: 199 IWSLGIMAIEMIEGEPP----YLNEN----------PLRALYLI----ATNGTPELQNPE 240
Query: 288 QCVSFVFNLAMECTVESAEQRINAKEI 314
+ + + C E+R +AKE+
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 9e-49
Identities = 64/279 (22%), Positives = 114/279 (40%), Gaps = 29/279 (10%)
Query: 40 QATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVF---HLQCGGVFKSFDVECEVMKS 95
+ + F ++G GSF +V AR + E A+K+ H+ E +VM
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 96 IRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEY 155
+ H +K+ T +D+ L Y +G L K + D ++ +ALEY
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEY 123
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
LH +IH DLKP N+LL+++M ++DFG AK+L+ E + + T Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 216 YGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275
E + D+++ G ++ + P F + I +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAG-------------NEYLIFQKII 223
Query: 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
+ E+ +L + V A +R+ +E+
Sbjct: 224 ----KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-48
Identities = 73/301 (24%), Positives = 125/301 (41%), Gaps = 45/301 (14%)
Query: 43 DGFSENNLIGRGSFGSVYKARIQDG---MEVAVKVFH-LQCGGVFKSFDVECEVMKSI-R 97
+ ++IG G+FG V KARI+ M+ A+K + F E EV+ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 98 HRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLY---------------SSNCVLDIFQR 142
H N+I ++ C + + L +EY PHG+L L S+ L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 143 LNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQ 202
L+ DVA ++YL IH DL N+L+ +N VA ++DFG+++ G++ +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262
T + +MA E +TN DV+S+G++L E +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT------------------ 225
Query: 263 LPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322
P M + + C V++L +C E +R + +I+ L ++
Sbjct: 226 -PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
Query: 323 D 323
+
Sbjct: 285 E 285
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (411), Expect = 6e-48
Identities = 50/268 (18%), Positives = 96/268 (35%), Gaps = 26/268 (9%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
+G G+FG V++ G A K ++ E + M +RH L+ +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+D+ ++ E+M G L + + + + + + M V L ++H +H D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149
Query: 169 LKPSNVLL--DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG 226
LKP N++ + L DFG+ L + K T T + APE V
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKPVGYYT 206
Query: 227 DVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286
D++S G++ + P F GE + ++ + + +
Sbjct: 207 DMWSVGVLSYILLSGLSP----FGGENDDE---------TLRNVKSCDWNMDDSAFSGIS 253
Query: 287 EQCVSFVFNLAMECTVESAEQRINAKEI 314
E F+ + + R+ +
Sbjct: 254 EDGKDFI----RKLLLADPNTRMTIHQA 277
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 2e-47
Identities = 58/295 (19%), Positives = 124/295 (42%), Gaps = 38/295 (12%)
Query: 45 FSENNLIGRGSFGSVYKA------RIQDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIR 97
+ + +G+GSFG VY+ + + VA+K + F E VMK
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 98 HRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLY---------SSNCVLDIFQRLNIMID 148
++++++ S +++E M G L+ L + + + + +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 149 VAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLAT 208
+A + YL+ + +H DL N ++ ++ + DFG+ + + D + + L
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 209 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268
+ +M+PE ++G +T DV+SFG++L E T + + + E L++
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----------- 247
Query: 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323
+++ LL + D C +F L C + + R + EI++ + + +
Sbjct: 248 -VMEGGLLDKPDN-------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-47
Identities = 59/279 (21%), Positives = 104/279 (37%), Gaps = 29/279 (10%)
Query: 50 LIGRGSFGSVYKARI----QDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKI 104
IG G FG V++ + VA+K V + F E M+ H +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
I + ++ +++E G L L LD+ + ++ AL YL S
Sbjct: 74 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVST 224
+H D+ NVL+ N L DFG+++ + K+ L I +MAPE R ++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTS 188
Query: 225 NGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFA 284
DV+ FG+ + E P ++ D +
Sbjct: 189 ASDVWMFGVCMWEILMHGVK-------------------PFQGVKNNDVIGRIENGERLP 229
Query: 285 AKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323
C +++L +C +R E+ +L I +
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (406), Expect = 4e-47
Identities = 50/268 (18%), Positives = 99/268 (36%), Gaps = 26/268 (9%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
+G G+FG V++ G K + + E +M + H LI +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ L+LE++ G L + + + + + +N M L+++H ++H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 169 LKPSNVLLD--DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG 226
+KP N++ + + DFG+A L + + T AT + APE V
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 227 DVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286
D+++ G++ + P FAGE L+ + + ED +
Sbjct: 210 DMWAIGVLGYVLLSGLSP----FAGEDDLETL---------QNVKRCDWEFDEDAFSSVS 256
Query: 287 EQCVSFVFNLAMECTVESAEQRINAKEI 314
+ F+ + +R+ +
Sbjct: 257 PEAKDFI----KNLLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 155 bits (392), Expect = 6e-46
Identities = 62/292 (21%), Positives = 123/292 (42%), Gaps = 31/292 (10%)
Query: 42 TDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG---GVFKSFDVECEVMKSIR 97
+D + ++G G V+ AR ++ +VAVKV + F E + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 98 HRNLIKIISTCSNDDFKA----LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAAL 153
H ++ + T + +V+EY+ +L +++ + + + ++ D AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLA-TIGYM 212
+ H +IH D+KP+N+++ + DFGIA+ + S +QT + T Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 213 APEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272
+PE R V DVYS G +L E T + P F G+ S + +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD-------------SPVSVAY 224
Query: 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI-NAKEIVTRLLKIRD 323
++ A E + + + ++ ++ E R A E+ L+++ +
Sbjct: 225 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-44
Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 47/304 (15%)
Query: 43 DGFSENNLIGRGSFGSVYKAR--------IQDGMEVAVKVFHLQCG-GVFKSFDVECEVM 93
D +G G+FG V A +VAVK+ E E+M
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 94 KSI-RHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCL---------------YSSNCVL 137
K I +H+N+I ++ C+ D +++EY G+L + L ++ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 138 DIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197
++ VA +EYL S IH DL NVL+ ++ V ++DFG+A+ + D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKY 257
K T + +MAPE + + DV+SFG++L E FT
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236
Query: 258 WVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317
P + + + L +E C + ++ + +C QR K++V
Sbjct: 237 ------PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 318 LLKI 321
L +I
Sbjct: 291 LDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-42
Identities = 52/268 (19%), Positives = 105/268 (39%), Gaps = 27/268 (10%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
+GRG FG V++ K ++ E ++ RHRN++ + +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ + ++ E++ + + + +S L+ + ++ + V AL++LH S + H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 169 LKPSNVLLD--DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG 226
++P N++ + + +FG A+ L D + Y APE + VST
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPEVHQHDVVSTAT 184
Query: 227 DVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAK 286
D++S G ++ + P F E + I++A E+
Sbjct: 185 DMWSLGTLVYVLLSGINP----FLAETNQQII---------ENIMNAEYTFDEEAFKEIS 231
Query: 287 EQCVSFVFNLAMECTVESAEQRINAKEI 314
+ + FV V+ + R+ A E
Sbjct: 232 IEAMDFV----DRLLVKERKSRMTASEA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-41
Identities = 60/306 (19%), Positives = 109/306 (35%), Gaps = 45/306 (14%)
Query: 43 DGFSENNLIGRGSFGSVYKAR------IQDGMEVAVKVFHLQCG-GVFKSFDVECEVMKS 95
D +GRG+FG V +A VAVK+ ++ E +++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 96 IRHRNLIKII--STCSNDDFKALVLEYMPHGSLEKCLYSSNC---------------VLD 138
I H + + + +++E+ G+L L S L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 139 IFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198
+ + VA +E+L S IH DL N+LL + V + DFG+A+ + +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYW 258
+ + +MAPE + + DV+SFG++L E F+ + G + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEF 246
Query: 259 VSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRL 318
L +E A + ++ ++C QR E+V L
Sbjct: 247 CRRL---------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 319 LKIRDS 324
+ +
Sbjct: 292 GNLLQA 297
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 5e-41
Identities = 49/275 (17%), Positives = 97/275 (35%), Gaps = 23/275 (8%)
Query: 42 TDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHR 99
D + +++G G+F V A + VA+K + G S + E V+ I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 100 NLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG 159
N++ + + L+++ + G L + ++ V A++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE 219
LD++ +SDFG++K+ ED + T GY+APE +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 183
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279
S D +S G++ P F E + ++ + L +
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP----FYDE-------------NDAKLFEQILKAEY 226
Query: 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
+ + + + E+R ++
Sbjct: 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 142 bits (358), Expect = 8e-41
Identities = 63/289 (21%), Positives = 109/289 (37%), Gaps = 41/289 (14%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDV---------ECEV 92
+ + ++GRG V + E AVK+ + GG F + +V E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 93 MKSIR-HRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAA 151
++ + H N+I++ T + F LV + M G L L + L + IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121
Query: 152 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGY 211
+ LH ++H DLKP N+LLDD+M L+DFG + L D + + T Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSY 175
Query: 212 MAPEYGREGRVSTNG------DVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI 265
+APE + D++S G+++ P F
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHR------------- 218
Query: 266 SVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
M ++ + + V +L V ++R A+E
Sbjct: 219 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 143 bits (361), Expect = 2e-40
Identities = 53/241 (21%), Positives = 100/241 (41%), Gaps = 16/241 (6%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHL------QCGGVFKSFDVECEVMKS 95
+ FS + +IGRG FG VY R G A+K Q + + + ++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 96 IRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEY 155
++ + D + +L+ M G L L + ++ LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE 215
+H + V++ DLKP+N+LLD++ +SD G+A + K ++ T GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPE 175
Query: 216 YGREGR-VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274
++G ++ D +S G ML + P + + ++ + + + +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 275 L 275
L
Sbjct: 236 L 236
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 141 bits (357), Expect = 3e-40
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 22/225 (9%)
Query: 49 NLIGRGSFGSVYKAR-IQDGMEVAVKVFH---LQCGGVFKSFDVECEVMKSIRHRNLIKI 104
+G GSFG V+ R +G A+KV + + + E ++ + H +I++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 105 ISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPV 164
T + ++++Y+ G L + +V ALEYLH S +
Sbjct: 70 WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125
Query: 165 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVST 224
I+ DLKP N+LLD N ++DFG AK + + T Y+APE +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNK 180
Query: 225 NGDVYSFGIMLMETFTKKKP---------TDKIFAGEMTLKYWVS 260
+ D +SFGI++ E P +KI E+ + +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN 225
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 8e-40
Identities = 66/284 (23%), Positives = 116/284 (40%), Gaps = 28/284 (9%)
Query: 49 NLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQC-----GGVFKSFDVECEVMKSIRHRNLI 102
+ +G G F +VYKAR VA+K L G+ ++ E ++++ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 103 KIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
++ + +LV ++M + ++ VL M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 163 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV 222
++H DLKP+N+LLD+N V L+DFG+AK +++ T + T Y APE R+
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 223 -STNGDVYSFGIMLMETFTKKKP---------TDKIFA--GEMTLKYWVSNLLPISVMEI 270
D+++ G +L E + +IF G T + W +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
+ AA + + + + + RI A +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLI----QGLFLFNPCARITATQA 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-38
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 11/207 (5%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGV---FKSFDVECEVM-KSIR 97
+ F + ++G+GSFG V+ A + A+K + + VE V+ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 98 HRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH 157
H L + T + V+EY+ G L + S + D+ + ++ L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYG 217
S +++ DLK N+LLD + ++DFG+ K D T Y+APE
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEIL 175
Query: 218 REGRVSTNGDVYSFGIMLMETFTKKKP 244
+ + + D +SFG++L E + P
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-38
Identities = 65/292 (22%), Positives = 113/292 (38%), Gaps = 35/292 (11%)
Query: 45 FSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIK 103
+++ +IG GSFG VY+A+ G VA+K + + E ++M+ + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 104 IISTC------SNDDFKALVLEYMPHGSLEKCLY--SSNCVLDIFQRLNIMIDVAAALEY 155
+ ++ + LVL+Y+P + + L + M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 156 LHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAP 214
+H S + H D+KP N+LLD D V L DFG AK L + + +
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPE 192
Query: 215 EYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEM---TLKYWVSNLLPISVMEIV 271
+++ DV+S G +L E + F G+ L + L + +I
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 272 DANLLSREDKHFAAKEQCVSFVF---------NLAMECTVESAEQRINAKEI 314
+ N E K K + VF L + R+ E
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (342), Expect = 3e-38
Identities = 54/281 (19%), Positives = 94/281 (33%), Gaps = 27/281 (9%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
IG GSFG +Y I G EVA+K+ ++ +E ++ K ++ I I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ +++ + SLE + + L + + + +EY+H S IH D
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128
Query: 169 LKPSNVL---LDDNMVAHLSDFGIAKLLTGED-----QSKSQTQTLATIGYMAPEYGREG 220
+KP N L + ++ DFG+AK + T Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 221 RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280
S D+ S G +LM P + A KY + +S V E
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248
Query: 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321
+ C + + + + +
Sbjct: 249 ATYLNF-------------CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-38
Identities = 59/283 (20%), Positives = 104/283 (36%), Gaps = 35/283 (12%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHL------QCGGVFKSFDVECEVMKS 95
D + +G G F V K R G++ A K + G + + E ++K
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 96 IRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEY 155
I+H N+I + N L+LE + G L + L + + + + Y
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYY 128
Query: 156 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSKSQTQTLATIGY 211
LH S + H DLKP N++L D V + DFG+A + D T +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182
Query: 212 MAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271
+APE + D++S G++ + P F G+ + V
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDT----------KQETLANV 228
Query: 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
A ED++F + + V+ ++R+ ++
Sbjct: 229 SAVNYEFEDEYF---SNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 4e-38
Identities = 61/294 (20%), Positives = 111/294 (37%), Gaps = 19/294 (6%)
Query: 37 ELFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFH-LQCGGVFKSFDVECEVMK 94
++F ++ + IG G++G V A + + VA+K + + E +++
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 95 SIRHRNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYS--SNCVLDIFQRLNIMIDVAAA 152
RH N+I I + + Y+ + LY L + +
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 153 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSKSQTQTLATIGY 211
L+Y+H SA V+H DLKPSN+LL+ + DFG+A++ D + T+ +AT Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 212 MAPEYGREGRVSTN-GDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270
APE + T D++S G +L E + + + P
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 271 VDANLLSREDKHFAAKEQCVSF----------VFNLAMECTVESAEQRINAKEI 314
NL +R + V + +L + + +RI ++
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 134 bits (338), Expect = 6e-38
Identities = 60/278 (21%), Positives = 108/278 (38%), Gaps = 19/278 (6%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIIS 106
IG G++G VYKA+ G A+K L+ G+ + E ++K ++H N++K+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIH 166
LV E++ L+K L L+ + ++ + + Y H V+H
Sbjct: 68 VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 167 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNG 226
DLKP N+L++ ++DFG+A+ G K + + + ST
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 227 DVYSFGIMLMETFTKKKP---------TDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277
D++S G + E +IF T N ++ + D N
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS--KNWPNVTELPKYDPNFTV 240
Query: 278 REDKHFAAKEQCVSFVF-NLAMECTVESAEQRINAKEI 314
E + + + + +L + QRI AK+
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 7e-38
Identities = 65/284 (22%), Positives = 118/284 (41%), Gaps = 17/284 (5%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHR 99
+ F + IG G++G VYKAR G VA+K L GV + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 100 NLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG 159
N++K++ ++ LV E++ + S+ + + + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 160 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE-YGR 218
S V+H DLKP N+L++ L+DFG+A+ ++ T + T+ Y APE
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278
ST D++S G + E T++ + + + + P V+ ++
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 279 EDKHFAAKEQCVSFVF--------NLAMECTVESAEQRINAKEI 314
+ Q S V +L + +RI+AK
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-37
Identities = 49/275 (17%), Positives = 97/275 (35%), Gaps = 34/275 (12%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVM-KSIRHRNLIKIIST 107
++G G G V + + + A+K+ E E+ ++ + ++++I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 108 C----SNDDFKALVLEYMPHGSLEKCLYS-SNCVLDIFQRLNIMIDVAAALEYLHFGYSA 162
+ +V+E + G L + + + IM + A++YLH S
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 163 PVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE 219
+ H D+KP N+L N + L+DFG AK T + + T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 220 GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279
+ + D++S G+++ P ++ + + + +S E
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
K QR+ E
Sbjct: 248 VKMLIRN-------------LLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 3e-37
Identities = 53/228 (23%), Positives = 87/228 (38%), Gaps = 21/228 (9%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVF------KSFDVECEVMKSIR--HRN 100
L+G G FGSVY + D + VA+K + +E ++K +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 101 LIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
+I+++ D L+LE + L + V A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 161 SAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGRE 219
+ V+H D+K N+L+D + L DFG LL T T Y PE+ R
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRY 183
Query: 220 GRVSTNG-DVYSFGIMLMETFTKKKP---TDKIFAGEMTLKYWVSNLL 263
R V+S GI+L + P ++I G++ + VS+
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-36
Identities = 68/288 (23%), Positives = 119/288 (41%), Gaps = 32/288 (11%)
Query: 49 NLIGRGSFGSVYKAR--IQDGMEVAVKVFHLQCG--GVFKSFDVECEVMK---SIRHRNL 101
IG G++G V+KAR G VA+K +Q G G+ S E V++ + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 102 IKIISTCSNDDFKA-----LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYL 156
+++ C+ LV E++ + ++M + L++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 157 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEY 216
H S V+H DLKP N+L+ + L+DFG+A++ + T + T+ Y APE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEV 186
Query: 217 GREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGE---MTLKYWVSNLLPISVMEIVDA 273
+ +T D++S G + E F +K F G L + + +
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPL----FRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 274 NLLSREDKHFAAKEQCVSFV-------FNLAMECTVESAEQRINAKEI 314
L R+ H + + FV +L ++C + +RI+A
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 126 bits (317), Expect = 1e-34
Identities = 41/289 (14%), Positives = 84/289 (29%), Gaps = 33/289 (11%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
IG GSFG +++ + + +VA+K + E K + I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 109 SNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCD 168
+ +++ + SLE L + + A ++ +H +++ D
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126
Query: 169 LKPSNVLLDDNMVAH-----LSDFGIAKLLTGEDQSKSQ-----TQTLATIGYMAPEYGR 218
+KP N L+ + + DFG+ K + T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYW--VSNLLPISVMEIVDANLL 276
S D+ + G + M P + A KY + E+
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA---- 242
Query: 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325
+ + + + + K+ + L
Sbjct: 243 -----------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-34
Identities = 59/291 (20%), Positives = 117/291 (40%), Gaps = 29/291 (9%)
Query: 49 NLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKII 105
IG+G+FG V+KAR + G +VA+K ++ G + E ++++ ++H N++ +I
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 106 STCSNDDFKA--------LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLH 157
C LV ++ H + + +M + L L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQML---LNGLY 131
Query: 158 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQT--LATIGYMAPE 215
+ + ++H D+K +NVL+ + V L+DFG+A+ + S+ T + T+ Y PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 216 YGREGR-VSTNGDVYSFGIMLMETFTKKKPTD---------KIFA--GEMTLKYWVSNLL 263
R D++ G ++ E +T+ I G +T + W +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 264 PISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
++ R+ K + +L + V QRI++ +
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 4e-34
Identities = 58/279 (20%), Positives = 109/279 (39%), Gaps = 19/279 (6%)
Query: 49 NLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG--GVFKSFDVECEVMKSIRHRNLIKII 105
IG G++G+V+KA+ + VA+K L GV S E ++K ++H+N++++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 106 STCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVI 165
+D LV E+ + + + D + + + L + H V+
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVL 123
Query: 166 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPE-YGREGRVST 224
H DLKP N+L++ N L++FG+A+ + + + T+ Y P+ ST
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 225 NGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFA 284
+ D++S G + E +P + LK L + + L +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 285 AKEQCVSFVF---------NLAMECTVESAEQRINAKEI 314
+L + QRI+A+E
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 5e-34
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 10/206 (4%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCG---GVFKSFDVECEVMKSIRH 98
+ F L+G+G+FG V R G A+K+ + E V+++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHF 158
L + D V+EY G L L S V + ++ +ALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR 218
S V++ D+K N++LD + ++DFG+ K + + T Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLE 178
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKP 244
+ D + G+++ E + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (306), Expect = 1e-32
Identities = 53/249 (21%), Positives = 99/249 (39%), Gaps = 22/249 (8%)
Query: 43 DGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFH---LQCGGVFKSFDVECEVMKSIRH 98
D F +G GSFG V + + G A+K+ + + E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 99 RNLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHF 158
L+K+ + ++ +V+EY+ G + L + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158
Query: 159 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGR 218
S +I+ DLKP N+L+D ++DFG AK + G + T +APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIIL 211
Query: 219 EGRVSTNGDVYSFGIMLMETFTKKKP---------TDKIFAGEMTLKYWVSNLLPISVME 269
+ D ++ G+++ E P +KI +G++ S+ L +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 270 IVDANLLSR 278
++ +L R
Sbjct: 272 LLQVDLTKR 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-32
Identities = 65/305 (21%), Positives = 116/305 (38%), Gaps = 33/305 (10%)
Query: 33 FSYLELFQATDGFSEN----NLIGRGSFGSVYKAR-IQDGMEVAVKVFH--LQCGGVFKS 85
F E+ + +G G++G+V A + G +VA+K + Q K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 86 FDVECEVMKSIRHRNLIKIISTCSNDDFKA------LVLEYMPHGSLEKCLYSSNCVLDI 139
E ++K +RH N+I ++ + D+ LV+ +M + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGE 120
Query: 140 FQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199
+ ++ + L Y+H +A +IH DLKP N+ ++++ + DFG+A+ + S
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADS 173
Query: 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP---------TDKIFA 250
+ + R + D++S G ++ E T K +I
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 251 GEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVF-NLAMECTVESAEQRI 309
T L + L E K FA+ S + NL + V AEQR+
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 310 NAKEI 314
A E
Sbjct: 294 TAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-30
Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 16/213 (7%)
Query: 43 DGFSENNLIGRGSFGSVYKAR----IQDGMEVAVKVFH----LQCGGVFKSFDVECEVMK 94
+ F ++G G++G V+ R G A+KV +Q + E +V++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 95 SIRHR-NLIKIISTCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAAL 153
IR L+ + + L+L+Y+ G L L F + I V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMA 213
L + +I+ D+K N+LLD N L+DFG++K ++ ++ TI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMA 198
Query: 214 PEYGREGRVSTNG--DVYSFGIMLMETFTKKKP 244
P+ R G + D +S G+++ E T P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 115 bits (289), Expect = 2e-30
Identities = 52/235 (22%), Positives = 106/235 (45%), Gaps = 20/235 (8%)
Query: 17 QLPNDANMP-PVATWRRFSYLELFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKV 74
++ D N P W S++ + D + +GRG + V++A I + +V VK+
Sbjct: 8 RVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI 67
Query: 75 FHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFK--ALVLEYMPHGSLEKCLY 131
K E ++++++R N+I + + + ALV E++ + ++
Sbjct: 68 LKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 132 SSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIA 190
+ L + M ++ AL+Y H S ++H D+KP NV++D ++ L D+G+A
Sbjct: 125 T----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177
Query: 191 KLLTGEDQSKSQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTKKKP 244
+ + +A+ + PE + + + D++S G ML +K+P
Sbjct: 178 EFY---HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-29
Identities = 56/294 (19%), Positives = 110/294 (37%), Gaps = 25/294 (8%)
Query: 38 LFQATDGFSENNLIGRGSFGSVYKAR-IQDGMEVAVKVFH--LQCGGVFKSFDVECEVMK 94
+++ + + + +G G++GSV A + G+ VAVK Q K E ++K
Sbjct: 13 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 95 SIRHRNLIKIISTCSND----DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVA 150
++H N+I ++ + +F + L G+ + L ++ +
Sbjct: 73 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 131
Query: 151 AALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIG 210
L+Y+H SA +IH DLKPSN+ ++++ + DFG+A+ E T
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWY 184
Query: 211 YMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKP---------TDKIFAGEMTLKYWVSN 261
+ D++S G ++ E T + I T +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 262 LLPISVMEIVDANLLSREDKHFAAKEQCVS-FVFNLAMECTVESAEQRINAKEI 314
+ +L +FA + +L + V +++RI A +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 5e-28
Identities = 41/212 (19%), Positives = 81/212 (38%), Gaps = 20/212 (9%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTC 108
+G G F +V+ A+ + + VA+K+ ++ + E ++++ + + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 109 SNDDFK---------------ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAAL 153
+N K +V E + L + + + I + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 154 EYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYM 212
+Y+H +IH D+KP NVL++ + +L IA L + T ++ T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 213 APEYGREGRVSTNGDVYSFGIMLMETFTKKKP 244
+PE D++S ++ E T
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 6e-27
Identities = 61/295 (20%), Positives = 107/295 (36%), Gaps = 40/295 (13%)
Query: 50 LIGRGSFGSVYKAR-IQDGMEVAVKVFH--LQCGGVFKSFDVECEVMKSIRHRNLIKIIS 106
IG G+ G V A VA+K Q K E +MK + H+N+I +++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 107 TCSNDDFK------ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGY 160
+ LV+E M + D + ++ + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH--- 136
Query: 161 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREG 220
SA +IH DLKPSN+++ + + DFG+A+ S T + T Y APE
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 221 RVSTNGDVYSFGIMLMETFTKKKP---------TDKIFAG------------EMTLKYWV 259
N D++S G ++ E K +K+ + T++ +V
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 260 SNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEI 314
N + + S + S +L + V +RI+ +
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.1 bits (202), Expect = 3e-19
Identities = 27/203 (13%), Positives = 63/203 (31%), Gaps = 31/203 (15%)
Query: 49 NLIGRGSFGSVYKARIQDGMEVAVKVFHL----------QCGGVFKSFDVECEVMKSIRH 98
L+G G +V+ + E VK + + F V
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 99 RNLIKIISTCSNDDF----KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALE 154
R L K+ + A+++E + L + + ++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117
Query: 155 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAP 214
+ ++H DL NVL+ + + + DF + + + + + +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEV---GEEGWREILERDVRNIIT 170
Query: 215 EYGREGRVSTNGDVYSFGIMLME 237
+ R R D+ S +++
Sbjct: 171 YFSRTYRTEK--DINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 335 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.96 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.39 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.98 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.55 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.46 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.38 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=380.70 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=213.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.++|++.+.||+|+||+||+|... +|+.||+|++........+.+.+|+++++.++||||+++++++.+.+.+|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 358999999999999999999764 6999999999876655668899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++||+|.+++... .+++..+..++.||+.||.||| +++++|+||||+|||++.+|.+||+|||++..+... ..
T Consensus 99 ~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QS 171 (293)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TC
T ss_pred cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc--cc
Confidence 9999999988765 5999999999999999999999 999999999999999999999999999999876422 22
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ..... ..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-------------~~~~~-----~~ 233 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-------------LIATN-----GT 233 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------------HHHHH-----CS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH-------------HHHhC-----CC
Confidence 3445679999999999999999999999999999999999999997643221110 11111 11
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.....+..+++.+.+||.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122334567788999999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-56 Score=381.83 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=209.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
.-++|++.+.||+|+||+||+|.++ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 3468999999999999999999865 68999999997553 234467889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++|+|.+++.... .+++..++.++.||+.||.||| +++++|+||||+||+++.++.+||+|||++..+.....
T Consensus 83 Ey~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp ECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred eccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 9999999999987543 7999999999999999999999 99999999999999999999999999999987643333
Q ss_pred ccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............. ...
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~------------~~~---- 222 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW------------KEK---- 222 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH------------HTT----
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH------------hcC----
Confidence 344456789999999999988776 578999999999999999999997654332222111 111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.........+++++.+|+.+||+.||++|||++|+++
T Consensus 223 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 223 --KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111123445777999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=378.92 Aligned_cols=263 Identities=27% Similarity=0.425 Sum_probs=210.9
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
.++|++.+.||+|+||+||+|+.+ ..||||+++.. +....+.+.+|++++++++||||+++++++.. +.+++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 478999999999999999999865 46999998654 34556789999999999999999999998754 56789999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+++|+|.+++......+++..+..++.||+.||.||| +++++||||||+||+++.++.+||+|||++.........
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999877668999999999999999999999 999999999999999999999999999999876433333
Q ss_pred cccccccccccccCccccCCC---CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 200 KSQTQTLATIGYMAPEYGREG---RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~---~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ...+.....
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~-------------~~~~~~~~~ 227 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-------------IFMVGRGYL 227 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-------------HHHHHHTSC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH-------------HHHHhcCCC
Confidence 344456789999999998653 4788999999999999999999999765332211 111111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
. ......+..+++++.+|+.+||+.||++|||++||++.|+.++.++
T Consensus 228 ~--p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 228 S--PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp C--CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred C--CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 1 1111223456788999999999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=378.26 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=207.5
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|++.+.||+|+||+||+|.+.+++.||||++.... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 36899999999999999999998888899999987543 34478999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
++|+|.+++......+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+|||++....... ...
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~ 158 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 158 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCC-cee
Confidence 999999999877778999999999999999999999 9999999999999999999999999999998764322 223
Q ss_pred cccccccccccCccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTK-KKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
.....+|..|+|||++.+..++.++||||||+++|||+++ .+||......+. ...+...
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~--------------~~~i~~~------ 218 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--------------VEDISTG------ 218 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH--------------HHHHHHT------
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH--------------HHHHHhc------
Confidence 3346789999999999999999999999999999999995 555544321111 1111111
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
.+...+..+++++.+|+.+||+.||++|||++||++.|+++.++
T Consensus 219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11122345577899999999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-55 Score=375.04 Aligned_cols=246 Identities=26% Similarity=0.366 Sum_probs=209.4
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++.+.||+|+||.||+|..+ +++.||+|++... .......+.+|+++++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 5899999998643 2344577899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++|+|.+++.... .+++..+..++.||+.||.||| +++++|+||||+||+++.++.+||+|||++....
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~---- 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 157 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----
T ss_pred eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecC----
Confidence 9999999999997654 7999999999999999999999 9999999999999999999999999999997653
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||......+. ......
T Consensus 158 ~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----------------~~~i~~-- 218 (263)
T d2j4za1 158 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----------------YKRISR-- 218 (263)
T ss_dssp CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------HHHHHT--
T ss_pred CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-----------------HHHHHc--
Confidence 2223456799999999999999999999999999999999999999976432211 111111
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.....+..+++++.+|+.+||+.||++|||++|+++.
T Consensus 219 --~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 219 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 0111234567789999999999999999999999863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-55 Score=379.54 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=212.6
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
+.|++.+.||+|+||.||+|.+. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999865 68999999998777777788999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
++|+|.+++.+....+++..+..++.||+.||.||| +++++|+||||+||+++.++.+||+|||++..... ....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC--Cccc
Confidence 999999998766667999999999999999999999 99999999999999999999999999999876521 1223
Q ss_pred cccccccccccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 202 QTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.....||+.|+|||++. +..++.++|||||||++|+|++|..||......+... .+..
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~-------------~i~~---- 229 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-------------KIAK---- 229 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-------------HHHH----
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH-------------HHHc----
Confidence 34567999999999874 4557899999999999999999999997654322111 1111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
........+..+++++.+||.+||+.||++|||++|+++
T Consensus 230 -~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 230 -SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223334567888999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=368.95 Aligned_cols=254 Identities=24% Similarity=0.409 Sum_probs=217.5
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|++.+.||+|+||+||+|++++++.||||+++.+.. ..+.+.+|++++++++||||+++++++.+.+.+++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 378999999999999999999998888999999986543 3478999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
++|+|.+++......+++..++.++.|+++||.||| +.+++|+||+|+||+++.++.+||+|||++...... ....
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 157 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS 157 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCC-Ccee
Confidence 999999998877778999999999999999999999 999999999999999999999999999999876432 2223
Q ss_pred cccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 202 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
.....+|..|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..+.. .
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~--------------~~i~~------~ 217 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--------------EHIAQ------G 217 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH--------------HHHHT------T
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH--------------HHHHh------C
Confidence 344678999999999999999999999999999999998 89999765432211 11111 1
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHH
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLK 320 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 320 (335)
.+...+..+++.+.+||.+||+.||++|||++|+++.|.+
T Consensus 218 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1222345567789999999999999999999999999854
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-54 Score=377.35 Aligned_cols=255 Identities=20% Similarity=0.281 Sum_probs=197.7
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
..+.++|++.+.||+|+||+||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++.+.+.+|+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 345678999999999999999999865 68999999997543 2334567899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC---CCCcEEEeeccccccc
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLL 193 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~---~~~~v~l~dfg~~~~~ 193 (335)
||||++|++|.+++...+ .+++..+..++.||+.||.||| +++++|+||||+||++. +++.+||+|||++...
T Consensus 85 vmE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEeccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999999997654 7999999999999999999999 99999999999999995 5789999999999865
Q ss_pred cCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA 273 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (335)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||......+ ....
T Consensus 161 ~~---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----------------~~~~ 220 (307)
T d1a06a_ 161 DP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-----------------LFEQ 220 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----------------HHHH
T ss_pred cC---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-----------------HHHH
Confidence 32 223344679999999999999999999999999999999999999997643221 1111
Q ss_pred hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 274 NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..........+....+++++.+|+.+||+.||++|||++|+++.
T Consensus 221 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 221 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11122222222334567889999999999999999999999873
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-53 Score=380.72 Aligned_cols=253 Identities=19% Similarity=0.251 Sum_probs=213.8
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.++|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.+.+.+++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999864 6899999999766555667889999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC--CCCcEEEeeccccccccCCcc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~--~~~~v~l~dfg~~~~~~~~~~ 198 (335)
++||+|.+++....+.+++..++.++.||+.||.||| +++++|+||||+||+++ .++.+||+|||++..+..
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--- 178 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 178 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT---
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccc---
Confidence 9999999999776668999999999999999999999 99999999999999996 467899999999987632
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........||+.|+|||++.+..++.++|||||||++|+|++|..||......+. +.......
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----------------~~~i~~~~ 241 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-----------------LRNVKSCD 241 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHHHTC
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-----------------HHHHHhCC
Confidence 2333456789999999999999999999999999999999999999976432211 11111111
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..........+++++.+||.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111222234567789999999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-54 Score=376.05 Aligned_cols=262 Identities=25% Similarity=0.395 Sum_probs=217.8
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
.++|++.+.||+|+||+||+|.+. +++.||||+++.+.. ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 468999999999999999999875 588999999875543 457899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 121 MPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 121 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
+++|+|.+++... ...+++..++.++.||+.||.||| +++++||||||+|||++.++.+||+|||++...... ..
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TY 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-SS
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC-Cc
Confidence 9999999998753 457999999999999999999999 999999999999999999999999999999876432 22
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......+++.|+|||++.+..++.++|||||||++|+|++|..||........ ....+...
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-------------~~~~i~~~----- 232 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------VYELLEKD----- 232 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------------HHHHHHTT-----
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-------------HHHHHhcC-----
Confidence 333445688999999999999999999999999999999997776543222111 11222221
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
.+...+..+++.+.+|+.+||+.||++|||++|+++.|+.+..+-..
T Consensus 233 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~~ 279 (287)
T d1opja_ 233 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 279 (287)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSCH
T ss_pred -CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCCC
Confidence 12223455678899999999999999999999999999988655443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=376.00 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=208.4
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++++.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.+.+.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999864 6899999998743 2334578999999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||++||+|.+++...+ .+++..++.++.|++.||.||| +.+++|+||||+||++++++.+||+|||++..+.....
T Consensus 88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999887654 7999999999999999999999 99999999999999999999999999999987643333
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
........||+.|+|||++.+..++.++|||||||++|+|++|..||........ .......
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----------------~~~i~~~- 225 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----------------FQKIIKL- 225 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHHTT-
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-----------------HHHHHcC-
Confidence 3344456799999999999999999999999999999999999999976432111 1111111
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.+..+..+++++.+||.+||+.||.+|||++|++..-+
T Consensus 226 ---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 226 ---EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp ---CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred ---CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 11123456778999999999999999999999866543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-54 Score=376.07 Aligned_cols=259 Identities=23% Similarity=0.429 Sum_probs=204.9
Q ss_pred cCCCCccceeeecCceEEEEEEEcC-C---cEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD-G---MEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~-~---~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.++|++.+.||+|+||+||+|..+. + ..||+|.+.... ....+.+.+|++++++++||||+++++++...+.+++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3678899999999999999998652 3 358888876543 3445679999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+++|+|.+++....+.+++..+..++.||+.||.||| +++++||||||+|||++.++.+||+|||++..+...
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999998887778999999999999999999999 999999999999999999999999999999876432
Q ss_pred cccc---ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 197 DQSK---SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 197 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
.... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||......+. ...+.
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~--------------~~~i~ 247 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV--------------INAIE 247 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------------HHHHH
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH--------------HHHHH
Confidence 2211 1223457899999999999999999999999999999998 8999876432211 11111
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
.. .+.+.+..+++.+.+|+.+||+.||.+|||+.||++.|+++..
T Consensus 248 ~~------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 248 QD------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TT------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cC------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11 1222344567889999999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-53 Score=379.26 Aligned_cols=254 Identities=18% Similarity=0.234 Sum_probs=214.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
..++|++++.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+++.+|+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3468999999999999999999864 699999999987655556778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC--CCCcEEEeeccccccccCCc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~--~~~~v~l~dfg~~~~~~~~~ 197 (335)
|++||+|.+.+......+++..++.++.||+.||.||| +.+++|+||||+|||++ .++.+||+|||++..+..
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-- 181 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-- 181 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCC--
Confidence 99999999988777768999999999999999999999 99999999999999997 678999999999987642
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
........+|+.|+|||++.+..++.++|||||||++|+|++|..||....... .+......
T Consensus 182 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----------------~~~~i~~~ 243 (352)
T d1koba_ 182 -DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-----------------TLQNVKRC 243 (352)
T ss_dssp -TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----------------HHHHHHHC
T ss_pred -CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHhC
Confidence 223344678999999999999999999999999999999999999997643221 11111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
...........+++++.+||.+||+.||.+|||++|+++.
T Consensus 244 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111112234567789999999999999999999999873
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-54 Score=370.33 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=196.2
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeec--CCeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSN--DDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 116 (335)
.++|.+.+.||+|+||+||+|..+ +|+.||+|++.... +...+.+.+|++++++++||||+++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999765 68999999987553 3345678899999999999999999999865 567899
Q ss_pred EEEecCCCChHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCC-----eEecCCCCCCEEECCCCcEEEeecc
Q 019843 117 VLEYMPHGSLEKCLYS---SNCVLDIFQRLNIMIDVAAALEYLHFGYSAP-----VIHCDLKPSNVLLDDNMVAHLSDFG 188 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~-----i~h~di~p~Nilv~~~~~v~l~dfg 188 (335)
||||+++|+|.+++.. ....+++..++.++.||+.||.||| +++ |+||||||+|||++.++.+||+|||
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 9999999999999864 2457999999999999999999999 654 9999999999999999999999999
Q ss_pred ccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 189 IAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
++..+... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......+. .
T Consensus 160 ~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~--------------~ 223 (269)
T d2java1 160 LARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--------------A 223 (269)
T ss_dssp HHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------------H
T ss_pred ceeecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH--------------H
Confidence 99876422 2223456789999999999999999999999999999999999999976432211 1
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..+...... ..+..+++++.+|+.+||+.||++|||++|+++
T Consensus 224 ~~i~~~~~~------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 224 GKIREGKFR------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHTCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCC------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111111111 113346778999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=368.52 Aligned_cols=257 Identities=23% Similarity=0.392 Sum_probs=210.7
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|++.+.||+|+||.||+|.+++++.||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 46899999999999999999999888899999997543 344789999999999999999999998765 4578999999
Q ss_pred CCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++|+|.+++... ...+++..++.++.||++||.||| +++++||||||+||+++.++.+||+|||++..+.... ..
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT 165 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-cc
Confidence 999999977643 235899999999999999999999 9999999999999999999999999999998764322 23
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
......+++.|+|||++.+..++.++|||||||++|||++|..|+......... ...+.. .
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~-------------~~~i~~------~ 226 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-------------IQNLER------G 226 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------------HHHHHT------T
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH-------------HHHHHh------c
Confidence 334567889999999999889999999999999999999965554332211111 111111 1
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
.+...+..+++++.+|+.+||+.||++|||++||++.|+.+-.
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1222344567889999999999999999999999999987654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=366.56 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=211.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC------CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC------GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
..++|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4578999999999999999999864 68999999986432 2245789999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC----cEEEeeccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGI 189 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~----~v~l~dfg~ 189 (335)
.++||||++||+|.+++.... .+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .+|++|||+
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999997654 7999999999999999999999 99999999999999998776 599999999
Q ss_pred cccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
+..... ........+|+.|+|||++.+..++.++||||+||++|+|++|..||......+.
T Consensus 164 a~~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---------------- 224 (293)
T d1jksa_ 164 AHKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---------------- 224 (293)
T ss_dssp CEECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------
T ss_pred hhhcCC---CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH----------------
Confidence 987632 2233456789999999999999999999999999999999999999976432211
Q ss_pred HHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 270 IVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..................+++.+.+||.+||+.||++|||++|+++
T Consensus 225 -~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 225 -LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -HHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111112222233456788999999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=361.77 Aligned_cols=247 Identities=24% Similarity=0.366 Sum_probs=201.0
Q ss_pred CCC-CccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeec----CCee
Q 019843 43 DGF-SENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN----DDFK 114 (335)
Q Consensus 43 ~~y-~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 114 (335)
++| ++.+.||+|+||+||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.+ ...+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 345 67789999999999999865 5889999998754 23345678999999999999999999999864 4578
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCC--eEecCCCCCCEEEC-CCCcEEEeeccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAP--VIHCDLKPSNVLLD-DNMVAHLSDFGIAK 191 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~--i~h~di~p~Nilv~-~~~~v~l~dfg~~~ 191 (335)
++||||+++++|.+++.+.. .+++..+..++.||+.||.||| +++ ++|+||||+|||++ +++.+||+|||++.
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 99999999999999997654 7999999999999999999999 888 99999999999996 58899999999997
Q ss_pred cccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 192 LLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
... ........||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........
T Consensus 164 ~~~----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~--------------- 223 (270)
T d1t4ha_ 164 LKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR--------------- 223 (270)
T ss_dssp GCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---------------
T ss_pred ecc----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH---------------
Confidence 642 223345679999999999875 599999999999999999999999975432221111
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..... ......+..+++++.+||.+||+.||++|||++|+++
T Consensus 224 -~i~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 224 -RVTSG--VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -HHTTT--CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHcC--CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11110 1111223345677999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=368.75 Aligned_cols=263 Identities=24% Similarity=0.408 Sum_probs=216.2
Q ss_pred cCCCCccce-eeecCceEEEEEEEc---CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 42 TDGFSENNL-IGRGSFGSVYKARIQ---DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~-lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.++|.+... ||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++..+ .+++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEE
Confidence 456777775 999999999999754 35579999997553 33457899999999999999999999998754 5789
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+++|+|.+++......+++..+..++.||+.||.||| +++++|+||||+||+++.++.+||+|||++..+...
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999998776668999999999999999999999 999999999999999999999999999999877533
Q ss_pred ccc-cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 197 DQS-KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 197 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+. ...+..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--------------~~~i~~- 227 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--------------MAFIEQ- 227 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--------------HHHHHT-
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHc-
Confidence 222 22334568899999999998999999999999999999998 8999976432211 111111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccc
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 328 (335)
..+...+..+|+++.+||.+||+.||++|||+.+|++.|+....++...
T Consensus 228 -----~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 228 -----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred -----CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 1122334567888999999999999999999999999999877655443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=377.30 Aligned_cols=267 Identities=22% Similarity=0.349 Sum_probs=210.8
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
..++|.+.+.||+|+||+||+|... +|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999865 68999999997653 344577899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCC-CeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~-~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
||++||+|.+++.+.. .+++..+..++.||+.||.||| ++ +|+||||||+|||++.+|.+||+|||++..+.
T Consensus 84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~--- 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--- 156 (322)
T ss_dssp ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH---
T ss_pred EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccC---
Confidence 9999999999997654 6999999999999999999999 75 89999999999999999999999999998653
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh---------------
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL--------------- 262 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~--------------- 262 (335)
........||+.|+|||++.+..++.++||||+||++|+|++|+.||.................
T Consensus 157 -~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 157 -DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp -HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred -CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2223456899999999999999999999999999999999999999976543322111000000
Q ss_pred ----------cChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 263 ----------LPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 263 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.........+......... . .....+.++.+|+.+||..||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPK-L-PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCC-C-CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhHHHHHhhhhccCCcc-C-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0001111111111111100 0 012246779999999999999999999999984
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-53 Score=374.43 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=210.2
Q ss_pred CCCCccceeeecCceEEEEEEEcC-C-----cEEEEEEeecC-CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCee
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQD-G-----MEVAVKVFHLQ-CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~-~-----~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 114 (335)
++|.+.+.||+|+||+||+|++.. + ..||+|++... .......+.+|+.++.++ +||||+++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 689999999999999999997542 2 36899988643 334557889999999998 899999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCC
Q 019843 115 ALVLEYMPHGSLEKCLYSSN----------------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPS 172 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~ 172 (335)
++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +++|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence 99999999999999997543 25899999999999999999999 999999999999
Q ss_pred CEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCccccc
Q 019843 173 NVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAG 251 (335)
Q Consensus 173 Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~ 251 (335)
||+++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654433334445678999999999999999999999999999999998 89999765432
Q ss_pred chhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHH
Q 019843 252 EMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLL 319 (335)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 319 (335)
.. ...++... .+++.+..+++++.+||.+||+.||++|||++||++.|.
T Consensus 274 ~~-------------~~~~~~~~------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 AN-------------FYKLIQNG------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HH-------------HHHHHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH-------------HHHHHhcC------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 11222221 122334556788999999999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=364.50 Aligned_cols=260 Identities=25% Similarity=0.441 Sum_probs=206.4
Q ss_pred cCCCCccceeeecCceEEEEEEEcCC-----cEEEEEEeecCCC-chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDG-----MEVAVKVFHLQCG-GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
.+.|+..++||+|+||.||+|.++.. ..||||++..... .....+.+|++++++++||||+++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 36789999999999999999976532 4699999875433 34457889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||+.++++.+++......+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++..+..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999988877778999999999999999999999 99999999999999999999999999999987643
Q ss_pred Ccc-ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQ-SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
... ........+|+.|+|||++.+..++.++|||||||++|||++|..||........ ....+...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-------------~~~~i~~~ 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------------VMKAINDG 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------------HHHHHHTT
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-------------HHHHHhcc
Confidence 221 2223345689999999999999999999999999999999997666443221111 11112211
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
.+.+.+..+++.+.+|+.+||+.||++|||+.||++.|+++.+
T Consensus 230 ------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1222344567789999999999999999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-53 Score=364.22 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=204.9
Q ss_pred ceeeecCceEEEEEEEc---CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEecCC
Q 019843 49 NLIGRGSFGSVYKARIQ---DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYMPH 123 (335)
Q Consensus 49 ~~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 123 (335)
+.||+|+||+||+|.+. +++.||||+++.. +....+.+.+|++++++++||||+++++++..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 57999999999999754 3567999998654 334457899999999999999999999999654 56899999999
Q ss_pred CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc-ccc
Q 019843 124 GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS-KSQ 202 (335)
Q Consensus 124 ~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~-~~~ 202 (335)
|+|.+++.... .+++..++.++.||+.||.||| +++++|+||||+||+++.++.+|++|||++..+...... ...
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999987654 7999999999999999999999 999999999999999999999999999999876433222 223
Q ss_pred ccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccccc
Q 019843 203 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSREDK 281 (335)
Q Consensus 203 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (335)
....+|+.|+|||++.+..++.++||||||+++|||++ |..||......+. ...+.. ..
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--------------~~~i~~------~~ 227 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--------------TAMLEK------GE 227 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------------HHHHHT------TC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH--------------HHHHHc------CC
Confidence 34568999999999999999999999999999999998 8999986432211 112221 12
Q ss_pred chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 282 HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 282 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
+.+.+..+|+++.+|+.+||+.||++|||+++|++.|+....+.
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 23334567888999999999999999999999999998765443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.3e-52 Score=361.30 Aligned_cols=262 Identities=21% Similarity=0.356 Sum_probs=208.1
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC----
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD---- 112 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 112 (335)
..++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+++++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 4688999999999999999999764 68999999997542 334567899999999999999999999987643
Q ss_pred eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 113 FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
.+|+||||++|++|.+++...+ .+++..++.++.||+.||.||| +.+++|+||||+||+++.++..+++|||.+..
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred eEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence 4889999999999999887654 7999999999999999999999 99999999999999999999999999999875
Q ss_pred ccCCc-cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 193 LTGED-QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 193 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
..... .........||+.|+|||++.+..++.++|||||||++|+|++|.+||......+. .
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----------------~ 223 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----------------A 223 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----------------H
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-----------------H
Confidence 53221 22234456799999999999999999999999999999999999999976432221 1
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCC-CHHHHHHHHHHHHh
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRI-NAKEIVTRLLKIRD 323 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-s~~ell~~L~~~~~ 323 (335)
.................+|+++.++|.+||+.||.+|| |++++++.|.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 224 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp HHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred HHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 11111111111222345678899999999999999999 89999999988763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-52 Score=365.06 Aligned_cols=254 Identities=18% Similarity=0.266 Sum_probs=212.5
Q ss_pred hhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 40 QATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 40 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
+..++|++.+.||+|+||+||+|.++ +++.||+|++..... ....+.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 35689999999999999999999865 688999999976543 3356889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCC--CcEEEeeccccccccCC
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDN--MVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~--~~v~l~dfg~~~~~~~~ 196 (335)
||++|++|.+++...+..+++..++.++.||+.||.||| +.+++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~-- 155 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-- 155 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccc--
Confidence 999999999999877668999999999999999999999 9999999999999999854 489999999998653
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhc
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLL 276 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (335)
.........+++.|+|||.+.+..++.++|||||||++|+|++|..||......+ .......
T Consensus 156 -~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-----------------~~~~i~~ 217 (321)
T d1tkia_ 156 -PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----------------IIENIMN 217 (321)
T ss_dssp -TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----------------HHHHHHH
T ss_pred -cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHh
Confidence 2233445678999999999999999999999999999999999999997653221 1111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 277 SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 277 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
............+++++.+||.+||..||++|||++|+++.
T Consensus 218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112222233567789999999999999999999999873
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-52 Score=366.52 Aligned_cols=245 Identities=25% Similarity=0.326 Sum_probs=202.8
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC---chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG---GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
+.|+..+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999764 688999999875532 33467889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+++++|..++... +++++..++.++.||+.||.||| +++++||||||+|||++.++.+||+|||++....
T Consensus 95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~---- 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---- 166 (309)
T ss_dssp ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS----
T ss_pred EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccC----
Confidence 999999887766544 47999999999999999999999 9999999999999999999999999999998642
Q ss_pred ccccccccccccccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 199 SKSQTQTLATIGYMAPEYGRE---GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+.. ..+....
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~-------------~~i~~~~- 230 (309)
T d1u5ra_ 167 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------------YHIAQNE- 230 (309)
T ss_dssp --SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------------HHHHHSC-
T ss_pred --CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH-------------HHHHhCC-
Confidence 2234579999999999864 45899999999999999999999999764322111 1111110
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
. ....+..+++.+.+||.+||+.||.+|||++|+++
T Consensus 231 ---~--~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 ---S--PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---C--CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---C--CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0 00112345777999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=360.35 Aligned_cols=258 Identities=22% Similarity=0.373 Sum_probs=203.9
Q ss_pred cCCCCccceeeecCceEEEEEEEcC----CcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD----GMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
.++|.+.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|++++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3689999999999999999997642 3468888876443 334567999999999999999999999986 467899
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
||||+++|+|.+++......+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..+...
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999998877778999999999999999999999 999999999999999999999999999999865322
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
.........+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+.. ..+..
T Consensus 162 -~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~--------------~~i~~-- 224 (273)
T d1mp8a_ 162 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--------------GRIEN-- 224 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--------------HHHHT--
T ss_pred -cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH--------------HHHHc--
Confidence 2223344568899999999999999999999999999999998 89998765432221 11111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
....+.+..+++.+.+||.+||+.||++|||++||++.|+++.++
T Consensus 225 ----~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 225 ----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111223456788899999999999999999999999999988755
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-51 Score=354.09 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=208.1
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC---------chhHHHHHHHHHHHhCC-CCceEEEeeeeec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG---------GVFKSFDVECEVMKSIR-HRNLIKIISTCSN 110 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 110 (335)
.++|.+.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999864 689999999975432 12346888999999996 9999999999999
Q ss_pred CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
++..|+||||+++++|.+++..+. ++++..++.++.||+.||.||| +++++|+||+|+||+++.++.+||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence 999999999999999999997654 7999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCccccccccccccccccCccccC------CCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcC
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGR------EGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLP 264 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 264 (335)
..+.. ........||..|+|||.+. ...++.++||||+||++|+|++|+.||........
T Consensus 158 ~~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~----------- 223 (277)
T d1phka_ 158 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM----------- 223 (277)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------
T ss_pred eEccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-----------
Confidence 87632 22334567999999999875 33578899999999999999999999986432111
Q ss_pred hhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 265 ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..................+++++.+|+.+||+.||++|||++|+++
T Consensus 224 ------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 224 ------LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ------HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ------HHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111111111122223467888999999999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=366.18 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=210.4
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|.+++.||+|+||.||+|..+ +|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999864 6999999999743 2334577889999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||++||+|.+++.... .+++..++.++.||+.||.||| +++++||||||+||+++.+|.+||+|||++..... .
T Consensus 85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--D 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--T
T ss_pred eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccccc--C
Confidence 9999999999988654 7999999999999999999999 99999999999999999999999999999986532 1
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||......+. .......
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----------------~~~i~~~- 220 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----------------FELILME- 220 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHHHC-
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-----------------HHHHhcC-
Confidence 2234456799999999999999999999999999999999999999976532211 1111111
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCCC-----HHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-----AKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 317 (335)
....+..+++++.+||.+||+.||.+||+ ++|+++.
T Consensus 221 ---~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 ---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11223456788999999999999999995 8888763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=364.49 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=209.2
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCc----EEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGM----EVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~----~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 116 (335)
++|++.+.||+|+||+||+|.+. +|+ +||+|.+... +....+.+.+|++++++++||||+++++++.+++ .++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence 57999999999999999999764 343 5888888643 3445678999999999999999999999998755 567
Q ss_pred EEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCC
Q 019843 117 VLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 196 (335)
Q Consensus 117 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~ 196 (335)
+++++.+++|.+.+......+++..++.++.||+.||.||| +++++||||||+||+++.++.+||+|||++..+...
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 88999999999998888778999999999999999999999 999999999999999999999999999999877543
Q ss_pred ccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
..........+|+.|+|||++.++.++.++|||||||++|||+| |.+||......+. ...+...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~--------------~~~i~~~- 229 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------------SSILEKG- 229 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH--------------HHHHHHT-
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH--------------HHHHHcC-
Confidence 33333444568999999999999999999999999999999998 7899876543221 1222221
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 276 LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 276 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
.+.+.+..+++.+.+|+.+||+.||.+|||+.|+++.|.++..+
T Consensus 230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 12223455678899999999999999999999999999988654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=357.30 Aligned_cols=250 Identities=31% Similarity=0.460 Sum_probs=202.4
Q ss_pred CCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec-CCeeEEEEEec
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN-DDFKALVLEYM 121 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 121 (335)
++|++.+.||+|+||.||+|..+ |..||||+++.+ ...+.+.+|++++++++||||+++++++.+ .+.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 57889999999999999999986 789999998654 344789999999999999999999998854 56789999999
Q ss_pred CCCChHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHGSLEKCLYSSN-CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++|+|.+++.... ..+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.++++|||++.... .
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~-----~ 155 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----S 155 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecC-----C
Confidence 9999999997542 35899999999999999999999 9999999999999999999999999999998642 2
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
......++..|+|||++.+..++.++||||||+++|||++ |.+||......+.. ..+..
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~--------------~~i~~------ 215 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--------------PRVEK------ 215 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH--------------HHHTT------
T ss_pred CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH--------------HHHHc------
Confidence 3334567889999999998999999999999999999998 78887764332211 11111
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
..+.+.+..+++.+.+|+.+||..||++|||+.++++.|++++.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 12223344567789999999999999999999999999998864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-51 Score=361.16 Aligned_cols=245 Identities=25% Similarity=0.304 Sum_probs=208.3
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++.+.||+|+||+||+|+.+ +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999864 5899999999743 2344578899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||++|++|..++.... .+++..+..++.||+.||.||| +++++|+||||+||+++.+|.+||+|||++....
T Consensus 84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~---- 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---- 155 (316)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS----
T ss_pred eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEec----
Confidence 9999999999887665 7889999999999999999999 9999999999999999999999999999998763
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||......+. .......
T Consensus 156 -~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----------------~~~i~~~- 216 (316)
T d1fota_ 156 -DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----------------YEKILNA- 216 (316)
T ss_dssp -SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------------HHHHHHC-
T ss_pred -cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-----------------HHHHHcC-
Confidence 223346799999999999999999999999999999999999999976432211 1111111
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVTR 317 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~ 317 (335)
....+..+++++.+++.+||..||.+|+ |++++++.
T Consensus 217 ---~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 ---ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1112344577799999999999999996 89999863
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=357.58 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=206.2
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++|++.+.||+|+||.||+|.+++++.||||++..... ..+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 468999999999999999999988888899999975533 44789999999999999999999999865 4578999999
Q ss_pred CCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 122 PHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 122 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
++|+|..++... ...+++..++.++.+|+.||.||| +.+++|+||||+||+++.++.+||+|||++..+.... ..
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 169 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-ce
Confidence 999999887643 346999999999999999999999 9999999999999999999999999999998663222 23
Q ss_pred ccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccccc
Q 019843 201 SQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRED 280 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (335)
......+++.|+|||++.+..++.++||||||+++|||++|..||......... ...+...
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~-------------~~~i~~~------ 230 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------------LDQVERG------ 230 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------------HHHHHTT------
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH-------------HHHHHhc------
Confidence 334466899999999999999999999999999999999976665443221111 1111111
Q ss_pred cchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 281 KHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 281 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
.+.+.+..+++++.++|.+||+.||++|||+++|++.|+....+.
T Consensus 231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 112234556788999999999999999999999999888765443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-52 Score=357.26 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=202.7
Q ss_pred cCCCCccceeeecCceEEEEEEEcC----CcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD----GMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
.++|++.+.||+|+||.||+|.... ...||||++..+ .....+.+.+|++++++++||||+++++++.++ ..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence 4679999999999999999997532 236899998654 344567899999999999999999999999764 56
Q ss_pred EEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccccccc
Q 019843 115 ALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 194 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~ 194 (335)
++||||++++++.+.+....+.+++..++.++.||+.||.||| +++++||||||+||+++.++.+||+|||++..+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 8999999999999988877668999999999999999999999 9999999999999999999999999999999764
Q ss_pred CCcc-ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 195 GEDQ-SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 195 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
.... ........++..|+|||++.+..++.++||||||+++|||++ |..||......+. ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~-----------------~~ 225 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----------------LH 225 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----------------HH
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-----------------HH
Confidence 3322 223334567889999999999999999999999999999998 8999876432221 11
Q ss_pred hhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHH
Q 019843 273 ANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKI 321 (335)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 321 (335)
.... ...+.+.+..+|+.+.+|+.+||+.||++|||++||.+.|.+.
T Consensus 226 ~i~~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 226 KIDK--EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHT--SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHh--CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111 1122233456678899999999999999999999999998875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-51 Score=358.70 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=213.3
Q ss_pred hcCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCCc-hhHHHHHHHHHHHhCCCCceEEEeeeeecCCe
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCGG-VFKSFDVECEVMKSIRHRNLIKIISTCSNDDF 113 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 113 (335)
..++|.+.+.||+|+||.||+|+++ +++.||||++...... ....+.+|++++++++||||+++++++...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3578999999999999999999764 3578999998765433 45679999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCC
Q 019843 114 KALVLEYMPHGSLEKCLYSSN-----------------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLK 170 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~ 170 (335)
.+++||++++|+|.+++.... ..+++..++.++.|++.||+||| +.+++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEc
Confidence 999999999999999986432 24889999999999999999999 9999999999
Q ss_pred CCCEEECCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCC-CCCCccc
Q 019843 171 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKK-KPTDKIF 249 (335)
Q Consensus 171 p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~-~pf~~~~ 249 (335)
|+||+++.++.+||+|||++..+.+...........+++.|+|||.+.+..++.++|||||||++|||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998765444444445567889999999999999999999999999999999986 5666543
Q ss_pred ccchhhHhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 250 AGEMTLKYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
..+. ...+... .....+..+++++.+|+.+||+.||++|||+.||++.|+++.
T Consensus 248 ~~e~--------------~~~v~~~------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEEV--------------IYYVRDG------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHH--------------HHHHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHH--------------HHHHHcC------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2211 1111111 112234556778999999999999999999999999999863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-51 Score=362.57 Aligned_cols=244 Identities=20% Similarity=0.241 Sum_probs=207.9
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++|++++.||+|+||.||+|.++ +|+.||||++... .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999865 6999999998643 2344577899999999999999999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 198 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~ 198 (335)
||+.+|+|.+++.... .+++..++.++.||+.||.||| +++|+|+||||+|||++.+|.+||+|||++..+.
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~---- 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---- 192 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS----
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecc----
Confidence 9999999999987654 7999999999999999999999 9999999999999999999999999999998763
Q ss_pred ccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhccc
Q 019843 199 SKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSR 278 (335)
Q Consensus 199 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (335)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ +......
T Consensus 193 -~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----------------~~~i~~~- 253 (350)
T d1rdqe_ 193 -GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-----------------YEKIVSG- 253 (350)
T ss_dssp -SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHHHC-
T ss_pred -cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH-----------------HHHHhcC-
Confidence 223346799999999999999999999999999999999999999976432111 1111111
Q ss_pred cccchhhHHHHHHHHHHHHHHhchhccccCC-----CHHHHHH
Q 019843 279 EDKHFAAKEQCVSFVFNLAMECTVESAEQRI-----NAKEIVT 316 (335)
Q Consensus 279 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~ 316 (335)
....+..+++++.+||.+||+.||.+|+ |++++++
T Consensus 254 ---~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 254 ---KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1112345677899999999999999994 8999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-50 Score=362.03 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=203.0
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC---CchhHHH---HHHHHHHHhCCCCceEEEeeeeecCCeeE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC---GGVFKSF---DVECEVMKSIRHRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 115 (335)
++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+ ..++++++.++||||+++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999865 58999999986331 1112223 34577777888999999999999999999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccC
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~ 195 (335)
+||||++||+|.+++.... .+++..++.++.||+.||.||| +++++|+||||+|||++.+|.+||+|||++..+..
T Consensus 84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999997654 7899999999999999999999 99999999999999999999999999999987642
Q ss_pred CccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhh
Q 019843 196 EDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDAN 274 (335)
Q Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... .+....
T Consensus 160 ----~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--------------~~~~~~ 221 (364)
T d1omwa3 160 ----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------------EIDRMT 221 (364)
T ss_dssp ----SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--------------HHHHHS
T ss_pred ----CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--------------HHHHhc
Confidence 23345679999999999864 56899999999999999999999999865432221 111111
Q ss_pred hccccccchhhHHHHHHHHHHHHHHhchhccccCCC-----HHHHHHH
Q 019843 275 LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-----AKEIVTR 317 (335)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~~ 317 (335)
.......+..+++++.+||.+||+.||++||| ++|+++.
T Consensus 222 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 222 ----LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ----SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ----ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11111223456778999999999999999999 7888763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-51 Score=356.18 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=202.2
Q ss_pred cCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhC-CCCceEEEeeeeec-CC
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSI-RHRNLIKIISTCSN-DD 112 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 112 (335)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+..|...+.++ +|+||+.+++++.. ..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 478999999999999999999753 24679999987543 33456677888888777 78999999998765 55
Q ss_pred eeEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC
Q 019843 113 FKALVLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD 177 (335)
Q Consensus 113 ~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~ 177 (335)
.+++||||+++|+|.+++.... ..+++..++.++.||+.||.||| +++++||||||+||+++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence 7899999999999999997532 35899999999999999999999 99999999999999999
Q ss_pred CCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCC-CCCCcccccchhhH
Q 019843 178 DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKK-KPTDKIFAGEMTLK 256 (335)
Q Consensus 178 ~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~-~pf~~~~~~~~~~~ 256 (335)
.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++|. +||.........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~-- 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence 99999999999998765444444445567999999999999999999999999999999999864 677654332211
Q ss_pred hHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHH
Q 019843 257 YWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIR 322 (335)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 322 (335)
...+.... +...+..+++++.+++.+||+.||++|||++|+++.|+++.
T Consensus 247 -----------~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 247 -----------CRRLKEGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp -----------HHHHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----------HHHHhcCC------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11121111 12223456778999999999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=356.74 Aligned_cols=252 Identities=21% Similarity=0.258 Sum_probs=202.4
Q ss_pred cCCCCcc-ceeeecCceEEEEEEE-cCCcEEEEEEeecCCCchhHHHHHHHHHHHh-CCCCceEEEeeeeec----CCee
Q 019843 42 TDGFSEN-NLIGRGSFGSVYKARI-QDGMEVAVKVFHLQCGGVFKSFDVECEVMKS-IRHRNLIKIISTCSN----DDFK 114 (335)
Q Consensus 42 ~~~y~~~-~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~ 114 (335)
-++|.+. +.||+|+||+||+|.+ .+++.||||+++.. ..+.+|++++.+ .+||||+++++++.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 4689886 4699999999999976 46899999998643 567789998655 489999999999865 4678
Q ss_pred EEEEEecCCCChHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC---CCcEEEeecccc
Q 019843 115 ALVLEYMPHGSLEKCLYSS-NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIA 190 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~---~~~v~l~dfg~~ 190 (335)
|+||||++||+|.+++... ...+++..++.++.||+.||.||| +.+++||||||+||+++. ++.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence 9999999999999999764 347999999999999999999999 999999999999999985 567999999999
Q ss_pred ccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 191 KLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .+
T Consensus 162 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-------------~~ 225 (335)
T d2ozaa1 162 KETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------------GM 225 (335)
T ss_dssp EECCC---CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred eeccC---CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-------------HH
Confidence 87632 223345679999999999999999999999999999999999999997643222110 11
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
..................+++++.+||.+||+.||++|||+.|+++.
T Consensus 226 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111111111112234678889999999999999999999999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=352.43 Aligned_cols=275 Identities=23% Similarity=0.306 Sum_probs=205.2
Q ss_pred cCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHH--HHHHHHhCCCCceEEEeeeeecCC----eeE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDV--ECEVMKSIRHRNLIKIISTCSNDD----FKA 115 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~--e~~~l~~l~h~~i~~~~~~~~~~~----~~~ 115 (335)
+++|.+.+.||+|+||.||+|+.. |+.||||++.... ...+.. |+..+..++||||+++++++.+.+ ..+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 467889999999999999999875 8999999986542 233334 444555779999999999987643 688
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcc-----CCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG-----YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~-----~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
+||||+++|+|.+++.+. .+++..++.++.+++.||.|||.. .+++|+|+||||+||+++.++.+||+|||++
T Consensus 78 lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999999875 499999999999999999999921 1269999999999999999999999999999
Q ss_pred ccccCCccc--cccccccccccccCccccCCCC------CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhh
Q 019843 191 KLLTGEDQS--KSQTQTLATIGYMAPEYGREGR------VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNL 262 (335)
Q Consensus 191 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~------~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 262 (335)
......... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~-- 233 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP-- 233 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC--
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc--
Confidence 876432221 2334567999999999987643 567899999999999999999888654333222111111
Q ss_pred cChhHHHHHHh----hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 263 LPISVMEIVDA----NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 263 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
.........+. ...+.... ......++..+.+|+.+||+.||++|||+.||++.|+++.++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCG-GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCc-ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 01111222221 11111111 1123345677999999999999999999999999999987653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=357.25 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=205.0
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC---CCchhHHHHHHHHHHH-hCCCCceEEEeeeeecCCeeEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ---CGGVFKSFDVECEVMK-SIRHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 117 (335)
++|.+++.||+|+||+||+|... +|+.||||++... .......+..|..++. .++||||+++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999765 6899999999743 2333455666666654 68999999999999999999999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCc
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 197 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~ 197 (335)
|||+++|+|.+++.... .+++..+..++.||+.||.||| +++++|+||||+|||++.++.+||+|||++.....
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~-- 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML-- 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccc--
Confidence 99999999999997654 7899999999999999999999 99999999999999999999999999999986532
Q ss_pred cccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcc
Q 019843 198 QSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLS 277 (335)
Q Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (335)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... .......
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~-----------------~~~i~~~ 218 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----------------FHSIRMD 218 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHHHC
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH-----------------HHHHHcC
Confidence 22334456799999999999999999999999999999999999999976432211 1111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhchhccccCCCHH-HHHH
Q 019843 278 REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAK-EIVT 316 (335)
Q Consensus 278 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~ 316 (335)
....+..+++++.+||.+||..||.+|||+. |+++
T Consensus 219 ----~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 ----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1122345677899999999999999999995 6754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=354.92 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=211.4
Q ss_pred cCCCCccceeeecCceEEEEEEEcC--------CcEEEEEEeecCCC-chhHHHHHHHHHHHhC-CCCceEEEeeeeecC
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQD--------GMEVAVKVFHLQCG-GVFKSFDVECEVMKSI-RHRNLIKIISTCSND 111 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 111 (335)
.++|.+.+.||+|+||.||+|+... +..||||+++.+.. .....+.+|...+.++ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4689999999999999999997432 24699999976543 3457788899999888 799999999999999
Q ss_pred CeeEEEEEecCCCChHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEE
Q 019843 112 DFKALVLEYMPHGSLEKCLYSSN---------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLL 176 (335)
Q Consensus 112 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv 176 (335)
+..++||||+++|+|.+++.... ..+++..++.++.||+.||.||| +.+++||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 99999999999999999997543 35899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhh
Q 019843 177 DDNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTL 255 (335)
Q Consensus 177 ~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~ 255 (335)
+.++.+||+|||++................+++.|+|||.+.++.++.++||||||+++|+|++ |.+||.......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence 9999999999999987755444445556778999999999999999999999999999999998 788886543221
Q ss_pred HhHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 256 KYWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
....+... .....+..+++++.+||.+||+.||.+|||+.||++.|+++.+
T Consensus 246 -----------~~~~i~~~------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 -----------LFKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -----------HHHHHHTT------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------HHHHHHcC------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11112111 1222344567889999999999999999999999999988743
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=354.38 Aligned_cols=257 Identities=28% Similarity=0.457 Sum_probs=207.6
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCc--EEEEEEeecC-CCchhHHHHHHHHHHHhC-CCCceEEEeeeeecCCeeEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGM--EVAVKVFHLQ-CGGVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFKALV 117 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~--~v~iK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 117 (335)
++|++.+.||+|+||.||+|.++ +|. .|+||.+... .....+.+.+|++++.++ +||||+++++++.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 78999999999999999999765 344 4778877533 344567899999999998 799999999999999999999
Q ss_pred EEecCCCChHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcE
Q 019843 118 LEYMPHGSLEKCLYSS---------------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 182 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v 182 (335)
|||+++|+|.+++... ...+++..++.++.||+.||.||| +.+++||||+|+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999998643 347999999999999999999999 9999999999999999999999
Q ss_pred EEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCC-CCCCcccccchhhHhHhhh
Q 019843 183 HLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKK-KPTDKIFAGEMTLKYWVSN 261 (335)
Q Consensus 183 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~-~pf~~~~~~~~~~~~~~~~ 261 (335)
||+|||++.... .........+|..|+|||.+.+..++.++||||||+++|||++|. +||......+
T Consensus 167 kl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--------- 234 (309)
T d1fvra_ 167 KIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------- 234 (309)
T ss_dssp EECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------
T ss_pred EEcccccccccc---ccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---------
Confidence 999999997642 222233456899999999999999999999999999999999976 5665432111
Q ss_pred hcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhh
Q 019843 262 LLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSL 325 (335)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 325 (335)
+.+.... ..+.+.+..+++++.+||.+||+.||++|||++||++.|+++..+.
T Consensus 235 --------~~~~i~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 235 --------LYEKLPQ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp --------HHHHGGG---TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred --------HHHHHHh---cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1111111 1223334567788999999999999999999999999999987543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=350.05 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=209.3
Q ss_pred cceeeecCceEEEEEEEcC----CcEEEEEEeecC-CCchhHHHHHHHHHHHhCCCCceEEEeeeeec-CCeeEEEEEec
Q 019843 48 NNLIGRGSFGSVYKARIQD----GMEVAVKVFHLQ-CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN-DDFKALVLEYM 121 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~----~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 121 (335)
.++||+|+||+||+|.+.+ ...||||+++.. +......+.+|++++++++||||+++++++.. ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5789999999999998643 235899998643 44456789999999999999999999999765 56899999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc--
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS-- 199 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~-- 199 (335)
++++|.+++.......++..++.++.|++.||.||| +.+++||||||+|||+++++.+||+|||++..+......
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999887778889999999999999999999 999999999999999999999999999999876433222
Q ss_pred cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhhcccc
Q 019843 200 KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANLLSRE 279 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (335)
.......+|..|+|||.+.+..++.++||||||+++|||++|..||........... .+..
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~-------------~i~~------ 249 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-------------YLLQ------ 249 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH-------------HHHT------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH-------------HHHc------
Confidence 223345689999999999999999999999999999999998888765432211111 1111
Q ss_pred ccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhcc
Q 019843 280 DKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLI 327 (335)
Q Consensus 280 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 327 (335)
..+...+..+++.+.+||.+||+.||++|||+.||++.|+++..++..
T Consensus 250 g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 111222345677899999999999999999999999999999876543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=348.29 Aligned_cols=270 Identities=23% Similarity=0.287 Sum_probs=203.7
Q ss_pred CCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
++|++++.||+|+||+||+|.+ .+|+.||+|++.... ......+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999986 468999999996543 2345788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
|+.++.+..........+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||.+.... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~--~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPV 156 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC--CCS
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceecc--CCc
Confidence 99665444443444557999999999999999999999 9999999999999999999999999999998653 223
Q ss_pred cccccccccccccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcCh-hHHHHHHhh--h
Q 019843 200 KSQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPI-SVMEIVDAN--L 275 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~ 275 (335)
.......+|+.|+|||++.... ++.++|+||+||++|+|++|+.||......+...........+. ......... .
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 3344567999999999877655 57899999999999999999999976543222111111000000 000000000 0
Q ss_pred c----c-ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 276 L----S-REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 276 ~----~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
. . ...........+++++.+|+.+||..||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 0 0000011112456779999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=349.36 Aligned_cols=260 Identities=23% Similarity=0.361 Sum_probs=215.5
Q ss_pred CCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCCC-chhHHHHHHHHHHHhC-CCCceEEEeeeeecCCee
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQCG-GVFKSFDVECEVMKSI-RHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 114 (335)
++|.+.+.||+|+||.||+|++. +++.||||+++.... .....+.+|+.++..+ +||||+++++++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 78999999999999999999752 356899999976543 3455788999999999 699999999999999999
Q ss_pred EEEEEecCCCChHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEEC
Q 019843 115 ALVLEYMPHGSLEKCLYSSN-----------------CVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLD 177 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~ 177 (335)
++||||+++|+|.+++.... ..+++..+..++.||+.||.||| +++++|+||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence 99999999999999987532 25899999999999999999999 99999999999999999
Q ss_pred CCCcEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCcccccchhhH
Q 019843 178 DNMVAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-KKKPTDKIFAGEMTLK 256 (335)
Q Consensus 178 ~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~-g~~pf~~~~~~~~~~~ 256 (335)
.++.++++|||.+................+|+.|+|||++.+..++.++||||||+++|+|++ |.+||......+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~---- 255 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH----
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH----
Confidence 999999999999987754444445556788999999999999999999999999999999999 555554432211
Q ss_pred hHhhhhcChhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 257 YWVSNLLPISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
....++...... ..+..+++.+.+||.+||+.||++|||++||++.|++...+
T Consensus 256 ---------~~~~~i~~~~~~------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 256 ---------KFYKMIKEGFRM------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp ---------HHHHHHHHTCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------HHHHHHhcCCCC------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 122233332221 22334567799999999999999999999999999876554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-49 Score=346.79 Aligned_cols=267 Identities=20% Similarity=0.269 Sum_probs=203.6
Q ss_pred CCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEe
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEY 120 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 120 (335)
++|.+.+.||+|+||+||+|.+++|+.||||++.... ....+.+.+|+.++++++||||+++++.+.+.+..++++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999998889999999997543 33457899999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCcccc
Q 019843 121 MPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSK 200 (335)
Q Consensus 121 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~ 200 (335)
+.++.+..+. ...+.+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+|++|||.+...... ..
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR 155 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC--cc
Confidence 9776555544 44458999999999999999999999 999999999999999999999999999999876322 22
Q ss_pred ccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh------
Q 019843 201 SQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA------ 273 (335)
Q Consensus 201 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 273 (335)
......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||......+.....+. .........+.+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR-ILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCCCCTTTSTTGGGSTTC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHH-hhCCCChhhccchhhhhhc
Confidence 33445688999999998764 568999999999999999999999976543222111111 0000000000000
Q ss_pred ---hhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 274 ---NLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 274 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
...............+++.+.+|+.+||..||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000111111122345678999999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=347.57 Aligned_cols=242 Identities=24% Similarity=0.278 Sum_probs=199.4
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCC------chhHHHHHHHHHHHhCC--CCceEEEeeeeecC
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG------GVFKSFDVECEVMKSIR--HRNLIKIISTCSND 111 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 111 (335)
..++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.++++++ ||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4679999999999999999999865 689999999874321 12244678999999986 89999999999999
Q ss_pred CeeEEEEEecCC-CChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC-CCcEEEeeccc
Q 019843 112 DFKALVLEYMPH-GSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGI 189 (335)
Q Consensus 112 ~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~-~~~v~l~dfg~ 189 (335)
+..++|||++.+ +++.+++.... .+++..++.++.||+.||.||| +.+++|+||||+||+++. ++.+||+|||+
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CeEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccc
Confidence 999999999976 57777776543 7999999999999999999999 999999999999999985 57999999999
Q ss_pred cccccCCccccccccccccccccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
+.... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 158 a~~~~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------------ 215 (273)
T d1xwsa_ 158 GALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------------ 215 (273)
T ss_dssp CEECC----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------------
T ss_pred ceecc----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------------
Confidence 98653 223345679999999999887665 5678999999999999999999975311
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
+.... ...+..+++++.+||.+||+.||++|||++|+++.
T Consensus 216 -i~~~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 216 -IIRGQ--------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -HHHCC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -Hhhcc--------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11100 01123456779999999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=349.98 Aligned_cols=259 Identities=21% Similarity=0.380 Sum_probs=214.3
Q ss_pred cCCCCccceeeecCceEEEEEEEc------CCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCee
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ------DGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFK 114 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 114 (335)
.++|.+.+.||+|+||+||+|.+. ++..||||+++... ......+.+|++++++++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 478999999999999999999753 25789999997543 33445689999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEe
Q 019843 115 ALVLEYMPHGSLEKCLYSS---------NCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 185 (335)
Q Consensus 115 ~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~ 185 (335)
++||||+++|+|.+++... ...+++..+..++.++++||.||| +++++||||||+|||++.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence 9999999999999988632 135789999999999999999999 9999999999999999999999999
Q ss_pred eccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCC-CCCCcccccchhhHhHhhhhcC
Q 019843 186 DFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKK-KPTDKIFAGEMTLKYWVSNLLP 264 (335)
Q Consensus 186 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~ 264 (335)
|||++..+.............+++.|+|||.+.+..++.++||||||+++|||++|. +||......+..
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~---------- 245 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---------- 245 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH----------
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH----------
Confidence 999998775444444455567899999999999999999999999999999999985 666553221110
Q ss_pred hhHHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHh
Q 019843 265 ISVMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRD 323 (335)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 323 (335)
..+.+ ......+..+++.+.+++.+||+.||.+|||+++|++.|++..+
T Consensus 246 ---~~i~~-------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 ---RFVME-------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---HHHHT-------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---HHHHh-------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 11222345567789999999999999999999999999987644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=346.08 Aligned_cols=269 Identities=22% Similarity=0.289 Sum_probs=202.9
Q ss_pred cCCCCccceeeecCceEEEEEEEc-C-CcEEEEEEeecCC--CchhHHHHHHHHHHHhC---CCCceEEEeeeeec----
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-D-GMEVAVKVFHLQC--GGVFKSFDVECEVMKSI---RHRNLIKIISTCSN---- 110 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~-~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~---- 110 (335)
.++|++++.||+|+||+||+|.+. + ++.||||++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 479999999999999999999863 4 5679999986542 22334566777777665 79999999999853
Q ss_pred -CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 111 -DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 111 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
....++++|+++++.+..........+++..++.++.|++.||.||| +++|+|+||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 45788999999887776666666667999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME 269 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 269 (335)
+.... .........||+.|+|||++.+..++.++||||+||++|+|++|+.||......+. +..............
T Consensus 163 ~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 163 ARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEED 238 (305)
T ss_dssp CCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGGG
T ss_pred hhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCchhc
Confidence 87652 23344567799999999999999999999999999999999999999976543221 111111110000000
Q ss_pred HH------Hhhhc-cccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 270 IV------DANLL-SREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 270 ~~------~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
+. ..... ............+++.+.+|+.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00000 00011111123456779999999999999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=346.66 Aligned_cols=262 Identities=23% Similarity=0.263 Sum_probs=196.3
Q ss_pred cceeeecCceEEEEEEEc-CCcEEEEEEeecCCC-----chhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEEec
Q 019843 48 NNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCG-----GVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLEYM 121 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 121 (335)
.++||+|+||+||+|.+. +|+.||||++..... .....+.+|++++++++||||+++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999864 589999999864421 22457889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccccc
Q 019843 122 PHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSKS 201 (335)
Q Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~~~ 201 (335)
.++++..+.. ....+++..+..++.||+.||.||| +++++|+||||+||+++.++.+||+|||++...... ...
T Consensus 83 ~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRA 156 (299)
T ss_dssp SEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCC
T ss_pred cchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCC--ccc
Confidence 8877666544 4457999999999999999999999 999999999999999999999999999999865322 223
Q ss_pred cccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHh------h
Q 019843 202 QTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDA------N 274 (335)
Q Consensus 202 ~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 274 (335)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||......+... .............+.+. .
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~-~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT-RIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH-HHHHhcCCCChhhccchhccchhh
Confidence 334578999999998865 457999999999999999999999997654322211 11111000000000000 0
Q ss_pred hcccc-ccc-hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 275 LLSRE-DKH-FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 275 ~~~~~-~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
..... ... ......+++++.+|+.+||..||++|||++|+|+
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000 000 0011234677999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.2e-47 Score=329.54 Aligned_cols=269 Identities=16% Similarity=0.164 Sum_probs=216.2
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 118 (335)
.+++|++++.||+|+||+||+|.+. +|+.||+|++..... ...+.+|++.++.+. |+|++.+++++......++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 4689999999999999999999865 589999999865432 255788999999996 489999999999999999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC-----CCcEEEeeccccccc
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLL 193 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~-----~~~v~l~dfg~~~~~ 193 (335)
|++ +++|.+++......++...+..++.|++.||.||| +.+++|+||||+||+++. ++.++|+|||++..+
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999 78999999877778999999999999999999999 999999999999999964 578999999999876
Q ss_pred cCCccc-----cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHH
Q 019843 194 TGEDQS-----KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVM 268 (335)
Q Consensus 194 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||............ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~----------~ 226 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY----------E 226 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH----------H
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH----------H
Confidence 432111 2233457999999999999999999999999999999999999999765433221110 0
Q ss_pred HHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhhhccc
Q 019843 269 EIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDSLLIC 328 (335)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 328 (335)
.+..... ..........+|+++.+++..|++.+|++||+++.+.+.|+++..+....
T Consensus 227 ~i~~~~~---~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 227 RIGEKKQ---STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HHHHHHH---HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHhccC---CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 0111100 00111112346778999999999999999999999999999887666544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-47 Score=333.02 Aligned_cols=265 Identities=20% Similarity=0.241 Sum_probs=207.2
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCc-eEEEeeeeecCCeeEEEE
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN-LIKIISTCSNDDFKALVL 118 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 118 (335)
.+++|++++.||+|+||.||+|.+. +|+.||||++..... ...+..|+++++.++|++ |+.+.+++.+.+..++||
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 4578999999999999999999764 589999999876533 256788999999997655 566677778889999999
Q ss_pred EecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECC---CCcEEEeeccccccccC
Q 019843 119 EYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTG 195 (335)
Q Consensus 119 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~---~~~v~l~dfg~~~~~~~ 195 (335)
|++ ++++.+.+......+++..+..++.|++.||+||| +++++|+||||+||+++. +..++++|||++..+..
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999 66777777766668999999999999999999999 999999999999999864 45799999999987743
Q ss_pred Cccc-----cccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHH
Q 019843 196 EDQS-----KSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEI 270 (335)
Q Consensus 196 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (335)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............ ...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~----------~~~ 228 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY----------ERI 228 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H----------HHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH----------HHh
Confidence 2211 2234557999999999999999999999999999999999999999765433222110 000
Q ss_pred HHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHHHHHHHhh
Q 019843 271 VDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTRLLKIRDS 324 (335)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 324 (335)
..... ..........+|+++.+++.+||+.||++||+++++.+.|+.+..+
T Consensus 229 ~~~~~---~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 229 SEKKM---STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHH---HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hcccC---CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 00000 0011111235678899999999999999999999999998877543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=340.76 Aligned_cols=275 Identities=20% Similarity=0.211 Sum_probs=203.6
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEE-cCCcEEEEEEeecCC-CchhHHHHHHHHHHHhCCCCceEEEeeeeecCC---
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARI-QDGMEVAVKVFHLQC-GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD--- 112 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 112 (335)
++..+++|++++.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 456778999999999999999999975 479999999997543 334567889999999999999999999987543
Q ss_pred -eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 113 -FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 113 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
..+++++++.+++|.+++... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 233445566699999999765 4999999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCccc-cccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChh---
Q 019843 192 LLTGEDQS-KSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPIS--- 266 (335)
Q Consensus 192 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 266 (335)
........ .......+++.|+|||++.. ..++.++||||+||++|+|++|..||..................+..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 76432221 22345678999999999854 56788999999999999999999999765432221111110000100
Q ss_pred -------HHHHHHhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 267 -------VMEIVDANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 267 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
......................+++++.+|+.+||..||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111000000001011122446679999999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=339.71 Aligned_cols=265 Identities=25% Similarity=0.278 Sum_probs=200.0
Q ss_pred hcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeecCC-----
Q 019843 41 ATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSNDD----- 112 (335)
Q Consensus 41 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 112 (335)
..++|++++.||+|+||+||+|.+. +|+.||||++... +....+.+.+|+++++.++||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 5689999999999999999999865 5999999999754 2334567889999999999999999999987654
Q ss_pred -eeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 113 -FKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 113 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
.+++||||+ +.+|..++... .+++..++.++.||+.||.||| +.+++|+||||+||+++.++.++++|||++.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence 579999999 67888877654 5999999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc-------
Q 019843 192 LLTGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL------- 263 (335)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~------- 263 (335)
... .......+|+.|+|||++.+ ..++.++||||+||++|+|++|..||........ +........
T Consensus 170 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 170 QAD-----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFV 243 (346)
T ss_dssp ECC-----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHH
T ss_pred ccC-----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhccCCCcHHHH
Confidence 653 22345678999999998876 4568999999999999999999999976532221 111111111
Q ss_pred ---ChhHHHHHHhhhccccccc-hhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 264 ---PISVMEIVDANLLSREDKH-FAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 264 ---~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
................... ......+++++.+||.+||..||++|||++|+|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0011111111111111111 11123456779999999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=328.32 Aligned_cols=268 Identities=22% Similarity=0.258 Sum_probs=207.4
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecCCeeEEEEE
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSNDDFKALVLE 119 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 119 (335)
++|++++.||+|+||+||+|++. +++.||||+++... ......+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999864 68899999997543 3456789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccccCCccc
Q 019843 120 YMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 199 (335)
Q Consensus 120 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~~~~~~~ 199 (335)
++.++++..++... +.+++..+..++.|++.||+||| +++|+|+||||+||+++.++.+||+|||.+...... .
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--V 155 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--C
T ss_pred eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCC--C
Confidence 99888888776644 47899999999999999999999 999999999999999999999999999999876422 2
Q ss_pred cccccccccccccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHH------HHH
Q 019843 200 KSQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVME------IVD 272 (335)
Q Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 272 (335)
.......++..|+|||++.+.. ++.++||||+||++|+|++|..||..................+..... ..+
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 2333445778899999887665 689999999999999999999997543332222221111111100000 000
Q ss_pred hh---hccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 273 AN---LLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 273 ~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
.. ..............+++.+.+|+.+||+.||++|||++|+|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000111111222345677999999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-46 Score=331.23 Aligned_cols=262 Identities=20% Similarity=0.276 Sum_probs=201.7
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeeec--CCeeEEE
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSN--DDFKALV 117 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv 117 (335)
.++|++++.||+|+||+||+|+.. +|+.||+|+++.. ....+.+|+++++.+. ||||+++++++.. ....++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 368999999999999999999864 6899999998743 3467889999999995 9999999999874 4578999
Q ss_pred EEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-cEEEeeccccccccCC
Q 019843 118 LEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTGE 196 (335)
Q Consensus 118 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~-~v~l~dfg~~~~~~~~ 196 (335)
|||+++++|..+. ..+++..+..++.||+.||.||| +++|+|+||||+|||++.++ .++|+|||++..+..
T Consensus 111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccC-
Confidence 9999999997753 35999999999999999999999 99999999999999998655 689999999987632
Q ss_pred ccccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHHhhh
Q 019843 197 DQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVDANL 275 (335)
Q Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
........+|..|+|||.+.+. .++.++||||+||++|+|++|..||..............................
T Consensus 183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2234456789999999997765 4799999999999999999999999765433222211111111111111111110
Q ss_pred ccc-----------------cccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 276 LSR-----------------EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 276 ~~~-----------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
... ..........+++++.+||.+||..||++|||++|+|+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00111122346778999999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=331.35 Aligned_cols=272 Identities=21% Similarity=0.312 Sum_probs=198.6
Q ss_pred cCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecC--CCchhHHHHHHHHHHHhCCCCceEEEeeeeec--------
Q 019843 42 TDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQ--CGGVFKSFDVECEVMKSIRHRNLIKIISTCSN-------- 110 (335)
Q Consensus 42 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------- 110 (335)
-++|++++.||+|+||+||+|.+. +|+.||||++..+ .......+.+|+++++.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 389999999999999999999864 6999999998644 33455778899999999999999999998754
Q ss_pred CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 019843 111 DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 190 (335)
Q Consensus 111 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~ 190 (335)
.+..++|||++.++.+.. .......+++..++.++.||+.||.||| +.+++||||||+||+++.++.+|++|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 456889999997665554 4445557999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCcc--ccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhH--hHhhhhcCh
Q 019843 191 KLLTGEDQ--SKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLK--YWVSNLLPI 265 (335)
Q Consensus 191 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~--~~~~~~~~~ 265 (335)
..+..... ........+|+.|+|||++.+. .++.++||||+||++|+|++|+.||........... .......+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 76642221 1223345689999999998765 689999999999999999999999976432221110 000000000
Q ss_pred --------hHHHHHHhhhcc-ccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 266 --------SVMEIVDANLLS-REDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 266 --------~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.....+...... ............++.+.+||.+||..||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000000 0000001112235668899999999999999999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=333.13 Aligned_cols=263 Identities=23% Similarity=0.301 Sum_probs=196.3
Q ss_pred CCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCceEEEeeeeec------CCeeEE
Q 019843 44 GFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRNLIKIISTCSN------DDFKAL 116 (335)
Q Consensus 44 ~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~l 116 (335)
+|+.+++||+|+||+||+|++. +|+.||||++..+.. ...+|++++++++||||+++++++.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 7999999999999999999875 689999999975532 23469999999999999999999853 346789
Q ss_pred EEEecCCCChHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCC-cEEEeeccccccc
Q 019843 117 VLEYMPHGSLEKCLY--SSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLL 193 (335)
Q Consensus 117 v~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~-~v~l~dfg~~~~~ 193 (335)
||||++++.+..+.. .....+++..+..++.||+.||.||| +++|+||||||+|||++.++ .+||+|||++..+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999997654443332 23457999999999999999999999 99999999999999999775 8999999999876
Q ss_pred cCCccccccccccccccccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHHH
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIVD 272 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (335)
.. ........++..|+|||.+.+ ..++.++||||+||++|+|++|..||......+. +..............+..
T Consensus 174 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHH
T ss_pred cC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhh
Confidence 32 223344678999999998765 5689999999999999999999999976543222 111111111111111111
Q ss_pred hh--h----ccccc-c--chhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 273 AN--L----LSRED-K--HFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 273 ~~--~----~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
.. . ..... . .......+++++.+|+.+||..||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10 0 00000 0 001112356779999999999999999999999863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=334.55 Aligned_cols=268 Identities=23% Similarity=0.204 Sum_probs=197.0
Q ss_pred hhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeec-----
Q 019843 39 FQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSN----- 110 (335)
Q Consensus 39 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 110 (335)
+.+.++|++++.||+|+||+||+|.+. +|+.||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 13 f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 345689999999999999999999865 59999999997543 3345678899999999999999999999853
Q ss_pred -CCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 111 -DDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 111 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
...+|+||||+.++.+. .+. ..+++..++.++.||+.||.||| +.|++|+||||+||+++.++.++++|||+
T Consensus 93 ~~~~~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 93 EFQDVYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp TCCEEEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred cCceeEEEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhh
Confidence 47889999999765444 343 25899999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc------
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL------ 263 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~------ 263 (335)
+.... .........+|..|+|||++.+..++.++||||+||++++|++|+.||........... ......
T Consensus 166 ~~~~~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~-i~~~~~~~~~~~ 241 (355)
T d2b1pa1 166 ARTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK-VIEQLGTPCPEF 241 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCHHH
T ss_pred hhccc---cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHH-HHHhccCCCHHH
Confidence 87653 23344556789999999999999999999999999999999999999975432221111 110000
Q ss_pred ----ChhHHHHHHhhh------------ccccccchhhHHHHHHHHHHHHHHhchhccccCCCHHHHHHH
Q 019843 264 ----PISVMEIVDANL------------LSREDKHFAAKEQCVSFVFNLAMECTVESAEQRINAKEIVTR 317 (335)
Q Consensus 264 ----~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 317 (335)
............ ..............++++.+|+.+||..||++|||++|+|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 011111111110 001111222344568889999999999999999999999854
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=334.44 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=204.0
Q ss_pred CCCCccceeeecCceEEEEEEEc----CCcEEEEEEeecC----CCchhHHHHHHHHHHHhCCC-CceEEEeeeeecCCe
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ----DGMEVAVKVFHLQ----CGGVFKSFDVECEVMKSIRH-RNLIKIISTCSNDDF 113 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 113 (335)
++|++++.||+|+||+||+|... +|+.||||+++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999752 4789999998533 22345678899999999965 899999999999999
Q ss_pred eEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccccccc
Q 019843 114 KALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 193 (335)
Q Consensus 114 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~~ 193 (335)
.++++||+.+++|.+++.... .+++..+..++.||+.||.||| +.+++|+||+|+||+++.+|.++|+|||++..+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999987665 6789999999999999999999 999999999999999999999999999999876
Q ss_pred cCCccccccccccccccccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhcChhHHHHH
Q 019843 194 TGEDQSKSQTQTLATIGYMAPEYGREG--RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLLPISVMEIV 271 (335)
Q Consensus 194 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (335)
... .........+++.|+|||.+.+. .++.++|||||||++|+|++|..||........... +.
T Consensus 180 ~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~-------------i~ 245 (322)
T d1vzoa_ 180 VAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE-------------IS 245 (322)
T ss_dssp CGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-------------HH
T ss_pred ccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HH
Confidence 322 23334456789999999998764 468899999999999999999999976543322111 11
Q ss_pred HhhhccccccchhhHHHHHHHHHHHHHHhchhccccCCC-----HHHHHH
Q 019843 272 DANLLSREDKHFAAKEQCVSFVFNLAMECTVESAEQRIN-----AKEIVT 316 (335)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-----~~ell~ 316 (335)
.... ......+..+++++.+|+.+||..||++||| ++|+++
T Consensus 246 ~~~~----~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 246 RRIL----KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHH----HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred Hhcc----cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1110 0111123456778999999999999999994 888876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=332.23 Aligned_cols=268 Identities=21% Similarity=0.250 Sum_probs=201.3
Q ss_pred HhhhcCCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCC--CchhHHHHHHHHHHHhCCCCceEEEeeeeecC---
Q 019843 38 LFQATDGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQC--GGVFKSFDVECEVMKSIRHRNLIKIISTCSND--- 111 (335)
Q Consensus 38 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 111 (335)
++.+.++|++.+.||+|+||+||+|.+. +|+.||||++.... ......+.+|+++++.++||||+++++++...
T Consensus 13 ~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 13 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred cccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence 3456789999999999999999999764 69999999997543 23456788999999999999999999998532
Q ss_pred --CeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 019843 112 --DFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 189 (335)
Q Consensus 112 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~ 189 (335)
...+++++++.+++|.+++..+ .+++..+..++.||+.||.||| +++++||||||+||+++.+|.++++|||+
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred ccCceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccch
Confidence 3345667778899999998654 5999999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCccccccccccccccccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCcccccchhhHhHhhhhc-----
Q 019843 190 AKLLTGEDQSKSQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEMTLKYWVSNLL----- 263 (335)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~----- 263 (335)
+... ........++..|+|||...+. .++.++|||||||++|+|++|..||..................
T Consensus 168 a~~~-----~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 168 ARHT-----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp --CC-----TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hccc-----CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 8754 3334456789999999987665 4688999999999999999999999765432221111110000
Q ss_pred -----ChhHHHHHHhhhccccccch-hhHHHHHHHHHHHHHHhchhccccCCCHHHHHH
Q 019843 264 -----PISVMEIVDANLLSREDKHF-AAKEQCVSFVFNLAMECTVESAEQRINAKEIVT 316 (335)
Q Consensus 264 -----~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 316 (335)
......... .........+ .....+++++.+||.+||..||++|||++|+|+
T Consensus 243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 243 LKKISSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HTTCCCHHHHHHHT-TSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhhhhhh-hcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000111111 1111111111 111245777999999999999999999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-41 Score=302.03 Aligned_cols=265 Identities=16% Similarity=0.204 Sum_probs=190.0
Q ss_pred CCCCccceeeecCceEEEEEEEc-CCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-----------CCceEEEeeeeec
Q 019843 43 DGFSENNLIGRGSFGSVYKARIQ-DGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-----------HRNLIKIISTCSN 110 (335)
Q Consensus 43 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~ 110 (335)
++|++++.||+|+||+||+|+.. +|+.||||+++.+. ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999864 68999999997542 23467788998888775 5789999988754
Q ss_pred --CCeeEEEEEecCCCCh-HH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCC-CCeEecCCCCCCEEECCCC-----
Q 019843 111 --DDFKALVLEYMPHGSL-EK-CLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYS-APVIHCDLKPSNVLLDDNM----- 180 (335)
Q Consensus 111 --~~~~~lv~e~~~~~~L-~~-~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~~i~h~di~p~Nilv~~~~----- 180 (335)
....++++.++..+.. .. ........+++..+..++.||+.||.||| + .+|+|+||||+||+++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCccccc
Confidence 4566667766544432 22 22334557899999999999999999999 6 8999999999999998665
Q ss_pred -cEEEeeccccccccCCccccccccccccccccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCcccccch-----h
Q 019843 181 -VAHLSDFGIAKLLTGEDQSKSQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTKKKPTDKIFAGEM-----T 254 (335)
Q Consensus 181 -~v~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~~l~~ll~g~~pf~~~~~~~~-----~ 254 (335)
.++++|||.+... ........+|+.|+|||++.+..++.++|+||+||++++|++|..||........ .
T Consensus 169 ~~~kl~dfg~s~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWY-----DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEET-----TBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccc-----ccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 4999999998754 2334556799999999999999999999999999999999999999975432111 1
Q ss_pred hHhHhhhhcChhHHHHHHh---------h-hccc------------cccchhhHHHHHHHHHHHHHHhchhccccCCCHH
Q 019843 255 LKYWVSNLLPISVMEIVDA---------N-LLSR------------EDKHFAAKEQCVSFVFNLAMECTVESAEQRINAK 312 (335)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~---------~-~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 312 (335)
................... . .... ...........++.+.+|+.+||..||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111111111000000000 0 0000 0011122345678899999999999999999999
Q ss_pred HHHH
Q 019843 313 EIVT 316 (335)
Q Consensus 313 ell~ 316 (335)
|+|+
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=2.5e-24 Score=174.72 Aligned_cols=169 Identities=16% Similarity=0.161 Sum_probs=120.2
Q ss_pred CCccceeeecCceEEEEEEEcCCcEEEEEEeecCCC------------------chhHHHHHHHHHHHhCCCCceEEEee
Q 019843 45 FSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCG------------------GVFKSFDVECEVMKSIRHRNLIKIIS 106 (335)
Q Consensus 45 y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 106 (335)
+.+.+.||+|+||+||+|...+|+.||||+++.... ........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 457899999999999999988899999998753211 01233456888999999999988876
Q ss_pred eeecCCeeEEEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEecCCCCCCEEECCCCcEEEee
Q 019843 107 TCSNDDFKALVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 186 (335)
Q Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~~i~h~di~p~Nilv~~~~~v~l~d 186 (335)
... .+++||++++..+.+ ++......++.+++.++.+|| +.+++|+||||+||+++++ .++|+|
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEE
Confidence 533 369999998765543 344446779999999999999 9999999999999999965 589999
Q ss_pred ccccccccCCcccccccccc-ccccccCccccCCCCCCCccchhhHHHHH
Q 019843 187 FGIAKLLTGEDQSKSQTQTL-ATIGYMAPEYGREGRVSTNGDVYSFGIML 235 (335)
Q Consensus 187 fg~~~~~~~~~~~~~~~~~~-~~~~y~aPE~~~~~~~~~~sDiwslG~~l 235 (335)
||.+.....+.........+ ... +.+ ...++.++|+||+.--+
T Consensus 146 FG~a~~~~~~~~~~~l~rd~~~~~-----~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWREILERDVRNII-----TYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHHHHHHHHHHHH-----HHH-HHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHHHHHHHHH-----HHH-cCCCCCcccHHHHHHHH
Confidence 99987542111000000000 000 111 24578899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.96 E-value=2.4e-09 Score=89.39 Aligned_cols=149 Identities=17% Similarity=0.120 Sum_probs=107.6
Q ss_pred HHhhhcCCCCccceeeecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeE
Q 019843 37 ELFQATDGFSENNLIGRGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKA 115 (335)
Q Consensus 37 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 115 (335)
+.....+.|++++..+.++.+.||+.... ++.+++|............+..|...++.+. +-.+.+++.+..+.+..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 55566678888888777777899998754 6778889876554444566788888888774 444677788888889999
Q ss_pred EEEEecCCCChHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcc------------------------------------
Q 019843 116 LVLEYMPHGSLEKCLYSSNCVLDIFQRLNIMIDVAAALEYLHFG------------------------------------ 159 (335)
Q Consensus 116 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~------------------------------------ 159 (335)
+||++++|.++.+..... .. ...++.+++..+..||..
T Consensus 87 lv~~~l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEeccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999998886644211 11 223455666667777720
Q ss_pred --------------------CCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 160 --------------------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 160 --------------------~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
....++|||+.|.||++++++.+-++||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012379999999999999876677999988763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.39 E-value=1.4e-06 Score=71.70 Aligned_cols=130 Identities=17% Similarity=0.136 Sum_probs=88.0
Q ss_pred eeeecC-ceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCC--CCceEEEeeeeecCCeeEEEEEecCCCCh
Q 019843 50 LIGRGS-FGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIR--HRNLIKIISTCSNDDFKALVLEYMPHGSL 126 (335)
Q Consensus 50 ~lg~g~-~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 126 (335)
.+..|. .+.||+....++..+++|...... ...+..|...++.+. .-.+++++.+..+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 334444 478999988878889999865443 245677788887763 33466778888888889999999988766
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc------------------------------------------------
Q 019843 127 EKCLYSSNCVLDIFQRLNIMIDVAAALEYLHF------------------------------------------------ 158 (335)
Q Consensus 127 ~~~l~~~~~~~~~~~~~~i~~~l~~~l~~Lh~------------------------------------------------ 158 (335)
.+. ..... ..+.++...+..||.
T Consensus 94 ~~~------~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSS------HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTS------CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred ccc------cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 431 11111 123344455555551
Q ss_pred -------cCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 019843 159 -------GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 191 (335)
Q Consensus 159 -------~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~ 191 (335)
.....++|||+.|.||+++.++.+-++||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 001237999999999999987667899998775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.98 E-value=1.7e-05 Score=69.43 Aligned_cols=77 Identities=14% Similarity=0.195 Sum_probs=49.8
Q ss_pred cceeeecCceEEEEEEEcC-CcEEEEEEeecC------C-CchhHHHHHHHHHHHhCC-C--CceEEEeeeeecCCeeEE
Q 019843 48 NNLIGRGSFGSVYKARIQD-GMEVAVKVFHLQ------C-GGVFKSFDVECEVMKSIR-H--RNLIKIISTCSNDDFKAL 116 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~------~-~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~l 116 (335)
.+.||.|....||++...+ ++.+++|.-... . .....+...|++.++.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4678999999999997654 678999975421 1 123355667888888762 2 345556554 3445578
Q ss_pred EEEecCCCCh
Q 019843 117 VLEYMPHGSL 126 (335)
Q Consensus 117 v~e~~~~~~L 126 (335)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.55 E-value=0.0001 Score=62.23 Aligned_cols=158 Identities=15% Similarity=0.037 Sum_probs=86.4
Q ss_pred ccCHHHHhhhcCCCCccceee-----ecCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCC-----Cce
Q 019843 32 RFSYLELFQATDGFSENNLIG-----RGSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRH-----RNL 101 (335)
Q Consensus 32 ~~~~~~~~~~~~~y~~~~~lg-----~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-----~~i 101 (335)
.++..++....++|.+++... .|---+.|..+..+| .+++|++.... ....+..|++++..+.. |..
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 457788888999998865554 455578899987754 58999986432 22455556666666632 222
Q ss_pred EEEe-e--eeecCCeeEEEEEecCCCChHHH-----------H---h---cC-----CC------------------CCC
Q 019843 102 IKII-S--TCSNDDFKALVLEYMPHGSLEKC-----------L---Y---SS-----NC------------------VLD 138 (335)
Q Consensus 102 ~~~~-~--~~~~~~~~~lv~e~~~~~~L~~~-----------l---~---~~-----~~------------------~~~ 138 (335)
+... | +.........++.+..+...... + . .. .. ...
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 1111 0 11224455667776655332110 0 0 00 00 000
Q ss_pred HHHHHHHHHHHHHHHHHHh-ccCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 139 IFQRLNIMIDVAAALEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 139 ~~~~~~i~~~l~~~l~~Lh-~~~~~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
.......+..+...+...+ .....+++|||+.++||+++.+...-++||+.+..
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1111112222222233322 12357899999999999999887778999998763
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.46 E-value=0.00025 Score=60.17 Aligned_cols=136 Identities=15% Similarity=0.135 Sum_probs=79.1
Q ss_pred cCceEEEEEEEcCCcEEEEEEeecCCCchhHHHHHHHHHHHhCCCCc--eEEEe-----eeeecCCeeEEEEEecCCCCh
Q 019843 54 GSFGSVYKARIQDGMEVAVKVFHLQCGGVFKSFDVECEVMKSIRHRN--LIKII-----STCSNDDFKALVLEYMPHGSL 126 (335)
Q Consensus 54 g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~-----~~~~~~~~~~lv~e~~~~~~L 126 (335)
+.--.||++...+|+.+|+|+...... ....+..|...+..|...+ ++..+ ..+...+..+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 334689999988899999999775432 3466788888888774221 11111 123446678889999876433
Q ss_pred H-----HH------Hh-------cC----CCCCCH----------------------HHHHHHHHHHHHHHHHHh-ccCC
Q 019843 127 E-----KC------LY-------SS----NCVLDI----------------------FQRLNIMIDVAAALEYLH-FGYS 161 (335)
Q Consensus 127 ~-----~~------l~-------~~----~~~~~~----------------------~~~~~i~~~l~~~l~~Lh-~~~~ 161 (335)
. .+ +. .. ....+. ......+..+...+...- ....
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 1 11 10 00 001111 112223333333333322 1224
Q ss_pred CCeEecCCCCCCEEECCCCcEEEeecccccc
Q 019843 162 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 192 (335)
Q Consensus 162 ~~i~h~di~p~Nilv~~~~~v~l~dfg~~~~ 192 (335)
.+++|||+++.||+++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 578999999999999743 45899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.38 E-value=0.00032 Score=61.15 Aligned_cols=73 Identities=16% Similarity=0.210 Sum_probs=50.2
Q ss_pred cceeeecCceEEEEEEEcC--------CcEEEEEEeecCCCchhHHHHHHHHHHHhCC-CCceEEEeeeeecCCeeEEEE
Q 019843 48 NNLIGRGSFGSVYKARIQD--------GMEVAVKVFHLQCGGVFKSFDVECEVMKSIR-HRNLIKIISTCSNDDFKALVL 118 (335)
Q Consensus 48 ~~~lg~g~~~~v~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 118 (335)
++.|+.|-.-.+|++...+ .+.|++++.. .... .....+|..+++.+. +.-.+++++++.+ ++|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4678888889999997653 3568888865 3333 345668899998884 3334567777653 5889
Q ss_pred EecCCCCh
Q 019843 119 EYMPHGSL 126 (335)
Q Consensus 119 e~~~~~~L 126 (335)
+|++|.++
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|